Drug_Name	PubChem_CID	Broad_ID	SMILES	MoA	Target_Gene
[sar9,met(o2)11]-substance-p	163829	BRD-K89787693	CC(C)C[C@H](NC(=O)CN(C)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CCS(C)(=O)=O)C(N)=O	tachykinin antagonist	TACR1
A-1070722	49830684	BRD-K70329400	COc1ccc2c(NC(=O)Nc3cccc(n3)C(F)(F)F)ccnc2c1	glycogen synthase kinase inhibitor	GSK3A|GSK3B
A-1120	25138295	BRD-K59060513	OC(=O)c1ccccc1NC(=O)N1CCC(CC1)c1ccccc1C(F)(F)F	retinoid receptor ligand	RBP4
A-317491	9829395	BRD-K38019854	OC(=O)c1cc(C(O)=O)c(cc1C(O)=O)C(=O)N(Cc1cccc(Oc2ccccc2)c1)[C@H]1CCCc2ccccc12	purinergic receptor antagonist	P2RX3
A-33903	2729103	BRD-A40302156	CC(=O)NC1C(=O)Nc2ccccc2C(=N1)c1ccccc1		
A-366	76285486	BRD-K06182768	COc1cc2c(cc1OCCCN1CCCC1)N=C(N)C21CCC1	histone lysine methyltransferase inhibitor	EHMT1|EHMT2
A-412997	10425450	BRD-K62066682	Cc1cccc(NC(=O)CN2CCC(CC2)c2ccccn2)c1	dopamine receptor agonist	DRD4
A-438079	11673921	BRD-K13223831	Clc1cccc(-c2nnnn2Cc2cccnc2)c1Cl	purinergic receptor antagonist	P2RX7
A-582941	44190553	BRD-K79743788	CN1C[C@H]2CN(C[C@H]2C1)c1ccc(nn1)-c1ccccc1	nicotinic receptor agonist	CHRNA7
A-61603		BRD-K13142315	CS(=O)(=O)Nc1c(O)ccc2C(CCCc12)=C1NCCN1	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D
A-674563	11314340	BRD-K78177893	Cc1n[nH]c2ccc(cc12)-c1cncc(OC[C@@H](N)Cc2ccccc2)c1	AKT inhibitor	AKT1|PKIA|PRKACA
A-7	2735313	BRD-K03301001	NCCCCCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12	calmodulin antagonist	
A-769662	54708532	BRD-K41918892	Oc1ccccc1-c1ccc(cc1)-c1csc2[nH]c(=O)c(C#N)c(O)c12	AMPK activator	
A-784168	11420211	BRD-K87665527	FC(F)(F)c1cccnc1N1CCC(=CC1)C(=O)Nc1ccc(cc1)S(=O)(=O)C(F)(F)F	transient receptor potential channel antagonist	TRPV1
A-803467	16038374	BRD-K28570407	COc1cc(NC(=O)c2ccc(o2)-c2ccc(Cl)cc2)cc(OC)c1	sodium channel blocker	SCN10A
A-804598	53325874	BRD-K76894955	C[C@H](\N=C(\NC#N)Nc1cccc2ncccc12)c1ccccc1	purinergic receptor antagonist	P2RX7
A-839977	53325875	BRD-K60427831	Clc1cccc(c1Cl)-n1nnnc1NCc1ccccc1Oc1ccccn1	purinergic receptor antagonist	P2RX7
A-867744	23642319	BRD-K33059059	CCC(=O)c1cc(-c2ccc(Cl)cc2)n(c1C)-c1ccc(cc1)S(N)(=O)=O	acetylcholine receptor allosteric modulator	CHRNA3|CHRNA4|CHRNA7
A-887826	46919335	BRD-K20239555	CCCCOc1ccc(cc1Cl)-c1cncc(c1)C(=O)NCc1cccnc1N1CCOCC1	sodium channel blocker	SCN10A
A-922500	24768261	BRD-K81614372	OC(=O)[C@@H]1CCC[C@H]1C(=O)c1ccc(cc1)-c1ccc(NC(=O)Nc2ccccc2)cc1	diacylglycerol O acyltransferase inhibitor	DGAT1
A-939572	24905400	BRD-K99308908	CNC(=O)c1cccc(NC(=O)N2CCC(CC2)Oc2ccccc2Cl)c1	stearoyl-CoA desaturase inhibitor	SCD
A-967079	42641861	BRD-K70744942	CCC(=N/O)\C(C)=C\c1ccc(F)cc1	transient receptor potential channel antagonist	TRPA1
A-987306	25109291	BRD-K68982262	Nc1nc(N2CCNCC2)c2CCC3=C([C@@H]4CCCC[C@@H]4O3)c2n1	histamine receptor antagonist	ADORA1|AVPR1A|CCR1|CHRM1|CHRM2|CHRM3|CHRM4|DRD3|HTR1A|HTR1B|HTR2A|HTR2B|HTR3A|TACR2
AA-29504	23188887	BRD-K13944729	CCOC(=O)Nc1ccc(NCc2c(C)cc(C)cc2C)cc1N	GABA receptor positive allosteric modulator	GABRA1|GABRA4|GABRB3
abacavir	441300	BRD-K17443395	Nc1nc(NC2CC2)c2ncn([C@@H]3C[C@H](CO)C=C3)c2n1	nucleoside reverse transcriptase inhibitor	
abafungin	159326	BRD-K77432251	Cc1ccc(Oc2ccccc2-c2csc(N=C3NCCCN3)n2)c(C)c1	sterol methyltransferase inhibitor	
abamectin	5702208	BRD-A25579302	CCC(C)[C@H]1O[C@@]2(C[C@@H]3C[C@@H](C\C=C(C)\[C@@H](OC4C[C@H](OC)C(O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C4/CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)C=C[C@@H]1C	benzodiazepine receptor agonist	GABBR1|GABBR2
abametapir	15664	BRD-K65498798	Cc1ccc(nc1)-c1ccc(C)cn1	metalloproteinase inhibitor	MMP9
ABC-294640	15604015	BRD-A70814879	Clc1ccc(cc1)C12CC3CC(CC(C3)(C1)C(=O)NCc1ccncc1)C2	sphingosine kinase inhibitor	SPHK2
abemaciclib	46220502	BRD-K33622447	CCN1CCN(Cc2ccc(Nc3ncc(F)c(n3)-c3cc(F)c4nc(C)n(C(C)C)c4c3)nc2)CC1	CDK inhibitor	CDK4|CDK6
abiraterone	132971	BRD-K50071428	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CC=C2c1cccnc1	androgen biosynthesis inhibitor	CYP11B1|CYP17A1
abiraterone-acetate	9821849	BRD-K24048528	CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC=C4c4cccnc4)[C@@H]3CC=C2C1	androgen biosynthesis inhibitor	CYP17A1
ABT-202	17928441	BRD-A29844814	NC1CCN(C1)c1cccnc1	acetylcholine receptor agonist	
ABT-239	9818903	BRD-K22749967	C[C@@H]1CCCN1CCc1cc2cc(ccc2o1)-c1ccc(cc1)C#N	histamine receptor antagonist	HRH1|HRH2|HRH3
ABT-491	154087	BRD-K97233161	CN(C)C(=O)n1cc(C(=O)c2ccc(Cn3c(C)nc4cnccc34)c(F)c2)c2c(cccc12)C#C	platelet activating factor receptor antagonist	PTAFR
ABT-639	46851313	BRD-K11792081	Fc1ccccc1NS(=O)(=O)c1cc(C(=O)N2CCN3CCC[C@@H]3C2)c(Cl)cc1F	calcium channel blocker	CACNA1G|CACNA1H|CACNA1I
ABT-702	1973	BRD-K36021395	Nc1ncnc2nc(cc(-c3cccc(Br)c3)c12)-c1ccc(nc1)N1CCOCC1	adenosine kinase inhibitor	ADK
ABT-724	5025739	BRD-K37714784	C(N1CCN(CC1)c1ccccn1)c1nc2ccccc2[nH]1	dopamine receptor agonist	DRD4
ABT-737	11228183	BRD-K56301217	CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1[N+]([O-])=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1	BCL inhibitor	BCL2|BCL2L1|BCL2L2
ABT-751	3035714	BRD-K91623615	COc1ccc(cc1)S(=O)(=O)Nc1cccnc1Nc1ccc(O)cc1	tubulin polymerization inhibitor	TUBB
AC-186	71245042	BRD-K53788420	Oc1ccc(cc1)C1(CCC(F)(F)CC1)c1ccccc1F	estrogen receptor agonist	ESR2
AC-261066	11530459	BRD-K31144453	CCCCOCCOc1nc(sc1C)-c1ccc(C(O)=O)c(F)c1	retinoid receptor agonist	RARB
AC-264613	25108278	BRD-K81548480	C\C(=N/NC(=O)[C@H]1[C@@H](CNC1=O)c1ccccc1)c1cccc(Br)c1	PAR agonist	F2RL1
AC-55541	9589606	BRD-A27911617	C\C(=N/NC(=O)C(NC(=O)c1ccccc1)c1n[nH]c(=O)c2ccccc12)c1cccc(Br)c1	PARP inhibitor	PARP2
AC-55649	1714884	BRD-K93176058	CCCCCCCCc1ccc(cc1)-c1ccc(cc1)C(O)=O	retinoid receptor agonist	RARA|RARB
AC-710	54760053	BRD-K15819326	CCN1C(C)(C)CC(CC1(C)C)Oc1ccc(nc1)C(=O)Nc1ccc(NC(=O)Nc2cc(on2)C(C)(C)C)cc1	PDGFR tyrosine kinase receptor inhibitor	CSF1R|FLT3|KIT|PDGFRA|PDGFRB
AC-7954-(+/-)	9797568	BRD-A49544621	CN(C)CCC1(Cc2ccccc2C(=O)O1)c1ccc(Cl)cc1	urotensin receptor agonist	UTS2R
acadesine	17513	BRD-K53448858	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1N	AMPK activator	
acalabrutinib	71226662	BRD-K64034691	CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(cc2)C(=O)Nc2ccccn2)c2c(N)nccn12	Bruton's tyrosine kinase (BTK) inhibitor	BTK
acalisib	11618268	BRD-K92517771	C[C@H](Nc1ncnc2[nH]cnc12)c1nc2ccc(F)cc2c(=O)n1-c1ccccc1	PI3K inhibitor	PIK3CB|PIK3CD
acamprosate	71158	BRD-K26262077	CC(=O)NCCCS(O)(=O)=O	glutamate receptor antagonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM5
acarbose	444254	BRD-K44276885	C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O	glucosidase inhibitor	AMY2A|GAA|MGAM|SI
ACDPP	16759169	BRD-K68633617	CN(C)c1nc(N)c(nc1Cl)C(=O)Nc1cccnc1	glutamate receptor antagonist	GRM5
acebutolol	1978	BRD-A29260609	CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(c1)C(C)=O	adrenergic receptor antagonist	ADRB1|ADRB2
acecainide	4342	BRD-K07753030	CCN(CC)CCNC(=O)c1ccc(NC(C)=O)cc1	polarization inhibitor	SCN5A
aceclidine	1979	BRD-A32673558	CC(=O)OC1CN2CCC1CC2	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
aceclofenac	71771	BRD-K68538666	OC(=O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl	prostanoid receptor antagonist	PTGS2
acedapsone	6477	BRD-K97417064	CC(=O)Nc1ccc(cc1)S(=O)(=O)c1ccc(NC(C)=O)cc1		
acedoben	19266	BRD-K47195926	CC(=O)Nc1ccc(cc1)C(O)=O		
acefylline	69550	BRD-K44004064	Cn1c2ncn(CC(O)=O)c2c(=O)n(C)c1=O	adenosine receptor agonist	ADORA1
aceglutamide	182230	BRD-K13619941	CC(=O)N[C@@H](CCC(N)=O)C(O)=O		
acemetacin	1981	BRD-K67563174	COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)OCC(O)=O)c2c1	cyclooxygenase inhibitor	PTGS1|PTGS2
aceneuramic-acid	445063	BRD-K36262466	CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O		AZGP1|CES1|MBL2|REG1A|SELE|SELP|SIGLEC1
acenocoumarol	54676537	BRD-A65051990	CC(=O)CC(c1ccc(cc1)[N+]([O-])=O)c1c(O)c2ccccc2oc1=O	vitamin K antagonist	VKORC1
acepromazine	6077	BRD-K37814297	CN(C)CCCN1c2ccccc2Sc2ccc(cc12)C(C)=O	dopamine receptor antagonist	ADRA1A|ADRA1B|DRD1|DRD2|HTR1A|HTR2A
acesulfame-potassium	36573	BRD-K50850824	CC1=CC(=O)NS(=O)(=O)O1		
acetanilide	904	BRD-K11094367	CC(=O)Nc1ccccc1	hydrogen peroxide decomposition inhibitor	
acetarsol	1985	BRD-K99048103	CC(=O)Nc1cc(ccc1O)[As](O)(O)=O		
acetazolamide	1986	BRD-K43457670	CC(=O)Nc1nnc(s1)S(N)(=O)=O	carbonic anhydrase inhibitor	AQP1|CA1|CA12|CA14|CA2|CA3|CA4|CA7
acetohexamide	1989	BRD-K52960356	CC(=O)c1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1	ATP channel blocker	ABCC8|KCNJ1|KCNJ10|KCNJ11
acetohydroxamic-acid	1990	BRD-K21615095	CC(=O)NO	urease inhibitor	MMP12
acetophenazine	17676	BRD-K42938903	CC(=O)c1ccc2Sc3ccccc3N(CCCN3CCN(CCO)CC3)c2c1	dopamine receptor antagonist	DRD1|DRD2
acetriazoic-acid	6806	BRD-K46416130	CC(=O)Nc1c(I)cc(I)c(C(O)=O)c1I		
acetyl-farnesyl-cysteine	6438381	BRD-K79437791	CC(=O)N[C@@H](CSC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=O	methyltransferase inhibitor	PPARG
acetyl-l-leucine	70912	BRD-K27406233	CC(C)C[C@H](NC(C)=O)C(O)=O		
acetyl-11-keto-beta-boswellic-acid	45359902	BRD-A44696962	C[C@@H]1CC[C@]2(C)CC[C@]3(C)C(=CC(=O)C4[C@@]5(C)CC[C@@H](OC(C)=O)[C@@](C)(C5CC[C@@]34C)C(O)=O)[C@@H]2[C@H]1C	lipoxygenase inhibitor	HSD11B1|HSD11B2
acetylcholine	187	BRD-K82381502	CC(=O)OCC[N+](C)(C)C	acetylcholine receptor agonist	ACHE|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2
acetylcysteine	12035	BRD-K59058747	CC(=O)N[C@@H](CS)C(O)=O	mucolytic agent	ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11
acetylsalicylsalicylic-acid	10745	BRD-K46585355	CC(=O)Oc1ccccc1C(=O)Oc1ccccc1C(O)=O	cyclooxygenase inhibitor	
acexamic-acid	2005	BRD-K72215350	CC(=O)NCCCCCC(O)=O	5 alpha reductase inhibitor	GAST
acifran	51576	BRD-A29520968	CC1(OC(=CC1=O)C(O)=O)c1ccccc1	cholesterol inhibitor	HCAR2|HCAR3
acipimox	5310993	BRD-K63736853	Cc1cnc(c[n+]1[O-])C(O)=O	cholesterol inhibitor	HCAR2
acitazanolast	2006	BRD-K74236708	OC(=O)C(=O)Nc1cccc(c1)-c1nnn[nH]1	mediator release inhibitor	
acitretin	5284513	BRD-K62012036	COc1cc(C)c(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)c(C)c1C	retinoid receptor agonist	RARA|RARB|RARG|RBP1|RXRA|RXRB|RXRG|STAT3
acivicin	16758175	BRD-K13050541	N[C@H]([C@@H]1CC(Cl)=NO1)C(O)=O	gamma glutamyltransferase Inhibitors	CTPS1
aclarubicin	2008	BRD-A80805100	CCC1(O)CC(OC2CC(C(OC3CC(O)C(OC4CCC(=O)C(C)O4)C(C)O3)C(C)O2)N(C)C)c2c(cc3C(=O)c4cccc(O)c4C(=O)c3c2O)C1C(=O)OC	topoisomerase inhibitor	TOP1|TOP2A
aclidinium	11434515	BRD-K74363950	OC(C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c1cccs1)c1cccs1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
ACPC	535	BRD-K66465025	NC1(CC1)C(O)=O	glutamate receptor antagonist	
acriflavine	452192	BRD-M87138257	Nc1ccc2cc3ccc(N)cc3nc2c1.C[n+]1c2cc(N)ccc2cc2ccc(N)cc12	hypoxia inducible factor inhibitor	HIF1A
acriflavinium	2016	BRD-K97874492	C[n+]1c2cc(N)ccc2cc2ccc(N)cc12	hypoxia inducible factor inhibitor	HIF1A
acrisorcin	24144	BRD-M49658242	CCCCCCc1ccc(O)cc1O.Nc1c2ccccc2nc2ccccc12	other antifungal	
acrivastine	40466858	BRD-K50163129	Cc1ccc(cc1)C(=C/CN1CCCC1)\c1cccc(\C=C\C(O)=O)n1	histamine receptor antagonist	HRH1
acrylate		BRD-M00184283	[Na].OC(=O)C=C	mucus protecting agent	
ACT-132577	25099191	BRD-K34843150	NS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1	endothelin receptor antagonist	EDNRA|EDNRB
ACT-462206	40924317	BRD-K19781342	COc1ccc(cc1)S(=O)(=O)N1CCC[C@H]1C(=O)Nc1cc(C)cc(C)c1	orexin receptor antagonist	HCRTR1|HCRTR2
actarit	2018	BRD-K33483813	CC(=O)Nc1ccc(CC(O)=O)cc1	interleukin receptor agonist	
ACTB-1003	23653175	BRD-K35936936	COCc1c(CN2CCOCC2)n2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cc(ccc2F)C(F)(F)F)c(F)c1	FGFR inhibitor; VEGFR inhibitor	KDR|TEK
actinomycin-d	78357827	BRD-K16547679	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)c2ccc(C)c3oc4c(C)c(=O)c(N)c(C(=O)N[C@H]5[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)c4nc23)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C1=O	RNA polymerase inhibitor	
actinoquinol	23674	BRD-K08837089	CCOc1ccc(c2cccnc12)S(O)(=O)=O		
ACY-1215	53340666	BRD-K82928847	ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c1ccccc1)c1ccccc1	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC6|HDAC8
acyclovir	2022	BRD-K32318651	Nc1nc2n(COCCO)cnc2c(=O)[nH]1	DNA polymerase inhibitor	PNP
AC1NDSS5	4581100	BRD-K10226125	CCCCCCCCCCCCCCCCCC[S+](CCC)c1ccccc1C(=O)OCC		
AD-5467	197383	BRD-A80280426	CC(C)C1Oc2c(cccc2N(CC(O)=O)C1=S)C(C)C	aldose reductase inhibitor	AKR1B1
adapalene	60164	BRD-K33127281	COc1ccc(cc1C12CC3CC(CC(C3)C1)C2)-c1ccc2cc(ccc2c1)C(O)=O	retinoid receptor agonist	RARA|RARB|RARG|RXRA|RXRB|RXRG
adaprev	5958	BRD-A73427433	OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O	TGF beta receptor inhibitor	IGF2R|M6PR
adaptavir	184644	BRD-K37151368	C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(N)=O	CC chemokine receptor antagonist	CCR5
adarotene	9864378	BRD-K00152668	OC(=O)\C=C\c1ccc(cc1)-c1ccc(O)c(c1)C12CC3CC(CC(C3)C1)C2	retinoid receptor agonist	RARB|RARG
adatanserin	130918	BRD-K67789209	O=C(NCCN1CCN(CC1)c1ncccn1)C12CC3CC(CC(C3)C1)C2	serotonin receptor agonist; serotonin receptor antagonist	HTR1A|HTR2A
ADD-233089	3083511	BRD-K43055376	Clc1ccc(cc1)N1CC(=NC1=O)N1CCOCC1	benzodiazepine receptor agonist	
adefovir	60172	BRD-K77484724	Nc1ncnc2n(CCOCP(O)(O)=O)cnc12	DNA polymerase inhibitor	
adefovir-dipivoxil	60871	BRD-K96159438	CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc12)OCOC(=O)C(C)(C)C	DNA polymerase inhibitor	
adelmidrol	176874	BRD-K78097265	OCCNC(=O)CCCCCCCC(=O)NCCO	anti-inflammatory agent	
ademetionine	24762165	BRD-K78185697	C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12	methyltransferase stimulant; phosphodiesterase inhibitor	AMD1|CBS|COMT|GNMT|MAT1A|MAT2A
adenine	190	BRD-K26060080	Nc1ncnc2[nH]cnc12	protein synthesis stimulant	ACACB|ACP1|APRT|MTAP|PECR|SRPK2
adenosine	60961	BRD-K01577834	Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4
adenosine-phosphate	83862	BRD-A10111329	Nc1ncnc2n(cnc12)C1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O	adenosine receptor agonist	ACSL1|ACSS1|ACSS2|ADCY1|ADK|CREB1|FBP1|HINT1|PDE4B|PDE4D|PIM1|PRKAA1|PRKAB1|PRKAB2|PYGL|TRPM4
adenosine-triphosphate	5957	BRD-A31990649	Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O	adenosine receptor agonist	ABCA1|ABCB1|ABCB11|ABCC2|ABCC8|ABCC9|ABCG1|ABL1|ABL2|ACSL1|ACSS1|ACSS2|ACVR1|ACVR1B|ACVRL1|ADCY1|ADRBK1|ADRBK2|AFG3L2|AKT1|ALK|AMHR2|APAF1|ARAF|ASNA1|ASNS|ASS1|CDK15|GPR17|ITPR1|NAE1|NT5C2|P2RY1|P2RY11|P2RY13|P2RY2|P2RY4|PRKAA1|RYR1|RYR2|RYR3|SLC25A4|TNK2|TRPM4|TRPM7
adiphenine	2031	BRD-K60907894	CCN(CC)CCOC(=O)C(c1ccccc1)c1ccccc1	acetylcholine receptor antagonist	CHRNA1
adipic-acid	196	BRD-K10656395	OC(=O)CCCCC(O)=O	solute carrier family member inhibitor	SLC22A6
adiporon	16307093	BRD-K68810443	O=C(COc1ccc(cc1)C(=O)c1ccccc1)NC1CCN(Cc2ccccc2)CC1	adiponectin receptor agonist	ADIPOR1|ADIPOR2
ADL5859	11417954	BRD-K39624409	CCN(CC)C(=O)c1ccc(cc1)C1=CC2(CCNCC2)Oc2cccc(O)c12	opioid receptor agonist	OPRD1
adoprazine	9887537	BRD-K34870043	Fc1ccc(cc1)-c1cncc(CN2CCN(CC2)c2cccc3OCCOc23)c1	dopamine receptor antagonist; serotonin receptor agonist	DRD2|HTR1A
adrafinil	3033226	BRD-A90926615	ONC(=O)CS(=O)C(c1ccccc1)c1ccccc1	adrenergic receptor agonist	
adrenalone	7436	BRD-K82343404	CNCC(=O)c1ccc(O)c(O)c1	adrenergic receptor agonist	ADRA1A
adrenosterone	223997	BRD-K17368287	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O	11-beta hydroxysteroid dehydrogenase inhibitor	HSD11B1|HSD11B2
ADX-10059	10331863	BRD-K77911775	Cc1cc(C)c(N)c(n1)C#Cc1cccc(F)c1	glutamate receptor negative allosteric modulator	GRM5
ADX-47273	11383075	BRD-K56543881	Fc1ccc(cc1)C(=O)N1CCC[C@@H](C1)c1nc(no1)-c1ccc(F)cc1	glutamate receptor modulator	GRM5
AEE788	10297043	BRD-K40718343	CCN1CCN(Cc2ccc(cc2)-c2cc3c(N[C@H](C)c4ccccc4)ncnc3[nH]2)CC1	EGFR inhibitor; VEGFR inhibitor	EGFR|ERBB2|ERBB4|FGFR2|FGFR3|KDR
AEG3482	698112	BRD-K77634909	NS(=O)(=O)c1nn2cc(nc2s1)-c1ccccc1	HSP inducer	
afalanine	74839	BRD-K53205568	CC(=O)N[C@@H](Cc1ccccc1)C(O)=O	dopamine receptor agonist	DRD2
afatinib	10184653	BRD-K66175015	CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1	EGFR inhibitor	EGFR|ERBB2|ERBB4
afimoxifene	449459	BRD-K04210847	CC\C(c1ccccc1)=C(/c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1	estrogen receptor antagonist	ESR1|ESR2|ESRRG|PLD1|PRKCD|PRKCE|PRKCQ|PRKCZ
afloqualone	2040	BRD-K69247067	Cc1ccccc1-n1c(CF)nc2ccc(N)cc2c1=O	acetylcholine receptor antagonist	
AFN-1252	10407120	BRD-K23791635	CN(Cc1oc2ccccc2c1C)C(=O)\C=C\C1=CNC2=NC(=O)CCC2=C1	FABI inhibitor	
afobazole	9862937	BRD-K37793595	CCOc1ccc2[nH]c(SCCN3CCOCC3)nc2c1	anxiolytic	
AF38469	72706115	BRD-K47816470	Cc1cccc(NC(=O)c2ccc(cc2C(O)=O)C(F)(F)F)n1	sortilin inhibitor	SORT1
AG-1024	2044	BRD-K08310154	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O	insulin growth factor receptor inhibitor	IGF1R
AG-14361	9840076	BRD-K00615600	CN(C)Cc1ccc(cc1)-c1nc2cccc3C(=O)NCCn1c23	PARP inhibitor	PARP1
AG-490	5328779	BRD-K47105409	Oc1ccc(cc1O)\C=C(/C#N)C(=O)NCc1ccccc1	EGFR inhibitor; JAK inhibitor	EGFR|JAK2|JAK3
AG-555	5328770	BRD-K34428485	Oc1ccc(\C=C(/C#N)C(=O)NCCCc2ccccc2)cc1O	tyrosine kinase inhibitor	CDK2
AG-556	5328775	BRD-K81048131	Oc1ccc(\C=C(/C#N)C(=O)NCCCCc2ccccc2)cc1O	tyrosine kinase inhibitor	
AGI-5198	56645356	BRD-A56371469	Cc1nccn1CC(=O)N(C(C(=O)NC1CCCCC1)c1ccccc1C)c1cccc(F)c1	isocitrate dehydrogenase inhibitor	IDH1
AGI-6780	71299339	BRD-K04691817	FC(F)(F)c1cccc(NC(=O)Nc2cc(ccc2-c2ccsc2)S(=O)(=O)NC2CC2)c1	isocitrate dehydrogenase inhibitor	IDH2
AGM-1470	6517043	BRD-A78111609	CO[C@@H]1[C@@H](CC[C@]2(CO2)C1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)NC(=O)CCl	cell cycle inhibitor	METAP2
agmatine	199	BRD-K49738308	NCCCCNC(N)=N	nitric oxide synthase inhibitor	ADRA2C|ASIC3|CACNA1B|CHRNA1|GRIN1|KCNJ1|NISCH
AGN-192403	10057719	BRD-A18074780	CC(C)[C@@H]1C2CCC(C2)[C@H]1N	imidazoline receptor ligand	NISCH
AGN-194310	9867046	BRD-K70262971	CCc1ccc(cc1)C1=CC(C)(C)Sc2ccc(cc12)C#Cc1ccc(cc1)C(O)=O	retinoid receptor antagonist	RXRA|RXRB|RXRG
AGN-195183	9867758	BRD-K32533226	CC1(C)CCC(C)(C)c2c(Cl)c(O)c(cc12)C(=O)Nc1cc(F)c(C(O)=O)c(F)c1	retinoid receptor agonist	RARA
agomelatine	82148	BRD-K84698278	COc1ccc2cccc(CCNC(C)=O)c2c1	melatonin receptor agonist; serotonin receptor antagonist	HTR2A|HTR2B|HTR2C|MTNR1A|MTNR1B
AGP-103	8215	BRD-K91495480	CCCCCCCCCCCCCCCCCCCCCC(O)=O	membrane permeability inhibitor	
AH-7614	233085	BRD-K10852420	Cc1ccc(cc1)S(=O)(=O)NC1c2ccccc2Oc2ccccc12	free fatty acid receptor antagonist	FFAR4
AH11110	3386873	BRD-A64808605	OC(COc1ccccc1-c1ccccc1)CC(=N)N1CCCCC1	adrenergic receptor ligand	ADRA1B
AH6809	119461	BRD-K59339270	CC(C)Oc1ccc2c(c1)oc1ccc(cc1c2=O)C(O)=O	prostanoid receptor antagonist	PTGDR|PTGER1|PTGER2|PTGER3
AI-10-49	49806644	BRD-K89899948	FC(F)(F)Oc1ccc2nc([nH]c2c1)-c1ccc(OCCOCCOc2ccc(nc2)-c2nc3ccc(OC(F)(F)F)cc3[nH]2)cn1	core binding factor inhibitor	CBFB
AIM-100	11501591	BRD-K85139301	C(Nc1ncnc2oc(c(-c3ccccc3)c12)-c1ccccc1)[C@@H]1CCCO1	tyrosine kinase inhibitor	TNK2
ajmaline	16667686	BRD-A48300215	CC[C@H]1C2CC3[C@@H]4N(C)c5ccccc5[C@]44C[C@@H](C2C4O)N3[C@@H]1O	sodium channel blocker	SCN5A
AJ76-(+)	122334	BRD-K76677554	CCCN[C@@H]1CCc2c(OC)cccc2[C@@H]1C	dopamine receptor antagonist	DRD2|DRD3|DRD4
AK-7	1328033	BRD-K09143580	Brc1cccc(NC(=O)c2cccc(c2)S(=O)(=O)N2CCCCCC2)c1	SIRT inhibitor	SIRT2
AKBA	11168203	BRD-K54907283	C[C@@H]1CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@@H](OC(C)=O)[C@@](C)([C@@H]5CC[C@@]34C)C(O)=O)[C@@H]2[C@H]1C	lipoxygenase inhibitor	ALOX5
aklomide	2075	BRD-K26807903	NC(=O)c1ccc(cc1Cl)[N+]([O-])=O		
AL-8697	25060093	BRD-K44731351	Cc1c(F)cc(cc1-c1c(F)cn2c(nnc2c1F)C(C)(C)C)C(=O)NC1CC1	p38 MAPK inhibitor	MAPK14
alacepril	71992	BRD-K51784806	C[C@H](CSC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O	angiotensin converting enzyme inhibitor	ACE
alafosfalin	71957	BRD-K80403280	C[C@H](N)C(=O)N[C@@H](C)P(O)(O)=O	bacterial cell wall synthesis inhibitor	
alagebrium	216305	BRD-K96029467	Cc1sc[n+](CC(=O)c2ccccc2)c1C	glycosylation inhibitor	
alanine	57383916	BRD-A33317514	CC(N)C(O)=O		AARS|AARS2|ABAT|AGXT|AGXT2|GPRC6A|GPT|GPT2|KYNU|NFS1|PHYKPL|SLC1A4|SLC36A1|SLC7A8
alantolactone	72724	BRD-K53731810	C[C@H]1CCC[C@]2(C)C[C@H]3OC(=O)C(=C)[C@H]3C=C12	apoptosis stimulant; STAT inhibitor	STAT3
alaproclate	2081	BRD-A14966924	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	serotonin receptor antagonist	SLC6A4
alarelin	9855027	BRD-K42140276	CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1	gonadotropin releasing factor hormone receptor antagonist	GNRH1
albendazole	2082	BRD-K79131256	CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1	tubulin polymerization inhibitor	TUBA1A|TUBB|TUBB4B
albendazole-oxide	83969	BRD-A67060370	CCCS(=O)c1ccc2nc(NC(=O)OC)[nH]c2c1	anthelmintic agent	
albuterol	2083	BRD-A88254928	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1	adrenergic receptor agonist	ADRB1|ADRB2
alcaftadine	19371515	BRD-K55991142	CN1CCC(CC1)=C1c2ncc(C=O)n2CCc2ccccc12	histamine receptor antagonist	HRH1
alclofenac	30951	BRD-K47492008	OC(=O)Cc1ccc(OCC=C)c(Cl)c1	cyclooxygenase inhibitor	PTGS1
alclometasone-dipropionate	129009982	BRD-A17407635	CCC(=O)OCC(=O)C1(OC(=O)CC)[C@H](C)C[C@H]2C3[C@H](Cl)CC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C	glucocorticoid receptor agonist	CYP3A4|NR3C1|SERPINA6
alcuronium	24776151	BRD-A84907376	OC\C=C1/C[N@+]2(CC=C)CC[C@@]34[C@@H]2C[C@@H]1\C1=C\N2C5[C@]6(CC[N@@+]7(CC=C)C\C(=C/CO)[C@H](C[C@@H]67)\C5=C\N(C31)c1ccccc41)c1ccccc21	muscle relaxant	CHRM1|CHRM2|CHRM3|CHRM4|CHRNA7
alda-1	831629	BRD-K06890060	Clc1cccc(Cl)c1C(=O)NCc1ccc2OCOc2c1	aldehyde dehydrogenase activator	ALDH2
aldoxorubicin	9810709	BRD-K68928792	COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(\CO)=N\NC(=O)CCCCCN1C(=O)C=CC1=O	topoisomerase inhibitor	TOP2A
alectinib	49806720	BRD-K11267252	CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N1CCC(CC1)N1CCOCC1	ALK tyrosine kinase receptor inhibitor	ALK|MET
alendronate	2088	BRD-K75527158	NCCCC(O)(P(O)(O)=O)P(O)(O)=O	bone resorption inhibitor	ATP6V1A|FDPS|PTPN4|PTPRE|PTPRS
alexidine	2090	BRD-A27883417	CCCCC(CC)C\N=C(/N)N\C(N)=N\CCCCCC\N=C(/N)N\C(N)=N\CC(CC)CCCC	phosphatidylglycerophosphatase inhibitor	PTPMT1
alfacalcidol	5282181	BRD-K49522529	CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	vitamin D receptor agonist	CYP27B1|VDR
alfadolone-acetate	24733	BRD-K51751936	CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C	benzodiazepine receptor agonist	
alfaxalone	104845	BRD-K41445866	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C	chloride channel agonist; benzodiazepine receptor agonist	GABBR1
alfuzosin	2092	BRD-A09056319	COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C1CCCO1	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|KCNH2
algestone-acetophenide	102011	BRD-A41774846	CC(=O)[C@@]12OC(C)(O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]21C)c1ccccc1		
alibendol	71916	BRD-K60102752	COc1cc(CC=C)cc(C(=O)NCCO)c1O	antispasmodic	
alimemazine	5574	BRD-A49225603	CC(CN(C)C)CN1c2ccccc2Sc2ccccc12	histamine receptor agonist	HRH1
alisertib	24771867	BRD-K75295174	COc1cc(Nc2ncc3CN=C(c4cc(Cl)ccc4-c3n2)c2c(F)cccc2OC)ccc1C(O)=O	Aurora kinase inhibitor	AURKA
aliskiren-hemifumarate	5493444	BRD-K30020243	COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)ccc1OC	renin inhibitor	REN
alizapride	43008	BRD-A03061970	COc1cc2[nH]nnc2cc1C(=O)NCC1CCCN1CC=C	dopamine receptor antagonist	DRD2
alizarin	6293	BRD-K73191876	Oc1ccc2C(=O)c3ccccc3C(=O)c2c1O		
allantoin	204	BRD-A96407378	NC(=O)NC1NC(=O)NC1=O	cosmetic	
allicin	65036	BRD-A60402836	C=CCSS(=O)CC=C	cytokine production inhibitor	TRPA1|TRPV1
allopregnanolone	22833567	BRD-A03204438	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	GABA receptor positive allosteric modulator	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB2|GABRG2
allopurinol	2094	BRD-K86307448	O=c1[nH]cnc2[nH]ncc12	xanthine oxidase inhibitor	XDH
allopurinol-riboside	92132014	BRD-A93407926	OC[C@H]1O[C@H](C(O)[C@H]1O)n1[nH]cc2c1ncnc2=O	anti-leishmanial agent	
allylestrenol	235905	BRD-K12872829	C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)CC=C	steroidal progestin	ESR1|PGR|SLC6A9
allylisothiocyanate	5971	BRD-K33219225	C=CCN=C=S	TRPV agonist	TRPA1
allylthiourea	1549517	BRD-K89634775	NC(S)=NCC=C	nitrification inhibitor	
almitrine	33887	BRD-K82677201	Fc1ccc(cc1)C(N1CCN(CC1)c1nc(NCC=C)nc(NCC=C)n1)c1ccc(F)cc1	neurotransmitter agonist	ATP1A1
almorexant	23727689	BRD-K84810405	CNC(=O)[C@H](N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(cc1)C(F)(F)F)c1ccccc1	orexin receptor antagonist	HCRTR1|HCRTR2
almotriptan	123606	BRD-K67601717	CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12	serotonin receptor agonist	HTR1B|HTR1D
aloe-emodin	10207	BRD-K04851519	OCc1cc(O)c2C(=O)c3c(O)cccc3C(=O)c2c1	anticancer agent	CASP8
alogliptin	11163584	BRD-A27084604	Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O	dipeptidyl peptidase inhibitor	DPP4
aloin	12305761	BRD-K02074536	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@H]1c2cccc(O)c2C(=O)c2c(O)cc(CO)cc12	angiogenesis inhibitor	
aloperine	162147	BRD-K96391852	C1CCN2C[C@H]3C[C@H](C=C4CCCN[C@@H]34)[C@H]2C1		
alosetron	2099	BRD-K46742498	Cc1[nH]cnc1CN1CCc2c(C1=O)c1ccccc1n2C	serotonin receptor antagonist	HTR3A
aloxistatin	65663	BRD-K91188791	CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C	protease inhibitor	CTSG
alpelisib	56649450	BRD-K54997624	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(c1)C(C)(C)C(F)(F)F	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
alpha-Asarone	636822	BRD-K72536715	COc1cc(OC)c(\C=C\C)cc1OC	cytochrome P450 inhibitor; HMGCR inhibitor	HMGCR
alpha-D-glucopyranose	79025	BRD-K87424134	OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O		
alpha-linolenic-acid	5280934	BRD-K33396764	CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O	omega 3 fatty acid stimulant	ELOVL4|FADS1|FADS2|FFAR1|FFAR4|PTGS2|SLC8A1|TRPV1
alpha-methylhistamine-dihydrobromide-(R)-(-)	156615	BRD-K80028314	C[C@@H](N)Cc1c[nH]cn1	histamine receptor agonist	HRH3
alpha-methylhistamine-dihydrobromide-(S)-(+)	6603865	BRD-K28308851	C[C@H](N)Cc1c[nH]cn1	histamine receptor agonist	HRH3
alpha-methylserotonin	2107	BRD-A17745711	CC(N)Cc1c[nH]c2ccc(O)cc12	serotonin receptor agonist	HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR4
alpha-tochopherol	2116	BRD-A82892199	CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(O)c(C)c(C)c2O1	antioxidant	
alpha-tochopheryl-acetate	2117	BRD-A61850409	CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(OC(C)=O)c(C)c(C)c2O1	antioxidant	
alpidem	54897	BRD-K66896751	CCCN(CCC)C(=O)Cc1c(nc2ccc(Cl)cn12)-c1ccc(Cl)cc1	benzodiazepine receptor agonist	GABRA1
alprenolol	2119	BRD-A00993607	CC(C)NCC(O)COc1ccccc1CC=C	adrenergic receptor antagonist	ADRB1|ADRB2|HTR1A
alprostadil	5280723	BRD-K52459643	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O	prostanoid receptor agonist	CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGER1|PTGER2|PTGER4|PTGIR
alrestatin	2120	BRD-K35498378	OC(=O)CN1C(=O)c2cccc3cccc(C1=O)c23	aldose reductase inhibitor	AKR1B1
ALS-8176	71621663	BRD-K21415491	Nc1ccn([C@@H]2O[C@@](CO)(CCl)[C@@H](O)[C@H]2F)c(=O)n1	RNA polymerase inhibitor	
altanserin	3033677	BRD-K00610438	Fc1ccc(cc1)C(=O)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1	serotonin receptor antagonist	HTR2A
althiazide	2122	BRD-A56675431	NS(=O)(=O)c1cc2c(NC(CSCC=C)NS2(=O)=O)cc1Cl	diuretic	
altinicline	3036156	BRD-K52681925	CN1CCC[C@H]1c1cncc(c1)C#C	nicotinic receptor agonist	CHRNA4|CHRNB2
altiratinib	54576299	BRD-K78627070	Fc1ccc(NC(=O)C2(CC2)C(=O)Nc2cc(F)c(Oc3ccnc(NC(=O)C4CC4)c3)cc2F)cc1	VEGFR inhibitor; MET inhibitor	KDR|MET|TEK
altrenogest	76973971	BRD-K14619660	C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(O)CC=C	progestogen hormone	PGR
altretamine	2123	BRD-K67043667	CN(C)c1nc(nc(n1)N(C)C)N(C)C	DNA synthesis inhibitor	
alverine	3678	BRD-K89055274	CCN(CCCc1ccccc1)CCCc1ccccc1	muscle relaxant	HTR1A
alvespimycin	5288674	BRD-K83988098	CO[C@H]1C[C@H](C)CC2=C(NCCN(C)C)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O	HSP inhibitor	HSP90AA1
alvimopan	51397022	BRD-K07857022	C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(O)=O)CC[C@@]1(C)c1cccc(O)c1	opioid receptor antagonist	OPRD1|OPRK1|OPRM1
alvocidib	5287969	BRD-K87909389	CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl	CDK inhibitor	CDK1|CDK2|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9|EGFR|PYGM
ALX-5407	6604909	BRD-K53979406	CN(CC[C@@H](Oc1ccc(cc1)-c1ccccc1)c1ccc(F)cc1)CC(O)=O	Glycine transporter 1 inhibitor	SLC6A9
AM-1241	10141893	BRD-A66116161	CN1CCCCC1Cn1cc(C(=O)c2cc(ccc2I)[N+]([O-])=O)c2ccccc12	cannabinoid receptor agonist	CNR1|CNR2
AM-24	11862	BRD-K59013864	Oc1c(I)cc(I)cc1I	lipoxygenase inhibitor	ALOX5
AM-251	2125	BRD-K92000912	Cc1c(nn(c1-c1ccc(I)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1	cannabinoid receptor antagonist	CNR1|GPR18|GPR55
AM-281	4302962	BRD-K59419204	Cc1c(nn(c1-c1ccc(I)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCOCC1	cannabinoid receptor antagonist	CNR1|CNR2|GPR55
AM-404	6604822	BRD-K55462201	CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)Nc1ccc(O)cc1	cyclooxygenase inhibitor; FAAH inhibitor; TRPV antagonist	CNR1|CNR2|FAAH|TRPV1
AM-580	2126	BRD-K06854232	CC1(C)CCC(C)(C)c2cc(ccc12)C(=O)Nc1ccc(cc1)C(O)=O	retinoid receptor agonist	RARA
AM-630	4302963	BRD-K63533170	COc1ccc(cc1)C(=O)c1c(C)n(CCN2CCOCC2)c2cc(I)ccc12	cannabinoid receptor antagonist	CNR1|CNR2
AM-92016	2129	BRD-A11813248	CN(CCc1ccc(Cl)c(Cl)c1)CC(O)COc1ccc(NS(C)(=O)=O)cc1	potassium channel blocker	GRIN1
amantadine	2130	BRD-K70330367	NC12CC3CC(CC(C3)C1)C2	glutamate receptor antagonist	DRD2|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A
ambazone		BRD-K11244467	NC(=N)N=Nc1ccc(NNC(S)=N)cc1	DNA damage inducer	
ambenonium	2131	BRD-K11292736	CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl	cholinesterase inhibitor	ACHE
ambrisentan	6918493	BRD-K41185545	COC([C@H](Oc1nc(C)cc(C)n1)C(O)=O)(c1ccccc1)c1ccccc1	endothelin receptor antagonist	EDNRA|EDNRB
ambroxol		BRD-K56558538	Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1	sodium channel blocker	CYP3A4
amcinonide	5702266	BRD-A36010170	CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1CC1C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C	glucocorticoid receptor agonist	ANXA1|NR3C1
AMD-3465	483559	BRD-K03019184	C(NCc1ccccn1)c1ccc(CN2CCCNCCNCCCNCC2)cc1	CC chemokine receptor antagonist	CXCR4
amdinocillin		BRD-K41051431	CC1(C)S[C@@H]2[C@H](\N=C\N3CCCCCC3)C(=O)N2[C@H]1C(O)=O	bacterial cell wall synthesis inhibitor	
AMD11070	11256587	BRD-K42948882	NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc12	CC chemokine receptor antagonist	CXCR4
ameltolide	13086	BRD-K48173020	Cc1cccc(C)c1NC(=O)c1ccc(N)cc1	anticonvulsant	
amezinium	71927	BRD-K51387999	COc1cc(N)cn[n+]1-c1ccccc1	adrenergic receptor agonist	ADRB2
amfenac	2136	BRD-K82122102	Nc1c(CC(O)=O)cccc1C(=O)c1ccccc1	cyclooxygenase inhibitor	PTGS1|PTGS2
amfepramone	7029	BRD-A37288617	CCN(CC)C(C)C(=O)c1ccccc1	adrenergic receptor agonist	SLC6A2|SLC6A3
amflutizole	54833	BRD-K50813454	Nc1c(snc1-c1cccc(c1)C(F)(F)F)C(O)=O	xanthine oxidase inhibitor	XDH
AMG-PERK-44	86583045	BRD-K04374714	Cc1ccc2cc(ccc2n1)-c1c(C)ccc(C(=O)c2c(-c3ccccc3)n(C)n(-c3ccccc3)c2=O)c1N	PERK inhibitor	EIF2AK4
AMG-208	24864821	BRD-K32285926	COc1ccc2c(OCc3nnc4ccc(nn34)-c3ccccc3)ccnc2c1	tyrosine kinase inhibitor	MET
AMG-232	58573469	BRD-K64925568	CC(C)[C@@H](CS(=O)(=O)C(C)C)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1	MDM inhibitor	MDM2
AMG-319	68947304	BRD-K21077415	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2ccc(F)cc2nc1-c1ccccn1	PI3K inhibitor	PIK3CD
AMG-337	44181686	BRD-K27061362	COCCOc1cnc2ccn([C@H](C)c3nnc4c(F)cc(cn34)-c3cnn(C)c3)c(=O)c2c1	MET inhibitor	MET
AMG-487	24957182	BRD-K90239174	CCOc1ccc(cc1)-n1c(nc2ncccc2c1=O)[C@@H](C)N(Cc1cccnc1)C(=O)Cc1ccc(OC(F)(F)F)cc1	CC chemokine receptor antagonist	
AMG-487-(+/-)	10282265	BRD-A01307728	CCOc1ccc(cc1)-n1c(nc2ncccc2c1=O)C(C)N(Cc1cccnc1)C(=O)Cc1ccc(OC(F)(F)F)cc1	CC chemokine receptor antagonist	CXCR3
AMG-517	16007367	BRD-K34185671	CC(=O)Nc1nc2c(Oc3cc(ncn3)-c3ccc(cc3)C(F)(F)F)cccc2s1	TRPV antagonist	TRPV1
AMG-548	11167112	BRD-K86673452	Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O	MAP kinase inhibitor	MAPK11|MAPK12|MAPK13|MAPK14
AMG-837	46854655	BRD-K43802723	CC#C[C@@H](CC(O)=O)c1ccc(OCc2cccc(c2)-c2ccc(cc2)C(F)(F)F)cc1	free fatty acid receptor agonist	FFAR1
AMG-925		BRD-K97452254	C[C@H]1CC[C@@H](CC1)n1c2cnccc2c2cnc(Nc3ccc4CN(CCc4n3)C(=O)CO)nc12	CDK inhibitor; FLT3 inhibitor	CDK4|CDK6|FLT3
AMG-9810	680502	BRD-K01995783	CC(C)(C)c1ccc(cc1)\C=C\C(=O)Nc1ccc2OCCOc2c1	TRPV antagonist	TRPV1
AMG319	77577663	BRD-A58947127	CC(Nc1ncnc2nc[nH]c12)c1cc2ccc(F)cc2nc1-c1ccccn1	PI3K inhibitor	PIK3CD
AMG458	24764449	BRD-K21782625	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1	MET inhibitor	MET
AMG900	24856041	BRD-K21728777	Cc1csc(c1)-c1nnc(Nc2ccc(Oc3ncccc3-c3ccnc(N)n3)cc2)c2ccccc12	Aurora kinase inhibitor	AURKA|AURKB|AURKC
AMI-1	67254	BRD-K75114721	Oc1cc(cc2cc(NC(=O)Nc3ccc4c(O)cc(cc4c3)S(O)(=O)=O)ccc12)S(O)(=O)=O	protein arginine N-methyltransferase inhibitor	PRMT1
amibegron	3035442	BRD-K24610819	CCOC(=O)COc1ccc2CC[C@@H](Cc2c1)NC[C@H](O)c1cccc(Cl)c1	adrenergic receptor agonist	ADRB3
amidopyrine	6009	BRD-K12568846	CN(C)c1c(C)n(C)n(-c2ccccc2)c1=O	analgesic agent	
amifampridine	5918	BRD-K80262108	Nc1ccncc1N	potassium channel blocker	
amiflamine	3043606	BRD-A19401019	CC(N)Cc1ccc(cc1C)N(C)C	monoamine oxidase inhibitor	MAOA|SLC6A2
amifostine	2141	BRD-K73947551	NCCCNCCSP(O)(O)=O	reducing agent	ALPPL2|ENPP1
amikacin	121493670	BRD-A01603276	NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1OC1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O	bacterial 30S ribosomal subunit inhibitor	
amiloride	16231	BRD-K97181089	NC(=N)NC(=O)c1nc(Cl)c(N)nc1N	sodium channel blocker	AOC1|ASIC1|ASIC2|ASIC3|PKD2|PKD2L1|PLAU|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC9A1|TRPC7|TRPV2
amineptine	34870	BRD-K24219278	OC(=O)CCCCCCNC1c2ccccc2CCc2ccccc12	dopamine receptor agonist	SLC6A2|SLC6A4
aminocaproic-acid	517030	BRD-K64931368	NCCCCCC(O)=O	plasminogen activator inhibitor	LPA|PLAT|PLG
aminoglutethimide	2145	BRD-A25234499	CCC1(CCC(=O)NC1=O)c1ccc(N)cc1	glucocorticoid receptor antagonist	CYP11A1|CYP19A1
aminoguanidine	2146	BRD-K25114078	NNC(N)=N	nitric oxide synthase inhibitor	NOS2
aminohydroxybutyric-acid	14625150	BRD-A40777960	NCC(O)CC(O)=O		
aminolevulinic-acid-benzyl-ester	9964521	BRD-K59998349	NCC(=O)CCC(=O)OCc1ccccc1		
aminomethyltransferase	1534	BRD-A28318179	CC1CCN=C(N)S1	nitric oxide synthase inhibitor	NOS2
aminopentamide	22565	BRD-A69917777	CC(CC(C(N)=O)(c1ccccc1)c1ccccc1)N(C)C	acetylcholine receptor antagonist	CHRM1
aminophylline	2153	BRD-K97799481	Cn1c2nc[nH]c2c(=O)n(C)c1=O	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D
aminopterin	169371	BRD-K87544030	Nc1nc(N)c2nc(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)cnc2n1	dihydrofolate reductase inhibitor	DHFR|SLC46A1
aminopurvalanol-a	6604931	BRD-K07762753	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1	CDK inhibitor; tyrosine kinase inhibitor	CDK1|CDK2|CDK5|CDK6
aminosalicylate	4649	BRD-K80267133	Nc1ccc(C(O)=O)c(O)c1	cyclooxygenase inhibitor	ALOX5|CHUK|PLA2G2E|PTGS1|PTGS2
aminothiadiazole	19909	BRD-K94837153	Nc1nncs1	inosine monophosphate dehydrogenase inhibitor	ADORA3|IMPDH1
aminothiazole	2155	BRD-K13421763	Nc1nccs1	cyclin D inhibitor	NOS2
amiodarone	2157	BRD-K17561142	CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1	potassium channel blocker	ADRB1|CACNA1H|CACNA2D2|KCNA7|KCNH2
amiprilose	121928	BRD-K97643133	CN(C)CCCO[C@H]1[C@H](O[C@@H]2OC(C)(C)O[C@H]12)[C@H](O)CO	CD antagonist	
amisulpride	2159	BRD-A60197193	CCN1CCCC1CNC(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC	dopamine receptor antagonist	DRD2|DRD3|HTR2A|HTR7
amitifadine	9795276	BRD-A68942014	Clc1ccc(cc1Cl)C12CC1CNC2	serotonin transporter (SERT) inhibitor	SLC6A2|SLC6A3|SLC6A4
amitraz		BRD-K33335792	CN(\C=N\c1ccc(C)cc1C)\C=N\c1ccc(C)cc1C	adrenergic receptor agonist	ADRA1A|ADRA2A
amitriptyline	2160	BRD-K53737926	CN(C)CCC=C1c2ccccc2CCc2ccccc12	norepinephrine inhibitor; norepinephrine reuptake inhibitor; serotonin receptor antagonist; serotonin norepinephrine reuptake inhibitor (SNRI)	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4
amlexanox	2161	BRD-K29530284	CC(C)c1ccc2oc3nc(N)c(cc3c(=O)c2c1)C(O)=O	histamine receptor modulator	FGF1|IL3|PDE4A|PDE4B|PDE4C|PDE4D|S100A12|S100A13
amlodipine	2162	BRD-A22032524	CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC	calcium channel blocker	CA1|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1|CACNA2D3|CACNB1|CACNB2|SMPD1
ammonium-glycyrrhizinate	129009943	BRD-K15318383	C[C@]12CC[C@@](C)(C[C@H]1C1=CC(=O)[C@@H]3[C@]4(C)CC[C@H](O[C@H]5O[C@@H]([C@@H](O)[C@H](O)[C@@H]5O[C@@H]5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)C(O)=O)C(O)=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)C(O)=O	thrombin inhibitor	HSD11B1|HSD11B2|SLCO1B1|SLCO1B3
ammonium-lactate	10129918	BRD-M29182745	N.CC(O)C(O)=O		HCAR1
ammonium-perfluorocaprylate	9554	BRD-K32531356	OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	Pim kinase inhibitor	PIM1
AMN-082	1894361	BRD-K23335153	C(CNC(c1ccccc1)c1ccccc1)NC(c1ccccc1)c1ccccc1	glutamate receptor modulator	GRM7
amodiaquine	2165	BRD-K91290917	CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O	histamine receptor agonist	HNMT
amonafide	50515	BRD-K56334280	CN(C)CCN1C(=O)c2cccc3cc(N)cc(C1=O)c23	topoisomerase inhibitor	TOP2A|TOP2B
amorolfine	54260	BRD-A37390343	CCC(C)(C)c1ccc(CC(C)CN2C[C@H](C)O[C@H](C)C2)cc1	membrane integrity inhibitor	
amoxapine	2170	BRD-K02265150	Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1	norepinephrine reputake inhibitor	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH4|HTR1A|HTR1B|HTR2A|HTR2B|HTR2C|HTR3A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4
amoxicillin	33613	BRD-K55044200	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(O)=O	penicillin binding protein inhibitor	CYP2C19|SLC15A1|SLC15A2|SLC22A6
AMPA-(RS)	1221	BRD-A34716233	Cc1onc(O)c1CC(N)C(O)=O	glutamate receptor agonist	GRIN1
AMPA-(S)	158397	BRD-K92493880	Cc1onc(O)c1C[C@H](N)C(O)=O	glutamate receptor agonist	GRIN1
ampalex	148184	BRD-K24771047	O=C(N1CCCCC1)c1ccc2nccnc2c1	glutamate receptor agonist	GRIA1|GRIA2|GRIA3|GRIA4
amperozide	73333	BRD-K52397688	CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	dopamine receptor antagonist	FAAH|HTR2A
amphotericin-b	5280965	BRD-K27352494	C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O	membrane permeability enhancer	
ampicillin	6249	BRD-K68432770	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(O)=O	bacterial cell wall synthesis inhibitor	
ampiroxicam	2176	BRD-A39172021	CCOC(=O)OC(C)OC1=C(N(C)S(=O)(=O)c2ccccc12)C(=O)Nc1ccccn1	cyclooxygenase inhibitor	PTGS1|PTGS2
amprenavir	65016	BRD-K47827687	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1	HIV protease inhibitor	
amprolium	2178	BRD-K90027121	CCCc1ncc(C[n+]2ccccc2C)c(N)n1	thiamine uptake blocker	
ampyrone	2151	BRD-K20484910	Cc1c(N)c(=O)n(-c2ccccc2)n1C	cyclooxygenase inhibitor	
amrinone	3698	BRD-K45924332	Nc1cc(c[nH]c1=O)-c1ccncc1	phosphodiesterase inhibitor	PDE3A|PDE3B|PDE4B|TNF
amrubicin	3035016	BRD-K13843533	CC(=O)[C@@]1(N)C[C@H](O[C@H]2C[C@H](O)[C@H](O)CO2)c2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c2C1	topoisomerase inhibitor	TOP2A|TOP2B
amsacrine	2179	BRD-K68346641	COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12	topoisomerase inhibitor	KCNH2|TOP2A
amthamine	126688	BRD-K39670393	Cc1nc(N)sc1CCN	histamine receptor agonist	HRH2
amtolmetin-guacil	65655	BRD-K70924353	COc1ccccc1OC(=O)CNC(=O)Cc1ccc(C(=O)c2ccc(C)cc2)n1C	cyclooxygenase inhibitor	PTGS1|PTGS2
amuvatinib	11282283	BRD-K66538826	S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12	FLT3 inhibitor; KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; RAD51 inhibitor; RET tyrosine kinase inhibitor	KIT|MET
amygdalin	656516	BRD-K03504028	OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O[C@@H](C#N)c3ccccc3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	caspase activator	CASP3
amyl-nitrite	10026	BRD-K03326591	CCCCCO[N+][O-]	atrial natriuretic peptide receptor agonist	NPR1
amyleine	10767	BRD-A09062839	CCC(C)(CN(C)C)OC(=O)c1ccccc1	local anesthetic	
amylene-hydrate	6405	BRD-K93502141	CCC(C)(C)O	local anesthetic	
AMZ30	44607965	BRD-K00256256	[O-][N+](=O)c1cccc(c1)S(=O)(=O)n1cccc1\C=C(/C#N)S(=O)(=O)c1ccc(F)cc1	protein phosphatase inhibitor	
AM679	44627267	BRD-K88443722	COc1cnc(nc1)-c1ccc(Cn2c(CC(C)(C)C(O)=O)c(SC(C)(C)C)c3cc(OC[C@@H]4Cc5ccccc5N4C(C)=O)ccc23)cc1	cannabinoid receptor agonist; lipoxygenase inhibitor	ALOX5AP|CNR1|CNR2
ANA-12	2799722	BRD-A19609491	O=C(Nc1ccccc1C(=O)NC1CCCCNC1=O)c1cc2ccccc2s1	tropomyosin receptor kinase inhibitor	NTRK2
anabasine	2181	BRD-A24284985	C1CCC(NC1)c1cccnc1	acetylcholine receptor agonist	
anacetrapib	124603199	BRD-K44366189	COc1cc(F)c(cc1-c1ccc(cc1CN1[C@H](C)[C@H](OC1=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C(F)(F)F)C(C)C	cholesteryl ester transfer protein inhibitor	CETP
anagliptin	44513473	BRD-K05355328	Cc1cc2ncc(cn2n1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N	dipeptidyl peptidase inhibitor	DPP4
anagrelide	2182	BRD-K62200014	Clc1ccc2N=C3NC(=O)CN3Cc2c1Cl	phosphodiesterase inhibitor	PDE3A
anamorelin	9828911	BRD-K01174345	CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C1)C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(C)N	growth hormone secretagogue receptor agonist	GHSR
anandamide	5281969	BRD-K42352790	CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO	cannabinoid receptor agonist	CACNA1G|CACNA1H|CACNA1I|CNR1|CNR2|GLRA1|GPR18|GPR55|KCNA2|KCNK3|KCNK9|TRPM8|TRPV1
anastrozole	2187	BRD-K52172416	CC(C)(C#N)c1cc(Cn2cncn2)cc(c1)C(C)(C)C#N	aromatase inhibitor	CYP19A1
andarine	9824562	BRD-K82164249	CC(=O)Nc1ccc(OC[C@](C)(O)C(=O)Nc2ccc(c(c2)C(F)(F)F)[N+]([O-])=O)cc1	androgen receptor modulator	AR
andrographolide	6857767	BRD-A86619021	C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H](C\C=C3/[C@H](O)COC3=O)C(=C)CCC12	tumor necrosis factor production inhibitor	NFKB1
androstenone	86705	BRD-A64011898	CC12CCC3C(CCC4CC(=O)CCC34C)C1CC=C2	steroid	
androsterone	5879	BRD-K12329651	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@]34C)[C@@H]1CCC2=O	androgen receptor agonist	
anecortave-acetate	13037657	BRD-A53566267	CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3=CC[C@]12C	angiogenesis inhibitor	
anethole	637563	BRD-K49060658	COc1ccc(cc1)\C=C\C	glutathione transferase stimulant	
anethole-trithione	2194	BRD-K92490248	COc1ccc(cc1)-c1cc(=S)ss1	glutathione transferase stimulant	
anguidine	91518	BRD-K45724504	CC(=O)OC[C@]12CCC(C)=C[C@H]1O[C@@H]1[C@H](O)[C@@H](OC(C)=O)[C@@]2(C)[C@@]11CO1	protein synthesis inhibitor	SLC5A1
anidulafungin	15224271	BRD-A75305484	CCCCCOc1ccc(cc1)-c1ccc(cc1)-c1ccc(cc1)C(=O)NC1CC(O)C(O)NC(=O)C2C(O)C(C)CN2C(=O)C(NC(=O)C(NC(=O)C2CC(O)CN2C(=O)C(NC1=O)C(C)O)C(O)C(O)c1ccc(O)cc1)C(C)O	fungal 1,3-beta-D-glucan synthase inhibitor	
aniracetam	2196	BRD-K88611939	COc1ccc(cc1)C(=O)N1CCCC1=O	glutamate receptor agonist	DRD2|GRIA1|GRIA2|GRIA3|GRIA4|HTR2A
anisindione	2197	BRD-K47458712	COc1ccc(cc1)C1C(=O)c2ccccc2C1=O	vitamin K antagonist	GGCX
anisodamine	73440795	BRD-A29623586	CN1C2C[C@H](O)[C@H]1C[C@H](C2)OC(=O)[C@H](CO)c1ccccc1	lipid peroxidase inhibitor	ADRA1A
anisomycin	253602	BRD-K91370081	COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1	DNA synthesis inhibitor	NHP2L1|RPL10L|RPL11|RPL13A|RPL15|RPL19|RPL23|RPL23A|RPL26L1|RPL3|RPL37|RPL8|RSL24D1
anisotropine	657202	BRD-A06771424	CCCC(CCC)C(=O)OC1C[C@@H]2CC[C@H](C1)[N+]2(C)C	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3
anlotinib	25017411	BRD-K36949735	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1	VEGFR inhibitor; PDGFR tyrosine kinase receptor inhibitor	KDR|PDGFRB
anpirtoline	65854	BRD-K55424922	Clc1cccc(SC2CCNCC2)n1	serotonin receptor agonist	HTR1B
ANR-94	11805896	BRD-K31170746	CCOc1nc2c(N)ncnc2n1CC	A1 adenosine receptor antagonist	ADORA2A
ansamitocin-p-3		BRD-K53252847	CO[C@@H]1C=C\C=C(C)/Cc2cc(OC)c(Cl)c(c2)N(C)C(=O)C[C@H](OC(=O)C(C)C)[C@]2(C)O[C@H]2[C@H](C)[C@@H]2C[C@@]1(O)NC(=O)O2	apoptosis stimulant	
antagonist-g	163960	BRD-K25863791	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(N)=N)C(N)=O	neuropeptide receptor antagonist	MAPK8
antalarmin	177990	BRD-K01363385	CCCCN(CC)c1nc(C)nc2n(c(C)c(C)c12)-c1c(C)cc(C)cc1C	corticosteroid releasing factor receptor antagonist	CRHR1
antazoline	2200	BRD-K99300445	C(N(Cc1ccccc1)c1ccccc1)C1=NCCN1	antihistamine	HRH1
anthralin	2202	BRD-K04725460	Oc1cccc2Cc3cccc(O)c3C(=O)c12	DNA synthesis inhibitor	
anthranilic-acid	2847479	BRD-K75167327	OC(=O)c1ccccc1NC(=O)C12CC3CC(CC(C3)C1)C2		
anthraquinone	6780	BRD-K15957397	O=C1c2ccccc2C(=O)c2ccccc12	CDC inhibitor	CDC25B
antimony-potassium	101108071	BRD-A53836783	OC(=O)C1O[Sb]2OC(C(O[Sb]3OC1C(=O)O3)C(O)=O)C(=O)O2		
antimonyl		BRD-A74328360	O=C1O[SbH]23OC1C1O[SbH]4(OC(C(O2)C(=O)O3)C(=O)O4)OC1=O		
antimycin-a	6420045	BRD-A67709388	CCCCCC[C@@H]1[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)C(NC(=O)c2cccc(NC=O)c2O)[C@@H](C)OC1=O	ATP synthase inhibitor	CYCS
antioxine	10364	BRD-K15541734	CC(C)c1ccc(C)c(O)c1		
AN2718	11845944	BRD-K21920947	OB1OCc2cc(Cl)ccc12	leucyl-tRNA synthetase inhibitor	
AP-18	9584673	BRD-K32143970	CC(=C/c1ccc(Cl)cc1)\C(C)=N\O	transient receptor potential channel antagonist	TRPA1
apabetalone	24871506	BRD-K20001883	COc1cc(OC)c2c(c1)[nH]c(nc2=O)-c1cc(C)c(OCCO)c(C)c1	apolipoprotein expression enhancer	BRD3
apafant	65889	BRD-K28115081	Cc1nnc2CN=C(c3cc(CCC(=O)N4CCOCC4)sc3-n12)c1ccccc1Cl	platelet activating factor receptor antagonist	PTAFR
apalutamide	24872560	BRD-K91308639	CNC(=O)c1ccc(cc1F)N1C(=S)N(C(=O)C11CCC1)c1cnc(C#N)c(c1)C(F)(F)F	androgen receptor antagonist	
apatinib	11315474	BRD-K25244359	O=C(Nc1ccc(cc1)C1(CCCC1)C#N)c1cccnc1NCc1ccncc1	RET tyrosine kinase inhibitor	CSK|KDR|KIT|RET
APC-100	99479	BRD-K07449869	Cc1c(C)c2OC(C)(C)CCc2c(C)c1O	anti-inflammatory agent; androgen receptor antagonist	AR
APcK-110	24786010	BRD-K72748448	COc1cc(OC)cc(c1)-c1ccc2c(n[nH]c2n1)-c1ccc(F)cc1	KIT inhibitor	KIT|STAT3
APD597	11691484	BRD-K86226872	COc1c(Nc2ccc(nc2C)S(C)(=O)=O)ncnc1OC1CCN(CC1)C(=O)OC(C)C	glucose dependent insulinotropic receptor agonist	GPR119
APD668	11705608	BRD-K10859802	CC(C)OC(=O)N1CCC(CC1)Oc1ncnc2n(ncc12)-c1ccc(cc1F)S(C)(=O)=O	glucose dependent insulinotropic receptor agonist	GPR119
aphidicolin	457964	BRD-K85140930	C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H]1CC[C@H]1C[C@@H]3C[C@]21CC[C@]3(O)CO	RNA synthesis inhibitor	
API-001	44247568	BRD-K26325692	Cc1cc(OCCN2CCOCC2)nn1-c1ccc2ccccc2c1	sigma receptor antagonist	SIGMAR1
API-1	24773090	BRD-K97840621	NC(=O)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c2c1=O	AKT inhibitor	AKT1|AKT2|AKT3
apigenin	5280443	BRD-K01493881	Oc1ccc(cc1)-c1cc(=O)c2c(O)cc(O)cc2o1	casein kinase inhibitor; cell proliferation inhibitor	AKR1B1|AR|CDK6|CFTR|CYP19A1|CYP1B1|HSD17B1
apixaban	10182969	BRD-K67121414	COc1ccc(cc1)-n1nc(C(N)=O)c2CCN(C(=O)c12)c1ccc(cc1)N1CCCCC1=O	coagulation factor inhibitor	F10
apocynin	2214	BRD-K64990520	COc1cc(ccc1O)C(C)=O	NADPH oxidase inhibitor	NOX4
apoptosis-activator-II	1901244	BRD-K15164005	Clc1ccc(CN2C(=O)C(=O)c3ccccc23)cc1Cl	carboxylesterase inhibitor	BCHE|CES1
APR-246	52918385	BRD-A09004963	COCC1(CO)N2CCC(CC2)C1=O	p53 activator	TP53
apraclonidine	2216	BRD-K38911213	Nc1cc(Cl)c(NC2=NCCN2)c(Cl)c1	adrenergic receptor agonist	ADRA1A|ADRA2A|ADRA2B|ADRA2C
apramycin	6710735	BRD-K36062294	CN[C@H]1[C@@H](O)[C@H]2O[C@@H](O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O)[C@H]3O)[C@H](N)C[C@@H]2O[C@@H]1O[C@H]1O[C@H](CO)[C@@H](N)[C@H](O)[C@H]1O	bacterial 30S ribosomal subunit inhibitor	
apratastat	11452716	BRD-K06883221	CC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)c1ccc(OCC#CCO)cc1	matrix metalloprotease inhibitor; tumor necrosis factor production inhibitor	ADAM17|MMP1|MMP13|MMP9
apremilast	11561674	BRD-K93208532	CCOc1cc(ccc1OC)[C@@H](CS(C)(=O)=O)N1C(=O)c2cccc(NC(C)=O)c2C1=O	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4C|PDE4D
aprepitant	46868135	BRD-K65170927	C[C@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F	tachykinin antagonist	TACR1
apricitabine	455041	BRD-K55172746	Nc1ccn([C@H]2CO[C@@H](CO)S2)c(=O)n1	nucleoside reverse transcriptase inhibitor	
aprindine	2218	BRD-K53236343	CCN(CC)CCCN(C1Cc2ccccc2C1)c1ccccc1	voltage-gated sodium channel blocker	CALM1|SCN5A
aptiganel	60840	BRD-K63919159	CCc1cccc(c1)N(C)C(=N)Nc1cccc2ccccc12	glutamate receptor antagonist	GRIN1
APTO-253	11960271	BRD-K68003372	Cc1[nH]c2ccc(F)cc2c1-c1nc2c([nH]1)c1cccnc1c1ncccc21	kruppel-like factor expression enhancer	KLF4
APY-29	42627755	BRD-K17511755	C1CC1c1cc(Nc2ccnc(Nc3ccc4nc[nH]c4c3)n2)[nH]n1	serine/threonine kinase inhibitor	ERN1
APY0201	56927660	BRD-K38627885	Cc1cccc(\C=N\Nc2cc(N3CCOCC3)n3nc(cc3n2)-c2ccncc2)c1	phosphoinositide dependent kinase inhibitor	IL12A|IL12B|PIKFYVE
AP1903	16135625	BRD-K28383148	CC[C@H](C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)NCCNC(=O)COc2cccc(c2)[C@@H](CCc2ccc(OC)c(OC)c2)OC(=O)[C@@H]2CCCCN2C(=O)[C@@H](CC)c2cc(OC)c(OC)c(OC)c2)c1)c1cc(OC)c(OC)c(OC)c1		
AP26113	57390074	BRD-K56032964	COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1)N1CCC(CC1)N(C)C	ALK tyrosine kinase receptor inhibitor	ALK|EGFR
AQ-RA741	129989	BRD-K81729199	CCN(CC)CCCCC1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc23)CC1	acetylcholine receptor antagonist	CHRM2
AR-A014418	448014	BRD-K67860401	COc1ccc(CNC(=O)Nc2ncc(s2)[N+]([O-])=O)cc1	glycogen synthase kinase inhibitor	GSK3B
AR-C155858	10226546	BRD-K42325600	CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(C(=O)N3C[C@H](O)CO3)c2c(=O)n(C)c1=O	monocarboxylate transporter inhibitor	SLC16A1|SLC16A7
AR-12	10027278	BRD-K90497590	NCC(=O)Nc1ccc(cc1)-n1nc(cc1-c1ccc2c(ccc3ccccc23)c1)C(F)(F)F	phosphoinositide dependent kinase inhibitor	PDPK1
AR-42	6918848	BRD-K13167095	CC(C)[C@H](C(=O)Nc1ccc(cc1)C(=O)NO)c1ccccc1	HDAC inhibitor	HDAC1
arachidonic-acid	444899	BRD-K03070961	CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O	cytochrome P450 inhibitor	CLCN2|KCNJ4|KCNK10|KCNK18|KCNK2|PRKCZ|PTGS1|TRPC6|TRPM2
arbidol	131411	BRD-K73881242	CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12	cytochrome P450 inhibitor	CYP3A4
arbutin	440936	BRD-K08037784	OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O	melanin inhibitor	TYR
ARC-239	609483	BRD-K93188295	COc1ccccc1N1CCN(CCN2C(=O)c3ccccc3C(C)(C)C2=O)CC1	adrenergic receptor antagonist	ADRA2A|ADRA2B|ADRA2C
arctigenin	64981	BRD-K53523901	COc1cc(C[C@@H]2[C@@H](Cc3ccc(OC)c(OC)c3)COC2=O)ccc1O	MEK inhibitor	CHUK|MAP2K1
arcyriaflavin-a	5327723	BRD-K72726508	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21	CDK inhibitor	CCND1|CDK4
ardeparin	772	BRD-A83644949	CC(=O)NC1C(O)OC(COS(O)(=O)=O)C(OC2OC(C(OC3OC(CO)C(OC4OC(C(O)C(O)C4OS(O)(=O)=O)C(O)=O)C(OS(O)(=O)=O)C3NS(O)(=O)=O)C(O)C2OS(O)(=O)=O)C(O)=O)C1O	thrombin inhibitor	SERPINC1|SERPIND1
arecaidine-but-2-ynyl-ester	4214594	BRD-K63792901	CC#CCOC(=O)C1=CCCN(C)C1	acetylcholine receptor agonist	CHRM2
arecaidine-propargyl-ester	2229	BRD-K23922020	CN1CCC=C(C1)C(=O)OCC#C	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4
arecoline	2230	BRD-K88646909	COC(=O)C1=CCCN(C)C1	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4
argatroban	92722	BRD-A48261811	C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)c1cccc2CC(C)CNc12	thrombin inhibitor	F2
arglabin	5574924	BRD-K62734952	CC1=CC[C@]23O[C@@]2(C)CC[C@@H]2[C@H](OC(=O)C2=C)[C@@H]13	farnesyltransferase inhibitor	FNTA|NFKB1
aripiprazole	60795	BRD-K70358946	Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl	serotonin receptor agonist; serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7
armodafinil	9690109	BRD-K87278688	NC(=O)C[S@@](=O)C(c1ccccc1)c1ccccc1	adrenergic receptor agonist	SLC6A3
arofylline	166553	BRD-K33852358	CCCn1c(=O)n(-c2ccc(Cl)cc2)c2[nH]cnc2c1=O	phosphodiesterase inhibitor	PDE4A
arotinolol	2239	BRD-A28044053	CC(C)(C)NCC(O)CSc1nc(cs1)-c1ccc(s1)C(N)=O	adrenergic receptor antagonist	ADRB3
ARQ-092	53262401	BRD-K60171656	Nc1ncccc1-c1nc2ccc(nc2n1-c1ccc(cc1)C1(N)CCC1)-c1ccccc1	AKT inhibitor	AKT2
ARQ-621	25110841	BRD-K43436647	NCCCN([C@H](CC#C)c1nc2cc(Cl)ccc2c(=O)n1Nc1ccccc1)C(=O)c1cccc(Cl)c1F	kinesin-like spindle protein inhibitor	KIF11
ARRY-334543	42642648	BRD-K46386702	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1	EGFR inhibitor	ERBB2
arsanilic-acid	6432805	BRD-K24179883	Nc1ccc(cc1)[As](O)(O)=O		LYZ
arsenic-trioxide		BRD-K47190141	O[AsH]O[AsH]O	apoptosis stimulant	AKT1|CCND1|IKBKB|JUN|MAPK1|MAPK3|TXNRD1
artemether	68911	BRD-K39621635	CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3	antimalarial agent	ATP1A1
artemisinin	68827	BRD-K13112821	C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	DNA synthesis inhibitor	CYP2B6
artemotil	3000469	BRD-K96006160	CCO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3		
artesunate	6917864	BRD-K54634444	C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	DNA synthesis inhibitor	
articaine	32170	BRD-A70514680	CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC	local anesthetic	
arundic-acid	208925	BRD-K49223707	CCCCCC[C@@H](CCC)C(O)=O	astrocyte modulating agent	PTGS2|S100B
ARV-825	92044400	BRD-A00047421	Cc1sc-2c(c1C)C(=N[C@@H](CC(=O)Nc1ccc(OCCOCCOCCOCCNc3cccc4C(=O)N(C5CCC(=O)NC5=O)C(=O)c34)cc1)c1nnc(C)n-21)c1ccc(Cl)cc1	bromodomain inhibitor	BRD4
AS-1269574	5332859	BRD-K07656463	Cc1cc(NCCO)nc(n1)-c1ccc(Br)cc1	glucose dependent insulinotropic receptor agonist	GPR119
AS-1892802	46911016	BRD-K27051047	OC[C@@H](NC(=O)Nc1ccc(cc1)-c1ccncc1)c1ccccc1	rho associated kinase inhibitor	ROCK1
AS-1949490	44473434	BRD-K61936403	C[C@H](NC(=O)c1sccc1OCc1ccc(Cl)cc1)c1ccccc1	SHIP2 phosphatase inhibitor	INPP5D
AS-2034178	24808572	BRD-K75254015	OC(=O)CCc1ccc(NCc2cccc3N(CCOc4ccccc4)CCCc23)cc1F	free fatty acid receptor agonist	FFAR1
AS-2444697	52913874	BRD-K73565918	Cc1cc(ccn1)-c1nc(co1)C(=O)Nc1cn(nc1C(N)=O)C1CCOCC1	interleukin inhibitor	IRAK4
AS-252424	11630874	BRD-K14988953	Oc1cc(F)ccc1-c1ccc(\C=C2/SC(=O)NC2=O)o1	PI3K inhibitor	PIK3CG
AS-604850	5287855	BRD-K63915849	FC1(F)Oc2ccc(cc2O1)\C=C1/SC(=O)NC1=O	PI3K inhibitor	PIK3CA|PIK3CG
AS-703026	44187362	BRD-K89014967	OC[C@@H](O)CNC(=O)c1ccncc1Nc1ccc(I)cc1F	MEK inhibitor	MAP2K1|MAP2K2
AS-77	11302540	BRD-K62427771	O=c1ccc2c(OCCCCOc3ccccc3)c3ccoc3cc2o1	potassium channel blocker	KCNA3|KCNA5|KCNN4
ASA-404	123964	BRD-K27938825	Cc1ccc2c(oc3c(CC(O)=O)cccc3c2=O)c1C	angiogenesis inhibitor	
asaraldehyde	20525	BRD-K88219015	COc1cc(OC)c(C=O)cc1OC	cyclooxygenase inhibitor	PTGS2
ASC-J9	9952605	BRD-K30331124	COc1ccc(cc1OC)\C=C\C(=O)CC(=O)\C=C\c1ccc(OC)c(OC)c1	androgen receptor enhancer	AR
ascomycin	6507974	BRD-A72381333	CCC1\C=C(C)\CC(C)CC(OC)C2OC(O)(C(C)CC2OC)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)C(O)CC1=O)C(\C)=C\C1CCC(O)C(C1)OC	calcineurin inhibitor	FKBP1A
ascorbic-acid	9888239	BRD-A85242401	OC[C@H](O)[C@H]1OC(=O)C(=O)C1O	antioxidant	ALKBH2|ALKBH3|BBOX1|DBH|EGLN1|EGLN2|EGLN3|KDM5D|LCT|OGFOD1|OGFOD2|P3H1|P3H2|P3H3|P4HA1|P4HTM|PAM|PHYH|PLOD1|PLOD2|PLOD3|SLC23A1|SLC23A2|TMLHE
asenapine	163091	BRD-K95260951	CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21	dopamine receptor antagonist; serotonin receptor antagonist	ADRA1A|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|HRH1|HRH2|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
asiatic-acid	119034	BRD-K35079116	C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O	apoptosis stimulant	PYGM
ASP-2535	9800113	BRD-K07150325	CC(C)c1nnc(-c2ccc(nc2)-c2ccccc2)n1-c1cccc2nonc12	glycine transporter inhibitor	SLC6A9
aspartame	134601	BRD-K78841970	COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(O)=O		TAS1R2|TRPV1
aspirin	2244	BRD-K11433652	CC(=O)Oc1ccccc1C(O)=O	cyclooxygenase inhibitor	AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53
ASP3026	25134326	BRD-K06542892	COc1cc(ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1)N1CCC(CC1)N1CCN(C)CC1	ALK tyrosine kinase receptor inhibitor	ALK
AST-1306	24739943	BRD-K26838195	Fc1cccc(COc2ccc(Nc3ncnc4ccc(NC(=O)C=C)cc34)cc2Cl)c1	EGFR inhibitor	EGFR|ERBB2
astaxanthin	5281224	BRD-K51832961	CC(\C=C\C=C(C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)[C@@H](O)CC1(C)C	antioxidant	
astemizole	2247	BRD-K37249724	COc1ccc(CCN2CCC(CC2)Nc2nc3ccccc3n2Cc2ccc(F)cc2)cc1	histamine receptor antagonist	HRH1|KCNH1|KCNH2
astragaloside-a	13943299	BRD-K08188887	CC(C)(O)[C@H]1CC[C@](C)(O1)[C@H]1[C@@H](O)C[C@@]2(C)[C@@H]3C[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]4[C@]5(C[C@@]35CC[C@]12C)CC[C@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)C4(C)C	antiinflammatory agent	
asunaprevir	16076883	BRD-K87028197	COc1cnc(O[C@@H]2C[C@H](N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C2CC2)c2cc(Cl)ccc12	HCV inhibitor	
asymmetrical-dimethylarginine	123831	BRD-K36269323	CN(C)C(=N)NCCC[C@H](N)C(O)=O	nitric oxide synthase inhibitor	NOS2|NOS3
AT-1015	9805664	BRD-K06496777	O=CN1CCC(CC1)C(=O)NCCN1CCC(CC1)=C1c2ccccc2C=Cc2ccccc12	serotonin receptor antagonist	HTR2A
AT-7519	11338033	BRD-K13390322	Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1	CDK inhibitor	CDK1|CDK2|CDK4|CDK5|CDK6|CDK9
AT-9283		BRD-K24576554	O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1	Aurora kinase inhibitor; JAK inhibitor	AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A
ataluren	11219835	BRD-K94830329	OC(=O)c1cccc(c1)-c1noc(n1)-c1ccccc1F	CFTR channel agonist; dystrophin stimulant	DMD
atazanavir	148192	BRD-K09757388	COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(cc1)-c1ccccn1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C	HIV protease inhibitor	
ATB-346	25065981	BRD-A52551912	COc1ccc2cc(ccc2c1)C(C)C(=O)Oc1ccc(cc1)C(N)=S	cyclooxygenase inhibitor	PTGER2
atenolol-(+)	180559	BRD-K68075732	CC(C)NC[C@@H](O)COc1ccc(CC(N)=O)cc1	adrenergic receptor antagonist	
atenolol-(+/-)	2249	BRD-A20239487	CC(C)NCC(O)COc1ccc(CC(N)=O)cc1	adrenergic receptor antagonist	ADRB1|ADRB2
atenolol-(-)	175540	BRD-K44993696	CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1	adrenergic receptor antagonist	
atglistatin	71699712	BRD-K43363084	CN(C)C(=O)Nc1cccc(c1)-c1ccc(cc1)N(C)C	adipose triglyceride lipase inhibitor	
atipamezole	71310	BRD-K39252998	CCC1(Cc2ccccc2C1)c1cnc[nH]1	adrenergic receptor antagonist	
atiprimod	129869	BRD-K38527262	CCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1	JAK inhibitor; STAT inhibitor	JAK2|STAT3
atizoram	9861730	BRD-K76614248	COc1ccc(cc1O[C@H]1C[C@@H]2CC[C@H]1C2)C1CNC(=O)NC1	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4C|PDE4D
ATN-161	9960285	BRD-K00521308	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O	integrin antagonist	ITGA5|ITGAV|ITGB1|ITGB3
atomoxetine	54841	BRD-K20141153	CNCC[C@@H](Oc1ccccc1C)c1ccccc1	norepinephrine transporter inhibitor	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A3|SLC6A4
atorvastatin	60823	BRD-K69726342	CC(C)c1c(C(=O)Nc2ccccc2)c(c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(O)=O)-c1ccccc1	HMGCR inhibitor	AHR|DPP4|HMGCR
atosiban	68613	BRD-A85261566	CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)C(NC(=O)[C@@H](NC2=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)cc1	oxytocin receptor antagonist	AVPR1A|AVPR1B|AVPR2|OXTR
atovaquone		BRD-A19795905	Clc1ccc(cc1)[C@H]1CC[C@@H](CC1)C1C(=O)C(=O)c2ccccc2C1=O	mitochondrial electron transport inhibitor	DHODH
ATPA	2252	BRD-A65145453	CC(C)(C)c1onc(O)c1CC(N)C(O)=O	glutamate receptor agonist	GRIA2|GRIK1
atracurium	47319	BRD-A75935363	COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC	acetylcholine receptor antagonist	CHRNA2
atrasentan	159594	BRD-K16295392	CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1c1ccc(OC)cc1)C(O)=O)c1ccc2OCOc2c1	endothelin receptor antagonist	EDNRA
atropine		BRD-A27290375	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
atropine-oxide	20710	BRD-A70067498	C[N+]1([O-])C2CCC1CC(C2)OC(=O)C(CO)c1ccccc1	acetylcholine receptor antagonist	
AT13148	24905401	BRD-K32127727	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(cc1)-c1cn[nH]c1	protein kinase inhibitor	AKT1|AKT2|AKT3|ROCK1|ROCK2|SGK3
AT13387	11955716	BRD-K58435339	CC(C)c1cc(C(=O)N2Cc3ccc(CN4CCN(C)CC4)cc3C2)c(O)cc1O	HSP antagonist	HSP90AA1
AT7867	11175137	BRD-K12040459	Clc1ccc(cc1)C1(CCNCC1)c1ccc(cc1)-c1cn[nH]c1	AKT inhibitor	AKT2|GSK3B|PKIA|PRKACA
auranofin	70788951	BRD-K73841932	CCP(CC)(CC)[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O	NFkB pathway inhibitor	IKBKB|PRDX5|TRPA1
aurora-a-inhibitor-i	44139710	BRD-K53561341	CCN1CCN(CC1)C(=O)Cc1ccc(Nc2ncc(F)c(Nc3ccc(cc3)C(=O)Nc3ccccc3Cl)n2)cc1	Aurora kinase inhibitor	AURKA
aurothioglucose	454937	BRD-A89825407	OC[C@H]1OC(S[Au])[C@H](O)[C@@H](O)[C@@H]1O	PKC inhibitor	PRKCI
autotaxin-modulator-1		BRD-A94640958	C[C@@H](N1C2CCC1CC(C2)C(O)=O)c1ccc2ccc(O[C@H]3CC[C@H](CC3)C(F)(F)F)c(c2c1)C(F)(F)F	autotaxin inhibitor	ENPP2
AV-412	9806229	BRD-K23190681	CN1CCN(CC1)C(C)(C)C#Cc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=C	protein tyrosine kinase inhibitor	EGFR|ERBB2
AV-608	9917079	BRD-K96615647	FC(F)(F)c1cc(cc(c1)C(F)(F)F)C(=O)N1CC[C@@H](C[C@H]1Cc1ccc(Cl)cc1)NC(=O)c1ccnc2ccccc12	tachykinin antagonist	TACR1
avagacestat	46883536	BRD-K83720053	NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(cc1F)-c1ncon1)S(=O)(=O)c1ccc(Cl)cc1	gamma secretase inhibitor	PSEN1
avanafil	9869929	BRD-K65781196	COc1ccc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl	phosphodiesterase inhibitor	PDE5A
avasimibe	166558	BRD-K67901620	CC(C)c1cc(C(C)C)c(CC(=O)NS(=O)(=O)Oc2c(cccc2C(C)C)C(C)C)c(c1)C(C)C	ACAT inhibitor	CES1
avatrombopag	9852519	BRD-K68544925	OC(=O)C1CCN(CC1)c1ncc(cc1Cl)C(=O)Nc1nc(-c2cc(Cl)cs2)c(s1)N1CCN(CC1)C1CCCCC1	thrombopoietin receptor agonist	MPL
AVE-0991	9851724	BRD-K36154108	CCNC(=O)NS(=O)(=O)c1sc(CC(C)C)cc1-c1ccc(Cn2c(C=O)c(OC)nc2-c2ccccc2)cc1	angiotensin receptor agonist	MRGPRX1
avibactam	90333665	BRD-K85882401	NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O	beta lactamase inhibitor	
AVL-292	59174488	BRD-K87782578	COCCOc1ccc(Nc2ncc(F)c(Nc3cccc(NC(=O)C=C)c3)n2)cc1	Bruton's tyrosine kinase (BTK) inhibitor	BTK|YES1
AVN-944	9918559	BRD-K62196610	CC[C@H](CC#N)OC(=O)N[C@@H](C)c1cccc(NC(=O)Nc2ccc(-c3cnco3)c(OC)c2)c1	inosine monophosphate dehydrogenase inhibitor	IMPDH1|IMPDH2
avobenzone	51040	BRD-K14401183	COc1ccc(cc1)C(=O)CC(=O)c1ccc(cc1)C(C)(C)C	UV blocker	TYR
avridine	37186	BRD-K26665484	CCCCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCCCC)CCCN(CCO)CCO	immunostimulant	
axitinib	6450551	BRD-K29905972	CNC(=O)c1ccccc1Sc1ccc2c(\C=C\c3ccccn3)n[nH]c2c1	PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor	CSF1|FLT1|FLT4|KDR|PLK4
AY-9944		BRD-K77012840	Clc1ccccc1CNC[C@H]1CC[C@H](CNCc2ccccc2Cl)CC1	hedgehog pathway modulator	
AZ-10417808	16759160	BRD-K36258877	[O-][N+](=O)c1cc(C(=O)NCC=C)c2nc(Nc3ccc(Cl)c(Cl)c3)[nH]c(=O)c2c1	caspase inhibitor	CASP3
AZ-10606120	10310632	BRD-K09907507	OCCNCCNc1ccc2c(NC(=O)CC34CC5CC(CC(C5)C3)C4)cccc2n1	purinergic receptor antagonist	P2RX7
AZ-12080282	25253556	BRD-K05973499	Cc1ccc(cc1NC(=O)c1ccc(OCc2ccccn2)cc1)-c1ncc[nH]1	hedgehog pathway inhibitor	DHH
AZ-628	11676786	BRD-K05804044	Cc1ccc(NC(=O)c2cccc(c2)C(C)(C)C#N)cc1Nc1ccc2ncn(C)c(=O)c2c1	RAF inhibitor	BRAF|RAF1
azacitidine	9444	BRD-K03406345	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1	DNA methyltransferase inhibitor	DNMT1|DNMT3A
azacyclonol	15723	BRD-K97061094	OC(C1CCNCC1)(c1ccccc1)c1ccccc1	histamine receptor antagonist	HRH1
azaguanine-8	8646	BRD-K53114651	Nc1nc2[nH]nnc2c(=O)[nH]1	purine antagonist	PNP
azalomycin-b	129010077	BRD-K96104201	CC[C@@H]1[C@@H](C)O[C@](O)(C[C@H]1O[C@H]1C[C@H](O)[C@H](O)[C@H](C)O1)[C@@H](C)[C@H](O)[C@H](C)[C@@H]1OC(=O)\C=C\C=C\[C@@H](C)[C@H](OC(=O)\C=C\C=C\[C@@H]1C)[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](O[C@H]2C[C@H](O)[C@H](O)[C@H](C)O2)[C@H](CC)[C@@H](C)O1	bacterial 50S ribosomal subunit inhibitor	
azaperone	15443	BRD-K45861246	Fc1ccc(cc1)C(=O)CCCN1CCN(CC1)c1ccccn1	dopamine receptor antagonist	DRD2|DRD3
azapropazone	26098	BRD-A70182876	CCCC1C(=O)N2N(C1=O)c1cc(C)ccc1N=C2N(C)C	cyclooxygenase inhibitor	PTGS2
azaserine		BRD-A67065070	NC(COC(=O)C=[N+]=[N-])C(O)=O	purine antagonist	
azasetron	2264	BRD-A44133049	CN1C(=O)COc2c1cc(Cl)cc2C(=O)NC1CN2CCC1CC2	serotonin receptor antagonist	HTR3A|HTR3B
azatadine	19861	BRD-K77821588	CN1CCC(CC1)=C1c2ccccc2CCc2cccnc12	histamine receptor antagonist	HRH1
azathioprine	2265	BRD-K32821942	Cn1cnc(c1Sc1[nH]cnc2ncnc12)[N+]([O-])=O	dehydrogenase inhibitor	HPRT1|IMPDH1|PPAT
AZD1080		BRD-K61041538	Oc1[nH]c2ccc(cc2c1-c1ccc(CN2CCOCC2)cn1)C#N	glycogen synthase kinase inhibitor	GSK3A|GSK3B
AZD1208	58423153	BRD-K21908111	N[C@@H]1CCCN(C1)c1c(cccc1-c1ccccc1)\C=C1/SC(=O)NC1=O	Pim kinase inhibitor	PIM1|PIM2|PIM3
AZD1283	23649325	BRD-K77060810	CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1	purinergic receptor antagonist	P2RY12
AZD1446	24795080	BRD-A44188509	Clc1ccc(o1)C(=O)N1CC2CNCC2C1	acetylcholine receptor agonist	CHRNA4|CHRNB2
AZD1480	16659841	BRD-K65928735	C[C@H](Nc1ncc(Cl)c(Nc2cc(C)[nH]n2)n1)c1ncc(F)cn1	JAK inhibitor	JAK1|JAK2|JAK3
AZD1981	11292191	BRD-K83186168	CC(=O)Nc1cccc2n(CC(O)=O)c(C)c(Sc3ccc(Cl)cc3)c12	CRTH receptor antagonist	PTGDR2
AZD2014	25262792	BRD-K99113996	CNC(=O)c1cccc(c1)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C	mTOR inhibitor	MTOR
AZD2461	44199317	BRD-K85014146	COC1CCN(CC1)C(=O)c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F	PARP inhibitor	
AZD2858	10138980	BRD-K85849709	CN1CCN(CC1)S(=O)(=O)c1ccc(cc1)-c1cnc(N)c(n1)C(=O)Nc1cccnc1	glycogen synthase kinase inhibitor	GSK3B
AZD3264	91666658	BRD-K14287049	Cc1noc(C)c1-c1ccc(-c2cc(C(N)=O)c(NC(N)=O)s2)c(O[C@H]2CCNC2)c1	IKK inhibitor	IKBKB
AZD3463	56599293	BRD-K24593301	COc1cc(ccc1Nc1ncc(Cl)c(n1)-c1c[nH]c2ccccc12)N1CCC(N)CC1	ALK tyrosine kinase receptor inhibitor; insulin growth factor receptor inhibitor	ALK|IGF1R
AZD3514	46893585	BRD-K84996356	CC(=O)N1CCN(CCOc2ccc(cc2)C2CCN(CC2)C2=Nn3c(CC2)nnc3C(F)(F)F)CC1	androgen receptor modulator	AR
AZD3759	78209992	BRD-K41626799	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C	EGFR inhibitor	EGFR
AZD3839	60210951	BRD-A54654253	NC1N[C@](c2cccc(F)c12)(c1ccnc(c1)C(F)F)c1cccc(c1)-c1cncnc1	beta-secretase inhibitor	BACE1
AZD3965	10369242	BRD-K25210703	CC(C)n1c2sc(Cc3c(C)[nH]nc3C(F)(F)F)c(C(=O)N3C[C@](C)(O)CO3)c2c(=O)n(C)c1=O	monocarboxylate transporter inhibitor	SLC16A1
AZD3988		BRD-K73984371	OC(=O)C[C@H]1CC[C@@H](CC1)c1ccc(NC(=O)c2nnc(Nc3ccc(F)c(F)c3)o2)cc1	diacylglycerol kinase inhibitor	DGAT1
AZD4282	5257127	BRD-K72369578	NCC(O)=O	glutamate receptor antagonist	AGXT|AGXT2|ALAS1|ALAS2|BAAT|GARS|GATM|GCAT|GCSH|GLDC|GLRA1|GLRA2|GLRA3|GLRB|GLYAT|GLYATL1|GLYATL2|GNMT|GPR18|GPRC6A|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3B|GSS|PIPOX|SHMT1|SHMT2|SLC32A1|SLC36A1|SLC6A5|SLC6A9
AZD4547	51039095	BRD-K28392481	COc1cc(CCc2cc(NC(=O)c3ccc(cc3)N3C[C@H](C)N[C@H](C)C3)n[nH]2)cc(OC)c1	FGFR inhibitor	FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR
AZD5069	59149652	BRD-K34801930	C[C@H](Nc1cc(NS(=O)(=O)N2CCC2)nc(SCc2cccc(F)c2F)n1)[C@@H](O)CO	CC chemokine receptor antagonist	CXCR2
AZD5363	25227436	BRD-K99023089	NC1(CCN(CC1)c1ncnc2[nH]ccc12)C(=O)N[C@@H](CCO)c1ccc(Cl)cc1	AKT inhibitor	AKT1|AKT2|AKT3
AZD5438	16747683	BRD-K72414522	CC(C)n1c(C)ncc1-c1ccnc(Nc2ccc(cc2)S(C)(=O)=O)n1	CDK inhibitor	KCNH2
AZD5582	49847690	BRD-K88767641	CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1[C@@H](Cc2ccccc12)OCC#CC#CCO[C@@H]1Cc2ccccc2[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC)C1CCCCC1	XIAP inhibitor	BIRC2|BIRC3|XIAP
AZD6482	44137675	BRD-K58772419	C[C@@H](Nc1ccccc1C(O)=O)c1cc(C)cn2c1nc(cc2=O)N1CCOCC1	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
AZD6738	86660217	BRD-A36013532	C[C@@H]1COCCN1c1cc(nc(n1)-c1ccnc2[nH]ccc12)C1(CC1)S(C)(=N)=O	ATR kinase inhibitor	ATR
AZD6765	3038485	BRD-A94033181	NC(Cc1ccccn1)c1ccccc1	glutamate receptor antagonist	GRIN1
AZD7545	9805105	BRD-A87435144	CN(C)C(=O)c1ccc(cc1)S(=O)(=O)c1ccc(NC(=O)C(C)(O)C(F)(F)F)c(Cl)c1	pyruvate dehydrogenase kinase inhibitor	PDK1
AZD7687		BRD-K31495718	Cc1nc(C)c(nc1C(N)=O)-c1ccc(cc1)[C@H]1CC[C@H](CC(O)=O)CC1	diacylglycerol O acyltransferase inhibitor	DGAT1
AZD7762	11152667	BRD-K86525559	NC(=O)Nc1cc(sc1C(=O)N[C@H]1CCCNC1)-c1cccc(F)c1	CHK inhibitor	CHEK1|CHEK2
AZD8055	25262965	BRD-K69932463	COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C	mTOR inhibitor	MTOR
AZD8186	52913813	BRD-K47289408	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(cc2c1oc(cc2=O)N1CCOCC1)C(=O)N(C)C	PI3K inhibitor	PIK3CB|PIK3CD
AZD8330	16666708	BRD-K37687095	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O	MEK inhibitor	
AZD8835	76685059	BRD-K82894950	CCn1nc(nc1-c1cnc(N)c(n1)-c1nnc(o1)C(C)(C)C)C1CCN(CC1)C(=O)CCO	PI3K inhibitor	PIK3CA|PIK3CD
AZD8931	11488320	BRD-K98572433	CNC(=O)CN1CCC(CC1)Oc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC	EGFR inhibitor	EGFR|ERBB2|ERBB3
AZD9272	9838729	BRD-K61043483	Fc1ccc(nc1)-c1noc(n1)-c1cc(F)cc(c1)C#N	glutamate receptor antagonist	GRM5
AZD9496	86287635	BRD-K73235735	C[C@@H]1Cc2c([nH]c3ccccc23)[C@H](N1CC(C)(C)F)c1c(F)cc(\C=C\C(O)=O)cc1F	estrogen receptor agonist	ESR1
AZD9668	46861623	BRD-K31476763	Cc1c(cc(C(=O)NCc2ccc(cn2)S(C)(=O)=O)c(=O)n1-c1cccc(c1)C(F)(F)F)-c1ccnn1C	elastase inhibitor	ELANE
azelaic-acid	19347555	BRD-K08976401	OC(=O)CCCCCCCC(O)=O	tyrosinase inhibitor	AKR1D1|SRD5A2|TYR
azelastine	2267	BRD-A68888262	CN1CCCC(CC1)n1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O	histamine receptor antagonist	HRH1
azeliragon	11180124	BRD-K51899933	CCCCc1nc(cn1-c1ccc(Oc2ccc(Cl)cc2)cc1)-c1ccc(OCCCN(CC)CC)cc1	RAGE receptor antagonist	AGER
azelnidipine	65948	BRD-A01098288	CC(C)OC(=O)C1=C(C)NC(N)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC1CN(C1)C(c1ccccc1)c1ccccc1	calcium channel blocker	CACNA1C
azilsartan	9825285	BRD-K81074237	CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1	angiotensin receptor antagonist	AGTR1|AGTR2
azilsartan-medoxomil	11238823	BRD-K25723200	CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1	angiotensin receptor antagonist	AGTR1|AGTR2
azimilide	9571004	BRD-K38913877	CN1CCN(CCCCN2C(=O)CN(\N=C\c3ccc(o3)-c3ccc(Cl)cc3)C2=O)CC1	potassium channel blocker	KCNA5|KCNE1|KCNH2|KCNQ1
azithromycin	447043	BRD-K74501079	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O	bacterial 50S ribosomal subunit inhibitor	MLNR
azlocillin	6479523	BRD-K60663764	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(O)=O	bacterial cell wall synthesis inhibitor	
AZM-475271	5330175	BRD-K51329597	COc1ccc(Cl)c(Nc2ncnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c1	src inhibitor	SRC
azodicarbonamide	5462814	BRD-K87036601	NC(=O)\N=N\C(N)=O	DNA synthesis inhibitor	
azomycin-(2-nitroimidazole)	10701	BRD-K26824830	[O-][N+](=O)c1ncc[nH]1	protein synthesis inhibitor	
azosemide	2273	BRD-K68770713	NS(=O)(=O)c1cc(-c2nnn[nH]2)c(NCc2cccs2)cc1Cl	electrolyte reabsorption inhibitor	SLC12A1|SLC12A2
aztreonam	5742832	BRD-K62607865	C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\c2csc(N)n2)C(=O)N1S(O)(=O)=O	bacterial cell wall synthesis inhibitor	
AZ191	72716071	BRD-K80935598	COc1cc(ccc1Nc1nccc(n1)-c1cn(C)c2cnccc12)N1CCN(C)CC1	DYRK inhibitor	DYRK1B
AZ20	46244454	BRD-K42436189	C[C@@H]1COCCN1c1cc(nc(n1)-c1cccc2[nH]ccc12)C1(CC1)S(C)(=O)=O	ATR kinase inhibitor	ATR|MTOR
AZ3146	56973724	BRD-K59146805	COc1cc(OC2CCN(C)CC2)ccc1Nc1ncc2n(C)c(=O)n(C3CCCC3)c2n1	monopolar spindle 1 kinase inhibitor	
AZ505	24961094	BRD-K76244476	Oc1ccc(CCNCCN(C2CCCCC2)C(=O)CCNCCc2ccc(Cl)c(Cl)c2)c2OCC(=O)Nc12	histone lysine methyltransferase inhibitor	SMYD2
AZ5104	71496460	BRD-K81958169	COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc1nccc(n1)-c1c[nH]c2ccccc12	EGFR inhibitor	EGFR
AZ960	25099184	BRD-K64888243	C[C@H](Nc1nc(Nc2cc(C)[nH]n2)c(F)cc1C#N)c1ccc(F)cc1	JAK inhibitor	JAK2
A0001	2734086	BRD-K57865272	CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@@](C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O		
A12B4C3	6610064	BRD-A30000356	CCCCCCCCCCC(O)C1C=CC2C(N1Nc1ccc(cc1)[N+]([O-])=O)C(=O)N(C2=O)c1ccccc1	polynucleotide kinase/phosphatase inhibitor	PNKP
A205804	9839311	BRD-K77627880	Cc1ccc(Sc2cncc3sc(cc23)C(N)=O)cc1	ICAM1 expression inhibitor	ICAM1|SELE
A61603	4038180	BRD-A83650191	CS(=O)(=O)Nc1c(O)ccc2C(CCCc12)C1=NCCN1	adrenergic receptor agonist	ADRA1A
A66	42636535	BRD-K49055432	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(n1)C(C)(C)C	PI3K inhibitor	PIK3CA
A740003	11351968	BRD-A78952587	COc1ccc(CC(=O)NC(N\C(Nc2cccc3ncccc23)=N\C#N)C(C)(C)C)cc1OC	purinergic receptor antagonist	P2RX7
A77636		BRD-K72226571	NC[C@@H]1O[C@@H](Cc2c(O)c(O)ccc12)[C@@]12CC3CC(CC(C3)C1)C2	dopamine receptor agonist	CALY
A922500	24768273	BRD-K28861668	OC(=O)[C@H]1CCC[C@H]1C(=O)c1ccc(cc1)-c1ccc(NC(=O)Nc2ccccc2)cc1	diacylglycerol O acyltransferase inhibitor	DGAT1
bacampicillin	441397	BRD-A41698174	CCOC(=O)OC(C)OC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O	bacterial cell wall synthesis inhibitor	
bacitracin	2283	BRD-A49374018	CCC(C)C(N)C1=NC(CS1)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(C(C)CC)C(=O)NCCCCC1NC(=O)C(CC(N)=O)NC(=O)C(CC(O)=O)NC(=O)C(Cc2c[nH]cn2)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)C(CCCN)NC1=O)C(C)CC	bacterial cell wall synthesis inhibitor	A2M|IDE
bacitracin-zinc		BRD-A06016120	CC[C@H](C)[C@H](N)C1=NCC(S1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]1CCC(=O)O[Zn]OC(=O)C[C@H]2NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC(=O)[C@H](CCCCNC(=O)[C@H](CC(N)=O)NC2=O)NC(=O)[C@@H](NC1=O)[C@H](C)CC)[C@H](C)CC	bacterial cell wall synthesis inhibitor	
baclofen	2284	BRD-A84174873	NCC(CC(O)=O)c1ccc(Cl)cc1	benzodiazepine receptor agonist	GABBR1|GABBR2|KCTD12|KCTD16|KCTD8
baclofen-(R)	44602	BRD-K62353271	NC[C@H](CC(O)=O)c1ccc(Cl)cc1	benzodiazepine receptor agonist	GABBR1|GABBR2
BADGE	2286	BRD-A16694057	CC(C)(c1ccc(OCC2CO2)cc1)c1ccc(OCC2CO2)cc1	PPAR receptor antagonist	PPARG
bafetinib	74333653	BRD-A75975749	CN(C)C1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc2ccc(C)c(Nc3ncc(cn3)-c3cncnc3)c2)C1	Bcr-Abl kinase inhibitor; LYN tyrosine kinase inhibitor	ABL1|BCR|LYN
BAG-956	24882589	BRD-K00652956	Cc1nc2cnc3ccc(cc3c2n1-c1ccc(cc1)C(C)(C)C#N)C#Cc1cccnc1	phosphoinositide dependent kinase inhibitor	PIK3CG
baicalein	5281605	BRD-K72327355	Oc1cc2oc(cc(=O)c2c(O)c1O)-c1ccccc1	lipoxygenase inhibitor	ALOX5|GLO1|PREP|SELL|SELP|TNF|XDH
baicalin	64982	BRD-K49962337	O[C@H]1[C@H](Oc2cc3oc(cc(=O)c3c(O)c2O)-c2ccccc2)O[C@@H]([C@@H](O)[C@@H]1O)C(O)=O	beta glucuronidase inhibitor	PREP
bakuchiol	5468522	BRD-K09785578	CC(C)=CCC[C@@](C)(C=C)\C=C\c1ccc(O)cc1	DNA polymerase inhibitor	HIF1A
balaglitazone	9889200	BRD-A00147595	Cn1c(COc2ccc(CC3SC(=O)NC3=O)cc2)nc2ccccc2c1=O	insulin sensitizer; PPAR receptor partial agonist	PPARG
balapiravir	11691726	BRD-K47976015	CC(C)C(=O)OC[C@]1(O[C@H]([C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C)n1ccc(N)nc1=O)N=[N+]=[N-]	RNA polymerase inhibitor	
balicatib	10201696	BRD-K27204852	CCCN1CCN(CC1)c1ccc(cc1)C(=O)NC1(CCCCC1)C(=O)NCC#N	cathepsin inhibitor	CTSK
balofloxacin	65958	BRD-A47790386	CNC1CCCN(C1)c1c(F)cc2c(c1OC)n(cc(C(O)=O)c2=O)C1CC1	bacterial DNA gyrase inhibitor	
balsalazide		BRD-K41410256	OC(=O)CCNC(=O)c1ccc(cc1)N=Nc1ccc(O)c(c1)C(O)=O	cyclooxygenase inhibitor	ALOX5|PPARG|PTGS1|PTGS2
bambuterol	54766	BRD-A17462676	CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(c1)C(O)CNC(C)(C)C	adrenergic receptor agonist	ADRB2|BCHE
BAM7	5754137	BRD-K07442505	CCOc1ccccc1N\N=C1C(=O)N(N=C\1C)c1nc(cs1)-c1ccccc1	BAX activator	BAX
BAN-ORL-24	10296561	BRD-K47049295	O=C(NCCCN1CCC2(CC1)OCc1ccccc21)[C@H]1CCCN1Cc1ccccc1	nociceptin/orphanin FQ receptor antagonist	OPRL1
barasertib	11497983	BRD-K31928526	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(O)(O)=O	Aurora kinase inhibitor	AURKA|AURKB
barasertib-HQPA	16007391	BRD-K63923597	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1	Aurora kinase inhibitor	AURKB
barbital	2294	BRD-K83359602	CCC1(CC)C(=O)NC(=O)NC1=O	sedative	CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GRIA2|GRIK2
bardoxolone	400010	BRD-K20545304	CC1(C)CC[C@@]2(CC[C@]3(C)[C@@H]([C@@H]2C1)C(=O)C=C1[C@@]2(C)C=C(C#N)C(=O)C(C)(C)[C@@H]2CC[C@@]31C)C(O)=O	nuclear factor erythroid derived; like (NRF2) activator	NOS2|PPARG
bardoxolone-methyl	400769	BRD-K69694239	COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2	nuclear factor erythroid derived; like (NRF2) activator	PPARG|STAT3
baricitinib	44205240	BRD-K53581288	CCS(=O)(=O)N1CC(CC#N)(C1)n1cc(cn1)-c1ncnc2[nH]ccc12	JAK inhibitor	JAK1|JAK2
barium-6-O-phosphonato-D-glucose	439958	BRD-K67760597	O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H](O)C=O		GPI
barnidipine	443869	BRD-K78781788	COC(=O)C1=C(C)NC(C)=C([C@H]1c1cccc(c1)[N+]([O-])=O)C(=O)O[C@H]1CCN(Cc2ccccc2)C1	calcium channel blocker	
basic-fuchsin	12448	BRD-K26362911	CC1=CC(C=CC1=N)=C(c1ccc(N)cc1)c1ccc(N)cc1		
basimglurant	11438771	BRD-K62387885	Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(F)cc1	glutamate receptor antagonist	GRM5
batimastat	5362422	BRD-K82818427	CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)[C@H](CSc1cccs1)C(=O)NO	matrix metalloprotease inhibitor	ADAM28|ADAMTS5|MMP12|MMP16|MMP2|MMP8
bavisant	16061509	BRD-K79595931	O=C(N1CCN(CC1)C1CC1)c1ccc(CN2CCOCC2)cc1	histamine receptor antagonist	HRH3
BAX-channel-blocker	2729027	BRD-A18763547	OC(CN1CCNCC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc12	cytochrome C release inhibitor	BAX
BAY-K-8644-(+/-)	2303	BRD-A05457250	COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1C(F)(F)F)[N+]([O-])=O	L-type calcium channel activator	
BAY-K-8644-(s)-(-)	6603728	BRD-K14329163	COC(=O)C1=C(C)NC(C)=C([C@H]1c1ccccc1C(F)(F)F)[N+]([O-])=O	L-type calcium channel activator	CACNA1C
bay-w-9798	2167221	BRD-K44471774	COC(=O)C1=C(C)N(C)C(C)=C(C1c1ccc(cc1)C(F)(F)F)C(=O)OC	antioxidant	
BAY-11-7082	5353431	BRD-K15025317	Cc1ccc(cc1)S(=O)(=O)\C=C\C#N	NFkB pathway inhibitor	RELA
BAY-11-7085	5353432	BRD-K48684885	CC(C)(C)c1ccc(cc1)S(=O)(=O)\C=C\C#N	NFkB pathway inhibitor	NFKBIA
BAY-41-2272	9798973	BRD-K32033120	Nc1nc(ncc1C1CC1)-c1nn(Cc2ccccc2F)c2ncccc12	guanylyl cyclase activator	GUCY1A3|GUCY1B3
BAY-60-6583	11717831	BRD-K32952627	NC(=O)CSc1nc(N)c(C#N)c(-c2ccc(OCC3CC3)cc2)c1C#N	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3
bay-60-7550	25273570	BRD-K86932920	COc1ccc(Cc2nn3c(nc(C)c3c(=O)[nH]2)[C@@H](CCCc2ccccc2)[C@@H](C)O)cc1OC	phosphodiesterase inhibitor	PDE2A
BAY-61-3606	10200390	BRD-K53281329	COc1ccc(cc1OC)-c1cc2nccn2c(Nc2ncccc2C(N)=O)n1	syk inhibitor	SYK
BAY-85-8050	102871	BRD-A11731518	NC(CC(F)C(O)=O)C(O)=O		
BAY-87-2243	67377767	BRD-K70463136	Cc1cc(nn1Cc1ccnc(c1)N1CCN(CC1)C1CC1)-c1nc(no1)-c1ccc(OC(F)(F)F)cc1	hypoxia inducible factor inhibitor	HIF1A
bazedoxifene	154257	BRD-K90195324	Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12	selective estrogen receptor modulator (SERM)	ESR1|ESR2
BAZ2-ICR	91654625	BRD-K66830666	Cn1cc(CCn2cnc(-c3cnn(C)c3)c2-c2ccc(cc2)C#N)cn1	bromodomain inhibitor	ZNF215
BC-11	60126757	BRD-K14646328	NC(=N)SCc1ccc(cc1)B(O)O	urokinase inhibitor	PLAU
BCI-540	214346	BRD-K23672206	Cc1oc2nc3CCCCc3c(NC(=O)CN3CCCC3=O)c2c1C	glutamate receptor agonist	
BCTC	9929425	BRD-K66541497	CC(C)(C)c1ccc(NC(=O)N2CCN(CC2)c2ncccc2Cl)cc1	TRPV antagonist	TRPV1
BCX-1470	9822205	BRD-K90472149	NC(=N)c1cc2ccc(OC(=O)c3cccs3)cc2s1	serine protease inhibitor; complement inhibitor	CFD
BD-1008	126388	BRD-K17008822	CN(CCN1CCCC1)CCc1ccc(Cl)c(Cl)c1	sigma receptor antagonist	
BD-1047	188914	BRD-K36864847	CN(C)CCN(C)CCc1ccc(Cl)c(Cl)c1	adrenergic receptor antagonist	SIGMAR1
BD-1063	574780	BRD-K29668683	CN1CCN(CCc2ccc(Cl)c(Cl)c2)CC1	sigma receptor antagonist	SIGMAR1
BE-2254	34772	BRD-A24429032	Oc1ccc(CCNCC2CCc3ccccc3C2=O)cc1	adrenergic receptor antagonist	ADRA1A
beclamide	10391	BRD-K44824027	ClCCC(=O)NCc1ccccc1	anticonvulsant	
beclomethasone	2308	BRD-A73385064	CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(O)C(=O)CO	glucocorticoid receptor agonist	NR3C1|SERPINA6
beclomethasone-dipropionate	21700	BRD-K97810537	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]12C	glucocorticoid receptor agonist	GPR97|NR3C1
bedaquiline	5388906	BRD-K90817094	COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12	ATPase inhibitor	
befuraline	68664	BRD-K99077012	O=C(N1CCN(Cc2ccccc2)CC1)c1cc2ccccc2o1		
begacestat	11269353	BRD-K58319700	OC[C@@H](NS(=O)(=O)c1ccc(Cl)s1)C(C(F)(F)F)C(F)(F)F	gamma secretase inhibitor	PSEN1
bekanamycin	439318	BRD-K73425385	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O	bacterial 30S ribosomal subunit inhibitor	
belinostat	6918638	BRD-K17743125	ONC(=O)\C=C\c1cccc(c1)S(=O)(=O)Nc1ccccc1	HDAC inhibitor	HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
bemegride	2310	BRD-K14993104	CCC1(C)CC(=O)NC(=O)C1	chemoreceptor agonist	GABRA1
bemesetron	1683	BRD-A85587465	CN1C2CCC1CC(C2)OC(=O)c1cc(Cl)cc(Cl)c1	serotonin receptor antagonist	HTR3A|HTR3B
bemotrizinol		BRD-A92974210	CCCCC(CC)COc1ccc(c(O)c1)-c1nc(nc(n1)-c1ccc(OCC(CC)CCCC)cc1O)-c1ccc(OC)cc1		
benaxibine	228105	BRD-A90642009	OC1COC(Nc2ccc(cc2)C(O)=O)C(O)C1O		
benazepril	40466887	BRD-K49807096	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(O)=O)C1=O	angiotensin converting enzyme inhibitor	ACE
bendamustine	65628	BRD-K17068645	Cn1c(CCCC(O)=O)nc2cc(ccc12)N(CCCl)CCCl	DNA inhibitor	
bendazac	2313	BRD-K19515365	OC(=O)COc1nn(Cc2ccccc2)c2ccccc12	cyclooxygenase inhibitor	PTGS1|PTGS2
bendroflumethiazide	2315	BRD-A80017228	NS(=O)(=O)c1cc2c(NC(Cc3ccccc3)NS2(=O)=O)cc1C(F)(F)F	sodium/potassium/chloride transporter inhibitor	CA1|CA2|CA4|KCNMA1|SLC12A1|SLC12A3
benethamine	65055	BRD-K13473780	C(Cc1ccccc1)NCc1ccccc1		
benfluorex	2318	BRD-A22305049	CC(Cc1cccc(c1)C(F)(F)F)NCCOC(=O)c1ccccc1	gluconeogenesis inhibitor	HMGCR
benfluralin	2319	BRD-K33903083	CCCCN(CC)c1c(cc(cc1[N+]([O-])=O)C(F)(F)F)[N+]([O-])=O		CYP1A1|CYP1A2|CYP2B6|CYP3A4|ESR1|MMP1|SULT2A1|UGT1A1
benfotiamine	5282168	BRD-K07359318	C\C(N(Cc1cnc(C)nc1N)C=O)=C(\CCOP(O)(O)=O)SC(=O)c1ccccc1	antioxidant	AGER
benidipine	656668	BRD-K97181463	COC(=O)C1=C(C)NC(C)=C([C@@H]1c1cccc(c1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(Cc2ccccc2)C1	calcium channel blocker	CACNA1C|CACNA1G
benperidol	16363	BRD-K79425933	Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O	dopamine receptor antagonist	DRD2
benproperine	2326	BRD-A42423104	CC(COc1ccccc1Cc1ccccc1)N1CCCCC1	antitussive	SCN5A
benserazide	2327	BRD-A61194565	NC(CO)C(=O)NNCc1ccc(O)c(O)c1O	DOPA decarboxylase inhibitor	DDC
bentazepam		BRD-K89490285	O=C1CN=C(c2c3CCCCc3sc2N1)c1ccccc1	benzodiazepine receptor agonist	
bentiromide	6957673	BRD-K58794715	OC(=O)c1ccc(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1		HPN
benurestat	38000	BRD-K88553858	ONC(=O)CNC(=O)c1ccc(Cl)cc1	urease inhibitor	
benzalkonium	2330	BRD-K34234316	CCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1	Cationic surfactant	
benzamil	108107	BRD-K87158025	NC(NCc1ccccc1)=NC(=O)c1nc(Cl)c(N)nc1N	sodium channel blocker	ASIC1|PKD2L1|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC8A1
benzbromarone	2333	BRD-K11717138	CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1	chloride channel blocker	ABCC1
benzenemethanol,-2,5-dimethyl-[[(1-methylethyl)amino]methyl]	22168	BRD-A98083480	CC(C)NCC(O)c1cc(C)ccc1C		
benzethonium	2335	BRD-K72723676	CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1	sodium channel blocker	SCN10A
benznidazole	31593	BRD-K56156805	[O-][N+](=O)c1nccn1CC(=O)NCc1ccccc1	DNA synthesis inhibitor	
benzo[d]thiazole-2(3h)-thione	697993	BRD-K55160477	Sc1nc2ccccc2s1		
benzocaine	2337	BRD-K75466013	CCOC(=O)c1ccc(N)cc1	sodium channel blocker	SCN10A
benzoclidine	65630	BRD-A45929034	O=C(OC1CN2CCC1CC2)c1ccccc1		
benzofenac	91676	BRD-K26556907	OC(=O)Cc1ccc(OCc2ccccc2)c(Cl)c1		
benzoic-acid	20144841	BRD-K53397409	OC(=O)c1ccccc1	food preservative	DAO|HRSP12|PRDX5|RAB9A
benzoin	8400	BRD-A55748233	OC(C(=O)c1ccccc1)c1ccccc1		CES1
benzonatate	7699	BRD-K91699951	CCCCNc1ccc(cc1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC	local anesthetic	SCN5A
benzoquinonium-dibromide	9394	BRD-K18772613	CC[N+](CC)(CCCNC1=CC(=O)C(NCCC[N+](CC)(CC)Cc2ccccc2)=CC1=O)Cc1ccccc1	cholinergic receptor antagonist	CHRNA1
benzotript	2787526	BRD-A87983072	OC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1	CCK receptor antagonist	CCKAR|CCKBR
benzoxiquine	6855	BRD-K70327191	O=C(Oc1cccc2cccnc12)c1ccccc1	antiinfective drug	
benzoyl-peroxide	7187	BRD-K59986511	O=C(OOC(=O)c1ccccc1)c1ccccc1	oxidizing agent	
benzoylpas	10718	BRD-K20431737	OC(=O)c1ccc(NC(=O)c2ccccc2)cc1O		
benzthiazide	2343	BRD-K21450440	NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O	carbonic anhydrase inhibitor	CA1|CA12|CA2|CA4|CA9|SLC12A3
benztropine-mesylate	6832	BRD-K48061146	CN1[C@@H]2CC[C@@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1	acetylcholine receptor antagonist	CHRM1|HRH1|SLC6A3
benzydamine	12555	BRD-K28542495	CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12	prostanoid receptor antagonist	
benzyl-alcohol	244	BRD-K98494274	OCc1ccccc1	local anesthetic	
benzyl-benzoate	2345	BRD-K52072429	O=C(OCc1ccccc1)c1ccccc1	lipase inhibitor	LIPE
benzyl-isothiocyanate	2346	BRD-K80253852	S=C=NCc1ccccc1	methylazoxymethanol acetate inhibitor	
benzyldimethylhexadecylammonium	31203	BRD-K23403298	CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1	cationic surfactant	
benzyldimethyloctylammonium	13741	BRD-K11576103	CCCCCCCC[N+](C)(C)Cc1ccccc1		
benzylpenicillin	5904	BRD-K55191674	CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(O)=O	penicillin binding protein inhibitor	
bephenium-hydroxynaphthoate	19667	BRD-K47878171	C[N+](C)(CCOc1ccccc1)Cc1ccccc1	anthelmintic agent	
bepotastine	164522	BRD-K98624455	OC(=O)CCCN1CCC(CC1)O[C@@H](c1ccc(Cl)cc1)c1ccccn1	histamine receptor antagonist	HRH1
bepridil	2351	BRD-A91008255	CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1	calcium channel blocker	ATP1A1|CACNA1A|CACNA1H|CACNA2D2|CALM1|KCNQ1|KCNQ4|PDE1A|PDE1B|TNNC1
berberine	2353	BRD-K14796088	COc1ccc2cc3-c4cc5OCOc5cc4CC[n+]3cc2c1OC	LDL receptor activator	LDLR
bergapten	2355	BRD-K12968785	COc1c2ccoc2cc2oc(=O)ccc12		
bergenin	66065	BRD-K04176066	COc1c(O)cc2C(=O)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]3c2c1O	interleukin inhibitor	IL1B|TNF
besifloxacin	10178705	BRD-K10196357	N[C@@H]1CCCCN(C1)c1c(F)cc2c(c1Cl)n(cc(C(O)=O)c2=O)C1CC1	bacterial DNA gyrase inhibitor	
BET-BAY-002	73425805	BRD-K72735080	Cc1nnc(C[C@@H]2C=C(c3ccc(Cl)cc3)c3ccccc3-n3c(C)nnc23)o1	bromodomain inhibitor	
beta-amyloid-synthesis-inhibitor	9882580	BRD-K38687824	Oc1cccc(Nc2ccc(Nc3cccc(O)c3)nn2)c1	beta amyloid synthesis inhibitor	APP
beta-carotene	5280489	BRD-K74225533	CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C		
beta-CCB	128618	BRD-K87349602	CCCCOC(=O)c1cc2c(cn1)[nH]c1ccccc21	benzodiazepine receptor ligand	GABRA1|GABRG2
beta-elemene	6918391	BRD-K21045639	CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@@H](C1)C(C)=C	apoptosis stimulant	MMP2|MMP9
beta-funaltrexamine	5311018	BRD-K95110148	COC(=O)\C=C\C(=O)N[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CC1)c45	opioid receptor antagonist	OPRD1|OPRK1|OPRM1
beta-glycerophosphoric-acid	2526	BRD-K39061174	OCC(CO)OP(O)(O)=O		
beta-hydroxy-beta-methylbutyrate	129010087	BRD-M02899238	CC(C)(O)CC(O)=O.CC(C)(O)CC(O)=O	protein synthesis stimulant	MTOR
beta-Hydroxybutyrate	441	BRD-A41387824	CC(O)CC(O)=O		HCAR2
beta-lapachone	3885	BRD-K28061410	CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O	topoisomerase inhibitor	TOP1
beta-naphthol	8663	BRD-K21164796	Oc1ccc2ccccc2c1		
betahistine	2366	BRD-K91315211	CNCCc1ccccn1	histamine receptor agonist; histamine receptor antagonist	HRH1|HRH3
betaine	248	BRD-K12014493	C[N+](C)(C)CC(O)=O	nitric oxide donor	
betamethasone	6710614	BRD-A02180903	C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	glucocorticoid receptor agonist	NR3C1
betamethasone-acetate	45006158	BRD-A92177080	C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O	glucocorticoid receptor agonist	NR3C1
betamethasone-dipropionate	21800	BRD-K58148589	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C	anti-inflammatory agent	
betamethasone-valerate	16533	BRD-K34032314	CCCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CO	glucocorticoid receptor agonist	NR3C1
betamipron	71651	BRD-K82142815	OC(=O)CCNC(=O)c1ccccc1	panipenem uptake inhibitor	
betaxolol	2369	BRD-A02759312	CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1	adrenergic receptor antagonist	ADRB1|ADRB2
betazole	7741	BRD-K20075662	NCCc1cc[nH]n1	histamine receptor agonist	HRH2
bethanechol	2370	BRD-A99833829	CC(C[N+](C)(C)C)OC(N)=O	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4
BETP	49868481	BRD-A60153876	CCS(=O)c1nc(cc(n1)C(F)(F)F)-c1cccc(OCc2ccccc2)c1	glucagon-like peptide receptor positive allosteric modulator	GLP1R
betrixaban	10275777	BRD-K45275534	COc1ccc(NC(=O)c2ccc(cc2)C(=N)N(C)C)c(c1)C(=O)Nc1ccc(Cl)cn1	coagulation factor inhibitor	KCNH2
betulinic-acid	64971	BRD-K45401373	CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O	apoptosis stimulant; NFkB pathway inhibitor	GPBAR1
bevantolol	2372	BRD-A18233884	COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC	adrenergic receptor antagonist	ADRA1A|ADRB1|ADRB2
bevirimat-dimeglumine	457928	BRD-K16898998	CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O	HIV capsid assembly inhibitor	
bexarotene	82146	BRD-K92441787	Cc1cc2c(cc1C(=C)c1ccc(cc1)C(O)=O)C(C)(C)CCC2(C)C	retinoid receptor agonist	RXRA|RXRB|RXRG
bezafibrate	39042	BRD-K46018455	CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(O)=O	PPAR receptor agonist	PPARA|PPARD|PPARG
BF2.649	9948102	BRD-K21673112	Clc1ccc(CCCOCCCN2CCCCC2)cc1	histamine receptor antagonist	HRH3
BGT226	11978790	BRD-K29415052	COc1ccc(cn1)-c1ccc2ncc3n(C)c(=O)n(-c4ccc(N5CCNCC5)c(c4)C(F)(F)F)c3c2c1	PI3K inhibitor	MTOR|PIK3CA|PIK3CB|PIK3CG
BHQ	2374	BRD-K95603879	CC(C)(C)c1cc(O)c(cc1O)C(C)(C)C	ATPase inhibitor	ATP2A1
BI-D1870	25023738	BRD-A81370665	CC(C)CCN1C(C)C(=O)N(C)c2cnc(Nc3cc(F)c(O)c(F)c3)nc12	ribosomal protein inhibitor	RPS6KA1|RPS6KA2|RPS6KA3|RPS6KA6
BI-224436	66561902	BRD-K53422148	Cc1nc2ccccc2c(-c2ccc3OCCc4ccnc2c34)c1[C@H](OC(C)(C)C)C(O)=O	HIV integrase inhibitor	
BI-2536	11364421	BRD-K64890080	CC[C@H]1N(C2CCCC2)c2nc(Nc3ccc(cc3OC)C(=O)NC3CCN(C)CC3)ncc2N(C)C1=O	PLK inhibitor	BRD4|PLK1|PLK2|PLK3
BI-78D3	2747117	BRD-K73982490	Oc1nnc(Sc2ncc(s2)[N+]([O-])=O)n1-c1ccc2OCCOc2c1	JNK inhibitor	MAPK8
BI-847325	88593899	BRD-K37492701	CCNC(=O)C#Cc1ccc2c(NC(=O)\C2=C(\Nc2ccc(CN(C)C)cc2)c2ccccc2)c1	MEK inhibitor; Aurora kinase inhibitor	AURKA|AURKB|AURKC|MAP2K1|MAP2K2
biapenem	71340	BRD-A80321291	C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3Cn4cnc[n+]4C3)=C(N2C1=O)C(O)=O	bacterial cell wall synthesis inhibitor	
BIBN4096	6918509	BRD-K43927145	NCCCC[C@H](NC(=O)[C@@H](Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(CC1)N1Cc2ccccc2NC1=O)C(=O)N1CCN(CC1)c1ccncc1	calcitonin antagonist	CALCA|CALCRL|RAMP1
BIBR-1532	9927531	BRD-K04623885	C\C(=C/C(=O)Nc1ccccc1C(O)=O)c1ccc2ccccc2c1	telomerase inhibitor	TERT
BIBU-1361	17756796	BRD-K49294207	CCN(CC)CC1CCN(CC1)c1ncc2ncnc(Nc3ccc(F)c(Cl)c3)c2n1	EGFR inhibitor	EGFR
BIBX-1382	6918508	BRD-K70914287	CN1CCC(CC1)Nc1ncc2ncnc(Nc3ccc(F)c(Cl)c3)c2n1	EGFR inhibitor	EGFR|ERBB2
bicalutamide	2375	BRD-A29485665	CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F	androgen receptor antagonist	AR
bicifadine	47953	BRD-A24208517	Cc1ccc(cc1)C12CC1CNC2	serotonin receptor antagonist; dopamine reuptake inhibitor	DRD2|SLC6A2|SLC6A4
bicuculline-(+)	46783703	BRD-A07870296	CN1CCc2cc3OCOc3cc2C1[C@@H]1OC(=O)c2c1ccc1OCOc21	GABA receptor antagonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|KCNN1
bicuculline-methochloride-(-)	124202188	BRD-A57798559	C[N+]1(C)CCc2cc3OCOc3cc2C1[C@@H]1OC(=O)c2c1ccc1OCOc21	GABA receptor antagonist	
bicyclol	9821754	BRD-K16546375	COC(=O)c1cc(OC)c2OCOc2c1-c1c2OCOc2c(OC)cc1CO	NFkB pathway inhibitor	HSPA1A|HSPB1
bifemelane	2377	BRD-K18779551	CNCCCCOc1ccccc1Cc1ccccc1	acetylcholine release enhancer	MAOA|MAOB
bifendate	108213	BRD-K26581543	COC(=O)c1cc(OC)c2OCOc2c1-c1c2OCOc2c(OC)cc1C(=O)OC		
bifonazole	2378	BRD-A94543220	c1cn(cn1)C(c1ccccc1)c1ccc(cc1)-c1ccccc1	sterol demethylase inhibitor	CYP2B6
BIIB021	16736529	BRD-K51967704	COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc23)c1C	HSP inhibitor	HSP90AA1
bilastine	185460	BRD-K51937257	CCOCCn1c(nc2ccccc12)C1CCN(CCc2ccc(cc2)C(C)(C)C(O)=O)CC1	histamine receptor antagonist	HRH1
bilobalide	12308750	BRD-A41714661	CC(C)(C)[C@]1(O)C[C@@H]2OC(=O)C[C@@]22C(=O)O[C@@H]3OC(=O)[C@H](O)C123	GABA receptor modulator	GLRA1|GLRA2|GLRB|HTR3A|HTR3B
bimatoprost	68184482	BRD-A45153512	CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(O)CCc1ccccc1	prostanoid receptor agonist	AKR1C3|PTGER1|PTGER3|PTGFR
BIMU-8	5311029	BRD-A62743154	CC(C)n1c2ccccc2n(C(=O)NC2C[C@@H]3CC[C@H](C2)N3C)c1=O	serotonin receptor agonist	HTR4
BINA	9868580	BRD-A13293292	Cc1c2C(=O)C(Cc2cc(OCc2cccc(c2)-c2ccc(cc2)C(O)=O)c1C)C1CCCC1	glutamate receptor positive allosteric modulator	GRM2
bindarit	71354	BRD-K36467523	CC(C)(OCc1nn(Cc2ccccc2)c2ccccc12)C(O)=O	NFkB pathway inhibitor	CCL2|CCL7|CCL8
BIO-1211	9961766	BRD-K03399463	CC(C)C[C@H](NC(=O)Cc1ccc(NC(=O)Nc2ccccc2C)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(O)=O	integrin antagonist	ITGA4|ITGB1
BIO-5192	10350459	BRD-K21318844	CC(C)C[C@H](N(C)C(=O)Cc1ccc(NC(=O)Nc2ccccc2C)cc1)C(=O)NCC[C@H](NC(=O)[C@@H]1CCCN1S(=O)(=O)c1cc(Cl)cc(Cl)c1)C(O)=O	integrin inhibitor	ITGA4|ITGB1
biotin	171548	BRD-K89210380	OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12	vitamin B	ACACA|ACACB|HLCS|MCCC1|MCCC2|PC|PCCA|PCCB|SLC5A6
bipenamol	43961	BRD-K47690382	NCc1ccccc1Sc1ccccc1CO	dipeptidyl peptidase inhibitor	CTSC
biperiden	2381	BRD-A00546892	OC(CCN1CCCCC1)(C1CC2CC1C=C2)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2
birinapant	49836020	BRD-K71221037	CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c([nH]c2cc(F)ccc12)-c1[nH]c2cc(F)ccc2c1C[C@@H]1C[C@H](O)CN1C(=O)[C@H](CC)NC(=O)[C@H](C)NC	XIAP inhibitor	BIRC2|XIAP
BIRT-377	9803375	BRD-K64880136	CN1C(=O)N(C(=O)[C@@]1(C)Cc1ccc(Br)cc1)c1cc(Cl)cc(Cl)c1	lymphocyte function-associated antigen negative modulator	ICAM1
bis(maltolato)oxovanadium(IV)	131853223	BRD-K16180792	Cc1occc(=O)c1O[V](=O)Oc1c(C)occc1=O	tyrosine phosphatase inhibitor	PTPN1
bisacodyl	2391	BRD-K39987650	CC(=O)Oc1ccc(cc1)C(c1ccc(OC(C)=O)cc1)c1ccccn1	laxative	
bisindolylmaleimide-ix	5083	BRD-K06543683	Cn1cc(C2=C(C(=O)NC2=O)c2cn(CCCSC(N)=N)c3ccccc23)c2ccccc12	PKC inhibitor	AKT1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SIRT1
bismuth(iii)-trifluoromethanesulfonate		BRD-M56276249	[Bi].OS(=O)(=O)C(F)(F)F.OS(=O)(=O)C(F)(F)F.OS(=O)(=O)C(F)(F)F	direct substitution catalyst	
bismuth-oxalate		BRD-M02179497	[Bi].[Bi].OC(=O)C(O)=O.OC(=O)C(O)=O.OC(=O)C(O)=O		
bismuth-subcitrate-potassium	118855610	BRD-A03880619	OC(=O)CC(O)(CC(=O)O[Bi]1OC(=O)CC(O)(CC(O)=O)C(=O)O1)C(O)=O		
bismuth-subgallate	102117152	BRD-K65978409	O[Bi]1Oc2cc(cc(O)c2O1)C(O)=O	nitric oxide synthase inhibitor	NOS1
bismuth-subsalicylate	53629521	BRD-K80528473	O[Bi]1OC(=O)c2ccccc2O1	antacid	
bisoctrizole	3571576	BRD-K00228584	CC(C)(C)CC(C)(C)c1cc(Cc2cc(cc(c2O)-n2nc3ccccc3n2)C(C)(C)CC(C)(C)C)c(O)c(c1)-n1nc2ccccc2n1		
bisoprolol	2405	BRD-A89175223	CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1	adrenergic receptor antagonist	ADRB1|ADRB2
bisphenol-a	6623	BRD-K41494493	CC(C)(c1ccc(O)cc1)c1ccc(O)cc1	synthetic estrogen	AR|ESR1|ESR2|ESRRG|PPARG
bithionol	2406	BRD-K39120595	Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O	autotaxin inhibitor	ESR1|ESR2|MCL1
bitopertin	24946690	BRD-K13756951	C[C@H](Oc1ccc(cc1C(=O)N1CCN(CC1)c1ncc(cc1F)C(F)(F)F)S(C)(=O)=O)C(F)(F)F	glycine transporter inhibitor; GlyT-1 inhibitor	SLC6A5|SLC6A9
bitoscanate	19958	BRD-K77548206	S=C=Nc1ccc(cc1)N=C=S	anthelmintic agent	
bivalirudin	131704509	BRD-K28054654	[2H]N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(O)=O	thrombin inhibitor	F2
BIX-01294	25150857	BRD-K26818574	COc1cc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC)N1CCCN(C)CC1	histone lysine methyltransferase inhibitor	EHMT1|EHMT2
BIX-02188	66524294	BRD-K20290250	CN(C)Cc1cccc(N\C(c2ccccc2)=C2/C(=O)Nc3cc(ccc23)C(N)=O)c1	MEK inhibitor	MAP2K5
BIX-02189	46931012	BRD-K73368362	CN(C)Cc1cccc(N\C(c2ccccc2)=C2/C(=O)Nc3cc(ccc23)C(=O)N(C)C)c1	MEK inhibitor	MAP2K5|MAPK7
BL-5583	95864	BRD-K75282704	OC(=O)c1cc2ccccc2s1	hypercalcaemic agent	
blebbistatin-(+/-)	3476986	BRD-A75817871	Cc1ccc2N=C3N(CCC3(O)C(=O)c2c1)c1ccccc1	ATPase inhibitor	MYH2
blebbistatin-(-)	5287792	BRD-K61295575	Cc1ccc2N=C3N(CC[C@@]3(O)C(=O)c2c1)c1ccccc1	ATPase inhibitor	
bleomycetin	16400006	BRD-A94813917	C[C@@H](O)[C@H](NC(=O)[C@@H](C)[C@H](O)[C@@H](C)NC(=O)C(NC(=O)c1nc(nc(N)c1C)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)[C@@H](O[C@H]1O[C@H](CO)[C@H](O)[C@@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1)C(=O)NCCc1nc(cs1)-c1nc(cs1)C(=O)NCCCNCCCCN	EGFR expression inhibitor	
bleomycin	46930982	BRD-A42083487	C[C@@H](O)[C@@H](NC(=O)[C@H](C)[C@@H](O)[C@H](C)NC(=O)[C@@H](NC(=O)c1nc(nc(N)c1C)[C@H](CC(N)=O)NC[C@@H](N)C(N)=O)C(O[C@H]1O[C@H](CO)[C@H](O)[C@@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1)C(=O)NCCc1nc(cs1)-c1nc(cs1)C(=O)NCCC[S+](C)C	DNA synthesis inhibitor	LIG1|LIG3
blonanserin	125564	BRD-K25943794	CCN1CCN(CC1)c1cc(-c2ccc(F)cc2)c2CCCCCCc2n1	dopamine receptor antagonist; serotonin receptor antagonist	DRD2|HTR2A
BLU9931	72710839	BRD-K72898849	COc1cc(OC)c(Cl)c(-c2ccc3nc(Nc4c(C)cccc4NC(=O)C=C)ncc3c2)c1Cl	FGFR inhibitor	FGFR4
BML-190	2415	BRD-K94379058	COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)N3CCOCC3)c2c1	cannabinoid receptor inverse agonist	CNR2
BML-284	11210285	BRD-K42624714	COc1cccc(c1)-c1cc(NCc2ccc3OCOc3c2)nc(N)n1	WNT agonist	
BMS-CCR2-22	24801690	BRD-K15119094	CSc1ccc(cc1)C(=O)N[C@@H]1CCCC[C@@H]1NC(=O)CNC(=O)c1cc(ccc1NC(=O)NC(C)C)C(F)(F)F	CC chemokine receptor antagonist	CCR2
BMS-182874	122272	BRD-K56509348	CN(C)c1cccc2c(cccc12)S(=O)(=O)Nc1onc(C)c1C	endothelin receptor antagonist	EDNRA
BMS-191011	10474339	BRD-K95609758	Oc1ccc(Cl)cc1Cn1nc(oc1=O)-c1ccc(cc1)C(F)(F)F	potassium channel activator	KCNMA1
BMS-191095	9822753	BRD-K01231377	CC1(C)Oc2ccc(cc2[C@@H]([C@H]1O)N(Cc1ncc[nH]1)c1ccc(Cl)cc1)C#N	KATP activator; potassium channel agonist	
BMS-265246	5329775	BRD-K62814476	CCCCOc1c(cnc2[nH]ncc12)C(=O)c1c(F)cc(C)cc1F	CDK inhibitor	CDK1|CDK2
BMS-299897	11249248	BRD-K02950022	C[C@@H](N(c1cc(F)ccc1F)S(=O)(=O)c1ccc(Cl)cc1)c1ccc(F)cc1CCCC(O)=O	gamma secretase inhibitor	
BMS-309403	16122583	BRD-K87956243	CCc1c(c(nn1-c1ccccc1-c1cccc(OCC(O)=O)c1)-c1ccccc1)-c1ccccc1	fatty acid binding protein inhibitor	FABP4
BMS-345541	9813758	BRD-K13566078	Cc1cnc2c(NCCN)nc3ccc(C)cc3n12	IKK inhibitor	CHUK|IKBKB
BMS-387032	3025986	BRD-K43389698	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1	CDK inhibitor; cell cycle inhibitor; MCL1 inhibitor	CDK2|CDK7|CDK9
BMS-470539	9915813	BRD-K22000702	CCCC(=O)C1(CCN(CC1)C(=O)[C@@H](Cc1ccc(OC)cc1)NC(=O)[C@@H](N)Cc1cncn1C)c1ccccc1	melanocortin receptor agonist	MC1R
BMS-536924		BRD-K34581968	Cc1cc(cc2[nH]c(nc12)-c1c(NC[C@@H](O)c2cccc(Cl)c2)cc[nH]c1=O)N1CCOCC1	IGF-1 inhibitor	AKT1|CCNE1|CDK2|CYP3A4|ERBB2|IGF1R|KDR|LCK|MAPK1|MET|PDGFRA|PDGFRB
BMS-566419	9913339	BRD-K56932272	CCN1CCN(CC1)c1ccc(cn1)C(C)(C)NC(=O)c1cc2[nH]c3ccccc3c(=O)c2cc1F	inosine monophosphate dehydrogenase inhibitor	IMPDH1|IMPDH2
BMS-587101	11635371	BRD-K20093108	CN1C(=O)N(C(=O)[C@]11CN(Cc2cc(cs2)C(O)=O)C[C@H]1c1ccc(cc1)C#N)c1cc(Cl)cc(Cl)c1	integrin antagonist	ITGAL|ITGB2
BMS-599626	10437018	BRD-K07106112	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4n(Cc5cccc(F)c5)ncc4c3)c12	EGFR inhibitor; protein tyrosine kinase inhibitor	EGFR|ERBB2|ERBB4
BMS-626529	11317439	BRD-K97883416	COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12	HIV attachment inhibitor	
BMS-649	127019	BRD-K25991633	CC1(C)CCC(C)(C)c2cc(ccc12)C1(OCCO1)c1ccc(cc1)C(O)=O	retinoid receptor agonist	RXRA
BMS-688521	11699447	BRD-K85649978	CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1ccc(cn1)C(O)=O)c1cc(Cl)cc(Cl)c1	leukocyte function-associated antigen receptor antagonist; ICAM1 antagonist	ICAM1
BMS-690514	11349170	BRD-K76239644	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1	EGFR inhibitor; VEGFR inhibitor	EGFR|ERBB2|FLT3|KDR
BMS-707035	54682040	BRD-K49555808	Cn1c(nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O)N1CCCCS1(=O)=O	HIV integrase inhibitor	
BMS-754807	24785538	BRD-K13049116	C[C@]1(CCCN1c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1ccc(F)nc1	IGF-1 inhibitor	AKT1|IGF1R
BMS-777607	24794418	BRD-K40738845	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1	AXL kinase inhibitor; c-Met inhibitor; FLT3 inhibitor; hepatocyte growth factor receptor inhibitor; macrophage migration inhibiting factor inhibitor; tyrosine kinase inhibitor	AXL|MERTK|MET|MST1R|TYRO3
BMS-806	5495818	BRD-K55773932	COc1cc[nH]c2ncc(C(=O)C(=O)N3CCN(C[C@H]3C)C(=O)c3ccccc3)c12	HIV attachment inhibitor	
BMS-817378	44137813	BRD-K81026553	Nc1nccc(Oc2ccc(NC(=O)c3cn(COP(O)(O)=O)cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl	c-Met inhibitor; VEGFR inhibitor	KDR|MET
BMS-833923	57662985	BRD-K33245965	CNCc1ccc(C)c(NC(=O)c2ccc(Nc3nc(-c4ccccc4)c4ccccc4n3)cc2)c1	smoothened receptor antagonist	SMO
BMS-863233	57899889	BRD-K12511835	Clc1ccc2oc3c(nc([nH]c3=O)[C@@H]3CCCN3)c2c1	CDC inhibitor	CDC7|PIM1
BMS-927711	51049968	BRD-K55781385	N[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)n2c3cccnc3[nH]c2=O)c2ncccc12)c1cccc(F)c1F	calcitonin antagonist	CALCA
BMS-983970	73388374	BRD-K22316123	NC(=O)[C@@H](CC1CC1)[C@@H](CCC(F)(F)F)C(=O)N[C@H]1N=C(c2ccccc2)c2cccc(F)c2NC1=O	notch signaling inhibitor	
BMS-986020	46213949	BRD-K23952234	C[C@@H](OC(=O)Nc1c(C)noc1-c1ccc(cc1)-c1ccc(CC(O)=O)cc1)c1ccccc1	lysophosphatidic acid receptor antagonist	LPAR1
BMY-14802	108046	BRD-A15435692	OC(CCCN1CCN(CC1)c1ncc(F)cn1)c1ccc(F)cc1	sigma receptor antagonist	HTR1A
BMY-45778	127861	BRD-K84895041	OC(=O)COc1cccc(c1)-c1ocnc1-c1nc(c(o1)-c1ccccc1)-c1ccccc1	IP1 prostacyclin receptor agonist	PTGIR
BMY-7378	2419	BRD-K31054881	COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1	adrenergic receptor antagonist; serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|HTR1A
BNC105	24786555	BRD-K20468903	COc1ccc2c(C(=O)c3cc(OC)c(OC)c(OC)c3)c(C)oc2c1O	tubulin polymerization inhibitor	
BNTX	44369694	BRD-A55484088	Oc1ccc2CC3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=O)\C(C[C@@]35O)=C\c1ccccc1	opioid receptor antagonist	OPRD1|OPRK1|OPRM1
boceprevir	10324367	BRD-A09735281	CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C	HCV inhibitor	CMA1|CTSA|CTSF|CTSK|CTSL|CTSS
bonaphthone	23384	BRD-K34149328	Brc1ccc2C(=O)C(=O)C=Cc2c1		
bopindolol	44112	BRD-A07563059	Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3|HTR1A|HTR1B
bornyl-acetate	6448	BRD-A41385909	CC(=O)OC1CC2CCC1(C)C2(C)C		
boronophenylalanine	150315	BRD-K50122911	N[C@@H](Cc1ccc(cc1)B(O)O)C(O)=O		
bortezomib	387447	BRD-K88510285	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O	NFkB pathway inhibitor; proteasome inhibitor	PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA
bosentan	104865	BRD-K74763371	COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(cc2)C(C)(C)C)nc(nc1OCCO)-c1ncccn1	endothelin receptor antagonist	EDNRA|EDNRB
bosutinib	5328940	BRD-K99964838	COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl	Abl kinase inhibitor; Bcr-Abl kinase inhibitor; src inhibitor	ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK
BP-554	134117	BRD-K45479396	C(COc1ccc2OCOc2c1)CN1CCN(CC1)c1ccccc1	serotonin receptor agonist	HTR1A
BP-897	3038495	BRD-K17378184	COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1	dopamine receptor agonist	ADRA1A|ADRA1D|ADRA2A|DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2B
BQ-123	4490093	BRD-A59961917	CC(C)CC1NC(=O)C(NC(=O)C2CCCN2C(=O)C(CC(O)=O)NC(=O)C(Cc2c[nH]c3ccccc23)NC1=O)C(C)C	endothelin receptor antagonist	EDNRA
BQ-788	5311032	BRD-K02490038	CCCC[C@@H](NC(=O)[C@@H](Cc1cn(C(=O)OC)c2ccccc12)NC(=O)[C@H](CC(C)(C)C)NC(=O)N1[C@@H](C)CCC[C@H]1C)C(O)=O	endothelin receptor antagonist	EDNRB
BQU57	77845606	BRD-A40257118	Cc1nn(C)c2OC(N)=C(C#N)C(c12)c1ccc(cc1)C(F)(F)F	Ras GTPase inhibitor	RALA|RALB
BRD-7389	1080352	BRD-K15107389	O=C1c2ccccc2-c2c(NCCc3ccccc3)c(=O)[nH]c3cccc1c23	ribosomal protein inhibitor	RPS6KA1|RPS6KA2|RPS6KA3
BRD-9876	613000	BRD-K89329876	CC(C)(C)c1ccc2cc(C#N)c(cc2c1)C#N	kinesin inhibitor	KIF11
BRD4770	72193870	BRD-K72264770	COC(=O)c1ccc2n(CCCc3ccccc3)c(NC(=O)c3ccccc3)nc2c1	histone lysine methyltransferase inhibitor	EHMT2
brefeldin-a	5287620	BRD-K77841042	C[C@H]1CCC\C=C\[C@@H]2C[C@H](O)C[C@H]2[C@H](O)\C=C\C(=O)O1	protein synthesis inhibitor	ARF1|CYTH2
bremelanotide	9941379	BRD-K06328344	CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)C(O)=O	melanocortin receptor agonist	MC1R|MC2R|MC3R|MC4R|MC5R
brequinar	57030	BRD-K96123349	Cc1c(nc2ccc(F)cc2c1C(O)=O)-c1ccc(cc1)-c1ccccc1F	dihydroorotate dehydrogenase inhibitor	DHODH
bretazenil	107926	BRD-K96936751	CC(C)(C)OC(=O)c1ncn-2c1[C@@H]1CCCN1C(=O)c1c(Br)cccc-21	GABA benzodiazepine site receptor partial agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6
bretylium	2431	BRD-K49669424	CC[N+](C)(C)Cc1ccccc1Br	norepinephrine inhibitor	ATP1A1
brexpiprazole	11978813	BRD-K00911143	O=c1ccc2ccc(OCCCCN3CCN(CC3)c3cccc4sccc34)cc2[nH]1	dopamine receptor partial agonist	DRD2
briciclib	11248490	BRD-K05531427	COc1cc(OC)c(\C=C\S(=O)(=O)Cc2ccc(OC)c(OP(O)(O)=O)c2)c(OC)c1	cyclin D inhibitor	CCND1
brigatinib	68165256	BRD-K56981171	COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1)N1CCC(CC1)N1CCN(C)CC1	ALK tyrosine kinase receptor inhibitor; EGFR inhibitor	ALK|EGFR
brilliant-green	12450	BRD-K60348325	CCN(CC)c1ccc(cc1)C(c1ccccc1)=C1C=CC(C=C1)=[N+](CC)CC		
brimonidine	2435	BRD-K68264559	Brc1c(NC2=NCCN2)ccc2nccnc12	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C
brinzolamide	68844	BRD-K74913225	CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(N)(=O)=O	carbonic anhydrase inhibitor	CA1|CA12|CA14|CA2|CA4|CA5A|CA7
brivanib	11234052	BRD-K28428262	C[C@@H](O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C	FGFR inhibitor; VEGFR inhibitor	CYP3A4|FGFR1|FLT1|KCNH2|KDR
brivanib-alaninate	11154925	BRD-K57187269	C[C@H](COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C)OC(=O)[C@H](C)N	FGFR inhibitor; VEGFR inhibitor	FGFR3
brivaracetam	9837243	BRD-K00634421	CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1	voltage-gated sodium channel blocker	SV2A
brivudine	44629987	BRD-A63675168	OC[C@H]1O[C@H](CC1O)n1cc(\C=C\Br)c(=O)[nH]c1=O	DNA directed DNA polymerase inhibitor	
BRL-15572	3654103	BRD-A51829654	OC(CN1CCN(CC1)c1cccc(Cl)c1)C(c1ccccc1)c1ccccc1	serotonin receptor antagonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6
BRL-26314	10039824	BRD-A57806482	OC(=O)C(Cc1ccccc1)NCc1ccc(Cl)cc1	cholesterol inhibitor	LPL
BRL-37344	9841972	BRD-K07507905	C[C@H](Cc1ccc(OCC(O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3
BRL-44408	121850	BRD-A67949680	CC1N(CC2=NCCN2)Cc2ccccc12	adrenergic receptor antagonist	ADRA2A|ADRA2B|ADRA2C
BRL-50481	2921148	BRD-K84266862	CN(C)S(=O)(=O)c1cc(ccc1C)[N+]([O-])=O	phosphodiesterase inhibitor	PDE7A|PDE7B
BRL-52537	5244802	BRD-A37347161	Clc1ccc(CC(=O)N2CCCCC2CN2CCCC2)cc1Cl	opioid receptor agonist	OPRK1
BRL-54443	2438	BRD-K17868609	CN1CCC(CC1)c1c[nH]c2ccc(O)cc12	serotonin receptor agonist	HTR1E|HTR1F
brolitene	1550874	BRD-K76021681	OCCNC(=O)\C=C\c1ccccc1	muscle relaxant	RYR1
bromantan	4660557	BRD-K86358349	Brc1ccc(NC2C3CC4CC(C3)CC2C4)cc1	dopamine reuptake inhibitor; serotonin reuptake inhibitor	
bromebric-acid	5284375	BRD-K17874929	COc1ccc(cc1)C(=O)C(\Br)=C\C(O)=O	purine antagonist; DNA synthesis inhibitor	
bromfenac	60726	BRD-K47679368	Nc1c(CC(O)=O)cccc1C(=O)c1ccc(Br)cc1	cyclooxygenase inhibitor	PTGS1|PTGS2
bromhexine	2442	BRD-K47631482	CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1	mucolytic agent	
bromindione	14369	BRD-K50490982	Brc1ccc(cc1)C1C(=O)c2ccccc2C1=O	anticoagulant	
bromocriptine	31101	BRD-K14496212	CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C	dopamine receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7
bromopride	2446	BRD-K73642618	CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC	dopamine receptor antagonist	DRD2
bromosporine	72943187	BRD-K44665581	CCOC(=O)Nc1cc(nn2c(C)nnc12)-c1ccc(C)c(NS(C)(=O)=O)c1	bromodomain inhibitor	
bromperidol	2448	BRD-K78643075	OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Br)cc1	dopamine receptor antagonist	DRD2
brompheniramine	6834	BRD-A68723818	CN(C)CCC(c1ccc(Br)cc1)c1ccccn1	histamine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1
bronopol	2450	BRD-K33457401	OCC(Br)(CO)[N+]([O-])=O		
bropirimine	65457	BRD-K17500877	Nc1nc(-c2ccccc2)c(Br)c(=O)[nH]1	interferon inducer	
broxaldine	77262	BRD-K36222532	Cc1ccc2c(Br)cc(Br)c(OC(=O)c3ccccc3)c2n1		
broxaterol	71149	BRD-A08316590	CC(C)(C)NCC(O)c1cc(Br)no1	adrenergic receptor agonist	ADRB2
broxuridine	6035	BRD-K79095980	OC[C@H]1O[C@H](C[C@@H]1O)n1cc(Br)c(=O)[nH]c1=O	antimetabolite	
broxyquinoline	2453	BRD-K23301018	Oc1c(Br)cc(Br)c2cccnc12	antiprotozoal agent	
bruceantin	91930061	BRD-A36057565	COC(=O)[C@]12OC[C@@]34[C@H]1[C@@H](OC(=O)\C=C(/C)C(C)C)C(=O)O[C@@H]3C[C@H]1C(C)C(=O)C(=O)C[C@]1(C)[C@H]4[C@@H](O)[C@@H]2O	protein synthesis inhibitor	
brucine	9649	BRD-A41995253	COc1cc2N3C4[C@@H]5C(CC3=O)OCC=C3CN6CC[C@]4([C@@H]6C[C@H]53)c2cc1OC	glycine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
bryostatin-1	23947600	BRD-K47405978	CCC\C=C\C=C\C(=O)O[C@H]1\C(C[C@H]2C[C@@H](OC(=O)C[C@H](O)C[C@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C\C(C[C@@H](O4)\C=C/C(C)(C)[C@]1(O)O2)=C\C(=O)OC)O3)[C@@H](C)O)=C\C(=O)OC	protein kinase C inhibitor	PRKCE
BS-181	49867929	BRD-K31313613	CC(C)c1cnn2c(NCc3ccccc3)cc(NCCCCCCN)nc12	CDK inhibitor	CDK7
BTB06584	2799764	BRD-K37933329	[O-][N+](=O)c1ccc(cc1OC(=O)c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1	ATPase inhibitor	ATP5F1
BTB1	291461	BRD-K89000287	[O-][N+](=O)c1cc(Cl)ccc1S(=O)(=O)c1ccccc1	mitotic kinesin inhibitor	KIF18A
BTS	95801	BRD-K64178227	Cc1ccc(cc1)S(=O)(=O)NCc1ccccc1		
BTS-54505	134772	BRD-A68304895	CC(C)CC(N)C1(CCC1)c1ccc(Cl)cc1	dopamine reuptake inhibitor	SLC6A2|SLC6A3|SLC6A4
BTS-72664	3801739	BRD-A65793993	CC(Oc1ccc(Cl)cc1)c1ccnc2ncnn12	GABA receptor antagonist	GABBR1
BTT-3033	49841251	BRD-K01492390	CN(c1ccc(NC(=O)Nc2ccccc2)cc1)S(=O)(=O)c1cnn(c1)-c1ccc(F)cc1	integrin inhibitor	ITGA2|ITGB1
BTZ043-racemate	49769085	BRD-A53037217	CC1COC2(CCN(CC2)c2nc(=O)c3cc(cc([N+]([O-])=O)c3s2)C(F)(F)F)O1	DPRE1 inhibitor	
BU-224	2457	BRD-K55344148	C1CN=C(N1)c1ccc2ccccc2n1	imidazoline receptor ligand	MAOA|MAOB
BU-239	4520732	BRD-K11696279	C1CN=C(N1)c1cnc2ccccc2n1	imidazoline receptor ligand; imidazoline receptor agonist	
bucetin	14130	BRD-A88684804	CCOc1ccc(NC(=O)CC(C)O)cc1	analgesic agent	
bucillamine	656604	BRD-K24697665	CC(C)(S)C(=O)N[C@@H](CS)C(O)=O	immunosuppressant	
bucladesine	9687	BRD-A94624445	CCCC(=O)Nc1ncnc2n(cnc12)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC	adenosine receptor agonist; cAMP stimulant	PRKACA
buclizine	6729	BRD-A91444184	CC(C)(C)c1ccc(CN2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)cc1	histamine receptor antagonist	CHRM1|HRH1
budesonide	5281004	BRD-A34299591	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	glucocorticoid receptor agonist	NR3C1
budipine	68778	BRD-K18324993	CC(C)(C)N1CCC(CC1)(c1ccccc1)c1ccccc1	glutamate receptor antagonist	GRIN1
bufexamac	2466	BRD-K36660044	CCCCOc1ccc(CC(=O)NO)cc1	cyclooxygenase inhibitor	HDAC10|HDAC6
buflomedil	2467	BRD-K19462402	COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1	adrenergic receptor antagonist; calcium channel blocker	ADRA1A
bumetanide	2471	BRD-K38197229	CCCCNc1cc(cc(c1Oc1ccccc1)S(N)(=O)=O)C(O)=O	solute carrier family member inhibitor	CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5
bunazosin	2472	BRD-K35034482	CCCC(=O)N1CCCN(CC1)c1nc(N)c2cc(OC)c(OC)cc2n1	adrenergic receptor antagonist	ADRA1A
buparlisib	16654980	BRD-K42191735	Nc1cc(c(cn1)-c1cc(nc(n1)N1CCOCC1)N1CCOCC1)C(F)(F)F	PI3K inhibitor	PIK3CA|PIK3CG
buparvaquone	54158101	BRD-A07947329	CC(C)(C)C1CCC(CC2C(=O)C(=O)c3ccccc3C2=O)CC1	antiprotozoal agent	
buphenine	4567	BRD-A36267905	CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1	adrenergic receptor agonist	ADRB2
bupicomide	31447	BRD-K51700582	CCCCc1ccc(nc1)C(N)=O	adrenergic receptor antagonist	ADRB1
bupivacaine	2474	BRD-A01636364	CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C	sodium channel blocker	KCNA5|PTGER1|SCN10A|SCN4A
bupranolol	2475	BRD-A48420483	Cc1ccc(Cl)c(OCC(O)CNC(C)(C)C)c1	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3
bupropion	444	BRD-A05186015	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	dopamine uptake inhibitor	CHRNA3|SLC6A2|SLC6A3
buramate	20787	BRD-K30360804	OCCOC(=O)NCc1ccccc1	antiepileptic	
buspirone	2477	BRD-K93461745	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1	serotonin receptor agonist	DRD2|HTR1A
busulfan	2478	BRD-K23204545	CS(=O)(=O)OCCCCOS(C)(=O)=O	DNA inhibitor	
butabindide	9817923	BRD-K40581315	CCCCNC(=O)[C@@H]1Cc2ccccc2N1C(=O)[C@@H](N)CC	tripeptidyl peptidase inhibitor	TPP2
butacaine	2480	BRD-K99622919	CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1	local anesthetic	
butaclamol	37461	BRD-K23082237	CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc([C@H]2C1)c34	dopamine receptor antagonist	DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A
butalbital	2481	BRD-K71350836	CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O	GABA receptor antagonist	CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2
butamben	2482	BRD-K27217864	CCCCOC(=O)c1ccc(N)cc1	sodium channel blocker	
butein	5281222	BRD-K17497770	Oc1ccc(C(=O)\C=C\c2ccc(O)c(O)c2)c(O)c1	EGFR inhibitor; src inhibitor	ACE
butenafine	2484	BRD-K90630139	CN(Cc1ccc(cc1)C(C)(C)C)Cc1cccc2ccccc12	fungal squalene epoxidase inhibitor	SQLE
buthionine-sulfoximine	119565	BRD-A47706533	CCCCS(=N)(=O)CC[C@H](N)C(O)=O	glutathione transferase inhibitor	GCLM
butibufen	41643	BRD-A46136514	CCC(C(O)=O)c1ccc(CC(C)C)cc1	cyclooxygenase inhibitor	
butoconazole	47472	BRD-A16665823	Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1	bacterial cell wall synthesis inhibitor	
butofilolol	68838	BRD-A27274504	CCCC(=O)c1cc(F)ccc1OCC(O)CNC(C)(C)C	adrenergic receptor antagonist	
butorphanol-(+)-tartrate	5361092	BRD-K42417338	Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)c2c1	opioid receptor agonist; opioid receptor antagonist	OPRD1|OPRK1|OPRM1
butyl-paraben	7184	BRD-K08287586	CCCCOC(=O)c1ccc(O)cc1	DNA synthesis inhibitor	
butylated-hydroxyanisole	8456	BRD-K93035859	COc1ccc(O)c(c1)C(C)(C)C	antioxidant	
butylated-hydroxytoluene	31404	BRD-K53153417	Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C	carbonic anhydrase inhibitor	CA2
butylphthalide	61361	BRD-A59378440	CCCCC1OC(=O)c2ccccc12	potassium channel antagonist	KCNK2
butylscopolamine-bromide		BRD-A53951045	CCCC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@@H](CO)c1ccccc1	cholinergic receptor antagonist	
BU226	3410883	BRD-K56115039	C1CN=C(N1)c1cc2ccccc2cn1	imidazoline receptor ligand	
BVD-523	11719003	BRD-K28965160	CC(C)Nc1cc(-c2c[nH]c(c2)C(=O)N[C@H](CO)c2cccc(Cl)c2)c(Cl)cn1	MAP kinase inhibitor	
BVT-2733	6918651	BRD-K01742705	CN1CCN(CC1)C(=O)Cc1csc(NS(=O)(=O)c2cccc(Cl)c2C)n1	11-beta hydroxysteroid dehydrogenase inhibitor	HSD17B1
BVT-948	6604934	BRD-K68567222	CC1(C)C(=O)NC2=C1C(=O)C(=O)c1ccccc21	tyrosine phosphatase inhibitor	PTPN1|PTPN11|PTPN2
BW-A4C	6438354	BRD-K80194255	CC(=O)N(O)C\C=C\c1cccc(Oc2ccccc2)c1	lipoxygenase inhibitor	ALOX5
BW-B70C	5353454	BRD-A55946879	CC(\C=C\c1cccc(Oc2ccc(F)cc2)c1)N(O)C(N)=O	lipoxygenase inhibitor	ALOX5
BW-180C	13019201	BRD-K57927309	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O	opioid receptor agonist	OPRD1|OPRM1
BW-373U86	119029	BRD-K74990253	CCN(CC)C(=O)c1ccc(cc1)[C@@H](N1C[C@@H](C)N(CC=C)C[C@@H]1C)c1cccc(O)c1	opioid receptor agonist	OPRD1
BW-616U	11722381	BRD-K07061232	CNC(=O)c1ccc2C(=O)c3ccccc3S(=O)(=O)c2c1	monoamine oxidase inhibitor	MAOA
BW-723C86	4284720	BRD-A17428743	CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12	serotonin receptor agonist	HTR2A|HTR2B|HTR2C
BX-795	10077147	BRD-K47983010	Ic1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCCNC(=O)c1cccs1	IKK inhibitor	CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1
BX-912	11754511	BRD-K49669041	Brc1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCc1c[nH]cn1	pyruvate dehydrogenase kinase inhibitor	CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1
BYK-204165	25113764	BRD-K61665160	Cn1cccc1\C=C1/C(=O)NC(=O)c2ccccc12	PARP inhibitor	PARP1
C-021	25141190	BRD-K98179423	COc1cc2nc(nc(NC3CCCCCC3)c2cc1OC)N1CCC(CC1)N1CCCCC1	CC chemokine receptor antagonist	CCR4
C-1	3545	BRD-K72462751	O=S(=O)(N1CCNCC1)c1cccc2cnccc12	protein kinase inhibitor	PRKCA
C-751	99170	BRD-K15337272	CCOC(=O)c1c[nH]cn1		
cabagin	145692	BRD-K41504985	C[S+](C)CC[C@H](N)C(O)=O		
cabaletta	7427	BRD-K54028654	OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	pharmacological chaperone	
cabazitaxel	129009963	BRD-K06858286	CO[C@@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@@H](OC(=O)c3ccccc3)[C@@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C(C)=C([C@@H](OC)C(=O)[C@]12C)C3(C)C	microtubule inhibitor	TUBA4A|TUBB|TUBB1
cabergoline	54746	BRD-K86882815	CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1	dopamine receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR7
cabotegravir	54713659	BRD-K76819217	C[C@H]1CO[C@@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12	HIV integrase inhibitor	
cabozantinib	25102847	BRD-K51544265	COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC	RET tyrosine kinase inhibitor; VEGFR inhibitor	KDR|MET
CaCCinh-A01	2898877	BRD-A90751343	CC(C)(C)C1CCc2c(C1)sc(NC(=O)c1ccco1)c2C(O)=O	calcium-activated chloride channel inhibitor	CLCA1
cadralazine	2515	BRD-A78134170	CCOC(=O)NNc1ccc(nn1)N(CC)CC(C)O	adrenergic receptor antagonist	
cafestol	108052	BRD-K46741531	C[C@@]12CCc3occc3[C@H]1CC[C@@]13C[C@@H](CC[C@@H]21)[C@@](O)(CO)C3	pregnane X receptor agonist	
caffeic-acid	689043	BRD-K09900591	OC(=O)\C=C\c1ccc(O)c(O)c1	HIV integrase inhibitor; lipoxygenase inhibitor; nitric oxide production inhibitor; tumor necrosis factor production inhibitor	ALOX5|MIF
caffeic-acid-phenethyl-ester	5281787	BRD-K96188950	Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O	HIV integrase inhibitor	RELA
caffeine	2519	BRD-K02404261	Cn1cnc2n(C)c(=O)n(C)c(=O)c12	adenosine receptor antagonist; phosphodiesterase inhibitor	ADORA1|ADORA2A|ADORA2B|ADORA3|ATM|ITPR1|ITPR2|ITPR3|PDE10A|PDE11A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|PIK3CA|PIK3CB|PIK3CD|PRKDC|RYR1|RYR2|RYR3
calcifediol	5283731	BRD-K77175907	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C	vitamin D receptor agonist	VDR
calcipotriol	5288783	BRD-K56429665	C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	vitamin D receptor agonist	VDR
calcitriol	5280453	BRD-K27316855	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	vitamin D receptor agonist	VDR
calcium-gluceptate	25588	BRD-K35952844	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O		
calcium-levofolinate	149436	BRD-K97009491	Nc1nc(=O)c2N(C=O)[C@@H](CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2[nH]1		
Calhex-231	11849514	BRD-K19811997	C[C@@H](N[C@H]1CCCC[C@@H]1NC(=O)c1ccc(Cl)cc1)c1cccc2ccccc12	calcium sensing receptor negative allosteric modulator	CASR
calpeptin	73364	BRD-K26134695	CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O	calpain inhibitor	
camicinal	15984937	BRD-K23248433	C[C@H]1CN(Cc2ccc(CC(=O)N3CCC(CC3)Nc3cccc(F)c3)cc2)CCN1	motilin receptor agonist	MLNR
CaMKII-IN-1	50898538	BRD-K35772771	Cc1c(Cl)cccc1S(=O)(=O)Nc1nc(NCCc2ccccc2)nc2CCN(Cc3ccccc3)Cc12	calcium/calmodulin dependent protein kinase inhibitor	AKT1|CAMK2A|CAMK4|MYLK
camostat-mesilate	2536	BRD-K43806473	CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(N)=N)cc2)cc1	protease inhibitor	PRSS1
camphor-(+)	159055	BRD-K10034334	CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2		TRPV1
camphor-(1r)	5284500	BRD-K15714472	CC1(C)[C@@H]2CC[C@]1(C)C(=O)C2	TRPV activator	
camptothecin	24360	BRD-K37890730	CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccccc4cc3Cn1c2=O	topoisomerase inhibitor	TOP1
camylofine-chlorhydrate	5902	BRD-A91733352	CCN(CC)CCNC(C(=O)OCCC(C)C)c1ccccc1		
canagliflozin	24812758	BRD-K90868879	Cc1ccc(cc1Cc1ccc(s1)-c1ccc(F)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O	sodium/glucose cotransporter inhibitor	SLC5A1|SLC5A2
candesartan	2541	BRD-K84091759	CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1	angiotensin receptor antagonist	AGTR1
candesartan-cilextil	2540	BRD-A65671304	CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1	angiotensin receptor antagonist	AGTR1|AGTR2
candicidin	51371318	BRD-A37348498	CC(CC(C)C1OC(=O)CC(=O)CCCC(=O)CC(O)CC(O)CC(O)CC(=O)CC(O)C(C(O)CC(O[C@@H]2O[C@H](C)[C@H](O)[C@@H](O)[C@@H]2N)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C1C)C(O)=O)C(O)CC(=O)c1ccc(N)cc1	fungal ergosterol inhibitor	
canertinib	156414	BRD-K50168500	Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)C=C)cc23)cc1Cl	EGFR inhibitor	AKT1|EGFR|ERBB2|ERBB4
canrenone	6710732	BRD-A20644369	C[C@]12CCC3C(C=CC4=CC(=O)CC[C@]34C)C1CC[C@@]21CCC(=O)O1	mineralocorticoid receptor antagonist	NR3C2
cantharidin	5944	BRD-K80684056	C[C@]12[C@@H]3CC[C@@H](O3)[C@@]1(C)C(=O)OC2=O	protein phosphatase inhibitor	
capadenoson	9936489	BRD-K97025174	Nc1nc(SCc2csc(n2)-c2ccc(Cl)cc2)c(C#N)c(-c2ccc(OCCO)cc2)c1C#N	adenosine receptor agonist	ADORA1
capecitabine	60953	BRD-K61192372	CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O	DNA synthesis inhibitor; thymidylate synthase inhibitor	TYMS
capobenic-acid	30627	BRD-K04282412	COc1cc(cc(OC)c1OC)C(=O)NCCCCCC(O)=O		
capreomycin	5841036	BRD-A33801468	NCCCC(N)CC(=O)NCC1NC(=O)C(CO)NC(=O)C(N)CNC(=O)C(NC(=O)\C(NC1=O)=C/NC(N)=O)C1CCNC(=N)N1	protein synthesis inhibitor	
caprylic-acid	379	BRD-K35170555	CCCCCCCC(O)=O		
capsaicin	1548943	BRD-K50590187	COc1cc(CNC(=O)CCCC\C=C\C(C)C)ccc1O	TRPV agonist	CFTR|TRPV1
capsazepine	2733484	BRD-K44849676	Oc1cc2CCCN(Cc2cc1O)C(=S)NCCc1ccc(Cl)cc1	TRPV agonist	TRPV1|TRPV4
captamine	25799	BRD-K81645907	CN(C)CCS		
captan	8606	BRD-A79857384	ClC(Cl)(Cl)SN1C(=O)C2CC=CCC2C1=O		
captopril	44093	BRD-K54529596	C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O	angiotensin converting enzyme inhibitor	ACE|LTA4H|MMP2|MMP9
caracemide	54747	BRD-K62790656	CNC(=O)ON(C(C)=O)C(=O)NC	ribonucleotide reductase inhibitor	RRM1
caramiphen	6472	BRD-K59895502	CCN(CC)CCOC(=O)C1(CCCC1)c1ccccc1	cholinergic receptor antagonist	CHRM1|CHRM2
carazolol	71739	BRD-A50675490	CC(C)NCC(O)COc1cccc2[nH]c3ccccc3c12	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3
carbachol	2551	BRD-K75037734	C[N+](C)(C)CCOC(N)=O	cholinergic receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2
carbadox		BRD-K56735750	COC(=O)N\N=C\c1c[n+]([O-])c2ccccc2[n+]1[O-]	other antibiotic	
carbamazepine	2554	BRD-K71799949	NC(=O)N1c2ccccc2C=Cc2ccccc12	carboxamide antiepileptic	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
carbaril	6129	BRD-K54208592	CNC(=O)Oc1cccc2ccccc12	acetylcholinesterase inhibitor	
carbarsone	8480	BRD-K94848716	NC(=O)Nc1ccc(cc1)[As](O)(O)=O	antiprotozoal agent	
carbazochrome	6258971	BRD-A11070335	CN1C(CC2=C\C(=N\NC(N)=O)C(=O)C=C12)S(O)(=O)=O		
carbendazim	25429	BRD-K12906202	COC(=O)Nc1nc2ccccc2[nH]1	microtubule inhibitor; tubulin polymerization inhibitor	TP53|TUBB
carbenicillin	20824	BRD-A13078313	CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)c3ccccc3)C(=O)N2[C@H]1C(O)=O	bacterial cell wall synthesis inhibitor	
carbenoxolone	22793089	BRD-A29700858	CC1(C)[C@H](CC[C@@]2(C)C1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C(O)=O)OC(=O)CCC(O)=O	11-beta hydroxysteroid dehydrogenase inhibitor	GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|HSD11B1|PANX1|PANX2|PANX3
carbetapentane	2562	BRD-K06181161	CCN(CC)CCOCCOC(=O)C1(CCCC1)c1ccccc1	acetylcholine receptor antagonist	CHRM2
carbetocin	16681432	BRD-K56107812	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O	oxytocin receptor agonist	OXTR
carbidopa	28082766	BRD-K78712176	C[C@@](Cc1ccc(O)c(O)c1)(NN)C(O)=O	aromatic L-amino acid decarboxylase inhibitor	DDC
carbimazole	31072	BRD-K87156652	CCOC(=O)n1ccn(C)c1=S	antithyroid agent	TPO
carbinoxamine	2564	BRD-A29426959	CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1	histamine receptor antagonist	HRH1
carboplatin	122130863	BRD-K90947825	N[Pt]1(N)OC(=O)C2(CCC2)C(=O)O1	DNA alkylating agent; DNA inhibitor	
carboxyamidotriazole	108144	BRD-K68408772	NC(=O)c1nnn(Cc2cc(Cl)c(C(=O)c3ccc(Cl)cc3)c(Cl)c2)c1N	calcium channel blocker	CXCL8
carboxylosartan	108185	BRD-K23533833	CCCCc1nc(Cl)c(C(O)=O)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1	angiotensin antagonist	AGTR1
carboxypyridine-disulfide	85040	BRD-K26530649	OC(=O)c1ccc(SSc2ccc(cn2)C(O)=O)nc1		
cardiogenol-c	11345983	BRD-K99174507	COc1ccc(Nc2nccc(NCCO)n2)cc1	cardiomyogenesis inducer	
cardionogen-1	663145	BRD-K50905564	C1CCC(CC1)c1nn2c(nnc2s1)-c1ccco1	WNT signaling inhibitor	CTNNB1
carebastine	40479695	BRD-K49554218	CC(C)(C(O)=O)c1ccc(cc1)C(=O)CCCN1CCC(CC1)OC(c1ccccc1)c1ccccc1	histamine receptor antagonist	HRH1
carfilzomib	11556711	BRD-K15179879	CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1	proteasome inhibitor	PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9
carglumic-acid	121396	BRD-K60240222	NC(=O)N[C@@H](CCC(O)=O)C(O)=O	carbamoyl phosphate synthase activator	CPS1
caricotamide	403128	BRD-K90215590	NC(=O)CN1C=CCC(=C1)C(N)=O	NADPH quinone oxidoreductase inhibitor	NQO2
cariporide	151172	BRD-K21670884	CC(C)c1ccc(cc1S(C)(=O)=O)C(=O)N=C(N)N	sodium/hydrogen exchanger inhibitor	SLC9A1
cariprazine		BRD-K57764956	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2cccc(Cl)c2Cl)CC1	dopamine receptor antagonist	DRD2|DRD3
carisoprodol	2576	BRD-A99939097	CCCC(C)(COC(N)=O)COC(=O)NC(C)C	acetylcholine receptor antagonist	CYP2C19
carmofur	2577	BRD-K11630072	CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O	thymidylate synthase inhibitor	TYMS
carmoterol	63952	BRD-K25095405	COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c3nc(O)ccc23)cc1	adrenergic receptor agonist	ADRB2
carmoxirole	57364	BRD-K82484965	OC(=O)c1ccc2[nH]cc(CCCCN3CCC(=CC3)c3ccccc3)c2c1	dopamine receptor agonist	DRD2
carmustine	2578	BRD-K36234266	[O-][N+]N(CCCl)C(=O)NCCCl	DNA alkylating agent; DNA inhibitor	GSR
carnitine-(D/L)	85	BRD-A89594340	C[N+](C)(C)CC(O)CC(O)=O		
carnosine	5249653	BRD-A96051074	NCCC(=O)NC(Cc1cnc[nH]1)C(O)=O	antiglycating agent	
caroverine		BRD-K65900713	CCN(CC)CCN1C(=O)C(Nc2ccccc12)=Cc1ccc(OC)cc1	glutamate receptor antagonist; calcium channel blocker	
caroxazone	29083	BRD-K92129045	NC(=O)CN1Cc2ccccc2OC1=O	monoamine oxidase inhibitor	MAOA|MAOB
carprofen	2581	BRD-A17411484	CC(C(O)=O)c1ccc2c(c1)[nH]c1ccc(Cl)cc21	cyclooxygenase inhibitor	PTGS1|PTGS2
carsalam	16258	BRD-K13238618	O=c1[nH]c(=O)c2ccccc2o1	analgesic agent	
carteolol	2583	BRD-A42167015	CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12	adrenergic receptor antagonist	ADRB1|ADRB2
carumonam	6540466	BRD-K71026158	NC(=O)OC[C@@H]1[C@H](NC(=O)C(=N/OCC(O)=O)\c2csc(N)n2)C(=O)N1S(O)(=O)=O	bacterial cell wall synthesis inhibitor	
carvedilol	2585	BRD-A10977446	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|GJA1|HIF1A|KCNH2|NDUFC2|NPPB|SELE|VCAM1|VEGFA
carzenide	8739	BRD-K09295674	NS(=O)(=O)c1ccc(cc1)C(O)=O		CA1|CA12|CA14|CA2|CA6|CA9
casanthranol-variant	51371307	BRD-K12413266	OC[C@H]1O[C@@H](O[C@@H]2c3cccc(O)c3C(=O)c3c(O)cc(CO)cc23)[C@H](O)[C@H](O)[C@H]1O		
casin	2882155	BRD-A25043798	OCCNC1CCCc2c1[nH]c1ccc(cc21)-c1ccccc1	GTPase inhibitor	CDC42
caspofungin	66577042	BRD-A31685486	CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@@H](O)[C@H](O)c1ccc(O)cc1)[C@H](O)CCN	fungal 1,3-beta-D-glucan synthase inhibitor; bacterial cell wall synthesis inhibitor	
caspofungin-acetate	71295847	BRD-K49793107	CC[C@@H](C)C[C@@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)cc1)[C@H](O)CCN	fungal 1,3-beta-D-glucan synthase inhibitor	
castanospermine	54445	BRD-K20897876	O[C@H]1CCN2C[C@H](O)[C@@H](O)[C@H](O)[C@@H]12	glucosidase inhibitor	GAA|GBA
catharanthine	5458190	BRD-K92377961	CCC1=C[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@](C2)([C@@H]13)C(=O)OC	tubulin polymerization inhibitor	
cathepsin-inhibitor-1	44224135	BRD-K40269473	Cn1nc(cc1C(=O)N[C@@H](Cc1cccc(Cl)c1)C(=O)NCC#N)C(C)(C)C	cathepsin inhibitor	CTSB|CTSL|CTSV
CAY10505	1204893	BRD-K40366680	Fc1ccc(cc1)-c1ccc(\C=C2\SC(=O)NC2=O)o1	PI3K inhibitor	PIK3CG
CB-03-01	11750009	BRD-K41779183	CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)CO	androgen receptor antagonist	AR
CB-10-277		BRD-K59929863	CN(C)\N=N\c1ccc(cc1)C(O)=O	DNA synthesis inhibitor	
CB-5083	73051434	BRD-K49048664	Cc1cc2c(cccc2n1-c1nc2CCOCc2c(NCc2ccccc2)n1)C(N)=O	valosin-containing protein inhibitor	VCP
CB-839	71577426	BRD-K58070273	FC(F)(F)Oc1cccc(CC(=O)Nc2ccc(CCCCc3nnc(NC(=O)Cc4ccccn4)s3)nn2)c1	glutaminase inhibitor	GLS
CBiPES	9864510	BRD-K34675210	CCS(=O)(=O)N(Cc1cccnc1)c1cccc(c1)-c1ccc(cc1)C#N	glutamate receptor positive allosteric modulator	GRM2
CBS,-N-Cyclohexyl-2-benzothiazolesulfenamide	7232	BRD-K64191834	C1CCC(CC1)NSc1nc2ccccc2s1		
CBS-1114	214466	BRD-K91874254	N=C(NNc1ccccc1)c1ccccc1	lipoxygenase inhibitor	ALOX5
CC-115	58298318	BRD-K16755045	CCN1C(=O)CN=C2NC=C(N=C12)c1ccc(nc1C)-c1nnc[nH]1	mTOR inhibitor; DNA protein kinase inhibitor	MTOR
CC-223		BRD-K88737571	CO[C@H]1CC[C@@H](CC1)N1C(=O)CNc2ncc(nc12)-c1ccc(nc1)C(C)(C)O	mTOR inhibitor	MTOR
CC-401	10430360	BRD-K45746021	C(CN1CCCCC1)Oc1cccc(c1)-c1n[nH]c2ccc(cc12)-c1ncn[nH]1	JNK inhibitor	MAPK8
CC-930		BRD-K48213016	O[C@H]1CC[C@@H](CC1)Nc1ncc2nc(Nc3c(F)cc(F)cc3F)n([C@H]3CCOC3)c2n1	JNK inhibitor	
CCG-1423	2726015	BRD-A79726147	CC(ONC(=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C(=O)Nc1ccc(Cl)cc1	apoptosis stimulant	RHOC|SRF
CCG-50014	2733079	BRD-K08893438	Cc1ccc(cc1)-n1sc(=O)n(Cc2ccc(F)cc2)c1=O	G protein signaling inhibitor	RGS4|RGS8
CCG-63802	6057678	BRD-K26970495	Cc1cccc(Oc2nc3c(C)cccn3c(=O)c2\C=C(/C#N)c2nc3ccccc3s2)c1	G protein signaling inhibitor	RGS4
CCG-63808	5948316	BRD-K68474505	Cc1cccn2c1nc(Oc1ccc(F)cc1)c(\C=C(/C#N)c1nc3ccccc3s1)c2=O	G protein signaling inhibitor	RGS4
CCMI	67042344	BRD-K16338837	Cc1cc(on1)C(=CNc1ccc(Cl)cc1)C(=O)Nc1ccc(Cl)cc1	acetylcholine receptor allosteric modulator	CHRNA7
CCMQ	3337816	BRD-K06159959	OC(=O)Cc1cc2ccccc2nc1C(O)=O	homoquinolinic acid binding inhibitor	
CCT-031374	2853753	BRD-K90999434	O=C(CN1C2=NCCN2c2ccccc12)c1ccc(cc1)-c1ccccc1	WNT signaling inhibitor	CTNNB1
CCT018159		BRD-K65503129	CCc1cc(-c2n[nH]c(C)c2-c2ccc3OCCOc3c2)c(O)cc1O	HSP inhibitor	HSP90AA1|HSP90AB1
CCT128930	17751819	BRD-K76406695	NC1(Cc2ccc(Cl)cc2)CCN(CC1)c1ncnc2[nH]ccc12	AKT inhibitor	PKIA|PRKACA
CCT129202	16202152	BRD-K57136142	CN(C)c1ccc(cc1)-c1nc2c(N3CCN(CC(=O)Nc4nccs4)CC3)c(Cl)cnc2[nH]1	Aurora kinase inhibitor	AURKA|AURKB|AURKC
CCT137690	25154041	BRD-K03289018	CN1CCN(CC1)c1ccc(cc1)-c1nc2c(N3CCN(Cc4cc(C)on4)CC3)c(Br)cnc2[nH]1	Aurora kinase inhibitor	AURKA|AURKB|AURKC
CC4	91654624	BRD-K17751100	O=c1cccc2[C@@H]3C[C@@H](CN(CCN4C[C@@H]5C[C@H](C4)c4cccc(=O)n4C5)C3)Cn12	nicotinic receptor agonist	CHRNB2
CD-1530	9952709	BRD-K09619322	OC(=O)c1ccc(cc1)-c1ccc2cc(O)c(cc2c1)C12CC3CC(CC(C3)C1)C2	retinoid receptor agonist	RARG
CD-437	135411	BRD-K28907958	OC(=O)c1ccc2cc(ccc2c1)-c1ccc(O)c(c1)C12CC3CC(CC(C3)C1)C2	retinoid receptor agonist	RARG
CDBA	320761	BRD-A08079565	OCC1OC2OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(OC6C(CO)OC(OC7C(CO)OC(OC8C(CO)OC(OC1C(O)C2O)C(O)C8O)C(O)C7O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O		
CDK1-5-inhibitor	438981	BRD-K87932577	Nc1n[nH]c2nc3ccccc3nc12	CDK inhibitor; glycogen synthase kinase inhibitor	CDK1|CDK5|GSK3B
CDK9-IN-6		BRD-K43914553	COC[C@H](C)N[C@H]1CC[C@@H](CC1)Nc1cc(c(Cl)cn1)-c1cccc(NCC2(CCOCC2)C#N)n1	CDK inhibitor	CDK9
CDPPB	11245456	BRD-K02213468	O=C(Nc1cc(nn1-c1ccccc1)-c1ccccc1)c1cccc(c1)C#N	glutamate receptor positive allosteric modulator	GRM5
cebranopadol		BRD-K48141473	CN(C)[C@]1(CC[C@@]2(CC1)OCCc1c2[nH]c2ccc(F)cc12)c1ccccc1	opioid receptor agonist	OPRL1|OPRM1
cediranib	9933475	BRD-K86930074	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1	KIT inhibitor; VEGFR inhibitor	CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB
cedrol	522667	BRD-A61188230	CC1CCC2C(C)(C)C3CC12CCC3(C)O		
cedrol-(+)	65575	BRD-K96362839	C[C@@H]1CC[C@H]2C(C)(C)[C@H]3C[C@@]12CC[C@@]3(C)O	sedative	
cefaclor	51039	BRD-K20338176	N[C@@H](C(=O)N[C@H]1[C@H]2SCC(Cl)=C(N2C1=O)C(O)=O)c1ccccc1	bacterial cell wall synthesis inhibitor	
cefadroxil	441194	BRD-A56858165	CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(N)c1ccc(O)cc1)C2=O)C(O)=O	bacterial cell wall synthesis inhibitor	SLC15A1|SLC15A2|SLC22A6|SLC22A8
cefalonium	21744	BRD-K15514357	NC(=O)c1cc[n+](CC2=C(N3[C@H](SC2)[C@H](NC(=O)Cc2cccs2)C3=O)C(O)=O)cc1	bacterial cell wall synthesis inhibitor	
cefamandole	456255	BRD-K27130738	Cn1nnnc1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](O)c1ccccc1)C2=O)C(O)=O	bacterial cell wall synthesis inhibitor	
cefamandole-nafate	5284527	BRD-K17903788	Cn1nnnc1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](OC=O)c1ccccc1)C2=O)C(O)=O	bacterial cell wall synthesis inhibitor	
cefathiamidine	15942748	BRD-K63835048	CC(C)N\C(SCC(=O)N[C@H]1[C@H]2SCC(COC(C)=O)=C(N2C1=O)C(O)=O)=N/C(C)C	bacterial cell wall synthesis inhibitor	
cefazolin	33255	BRD-K99750640	Cc1nnc(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cn2cnnn2)C3=O)C(O)=O)s1	bacterial cell wall synthesis inhibitor	PON1
cefcapene-pivoxil	5282438	BRD-K27515606	CC\C=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1	bacterial cell wall synthesis inhibitor	
cefdinir	6915944	BRD-K15766189	Nc1nc(cs1)C(=N\O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O	bacterial cell wall synthesis inhibitor	MPO
cefditoren-pivoxil	6437877	BRD-K72167406	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(\C=C/c3scnc3C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1	bacterial cell wall synthesis inhibitor	
cefepime	9615346	BRD-A12077521	CO\N=C(\C(=O)NC1C2SCC(C[N+]3(C)CCCC3)=C(N2C1=O)C(O)=O)c1csc(N)n1	bacterial cell wall synthesis inhibitor	
cefetamet	5487888	BRD-K27798832	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C)=C(N2C1=O)C(O)=O)c1csc(N)n1	bacterial cell wall synthesis inhibitor	
cefetamet-pivoxil	5486182	BRD-K21372554	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1	bacterial cell wall synthesis inhibitor	
cefixime	5362065	BRD-K71059170	Nc1nc(cs1)C(=N\OCC(O)=O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O	bacterial cell wall synthesis inhibitor	
cefmenoxime	9577231	BRD-A20839672	CO\N=C(\C(=O)NC1C2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O)c1csc(N)n1	bacterial cell wall synthesis inhibitor	
cefmetazole	42008	BRD-K48470486	CO[C@]1(NC(=O)CSCC#N)[C@H]2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O	bacterial cell wall synthesis inhibitor	
cefminox	71141	BRD-K77073709	CO[C@]1(NC(=O)CSC[C@@H](N)C(O)=O)[C@H]2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O	bacterial cell wall synthesis inhibitor	
cefodizime	5361871	BRD-K22641081	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSc3nc(C)c(CC(O)=O)s3)=C(N2C1=O)C(O)=O)c1csc(N)n1	bacterial cell wall synthesis inhibitor	
cefonicid	43594	BRD-K34058848	O[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSc3nnnn3CS(O)(=O)=O)=C(N2C1=O)C(O)=O)c1ccccc1	bacterial cell wall synthesis inhibitor	
cefoperazone	44187	BRD-K02292852	CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SCC(CSc4nnnn4C)=C(N3C2=O)C(O)=O)c2ccc(O)cc2)C(=O)C1=O	bacterial cell wall synthesis inhibitor	
ceforanide	43507	BRD-K37848908	NCc1ccccc1CC(=O)N[C@H]1[C@H]2SCC(CSc3nnnn3CC(O)=O)=C(N2C1=O)C(O)=O	penicillin binding protein inhibitor	
cefoselis	9830520	BRD-K72339976	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(Cn3ccc(=N)n3CCO)=C(N2C1=O)C(O)=O)c1csc(N)n1	bacterial cell wall synthesis inhibitor	
cefotaxime	5742673	BRD-K78364995	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(C)=O)=C(N2C1=O)C(O)=O)c1csc(N)n1	bacterial cell wall synthesis inhibitor	
cefotetan	50614	BRD-A78723049	CO[C@]1(NC(=O)C2SC(S2)=C(C(N)=O)C(O)=O)C2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O	bacterial cell wall synthesis inhibitor	
cefotiam	43708	BRD-K02275692	CN(C)CCn1nnnc1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)Cc1csc(N)n1)C2=O)C(O)=O	bacterial cell wall synthesis inhibitor	
cefotiam-cilexetil	2636	BRD-A76661185	CC(OC(=O)OC1CCCCC1)OC(=O)C1=C(CSc2nnnn2CCN(C)C)CSC2C(NC(=O)Cc3csc(N)n3)C(=O)N12	bacterial cell wall synthesis inhibitor	
cefoxitin	441199	BRD-K70976396	CO[C@]1(NC(=O)Cc2cccs2)[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O	bacterial cell wall synthesis inhibitor	
cefozopran	5491955	BRD-K46970505	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C[n+]3ccn4ncccc34)=C(N2C1=O)C(O)=O)c1nsc(N)n1	bacterial cell wall synthesis inhibitor	
cefpiramide	636405	BRD-K92872987	Cc1cc(O)c(cn1)C(=O)N[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O)c1ccc(O)cc1	bacterial cell wall synthesis inhibitor	
cefpirome	6917675	BRD-K56542719	CO\N=C(\C(=O)N[C@H]1[C@H]2SCC(C[n+]3cccc4CCCc34)=C(N2C1=O)C(O)=O)c1csc(N)n1	bacterial cell wall synthesis inhibitor	
cefpodoxime	6526396	BRD-A34205213	COCC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC)\c1csc(N)n1)C2=O)C(=O)OC(C)OC(=O)OC(C)C	bacterial cell wall synthesis inhibitor	
cefprozil	40466862	BRD-K24871708	C\C=C\C1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c1ccc(O)cc1)C2=O)C(O)=O	bacterial cell wall synthesis inhibitor	
cefradine	38103	BRD-K13797099	CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C1=CCC=CC1)C2=O)C(O)=O	bacterial cell wall synthesis inhibitor	CYP3A4
cefsulodin	656576	BRD-K03907181	NC(=O)c1cc[n+](CC2=C(N3[C@H](SC2)[C@H](NC(=O)[C@@H](c2ccccc2)S(O)(=O)=O)C3=O)C(O)=O)cc1	bacterial cell wall synthesis inhibitor	
ceftaroline-fosamil	10033059	BRD-K37252028	CCO\N=C(\C(=O)N[C@H]1[C@H]2SCC(Sc3nc(cs3)-c3cc[n+](C)cc3)=C(N2C1=O)C(O)=O)c1nsc(NP(O)(O)=O)n1	bacterial cell wall synthesis inhibitor	
ceftazidime	6321415	BRD-K52117081	CC(C)(O\N=C(/C(=O)N[C@H]1[C@H]2SCC(C[n+]3ccccc3)=C(N2C1=O)C(O)=O)c1csc(N)n1)C(O)=O	bacterial cell wall synthesis inhibitor	
ceftibuten	5282242	BRD-K11124378	Nc1nc(cs1)C(=C\CC(O)=O)\C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O	bacterial cell wall synthesis inhibitor	
ceftiofur	6328657	BRD-K82960980	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC(=O)c3ccco3)=C(N2C1=O)C(O)=O)c1csc(N)n1	bacterial cell wall synthesis inhibitor	
ceftizoxim	6533629	BRD-K04301924	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O)c1csc(N)n1	bacterial cell wall synthesis inhibitor	
ceftriaxone	5479530	BRD-K96734425	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSc3nc(=O)c(O)nn3C)=C(N2C1=O)C(O)=O)c1csc(N)n1	bacterial cell wall synthesis inhibitor	
cefuroxime	5479529	BRD-K02733959	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O)c1ccco1	bacterial cell wall synthesis inhibitor	
cefuroxime-axetil	6321416	BRD-A22303829	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OC(C)OC(C)=O)c1ccco1	bacterial cell wall synthesis inhibitor	
celecoxib	2662	BRD-K02637541	Cc1ccc(cc1)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)(F)F	cyclooxygenase inhibitor	CA12|PDPK1|PTGS2
celiprolol	2663	BRD-A95602221	CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(c1)C(C)=O	adrenergic receptor antagonist	ADRA2A|ADRB1|ADRB2
centazolone	72846	BRD-K31329721	Nn1cnc2cc3ccccc3cc2c1=O	monoamine oxidase inhibitor	
centpropazine	118176	BRD-A28958257	CCC(=O)c1ccc(OCC(O)CN2CCN(CC2)c2ccccc2)cc1	inositol monophosphatase inhibitor	
CEP-32496	56846693	BRD-K20722021	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(on4)C(C)(C)C(F)(F)F)c3)c2cc1OC	RAF inhibitor	BRAF|RAF1
CEP-33779	57336812	BRD-K37237504	CN1CCN(CC1)c1cccc(Nc2nc3c(cccn3n2)-c2ccc(cc2)S(C)(=O)=O)c1	JAK inhibitor	JAK2
CEP-37440	71721648	BRD-K72827473	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3C[C@H](CCCc3c2OC)N2CCN(CCO)CC2)ncc1Cl	ALK tyrosine kinase receptor inhibitor	ALK
cephalexin	27447	BRD-K90733503	CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O)C(O)=O	bacterial cell wall synthesis inhibitor	
cephalomannine	6436208	BRD-K68904758	C\C=C(/C)C(=O)N[C@H]([C@@H](O)C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)OC(C)=O)c1ccccc1	DNA polymerase inhibitor	
cephalosporin-c-zn	124079499	BRD-A44936478	CC(=O)OCC1=C2N3C(SC1)[C@H](NC(=O)CCCC(N)C(=O)O[Zn]OC2=O)C3=O	bacterial cell wall synthesis inhibitor	
cephalothin	6024	BRD-K28210218	CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)Cc1cccs1)C2=O)C(O)=O	bacterial cell wall synthesis inhibitor	
cephapirin	30699	BRD-K49880111	CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)CSc1ccncc1)C2=O)C(O)=O	bacterial cell wall synthesis inhibitor	
cepharanthine	10206	BRD-K96194081	COc1ccc2C[C@H]3N(C)CCc4cc(OC)c(Oc5c6OCOc6cc6CCN(C)[C@@H](Cc7ccc(Oc1c2)cc7)c56)cc34	NFkB pathway inhibitor	
cephradine	6710679	BRD-A90807417	CC1=C(N2C(SC1)[C@H](NC(=O)[C@H](N)C1=CCC=CC1)C2=O)C(O)=O	bacterial cell wall synthesis inhibitor	
ceramide	5497136	BRD-K41707108	CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(C)=O	phosphoenolpyruvate carboxylase activator; serine/threonine protein phosphatase activator	
ceritinib	57379345	BRD-K22149900	CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1	ALK tyrosine kinase receptor inhibitor	ALK|FLT3|IGF1R|INSR|TSSK1B
cerulenin	5282054	BRD-K52075040	C\C=C\C\C=C\CCC(=O)[C@H]1O[C@H]1C(N)=O	fatty acid synthase inhibitor	FASN
cetaben	47263	BRD-K86954340	CCCCCCCCCCCCCCCCNc1ccc(cc1)C(O)=O	cholesterol inhibitor; ACAT inhibitor	PPARA
cetilistat	9952916	BRD-K94863486	CCCCCCCCCCCCCCCCOc1nc2ccc(C)cc2c(=O)o1	triacylglycerol lipase inhibitor	PNLIP
cetirizine	2678	BRD-A42571354	OC(=O)COCCN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1	histamine receptor antagonist	HRH1
cetrimonium	2681	BRD-K47079459	CCCCCCCCCCCCCCCC[N+](C)(C)C		
cetrorelix	25074887	BRD-K76315403	CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O	gonadotropin releasing factor hormone receptor antagonist	GNRHR|LHCGR
cetylpyridinium	2683	BRD-K87700323	CCCCCCCCCCCCCCCC[n+]1ccccc1		
cevimeline	73417326	BRD-M98279124	C[C@H]1O[C@]2(CS1)CN1CCC2CC1.C[C@@H]1O[C@@]2(CS1)CN1CCC2CC1	acetylcholine receptor agonist	CHRM1|CHRM3
cevipabulin	11753543	BRD-A02473266	CNCCCOc1cc(F)c(c(F)c1)-c1c(Cl)nc2ncnn2c1NC(C)C(F)(F)F	microtubule stimulant; tubulin polymerization inhibitor	TUBB
CE3F4	21781066	BRD-A47940219	CC1CCc2c(cc(Br)c(F)c2Br)N1C=O	rap guanine nucleotide exchange factor inhibitor	RAPGEF3
CFM-1571	9844347	BRD-K64341947	COc1ccc(NC(=O)c2cc(OCCCN(C)C)nn2Cc2ccccc2)cc1	guanylate cyclase activator	
CFM-2	4377504	BRD-K42859542	COc1cc2CC(=O)NN=C(c3ccc(N)cc3)c2cc1OC	glutamate receptor antagonist	
CFTRinh-172	1554210	BRD-K72004355	OC(=O)c1ccc(cc1)\C=C1\SC(=S)N(C1=O)c1cccc(c1)C(F)(F)F	chloride channel blocker	CFTR
CF102	3035850	BRD-K52396582	CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NCc3cccc(I)c3)nc(Cl)nc12	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3
CG-400549	11844916	BRD-K48888725	Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O	FABI inhibitor	
CGH2466	5282339	BRD-K82028950	Nc1nc(c(s1)-c1ccncc1)-c1ccc(Cl)c(Cl)c1	adenosine receptor antagonist	ADORA1|ADORA2B|ADORA3
CGK-733	6605258	BRD-A50737080	[O-][N+](=O)c1cc(NC(=S)NC(NC(=O)C(c2ccccc2)c2ccccc2)C(Cl)(Cl)Cl)ccc1F	ATM kinase inhibitor; ATR kinase inhibitor	ATM|ATR
CGM097		BRD-K79584249	COc1cc2CC(=O)N([C@@H](c3ccc(Cl)cc3)c2cc1OC(C)C)c1ccc(cc1)N(C)C[C@H]1CC[C@@H](CC1)N1CCN(C)C(=O)C1	MDM inhibitor	MDM2
CGP-12177	2687	BRD-A40084411	CC(C)(C)NCC(O)COc1cccc2[nH]c(O)nc12	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3
CGP-13501	3519541	BRD-K95851186	CC(C)(Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)C=O	GABA receptor modulator	GABBR1
CGP-20712A	2685	BRD-A31575449	Cn1cc(nc1-c1ccc(OCC(O)CNCCOc2ccc(O)c(c2)C(N)=O)cc1)C(F)(F)F	adrenergic receptor antagonist	ADRB1|ADRB3
CGP-37157	2688	BRD-A35623999	Clc1ccc2NC(=O)CSC(c3ccccc3Cl)c2c1	mitochondrial Na+/Ca2+ exchanger antagonist; sodium/calcium exchange inhibitor	SLC8A1
CGP-37849	5950212	BRD-A90272038	C\C(CP(O)(O)=O)=C/C(N)C(O)=O	glutamate receptor antagonist	GRIN2A|GRIN2B|GRIN2C|GRIN2D
CGP-52411	1697	BRD-K13087974	O=C1NC(=O)c2cc(Nc3ccccc3)c(Nc3ccccc3)cc12	EGFR inhibitor	EGFR
CGP-53353	6711154	BRD-K32292990	Fc1ccc(Nc2cc3C(=O)NC(=O)c3cc2Nc2ccc(F)cc2)cc1	EGFR inhibitor; PKC inhibitor	EGFR|PRKCB
CGP-54626	197584	BRD-A74208568	C[C@H](NC[C@H](O)CP(O)(=O)CC1CCCCC1)c1ccc(Cl)c(Cl)c1	GABA receptor antagonist	GABBR1|GABBR2|KCTD12|KCTD16|KCTD8
CGP-55845	5311042	BRD-A89672324	C[C@H](NC[C@H](O)CP(O)(=O)Cc1ccccc1)c1ccc(Cl)c(Cl)c1	GABA receptor antagonist	GABBR1|GABBR2|KCTD12|KCTD16|KCTD8
CGP-57380	11644425	BRD-K42500029	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12	MAP kinase inhibitor	AURKB|LCK|MKNK1|MKNK2|SGK1
CGP-60474	644215	BRD-K79090631	OCCCNc1cc(ccn1)-c1ccnc(Nc2cccc(Cl)c2)n1	CDK inhibitor	CDK1|CDK2
CGP-71683		BRD-K34321528	Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12	neuropeptide receptor antagonist	NPY5R
CGP-74514	2794188	BRD-K56239177	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc12	CDK inhibitor	CDK1
CGP-78608	6604872	BRD-K60946979	C[C@@H](NCc1cc(Br)cc2[nH]c(=O)c(=O)[nH]c12)P(O)(O)=O	glutamate receptor antagonist	
CGP-7930	5024764	BRD-K65786282	CC(C)(CO)Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C	GABA receptor modulator	GABBR1
CGS-15943	2690	BRD-K49049886	Nc1nc2ccc(Cl)cc2c2nc(nn12)-c1ccco1	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
CGS-20625		BRD-K68103045	COc1ccc(cc1)-n1nc2c3CCCCCc3[nH]cc2c1=O	benzodiazepine receptor agonist; GABA benzodiazepine site receptor partial agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6
CGS-21680	57467688	BRD-K12614344	CCNC(=O)[C@H]1O[C@H]([C@@H](O)[C@@H]1O)n1cnc2c(N)nc(NCCc3ccc(CCC(O)=O)cc3)nc12	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3
CGS-9896	108030	BRD-K54093161	Clc1ccc(cc1)-n1[nH]c2c(cnc3ccccc23)c1=O	GABA receptor antagonist	GABRA1|GABRB2|GABRG2
CH-170	139570	BRD-K24820488	Cc1nc(Cn2cnc3n(C)c(=O)n(C)c(=O)c23)no1		
CH-5183284	66555680	BRD-K11683436	Cc1nc2ccc(cc2[nH]1)-n1ncc(C(=O)c2cc3ccccc3[nH]2)c1N	fibroblast growth factor inhibitor	FGFR1|FGFR2|FGFR3
CHC	5328791	BRD-K60302405	OC(=O)C(\C#N)=C\c1ccc(O)cc1	monocarboxylate transporter inhibitor	SLC16A1
chenodeoxycholic-acid	10133	BRD-K18135438	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	11-beta hydroxysteroid dehydrogenase inhibitor; FXR agonist	HSD11B1|NR1H4
CHF5074	9996409	BRD-K34508702	OC(=O)C1(CC1)c1ccc(c(F)c1)-c1ccc(Cl)c(Cl)c1	gamma secretase modulator	PSEN1
chicago-sky-blue-6b		BRD-K56483981	COc1cc(ccc1\N=N\c1ccc2c(cc(c(N)c2c1O)S(O)(=O)=O)S(O)(=O)=O)-c1ccc(\N=N\c2ccc3c(cc(c(N)c3c2O)S(O)(=O)=O)S(O)(=O)=O)c(OC)c1	glutamate inhibitor; macrophage migration inhibiting factor inhibitor	MIF
chidamide	9800555	BRD-K28537285	Nc1ccc(F)cc1NC(=O)c1ccc(CNC(=O)\C=C\c2cccnc2)cc1	HDAC inhibitor	HDAC10|HDAC3
chiniofon	11043	BRD-K52284881	Oc1c(I)cc(c2cccnc12)S(O)(=O)=O	antiprotozoal agent	
CHIR-124		BRD-K02241333	Clc1ccc2[nH]c(=O)c(-c3nc4ccccc4[nH]3)c(N[C@@H]3CN4CCC3CC4)c2c1	CHK inhibitor	CHEK1
CHIR-98014	53396311	BRD-K42973005	Nc1nc(NCCNc2ncc(c(n2)-c2ccc(Cl)cc2Cl)-n2ccnc2)ccc1[N+]([O-])=O	glycogen synthase kinase inhibitor	GSK3A|GSK3B
CHIR-99021	9956119	BRD-K16189898	Cc1c[nH]c(n1)-c1cnc(NCCNc2ccc(cn2)C#N)nc1-c1ccc(Cl)cc1Cl	glycogen synthase kinase inhibitor	CDK1|GSK3A|GSK3B|MAPK1
chloralose	2723807	BRD-A98174560	OCC(O)[C@H]1O[C@@H]2O[C@@H](O[C@@H]2[C@H]1O)C(Cl)(Cl)Cl		
chlorambucil	2708	BRD-K29458283	OC(=O)CCCc1ccc(cc1)N(CCCl)CCCl	DNA inhibitor	
chloramine-t	31388	BRD-K93546328	Cc1ccc(cc1)S(=O)(=O)NCl		
chloramphenicol	5959	BRD-K08111712	OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+]([O-])=O	bacterial 50S ribosomal subunit inhibitor	CD55
chloramphenicol-palmitate	12598150	BRD-K96424892	CCCCCCCCCCCCCCCC(=O)OC[C@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+]([O-])=O	protein synthesis inhibitor	
chloramphenicol-sodium-succinate	656580	BRD-K25209357	O[C@@H]([C@@H](COC(=O)CCC(O)=O)NC(=O)C(Cl)Cl)c1ccc(cc1)[N+]([O-])=O	protein synthesis inhibitor	
chlorazanil	10374	BRD-K21452876	Nc1ncnc(Nc2ccc(Cl)cc2)n1		
chlorcyclizine	2710	BRD-A57133233	CN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1	histamine receptor antagonist	HRH1
chlorfenson	6635	BRD-K89409436	Clc1ccc(OS(=O)(=O)c2ccc(Cl)cc2)cc1	other antifungal	
chlorhexidine	2713	BRD-K52256627	Clc1ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc2ccc(Cl)cc2)cc1	membrane integrity inhibitor	
chlorindanol	8961	BRD-K01653460	Oc1ccc(Cl)c2CCCc12		
chlorindione	70846	BRD-K61802864	Clc1ccc(cc1)C1C(=O)c2ccccc2C1=O		
chlorisondamine-diiodide	6244	BRD-K18030938	C[N+](C)(C)CC[N+]1(C)Cc2c(C1)c(Cl)c(Cl)c(Cl)c2Cl	acetylcholine receptor antagonist	CHRNA1
chlormadinone-acetate	6710779	BRD-A01593789	CC(=O)O[C@@]1(CCC2C3C=C(Cl)C4=CC(=O)CC[C@]4(C)C3CC[C@]12C)C(C)=O	5 alpha reductase inhibitor	PGR
chlormezanone	2717	BRD-A20348246	CN1C(c2ccc(Cl)cc2)S(=O)(=O)CCC1=O	GABA receptor modulator	GABRA1|TSPO
chlormidazole	71821	BRD-K60443845	Cc1nc2ccccc2n1Cc1ccc(Cl)cc1	fungal lanosterol demethylase inhibitor	
chlorobutanol	5977	BRD-K39495750	CC(C)(O)C(Cl)(Cl)Cl		
chlorocresol	1732	BRD-K89056082	Cc1cc(O)ccc1Cl	ryanodine receptor activator	
chlorogenic-acid	1794427	BRD-K47114202	O[C@@H]1C[C@](O)(C[C@@H](OC(=O)\C=C\c2ccc(O)c(O)c2)[C@@H]1O)C(O)=O	antioxidant	SLC37A4
chlorophyllide-cu-complex-na-salt		BRD-A63866086	CCc1c(C)c2=Cc3c(C=C)c(C)c4C=c5c(C)c(CCC(O)=O)c6=C7C(C(O)=O)C(=O)c8c(C)c9C=c1n2[Cu](n34)(n9c78)n56		
chlorophyllin	5479494	BRD-K23728266	CCc1c(C)c2cc3[nH]c(cc4nc([C@@H](CCC(O)=O)[C@@H]4C)c(CC(O)=O)c4nc(cc1[nH]2)c(C)c4C(O)=O)c(C)c3C=C		
chlorophyllin-copper	129010084	BRD-A92960111	CCC1=C(C)\C2=C\c3c(C=C)c(C)c4\C=C5/N=C(C(CCC(O)=O)C5C)/C(CC(O)=O)=c5/c(C(O)=O)c(C)/c(=C/C1=N/2)n5[Cu]n34	cytochrome P450 inhibitor	
chloroprocaine	8612	BRD-K86864073	CCN(CC)CCOC(=O)c1ccc(N)cc1Cl	sodium channel blocker	ATP1A1|CHRNA10|GRIN3A|HTR3A|SCN10A|SLC6A3
chloropyramine	25295	BRD-K83257731	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1	histamine receptor antagonist	HRH1
chloroquine	2719	BRD-A91699651	CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12	antimalarial agent	GSTA2|MRGPRX1|TLR9|TNF
chlorothiazide	2720	BRD-K88682005	NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O	diuretic	CA1|CA2|CA4|SLC12A3
chlorothymol	6982	BRD-K04358951	CC(C)c1cc(Cl)c(C)cc1O		
chlorotrianisene	11289	BRD-K27062708	COc1ccc(cc1)C(Cl)=C(c1ccc(OC)cc1)c1ccc(OC)cc1	estrogenic hormone	ESR1|ESR2
chloroxine	2722	BRD-K17075857	Oc1c(Cl)cc(Cl)c2cccnc12	opioid receptor antagonist	OPRK1
chloroxoquinoline	66593	BRD-K83335125	Oc1ccnc2cc(Cl)ccc12		
chloroxylenol	2723	BRD-K17223896	Cc1cc(O)cc(C)c1Cl	ATP synthase inhibitor	
chlorphenamine	2725	BRD-A04553218	CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1	histamine receptor antagonist	HRH1|SLC6A2|SLC6A3|SLC6A4
chlorphenesin	7697	BRD-A92262698	OCC(O)COc1ccc(Cl)cc1	muscle relaxant	
chlorphensin-carbamate	2724	BRD-A39230911	NC(=O)OCC(O)COc1ccc(Cl)cc1	muscle relaxant	
chlorproguanil	22323	BRD-K25494650	CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1	dihydrofolate reductase inhibitor	DHFR
chlorpromazine	2726	BRD-K89997465	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc12	dopamine receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALM1|CHRM1|CHRM3|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7|KCNH2|ORM1|ORM2|SMPD1|TRPC5
chlorpropamide	2727	BRD-K97746869	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1	ATP channel blocker	ABCC8|KCNJ10|KCNJ11
chlorpropham	2728	BRD-K59590127	CC(C)OC(=O)Nc1cccc(Cl)c1	antiviral	
chlorprothixene	667467	BRD-K36207157	CN(C)CC\C=C1\c2ccccc2Sc2ccc(Cl)cc12	dopamine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|HRH1|HTR2A|HTR2B|HTR2C
chlorpyrifos	2730	BRD-K08303368	CCOP(=S)(OCC)Oc1nc(Cl)c(Cl)cc1Cl	acetylcholinesterase inhibitor	ACHE
chlorquinaldol	6301	BRD-K90374350	Cc1ccc2c(Cl)cc(Cl)c(O)c2n1	other antibiotic	
chlortetracycline	57222566	BRD-A25492003	CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)ccc(Cl)c4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O	protein synthesis inhibitor	
chlorthalidone	2732	BRD-A26384407	NS(=O)(=O)c1cc(ccc1Cl)C1(O)NC(=O)c2ccccc12	carbonic anhydrase inhibitor	CA1|CA12|CA14|CA4|CA7|SLC12A1|SLC12A3
chlorzoxazone	2733	BRD-K98174813	Clc1ccc2oc(=O)[nH]c2c1	bacterial 30S ribosomal subunit inhibitor	KCNMA1|KCNN4
cholecalciferol	5280795	BRD-K62779383	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C		VDR
cholesterol	6710666	BRD-A42883684	CC(C)CCCC(C)[C@H]1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C		RORA
cholic-acid	221493	BRD-K43164539	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	bile acid	ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B
choline	305	BRD-K77300776	C[N+](C)(C)CCO	acetylcholine precursor	ACHE|BCHE|CHRNA2|PCYT1A|PCYT1B|PHOSPHO1|PLD1|PLD2
choline-alfoscerate	439285	BRD-A72390365	C[N+](C)(C)CCOP(O)(=O)OC[C@H](O)CO	acetylcholine precursor	GM2A
CHPG	3645780	BRD-A19381518	NC(C(O)=O)c1cc(O)ccc1Cl	glutamate receptor agonist	GRM5
CHR-6494	70679308	BRD-K76259716	CCCNc1ccc2ncc(-c3ccc4[nH]ncc4c3)n2n1	serine/threonine kinase inhibitor	GSG2
chromanol-(+/-)	90479790	BRD-M02075109	CCS(=O)(=O)N(C)[C@@H]1[C@@H](O)C(C)(C)Oc2ccc(cc12)C#N.CCS(=O)(=O)N(C)[C@H]1[C@H](O)C(C)(C)Oc2ccc(cc12)C#N	potassium channel blocker	
chromanol-293B-(-)-[3R,4S]	121846	BRD-K27911943	CCS(=O)(=O)N(C)[C@@H]1[C@@H](O)C(C)(C)Oc2ccc(cc12)C#N	potassium channel blocker	
chromocarb	2741	BRD-K94720315	OC(=O)c1cc(=O)c2ccccc2o1	antispasmodic	
chrysin	5281607	BRD-K22861715	Oc1cc(O)c2c(c1)oc(cc2=O)-c1ccccc1	breast cancer resistance protein inhibitor	AKR1B1|CDK6|CYP19A1|CYP1B1
chrysophanic-acid	10208	BRD-K59284035	Cc1cc(O)c2C(=O)c3c(O)cccc3C(=O)c2c1	EGFR inhibitor	EGFR|MTOR
chuanxiongzine	14296	BRD-K25691735	Cc1nc(C)c(C)nc1C		
CH223191		BRD-K22314899	Cc1cc(ccc1NC(=O)c1ccnn1C)\N=N\c1ccccc1C	aryl hydrocarbon receptor antagonist	AHR
CH5132799	49784945	BRD-K28352084	CS(=O)(=O)N1CCc2c1nc(nc2-c1cnc(N)nc1)N1CCOCC1	PI3K inhibitor	MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG
CH55	6184667	BRD-K71487808	CC(C)(C)c1cc(cc(c1)C(C)(C)C)C(=O)\C=C\c1ccc(cc1)C(O)=O	retinoid receptor binder	RARA|RARB
CI-844	200510	BRD-K83022601	O(c1ccccc1)c1cccnc1		
CI-923	135209	BRD-A50016482	CCNC(C)CN1CCc2c(C1)c(=O)oc1ccccc21	acetylcholine receptor antagonist	
CI-966	198693	BRD-K67680372	OC(=O)C1=CCCN(CCOC(c2ccc(cc2)C(F)(F)F)c2ccc(cc2)C(F)(F)F)C1	GAT inhibitor	SLC6A1
CI-976	122327	BRD-K88544581	CCCCCCCCCCC(C)(C)C(=O)Nc1c(OC)cc(OC)cc1OC	ACAT inhibitor	ACAT1|CES1
ciaftalan-zinc	114933	BRD-K01423020	[Zn]1n2c3\N=C4/N=C(c5ccccc45)/N=c4\n1\c(=N/C1=N/C(c5ccccc15)=N\c2c1ccccc31)c1ccccc41	reactive oxygen species stimulant	
cianidanol	9064	BRD-K58736316	O[C@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1ccc(O)c(O)c1	fatty acid synthase inhibitor	PTGS1
cibenzoline	129009921	BRD-K34251960	C1C(=C2NCCN2)C1(c1ccccc1)c1ccccc1	sodium channel blocker	
ciclesonide	6918155	BRD-K35245662	CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]21C)C1CCCCC1	glucocorticoid receptor agonist	NR3C1|SERPINA6
ciclopirox	2749	BRD-K13044802	Cc1cc(C2CCCCC2)n(O)c(=O)c1	membrane integrity inhibitor	ATP1A1
cicloprofen	37589	BRD-A94965935	CC(C(O)=O)c1ccc-2c(Cc3ccccc-23)c1	cyclooxygenase inhibitor	PTGS1|PTGS2
CID-16020046	16020046	BRD-A59391172	Cc1ccc(cc1)-c1[nH]nc2C(=O)N(C(c12)c1cccc(O)c1)c1ccc(cc1)C(O)=O	G protein-coupled receptor antagonist	GPR55
CID-2011756	2011756	BRD-K92781136	Clc1cccc(c1)-c1ccc(o1)C(=O)Nc1ccc(CN2CCOCC2)cc1	protein kinase inhibitor	PKD1
CID-2745687	9581011	BRD-K06405316	COC(=O)c1cnn(c1\C=N\N=C(/S)NC(C)(C)C)-c1ccc(F)cc1F	G protein-coupled receptor antagonist	GPR35
CID-5458317	6419844	BRD-A08840375	O=C1c2ccccc2C(NC2CCCCC2)\C1=C/c1ccccc1	MAP kinase phosphatase inhibitor	MAPK3
cidofovir	60613	BRD-K96153583	Nc1ccn(C[C@@H](CO)OCP(O)(O)=O)c(=O)n1	DNA polymerase inhibitor	
ciglitazone	2750	BRD-A93000692	CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1	PPAR receptor agonist	PPARG
cilastatin	6435415	BRD-K85518562	CC1(C)C[C@@H]1C(=O)N\C(C(O)=O)=C/CCCCSC[C@H](N)C(O)=O	dehydropeptidase inhibitor	DPEP1
cilazapril	40467985	BRD-K65518078	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](N2C1=O)C(O)=O	angiotensin converting enzyme inhibitor	ACE
cilengitide	176873	BRD-K57252450	CC(C)[C@@H]1N(C)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O	integrin antagonist	ITGAV|ITGB3
cilnidipine	5282138	BRD-A02743701	COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC\C=C\c1ccccc1	calcium channel blocker	CACNA1B
cilomilast	151170	BRD-K38473998	COc1ccc(cc1OC1CCCC1)C1(CCC(CC1)C(O)=O)C#N	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4D
cilostamide	2753	BRD-K28578425	CN(C1CCCCC1)C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1	phosphodiesterase inhibitor	PDE3A|PDE3B
cilostazol	2754	BRD-K67017579	O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1	phosphodiesterase inhibitor	PDE3A|PDE3B
CIM-0216	42887770	BRD-A75514485	Cc1cc(NC(=O)C(N2CCCc3ccccc23)c2ccccc2)no1	transient receptor potential channel agonist	TRPM3
cimaterol	2755	BRD-A65440446	CC(C)NCC(O)c1ccc(N)c(c1)C#N	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3
cimetidine	2756	BRD-K34157611	CN\C(NCCSCc1nc[nH]c1C)=N/C#N	histamine receptor antagonist	HRH2|SLC29A4|SLC47A1|SLC47A2
cimetropium		BRD-A99899486	C[N+]1(CC2CC2)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1	acetylcholine receptor antagonist	CHRM1
cinacalcet	156419	BRD-K73838513	C[C@@H](NCCCc1cccc(c1)C(F)(F)F)c1cccc2ccccc12	calcium channel activator	CASR
cinaciguat	9808022	BRD-K73440166	OC(=O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(cc1)C(O)=O	guanylate cyclase activator	GUCY1A3|GUCY1B3
cinalukast	6436135	BRD-K53720352	CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C2CCC2)c1)C(O)=O	leukotriene receptor antagonist	CYSLTR1
cinanserin	5475158	BRD-K40901640	CN(C)CCCSc1ccccc1NC(=O)\C=C\c1ccccc1	serotonin receptor antagonist	HTR2A
cinchocaine	3025	BRD-K99121711	CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1	sodium channel blocker	CALM1|SCN10A|SCN5A
cinchonidine	101744	BRD-K39079086	O[C@@H]([C@@H]1C[C@@H]2CC[N@]1C[C@@H]2C=C)c1ccnc2ccccc12	P glycoprotein inhibitor	
cinchonine	5702153	BRD-K14693417	O[C@@H]([C@H]1C[C@@H]2CC[N@]1C[C@@H]2C=C)c1ccnc2ccccc12	P glycoprotein inhibitor	CYP2D6
cinchophen	8593	BRD-K72915123	OC(=O)c1cc(nc2ccccc12)-c1ccccc1	analgesic agent	
cinepazet	6434395	BRD-K00531707	CCOC(=O)CN1CCN(CC1)C(=O)\C=C\c1cc(OC)c(OC)c(OC)c1	vasodilator	
cinepazide	5282459	BRD-K46839850	COc1cc(cc(OC)c1OC)\C=C\C(=O)N1CCN(CC(=O)N2CCCC2)CC1	calcium channel activator	
cinflumide	6434871	BRD-K25154476	Fc1cccc(c1)\C=C\C(=O)NC1CC1	muscle relaxant	
cinnamaldehyde	307	BRD-K38088841	O=CC=Cc1ccccc1	aldose reductase inhibitor; TRPV agonist	TRPA1
cinnarazine	1547484	BRD-K07220430	C(\C=C\c1ccccc1)N1CCN(CC1)C(c1ccccc1)c1ccccc1	calcium channel blocker	
cinoctramide	6443803	BRD-K08699567	COc1cc(cc(OC)c1OC)\C=C\C(=O)N1CCCCCCC1		
cinoxacin	2762	BRD-K14704277	CCn1nc(C(O)=O)c(=O)c2cc3OCOc3cc12	topoisomerase inhibitor	
cinoxate	5373773	BRD-K17828029	CCOCCOC(=O)\C=C\c1ccc(OC)cc1		
CINPA-1	969470	BRD-K24570280	CCOC(=O)Nc1ccc2CCc3ccccc3N(C(=O)CN(CC)CC)c2c1	CAR antagonist	NR1H4|NR1I3|PPARG
cinromide	688145	BRD-K66241279	CCNC(=O)\C=C\c1cccc(Br)c1		
cintriamide	6154037	BRD-K24507548	COc1cc(cc(OC)c1OC)\C=C\C(N)=O		
cipemastat	9824350	BRD-K95362002	CN1C(=O)N(C[C@@H]([C@@H](CC2CCCC2)C(=O)N2CCCCC2)C(=O)NO)C(=O)C1(C)C	metalloproteinase inhibitor	ADAM17|MMP1|MMP13|MMP2|MMP3|MMP8|MMP9
ciprofibrate	2763	BRD-A49358627	CC(C)(Oc1ccc(cc1)C1CC1(Cl)Cl)C(O)=O	PPAR receptor agonist	PPARA
ciprofloxacin	2764	BRD-K04804440	OC(=O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O	bacterial DNA gyrase inhibitor	TOP2A
ciproxifan	6422124	BRD-K01767299	O=C(C1CC1)c1ccc(OCCCc2c[nH]cn2)cc1	histamine receptor antagonist	ADRA2A|ADRA2C|HRH3|HRH4|HTR3A
CIQ	4231127	BRD-A35425966	COc1ccc(OCC2N(CCc3cc(OC)c(OC)cc23)C(=O)c2cccc(Cl)c2)cc1	glutamate receptor potentiator	GRIN2C|GRIN2D
cirazoline	2765	BRD-K54142781	C(Oc1ccccc1C1CC1)C1=NCCN1	adrenergic receptor agonist	ADRA1A
cis-aconitic-acid	643757	BRD-K71756122	OC(=O)C\C(=C\C(O)=O)C(O)=O		ACO2
cis-ACPD	16760136	BRD-M29936662	N[C@]1(CC[C@@H](C1)C(O)=O)C(O)=O.N[C@@]1(CC[C@H](C1)C(O)=O)C(O)=O	glutamate receptor agonist	GRM2|GRM3|GRM6|GRM7|GRM8
cis-exo-camphanediol-2,3	21626088	BRD-K41962502	CC1(C)[C@H]2CC[C@]1(C)[C@@H](O)[C@H]2O	nitric oxide stimulant	NOS3
cis-urocanic acid	1549103	BRD-K25146005	OC(=O)\C=C/c1c[nH]cn1	serotonin receptor agonist	HTR2A
cis-urocanic-acid	736715	BRD-K52670952	OC(=O)\C=C\c1c[nH]cn1	serotonin receptor agonist	HTR2A
cis-9,trans-11-Conjugated-linoleic-acid	5280644	BRD-K80025777	CCCCCC\C=C\C=C/CCCCCCCC(O)=O		
cisapride	2769	BRD-A12896037	COC1CN(CCCOc2ccc(F)cc2)CCC1NC(=O)c1cc(Cl)c(N)cc1OC	serotonin receptor agonist	HTR2A|HTR3A|HTR4|KCNH2
cisatracurium	62887	BRD-K17498618	COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC	acetylcholine receptor antagonist	CHRNA2
cisplatin	24191118	BRD-K69172251	N[Pt](N)(Cl)Cl	DNA alkylating agent; DNA synthesis inhibitor	XIAP
citalopram	2771	BRD-A47598013	CN(C)CCCC1(OCc2cc(ccc12)C#N)c1ccc(F)cc1	selective serotonin reuptake inhibitor (SSRI)	SLC6A2|SLC6A4
CITCO	9600409	BRD-K53263234	Clc1ccc(cc1)-c1nc2sccn2c1\C=N\OCc1ccc(Cl)c(Cl)c1	constitutive androstane receptor (CAR) agonist	NR1I3
citicoline	13805	BRD-A91728607	C[N+](C)(C)CCOP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc(N)nc1=O	membrane permeability enhancer; glutathione transferase stimulant	ACHE|SLC1A2
citiolone	14520	BRD-A57957888	CC(=O)NC1CCSC1=O	lipotropic; mucolytic agent	
citric-acid	19782904	BRD-K76792669	OC(=O)CC(O)(CC(O)=O)C(O)=O	coagulation factor inhibitor	AKR1B1|ANG|APRT|BHMT|C8G|CA4|CPB1|CS|CTDSP1|GNMT|HGS|HS3ST3A1|IL4I1|ITPA|LSM6|MDH2|MIF|PDE5A|PKD2L1|PLEKHA1|RNASE1|RNASE3|SRC|TNFSF13B|UCK2
CJ-033466	10429706	BRD-K21306330	CC(C)CN1CCC(CNC(=O)c2cc(Cl)c(N)n3cc(C)nc23)CC1	serotonin receptor agonist	HTR4
CK-636	588963	BRD-K81572616	Cc1[nH]c2ccccc2c1CCNC(=O)c1cccs1	actin related protein inhibitor	ACTR2|ACTR3|ARPC1B|ARPC2|ARPC3|ARPC4|ARPC5
CKD-712	9861306	BRD-A26458246	Oc1cc2CCNC(Cc3cccc4ccccc34)c2cc1O	NFkB pathway inhibitor	JAK2|STAT1
CKI-7	129236	BRD-K34303607	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12	casein kinase inhibitor	CSNK1G2
CL-218872	107950	BRD-K00662280	Cc1nnc2ccc(nn12)-c1cccc(c1)C(F)(F)F	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2
CL-225385	64799	BRD-K87573013	O=C(CC#N)c1ccccc1		
cladribine	20279	BRD-K93034159	Nc1nc(Cl)nc2n(cnc12)[C@H]1C[C@H](O)[C@@H](CO)O1	adenosine deaminase inhibitor; ribonucleotide reductase inhibitor	ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B
clarithromycin	84029	BRD-K49668410	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC	bacterial 50S ribosomal subunit inhibitor	CYP3A4
clavulanate	5280980	BRD-K94250879	OC\C=C1/O[C@@H]2CC(=O)N2[C@H]1C(O)=O	beta lactamase inhibitor	
clebopride	2780	BRD-K17294426	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1	dopamine receptor antagonist	ACHE|DRD2
clemastine	26987	BRD-K30240666	CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1	histamine receptor antagonist	HRH1
clemizole	2782	BRD-K04704168	Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc23)cc1	HCV inhibitor	
clenbuterol	2783	BRD-A75726477	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3|NGF|TNF
cleviprex	153994	BRD-A01563671	CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC	calcium channel blocker	CACNA1C|CACNA1D|CACNA1F|CACNA1S
clevudine	5270576	BRD-K18948558	Cc1cn([C@H]2O[C@@H](CO)[C@H](O)[C@@H]2F)c(=O)[nH]c1=O	DNA polymerase inhibitor	
clidinium	2784	BRD-A46066006	C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(c1ccccc1)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM3
climbazole	37907	BRD-A61676498	CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1	enzyme inducer	
clinafloxacin	4921596	BRD-A93964801	NC1CCN(C1)c1c(F)cc2c(c1Cl)n(cc(C(O)=O)c2=O)C1CC1	bacterial DNA gyrase inhibitor	
clindamycin	446598	BRD-K23586533	CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O	protein synthesis inhibitor	
clindamycin-palmitate	17750963	BRD-A76672327	CCCCCCCCCCCCCCCC(=O)OC1C(O)C(O)C(OC1SC)C(NC(=O)C1CC(CCC)CN1C)C(C)Cl	bacterial 50S ribosomal subunit inhibitor	
clindamycin-phosphate	443385	BRD-K27771035	CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]1O[C@H](SC)[C@H](OP(O)(O)=O)[C@@H](O)[C@H]1O	protein synthesis inhibitor	
clinofibrate	2787	BRD-A90625545	CCC(C)(Oc1ccc(cc1)C1(CCCCC1)c1ccc(OC(C)(CC)C(O)=O)cc1)C(O)=O	lipase clearing factor inhibitor	LPL
clioquinol	2788	BRD-K09255212	Oc1c(I)cc(Cl)c2cccnc12	chelating agent	OPRK1
clobazam	2789	BRD-K52408781	CN1c2ccc(Cl)cc2N(c2ccccc2)C(=O)CC1=O	GABA benzodiazepine site receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ
clobenpropit	2790	BRD-K71430621	Clc1ccc(CNC(=N)SCCCc2c[nH]cn2)cc1	histamine receptor antagonist	HRH1|HRH2|HRH3|HRH4
clobetasol-propionate	32798	BRD-K10799896	CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl	glucocorticoid receptor agonist	NR3C1|PLA2G1B
clobetasone-butyrate	71386	BRD-K58810291	CCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(=O)C[C@]12C)C(=O)CCl	corticosteroid agonist	NR3C1
clobutinol	26937	BRD-A43809092	CC(CN(C)C)C(C)(O)Cc1ccc(Cl)cc1	antitussive	
clocortolone-pivalate	5282493	BRD-K38003476	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C	steroid	NR3C1|PLA2G1B
clodronic-acid	25419	BRD-K72542090	OP(O)(=O)C(Cl)(Cl)P(O)(O)=O	bone resorption inhibitor	SLC25A4|SLC25A5|SLC25A6
clofarabine	119182	BRD-K34022604	Nc1nc(Cl)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F	ribonucleotide reductase inhibitor	POLA1|POLD1|POLE|RRM1|RRM2|RRM2B
clofazimine		BRD-K56614220	CC(C)\N=c1/cc2n(-c3ccc(Cl)cc3)c3ccccc3nc2cc1Nc1ccc(Cl)cc1	GK0582 inhibitor	
clofedanol	2795	BRD-A15687940	CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl	histamine receptor antagonist	HRH1
clofibrate	2796	BRD-K45252063	CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1	PPAR receptor agonist	LPL|PPARA
clofibric-acid	2797	BRD-K19111024	CC(C)(Oc1ccc(Cl)cc1)C(O)=O	PPAR receptor agonist	PPARA
clofilium	2798	BRD-K02680176	CCCCCCC[N+](CC)(CC)CCCCc1ccc(Cl)cc1	potassium channel blocker	KCNA5|KCNH1
clofoctol	2799	BRD-K02900412	CC(C)(C)CC(C)(C)c1ccc(O)c(Cc2ccc(Cl)cc2Cl)c1	protein synthesis inhibitor	
clomesone	100651	BRD-K39230570	CS(=O)(=O)CS(=O)(=O)OCCCl	DNA inhibitor	
clomethiazole	10783	BRD-K50422030	Cc1ncsc1CCCl	GABA receptor antagonist; GABA receptor modulator	GABRA1
clomifene	1548955	BRD-K29950728	CCN(CC)CCOc1ccc(cc1)C(=C(/Cl)c1ccccc1)\c1ccccc1	estrogen receptor antagonist	ESR1
clomipramine	2801	BRD-K52989797	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc12	serotonin transporter (SERT) inhibitor	GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4
clonazepam	2802	BRD-K38183498	[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1	GABA benzodiazepine site receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|TSPO
clonidine	2803	BRD-K98530306	Clc1cccc(Cl)c1N=C1NCCN1	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
clonixin-lysinate	3080836	BRD-M63173034	NCCCC[C@H](N)C(O)=O.Cc1c(Cl)cccc1Nc1ncccc1C(O)=O	cyclooxygenase inhibitor	
clopamide	2804	BRD-A85651701	CC1CCCC(C)N1NC(=O)c1ccc(Cl)c(c1)S(N)(=O)=O	sodium/chloride cotransporter inhibitor	
cloperastine	2805	BRD-A80908310	Clc1ccc(cc1)C(OCCN1CCCCC1)c1ccccc1	antitussive	
clopidogrel	60606	BRD-K27721098	COC(=O)[C@@H](N1CCc2sccc2C1)c1ccccc1Cl	purinergic receptor antagonist	P2RY12
clopidol	18087	BRD-K80036624	Cc1nc(C)c(Cl)c(O)c1Cl		
cloprostenol-(+/-)	5311053	BRD-K17850764	O[C@@H](COc1cccc(Cl)c1)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O	prostaglandin receptor agonist	PTGDR|PTGER1|PTGER3|PTGFR|TBXA2R
cloranolol	65814	BRD-A04971881	CC(C)(C)NCC(O)COc1cc(Cl)ccc1Cl	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3
clorgiline	4380	BRD-K73251053	CN(CCCOc1ccc(Cl)cc1Cl)CC#C	monoamine oxidase inhibitor	MAOA
clorotepine	1238	BRD-A19053834	CN1CCN(CC1)C1Cc2ccccc2Sc2ccc(Cl)cc12	dopamine receptor antagonist; adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|DRD2|HRH1|HTR2C|HTR6
clorprenaline	2810	BRD-A29281099	CC(C)NCC(O)c1ccccc1Cl	adrenergic receptor agonist	ADRB1|ADRB2
clorsulon	43231	BRD-K97521363	Nc1cc(C(Cl)=C(Cl)Cl)c(cc1S(N)(=O)=O)S(N)(=O)=O	glycolysis inhibitor	
closantel	42574	BRD-A19952358	Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O	chitinase inhibitor; NFkB pathway inhibitor	
clotiapine	16351	BRD-K10990317	CN1CCN(CC1)C1=Nc2ccccc2Sc2ccc(Cl)cc12		
clotrimazole	2812	BRD-K15916496	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1	cytochrome P450 inhibitor; imidazoline receptor ligand	CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8
cloxacillin	6098	BRD-K01244426	Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1ccccc1Cl	bacterial cell wall synthesis inhibitor	
cloxyquin	2817	BRD-K46982791	Oc1ccc(Cl)c2cccnc12	potassium channel activator	KCNK18
clozapine		BRD-K37289225	CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12	dopamine receptor antagonist; serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7
CL316243	5486546	BRD-K06467130	C[C@H](Cc1ccc2OC(Oc2c1)(C(O)=O)C(O)=O)NC[C@H](O)c1cccc(Cl)c1	adrenergic receptor agonist	ADRB3|UCP1|UCP2|UCP3
CMPD-1	11382492	BRD-K54095730	Oc1ccc(NC(=O)CCCc2ccc(cc2)-c2ccccc2F)cc1	p38 MAPK inhibitor	GNRHR|MAPK14
CNQX	3721046	BRD-K19438463	[O-][N+](=O)c1cc2[nH]c(=O)c(=O)[nH]c2cc1C#N	glutamate receptor antagonist	GRIA1|GRIA2|GRIA3|GRIA4
CNX-2006	56968072	BRD-K24869513	COc1cc(NC2CN(CCF)C2)ccc1Nc1ncc(c(Nc2cccc(NC(=O)C=C)c2)n1)C(F)(F)F	EGFR inhibitor	EGFR
CNX-774	59174579	BRD-K48443249	CNC(=O)c1cc(Oc2ccc(Nc3ncc(F)c(Nc4cccc(NC(=O)C=C)c4)n3)cc2)ccn1	Bruton's tyrosine kinase (BTK) inhibitor	BTK
CO-101244	6918409	BRD-K55677650	Cc1ccc(CC2(O)CCN(CCOc3ccc(O)cc3)CC2)cc1	glutamate receptor antagonist	GRIN2B
co-102862	9816959	BRD-K70912147	NC(=O)N\N=C\c1ccc(Oc2ccc(F)cc2)cc1		SCN4A|SCN9A
cobicistat	25151504	BRD-K51040301	CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1	cytochrome P450 inhibitor	CYP3A4|CYP3A43|CYP3A5|CYP3A7
cobimetinib	16222096	BRD-K03390685	OC1(CN(C1)C(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F)[C@@H]1CCCCN1	MEK inhibitor	
coenzyme-a	87642	BRD-A67956599	CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)n1cnc2c(N)ncnc12)[C@@H](O)C(=O)NCCC(=O)NCCS		ACAT2|CRAT|CS|DBI|HMGCR|KAT2A|KAT2B|KAT5
coenzyme-i	439153	BRD-A84188517	NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O		AASS|ACADS|ADH1A|ADH1B|ADH1C|ADH4|ADH5|ADH7|AKR1B1|AKR1C1|AKR1C2|AKR1C3|AKR1C4|ALDH1A1|ALDH1A2|ALDH1A3|ALDH1B1|ALDH2|ALDH3A1|ALDH3A2|ALDH3B1|ALDH3B2|ALDH4A1|ALDH5A1|ALDH6A1|ALDH7A1|ALDH9A1|AMT|BDH1|BLVRA|BLVRB|CDO1|CYB5R3|CYP17A1|CYP4A11|DHCR7|DHFR|DLAT|DLD|EHHADH|GAPDH|GAPDHS|GLUD1|GLUD2|GPD1|GSR|H6PD|HADH|HADHA|HIBADH|HMGCR|HMOX1|HMOX2|HPGD|HSD11B1|HSD11B2|HSD17B1|HSD17B10|HSD17B2|HSD17B3|HSD17B4|HSD17B7|HSD17B8|HSD3B1|HSD3B2|IDH3A|IDH3B|IDH3G|IMPDH1|IMPDH2|LDHA|LDHAL6A|LDHAL6B|LDHB|LDHC|MDH1|MDH2|ME1|ME2|ME3|MSMO1|MT-ND1|MT-ND2|MT-ND3|MT-ND4|MT-ND4L|MT-ND5|MT-ND6|MTHFD1|MTHFD2|NDUFA1|NDUFA10|NDUFA11|NDUFA12|NDUFA13|NDUFA2|NDUFA3|NDUFA4|NDUFA4L2|NDUFA5|NDUFA6|NDUFA7|NDUFA8|NDUFA9|NDUFAB1|NDUFB1|NDUFB10|NDUFB2|NDUFB3|NDUFB4|NDUFB5|NDUFB6|NDUFB7|NDUFB8|NDUFB9|NDUFC1|NDUFC2|NDUFS1|NDUFS2|NDUFS3|NDUFS4|NDUFS5|NDUFS6|NDUFS7|NDUFS8|NDUFV1|NDUFV2|NDUFV3|NNT|NQO2|NSDHL|OGDH|PDHA1|PDHA2|PDHB|PHGDH|PYCR1|PYCR2|QDPR|RDH5|SORD|TSTA3|TYR|UGDH
coenzyme-q10	5281915	BRD-K75043328	COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O		
colchicine	6167	BRD-K00259736	COc1cc2CC[C@H](NC(C)=O)c3cc(=O)c(OC)ccc3-c2c(OC)c1OC	microtubule inhibitor	GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8
colesevalam		BRD-U08520523			
colforsin	5702265	BRD-A55416093	CC(=O)O[C@H]1[C@@H](O)C2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C	adenylyl cyclase activator	ADCY2|ADCY5
colforsin-daproate	444029	BRD-K19388745	CN(C)CCC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C	adenylyl cyclase activator	
colfosceril-palmitate	160339	BRD-A95886749	CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC	pulmonary surfactant	
colistimethate	2836	BRD-A13668387	CCC(C)C1NC(=O)C(NC(=O)C(CCNCS(O)(=O)=O)NC(=O)C(CCNC(=O)C(NC(=O)C(CCNCS(O)(=O)=O)NC(=O)C(CCNCS(O)(=O)=O)NC1=O)C(C)O)NC(=O)C(CCNCS(O)(=O)=O)NC(=O)C(NC(=O)C(CCNCS(O)(=O)=O)NC(=O)CCCCC(C)C)C(C)O)C(C)CC	bacterial permeability inducer	
colistin	5311054	BRD-A18924964	CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O	bacterial permeability inducer	
colistin-b-sulfate	129009950	BRD-A36456202	CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)C(CCN)NC1=O)C(C)O	bacterial permeability inducer	
colistin-sulfate	45114150	BRD-A45201156	CCC(C)C1NC(=O)C(NC(=O)C(CCN)NC(=O)C(CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC1=O)C(C)O)NC(=O)C(CCN)NC(=O)C(NC(=O)C(CCN)NC(=O)CCCCC(C)C)C(C)O)C(C)CC	bacterial permeability inducer	
combretastatin-A-4	5351344	BRD-K61195623	COc1ccc(cc1O)\C=C/c1cc(OC)c(OC)c(OC)c1	tubulin polymerization inhibitor	
compound-w	16760376	BRD-K98143539	OC(=O)c1cc(Oc2ccc(cc2)[N+]([O-])=O)cc(Oc2ccc(cc2)[N+]([O-])=O)c1	beta-secretase inhibitor	BACE1
compound-401	10039361	BRD-K19655798	O=c1cc(nc2c3ccccc3ccn12)N1CCOCC1	DNA dependent protein kinase inhibitor	MTOR|PRKDC
compound-58112	155931	BRD-K76139886	COc1cccc(CN2C[Si](C)(C)O[Si](C)(C)C2)c1		
conivaptan	151171	BRD-K37385792	Cc1nc2CCN(C(=O)c3ccc(NC(=O)c4ccccc4-c4ccccc4)cc3)c3ccccc3-c2[nH]1	vasopressin receptor antagonist	AVPR1A|AVPR2
copanlisib	24989044	BRD-K24666289	COc1c(OCCCN2CCOCC2)ccc2C3=NCCN3C(NC(=O)c3cnc(N)nc3)=Nc12	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
copper-histidine	6971048	BRD-K36449075	N[C@H](Cc1c[nH]cn1)C(O)=O		HAL|HARS|HDC|SLC15A3|SLC15A4|SLC38A3|SLC38A5
COR-170	25033736	BRD-K74965187	CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c(=O)c2cc(ccc12)-c1ccccc1	cannabinoid receptor inverse agonist	CNR2
cordycepin	6303	BRD-K65428967	Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)C[C@H]1O	DNA inhibitor	
corosolic-acid	6918774	BRD-K27885593	C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O	PKC inhibitor; protein tyrosine kinase inhibitor	HSD11B1|PTPN1
corticosterone	5753	BRD-K73589401	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO	mineralocorticoid receptor agonist	HSD11B1|NCOA1|NR3C2
cortisone	6708812	BRD-A62731508	C[C@]12CC(=O)C3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@]2(O)C(=O)CO	glucocorticoid receptor agonist	NR3C1
cortisone-acetate	5745	BRD-K86161929	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C	glucocorticoid receptor agonist	NR3C1
cortodoxone	222786	BRD-K43736954	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO	androgen receptor antagonist	AR
costunolide	5281437	BRD-K26833429	C\C1=C/CC\C(C)=C\[C@H]2OC(=O)C(=C)[C@@H]2CC1	telomerase inhibitor	
cot-inhibitor-1	11584834	BRD-K98710228	Fc1ccc(Nc2c(cnc3c(Cl)cc(NCc4cn(CCN5CCCCCC5)nn4)cc23)C#N)cc1Cl	MAPK-interacting kinase inhibitor	MAP3K8
cot-inhibitor-2	44143370	BRD-K49468759	CCN1CCC(CC1)n1cc(CNc2cc(Cl)c3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3c2)nn1	MAPK-interacting kinase inhibitor	MAP3K8
cotinine	854019	BRD-K94144010	CN1[C@@H](CCC1=O)c1cccnc1	nicotine metabolite	
coumarin	323	BRD-K23913458	O=c1ccc2ccccc2o1	vitamin K antagonist	CA1|CA12|CA14|CA2|CA4|CA6|CA9|CYP2A6
coumophos	2871	BRD-K41567533	CCOP(=S)(OCC)Oc1ccc2c(C)c(Cl)c(=O)oc2c1	cholinesterase inhibitor	
CP-316819	10273347	BRD-K53913008	CON(C)C(=O)[C@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2cc(Cl)ccc2[nH]1	glycogen phosphorylase inhibitor	PYGL
CP-339818	656767	BRD-K52113681	CCCCCN=c1ccn(Cc2ccccc2)c2ccccc12	potassium channel blocker	KCNA3
CP-376395	9862166	BRD-K31394475	CCC(CC)Nc1cc(C)nc(Oc2c(C)cc(C)cc2C)c1C	corticosteroid releasing factor receptor antagonist	CRHR1
CP-471474	9907286	BRD-K33234937	CC(C)(NS(=O)(=O)c1ccc(Oc2ccc(F)cc2)cc1)C(=O)NO	matrix metalloprotease inhibitor	MMP1|MMP13|MMP2|MMP3|MMP9
CP-532623	10145345	BRD-K36611520	CC[C@@H]1C[C@H](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(C)=O)c2cc(ccc2N1C(=O)OC(C)C)C(F)(F)F	cholesteryl ester transfer protein inhibitor	CETP
CP-640186	449097	BRD-K26921335	O=C([C@@H]1CCCN(C1)C1CCN(CC1)C(=O)c1c2ccccc2cc2ccccc12)N1CCOCC1	acetyl-CoA carboxylase inhibitor	ACACA|ACACB
CP-673451	10158940	BRD-K43621685	COCCOc1ccc2n(cnc2c1)-c1ccc2cccc(N3CCC(N)CC3)c2n1	PDGFR tyrosine kinase receptor inhibitor	KIT|PDGFRA|PDGFRB
CP-724714	9874913	BRD-K76908866	COCC(=O)NC\C=C\c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1	EGFR inhibitor; protein tyrosine kinase inhibitor	ERBB2
CP-775146	10410059	BRD-K96843359	CC(C)c1ccc(CC(=O)N2CCC[C@H](C2)c2cccc(OC(C)(C)C(O)=O)c2)cc1	PPAR receptor agonist	PPARA
CP-91149	9843900	BRD-K19171642	CN(C)C(=O)[C@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2cc(Cl)ccc2[nH]1	glycogen phosphorylase inhibitor	PYGL
CP-93129	124007	BRD-K81876028	O=c1ccc2[nH]cc(C3=CCNCC3)c2[nH]1	serotonin receptor agonist	HTR1A
CP-94253	4029677	BRD-K33860217	CCCOc1ccc2[nH]cc(C3=CCNCC3)c2n1	serotonin receptor agonist	HTR1B
CP-945,598	10052040	BRD-K09090949	CCNC1(CCN(CC1)c1ncnc2n(c(nc12)-c1ccccc1Cl)-c1ccc(Cl)cc1)C(N)=O	cannabinoid receptor antagonist	CNR1
CP-99994	5311057	BRD-K09946180	COc1ccccc1CN[C@H]1CCCN[C@H]1c1ccccc1	tachykinin antagonist	TACR1
CPA-inhibitor	44374998	BRD-A69126730	ON(CC(Cc1ccccc1)C(O)=O)C(=O)Cc1ccccc1	carboxypeptidase inhibitor	CPA1|CPA2
CPCCOEt	6278000	BRD-A05729358	CCOC(=O)C12CC1\C(=N/O)c1ccccc1O2	glutamate receptor antagonist	GRM1
CPI-0610	57389999	BRD-K19871656	Cc1noc2[C@H](CC(N)=O)N=C(c3ccc(Cl)cc3)c3ccccc3-c12	bromodomain inhibitor	BRD4
CPI-1189	151118	BRD-K11073688	CC(=O)Nc1ccc(cc1)C(=O)NC(C)(C)C	tumor necrosis factor release inhibitor	TNF
CPI-169	71712226	BRD-K97181972	CCS(=O)(=O)N1CCC(CC1)[C@@H](C)n1c(C)c(C(=O)NCc2c(OC)cc(C)[nH]c2=O)c2ccccc12	histone lysine methyltransferase inhibitor	EZH2
CPI-203	71291068	BRD-K15811707	Cc1sc-2c(c1C)C(=N[C@@H](CC(N)=O)c1nnc(C)n-21)c1ccc(Cl)cc1	bromodomain inhibitor	BRD4
CPI-360	73442743	BRD-K18319422	COc1cc(C)[nH]c(=O)c1CNC(=O)c1c(C)n([C@H](C)C2CCOCC2)c2ccccc12	histone lysine methyltransferase inhibitor	EZH2
CPI-613	24770514	BRD-A06916187	OC(=O)CCCCC(CCSCc1ccccc1)SCc1ccccc1	pyruvate dehydrogenase inhibitor	PDHA1
CPP	6603754	BRD-K66094457	OC(=O)[C@H]1CN(CCCP(O)(O)=O)CCN1	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
CPSI-1306-(+/-)	59723793	BRD-A81603255	Fc1ccc(C2=NOC(CC(=O)N3CCOCC3)C2)c(F)c1	macrophage migration inhibiting factor inhibitor	MIF
creatine	586	BRD-K19615002	CN(CC(O)=O)C(N)=N		CKB|CKM|CKMT1A|CKMT2|GAMT|SLC6A8
creatinine	588	BRD-K13495773	CN1CC(=O)NC1=N		
creatinol-phosphate	23342	BRD-K42991124	CN(CCOP(O)(O)=O)C(N)=N		
crenolanib	10366136	BRD-K22127577	CC1(COc2ccc3n(cnc3c2)-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1	PDGFR tyrosine kinase receptor inhibitor	CSF1R|FLT3|KIT|PDGFRA|PDGFRB
cresol	2879	BRD-K56940914	Cc1ccc(O)cc1		
cresopirine	78094	BRD-K58648841	CC(=O)Oc1c(C)cccc1C(O)=O		
cridanimod	38072	BRD-K97939847	OC(=O)Cn1c2ccccc2c(=O)c2ccccc12	progesterone receptor agonist	PGR
crisaborole	44591583	BRD-K43230258	OB1OCc2cc(Oc3ccc(cc3)C#N)ccc12	phosphodiesterase inhibitor	PDE4B
crizotinib	11626560	BRD-K78431006	C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl	ALK tyrosine kinase receptor inhibitor	ALK|MET
crizotinib-(S)	56671814	BRD-K40308497	C[C@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl	MTH1 inhibitor	NUDT1
croconazole	2880	BRD-K73701464	Clc1cccc(COc2ccccc2C(=C)n2ccnc2)c1	bacterial cell wall synthesis inhibitor	
cromakalim	76968376	BRD-M89827113	CC1(C)Oc2ccc(cc2[C@H]([C@@H]1O)N1CCCC1=O)C#N.CC1(C)Oc2ccc(cc2[C@@H]([C@H]1O)N1CCCC1=O)C#N		KCNJ8
cromoglicic-acid	2882	BRD-K20920669	OC(COc1cccc2oc(cc(=O)c12)C(O)=O)COc1cccc2oc(cc(=O)c12)C(O)=O	immunosuppressant	KCNMA1|S100P
crotamiton	688020	BRD-K57179821	CCN(C(=O)\C=C\C)c1ccccc1C	antipruritic	
CRT0044876	81409	BRD-K02816415	OC(=O)c1cc2cccc([N+]([O-])=O)c2[nH]1		
cryptotanshinone	160254	BRD-K33336844	C[C@H]1COC2=C1C(=O)C(=O)c1c2ccc2c1CCCC2(C)C	acetylcholinesterase inhibitor; STAT inhibitor	STAT3
crystal-violet	3468	BRD-K60025295	CN(C)c1ccc(cc1)C(c1ccc(cc1)N(C)C)=C1C=CC(C=C1)=[N+](C)C	other antibiotic	
CR8-(R)	10224714	BRD-K40331046	CC[C@H](CO)Nc1nc(NCc2ccc(cc2)-c2ccccn2)c2ncn(C(C)C)c2n1	CDK inhibitor	CCNA2
CS-110266	123692	BRD-K15519488	C1CCN(CC1)C1(CCCCC1)c1cc2ccccc2s1	dopamine receptor agonist	SLC6A3
CS-917	11289630	BRD-K35601925	CC(C)Cc1sc(N)nc1-c1ccc(o1)P(O)(O)=O	fructose biphosphate inhibitor	FBP1
CT-7758	10186367	BRD-K40870905	OC(=O)[C@H](Cc1ccc(Nc2nccc3ccncc23)cc1)NC1=C(Br)C(=O)C11CCCCC1	integrin antagonist	ITGA4
CTEP	11646823	BRD-K30572193	Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(OC(F)(F)F)cc1	glutamate receptor antagonist	GRM5
CTS-1027	3342298	BRD-K53508936	ONC(=O)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1	metalloproteinase inhibitor	MMP1|MMP13|MMP2|MMP3|MMP9
CTS21166	445649	BRD-K89071957	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(O)=O)C(C)C)[C@@H](O)C[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O	beta-secretase inhibitor	BACE1
CU-CPT-4a	53242268	BRD-K58234744	OC(=O)[C@@H](Cc1ccccc1)NC(=O)c1sc2cc(F)ccc2c1Cl	toll-like receptor inhibitor	TLR3
CU-T12-9	91826088	BRD-K89462779	CNc1ccc(cc1-n1cnc(c1)-c1ccc(cc1)C(F)(F)F)[N+]([O-])=O	toll-like receptor agonist	TLR1|TLR2
CUDC-101	24756910	BRD-K41278234	COc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCCCCCC(=O)NO	EGFR inhibitor	EGFR|ERBB2
CUDC-427	71600094	BRD-K69351586	CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)Nc1sc(nc1-c1ccccc1)-c1ncco1	apoptosis inhibitor	XIAP
CUDC-907	54575456	BRD-K77638923	COc1ccc(cn1)-c1nc(N2CCOCC2)c2sc(CN(C)c3ncc(cn3)C(=O)NO)cc2n1	PI3K inhibitor	HDAC2|PIK3R1
CUR-61414	10392802	BRD-K69624312	COc1cccc(CN([C@H]2C[C@H](N(Cc3ccc4OCOc4c3)C2)C(=O)N2CCNCC2)C(=O)CC(C)(C)C)c1	smoothened receptor antagonist	DHH|IHH|SMO
curcumin	969516	BRD-K07572174	COc1cc(ccc1O)\C=C\C(=O)CC(=O)\C=C\c1ccc(O)c(OC)c1	cyclooxygenase inhibitor; histone acetyltransferase inhibitor; lipoxygenase inhibitor; NFkB pathway inhibitor	APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH
curcumol	14240392	BRD-K41933240	CC(C)[C@@H]1C[C@@]23O[C@]1(O)CC(=C)[C@@H]2CC[C@@H]3C	JAK inhibitor	JAK1|JAK2|JAK3
cutamesine	9907323	BRD-K90777969	COc1ccc(CCN2CCN(CCCc3ccccc3)CC2)cc1OC	sigma receptor agonist	SIGMAR1
CV-1808	6917803	BRD-K49197823	Nc1nc(Nc2ccccc2)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	adenosine receptor agonist	ADORA2A
CVT-10216	23661666	BRD-K60659193	CS(=O)(=O)Nc1ccc(cc1)-c1coc2cc(OCc3cccc(c3)C(O)=O)ccc2c1=O	aldehyde dehydrogenase inhibitor	ALDH2
CW-008	59528098	BRD-K84068331	COc1ccn2ncc(-c3nc4[nH]nc(NC(=O)c5ccc(F)cc5)c4cc3F)c2c1	PKA activator	PRKACA
CX-4945	24748573	BRD-K81458380	OC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc21	casein kinase inhibitor	CSNK2A1|CSNK2A2|DAPK3|HIPK3
CX-516	1370	BRD-K25140590	O=C(N1CCCCC1)c1ccc2OCOc2c1	glutamate receptor modulator	
CX-5461	25257557	BRD-K12787259	CN1CCCN(CC1)c1ccc2c(n1)n1c3ccccc3sc1c(C(=O)NCc1cnc(C)cn1)c2=O	RNA polymerase inhibitor	
cyacetacide	8820	BRD-K39371216	NNC(=O)CC#N		
cyamemazine	62865	BRD-A42881122	CC(CN(C)C)CN1c2ccccc2Sc2ccc(cc12)C#N	serotonin receptor antagonist	HTR1A|HTR2A|HTR2C|HTR7
cyanocobalamin		BRD-A18627414	C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP(O)(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)n1cnc2cc(C)c(C)cc12	methylmalonyl CoA mutase stimulant; vitamin B	MMAA|MMACHC|MTHFR|MTR|MTRR|MUT
cyanopindolol	155346	BRD-A47884604	CC(C)(C)NCC(O)COc1cccc2[nH]c(cc12)C#N	adrenergic receptor antagonist	ADRB1|HTR1A|HTR1D
cyclamic-acid	7533	BRD-K50785021	OS(=O)(=O)NC1CCCCC1		
cyclandelate	2893	BRD-A27370296	CC1CC(CC(C)(C)C1)OC(=O)C(O)c1ccccc1	calcium channel blocker	CACNA2D1|CES1
cyclic-AMP	274	BRD-A41840684	Nc1ncnc2n(cnc12)C1OC2COP(O)(=O)OC2C1O		CNGA3|HCN2|PRKAR1A|PRKAR2B|TRPM7
cyclizine	6726	BRD-K79501723	CN1CCN(CC1)C(c1ccccc1)c1ccccc1	histamine receptor modulator	HRH1|SULT1E1
cyclobenzaprine	2895	BRD-K42348709	CN(C)CCC=C1c2ccccc2C=Cc2ccccc12	adrenergic receptor agonist; serotonin receptor agonist	HTR2A
cyclocreatine	2896	BRD-K14379200	OC(=O)CN1CCNC1=N	creatine kinase substrate	
cyclocytidine	25051	BRD-K67536197	OC[C@H]1O[C@@H]2[C@@H](Oc3nc(=N)ccn23)[C@@H]1O	DNA synthesis inhibitor; RNA synthesis inhibitor	
cycloheximide	6197	BRD-K36055864	C[C@H]1C[C@H](C)C(=O)[C@@H](C1)[C@H](O)CC1CC(=O)NC(=O)C1	protein synthesis inhibitor	RPL3
cyclopenthiazide	2904	BRD-A41250306	NS(=O)(=O)c1cc2c(NC(CC3CCCC3)NS2(=O)=O)cc1Cl	thiazide diuretic	
cyclopentolate	2905	BRD-A77291778	CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1	acetylcholine receptor antagonist	CHRM1
cyclophosphamide	2907	BRD-A09722536	ClCCN(CCCl)P1(=O)NCCCO1	DNA alkylating agent	CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP3A4|CYP3A5|CYP3A7
cyclopiazonic-acid	44483253	BRD-A10420615	CC(=O)C1C(=O)[C@@H]2[C@@H]3[C@@H](Cc4cccc5[nH]cc3c45)C(C)(C)N2C1=O	ATPase inhibitor	ATP2A1
cycloserine-(d)	51670069	BRD-K87226815	N[C@@H]1CONC1=O	bacterial cell wall synthesis inhibitor	GRIN1
cyclosporin-a	5280754	BRD-A69815203	CCC1NC(=O)C(C(O)C(C)C\C=C\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C	calcineurin inhibitor	PPP3CA
cyclosporine	5284373	BRD-K13533483	CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C	calcineurin inhibitor	ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3
cyclothiazide	2910	BRD-A38675539	NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C2CC3CC2C=C3)cc1Cl	glutamate receptor modulator	CA1|CA2|CA4|FXYD2|GRIA1|GRIA2|GRIA3|GRIA4|SLC12A3
cyclovalone	1550234	BRD-K59866480	COc1cc(ccc1O)\C=C1/CCC\C(C1=O)=C/c1ccc(O)c(OC)c1	breast cancer resistance protein inhibitor	ABCG2
cyclovirobuxin-d	260439	BRD-K27799744	CN[C@@H](C)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@@H]4[C@]5(C[C@@]35CC[C@]12C)CC[C@H](NC)C4(C)C	calcium channel modulator	
CYC116	6420138	BRD-K64866502	Cc1nc(N)sc1-c1ccnc(Nc2ccc(cc2)N2CCOCC2)n1	Aurora kinase inhibitor	AURKA|AURKB|KDR
CYM-50260	44620894	BRD-K69877120	FCc1ccc(OCCOc2ccc(Cl)cc2Cl)c(Cl)n1	sphingosine 1 phosphate receptor agonist	S1PR4
CYM-50358	53358422	BRD-K80666802	Cc1cc(CN)cc(C)c1NC(=O)c1ccc(o1)-c1cc(Cl)ccc1Cl	sphingosine 1-phosphate receptor antagonist	S1PR4
CYM-50769	50904505	BRD-K27732927	COc1ccc(Oc2c(Cl)cnn(C3c4ccccc4-c4ccccc34)c2=O)cc1	neuropeptide receptor antagonist	NPBWR1
CYM-5442	25110406	BRD-A43005764	CCOc1ccc(cc1OCC)-c1nc(no1)-c1cccc2C(CCc12)NCCO	sphingosine 1 phosphate receptor agonist	S1PR1
CYM-5520	25110470	BRD-K29151923	Cc1cc(C(=O)Cn2cc(ccc2=O)C#N)c(C)n1Cc1ccccc1	sphingosine 1 phosphate receptor agonist	S1PR2
CYM-5541	17253208	BRD-K75940276	O=C(N(C1CCCCC1)C1CCCCC1)c1cc(on1)C1CC1	sphingosine 1 phosphate receptor agonist	S1PR3
cypermethrin	2912	BRD-A62798249	CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1		
cyproheptadine	2913	BRD-K28143534	CN1CCC(CC1)=C1c2ccccc2C=Cc2ccccc12	histamine receptor antagonist	ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7
cyproterone	5702275	BRD-A48103086	CC(=O)[C@@]1(O)CCC2C3C=C(Cl)C4=CC(=O)[C@@H]5CC5[C@]4(C)C3CC[C@]12C	androgen receptor antagonist	AR
cyproterone-acetate	9880	BRD-K41141507	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C)C(C)=O	androgen receptor antagonist	ADORA1|AR
cyromazine	47866	BRD-K36711084	Nc1nc(N)nc(NC2CC2)n1		
cysteamine	118985556	BRD-K92611362	NCCS	tissue transglutaminase inhibitor	NPY2R|SST
CYT-997	11351021	BRD-K23363278	CCC[C@H](Nc1nc(ncc1C)-c1ccc(NC(=O)NCC)c(OC)c1)c1cccnc1	tubulin polymerization inhibitor	TUBB
cytarabine	6175	BRD-K71847383	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1	ribonucleotide reductase inhibitor	POLA1|POLB|POLD1|POLE
cytisine	10235	BRD-K74186897	O=c1cccc2[C@H]3CNC[C@H](C3)Cn12	acetylcholine receptor agonist	CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB2|CHRNB4
cytochalasin-b	44634701	BRD-K47000838	C[C@H]1[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]22OC(=O)\C=C/[C@H](O)CCC[C@@H](C)C\C=C\[C@H]2[C@H](O)C1=C	microtubule inhibitor	ACTB
cytochlor	92132144	BRD-K48988407	Nc1nc(=O)n(cc1Cl)[C@H]1C[C@@H](O)[C@@H](CO)O1		
cyt387	25062766	BRD-K87737963	O=C(NCC#N)c1ccc(cc1)-c1ccnc(Nc2ccc(cc2)N2CCOCC2)n1		JAK1|JAK2|JAK3
CY208-243	58144	BRD-K79353516	CN1Cc2ccccc2[C@H]2[C@H]1Cc1c[nH]c3cccc2c13	dopamine receptor agonist	CALY
CZC-54252	44252734	BRD-K87021635	COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1)N1CCOCC1	leucine rich repeat kinase inhibitor	LRRK2
CZC24832	42623951	BRD-K01377300	CC(C)(C)NS(=O)(=O)c1cncc(c1)-c1cc(F)c2nc(N)nn2c1	PI3K inhibitor	PIK3CG
C106	44134854	BRD-M12328004	CN1CCCC1c1cccnc1.Cc1ccc(cc1)C(=O)OC(C(OC(=O)c1ccc(C)cc1)C(O)=O)C(O)=O		
C11-Acetate	168049	BRD-K83914624	[Y+3]		ABAT|ACE|AKR1C3|CA2|CELA1|ESR2|FFAR2|FFAR3|HPRT1|LTA4H|MMP12|NOS1|NOS3|PLA2G1B|PTPN1|SOD1|TXN
C34	91691128	BRD-K43167535	CC(C)O[C@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1NC(C)=O	toll-like receptor inhibitor	TLR4
C646	2871948	BRD-K73383190	CC1=NN(C(=O)C1=Cc1ccc(o1)-c1cc(C)c(C)cc1[N+]([O-])=O)c1ccc(cc1)C(O)=O	histone acetyltransferase inhibitor	EP300
D-(+)-maltose	6255	BRD-K74377520	OC[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O		AMY2B|MGAM
D-alpha-tocopheryl-succinate	20353	BRD-K64636206	CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(OC(=O)CCC(O)=O)c(C)c(C)c2O1		
D-delta-Tocopherol	92094	BRD-K04657451	CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2cc(O)cc(C)c2O1		
D-limonene	440917	BRD-K20879694	CC(=C)[C@@H]1CCC(C)=CC1		
D-Phenylalanine	6919011	BRD-K00911807	N[C@H](Cc1ccccc1)C(O)=O	enkephalinase inhibitor	CCBL1|CRH|HCAR3
D-Serine	6857549	BRD-K71822263	N[C@H](CO)C(O)=O	glutamate receptor agonist	GLRA1|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|SERPINB3
D-4476	6419753	BRD-K09132007	NC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccccn1)-c1ccc2OCCOc2c1	TGF beta receptor inhibitor	CSNK1A1|CSNK1D|TGFB1
D-64131	3921152	BRD-K26997899	COc1ccc2[nH]c(cc2c1)C(=O)c1ccccc1	microtubule inhibitor	TUBB
D-7193	6995101	BRD-K32372024	CC(=O)N[C@@H](CSSC[C@H](NC(C)=O)C(O)=O)C(O)=O		
DAA-1106	10430788	BRD-K01080633	COc1ccc(OC)c(CN(C(C)=O)c2cc(F)ccc2Oc2ccccc2)c1	benzodiazepine receptor agonist	TSPO
dabigatran	216210	BRD-K38168441	Cn1c(CNc2ccc(cc2)C(N)=N)nc2cc(ccc12)C(=O)N(CCC(O)=O)c1ccccn1	thrombin inhibitor	F2
dabigatran-etexilate	213023	BRD-K57041787	CCCCCCOC(=O)\N=C(\N)c1ccc(NCc2nc3cc(ccc3n2C)C(=O)N(CCC(=O)OCC)c2ccccn2)cc1	thrombin inhibitor	F2
dabrafenib	44462760	BRD-K09951645	CC(C)(C)c1nc(c(s1)-c1ccnc(N)n1)-c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1F	RAF inhibitor	BRAF|LIMK1|NEK11|RAF1|SIK1
dacarbazine		BRD-K35520305	CN(C)\N=N\c1[nH]cnc1C(N)=O	DNA alkylating agent	PGD|POLA2
dacinostat	6445533	BRD-K56957086	OCCN(CCc1c[nH]c2ccccc12)Cc1ccc(\C=C\C(=O)NO)cc1	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
daclatasvir	25154714	BRD-K82861010	COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c1ncc([nH]1)-c1ccc(cc1)-c1ccc(cc1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C	HCV inhibitor	
dacomitinib	11511120	BRD-K57169635	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)\C=C\CN1CCCCC1	EGFR inhibitor	EGFR|ERBB2|ERBB4
dactinomycin	457193	BRD-K70578146	CC(C)[C@H]1NC(=O)[C@@H](NC(=O)c2ccc(C)c3oc4c(C)c(=O)c(N)c(C(=O)N[C@H]5[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]6CCCN6C(=O)[C@H](NC5=O)C(C)C)c4nc23)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C1=O	RNA polymerase inhibitor	POLR2A
daidzein	5281708	BRD-K42095107	Oc1ccc(cc1)-c1coc2cc(O)ccc2c1=O	estrogen receptor agonist	ESRRA|ESRRB|ESRRG|TRPC5
dalargin	16397403	BRD-A89196962	CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)[C@H](C)NC(=O)C(N)Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O	opioid receptor agonist	OPRM1
dalbavancin	16134627	BRD-K30177383	CN[C@@H]1c2ccc(O)c(Oc3cc(O)c(Cl)c(c3)[C@@H]3NC(=O)[C@@H](Cc4ccc(Oc5cc6cc(Oc7ccc(cc7Cl)[C@@H](O)[C@@H]7NC(=O)[C@H](NC(=O)[C@@H]6NC3=O)c3ccc(O)c(c3)-c3c(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)cc(O)cc3[C@H](NC7=O)C(=O)NCCCN(C)C)c5O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)C(O)=O)cc4)NC1=O)c2	bacterial cell wall synthesis inhibitor	PNLIP
dalcetrapib	6918540	BRD-K18849474	CCC(CC)CC1(CCCCC1)C(=O)Nc1ccccc1SC(=O)C(C)C	cholesteryl ester transfer protein inhibitor	CETP
dalfampridine	1727	BRD-K22482860	Nc1ccncc1	potassium channel blocker	KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNJ13|KCNJ5|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2
daltroban	54343	BRD-K26813177	OC(=O)Cc1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1	thromboxane receptor antagonist	TBXA2R
daminozide	15331	BRD-K83452553	CN(C)NC(=O)CCC(O)=O	KDM2A inhibitor	KDM2A|KDM7A|PHF8
danazol	5702031	BRD-A92537424	C[C@]12CCC3C(CCC4=Cc5oncc5C[C@]34C)C1CC[C@@]2(O)C#C	estrogen receptor antagonist; progesterone receptor agonist	AR|CCL2|ESR1|GNRHR|GNRHR2|PGR
danegaptide	16656685	BRD-K35589454	NCC(=O)N1C[C@@H](C[C@H]1C(O)=O)NC(=O)c1ccccc1	gap junction modulator	
danirixin	24780598	BRD-K13769342	Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(c1O)S(=O)(=O)[C@H]1CCCNC1	CC chemokine receptor antagonist	CXCR2
danofloxacin	25273623	BRD-K45916615	CN1C[C@@H]2C[C@H]1CN2c1cc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1	bacterial DNA gyrase inhibitor	
danoprevir	11285588	BRD-K08111240	CC(C)(C)OC(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)OC(=O)N1Cc2cccc(F)c2C1)C(=O)NS(=O)(=O)C1CC1	HCV inhibitor	
dantrolene	6914273	BRD-K81272440	[O-][N+](=O)c1ccc(cc1)-c1ccc(\C=N\N2CC(=O)NC2=O)o1	calcium channel blocker	RYR1|RYR3
dantron	2950	BRD-K10065684	Oc1cccc2C(=O)c3cccc(O)c3C(=O)c12	laxative	
danusertib	11442891	BRD-K07881437	CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1)c1ccccc1	Aurora kinase inhibitor; growth factor receptor inhibitor	AURKA|AURKB|AURKC|FGFR1|NTRK1|RET|SLK
dapagliflozin	9887712	BRD-K58160573	CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1	sodium/glucose cotransporter inhibitor	SLC5A1|SLC5A2
daphnetin	5280569	BRD-K61269089	Oc1ccc2ccc(=O)oc2c1O	protein kinase inhibitor	
dapiprazole	3033538	BRD-K33133047	Cc1ccccc1N1CCN(CCc2nnc3CCCCn23)CC1	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D
dapivirine	214347	BRD-K12885236	Cc1cc(C)c(Nc2ccnc(Nc3ccc(cc3)C#N)n2)c(C)c1	non-nucleoside reverse transcriptase inhibitor	CYP3A4|CYP3A5
dapoxetine	71353	BRD-K51579475	CN(C)[C@@H](CCOc1cccc2ccccc12)c1ccccc1	selective serotonin reuptake inhibitor (SSRI)	HTR1A|HTR1B|HTR2C|SLC6A4
daprodustat	91617630	BRD-K06455935	OC(=O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O	hypoxia inducible factor inhibitor	EGLN1
dapsone	2955	BRD-K62363391	Nc1ccc(cc1)S(=O)(=O)c1ccc(N)cc1	bacterial antifolate	DHFR
DAPT	5311272	BRD-K47177710	C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@H](C(=O)OC(C)(C)C)c1ccccc1	gamma secretase inhibitor	
daptomycin	46930993	BRD-K94358652	CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)c2ccccc2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@@H](C)CC(O)=O	bacterial cell wall synthesis inhibitor	
darapladib	9939609	BRD-K19085898	CCN(CC)CCN(Cc1ccc(cc1)-c1ccc(cc1)C(F)(F)F)C(=O)Cn1c2CCCc2c(=O)nc1SCc1ccc(F)cc1	phospholipase inhibitor	PLA2G7
darglitazone	53702456	BRD-K82908348	Cc1oc(nc1CCC(=O)c1ccc(Cc2sc(O)nc2O)cc1)-c1ccccc1	PPAR receptor antagonist	PPARG
darifenacin	444031	BRD-K95773607	NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c1ccccc1)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
darunavir	213039	BRD-K84986517	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1	HIV protease inhibitor	CYP3A4
darusentan	177236	BRD-K54863166	COc1cc(OC)nc(O[C@H](C(O)=O)C(OC)(c2ccccc2)c2ccccc2)n1	endothelin receptor antagonist	EDNRA
dasabuvir	56640146	BRD-K02943813	COc1c(cc(cc1C(C)(C)C)-n1ccc(=O)[nH]c1=O)-c1ccc2cc(NS(C)(=O)=O)ccc2c1	HCV inhibitor	
dasatinib	3062316	BRD-K49328571	Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1	Bcr-Abl kinase inhibitor; ephrin inhibitor; KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; src inhibitor; tyrosine kinase inhibitor	ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1
DAU-5884		BRD-K31633810	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)N1Cc2ccccc2NC1=O	acetylcholine receptor antagonist	CHRM3
daucosterol	5742590	BRD-K14276241	CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)C	apoptosis stimulant	
daunorubicin	30323	BRD-K43389675	COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O	RNA synthesis inhibitor; topoisomerase inhibitor	TOP2A|TOP2B
dazmegrel	53555	BRD-K20738689	Cc1c(Cn2ccnc2)c2ccccc2n1CCC(O)=O	thromboxane synthase inhibitor	TBXAS1
dazoxiben	53001	BRD-K82767007	OC(=O)c1ccc(OCCn2ccnc2)cc1	thromboxane synthase inhibitor	TBXAS1
DBeQ	676352	BRD-K59204667	C(Nc1nc(NCc2ccccc2)c2ccccc2n1)c1ccccc1	ATPase inhibitor	CASP3
DBPR108	44201003	BRD-K83020231	CC(C)(CC(=O)N1CCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N	dipeptidyl peptidase inhibitor	DPP4
DC-260126	2843133	BRD-K10596918	CCCCc1ccc(NS(=O)(=O)c2ccc(F)cc2)cc1	free fatty acid receptor antagonist	FFAR1
DCC-2618	46208890	BRD-K49246350	Cn1cc(cn1)-c1cc(Oc2cc(F)c(NC(=O)C3(CC3)C(=O)Nc3ccccc3)cc2F)ccn1	PDGFR tyrosine kinase receptor inhibitor; KIT inhibitor	KIT|PDGFRA
DCEBIO	656765	BRD-K89299012	CCn1c(O)nc2cc(Cl)c(Cl)cc12	potassium channel activator	KCNN2|KCNN3|KCNN4
DCPIB	10071166	BRD-A39255369	CCCCC1(Cc2cc(OCCCC(O)=O)c(Cl)c(Cl)c2C1=O)C1CCCC1	chloride channel blocker; gap junction modulator; glutamate inhibitor	SLC1A2
DDR1-IN-1	72836888	BRD-K61845293	CCN1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc2ccc(C)c(Oc3ccc4NC(=O)Cc4c3)c2)CC1	discoidin domain receptor inhibitor	DDR1|DDR2
debrisoquin	2966	BRD-K80419150	NC(=N)N1CCc2ccccc2C1	adrenergic neuron blocker	SLC6A2
decamethonium	2968	BRD-K49783248	C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C	acetylcholine receptor agonist	ACHE|CHRNA2
decamethoxine	162291	BRD-A56320380	CC(C)C1CCC(C)CC1OC(=O)C[N+](C)(C)CCCCCCCCCC[N+](C)(C)CC(=O)OC1CC(C)CCC1C(C)C	antiseptic	
decernotinib	71187083	BRD-A95300432	CCC(C)(Nc1ccnc(n1)-c1c[nH]c2ncccc12)C(=O)NCC(F)(F)F	JAK inhibitor	JAK3
decitabine	451668	BRD-K79254416	Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1	DNA methyltransferase inhibitor	DNMT1|DNMT3A
decoquinate	29112	BRD-K17641316	CCCCCCCCCCOc1cc2c(O)c(cnc2cc1OCC)C(=O)OCC	antiprotozoal agent	
defactinib	25117126	BRD-K43578482	CNC(=O)c1ccc(Nc2ncc(c(NCc3nccnc3N(C)S(C)(=O)=O)n2)C(F)(F)F)cc1	focal adhesion kinase inhibitor	PTK2
deferasirox		BRD-K97010173	OC(=O)c1ccc(cc1)-n1nc(nc1-c1ccccc1O)-c1ccccc1O	chelating agent	CYP3A4
deferiprone	2972	BRD-K06878038	Cc1c(O)c(=O)ccn1C	chelating agent	UGT1A6
deferoxamine-mesylate	2973	BRD-K09821361	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN	chelating agent	
deflazacort	73707512	BRD-K96006502	CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]21C	glucocorticoid receptor agonist	NR3C1
deforolimus	11520894	BRD-K62304154	CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OP(C)(C)=O	mTOR inhibitor	MTOR
degarelix	44208978	BRD-A88562598	CC(C)CC(NC(=O)C(Cc1ccc(NC(N)=O)cc1)NC(=O)C(Cc1ccc(NC(=O)C2CC(=O)NC(=O)N2)cc1)NC(=O)C(CO)NC(=O)C(Cc1cccnc1)NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)C(Cc1ccc2ccccc2c1)NC(C)=O)C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(N)=O	gonadotropin releasing factor hormone receptor antagonist	GNRHR
dehydroacetic-acid	122903	BRD-A17300716	CC(=O)C1C(=O)OC(C)=CC1=O		
dehydrocholate	6602440	BRD-A64125466	C[C@H](CCC(O)=O)[C@H]1CCC2C3C(CC(=O)[C@]12C)[C@@]1(C)CCC(=O)CC1CC3=O		
dehydrocholate-acid	6710667	BRD-A11551002	CC(CCC(O)=O)[C@H]1CCC2C3C(CC(=O)[C@]12C)[C@@]1(C)CCC(=O)C[C@H]1CC3=O		
dehydrocorydaline	34781	BRD-K67186445	COc1cc2CC[n+]3cc4c(OC)c(OC)ccc4c(C)c3-c2cc1OC	acetylcholinesterase inhibitor	ACHE
dehydroepiandrosterone	5881	BRD-K41256143	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O	protein synthesis stimulant	ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1
dehydroepiandrosterone-sulfate	12594	BRD-K15360631	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@H](CC[C@]34C)OS(O)(=O)=O)[C@@H]1CCC2=O	androgen receptor agonist; estrogen receptor agonist	AR|ESR1|ESR2
delamanid	6480466	BRD-K17480742	C[C@]1(COc2ccc(cc2)N2CCC(CC2)Oc2ccc(OC(F)(F)F)cc2)Cn2cc(nc2O1)[N+]([O-])=O	bacterial cell wall synthesis inhibitor	
delanzomib	24800541	BRD-K59325863	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)c1cccc(n1)-c1ccccc1)[C@@H](C)O)B(O)O	proteasome inhibitor	CMA1|CTSG|CYP3A4|ELANE
delapril	40466929	BRD-K00573984	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(O)=O)C1Cc2ccccc2C1	angiotensin converting enzyme inhibitor	ACE
delavirdine	5625	BRD-K34068325	CC(C)Nc1cccnc1N1CCN(CC1)C(=O)c1cc2cc(NS(C)(=O)=O)ccc2[nH]1	non-nucleoside reverse transcriptase inhibitor	CYP3A4
delivert	78357780	BRD-K45503887	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](Cc1ccccc1)C(O)=O	angiotensin receptor agonist	AGTR1|AGTR2
delphinidin	128853	BRD-K79107392	Oc1cc(O)c2cc(O)c([o+]c2c1)-c1cc(O)c(O)c(O)c1	membrane permeability inhibitor	GLO1
delta-Tocotrienol	5282350	BRD-K85776940	CC(C)=CCC\C(C)=C\CC\C(C)=C\CC[C@]1(C)CCc2cc(O)cc(C)c2O1	HMGCR inhibitor	HMGCR
deltarasin	73292904	BRD-K90830492	C(Oc1ccc(cc1)-c1nc2ccccc2n1Cc1ccccc1)[C@H](C1CCNCC1)n1c(nc2ccccc12)-c1ccccc1	phosphodiesterase inhibitor	KRAS
demecarium	5966	BRD-K51471001	CN(CCCCCCCCCCN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C)C(=O)Oc1cccc(c1)[N+](C)(C)C	acetylcholinesterase inhibitor	ACHE|BCHE
demeclocycline	10050129	BRD-A34145622	CN(C)[C@H]1[C@@H]2C[C@@H]3[C@H](O)c4c(Cl)ccc(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O	bacterial 30S ribosomal subunit inhibitor	
denatonium-benzoate	15488	BRD-K34122555	CC[N+](CC)(CC(=O)Nc1c(C)cccc1C)Cc1ccccc1		
denotivir	39976	BRD-K01773083	Cc1nsc(NC(=O)c2ccccc2)c1C(=O)Nc1ccc(Cl)cc1	antiviral	
deoxyarbutin	11745519	BRD-A62562325	Oc1ccc(OC2CCCCO2)cc1	tyrosinase inhibitor	
deoxycholic-acid	222528	BRD-K41170226	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	biliverdin reductase A activator; G protein-coupled receptor agonist	EFTUD1|FPR1|GPBAR1
deoxycorticosterone-acetate	5952	BRD-K24556098	CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	progestogen hormone	NR3C2
deoxyepinephrine	4382	BRD-K33151569	CNCCc1ccc(O)c(O)c1	adrenergic receptor agonist; dopamine receptor agonist	ADRA1A|DRD1|DRD2
deptropine	203911	BRD-A65797496	CN1[C@H]2CC[C@@H]1CC(C2)OC1c2ccccc2CCc2ccccc12	histamine receptor antagonist	HRH1
dequalinium	2993	BRD-K77685957	Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc12	PKC inhibitor	KCNN1|KCNN3
deracoxib	3058754	BRD-K68558722	COc1ccc(cc1F)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)F	cyclooxygenase inhibitor	PTGS2
deserpidine	8550	BRD-K29462201	CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1	angiotensin converting enzyme inhibitor	ACE|SLC18A2
desipramine	2995	BRD-K60762818	CNCCCN1c2ccccc2CCc2ccccc12	tricyclic antidepressant	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A4|SMPD1
deslanoside	28620	BRD-K99919177	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1	Na/K-ATPase inhibitor	ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2
desloratadine	124087	BRD-K82357231	Clc1ccc2c(CCc3cccnc3C2=C2CCNCC2)c1	histamine receptor antagonist	HRH1
desmethylclozapine		BRD-K10042277	Clc1ccc2Nc3ccccc3C(=Nc2c1)N1CCNCC1	acetylcholine receptor agonist	HTR2C
desmopressin-acetate	27991	BRD-A49399758	NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CCSSCC(NC(=O)C(CC(N)=O)NC1=O)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=N)C(=O)NCC(N)=O	vasopressin receptor agonist	AVPR1A|AVPR1B|AVPR2|OXTR
desogestrel	40973	BRD-K46061689	CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	progesterone receptor agonist	ESR1|PGR
desonide	5311066	BRD-K21528677	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	glucocorticoid receptor agonist	NR3C1|PLA2G1B
desoximetasone	45006167	BRD-A49447682	C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO	glucocorticoid receptor agonist	NR3C1|PLA2G1B
desoxycorticosterone-pivalate	11876263	BRD-K26024145	CC(C)(C)C(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	corticosteroid agonist	NR3C2
desoxycortone	6166	BRD-K98521173	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO	mineralocorticoid receptor agonist	NR3C1|NR3C2
desoxypeganine	442894	BRD-K13819402	C1CN2Cc3ccccc3N=C2C1	acetylcholinesterase inhibitor; monoamine oxidase inhibitor	ACHE
desvenlafaxine	125017	BRD-A98845662	CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1	serotonin norepinephrine reuptake inhibitor (SNRI)	SLC6A2|SLC6A3|SLC6A4
detomidine	56032	BRD-K77597856	Cc1cccc(Cc2c[nH]cn2)c1C	adrenergic receptor agonist	ADRA2A
dexamethasone	5702035	BRD-A10188456	C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	glucocorticoid receptor agonist	ANXA1|NOS2|NR0B1|NR3C1|NR3C2
dexamethasone-acetate	236702	BRD-K47635719	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O	glucocorticoid receptor agonist	
dexamethasone-sodium-phosphate	45006166	BRD-A79380603	C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(O)(O)=O	glucocorticoid receptor agonist	NR3C1
dexchlorpheniramine	33036	BRD-K39462424	CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1	histamine receptor antagonist	
dexfenfluramine	66265	BRD-K58626373	CCN[C@@H](C)Cc1cccc(c1)C(F)(F)F	serotonin receptor agonist	HTR2C|SLC6A4
dexfosfoserine	57689797	BRD-K30019776	N[C@@H](COP(O)(O)=O)C(O)=O	membrane integrity inhibitor	CFTR|GRM4|GRM6|GRM7|GRM8|KCNC4|PDPK1|PIM1|PRKACA|PRKCQ|PYGL|PYGM|REG1A|RHO|SERPINB3|SMAD2|TAOK2
dexlansoprazole	9578005	BRD-K05900209	Cc1c(OCC(F)(F)F)ccnc1C[S@@](=O)c1nc2ccccc2[nH]1	ATPase inhibitor	ATP4A|ATP4B
dexloxiglumide	65937	BRD-K07609981	CCCCCN(CCCOC)C(=O)[C@@H](CCC(O)=O)NC(=O)c1ccc(Cl)c(Cl)c1	CCK receptor antagonist	CCKAR
dexmedetomidine	5311068	BRD-K18423410	C[C@H](c1cnc[nH]1)c1cccc(C)c1C	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C
dexniguldipine	6918097	BRD-K44309363	COC(=O)C1=C(C)NC(C)=C([C@@H]1c1cccc(c1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1	calmodulin antagonist	ADORA3
dexpanthenol	131204	BRD-K71210479	CC(C)(CO)[C@@H](O)C(=O)NCCCO		
dexrazoxane	71384	BRD-K07265709	C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1	chelating agent; topoisomerase inhibitor	TOP2A|TOP2B
dextran	5460037	BRD-K67117832	OC[C@H]1O[C@H](OC[C@H]2O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O		
dextroamphetamine	5826	BRD-K21160401	C[C@H](N)Cc1ccccc1	monoamine oxidase inhibitor	ADRA1A|ADRA1B|SLC18A2|SLC6A2|SLC6A3|TAAR1
dextromethorphan	5360696	BRD-K33211335	COc1ccc2C[C@H]3[C@H]4CCCC[C@@]4(CCN3C)c2c1	glutamate receptor antagonist; sigma receptor agonist	CHRNA2|CHRNA3|CHRNA4|CHRNA7|CHRNB2|CHRNB4|CYBA|CYBB|GRIN3A|NCF1|NCF2|NCF4|OPRD1|OPRK1|OPRM1|PGRMC1|RAC1|RAC2|SIGMAR1|SLC6A2|SLC6A4
dextrose	107526	BRD-K51431759	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O		
DFB	6604893	BRD-K82002057	Fc1cccc(c1)\C=N\N=C\c1cccc(F)c1	glutamate receptor agonist	GRM5
DG-172	57342889	BRD-K75748943	CN1CCN(CC1)c1ccc(cc1)\C=C(/C#N)c1ccccc1Br	PPAR receptor inverse agonist	PPARD
DH-97	3467177	BRD-K06014311	CCCCC(=O)NCCc1c(Cc2ccccc2)[nH]c2ccccc12	melatonin receptor antagonist	MTNR1B
DHBP	80263	BRD-K41262162	CCCCCCC[n+]1ccc(cc1)-c1cc[n+](CCCCCCC)cc1	ryanodine receptor blocker	
diacerein	26248	BRD-K69122748	CC(=O)Oc1cccc2C(=O)c3cc(cc(OC(C)=O)c3C(=O)c12)C(O)=O	interleukin inhibitor	IL1B
diacetamate	17499	BRD-K93611241	CC(=O)Nc1ccc(OC(C)=O)cc1		
diadenosine-tetraphosphate	44286171	BRD-A15035311	Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H](C(O)C2O)n2cnc3c(N)ncnc23)C(O)C1O	adenosine kinase inhibitor	P2RY13|P2RY2
dianhydrogalactitol	15942827	BRD-K68502831	O[C@@H]([C@@H](O)[C@H]1CO1)[C@@H]1CO1	DNA alkylating agent	
diarylpropionitrile	102614	BRD-A27143604	Oc1ccc(CC(C#N)c2ccc(O)cc2)cc1	estrogen receptor agonist	ESR2
diatrizoic-acid	2140	BRD-K48247567	CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(O)=O)c1I		
diaveridine	21453	BRD-K97464279	COc1ccc(Cc2cnc(N)nc2N)cc1OC	dihydrofolate reductase inhibitor	
diazepam	3016	BRD-K16508793	CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1	benzodiazepine receptor agonist	ADRA1A|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3|TSPO
diazooxonorleucine	121478083	BRD-K38458514	N[C@@H](CCC(=O)C=[N+]=N)C(O)=O	glutamate receptor antagonist	
diazoxide	3019	BRD-K73109821	CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1	potassium channel activator	ATP1A1|CA1|CA2|KCNJ11|KCNJ8|KCNMA1|SLC12A3
dibekacin	470999	BRD-K48427910	NC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)O1	bacterial 30S ribosomal subunit inhibitor	
dibenzepine	9419	BRD-K79145749	CN(C)CCN1c2ccccc2N(C)c2ccccc2C1=O	norepinephrine reputake inhibitor	
dibenzothiophene	3023	BRD-K46863940	c1ccc2c(c1)sc1ccccc21		
dibutyl-phthalate	3026	BRD-K73477617	CCCCOC(=O)c1ccccc1C(=O)OCCCC		TRPA1
dichlorisone-acetate	5388959	BRD-K54187111	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](Cl)C[C@]12C		
dichloroacetate		BRD-M97302542	[Na].OC(=O)C(Cl)Cl	pyruvate dehydrogenase kinase inhibitor	PDK1
dichlorophen	3037	BRD-K62326629	Oc1ccc(Cl)cc1Cc1cc(Cl)ccc1O	anticestodal agent	
dichlorvos	3039	BRD-K23779958	COP(=O)(OC)OC=C(Cl)Cl	acetylcholinesterase inhibitor	
diclazuril	456389	BRD-A06426627	Clc1ccc(cc1)C(C#N)c1c(Cl)cc(cc1Cl)-n1ncc(=O)[nH]c1=O	antiprotozoal agent	
diclofenac	3033	BRD-K08252256	OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl	cyclooxygenase inhibitor	AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A
diclofenamide	3038	BRD-K71499074	NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(N)(=O)=O	carbonic anhydrase inhibitor	CA1|CA12|CA2|CA4|CA7
diclofensine	68871	BRD-A51078674	COc1ccc2C(CN(C)Cc2c1)c1ccc(Cl)c(Cl)c1	dopamine reuptake inhibitor	DRD1|MAOA|MAOB
dicloralurea	8313	BRD-A41657926	OC(NC(=O)NC(O)C(Cl)(Cl)Cl)C(Cl)(Cl)Cl		
dicloxacillin	18381	BRD-K05673000	Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1c(Cl)cccc1Cl	bacterial cell wall synthesis inhibitor	
dicoumarol	54676038	BRD-K82236179	Oc1c(Cc2c(O)c3ccccc3oc2=O)c(=O)oc2ccccc12	NADPH inhibitor	CRYZ|NQO1|VKORC1
dicyclohexylamine	7582	BRD-K57091285	C1CCC(CC1)NC1CCCCC1		
dicycloverine	3042	BRD-K68507560	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3
didanosine	50599	BRD-K99063460	OC[C@@H]1CC[C@@H](O1)n1cnc2c(O)ncnc12	nucleoside reverse transcriptase inhibitor	PNP
dideoxyadenosine	20039	BRD-K84794093	Nc1ncnc2n(cnc12)[C@H]1CC[C@@H](CO)O1	nucleoside reverse transcriptase inhibitor	
didox	3045	BRD-K94146583	ONC(=O)c1ccc(O)c(O)c1	ribonucleotide reductase inhibitor	RRM1
dienestrol	667476	BRD-K95309561	C\C=C(c1ccc(O)cc1)\C(c1ccc(O)cc1)=C\C	estrogen receptor agonist	ESR1
dienogest	68861	BRD-K50853363	C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N	progesterone receptor agonist	PGR
diethylcarbamazine	3052	BRD-K45542189	CCN(CC)C(=O)N1CCN(C)CC1	lipoxygenase inhibitor	ALOX5|PTGS1
diethylstilbestrol	448537	BRD-K45330754	CC\C(c1ccc(O)cc1)=C(\CC)c1ccc(O)cc1	estrogen receptor agonist	ESR1|ESR2|ESRRB|ESRRG
diethyltoluamide	4284	BRD-K94080537	CCN(CC)C(=O)c1cccc(C)c1	ionotropic receptor IR40a activator	
difenpiramide	100472	BRD-K96206066	O=C(Cc1ccc(cc1)-c1ccccc1)Nc1ccccn1	cyclooxygenase inhibitor; prostaglandin inhibitor	
diflorasone-diacetate	45114174	BRD-A66869276	C[C@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(C)=O)C(=O)COC(C)=O	glucocorticoid receptor agonist	NR3C1
difloxacin	40473223	BRD-K73923631	CN1CCN(CC1)c1cc2n(cc(C(O)=O)c(=O)c2cc1F)-c1ccc(F)cc1	bacterial DNA gyrase inhibitor	
diflunisal	3059	BRD-K22031190	OC(=O)c1cc(ccc1O)-c1ccc(F)cc1F	prostanoid receptor antagonist	PTGS1|PTGS2
difluprednate	129009925	BRD-K33720171	CCCC(=O)O[C@]1(CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]12C)C(=O)COC(C)=O	glucocorticoid receptor agonist	NR3C1
diftalone	30717	BRD-K80076813	O=C1N2Cc3ccccc3C(=O)N2Cc2ccccc12	cyclooxygenase inhibitor	
digitoxigenin	4369270	BRD-K18518344	C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@@H]2C1=CC(=O)OC1	ATPase inhibitor	ATP1A1
digitoxin	5702041	BRD-A93236127	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CCC5C4CC[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C	ATPase inhibitor	ATP1A1
digoxigenin	15478	BRD-K18619710	C[C@@]12[C@H](CC[C@]1(O)[C@@H]1CC[C@@H]3C[C@@H](O)CC[C@]3(C)[C@H]1C[C@H]2O)C1=CC(=O)OC1	steroid	
digoxin	5702042	BRD-A94756469	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CCC5C4C[C@@H](O)[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C	ATPase inhibitor	ATP1A1
dihomo-gamma-linolenic-acid	5280581	BRD-K20152659	CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O	prostanoid receptor agonist	PTGS1|PTGS2
dihydrexidine	6603820	BRD-K31471398	Oc1cc2CC[C@H]3NCc4ccccc4[C@@H]3c2cc1O	dopamine receptor agonist	DRD1|DRD2|DRD3|DRD4|DRD5
dihydroartemisinin	3000518	BRD-K62213621	C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	antimalarial agent	
dihydroergocristine	107715	BRD-K97440753	CC(C)[C@@]1(NC(=O)[C@@H]2C[C@H]3[C@@H](Cc4c[nH]c5cccc3c45)N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O	adrenergic receptor antagonist; prolactin inhibitor	ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7
dihydroergotamine	10531	BRD-K72166146	CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13)C(=O)N[C@]1(C)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O	serotonin receptor agonist	ADRA2A|DRD2|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7
dihydromyricetin	161557	BRD-K01614093	O[C@@H]1[C@H](Oc2cc(O)cc(O)c2C1=O)c1cc(O)c(O)c(O)c1		
dihydrostreptomycin	5702044	BRD-A67363467	CN[C@H]1C(O)C(O)C(CO)OC1OC1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)OC(C)[C@]1(O)CO	bacterial 30S ribosomal subunit inhibitor	
dihydrotachysterol	5353584	BRD-A34455052	CC(C)C(C)\C=C\C(C)C1CCC2C1(C)CCC\C2=C/C=C1\CC(O)CCC1C	vitamin analog	VDR
dihydrotestosterone	10635	BRD-K22525962	C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O	androgen receptor agonist	AR|HSD17B1
dihydroxyacetone	670	BRD-K18637542	OCC(=O)CO		
dihydroxyphenylglycine	108001	BRD-A20589515	NC(C(O)=O)c1cc(O)cc(O)c1	glutamate receptor agonist	GRM1|GRM5
diiodothyropropionic-acid	160565	BRD-K36802417	OC(=O)CCc1cc(I)c(Oc2ccc(O)cc2)c(I)c1	thyroid hormone stimulant	
dilazep	3074	BRD-K48722258	COc1cc(cc(OC)c1OC)C(=O)OCCCN1CCCN(CCCOC(=O)c2cc(OC)c(OC)c(OC)c2)CC1	adenosine reuptake inhibitor	SLC29A1
diloxanide	19529	BRD-K10974103	CN(C(=O)C(Cl)Cl)c1ccc(OC(=O)c2ccco2)cc1	protein synthesis inhibitor	
diltiazem	39186	BRD-K24023109	COc1ccc(cc1)[C@@H]1Sc2ccccc2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O	calcium channel blocker	CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5
dimaprit	3077	BRD-K23541596	CN(C)CCCSC(N)=N	histamine receptor agonist	HRH2|HRH3|HRH4
dimemorfan	3037918	BRD-K29812331	CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(C)cc31	sigma receptor agonist	SIGMAR1
dimenhydrinate	10660	BRD-M98649031	Cn1c2nc(Cl)[nH]c2c(=O)n(C)c1=O.CN(C)CCOC(c1ccccc1)c1ccccc1	histamine receptor antagonist	HRH1
dimercaprol	3080	BRD-A56152450	OCC(S)CS	chelating agent	
dimercaptosuccinic-acid	2724354	BRD-K88701661	OC(=O)[C@@H](S)[C@@H](S)C(O)=O	chelating agent	DNMT1
dimesna	65626	BRD-K30126819	OS(=O)(=O)CCSSCCS(O)(=O)=O	tubulin polymerization inhibitor	
dimethadione	3081	BRD-K43687498	CC1(C)OC(=O)NC1=O	oxazolidine antiepileptic	
dimethicone	24764	BRD-K26674746	C[Si](C)(C)O[Si](C)(C)C		
dimethindene-(S)-(+)	6604866	BRD-K83192048	C[C@@H](C1=C(CCN(C)C)Cc2ccccc12)c1ccccn1	acetylcholine receptor antagonist	HRH1
dimethisoquin	6857	BRD-K73391359	CCCCc1cc2ccccc2c(OCCN(C)C)n1	local anesthetic	
dimethyl-fumarate	637568	BRD-K31111078	COC(=O)\C=C\C(=O)OC	nuclear factor erythroid derived; like (NRF2) activator	KEAP1
dimethyl-isosorbide	237322	BRD-A17224697	COC1COC2C(COC12)OC	cosmetic moisturizer	
dimetindene	21855	BRD-A54141700	CC(C1=C(CCN(C)C)Cc2ccccc12)c1ccccn1	histamine receptor antagonist; cholinergic receptor antagonist	CHRM2|HRH1
dimetridazole	3090	BRD-K72728560	Cc1ncc(n1C)[N+]([O-])=O	bacterial DNA inhibitor	
diminazene-aceturate	2354	BRD-K92848252	NC(=N)c1ccc(N\N=N\c2ccc(cc2)C(N)=N)cc1	angiotensin converting enzyme activator	AOC1|PRDX5|PRSS1
dimpylate	3017	BRD-K60567437	CCOP(=S)(OCC)Oc1cc(C)nc(n1)C(C)C	acetylcholinesterase inhibitor	ACHE
dinaciclib	46926350	BRD-K13662825	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N1CCCC[C@H]1CCO	CDK inhibitor	CDK1|CDK2|CDK5|CDK9
dinitolmide	3092	BRD-K93240442	Cc1c(cc(cc1[N+]([O-])=O)[N+]([O-])=O)C(N)=O		
dinoprost	5280363	BRD-K81672972	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O	prostacyclin analog	PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|PTGIR|TBXA2R
dinoprostone	5280360	BRD-K26521938	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O	prostanoid receptor agonist	CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R
dioscin	129010051	BRD-K37723606	C[C@@H]1[C@@H]2[C@H](C[C@H]3[C@@H]4CC=C5C[C@@H](CC[C@]5(C)[C@@H]4CC[C@]23C)O[C@@H]2O[C@@H](CO)[C@@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)O[C@]11CC[C@@H](C)CO1	apoptosis stimulant	CXCR3
diosgenin	99474	BRD-K28690501	C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@]11CC[C@@H](C)CO1	steroid	
diosmetin	5281612	BRD-K26862302	COc1ccc(cc1O)-c1cc(=O)c2c(O)cc(O)cc2o1	aryl hydrocarbon receptor agonist	CYP1B1
diosmin	5281613	BRD-K94436377	COc1ccc(cc1O)-c1cc(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2o1	aryl hydrocarbon receptor agonist; capillary stabilizing agent	AHR
dioxybenzone	8569	BRD-K22193694	COc1ccc(C(=O)c2ccccc2O)c(O)c1	topical sunscreen agent	
dipeptamin	123935	BRD-K11595419	C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O		
diperodon	10831	BRD-A30693873	O=C(Nc1ccccc1)OCC(CN1CCCCC1)OC(=O)Nc1ccccc1	local anesthetic	
diphemanil	6127	BRD-K93441486	C[N+]1(C)CCC(CC1)=C(c1ccccc1)c1ccccc1	acetylcholine receptor antagonist	CHRM3
diphencyprone	65057	BRD-K51730347	O=c1c(c1-c1ccccc1)-c1ccccc1	immunostimulant	
diphenhydramine	3100	BRD-K47278471	CN(C)CCOC(c1ccccc1)c1ccccc1	histamine receptor antagonist	HRH1
diphenidol	3055	BRD-K01663662	OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4
diphenyleneiodonium	3101	BRD-K65814004	[I+]1c2ccccc2-c2ccccc12	nitric oxide synthase inhibitor	NOS2|NOS3
diphenylguanidine	7594	BRD-K12362304	N=C(Nc1ccccc1)Nc1ccccc1		
diphenylpyraline	3103	BRD-K22936972	CN1CCC(CC1)OC(c1ccccc1)c1ccccc1	dopamine uptake inhibitor	HRH1|SLC6A3
dipivefrine	3105	BRD-A47494775	CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1	adrenergic receptor agonist	ACHE|ADRA1A|ADRA2A|ADRB2|BCHE
dipraglurant	44557636	BRD-K64838454	Fc1ccc2nc(CCC#Cc3ccccn3)cn2c1	glutamate receptor negative allosteric modulator	GRM5
DIPT	26903	BRD-K75385383	CC(C)N(CCc1c[nH]c2ccccc12)C(C)C	dopamine reuptake inhibitor; serotonin reuptake inhibitor	HTR1A|HTR2A|HTR2C
dipyridamole	3108	BRD-K86301799	OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO	phosphodiesterase inhibitor	ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1
dipyrocetyl	68093	BRD-K47608922	CC(=O)Oc1cccc(C(O)=O)c1OC(C)=O	chelating agent	
dirithromycin	6473883	BRD-K52756523	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O	bacterial 50S ribosomal subunit inhibitor	
diroximel-fumarate	73330464	BRD-K87386013	COC(=O)\C=C\C(=O)OCCN1C(=O)CCC1=O	anti-inflammatory agent	
disodium sebacate	5192	BRD-K66672047	OC(=O)CCCCCCCCC(O)=O		HBA1|HBB
disopyramide	3114	BRD-A29734509	CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C	sodium channel blocker	CHRM1|CHRM2|CHRM3|KCND2|KCND3|KCNH2|SCN5A
disulfiram	3117	BRD-K32744045	CCN(CC)C(=S)SSC(=S)N(CC)CC	aldehyde dehydrogenase inhibitor; DNA methyltransferase inhibitor; TRPV agonist	ALDH2|DBH
dithranol	10187	BRD-K51807679	Oc1cccc2cc3cccc(O)c3c(O)c12	DNA synthesis inhibitor	
ditiocarb-sodium-trihydrate	8987	BRD-K40654626	CCN(CC)C(S)=S	immunostimulant	CA1|CA2|CA4
ditolylguanidine	7333	BRD-K33459542	Cc1ccccc1NC(=N)Nc1ccccc1C	sigma receptor agonist	GRIN1|GRIN2A|GRIN2B|SIGMAR1
divalproex-sodium	3121	BRD-K41260949	CCCC(CCC)C(O)=O	benzodiazepine receptor agonist	ALDH5A1
dixanthogen	10404	BRD-K05919151	CCOC(=S)SSC(=S)OCC		
dizocilpine-(+)	180081	BRD-K58930050	C[C@]12N[C@H](Cc3ccccc13)c1ccccc21	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
dizocilpine-(-)	6337640	BRD-K23163214	C[C@@]12N[C@@H](Cc3ccccc13)c1ccccc21	glutamate receptor antagonist	
DMAB-anabaseine	9926048	BRD-K26573499	CN(C)c1ccc(cc1)\C=C1CCCN=C/1c1cccnc1	adrenergic receptor agonist	CHRNA7
DMeOB	6891506	BRD-K36775483	COc1cccc(c1)\C=N\N=C\c1cccc(OC)c1		GRM5
DMH1	50997747	BRD-K39381259	CC(C)Oc1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccnc2ccccc12	ALK tyrosine kinase receptor inhibitor	ACVR1
DMH4	5329447	BRD-K40575944	C(CN1CCOCC1)Oc1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccccc1	VEGFR inhibitor	KDR
DMNB	88505	BRD-K03564313	COc1cc(C=O)c(cc1OC)[N+]([O-])=O	DNA dependent protein kinase inhibitor	
DMP-543	9887884	BRD-K89274813	Fc1cc(CC2(Cc3ccnc(F)c3)c3ccccc3C(=O)c3ccccc23)ccn1	acetylcholine release enhancer	
DMP-777	177992	BRD-K54936858	CCC[C@@H](NC(=O)N1[C@@H](Oc2ccc(cc2)C(=O)N2CCN(C)CC2)C(CC)(CC)C1=O)c1ccc2OCOc2c1	elastase inhibitor	MPO
DMPS	6321	BRD-A22971209	OS(=O)(=O)CC(S)CS	chelating agent	
DMSO	21584481	BRD-M56212252	CS(C)=O.CS(C)=O	control vehicle	
DNQX	3899541	BRD-K64400208	[O-][N+](=O)c1cc2[nH]c(=O)c(=O)[nH]c2cc1[N+]([O-])=O	glutamate receptor antagonist	GRIA1|GRIA2|GRIK1|GRIN1|GRIN2A|GRIN2B
dobutamine	36811	BRD-A78322124	CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1	adrenergic receptor agonist	ADRB1|ADRB2
docebenone	1967	BRD-K08290224	CC1=C(C)C(=O)C(CCCCC#CCCCC#CCO)=C(C)C1=O	lipoxygenase inhibitor	ALOX5
docetaxel	148124	BRD-K30577245	CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C([C@@H](O)C1=O)C2(C)C	tubulin polymerization inhibitor	BCL2|MAP2|MAP4|MAPT|NR1I2|TUBB|TUBB1
doconexent	445580	BRD-K39965020	CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O	PPAR receptor agonist	FFAR1|PTGS1|PTGS2
doconexent-ethyl-ester	9831416	BRD-K61937613	CCOC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC	omega 3 fatty acid stimulant	
docosanol	12620	BRD-K50050533	CCCCCCCCCCCCCCCCCCCCCCO	lipase clearing factor inhibitor	TLR7
docusate	11339	BRD-A00092689	CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(O)(=O)=O	laxative	
dodecyl-sulfate	57468502	BRD-K05680146	CCCCCCCCCCCCOS(O)(=O)=O		LYZ
dofequidar	213040	BRD-A14941520	OC(COc1cccc2ncccc12)CN1CCN(CC1)C(=O)C(c1ccccc1)c1ccccc1	MRP inhibitor; P glycoprotein inhibitor	ABCB1
dofetilide	71329	BRD-K86887724	CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1	potassium channel blocker	KCNH1|KCNH2|KCNJ12|KCNK2
dolasetron		BRD-K28029915	O=C(O[C@H]1C[C@H]2C[C@H]3C[C@@H](C1)N2CC3=O)c1c[nH]c2ccccc12	serotonin receptor antagonist	HTR3A
dolastatin-10	9810929	BRD-K78567475	CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C	tubulin polymerization inhibitor	TUBB
dolutegravir	117853645	BRD-K36386086	C[C@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12	HIV integrase inhibitor	CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1
domiphen	3149	BRD-K30431096	CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1		
domperidone	3151	BRD-K38305202	Clc1ccc2n(C3CCN(CCCn4c5ccccc5[nH]c4=O)CC3)c(=O)[nH]c2c1	dopamine receptor antagonist	DRD2|DRD3
donepezil	3152	BRD-A49160188	COc1cc2CC(CC3CCN(Cc4ccccc4)CC3)C(=O)c2cc1OC	acetylcholinesterase inhibitor	ACHE|HTR2A
donitriptan	197706	BRD-K31092604	NCCc1c[nH]c2ccc(OCC(=O)N3CCN(CC3)c3ccc(cc3)C#N)cc12	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR5A|HTR6
dopamine	681	BRD-K43887077	NCCc1ccc(O)c(O)c1	dopamine receptor agonist	DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4
doramapimod	156422	BRD-K74065929	Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12)C(C)(C)C	p38 MAPK inhibitor	MAPK11|MAPK12|MAPK13|MAPK14
doramectin	51371336	BRD-A16350940	CO[C@H]1C[C@H](OC2[C@H](C)OC(C[C@@H]2OC)O[C@H]2[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O[C@H]5C[C@@H](C\C=C2/C)O[C@@]2(C5)O[C@H](C5CCCCC5)[C@@H](C)C=C2)[C@]34O)O[C@@H](C)[C@@H]1O		
doripenem	6918242	BRD-K45319714	C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N2C1=O)C(O)=O	bacterial cell wall synthesis inhibitor	DPEP1
dorsomorphin	11524144	BRD-K54233340	C(CN1CCCCC1)Oc1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccncc1	AMPK inhibitor	ACVR1|BMPR1A|BMPR1B|EPHA2|FKBP1A|FLT1|FLT3|KDR|LCK|MKNK1|PRKAA1|RPS6KA1|SRC
dorzolamide	6604453	BRD-K71075609	CCN[C@@H]1C[C@H](C)S(=O)(=O)c2sc(cc12)S(N)(=O)=O	carbonic anhydrase inhibitor	CA1|CA12|CA14|CA2|CA4|CA7
dosulepin	5284550	BRD-K54759182	CN(C)CC\C=C1/c2ccccc2CSc2ccccc12	norepinephrine reuptake inhibitor; serotonin norepinephrine reuptake inhibitor (SNRI); tricyclic antidepressant	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|SLC6A2|SLC6A4
dovitinib		BRD-K85402309	CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O	EGFR inhibitor; FGFR inhibitor; FLT3 inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor	CSF1R|EGFR|FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|INSR|KDR|KIT|PDGFRA|PDGFRB
doxapram	3156	BRD-A46179541	CCN1CC(CCN2CCOCC2)C(C1=O)(c1ccccc1)c1ccccc1	potassium channel blocker	KCNK3|KCNK9
doxazosin	3157	BRD-A13188892	COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2ccccc2O1	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|KCNH2|KCNH6|KCNH7
doxepin	667468	BRD-K37694030	CN(C)CC\C=C1\c2ccccc2COc2ccccc12	histamine receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HRH2|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|KCNH2|SLC6A2|SLC6A4
doxercalciferol	46931009	BRD-K82928892	CC(C)[C@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1\C[C@@H](O)C[C@H](O)C1=C	vitamin D receptor agonist	VDR
doxifluridine	18343	BRD-K58262659	C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc(F)c(=O)[nH]c1=O	thymidylate synthase inhibitor	TYMS
doxofylline	50942	BRD-K70507123	Cn1c2ncn(CC3OCCO3)c2c(=O)n(C)c1=O	adenosine receptor antagonist	ADORA1|PDE4A|PDE4B|PDE4C|PDE4D
doxorubicin	31703	BRD-K92093830	COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO	topoisomerase inhibitor	TOP2A
doxycycline	54416523	BRD-A08545410	C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)c2c(O)cccc12	metalloproteinase inhibitor	MMP8
doxycycline-hyclate	129010001	BRD-M28128163	CCO.C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)c2c(O)cccc12.C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)c2c(O)cccc12	bacterial 30S ribosomal subunit inhibitor	
doxylamine	3162	BRD-A44008656	CN(C)CCOC(C)(c1ccccc1)c1ccccn1	histamine receptor antagonist	CHRM1|HRH1
DPC-681	456215	BRD-K37087535	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNCc1cccc(F)c1)C(C)(C)C)S(=O)(=O)c1cccc(N)c1	HIV protease inhibitor	
DPCPX	1329	BRD-K01824921	CCCn1c2[nH]c(nc2c(=O)n(CCC)c1=O)C1CCCC1	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
DPI-201106	5190	BRD-A64553394	OC(COc1cccc2[nH]c(cc12)C#N)CN1CCN(CC1)C(c1ccccc1)c1ccccc1	sodium channel activator	ADRB2
DPO-1	21678144	BRD-K99922388	CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1P(=O)(c1ccccc1)c1ccccc1	potassium channel blocker	KCNA5
DPPE	108092	BRD-K80315159	CCN(CC)CCOc1ccc(Cc2ccccc2)cc1	histamine receptor antagonist	ABCB1|HRH1
DQP-1105		BRD-A67976398	Cc1ccc2[nH]c(=O)c(C3=NN(C(C3)c3ccc(Br)cc3)C(=O)CCC(O)=O)c(-c3ccccc3)c2c1	glutamate receptor antagonist	GRIN2C|GRIN2D
DR-2313	10219702	BRD-K94920105	Cc1nc(=O)c2CSCCc2[nH]1	PARP inhibitor	PARP1|PARP3
DR-4485	9911844	BRD-A39794701	Clc1ccc(cc1)C1=CCN(CCCCC23CCCc4c2c(NC3=O)ccc4Cl)CC1	serotonin receptor antagonist	HTR7
DRF053-(R)	25168304	BRD-K25486274	CC[C@H](CO)Nc1nc(Nc2cccc(c2)-c2ccccn2)c2ncn(C(C)C)c2n1	CDK inhibitor	CSNK1A1
drofenine	3166	BRD-A22267103	CCN(CC)CCOC(=O)C(C1CCCCC1)c1ccccc1		
droloxifene	3033767	BRD-K38477637	CC\C(=C(\c1ccc(OCCN(C)C)cc1)c1cccc(O)c1)c1ccccc1	selective estrogen receptor modulator (SERM)	ESR1
dromostanolone-propionate	3170	BRD-A38706605	CCC(=O)OC1CCC2C3CCC4CC(=O)C(C)CC4(C)C3CCC12C	androgen receptor modulator	AR
dronedarone	208898	BRD-K05524748	CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c1c(CCCC)oc2ccc(NS(C)(=O)=O)cc12	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|KCNA5|KCNH2|KCNK2|SCN1A
droperidol	3168	BRD-K97158071	Fc1ccc(cc1)C(=O)CCCN1CCC(=CC1)n1c2ccccc2[nH]c1=O	dopamine receptor antagonist	ADRA1A|DRD2|DRD3|DRD4|HTR2A
dropropizine	3169	BRD-A29349577	OCC(O)CN1CCN(CC1)c1ccccc1	antitussive	
drospirenone	68873	BRD-K04394237	C[C@]12CC[C@H]3[C@@H]([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)[C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1	mineralocorticoid receptor antagonist	AR|NR3C2|PGR
drotaverine	6437862	BRD-K14658796	CCOc1ccc(\C=C2\NCCc3cc(OCC)c(OCC)cc23)cc1OCC	phosphodiesterase inhibitor	CACNA1C|PDE4A
droxicam	65679	BRD-K17219082	CN1c2c(oc(=O)n(-c3ccccn3)c2=O)-c2ccccc2S1(=O)=O	cyclooxygenase inhibitor	PTGS1
droxidopa	6989215	BRD-K20372197	N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O	norepinephrine precursor	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH
droxinostat	568416	BRD-K11558771	Cc1cc(Cl)ccc1OCCCC(=O)NO	HDAC inhibitor	HDAC6|HDAC8
DSR-6434	25071151	BRD-K46384285	CCCCNc1nc(N)c2[nH]c(=O)n(Cc3ccc(OCCN(C)C)nc3)c2n1	toll-like receptor agonist	TLR7
DS2-(806622)	979718	BRD-K09619578	Clc1ccc(cc1)C(=O)Nc1c(nc2ccccn12)-c1cccs1		
DU-728	107775	BRD-K08859203	N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O	structural glycoprotein antagonist	ITGA2B|ITGB3
duloxetine	60835	BRD-K71103788	CNCC[C@H](Oc1cccc2ccccc12)c1cccs1	norepinephrine reuptake inhibitor; serotonin norepinephrine reuptake inhibitor (SNRI)	HTR2A|HTR2C|HTR6|SLC6A2|SLC6A3|SLC6A4
DUP-697	3177	BRD-K06221026	CS(=O)(=O)c1ccc(cc1)-c1cc(Br)sc1-c1ccc(F)cc1	cyclooxygenase inhibitor	PTGS2
dutasteride	6918296	BRD-K30373883	C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)Nc1cc(ccc1C(F)(F)F)C(F)(F)F	5 alpha reductase inhibitor	SRD5A1|SRD5A2
DVD-111	180496	BRD-K22520627	CCOC(=O)CNC(=O)[C@@H]1CCCN1C(=O)Cc1ccccc1		
dyclonine	3180	BRD-K72259270	CCCCOc1ccc(cc1)C(=O)CCN1CCCCC1	sodium channel blocker	SCN10A|SCN5A
dydrogesterone	9051	BRD-K68620903	CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C	progesterone receptor agonist	PGR
dynasore		BRD-K87718015	Oc1ccc(\C=N\NC(=O)c2cc3ccccc3cc2O)cc1O	dynamin inhibitor	DNM1|DNM1L|DNM2
dynole-34-2	44157463	BRD-K23479488	CCCCCCCCNC(=O)C(=C\c1cn(CCCN(C)C)c2ccccc12)\C#N	dynamin inhibitor	DNM1
dyphylline	3182	BRD-A00827783	Cn1c2ncn(CC(O)CO)c2c(=O)n(C)c1=O	adenosine receptor antagonist; phosphodiesterase inhibitor	ADORA1|ADORA2A|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE7A|PDE7B
DY131	5497124	BRD-K58343622	CCN(CC)c1ccc(cc1)\C=N\NC(=O)c1ccc(O)cc1	estrogen-related receptor agonist	ESRRB|ESRRG
D609	2941	BRD-A77118605	SC(=S)OC1CC2CC1C1CCCC21	phospholipase inhibitor	
E-2012	11560787	BRD-K50564936	COc1cc(ccc1-n1cnc(C)c1)\C=C1/CCCN([C@@H](C)c2ccc(F)cc2)C1=O	gamma secretase modulator	APH1A|APH1B|PSENEN
E-4031	3185	BRD-K41713976	Cc1cccc(CCN2CCC(CC2)C(=O)c2ccc(NS(C)(=O)=O)cc2)n1	potassium channel blocker	KCNH1|KCNH2
E-64	439487	BRD-K06273313	CC(C)C[C@H](NC(=O)[C@@H]1O[C@H]1C(O)=O)C(=O)NCCCCN=C(N)N	cysteine protease inhibitor; calpain inhibitor	CTSS
eact	3173542	BRD-K53030960	COCCN(C(=O)c1cc(OC)c(OC)c(OC)c1)c1nc(cs1)-c1ccccc1	calcium-activated chloride channel inhibitor	ANO1
EB-47	53229989	BRD-K66998413	Nc1ncnc2n(cnc12)[C@H]1O[C@H]([C@H](O)[C@@H]1O)C(=O)N1CCN(CC(=O)Nc2cccc3C(=O)NCc23)CC1	PARP inhibitor	PARP1
ebastine	3191	BRD-K13314656	CC(C)(C)c1ccc(cc1)C(=O)CCCN1CCC(CC1)OC(c1ccccc1)c1ccccc1	histamine receptor antagonist	CYP3A4|HRH1
EBPC	219271	BRD-A96485169	CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1=O	aldose reductase inhibitor	AKR1B1
ebrotidine	65869	BRD-K22421059	NC(=N)Nc1nc(CSCCN\C=N\S(=O)(=O)c2ccc(Br)cc2)cs1	histamine receptor antagonist	HRH2
ebselen	3194	BRD-K29359156	O=c1n([se]c2ccccc12)-c1ccccc1	cyclooxygenase inhibitor; glutathione peroxidase agonist; H+/K+-ATPase inhibitor; nitric oxide synthase inhibitor	ALB
EC-144	11517212	BRD-K41705163	COc1c(C)cnc(Cn2cc(C#CCC(C)(C)O)c3c(Cl)nc(N)nc23)c1C	HSP inhibitor	HSP90AA1|HSP90AB1
EC-23	10314719	BRD-K81004638	CC1(C)CCC(C)(C)c2cc(ccc12)C#Cc1ccc(cc1)C(O)=O	retinoid receptor agonist	RARA|RARB|RARG
ecabapide	65885	BRD-K47371940	CNC(=O)c1cccc(NCC(=O)NCCc2ccc(OC)c(OC)c2)c1		
ecabet	65781	BRD-K03353589	CC(C)c1cc2CC[C@H]3[C@@](C)(CCC[C@]3(C)c2cc1S(O)(=O)=O)C(O)=O	gastrin inhibitor; urease inhibitor	NOXO1
ecamsule-triethanolamine	6442003	BRD-A47953250	CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C/c1ccc(cc1)\C=C1\C2CCC(CS(O)(=O)=O)(C1=O)C2(C)C		
echinomycin	3197	BRD-A68969091	CSC1SCC2N(C)C(=O)C(C)NC(=O)C(COC(=O)C(C(C)C)N(C)C(=O)C1N(C)C(=O)C(C)NC(=O)C(COC(=O)C(C(C)C)N(C)C2=O)NC(=O)c1cnc2ccccc2n1)NC(=O)c1cnc2ccccc2n1	DNA intercalating agent	
econazole	3198	BRD-A51820102	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1	lanosterol demethylase inhibitor; sterol demethylase inhibitor	CYP51A1|NPY1R|NPY2R|TRPM2|TRPV5
ectoine-zwitterion	129010044	BRD-K60902958	OC(=O)[C@@H]1CCNC(=C)N1		
edaglitazone	9825701	BRD-A25182582	Cc1oc(nc1CCOc1ccc(CC2SC(=O)NC2=O)c2sccc12)-c1ccccc1	PPAR receptor agonist	PPARG
edaravone	4021	BRD-K35458079	CC1=NN(C(=O)C1)c1ccccc1	nootropic agent	BCL2
edelfosine	6610230	BRD-A30403214	CCCCCCCCCCCCCCCCCCOC[C@H](COP(O)(=O)OCC[N+](C)(C)C)OC	phospholipase inhibitor	
editol	7615	BRD-A78588743	CC(O)CN(CCN(CC(C)O)CC(C)O)CC(C)O		
edoxaban	49822384	BRD-K29322660	CN(C)C(=O)[C@@H]1CC[C@H](NC(=O)C(=O)Nc2ccc(Cl)cn2)[C@H](C1)NC(=O)c1nc2CCN(C)Cc2s1	coagulation factor inhibitor	F10
edoxudine	66377	BRD-K86892782	CCc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O	DNA directed DNA polymerase inhibitor	
edrophonium	3202	BRD-K81128206	CC[N+](C)(C)c1cccc(O)c1	acetylcholinesterase inhibitor	ACHE|BCHE
EDTMP	15025	BRD-K54542929	OP(O)(=O)CN(CCN(CP(O)(O)=O)CP(O)(O)=O)CP(O)(O)=O	chelating agent	
EED226	123132228	BRD-K19002914	CS(=O)(=O)c1ccc(cc1)-c1cnc(NCc2ccco2)n2cnnc12	polycomb protein inhibitor	EED
efaproxiral	122335	BRD-K37355418	Cc1cc(C)cc(NC(=O)Cc2ccc(OC(C)(C)C(O)=O)cc2)c1	haemoglobin oxygen release stimulant	HBA1|HBB
efaroxan	72016	BRD-A10739734	CCC1(Cc2ccccc2O1)C1=NCCN1	adrenergic receptor antagonist	ADORA2A
efatutazone	9832447	BRD-A24560335	Cc1cc(Oc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)cc(C)c1N	PPAR receptor agonist	PPARG
efavirenz	64139	BRD-K40758068	FC(F)(F)[C@]1(OC(=O)Nc2ccc(Cl)cc12)C#CC1CC1	HIV protease inhibitor	CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4
efinaconazole	112500563	BRD-A30774155	C[C@@H](N1CCC(=C)CC1)C(O)(Cn1cncn1)c1ccc(F)cc1F	lanosterol demethylase inhibitor	CYP51A1
eflornithine	3009	BRD-A96292436	NCCCC(N)(C(F)F)C(O)=O	ornithine decarboxylase inhibitor	ARG2|ODC1
efloxate	8395	BRD-K55166090	CCOC(=O)COc1ccc2c(c1)oc(cc2=O)-c1ccccc1	vasodilator	
efonidipine-monoethanolate	15680981	BRD-M92675308	CCO.CC1=C(C(c2cccc(c2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(Cc1ccccc1)c1ccccc1	L-type calcium channel blocker; T-type calcium channel blocker	CACNA1C|CACNA1G
EGF816	72703790	BRD-K22514639	CN(C)C\C=C\C(=O)N1CCCC[C@H](C1)n1c(NC(=O)c2ccnc(C)c2)nc2cccc(Cl)c12	EGFR inhibitor	EGFR
eglumetad	213056	BRD-K65359424	N[C@]1(CC[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O	glutamate receptor agonist	GRM2|GRM3|GRM6|GRM8
EG00229	44631827	BRD-K50653584	NC(=N)NCCC[C@H](NC(=O)c1sccc1NS(=O)(=O)c1cccc2nsnc12)C(O)=O	neuropilin receptor antagonist	NRP1
EHop-016	51031035	BRD-K32289541	CCn1c2ccccc2c2cc(Nc3ccnc(NCCCN4CCOCC4)n3)ccc12	Ras GTPase inhibitor	RAC1|RAC3
EIPA	1795	BRD-K88120876	CCN(C(C)C)c1nc(N)c(nc1Cl)C(=O)N=C(N)N	transient receptor potential polycystic inhibitor; sodium/hydrogen exchanger inhibitor	ADRA2A|ASIC1|PKD2L1
EIT-hydrobromide	5139	BRD-K81623406	CCSC(N)=N	nitric oxide synthase inhibitor	NOS2|NOS3
EI1	72199293	BRD-K91535048	CCC(CC)n1ccc2c(cc(cc12)C#N)C(=O)NCc1c(C)cc(C)[nH]c1=O	histone lysine methyltransferase inhibitor	EZH2
elacridar	119373	BRD-K88807631	COc1cc2CCN(CCc3ccc(NC(=O)c4cccc5c4[nH]c4c(OC)cccc4c5=O)cc3)Cc2cc1OC	P glycoprotein inhibitor	ABCB1
elactocin	16760536	BRD-K63876426	CCC(\C=C\[C@H]1OC(=O)C=C[C@@H]1C)=C\[C@H](C)C\C=C\C(C)=C\[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C\C(C)=C\C(O)=O	exportin antagonist	XPO1
elafibranor	9864881	BRD-K03165895	CSc1ccc(cc1)C(=O)\C=C\c1cc(C)c(OC(C)(C)C(O)=O)c(C)c1	PPAR receptor agonist	PPARA|PPARD
elagolix	11250647	BRD-K55808645	COc1cccc(c1F)-c1c(C)n(Cc2c(F)cccc2C(F)(F)F)c(=O)n(C[C@H](NCCCC(O)=O)c2ccccc2)c1=O	gonadotropin releasing factor hormone receptor antagonist	GNRHR
elbasvir	71661251	BRD-K09735259	COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c1ncc([nH]1)-c1ccc2-c3cc4cc(ccc4n3[C@@H](Oc2c1)c1ccccc1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C	HCV inhibitor	
elemene	6431152	BRD-K79565391	CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C1)C(C)=C	VEGFR inhibitor	
elesclomol	300471	BRD-K82135108	CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1	oxidative stress inducer	HSPA1A
eletriptan	77993	BRD-K30652337	CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7
eliglustat	23652731	BRD-K86410485	CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2OCCOc2c1	Glycosyl transferase inhibitor	UGCG
elinogrel	16066663	BRD-K59271229	CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F	purinergic receptor antagonist	P2RY12
eliprodil	60703	BRD-A61392169	OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1	glutamate receptor antagonist	GRIN1|GRIN2B
ellagic-acid	5281855	BRD-K30466858	Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O	glutathione transferase inhibitor; non-nucleoside reverse transcriptase inhibitor	CA1|CA12|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9|CSNK2A1|GSK3B|PRKACA|PRKCA|PRKCB|SQLE|SYK
ELN-441958	11848206	BRD-K50699835	Clc1cccc2CN(C(=O)c12)c1cccc(c1)C(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1	bradykinin receptor antagonist	BDKRB1
eltanolone	92786	BRD-K18172896	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	membrane integrity inhibitor	GABRA1|GABRB2|GABRG2
eltoprazine	65853	BRD-K86171477	C1CN(CCN1)c1cccc2OCCOc12	serotonin receptor agonist	HTR1A|HTR1B
eltrombopag		BRD-K40496271	CC1=NN(C(=O)C\1=N\Nc1cccc(-c2cccc(c2)C(O)=O)c1O)c1ccc(C)c(C)c1	thrombopoietin receptor agonist	MPL
eluxadoline	11250029	BRD-K39560679	COc1ccc(CN([C@@H](C)c2ncc([nH]2)-c2ccccc2)C(=O)[C@@H](N)Cc2c(C)cc(cc2C)C(N)=O)cc1C(O)=O	opioid receptor modulator	OPRD1|OPRK1|OPRM1
elvitegravir	5277135	BRD-K54472332	COc1cc2n(cc(C(O)=O)c(=O)c2cc1Cc1cccc(Cl)c1F)[C@H](CO)C(C)C	HIV integrase inhibitor	
embelin	44483355	BRD-K86727142	CCCCCCCCCCCC1C(=O)C(=O)CC(=O)C1=O	HCV inhibitor; XIAP inhibitor	XIAP
EMD-1214063	25171648	BRD-K97963946	CN1CCC(COc2cnc(nc2)-c2cccc(Cn3nc(ccc3=O)-c3cccc(c3)C#N)c2)CC1	hepatocyte growth factor receptor inhibitor	MET
EMD-386088	10131112	BRD-K47659338	Cc1[nH]c2ccc(Cl)cc2c1C1=CCNCC1	serotonin receptor agonist	HTR6
EMD-53998	187079	BRD-A65248799	COc1ccc(cc1OC)C(=O)N1CCCc2cc(ccc12)C1=NNC(=O)SC1C	phosphodiesterase inhibitor	TNNC1
EMD-66684	9892554	BRD-K88759641	CCCCc1nc2ccn(CC(=O)N(C)C)c(=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1	angiotensin receptor antagonist	AGTR1
emedastine	3219	BRD-K15010214	CCOCCn1c(nc2ccccc12)N1CCCN(C)CC1	histamine receptor antagonist	HRH1
emetine	5702048	BRD-A25687296	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3C2C[C@@H]1CC1NCCc2cc(OC)c(OC)cc12	protein synthesis inhibitor	RPS2
emodin	3220	BRD-K58685305	Cc1cc(O)c2C(=O)c3c(O)cc(O)cc3C(=O)c2c1	11-beta hydroxysteroid dehydrogenase inhibitor	CSNK2A1
emorfazone	3221	BRD-K90629600	CCOc1c(cnn(C)c1=O)N1CCOCC1	antiinflammatory agent; cyclooxygenase inhibitor	
emoxipin	114681	BRD-K28982731	CCc1nc(C)ccc1O		
empagliflozin	11949646	BRD-K53765467	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(Cl)c(Cc2ccc(O[C@H]3CCOC3)cc2)c1	sodium/glucose cotransporter inhibitor	SLC5A1|SLC5A2
emtricitabine	60877	BRD-K61452026	Nc1nc(=O)n(cc1F)[C@@H]1CS[C@H](CO)O1	nucleoside reverse transcriptase inhibitor	
enalapril	40466924	BRD-K57545991	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O	angiotensin converting enzyme inhibitor	ACE
enalaprilat	5462501	BRD-K99447003	C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O	angiotensin converting enzyme inhibitor	ACE
enasidenib	89683805	BRD-K70601687	CC(C)(O)CNc1nc(Nc2ccnc(c2)C(F)(F)F)nc(n1)-c1cccc(n1)C(F)(F)F	isocitrate dehydrogenase inhibitor	IDH1
enbucrilate	23087	BRD-K66918327	CCCCOC(=O)C(=C)C#N		
enciprazine	50222	BRD-A62197763	COc1ccccc1N1CCN(CC(O)COc2cc(OC)c(OC)c(OC)c2)CC1	GABA receptor modulator	GABRA1
endo-IWR-1	44483163	BRD-K61314889	O=C(Nc1cccc2cccnc12)c1ccc(cc1)N1C(=O)[C@H]2[C@@H]3C[C@@H](C=C3)[C@H]2C1=O	PARP inhibitor	TNKS|TNKS2
endoxifen	10090750	BRD-K62752296	CC\C(c1ccccc1)=C(/c1ccc(O)cc1)c1ccc(OCCNC)cc1	estrogen receptor antagonist	ESR1
enflurane	3226	BRD-A51831848	FC(F)OC(F)(F)C(F)Cl	membrane permeability inhibitor	ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9|KCNN4
enilconazole	37175	BRD-A11776908	Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1	sterol demethylase inhibitor	CYP19A1|CYP1A2|CYP2B6|CYP2C9|CYP2J2|CYP3A4|CYP3A5|NR1I2|PPARA|PTGER2
eniluracil	43157	BRD-K26425819	Oc1ncc(C#C)c(O)n1	dihydropyrimidine dehydrogenase inhibitor	AOX1|DPYD|XDH
enisamium-iodide	2132298	BRD-K10029415	C[n+]1ccc(cc1)C(=O)NCc1ccccc1		
ENMD-2076	16041424	BRD-K68488863	CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(\C=C\c2ccccc2)n1	Aurora kinase inhibitor; FLT3 inhibitor; VEGFR inhibitor	AURKA|FLT3|KDR|PDGFRA|PTK2|SRC
enocitabine	71734	BRD-K32007074	CCCCCCCCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1	DNA synthesis inhibitor	CMPK1|RRM1|TYMS
enoxacin	28230148	BRD-K78113049	CCn1cc(C(O)=O)c(=O)c2cc(F)c(nc12)N1CCNCC1	topoisomerase inhibitor	TOP2A
enoximone	53708	BRD-K21152241	CSc1ccc(cc1)C(=O)c1[nH]c(O)nc1C	phosphodiesterase inhibitor	PDE3A
enoxolone	10114	BRD-K96137854	C[C@]12CC[C@@](C)(C[C@H]1C1=CC(=O)[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)C(O)=O	gap junction modulator	HSD11B1
enprofylline	1676	BRD-K35007173	CCCn1c2nc[nH]c2c(=O)[nH]c1=O	phosphodiesterase inhibitor	ADORA1|ADORA2A|ADORA2B|ADORA3|PDE4A|PDE4B
enrofloxacin	6957639	BRD-K76534306	CCN1CCN(CC1)c1cc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1	bacterial DNA gyrase inhibitor	
entacapone	5281081	BRD-K83636919	CCN(CC)C(=O)C(\C#N)=C\c1cc(O)c(O)c(c1)[N+]([O-])=O	catechol O methyltransferase inhibitor	COMT
entecavir	153941	BRD-K08206212	Nc1nc(=O)c2ncn([C@H]3C[C@H](O)[C@@H](CO)C3=C)c2[nH]1	DNA replication inhibitor; nucleoside reverse transcriptase inhibitor	
entinostat	4261	BRD-K77908580	Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC9
entrectinib	25141092	BRD-K39009484	CN1CCN(CC1)c1ccc(C(=O)Nc2n[nH]c3ccc(Cc4cc(F)cc(F)c4)cc23)c(NC2CCOCC2)c1	ALK tyrosine kinase receptor inhibitor; proto-oncogene tyrosine protein kinase inhibitor	ALK|NTRK1|NTRK2|NTRK3|ROS1
enzalutamide	15951529	BRD-K56851771	CNC(=O)c1ccc(cc1F)N1C(=S)N(C(=O)C1(C)C)c1ccc(C#N)c(c1)C(F)(F)F	androgen receptor antagonist	AR
enzastaurin	176167	BRD-K79404599	Cn1cc(C2=C(C(=O)NC2=O)c2cn(C3CCN(Cc4ccccn4)CC3)c3ccccc23)c2ccccc12	PKC inhibitor	AKT1|GSK3B|PRKCA|PRKCB|PRKCD|PRKCG
EN460	1016023	BRD-K86063171	OC(=O)c1cc(ccc1Cl)N1N=C(\C(=C\c2ccc(o2)-c2ccccc2)C1=O)C(F)(F)F	endoplasmic reticulum oxidation inhibitor	ERO1A
EO-1428	9801969	BRD-K42452249	Cc1ccccc1C(=O)c1ccc(Nc2ccc(Br)cc2N)cc1Cl	p38 MAPK inhibitor	MAPK11|MAPK14
epacadostat		BRD-K79450420	NS(=O)(=O)NCCNc1nonc1\C(Nc1ccc(F)c(Br)c1)=N\O	indoleamine 2,3-dioxygenase inhibitor	IDO1
epalrestat	1549120	BRD-K98054437	CC(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/c1ccccc1	aldose reductase inhibitor	AKR1B1
eperezolid	73214	BRD-K47554101	CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCN(CC2)C(=O)CO)c(F)c1	bacterial 30S ribosomal subunit inhibitor	
eperisone	3236	BRD-A04252265	CCc1ccc(cc1)C(=O)C(C)CN1CCCCC1	acetylcholine receptor antagonist	CYP2J2
ephedrine	9294	BRD-K45014108	CN[C@@H](C)[C@H](O)c1ccccc1	adrenergic receptor agonist	ACHE|ADRA1A|ADRB2|SLC18A2|SLC6A2
ephedrine-(racemic)	5032	BRD-A54236247	CNC(C)C(O)c1ccccc1	adrenergic receptor agonist	ADRA1A|ADRA2A
epiandrosterone	11875890	BRD-K42756753	C[C@]12CC[C@@H]3[C@@H](CC[C@H]4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O	steroid	G6PD
epicatechin-gallate-(-)	107905	BRD-K50660797	Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c1ccc(O)c(O)c1	bacterial DNA gyrase inhibitor	BACE1|FASN
epigallocatechin-gallate-(-)	65064	BRD-K55591206	Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c1cc(O)c(O)c(O)c1	bacterial DNA gyrase inhibitor	ELANE|EP300|FASN|KAT2B|MMP14|MMP2
epinastine	3241	BRD-A98990573	NC1=NCC2N1c1ccccc1Cc1ccccc21	histamine receptor antagonist	ADRA1A|ADRA2A|HRH1|HRH2|HTR2A|HTR7
epinephrine	5816	BRD-K63126190	CNC[C@H](O)c1ccc(O)c(O)c1	adrenergic receptor agonist; neurotransmitter	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF
epinephrine-(racemic)	4866774	BRD-A07765530	CNCC(O)c1ccc(O)c(O)c1	carbonic anhydrase activator	
epirizole	3242	BRD-K39339537	COc1cc(C)nn1-c1nc(C)cc(OC)n1	cyclooxygenase inhibitor	PTGS1|PTGS2
epirubicin	41867	BRD-K04548931	COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO	topoisomerase inhibitor	CHD1|TOP2A
epitiostanol	443935	BRD-K02314383	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H]5S[C@@H]5C[C@]34C)[C@@H]1CC[C@@H]2O	androgen receptor agonist	AR
eplerenone	443872	BRD-K19761926	COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]22CCC(=O)O2)[C@H]13	cytochrome P450 inhibitor	NR3C2
epomediol	115056	BRD-A59329714	CC1(C)OC2(C)C(O)CC1CC2O	cholesterol inhibitor	CYP7A1
epoprostenol	5282411	BRD-K64054020	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2O\C(C[C@H]12)=C/CCCC(O)=O	prostacyclin analog	P2RY12|PTGER1|PTGER4|PTGIR|PTGIS
epothilone-a	448799	BRD-K71823332	C[C@H]1CCC[C@H]2O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\c1csc(C)n1	microtubule stabilizing agent	
epothilone-b	129010071	BRD-K68164687	C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@@H](OC(=O)C[C@@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\c1csc(C)n1	microtubule stabilizing agent; tubulin polymerization inhibitor	TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA4A|TUBA8|TUBB|TUBB1|TUBB3|TUBB4A|TUBB4B
epothilone-d	447865	BRD-K52762805	C[C@H]1CCC\C(C)=C/C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\c1csc(C)n1	microtubule stabilizing agent; tubulin polymerization inhibitor	TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA4A|TUBA8|TUBB|TUBB1|TUBB3|TUBB4A|TUBB4B
EPPTB	25175634	BRD-K42536037	CCOc1cccc(NC(=O)c2ccc(N3CCCC3)c(c2)C(F)(F)F)c1	trace amine associated receptor antagonist	TAAR1
eprazinone	3245	BRD-A72212290	CCOC(CN1CCN(CC(C)C(=O)c2ccccc2)CC1)c1ccccc1	mucolytic agent	
eprinomectin	51371322	BRD-A91366704	CCC(C)[C@H]1O[C@@]2(C[C@@H]3C[C@@H](C\C=C(C)\[C@@H](OC4C[C@H](OC)C(O[C@H]5C[C@H](OC)[C@@H](NC(C)=O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C4/CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)C=C[C@@H]1C	benzodiazepine receptor agonist	
eprobemide	65659	BRD-K17979676	Clc1ccc(cc1)C(=O)NCCCN1CCOCC1	monoamine oxidase inhibitor	MAOA
eprodisate	428573	BRD-K11463116	OS(=O)(=O)CCCS(O)(=O)=O	antiamyloidogenic agent; amyloid protein inhibitor	SAA1
eprosartan	5281037	BRD-K67977190	CCCCc1ncc(\C=C(/Cc2cccs2)C(O)=O)n1Cc1ccc(cc1)C(O)=O	angiotensin receptor antagonist	AGTR1
eptifibatide	123610	BRD-A90547603	NC(=N)NCCCCC1NC(=O)CCSSCC(NC(=O)C2CCCN2C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CC(O)=O)NC(=O)CNC1=O)C(N)=O	platelet aggregation inhibitor	ITGA2B|ITGB3
EPZ-5676		BRD-K26531771	CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12)[C@@H]1C[C@H](CCc2nc3cc(ccc3[nH]2)C(C)(C)C)C1	histone lysine methyltransferase inhibitor	DOT1L
EPZ004777	56962336	BRD-K69070623	CC(C)N(CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc2c(N)ncnc12	histone lysine methyltransferase inhibitor	DOT1L
EPZ005687	60160561	BRD-K57754230	Cc1cc(C)c(CNC(=O)c2cc(cc3n(ncc23)C2CCCC2)-c2ccc(CN3CCOCC3)cc2)c(=O)[nH]1	histone lysine methyltransferase inhibitor	EZH2
EPZ011989		BRD-K87468701	CCN([C@H]1CC[C@@H](CC1)N(C)CCOC)c1cc(cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C#CCN1CCOCC1	histone lysine methyltransferase inhibitor	EZH2
EPZ015666	90241673	BRD-K70446295	O[C@@H](CNC(=O)c1cc(NC2COC2)ncn1)CN1CCc2ccccc2C1	protein arginine N-methyltransferase inhibitor	PRMT5
EPZ020411		BRD-K33586289	CNCCN(C)Cc1c[nH]nc1-c1ccc(O[C@H]2C[C@@H](C2)OCCC2CCOCC2)cc1	protein arginine N-methyltransferase inhibitor	PRMT6
equilin	3247	BRD-A88080608	CC12CCC3C(=CCc4cc(O)ccc34)C1CCC2=O	estrogen receptor agonist	HSD17B1
equol	91469	BRD-K54847683	Oc1ccc(cc1)[C@H]1COc2cc(O)ccc2C1	estrogen receptor agonist	ESR1|ESR2
ER-27319	9799509	BRD-K11927976	Cc1ccc2c(c1C)n(CCCN)c1ccccc1c2=O	mediator release inhibitor; SYK inhibitor	SYK
ER-50891	10094345	BRD-K18347943	CC(C)c1cccc2c(cc(nc12)-c1ccc([nH]1)-c1ccc(cc1)C(O)=O)-c1ccccc1	retinoid receptor antagonist	RARA
erastin	11214940	BRD-A25004090	CCOc1ccccc1-n1c(=O)c2ccccc2nc1C(C)N1CCN(CC1)C(=O)COc1ccc(Cl)cc1	ion channel antagonist	VDAC2
erbstatin-analog	5353609	BRD-K35573744	COC(=O)\C=C\c1cc(O)ccc1O	EGFR inhibitor; tyrosine kinase inhibitor	EGFR
ercalcitriol	9547243	BRD-K84163249	C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	vitamin D receptor agonist	VDR
erdafitinib	67462786	BRD-K84868168	COc1cc(OC)cc(c1)N(CCNC(C)C)c1ccc2ncc(nc2c1)-c1cnn(C)c1	FGFR inhibitor	FGFR1|FGFR2|FGFR3|FGFR4
erdosteine	65632	BRD-A05515753	OC(=O)CSCC(=O)NC1CCSC1=O	mucolytic agent	
ergocalciferol	5280793	BRD-K56155962	CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C	vitamin analog	VDR
ergonovine	6857771	BRD-A26387268	CC(CO)NC(=O)C1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34	adrenergic receptor agonist; serotonin receptor agonist	ADRA1A|HTR1E
ergosterol	444679	BRD-K03039262	CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	vitamin D precursor	
ergotamine	12082316	BRD-A43227343	CN1C[C@@H](C=C2[C@H]1Cc1c[nH]c3cccc2c13)C(=O)N[C@]1(C)O[C@@]2(O)C3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|DRD1|DRD2|DRD5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|SLC6A2
ERK5-IN-1	46844147	BRD-K64857848	COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCN(C)CC1	MAP kinase inhibitor	MAPK7
erlotinib	176870	BRD-K70401845	COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC	EGFR inhibitor	EGFR|NR1I2
ertapenem	129009917	BRD-A40472231	C[C@@H](O)C1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)Nc3cccc(c3)C(O)=O)=C(N2C1=O)C(O)=O	bacterial cell wall synthesis inhibitor	
erteberel	10286159	BRD-K80608265	Oc1ccc(cc1)[C@@H]1Oc2ccc(O)cc2[C@@H]2CCC[C@H]12	estrogen receptor agonist	ESR1|ESR2
ertugliflozin	59226838	BRD-K10071630	CCOc1ccc(Cc2cc(ccc2Cl)[C@@]23OC[C@@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)cc1	sodium/glucose cotransporter inhibitor	SLC5A2
erythritol	222285	BRD-K79315489	OC[C@H](O)[C@H](O)CO		
erythromycin	12560	BRD-K63550407	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	NFkB pathway inhibitor	MLNR
erythromycin-estolate	71277	BRD-K39746403	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	bacterial 50S ribosomal subunit inhibitor	ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1
erythromycin-ethylsuccinate	443953	BRD-K51677086	CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C	cytochrome P450 inhibitor; protein synthesis inhibitor	ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1
erythrosine	27873	BRD-K14920963	OC(=O)c1ccccc1-c1c2cc(I)c(O)c(I)c2oc2c(I)c(=O)c(I)cc12	coloring agent	
esaprazole	68835	BRD-K92426617	O=C(CN1CCNCC1)NC1CCCCC1		
escin	6857783	BRD-A90796352	C\C=C(\C)C(=O)O[C@@H]1[C@H](OC(C)=O)[C@]2(CO)[C@H](O)C[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O[C@@H]6O[C@@H]([C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C(O)=O)[C@](C)(CO)C5CC[C@@]34C)C2CC1(C)C	nitric oxide synthase stimulant	
escitalopram	146570	BRD-K70301876	CN(C)CCC[C@]1(OCc2cc(ccc12)C#N)c1ccc(F)cc1	selective serotonin reuptake inhibitor (SSRI)	ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4
esculin	5498067	BRD-K36270037	OC[C@H]1O[C@@H](Oc2cc3ccc(=O)oc3cc2O)[C@@H](O)[C@@H](O)[C@@H]1O	antioxidant	
eseroline-(-)	119198	BRD-K13629382	CN1CC[C@]2(C)[C@H]1N(C)c1ccc(O)cc21	acetylcholinesterase inhibitor	OPRD1|OPRM1
ESI-09	6077765	BRD-K77139516	CC(C)(C)c1cc(no1)C(=O)C(\C#N)=N\Nc1cccc(Cl)c1	EPAC inhibitor	RAPGEF3|RAPGEF4
eslicarbazepine-acetate	179344	BRD-K61237927	CC(=O)O[C@H]1Cc2ccccc2N(C(N)=O)c2ccccc12	sodium channel blocker	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
esmolol	59768	BRD-A07395371	COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1	adrenergic receptor antagonist	ADRB1
esomeprazole	9568614	BRD-K61443506	COc1ccc2[nH]c(nc2c1)[S@@](=O)Cc1ncc(C)c(OC)c1C	ATPase inhibitor	ATP4A
estetrol	27125	BRD-K75445017	C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1[C@@H](O)[C@@H](O)[C@@H]2O	selective estrogen receptor modulator (SERM)	ESR1
estradiol	5757	BRD-K18910433	C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	estrogen receptor agonist	ESR1|ESR2|GPER1|KCNMA1|NR1I2
estradiol-acetate	9818306	BRD-K53319039	CC(=O)Oc1ccc2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCc2c1	estrogen receptor agonist	ESR1
estradiol-benzoate	66442	BRD-A74765037	C[C@]12CCC3C(CCc4cc(OC(=O)c5ccccc5)ccc34)C1CC[C@@H]2O	contraceptive agent	ESR1
estradiol-cypionate	5702051	BRD-A91452556	C[C@]12CCC3C(CCc4cc(O)ccc34)C1CC[C@@H]2OC(=O)CCC1CCCC1	estrogen receptor agonist	ESR1
estradiol-valerate	13791	BRD-K66766661	CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C	estrogen receptor agonist	ESR1
estramustine	51371328	BRD-A70858459	C[C@]12CCC3C(CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)C1CC[C@@H]2O	DNA alkylating agent	ESR1|ESR2|MAP1A|MAP2
estramustine-phosphate	259329	BRD-K00077635	C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O	DNA synthesis inhibitor; microtubule inhibitor	ESR1|ESR2|MAP1A|MAP2
estriol	5756	BRD-K17016787	C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1C[C@@H](O)[C@@H]2O	estrogen receptor agonist	ESR1|ESR2
estrone	5870	BRD-K81839095	C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	estrogen receptor agonist; estrogenic hormone	ESR1|ESR2
estropipate	10861069	BRD-A22143024	C[C@]12CCC3C(CCc4cc(OS(O)(=O)=O)ccc34)C1CCC2=O	estrogen receptor agonist	ESR1|ESR2
eszopiclone	969472	BRD-K29220403	CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|TSPO
etacrynic-acid	3278	BRD-K63630713	CCC(=C)C(=O)c1ccc(OCC(O)=O)c(Cl)c1Cl	sodium/potassium/chloride transporter inhibitor	ATP1A1|SLC12A1
etafenone	3275	BRD-K84971356	CCN(CC)CCOc1ccccc1C(=O)CCc1ccccc1	calcium channel blocker	
etamsylate	17507	BRD-K71055333	Oc1ccc(O)c(c1)S(O)(=O)=O	haemostatic agent	
etanidazole	3276	BRD-K96042922	OCCNC(=O)Cn1ccnc1[N+]([O-])=O	bacterial cell wall synthesis inhibitor	
etazolate	3277	BRD-K64755930	CCOC(=O)c1cnc2n(CC)ncc2c1NN=C(C)C	phosphodiesterase inhibitor	GABRB3|PDE4A
ETC-1002	10472693	BRD-K63177377	CC(C)(CCCCCC(O)CCCCCC(C)(C)C(O)=O)C(O)=O	AMPK inhibitor	ACLY
ETC-159	86280523	BRD-K54264768	Cn1c2ncn(CC(=O)Nc3ccc(nn3)-c3ccccc3)c2c(=O)n(C)c1=O	porcupine inhibitor; beta catenin inhibitor	PORCN
etebenecid	14604	BRD-K24443618	CCN(CC)S(=O)(=O)c1ccc(cc1)C(O)=O	uricosuric blocker	
eterobarb	33925	BRD-K64834129	CCC1(C(=O)N(COC)C(=O)N(COC)C1=O)c1ccccc1	anticonvulsant	
ethacizin	107841	BRD-K10667240	CCOC(=O)Nc1ccc2Sc3ccccc3N(C(=O)CCN(CC)CC)c2c1	anticonvulsant	
ethacridine-lactate-monohydrate	2017	BRD-K24715592	CCOc1ccc2nc3cc(N)ccc3c(N)c2c1	DNA intercalating agent	
ethambutol	14052	BRD-K93231391	CC[C@@H](CO)NCCN[C@@H](CC)CO	bacterial cell wall synthesis inhibitor	
ethamivan	9363	BRD-K38055836	CCN(CC)C(=O)c1ccc(O)c(OC)c1	respiratory stimulant	
ethanolamine-oleate	51371306	BRD-M75061779	NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O	immunostimulant	F12|FABP4|FFAR1|FFAR4|PLD2
ethaverine	3280	BRD-K36756879	CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC	calcium channel blocker	
ethenzamide	3282	BRD-K88308881	CCOc1ccccc1C(N)=O	analgesic agent	
ethimizol	6168	BRD-K19672466	CCn1cnc(C(=O)NC)c1C(=O)NC		
ethinyl-estradiol	5991	BRD-K48195008	C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	estrogen receptor agonist; estrogenic hormone	ESR1|ESR2|NR1I2
ethionamide	2761171	BRD-K51207550	CCc1cc(ccn1)C(S)=N	mycolic synthesis inhibitor	
ethisterone	3288	BRD-A29111201	CC12CCC3C(CCC4=CC(=O)CCC34C)C1CCC2(O)C#C	progestogen hormone	TYR
ethopabate	6034	BRD-K02475039	CCOc1cc(NC(C)=O)ccc1C(=O)OC	antiprotozoal agent	
ethosuximide	3291	BRD-A99633051	CCC1(C)CC(=O)NC1=O	succinimide antiepileptic	CACNA1G|CACNA1H|CACNA1I
ethotoin	3292	BRD-A30205217	CCN1C(=O)NC(C1=O)c1ccccc1	hydantoin antiepileptic	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
ethoxyquin	3293	BRD-K56792340	CCOc1ccc2NC(C)(C)C=C(C)c2c1	antioxidant	
ethoxzolamide	3295	BRD-K18131774	CCOc1ccc2nc(sc2c1)S(N)(=O)=O	carbonic anhydrase inhibitor	CA1|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9
ethyl-paraben	8434	BRD-K02464583	CCOC(=O)c1ccc(O)cc1		
ethyl-pyruvate	12041	BRD-K47738867	CCOC(=O)C(C)=O	tumor necrosis factor production inhibitor	HMGB1|TNF
ethyl-vanillin	8467	BRD-K82104468	CCOc1cc(C=O)ccc1O		
ethyl-2-(carbamoyloxy)benzoate	145917	BRD-K21892374	CCOC(=O)c1ccccc1OC(N)=O		
ethylenediaminetetraacetic-acid	5232305	BRD-K82603084	OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CC(O)=O	PKC inhibitor	
ethylnorepinephrine	18538	BRD-A68509429	CCC(N)C(O)c1ccc(O)c(O)c1	bronchodilator	
ethynodiol-diacetate	9270	BRD-K46331928	CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(OC(C)=O)C#C)[C@@H]3CCC2=C1		ESR1|PGR
eticlopride	57267	BRD-K50417881	CCN1CCC[C@H]1CNC(=O)c1c(O)c(CC)cc(Cl)c1OC	dopamine receptor antagonist	DRD2|DRD3|DRD4
etidronic-acid	3305	BRD-K37949327	CC(O)(P(O)(O)=O)P(O)(O)=O	bone resorption inhibitor	ATP6V1A|PTPRS
etifenin	170344	BRD-K63979671	CCc1cccc(CC)c1NC(=O)CN(CC(O)=O)CC(O)=O	renal function diagnostic agent	
etifoxine	30768	BRD-A60821666	CCNC1=Nc2ccc(Cl)cc2C(C)(O1)c1ccccc1	GABA receptor modulator	GABRA1|GABRA2|GABRA3|GABRA5
etilefrine	3306	BRD-A09925278	CCNCC(O)c1cccc(O)c1	adrenergic receptor agonist	ADRA1A|ADRB1
etilevodopa	170345	BRD-K90982969	CCOC(=O)[C@@H](N)Cc1ccc(O)c(O)c1	dopamine receptor agonist	DRD3
etizolam	3307	BRD-K68232413	CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl	benzodiazepine receptor agonist	GABRA1
etodolac	3308	BRD-A74667430	CCc1cccc2c3CCOC(CC)(CC(O)=O)c3[nH]c12	cyclooxygenase inhibitor	PTGS1|PTGS2|RXRA
etofenamate	35375	BRD-K73541271	OCCOCCOC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F	cyclooxygenase inhibitor	PTGS1|PTGS2
etofibrate	65777	BRD-K49338325	CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCOC(=O)c1cccnc1	PPAR receptor agonist	PPARA
etofylline	1892	BRD-K83064458	Cn1c2ncn(CCO)c2c(=O)n(C)c1=O	adenosine receptor antagonist	ADORA1
etofylline-clofibrate	41109	BRD-K49840922	Cn1c2ncn(CCOC(=O)C(C)(C)Oc3ccc(Cl)cc3)c2c(=O)n(C)c1=O	platelet aggregation inhibitor	PPARA
etomidate	667484	BRD-K55055802	CCOC(=O)c1cncn1[C@H](C)c1ccccc1	GABA receptor modulator	ADRA2B|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ
etomoxir	9840324	BRD-K32405725	CCOC(=O)[C@@]1(CCCCCCOc2ccc(Cl)cc2)CO1	carnitine palmitoyltransferase inhibitor	CPT1A
etonogestrel	40976	BRD-A08302182	CCC12CC(=C)C3C(CCC4=CC(=O)CCC34)C1CC[C@@]2(O)C#C	progesterone receptor agonist	ESR1|PGR
etoposide	36462	BRD-K37798499	COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12	topoisomerase inhibitor	TOP2A|TOP2B
etoposide-phosphate	6918092	BRD-K72533376	COc1cc(cc(OC)c1OP(O)(O)=O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12	topoisomerase inhibitor	TOP2A
etoricoxib	123619	BRD-K54770957	Cc1ccc(cn1)-c1ncc(Cl)cc1-c1ccc(cc1)S(C)(=O)=O	cyclooxygenase inhibitor	PTGS2
etosalamide	208946	BRD-K60914966	CCOCCOc1ccccc1C(N)=O	anti-inflammatory agent	
etoxybamide	522232	BRD-K51364817	OCCCC(=O)NCCO		
ETP-45658	25229608	BRD-K15858023	Cn1ncc2c(nc(nc12)-c1cccc(O)c1)N1CCOCC1	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
ETP-46464	72199292	BRD-K24556407	CC(C)(C#N)c1ccc(cc1)N1C(=O)OCc2cnc3ccc(cc3c12)-c1cnc2ccccc2c1	ATR kinase inhibitor	
etravirine	193962	BRD-K74717603	Cc1cc(cc(C)c1Oc1nc(Nc2ccc(cc2)C#N)nc(N)c1Br)C#N	non-nucleoside reverse transcriptase inhibitor	CYP2C19|CYP2C9|CYP3A4
etretinate	5282375	BRD-K49076555	CCOC(=O)\C=C(C)\C=C\C=C(C)\C=C\c1c(C)cc(OC)c(C)c1C	protein synthesis inhibitor	RARA|RARB|RARG|RXRA|RXRB|RXRG
eucalyptol	2758	BRD-K29996876	CC12CCC(CC1)C(C)(C)O2	acetylcholinesterase inhibitor	ACHE
eucatropine	7534	BRD-A37942872	CC1CC(CC(C)(C)N1C)OC(=O)C(O)c1ccccc1	acetylcholine receptor antagonist	
eugenol	3314	BRD-K32977963	COc1cc(CC=C)ccc1O	androgen receptor antagonist	AR
EUK-134		BRD-K19741031	COc1cccc2C=[N+]3CC[N+]4=Cc5cccc(OC)c5O[Mn]34(Cl)Oc12	catalase stimulant	APP|SOD2
eupatilin	5273755	BRD-K47031502	COc1ccc(cc1OC)-c1cc(=O)c2c(O)c(OC)c(O)cc2o1	mucus protecting agent	
evacetrapib		BRD-K16551357	Cc1cc(C)c2N(C[C@H]3CC[C@@H](CC3)C(O)=O)CCC[C@H](N(Cc3cc(cc(c3)C(F)(F)F)C(F)(F)F)c3nnn(C)n3)c2c1	cholesteryl ester transfer protein inhibitor	CETP
evans-blue		BRD-K24548560	Cc1cc(ccc1\N=N\c1ccc2c(cc(c(N)c2c1O)S(O)(=O)=O)S(O)(=O)=O)-c1ccc(c(C)c1)\N=N\c1ccc2c(cc(c(N)c2c1O)S(O)(=O)=O)S(O)(=O)=O	glutamate receptor negative allosteric modulator	GRIA1|PTPN1
evatanepag	9890801	BRD-K11452913	CC(C)(C)c1ccc(CN(Cc2cccc(OCC(O)=O)c2)S(=O)(=O)c2cccnc2)cc1	prostaglandin inhibitor	PTGER2|PTGER4
everolimus	6442177	BRD-K13514097	CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OCCO	mTOR inhibitor	MTOR
evodiamine	151289	BRD-A68631409	CN1C2N(CCc3c2[nH]c2ccccc32)C(=O)c2ccccc12	ATPase inhibitor; TRPV agonist	TRPV1
EVP-6124	46196517	BRD-K71603915	Clc1cccc2cc(sc12)C(=O)N[C@H]1CN2CCC1CC2	acetylcholine receptor agonist	CHRNA7
EVP4593	509554	BRD-K68395654	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1	NFkB pathway inhibitor	
EW-7197	54766013	BRD-K74396648	Cc1cccc(n1)-c1[nH]c(CNc2ccccc2F)nc1-c1ccc2ncnn2c1	TGF beta receptor inhibitor	ACVR1B|TGFBR1
EX-527	5113032	BRD-A73908300	NC(=O)C1CCCc2c1[nH]c1ccc(Cl)cc21	SIRT inhibitor	SIRT1
exalamide	3316	BRD-K12609457	CCCCCCOc1ccccc1C(N)=O	membrane permeability inhibitor	
examorelin	6918297	BRD-K35304636	C[C@H](NC(=O)[C@@H](Cc1c(C)[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O	growth hormone releasing factor agonist	GHRHR|GHSR
exatecan-mesylate	151115	BRD-K92150287	CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cc(F)c(C)c5CC[C@H](N)c(c3Cn1c2=O)c45	topoisomerase inhibitor	TOP1
exemestane	60198	BRD-K33425534	C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O	aromatase inhibitor	CYP19A1
exenatide	129009895	BRD-K05505104	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O	GLP receptor agonist	GLP1R
exherin	9916058	BRD-K81795818	CC(C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(N)=O)NC(C)=O	cadherin antagonist	CDH2
exifone	40399	BRD-K65716359	Oc1ccc(C(=O)c2cc(O)c(O)c(O)c2)c(O)c1O	nootropic agent	TYR
exisulind	5472495	BRD-K37708699	CC1=C(CC(O)=O)c2cc(F)ccc2C\1=C/c1ccc(cc1)S(C)(=O)=O	phosphodiesterase inhibitor	PDE5A
exo-IWR-1	1163034	BRD-K96155658	O=C(Nc1cccc2cccnc12)c1ccc(cc1)N1C(=O)[C@H]2[C@H]3C[C@H](C=C3)[C@H]2C1=O	WNT signaling inhibitor negative control	TNKS
EXO-1	310557	BRD-K78633253	COC(=O)c1ccccc1NC(=O)c1ccc(F)cc1	ARF inhibitor	
ezatiostat	5310939	BRD-K98963219	CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@@H](C(=O)OCC)c1ccccc1	glutathione transferase inhibitor	GSTP1
ezetimibe	6710700	BRD-A41519720	OC(CC[C@@H]1[C@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1	cholesterol inhibitor; Niemann-Pick C1-like 1 protein antagonist	ANPEP|NPC1L1|SOAT1
ezutromid	886736	BRD-K25570267	CCN(CC)c1ccc(cc1)-n1nc2cc(C)c(N)cc2n1	utrophin enhancer	UTRN
E7449	25267262	BRD-K05444225	O=c1[nH][nH]c2nc(CN3Cc4ccccc4C3)nc3cccc1c23	PARP inhibitor	PARP1|PARP2|TNKS|TNKS2
F-11440	208928	BRD-K87948281	Cn1c(=O)cnn(CCCCN2CCN(CC2)c2ncccn2)c1=O	serotonin receptor agonist	HTR1A
fadrozole	59693	BRD-A25619068	N#Cc1ccc(cc1)C1CCCc2cncn12	aromatase inhibitor	CYP11B1|CYP19A1
fagomine	72259	BRD-K61536264	OC[C@H]1NCC[C@@H](O)[C@@H]1O	glucosidase inhibitor	GLB1
falecalcitriol	5282190	BRD-K08251020	C[C@H](CCCC(O)(C(F)(F)F)C(F)(F)F)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	vitamin D receptor agonist	VDR
famciclovir	3324	BRD-K45033733	CC(=O)OCC(CCn1cnc2cnc(N)nc12)COC(C)=O	DNA polymerase inhibitor	
famotidine	3325	BRD-K00673382	NC(N)=Nc1nc(CSCC\C(N)=N/S(N)(=O)=O)cs1	histamine receptor antagonist	HRH2
famprofazone	3326	BRD-A08255417	CC(Cc1ccccc1)N(C)Cc1c(C(C)C)c(=O)n(-c2ccccc2)n1C	cyclooxygenase inhibitor	
fananserin	60785	BRD-K08998509	Fc1ccc(cc1)N1CCN(CCCN2c3cccc4cccc(c34)S2(=O)=O)CC1	dopamine receptor antagonist; serotonin receptor antagonist	HTR2A
fanetizole	54339	BRD-K60798049	C(Cc1ccccc1)Nc1nc(cs1)-c1ccccc1	neutrophil superoxide production	
farnesyl-thiosalicylic-acid-amide	25187973	BRD-K14590126	CC(C)=CCC\C(C)=C\CC\C(C)=C\CSc1ccccc1C(N)=O	Ras GTPase inhibitor	HRAS
faropenem	3329	BRD-A49622760	CC(O)C1C2SC(C3CCCO3)=C(N2C1=O)C(O)=O	lactamase inhibitor	
faropenem-medoxomil	6918218	BRD-K59045783	C[C@@H](O)[C@@H]1[C@H]2SC([C@H]3CCCO3)=C(N2C1=O)C(=O)OCc1oc(=O)oc1C	lactamase inhibitor	
fasudil	3547	BRD-K76617868	O=S(=O)(N1CCCNCC1)c1cccc2cnccc12	rho associated kinase inhibitor	PKIA|PRKACA|ROCK1|ROCK2
favipiravir	492405	BRD-K04264130	NC(=O)c1nc(F)cnc1O	RNA polymerase inhibitor	
FCE-22250		BRD-A10991937	COC1\C=C\OC2(C)Oc3c(C2=O)c2c(O)c(\C=N\N=C\N4CCCCC4)c(NC(=O)\C(C)=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)c(O)c2c(O)c3C	DNA directed DNA polymerase inhibitor	
fdcyd	515328	BRD-K18157228	Nc1nc(=O)n(cc1F)[C@H]1C[C@H](O)[C@@H](CO)O1	DNA methyltransferase inhibitor	
febuxostat	134018	BRD-K48367671	CC(C)COc1ccc(cc1C#N)-c1nc(C)c(s1)C(O)=O	xanthine oxidase inhibitor	XDH
felbamate	3331	BRD-K99107520	NC(=O)OCC(COC(N)=O)c1ccccc1	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B
felbinac	3332	BRD-K91740057	OC(=O)Cc1ccc(cc1)-c1ccccc1	cyclooxygenase inhibitor	CTSL
felbinac-ethyl	26436	BRD-K26404903	CCOC(=O)Cc1ccc(cc1)-c1ccccc1	cyclooxygenase inhibitor	PTGS1|PTGS2
felodipine	3333	BRD-A30815329	CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC	calcium channel blocker	CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2|CALM1|CFTR|NR3C2|PDE1A|PDE1B|TNNC1|TNNC2
fenaclon	9376	BRD-K08791496	ClCCC(=O)NCCc1ccccc1		
fenbendazole	3334	BRD-K51318897	COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1	tubulin polymerization inhibitor	TUBB
fenbufen	3335	BRD-K12513978	OC(=O)CCC(=O)c1ccc(cc1)-c1ccccc1	cyclooxygenase inhibitor	PTGS1|PTGS2
fenclonine-(+/-)	25200499	BRD-A81615860	NC(Cc1ccc(Cl)cc1)C(O)=O	tryptophan hydroxylase inhibitor	PAH|TPH1|TPH2
fendiline	3336	BRD-A71033472	CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1	calcium channel blocker	HTR2B
fenigam	14113	BRD-A66920069	NCC(CC(O)=O)c1ccccc1	benzodiazepine receptor agonist	GABBR1|GABBR2
fenipentol	3338	BRD-A66284731	CCCCC(O)c1ccccc1	choleretic agent	
fenobam	162834	BRD-K41160163	CN1CC(=O)N=C1NC(=O)Nc1cccc(Cl)c1	glutamate receptor antagonist	GRM5
fenofibrate	3339	BRD-K50388907	CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c1ccc(Cl)cc1	PPAR receptor agonist	MMP25|PPARA
fenofibric-acid	64929	BRD-K30213273	CC(C)(Oc1ccc(cc1)C(=O)c1ccc(Cl)cc1)C(O)=O	cytochrome P450 inhibitor	CLCN1|PPARA
fenoldopam	3341	BRD-A50684349	Oc1ccc(cc1)C1CNCCc2c(Cl)c(O)c(O)cc12	dopamine receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD4|DRD5
fenoprofen	3342	BRD-A81129465	CC(C(O)=O)c1cccc(Oc2ccccc2)c1	prostaglandin inhibitor	PTGS1|PTGS2|SLC5A8
fenoterol	3343	BRD-A97104540	CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3
fenoverine	72098	BRD-K77564118	O=C(CN1CCN(Cc2ccc3OCOc3c2)CC1)N1c2ccccc2Sc2ccccc12	acetylcholine receptor antagonist	
fenoxaprop-p-ethyl	91707	BRD-K44777569	CCOC(=O)[C@@H](C)Oc1ccc(Oc2nc3ccc(Cl)cc3o2)cc1		NOS2|NOS3
fenretinide	5288209	BRD-K89085489	CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(=O)Nc1ccc(O)cc1	apoptosis stimulant; retinoid receptor agonist	RARA
fenspiride	3344	BRD-K26739552	O=C1NCC2(CCN(CCc3ccccc3)CC2)O1	bronchodilator	
fenthion	3346	BRD-K67217586	COP(=S)(OC)Oc1ccc(SC)c(C)c1	cholinesterase inhibitor	
fentiazac	28871	BRD-K16077845	OC(=O)Cc1sc(nc1-c1ccc(Cl)cc1)-c1ccccc1	cyclooxygenase inhibitor	PTGS1|PTGS2
fenticonazole	51755	BRD-A33697453	Clc1ccc(C(Cn2ccnc2)OCc2ccc(Sc3ccccc3)cc2)c(Cl)c1	bacterial cell wall synthesis inhibitor	
FERb-033		BRD-K61642990	O\N=C\c1ccc(-c2ccc(O)c(F)c2)c(Cl)c1O	EGFR inhibitor	ERBB2
ferrostatin-1	4068248	BRD-K97375133	CCOC(=O)c1ccc(NC2CCCCC2)c(N)c1	ferroptosis inhibitor	
ferulic-acid	445858	BRD-K66295376	COc1cc(\C=C\C(O)=O)ccc1O	antioxidant	CA1|CA12|CA14|CA2|CA4|CA6|CA9
fesoterodine	6918558	BRD-K46731503	CC(C)N(CC[C@H](c1ccccc1)c1cc(CO)ccc1OC(=O)C(C)C)C(C)C	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
fexaramine	5326713	BRD-K08864679	COC(=O)\C=C\c1cccc(c1)N(Cc1ccc(cc1)-c1ccc(cc1)N(C)C)C(=O)C1CCCCC1	FXR agonist	NR1H4
fexinidazole	68792	BRD-K37069697	CSc1ccc(OCc2ncc(n2C)[N+]([O-])=O)cc1		
fexofenadine	3348	BRD-A73368467	CC(C)(C(O)=O)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1	histamine receptor antagonist	HRH1
FG-2216	6914666	BRD-K56807945	OC(=O)CNC(=O)c1nc(Cl)c2ccccc2c1O	hypoxia inducible factor prolyl hydroxylase inhibitor	EGLN1|EGLN2|HIF1A
FG-4592	11256664	BRD-K14385366	Cc1nc(C(=O)NCC(O)=O)c(O)c2ccc(Oc3ccccc3)cc12	hypoxia inducible factor prolyl hydroxylase inhibitor	EGLN2
FG-7142	4375	BRD-K61951118	CNC(=O)c1cc2c(cn1)[nH]c1ccccc21	GABA benzodiazepine site receptor inverse agonist	
FGIN-1-27	132496	BRD-K09778810	CCCCCCN(CCCCCC)C(=O)Cc1c([nH]c2ccccc12)-c1ccc(F)cc1	inositol monophosphatase inhibitor	TSPO
FGIN-1-43	3995234	BRD-K66093087	CCCCCCN(CCCCCC)C(=O)Cc1c([nH]c2ccc(Cl)cc12)-c1ccc(Cl)cc1	benzodiazepine receptor agonist	TSPO
FH-535	3463933	BRD-K48112880	Cc1cc(ccc1NS(=O)(=O)c1cc(Cl)ccc1Cl)[N+]([O-])=O	PPAR receptor antagonist; WNT signaling inhibitor	PPARD|PPARG
FH1	94990	BRD-K44777625	CC(=O)Nc1ccc(Cc2ccc(NC(C)=O)cc2)cc1	hepatocyte function enhancer	
fiacitabine	50312	BRD-K07160047	Nc1nc(=O)n(cc1I)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F	DNA synthesis inhibitor	
fidarestat	3349	BRD-A63752151	NC(=O)C1CC2(NC(=O)NC2=O)c2cc(F)ccc2O1	aldose reductase inhibitor	AKR1B1
fidaxomicin		BRD-K57371763	CC[C@H]1\C=C(C)/[C@@H](O)C\C=C\C=C(CO[C@@H]2O[C@H](C)[C@@H](OC(=O)c3c(O)c(Cl)c(O)c(Cl)c3CC)[C@H](O)[C@@H]2OC)\C(=O)O[C@H](C\C=C(C)\C=C(C)[C@H]1O[C@@H]1OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@H]1O)[C@@H](C)O	RNA polymerase inhibitor	
filanesib	44224257	BRD-K37379014	CON(C)C(=O)N1N=C(S[C@@]1(CCCN)c1ccccc1)c1cc(F)ccc1F	kinesin inhibitor; kinesin-like spindle protein inhibitor	KIF11
filgotinib	49831257	BRD-K16803204	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1	JAK inhibitor	JAK1|JAK2|JAK3|TYK2
fimasartan	9870652	BRD-K21586122	CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1	angiotensin receptor antagonist	AGTR1
finafloxacin	11567473	BRD-K98384930	OC(=O)c1cn(C2CC2)c2c(C#N)c(N3C[C@@H]4NCCO[C@H]4C3)c(F)cc2c1=O	bacterial DNA gyrase inhibitor	
finasteride	57363	BRD-K01095011	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C	5 alpha reductase inhibitor	AKR1D1|SRD5A1|SRD5A2
fingolimod	107970	BRD-K88025533	CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1	immunosuppressant; sphingosine phosphate receptor agonist	S1PR1|S1PR5
fipexide	3351	BRD-K37688416	Clc1ccc(OCC(=O)N2CCN(Cc3ccc4OCOc4c3)CC2)cc1	psychoactive drug	
FIPI	16739265	BRD-K61560897	Fc1ccc2[nH]c(cc2c1)C(=O)NCCN1CCC(CC1)n1c2ccccc2[nH]c1=O	phospholipase inhibitor	PLD1|PLD2
fipronil	3352	BRD-A50675702	Nc1c(c(nn1-c1c(Cl)cc(cc1Cl)C(F)(F)F)C#N)S(=O)C(F)(F)F	chloride channel blocker; GABA gated chloride channel blocker	
firategrast	9935681	BRD-K17513304	CCOCc1cc(OC)c(-c2ccc(C[C@H](NC(=O)c3c(F)cccc3F)C(O)=O)cc2)c(OC)c1	integrin antagonist	ITGA4
firocoxib	208910	BRD-K09090523	CC1(C)OC(=O)C(OCC2CC2)=C1c1ccc(cc1)S(C)(=O)=O	cyclooxygenase inhibitor	PTGS2
fisetin	5281614	BRD-K31836715	Oc1ccc2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O	Aurora kinase inhibitor	CDK6|FASN
FIT	84008	BRD-K17896185	CCC(=O)N(C1CCN(CCc2ccc(cc2)N=C=S)CC1)c1ccccc1	opioid receptor agonist	OPRD1
FK-33-824	16760007	BRD-A01907367	C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N[C@H](CO)CCS(C)=O	opioid receptor agonist	OPRM1
FK-3311	164009	BRD-K38350380	CC(=O)c1ccc(NS(C)(=O)=O)c(Oc2ccc(F)cc2F)c1	cyclooxygenase inhibitor	PTGS2
FK-866	6914657	BRD-K58550667	O=C(NCCCCC1CCN(CC1)C(=O)c1ccccc1)\C=C\c1cccnc1	niacinamide phosphoribosyltransferase inhibitor	NAMPT
FK-888	107967	BRD-K83508485	CN(Cc1ccccc1)C(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)c1cn(C)c2ccccc12	tachykinin antagonist	TACR1|TACR2
FK-962	9816738	BRD-K80607346	CC(=O)N1CCC(CC1)NC(=O)c1ccc(F)cc1	somatostatin receptor agonist	
flavin-adenine-dinucleotide	703	BRD-A86545589	Cc1cc2nc3c(nc(=O)[nH]c3=O)n(CC(O)C(O)C(O)COP(O)(=O)OP(O)(=O)OCC3OC(C(O)C3O)n3cnc4c(N)ncnc34)c2cc1C		ACAD8|ACADM|ACADS|ACOX1|AIFM1|CYB5R1|CYB5R3|DAO|DLD|DPYD|ERO1LB|FDXR|GCDH|GFER|GSR|IL4I1|IVD|MAOA|MAOB|NOS1|NQO1|NQO2|POR|TXNRD1|XDH
flavoxate	3354	BRD-K47639036	Cc1c(oc2c(cccc2c1=O)C(=O)OCCN1CCCCC1)-c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM2
flecainide	3356	BRD-A09472452	FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC1CCCCN1	sodium channel blocker	KCNA5|KCNA7|SCN4A|SCN5A
fleroxacin	3357	BRD-K61717546	CN1CCN(CC1)c1c(F)cc2c(c1F)n(CCF)cc(C(O)=O)c2=O	topoisomerase inhibitor	
FLI-06	3103157	BRD-A44500574	CC1=C(C(c2ccc(cc2)[N+]([O-])=O)C2=C(CC(C)(C)CC2=O)N1)C(=O)OC1CCCCC1	notch signaling inhibitor	
flibanserin	6918248	BRD-K33637378	FC(F)(F)c1cccc(c1)N1CCN(CCn2c3ccccc3[nH]c2=O)CC1	serotonin receptor agonist	DRD4|HTR1A|HTR2A
flindokalner	214350	BRD-K56740996	COc1ccc(Cl)cc1[C@]1(F)C(=O)Nc2cc(ccc12)C(F)(F)F	potassium channel agonist	KCNMA1|KCNN4|KCNQ2|KCNQ4|KCNQ5
floctafenine	3360	BRD-A23418262	OCC(O)COC(=O)c1ccccc1Nc1ccnc2c(cccc12)C(F)(F)F	cyclooxygenase inhibitor	PTGS1|PTGS2
flopropione	3362	BRD-K43383936	CCC(=O)c1c(O)cc(O)cc1O	serotonin receptor antagonist	HTR1A
florfenicol	45114154	BRD-A30886737	CS(=O)(=O)c1ccc(cc1)C(O)[C@H](CF)NC(=O)C(Cl)Cl	protein synthesis inhibitor	
flosequinan	4474062	BRD-A79643124	Cn1cc(S(C)=O)c(=O)c2ccc(F)cc12	phosphodiesterase inhibitor	
floxuridine	5702211	BRD-A03757454	OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O	DNA synthesis inhibitor	TYMS
flubendazole	35802	BRD-K86003836	COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c1ccc(F)cc1	tubulin polymerization inhibitor	TUBB
flucloxacillin	21319	BRD-K27871792	Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1c(F)cccc1Cl	bacterial cell wall synthesis inhibitor	
fluconazole	3365	BRD-K05977355	OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F	sterol demethylase inhibitor	CYP51A1
flucytosine	3366	BRD-K82143716	Nc1nc(=O)[nH]cc1F	other antifungal	DNMT1
fludarabine	657237	BRD-K66788707	Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	ribonucleotide reductase inhibitor	ADA|RRM1|RRM2
fludarabine-phosphate	30751	BRD-K71106091	Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O	ribonucleotide reductase inhibitor	DCK|POLA1|POLD1|POLE|RRM1|RRM2|RRM2B
fludrocortisone-acetate	225609	BRD-K06408664	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C		AR|NR3C1|NR3C2
fludroxycortide	5702172	BRD-A49765801	CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)CC[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	glucocorticoid receptor agonist	NR3C1|SERPINA6
flufenamic-acid	3371	BRD-K44067360	OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F	chloride channel blocker	AKR1C3|ANO1|AR|GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|PANX1|PANX2|PANX3|PKD2L1|PTGS1|PTGS2|TRPC5|TRPM2|TRPM5
flumatinib	46848036	BRD-K68870568	CN1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc2cnc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1	Bcr-Abl kinase inhibitor	ABL1|PDGFRB
flumazenil	3373	BRD-K98769987	CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21	benzodiazepine receptor antagonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ
flumecinol	41870	BRD-A44181516	CCC(O)(c1ccccc1)c1cccc(c1)C(F)(F)F		
flumequine	3374	BRD-A69777949	CC1CCc2cc(F)cc3c2n1cc(C(O)=O)c3=O	topoisomerase inhibitor	
flumethasone	16490	BRD-K61496577	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	glucocorticoid receptor agonist	NR3C1|PLA2G1B
flumethasone-pivalate	5702055	BRD-A50064262	C[C@@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C	glucocorticoid receptor agonist	NR3C1|SERPINA6
flumexadol	65774	BRD-A43518428	FC(F)(F)c1cccc(c1)C1CNCCO1		
flunarizine	941361	BRD-K29582677	Fc1ccc(cc1)C(N1CCN(C\C=C\c2ccccc2)CC1)c1ccc(F)cc1	calcium channel blocker	CACNA1G|CACNA1H|CACNA1I|CALM1|HRH1
flunisolide	5702174	BRD-A65449987	CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)[C@@]2(O1)C(=O)CO	cytochrome P450 inhibitor	NR3C1
flunixin-meglumin	38081	BRD-K99984802	Cc1c(Nc2ncccc2C(O)=O)cccc1C(F)(F)F	prostanoid receptor antagonist	
fluocinolone-acetonide	6215	BRD-K94353609	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	glucocorticoid receptor agonist	NR3C1|SERPINA6
fluocinonide	9642	BRD-K57886322	CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C	glucocorticoid receptor agonist	NR3C1|SERPINA6|SMO
fluorescein	16850	BRD-K21913543	Oc1ccc2c(Oc3cc(O)ccc3C22OC(=O)c3ccccc23)c1		SLC22A6
fluorometholone	5702058	BRD-A13133631	C[C@H]1CC2C3CC[C@](O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)C2(C)C=CC(=O)C=C12	glucocorticoid receptor agonist	NR3C1
fluorometholone-acetate	240767	BRD-K02528732	C[C@H]1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]2(C)C=CC(=O)C=C12		NR3C1
fluoromethylcholine	404592	BRD-K51199656	C[N+](C)(CF)CCO		
fluoxetine	3386	BRD-A31159102	CNCCC(Oc1ccc(cc1)C(F)(F)F)c1ccccc1	selective serotonin reuptake inhibitor (SSRI)	ANO1|HTR2B|SLC6A4
fluoxymesterone	6446	BRD-K24255045	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C	androgen receptor modulator	AR|ESR1|NR3C1|PRLR
flupentixol	5281881	BRD-K70487031	OCCN1CCN(CC\C=C2\c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1	dopamine receptor antagonist	ADRA1A|CHRM1|DRD1|DRD2|DRD3|DRD5|HTR2A
fluphenazine	3372	BRD-K55127134	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1	dopamine receptor antagonist	CALM1|DRD1|DRD2|DRD5|HRH1|HTR2A|HTR6|HTR7
fluphenazine-decanoate	3388	BRD-K27898013	CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1	dopamine receptor antagonist	DRD2|HTR1B|HTR4
flupirtine	53276	BRD-K50720187	CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N	glutamate receptor antagonist	ADRA2A|KCNQ1|KCNQ2
fluprazine	71153	BRD-K44091134	NC(=O)NCCN1CCN(CC1)c1cccc(c1)C(F)(F)F	serotonin receptor agonist	HTR1A|HTR1B
flurbiprofen-(+/-)	3394	BRD-A86044036	CC(C(O)=O)c1ccc(c(F)c1)-c1ccccc1	cyclooxygenase inhibitor	PTGS1|PTGS2
flurbiprofen-(S)-(+)	72099	BRD-K69907333	C[C@H](C(O)=O)c1ccc(c(F)c1)-c1ccccc1	cyclooxygenase inhibitor	PTGS1|PTGS2
flurizan	92337	BRD-K75410565	C[C@@H](C(O)=O)c1ccc(c(F)c1)-c1ccccc1	gamma secretase inhibitor	APH1B|BACE1|IKBKG|PSEN1|PSEN2|PTGS1|PTGS2
flurofamide	51173	BRD-K67445247	NP(N)(=O)NC(=O)c1ccc(F)cc1	urease inhibitor	
flurothyl	9528	BRD-K14763542	FC(F)(F)COCC(F)(F)F		
fluroxene	9844	BRD-K56908511	FC(F)(F)COC=C	local anesthetic	
fluspirilene	3396	BRD-K77947974	Fc1ccc(cc1)C(CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1)c1ccc(F)cc1	dopamine receptor antagonist	CACNG1|DRD2|HRH1|HTR1A|HTR1D|HTR1E|HTR2A
flutamide	3397	BRD-K28307902	CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+]([O-])=O	androgen receptor antagonist	AHR|AR
fluticasone-propionate	444036	BRD-K62310379	CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF	glucocorticoid receptor agonist	NR3C1|NR3C2|PGR|PLA2G4A
flutrimazole	3401	BRD-A00218260	Fc1ccc(cc1)C(c1ccccc1)(c1ccccc1F)n1ccnc1	sterol demethylase inhibitor	
fluvastatin	446155	BRD-K66296774	CC(C)n1c(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)c(-c2ccc(F)cc2)c2ccccc12	HMGCR inhibitor	HMGCR
fluvoxamine	5324346	BRD-K53517854	COCCCC\C(c1ccc(cc1)C(F)(F)F)=N/OCCN	selective serotonin reuptake inhibitor (SSRI)	SLC6A4
fmoc-l-leucine	1549133	BRD-K15327298	CC(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc12)C(O)=O	PPAR receptor agonist	
folic-acid	6037	BRD-K18673820	Nc1nc(=O)c2nc(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)cnc2[nH]1	folate receptor ligand	FOLR2|FOLR3|SLC19A1|SLC46A1
fomepizole	3406	BRD-K56810756	Cc1cn[nH]c1	alcohol dehydrogenase inhibitor	ADH1A|ADH1B|ADH1C|AKR1A1|CAT
fomocaine	71693	BRD-K44942188	C(CN1CCOCC1)Cc1ccc(COc2ccccc2)cc1	voltage-gated sodium channel modulator	
foretinib	42642645	BRD-K03449891	COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1	VEGFR inhibitor	FLT1|FLT4|KDR|MET
formestane	16760178	BRD-A26503646	C[C@]12CC[C@H]3[C@@H](CCC4C(=O)C(=O)CC[C@]34C)[C@@H]1CCC2=O	aromatase inhibitor	CYP19A1
formononetin	5280378	BRD-K55567017	COc1ccc(cc1)-c1coc2cc(O)ccc2c1=O	alcohol dehydrogenase inhibitor	ADH1C|SLC5A2
formoterol	3034756	BRD-K54006094	COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1	adrenergic receptor agonist	ADRB2
forodesine	444499	BRD-K16505263	OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)c1c[nH]c2c1[nH]cnc2=O	purinergic receptor antagonist	PNP
foropafant	119368	BRD-K57774929	CC(C)c1cc(C(C)C)c(-c2csc(n2)N(CCN(C)C)Cc2cccnc2)c(c1)C(C)C	platelet activating factor receptor antagonist	PTAFR
forskolin	47936	BRD-K09602097	CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C	adenylyl cyclase activator	ADCY2|ADCY5|GNAS
fosamprenavir	131536	BRD-K59110290	CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1	HIV protease inhibitor	
fosaprepitant-dimeglumine	219090	BRD-K23848629	C[C@@H](O[C@H]1OCCN(Cc2nn(c(=O)[nH]2)P(O)(O)=O)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F	tachykinin antagonist	TACR1
fosbretabulin	370232	BRD-K68399195	COc1ccc(C=Cc2cc(OC)c(OC)c(OC)c2)cc1OP(O)(O)=O	tubulin polymerization inhibitor; VE-cadherin antagonist	CDH5
foscarnet	3415	BRD-K85146014	OC(=O)P(O)(O)=O	DNA polymerase inhibitor	
fosfestrol	3032325	BRD-K20801936	CC\C(c1ccc(OP(O)(O)=O)cc1)=C(\CC)c1ccc(OP(O)(O)=O)cc1	synthetic estrogen	ESR1|ESR2
fosfomycin	446987	BRD-K81101512	C[C@@H]1O[C@@H]1P(O)(O)=O	bacterial cell wall synthesis inhibitor	
fosfosal	3418	BRD-K28687144	OC(=O)c1ccccc1OP(O)(O)=O	phosphodiesterase inhibitor	PTGS1|PTGS2
fosfructose	172313	BRD-A19086570	O[C@@H]1[C@@H](COP(O)(O)=O)OC(O)(COP(O)(O)=O)[C@H]1O	fructose diphosphate stimulant	PKLR
fosinopril	6708482	BRD-A51382177	CCC(=O)O[C@@H](OP(=O)(CCCCc1ccccc1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C	angiotensin converting enzyme inhibitor	ACE
fosinoprilat	62956	BRD-A33506612	OC(=O)[C@@H]1C[C@H](CN1C(=O)CP(O)(=O)CCCCc1ccccc1)C1CCCCC1	angiotensin converting enzyme inhibitor	ACE
fosphenytoin	56339	BRD-K53809807	OP(O)(=O)OCN1C(=O)NC(C1=O)(c1ccccc1)c1ccccc1	sodium channel blocker	SCN5A
fostamatinib	11671467	BRD-K85178109	COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)N(COP(O)(O)=O)c4n3)n2)cc(OC)c1OC	SYK inhibitor	SYK
fotemustine	104799	BRD-A62893078	CCOP(=O)(OCC)C(C)NC(=O)N(CCCl)[N+][O-]	thioredoxin inhibitor	TXNRD1
foxy-5	44628955	BRD-K13005598	CSCC[C@H](NC=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O	WNT5a peptide mimetic	WNT5A
FPA-124	16034833	BRD-M17926088	Cl[Cu]Cl.NC(=S)N\N=C\c1coc2ccccc2c1=O	AKT inhibitor	
FPH1-(BRD-6125)	2210370	BRD-K61250484	Cc1ccc(Cl)cc1N(CC(=O)Nc1c(F)cccc1F)S(C)(=O)=O	hepatocyte function enhancer	
FPL-12495	164087	BRD-A09368919	CC(N)(Cc1ccccc1)c1ccccc1	glutamate receptor antagonist	
FPL-55712	105007	BRD-A96456596	CCCc1c(OCC(O)COc2ccc3c(oc(cc3=O)C(O)=O)c2CCC)ccc(C(C)=O)c1O	leukotriene receptor antagonist	
FPL-62064	128268	BRD-K59875992	COc1ccc(Nc2ccn(n2)-c2ccccc2)cc1	cyclooxygenase inhibitor; lipoxygenase inhibitor	
FPL-64176	3423	BRD-K78959463	COC(=O)c1c(C)[nH]c(C)c1C(=O)c1ccccc1Cc1ccccc1	calcium channel activator	CACNA1C|CACNA1S
FPS-ZM1	24752728	BRD-K87691185	Clc1ccc(cc1)C(=O)N(Cc1ccccc1)C1CCCCC1	RAGE receptor antagonist	AGER
FR-122047	196841	BRD-K30990140	COc1ccc(cc1)-c1nc(sc1-c1ccc(OC)cc1)C(=O)N1CCN(C)CC1	cyclooxygenase inhibitor	
FR-139317	107810	BRD-K19318328	CC(C)C[C@H](NC(=O)N1CCCCCC1)C(=O)N[C@H](Cc1cn(C)c2ccccc12)C(=O)N[C@H](Cc1ccccn1)C(O)=O	endothelin receptor antagonist	EDNRA
FR-180204	11493598	BRD-K68756823	Nc1[nH]nc2nnc(cc12)-c1c(nn2ccccc12)-c1ccccc1	MAP kinase inhibitor	MAPK1|MAPK3
FRAX486	68060125	BRD-K57243773	CCn1c2nc(Nc3ccc(N4CCNCC4)c(F)c3)ncc2cc(-c2ccc(Cl)cc2Cl)c1=O	serine/threonine kinase inhibitor	PAK1|PAK2|PAK3|PAK4
frentizole	33334	BRD-K07202345	COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1	immunosuppressant	
frovatriptan	77992	BRD-K08255599	CN[C@@H]1CCc2[nH]c3ccc(cc3c2C1)C(N)=O	serotonin receptor agonist	HTR1A|HTR1B|HTR1D
fruquintinib	44480399	BRD-K70504253	CNC(=O)c1c(C)oc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12	VEGFR inhibitor	KDR
ftaxilide	71895	BRD-K05724540	Cc1cccc(C)c1NC(=O)c1ccccc1C(O)=O		
ftorafur	288216	BRD-K99383816	Fc1cn([C@H]2CCCO2)c(=O)[nH]c1=O	thymidylate synthase inhibitor	TYMS
fudosteine	134669	BRD-K54838207	N[C@@H](CSCCCO)C(O)=O	mucolytic agent	
fulvestrant	104741	BRD-A85667082	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31	estrogen receptor antagonist	ESR1|ESR2|GPER1
fumagillin	16759605	BRD-A99367815	CO[C@@H]1[C@@H](CC[C@]2(CO2)C1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O	methionine aminopeptidase inhibitor	METAP2
furaltadone	9553856	BRD-A67514145	[O-][N+](=O)c1ccc(\C=N\N2CC(CN3CCOCC3)OC2=O)o1	bacterial DNA inhibitor	
furamidine	126437	BRD-K77758223	NC(=N)c1ccc(cc1)-c1ccc(o1)-c1ccc(cc1)C(N)=N	protein arginine N-methyltransferase inhibitor	PRMT1
furazolidone	5323714	BRD-K11756522	[O-][N+](=O)c1ccc(\C=N\N2CCOC2=O)o1	bacterial DNA inhibitor	
furegrelate	3437	BRD-K55529781	OC(=O)c1cc2cc(Cc3cccnc3)ccc2o1	thromboxane synthase inhibitor	TBXAS1
furosemide	118985385	BRD-K78010432	NS(=O)(=O)c1cc(C(O)=O)c(NCc2ccco2)cc1Cl	diuretic	CA2|GPR35|SLC12A1|SLC12A2
fursultiamine	3002119	BRD-A71157293	C\C(N(Cc1cnc(C)nc1N)C=O)=C(\CCO)SSCC1CCCO1	vitamin B	
fusidic-acid	3001077	BRD-A06935312	C[C@@H]1[C@H](O)CC[C@@]2(C)[C@H]1CC[C@@]1(C)C2[C@H](O)C[C@@H]2[C@]1(C)C[C@H](OC(C)=O)\C2=C(/CCC=C(C)C)C(O)=O	bacterial 30S ribosomal subunit inhibitor	
F351	11217901	BRD-K41267922	Cc1ccc(=O)n(c1)-c1ccc(O)cc1	TGF beta receptor inhibitor	TGFB1
g-caryophyllene	5281515	BRD-K26878113	C\C1=C/CCC(=C)[C@H]2CC(C)(C)[C@@H]2CC1	acetylcholinesterase inhibitor	ACHE
G-1	5322399	BRD-K62696033	CC(=O)c1ccc2N[C@H]([C@H]3CC=C[C@H]3c2c1)c1cc2OCOc2cc1Br	G protein-coupled receptor agonist	GPER1
G-15	90488870	BRD-M30288325	Brc1cc2OCOc2cc1[C@H]1Nc2ccccc2[C@H]2C=CC[C@@H]12.Brc1cc2OCOc2cc1[C@@H]1Nc2ccccc2[C@@H]2C=CC[C@H]12	estrogen receptor antagonist	GPER1
GABA-linoleamide	6438152	BRD-K46254452	CCCCC\C=C/C\C=C/CCCCCCCC(=O)NCCCC(O)=O	benzodiazepine receptor agonist	
gabapentin	3446	BRD-K62737565	NCC1(CC(O)=O)CCCCC1	calcium channel blocker	ADORA1|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B
gabapentin-enacarbil	9883933	BRD-A86665761	CC(C)C(=O)OC(C)OC(=O)NCC1(CC(O)=O)CCCCC1	adrenergic receptor agonist	CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8
gabazine	107896	BRD-K79905821	COc1ccc(cc1)-c1ccc(=N)n(CCCC(O)=O)n1	GABA receptor antagonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRG2
gabexate	3447	BRD-K59256312	CCOC(=O)c1ccc(OC(=O)CCCCCNC(N)=N)cc1	serine protease inhibitor	PRSS1|TPSAB1
gaboxadol	28360827	BRD-K89104321	Oc1noc2CNCCc12	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRD|GABRR1|GABRR2|GABRR3
gadobutrol		BRD-A67181951	OCC(O)[C@@H](CO)N1CCN2CCN3CCN(CC1)CC(=O)O[Gd](OC(=O)C3)OC(=O)C2	radiopaque medium	
gadodiamide	101673418	BRD-K38140108	CNC(=O)CN1CCN2CCN(CC(=O)NC)CC(=O)O[Gd](OC(=O)C1)OC(=O)C2	radiopaque medium	
gadopentetic-acid	131668252	BRD-K25106841	OC(=O)CN1CCN2CCN(CC(O)=O)CC(=O)O[Gd](OC(=O)C1)OC(=O)C2	contrast agent	
gadoterate-meglumine	121841	BRD-K11099631	OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1	radiopaque medium	
gadoteridol	24838311	BRD-A72401848	CC(O)CN1CCN2CCN3CCN(CC1)CC(=O)O[Gd](OC(=O)C2)OC(=O)C3	radiopaque medium	
galantamine	9651	BRD-K49481516	COc1ccc2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3Oc1c24	acetylcholinesterase inhibitor	ACHE|BCHE|CHRNA1|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB1|CHRNB2|CHRNB3|CHRNB4|CHRND|CHRNE|CHRNG
galeterone	11440648	BRD-A07986123	C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@]34C)C1CC=C2n1cnc2ccccc12	androgen receptor modulator	AR|CYP17A1
gallamine-triethiodide	3450	BRD-K43106192	CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC	acetylcholine receptor antagonist	ACHE|CHRM2|CHRNA1|CHRNA2
gallic-acid	370	BRD-K77345217	OC(=O)c1cc(O)c(O)c(O)c1	beta amyloid protein neurotoxicity inhibitor; PPAR receptor agonist	CA1|CA12|CA14|CA2|CA4|CA6|CA9|SELP
gallium-triquinolin-8-olate	16684839	BRD-K46648676	O([Ga](Oc1cccc2cccnc12)Oc1cccc2cccnc12)c1cccc2cccnc12		
gallopamil	1234	BRD-A52922642	COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2cc(OC)c(OC)c(OC)c2)cc1OC	L-type calcium channel blocker	ATP2A2
gambogic-acid	9852185	BRD-K08542803	CC(C)=CCC[C@@]1(C)Oc2c(CC=C(C)C)c3O[C@@]45[C@H]6C[C@@H](C=C4C(=O)c3c(O)c2C=C1)C(=O)[C@]5(C\C=C(\C)C(O)=O)OC6(C)C	caspase activator	BCL2
gamma-aminobutyric-acid	119	BRD-K77245796	NCCCC(O)=O	benzodiazepine receptor agonist	GABBR1|GABBR2|GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2|GATM|KCTD12|KCTD16|KCTD8|SLC6A1
gamma-linolenic-acid	5280933	BRD-K18059238	CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O	cyclooxygenase inhibitor; prostanoid receptor agonist	PTGS1|PTGS2
ganaxolone	6918305	BRD-K28217197	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C	GABA receptor modulator	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6
ganciclovir	3454	BRD-K22662435	Nc1nc2n(COC(CO)CO)cnc2c(=O)[nH]1	DNA polymerase inhibitor	
ganetespib		BRD-K38852836	CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3n(C)ccc3c2)c(O)cc1O	HSP inhibitor	HSP90AA1
ganglioside-gm1	16760449	BRD-A30703952	CCCCCCCCCCCCCCCCCC(=O)N[C@@H](COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(OC4OC(CO)C(O)C(O)C4O)C3NC(C)=O)C(OC3(CC(O)C(NC(C)=O)C(O3)C(O)C(O)CO)C(O)=O)C2O)C(O)C1O)[C@H](O)\C=C\CCCCCCCCCCCCC		
GANT-58	253078	BRD-K64451768	c1cc(ccn1)-c1sc(c(c1-c1ccncc1)-c1ccncc1)-c1ccncc1	GLI antagonist	GLI1
GANT-61	421610	BRD-K09485525	CN(C)c1ccccc1CN1CCCN(Cc2ccccc2N(C)C)C1c1ccncc1	GLI antagonist	GLI1|GLI2
garenoxacin	124093	BRD-K77038618	C[C@H]1NCc2cc(ccc12)-c1ccc2c(c1OC(F)F)n(cc(C(O)=O)c2=O)C1CC1	topoisomerase inhibitor	TOP2A
gastrodin	129010091	BRD-K81613478	OC[C@@H]1O[C@@H](Oc2ccc(CO)cc2)[C@H](O)[C@@H](O)[C@@H]1O		
gatifloxacin	4872633	BRD-A74980173	COc1c(N2CCNC(C)C2)c(F)cc2c1n(cc(C(O)=O)c2=O)C1CC1	bacterial DNA gyrase inhibitor	
gavestinel	6450546	BRD-K81981783	OC(=O)c1[nH]c2cc(Cl)cc(Cl)c2c1\C=C\C(=O)Nc1ccccc1	glutamate receptor antagonist	GLRB
GBR-12783	5788723	BRD-K92015269	C(CN1CCN(C\C=C\c2ccccc2)CC1)OC(c1ccccc1)c1ccccc1	dopamine uptake inhibitor	
GBR-12935	3456	BRD-K50135270	C(CN1CCN(CCOC(c2ccccc2)c2ccccc2)CC1)Cc1ccccc1	dopamine uptake inhibitor	AGTR1|SLC6A3
GBR-13069	5974189	BRD-K92577649	Fc1ccc(cc1)C(OCCN1CCN(C\C=C\c2ccccc2)CC1)c1ccc(F)cc1	dopamine uptake inhibitor	SLC6A3
GDC-0068	59671085	BRD-K71480163	CC(C)NC[C@@H](C(=O)N1CCN(CC1)c1ncnc2[C@@H](O)C[C@@H](C)c12)c1ccc(Cl)cc1	AKT inhibitor	AKT1|AKT2|AKT3|PRKG1
GDC-0152	46940575	BRD-K68938568	CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1	XIAP inhibitor	BIRC2|BIRC3|BIRC7|XIAP
GDC-0349	59239165	BRD-K43187018	CCNC(=O)Nc1ccc(cc1)-c1nc2CN(CCc2c(n1)N1CCOC[C@@H]1C)C1COC1	Pim kinase inhibitor	PIK3CA
GDC-0623	42642654	BRD-K46908090	OCCONC(=O)c1ccc2cncn2c1Nc1ccc(I)cc1F	MEK inhibitor	
GDC-0810	56941241	BRD-K61923022	CC\C(=C(\c1ccc(\C=C\C(O)=O)cc1)c1ccc2[nH]ncc2c1)c1ccc(F)cc1Cl	selective estrogen receptor destabilizer	ESR1
GDC-0834	25235170	BRD-A30984645	CN1CCN(C)C(=O)C1c1ccc(Nc2nc(cn(C)c2=O)-c2cccc(NC(=O)c3cc4CCCCc4s3)c2C)cc1	Bruton's tyrosine kinase (BTK) inhibitor	BTK
GDC-0879	11717001	BRD-K67578145	OCCn1cc(c(n1)-c1ccncc1)-c1ccc2c(CC\C2=N/O)c1	RAF inhibitor	BRAF
GDC-0941	17755052	BRD-K52911425	CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3[nH]ncc23)CC1	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
GDC-0980	25254071	BRD-K23228615	C[C@H](O)C(=O)N1CCN(Cc2sc3c(nc(nc3c2C)-c2cnc(N)nc2)N2CCOCC2)CC1	mTOR inhibitor; PI3K inhibitor	FGR|MAP3K9|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|SYK
GDC-0994	78160832	BRD-A20830788	Cn1nccc1Nc1nccc(n1)-c1ccn(C(CO)c2ccc(Cl)c(F)c2)c(=O)c1	MAP kinase inhibitor	MAPK1|MAPK3
gedunin	12004512	BRD-K02703275	CC(=O)O[C@@H]1C[C@H]2C(C)(C)C(=O)C=C[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](OC(=O)[C@H]4O[C@@]34[C@]12C)c1ccoc1	HSP inhibitor	HSP90AA1
gefitinib	123631	BRD-K64052750	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1	EGFR inhibitor	EGFR
geldanamycin	13017912	BRD-K43570081	CO[C@H]1C[C@H](C)CC2=C(OC)C(=O)C=C(NC(=O)\C(C)=C\C=C\[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O	HSP inhibitor	HSP90AA1|HSP90AB1
gemcadiol	37147	BRD-K43890836	CC(C)(CO)CCCCCCC(C)(C)CO	antilipemic	
gemcitabine	60750	BRD-K15108141	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1	ribonucleotide reductase inhibitor	CMPK1|RRM1|RRM2|TYMS
gemcitabine-elaidate	9828310	BRD-K09456915	CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)C(F)(F)[C@@H]1O	DNA synthesis inhibitor; apoptosis inhibitor	CMPK1|RRM1|TYMS
gemfibrozil	3463	BRD-K11129031	Cc1ccc(C)c(OCCCC(C)(C)C(O)=O)c1	lipoprotein lipase activator	LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1
gemifloxacin	9571107	BRD-A40787240	CO\N=C1/CN(CC1CN)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1	bacterial DNA gyrase inhibitor	
genipin	442424	BRD-K28824103	COC(=O)C1=CO[C@@H](O)[C@H]2[C@@H]1CC=C2CO	choleretic agent	
geniposide	107848	BRD-K57275767	COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]2[C@@H]1CC=C2CO	GLP receptor agonist	GLP1R
geniposidic-acid	443354	BRD-K73771095	OC[C@H]1O[C@@H](O[C@@H]2OC=C([C@H]3CC=C(CO)[C@@H]23)C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O	cyclooxygenase inhibitor	
genistein	5280961	BRD-K43797669	Oc1ccc(cc1)-c1coc2cc(O)cc(O)c2c1=O	tyrosine kinase inhibitor	CFTR|ESR1|ESR2|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5
gentamycin	5702060	BRD-A89445950	CNC(C)[C@@H]1CC[C@@H](N)[C@@H](OC2[C@@H](N)C[C@@H](N)[C@H](OC3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1	bacterial 50S ribosomal subunit inhibitor	HSPA8|LRP2
gentiopicrin	88708	BRD-K33131085	OC[C@H]1O[C@@H](O[C@@H]2OC=C3C(=O)OCC=C3[C@H]2C=C)[C@H](O)[C@@H](O)[C@@H]1O	glutamate receptor downregulator	GRIN2B
genz-123346	23652732	BRD-K70693421	CCCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2OCCOc2c1	glucosylceramidase inhibitor	UGCG
genz-644282	10294813	BRD-K99475619	CNCCn1c2c(cnc3cc4OCOc4cc23)c2cc(OC)c(OC)cc2c1=O	topoisomerase inhibitor	TOP1
gepefrine	102551	BRD-A04447196	CC(N)Cc1cccc(O)c1	adrenergic receptor agonist	
gepon	25075953	BRD-A56754222	CC(C)[C@@H](NC(=O)C(NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)C(CCCNC(N)=N)NC(=O)C(CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)C(CCC(O)=O)NC(=O)[C@H](N)C(C)O)C(C)O)C(=O)N[C@H](CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NC(CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O		
geranyl-farnesylacetate	5282182	BRD-K02780233	CC(C)=CCC\C(C)=C\CC\C(C)=C\CCC(=O)OC\C=C(/C)CCC=C(C)C	mucin production enhancer	
gestodene	3033968	BRD-K97197005	CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1C=C[C@@]2(O)C#C	contraceptive agent	
gestrinone	27812	BRD-K97472745	CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)C#C	progesterone receptor antagonist	AR|ESR1|PGR
GF109203X	2396	BRD-K31342827	CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c2c[nH]c3ccccc23)c2ccccc12	PKC inhibitor	PDPK1|PIM1|PRKCI|PRKCZ
GGsTop	23582776	BRD-A25625670	COP(=O)(CCC(N)C(O)=O)Oc1cccc(CC(O)=O)c1	gamma glutamyltransferase Inhibitors	GGT1
GGTI-298	9811606	BRD-K19669037	COC(=O)[C@H](CC(C)C)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1cccc2ccccc12	GGTase inhibitor	CDKN1A
gidazepam	121919	BRD-K22588750	NNC(=O)CN1c2ccc(Br)cc2C(=NCC1=O)c1ccccc1	GABA benzodiazepine site receptor agonist	
gilteritinib	49803313	BRD-K72280606	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(CC3)N3CCN(C)CC3)c(OC)c2)nc1NC1CCOCC1	FLT3 inhibitor	FLT3
gimeracil	54679224	BRD-K35687421	Oc1cc(=O)[nH]cc1Cl	dihydropyrimidine dehydrogenase inhibitor	DPYD
ginkgolide-a	23817960	BRD-A95121829	C[C@@H]1C(=O)O[C@H]2CC34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O	GABA receptor antagonist	GLRA1|GLRB
ginkgolide-b	90479819	BRD-A08430411	C[C@@H]1C(=O)OC2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O	platelet activating factor receptor antagonist	GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B
ginsenoside-c-k	9852086	BRD-K01942833	CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@@]21C	NFkB pathway inhibitor; nitric oxide synthase inhibitor	PTGS2
ginsenoside-rd	129010066	BRD-A84810646	CC(C)=CCCC(C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C	calcium channel blocker	
ginsenoside-rg3	12901619	BRD-A44511856	CC(C)=CCCC(C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C	angiogenesis inhibitor; apoptosis stimulant	KCNH2
givinostat	9804992	BRD-K13810148	CCN(CC)Cc1ccc2cc(COC(=O)Nc3ccc(cc3)C(=O)NO)ccc2c1	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
GKA-50	11340230	BRD-K03827870	COC[C@H](C)Oc1cc(O[C@@H](C)Cc2ccccc2)cc(c1)C(=O)Nc1ccc(cn1)C(O)=O	glucokinase activator	GCK
GKT137831	58496428	BRD-K79710622	CN(C)c1cccc(c1)-c1n(C)c(=O)cc2[nH]n(-c3ccccc3Cl)c(=O)c12	NADPH oxidase inhibitor	NOX1|NOX4
GK921	56682080	BRD-K38272302	C(CN1CCCC1)Oc1nc2cccnc2nc1C#Cc1ccccc1	transglutaminase inhibitor	TGM2
glafenine	3474	BRD-A38076815	OCC(O)COC(=O)c1ccccc1Nc1ccnc2cc(Cl)ccc12	DeltaF508-CFTR Correctors	CFTR
glasdegib	25166913	BRD-K34341643	CN1CC[C@H](C[C@@H]1c1nc2ccccc2[nH]1)NC(=O)Nc1ccc(cc1)C#N	hedgehog pathway inhibitor	SMO
gliclazide	3475	BRD-A61154809	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1	ATP channel blocker; insulin secretagogue	ABCC8|VEGFA
glimepiride		BRD-K34776109	CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O	insulin secretagogue	ABCC8|KCNJ1|KCNJ11
glipizide	3478	BRD-K12219985	Cc1cnc(cn1)C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1	sulfonylurea	ABCC8|KCNJ10|KCNJ11|PPARG
gliquidone	91610	BRD-K80396088	COc1ccc2c(c1)C(=O)N(CCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1)C(=O)C2(C)C	sulfonylurea	ABCC8|KCNJ10|KCNJ8
GLPG0492	59317190	BRD-K15893360	CN1C(=O)N(C(=O)[C@@]1(CO)c1ccccc1)c1ccc(C#N)c(c1)C(F)(F)F	androgen receptor modulator	AR
GLPG0492-R-enantiomer	59317173	BRD-K04643927	CN1C(=O)N(C(=O)[C@]1(CO)c1ccccc1)c1ccc(C#N)c(c1)C(F)(F)F	androgen receptor modulator	AR
glucaric-acid	33037	BRD-K60150658	O[C@@H]([C@H](O)[C@@H](O)C(O)=O)[C@H](O)C(O)=O		
gluconolactone	1549082	BRD-K04288422	OC[C@@H]1OC(=O)[C@@H](O)[C@H](O)[C@H]1O		LCT
glucosamine	441477	BRD-K29918010	N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O	glycosylated protein precursor	IFNG|IL1B|MMP9|NFKB2|TNF
glutamine-(l)	5961	BRD-K83896451	N[C@@H](CCC(N)=O)C(O)=O		CTPS1|GLUL|GPRC6A|PPAT
glutathione	124886	BRD-K69346723	N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O	antioxidant	ESD|GGT1|GLO1|GLRX|GLRX2|GPX1|GPX2|GPX3|GPX4|GPX5|GPX6|GPX7|GPX8|GSR|GSS|GSTA1|GSTA2|GSTA3|GSTA4|GSTA5|GSTK1|GSTM1|GSTM2|GSTM3|GSTM4|GSTM5|GSTO1|GSTO2|GSTP1|GSTT1|GSTZ1|HAGH|HPGDS|LTC4S|MGST1|MGST2|MGST3|TXNDC12
glutathione-monoisopropyl-ester	114894	BRD-K58937086	CC(C)OC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](N)C(O)=O	lipid peroxidase inhibitor	
gly-gln	123913	BRD-K85066592	NCC(=O)N[C@@H](CCC(N)=O)C(O)=O		
glyburide	3488	BRD-K36927236	COc1ccc(Cl)cc1C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1	ATP channel blocker; insulin secretagogue; sulfonylurea	ABCA1|ABCB11|ABCC8|ABCC9|CFTR|CPT1A|KCNJ1|KCNJ11|KCNJ5|KCNJ8|SLCO2B1
glycerol-monolaurate	14871	BRD-A10773072	CCCCCCCCCCCC(=O)OCC(O)CO	beta lactamase inhibitor	
glycitein	5317750	BRD-K78303961	COc1cc2c(cc1O)occ(-c1ccc(O)cc1)c2=O	tumor necrosis factor release inhibitor	TNF
glycopyrrolate	3494	BRD-A81233518	C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
GMX1778	148198	BRD-K69832040	Clc1ccc(OCCCCCCN\C(NC#N)=N\c2ccncc2)cc1	NAMPT inhibitor	NAMPT
GNF-2	5311510	BRD-K97056771	NC(=O)c1cccc(c1)-c1cc(Nc2ccc(OC(F)(F)F)cc2)ncn1	Bcr-Abl kinase inhibitor	ABL1|BCR
GNF-5	44129660	BRD-K87632963	OCCNC(=O)c1cccc(c1)-c1ncnc(Nc2ccc(cc2)OC(F)(F)F)c1	Bcr-Abl kinase inhibitor	ABL1|BCR
GNF-5837	59397065	BRD-K19975102	Cc1ccc(NC(=O)Nc2cc(ccc2F)C(F)(F)F)cc1Nc1ccc2c(NC(=O)\C2=C/c2ccc[nH]2)c1	growth factor receptor inhibitor	NTRK1|NTRK2|NTRK3
GNF-7	11478363	BRD-K69075588	CN1C(=O)N(Cc2cnc(Nc3ccc(C)nc3)nc12)c1cc(NC(=O)c2cccc(c2)C(F)(F)F)ccc1C	protein kinase inhibitor; glucokinase inhibitor	GCK|TNK2
GNTI	9826034	BRD-K64748124	NC(=N)Nc1ccc2[nH]c3c(C[C@@]4(O)[C@H]5Cc6ccc(O)c7O[C@@H]3[C@]4(CCN5CC3CC3)c67)c2c1	opioid receptor antagonist	OPRK1|OPRM1
go-6983	3499	BRD-K36984403	COc1ccc2n(CCCN(C)C)cc(C3=C(C(=O)NC3=O)c3c[nH]c4ccccc34)c2c1	protein kinase inhibitor	PRKCA|PRKCB|PRKCD|PRKCG|PRKCZ
golgicide-a	25113626	BRD-A57886255	Fc1cc(F)c2NC([C@@H]3CC=C[C@@H]3c2c1)c1cccnc1	ARF inhibitor	GBF1
golvatinib	16118392	BRD-K69001009	CN1CCN(CC1)C1CCN(CC1)C(=O)Nc1cc(Oc2ccc(NC(=O)C3(CC3)C(=O)Nc3ccc(F)cc3)c(F)c2)ccn1	VEGFR inhibitor	KDR|MET
gonadorelin	638793	BRD-K96874295	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O	gonadotropin releasing factor hormone receptor agonist	GNRHR|GNRHR2
goserelin-acetate	5311128	BRD-K99504665	CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O	gonadotropin releasing factor hormone receptor agonist	GNRHR|LHCGR
gossypol	3503	BRD-K19295594	CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O	BCL inhibitor; MCL1 inhibitor	BCL2
GPBAR-A	11656002	BRD-K67397687	Fc1ccccc1-c1ccnc2OCC(=O)N(Cc3cc(cc(c3)C(F)(F)F)C(F)(F)F)Cc12	G protein coupled receptor agonist	GPBAR1
GPI-1046	445501	BRD-K44869961	CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)OCCCc1cccnc1	FKBP inhibitor	FKBP1A
GPi-688	10477191	BRD-A90201073	OC[C@H](O)CN1C(=O)C(Cc2ccccc12)NC(=O)c1cc2cc(Cl)sc2[nH]1	glycogen phosphorylase inhibitor	
GPP-78	44819697	BRD-K83289131	O=C(CCCCCCCn1cc(nn1)-c1cccnc1)Nc1ccccc1-c1ccccc1	NAMPT inhibitor	NAMPT
GPR120-modulator-1	25017320	BRD-K19409553	Cc1cc(OCc2nc(cs2)-c2ccccc2Cl)ccc1OCC(O)=O	G protein-coupled receptor modulator	FFAR4
GP1a	10252734	BRD-K65285700	Cc1ccc-2c(Cc3c(nn(c-23)-c2ccc(Cl)cc2Cl)C(=O)NN2CCCCC2)c1	cannabinoid receptor agonist	CNR2
GP2a	16094766	BRD-K34608650	Cc1ccc-2c(Cc3c(nn(c-23)-c2ccc(Cl)cc2Cl)C(=O)NC2CCCCC2)c1	cannabinoid receptor agonist	CNR2
GR-103691	4302960	BRD-K50891186	COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(cc2)-c2ccc(cc2)C(C)=O)CC1	dopamine receptor antagonist	DRD3
GR-113808	119376	BRD-K49945136	Cn1cc(C(=O)OCC2CCN(CCNS(C)(=O)=O)CC2)c2ccccc12	serotonin receptor antagonist	HTR4
GR-127935	107780	BRD-K11911061	COc1ccc(NC(=O)c2ccc(cc2)-c2ccc(cc2C)-c2noc(C)n2)cc1N1CCN(C)CC1	serotonin receptor antagonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6
GR-135531	4284525	BRD-K83023055	COC(=O)Nc1ccc2[nH]cc(CCNC(C)=O)c2c1	melatonin receptor agonist	
GR-144053	173614	BRD-K12120659	NC(=N)c1ccc(cc1)N1CCN(CC1)C1CCN(CC(O)=O)CC1	integrin antagonist	ITGA2B|ITGB3
GR-159897	9953599	BRD-K52394958	COC1(C[S@@](=O)c2ccccc2)CCN(CCc2c[nH]c3ccc(F)cc23)CC1	tachykinin antagonist	TAC1|TACR2
GR-235	6450278	BRD-K26674531	C\C=C1/C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	estrogen receptor agonist; FXR antagonist; progesterone receptor agonist	NR1H4
GR-79236	9884817	BRD-K40578143	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N[C@H]3CCC[C@@H]3O)ncnc12	adenosine receptor agonist	ADORA1|ADORA2A
gramicidin	16170150	BRD-A52977603	CC(C)CC(NC(=O)C(C)NC(=O)CNC(=O)C(NC=O)C(C)C)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NCCO	bacterial permeability inducer	
gramine	6890	BRD-K26005076	CN(C)Cc1c[nH]c2ccccc12	norepinephrine reputake inhibitor	
granisetron	3510	BRD-A10967948	CN1C2CCCC1CC(C2)NC(=O)c1nn(C)c2ccccc12	serotonin receptor antagonist	HTR3A
grapiprant	11677589	BRD-K62050508	CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1	prostaglandin inhibitor	PTGER4
grazoprevir	44603531	BRD-K24943235	COc1ccc2nc3CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)N[C@@]4(C[C@H]4C=C)C(=O)NS(=O)(=O)C4CC4)Oc3nc2c1)C(C)(C)C	HCV inhibitor	
griseofulvin	441140	BRD-K08273968	COc1cc(OC)c(Cl)c2O[C@]3([C@H](C)CC(=O)C=C3OC)C(=O)c12	tubulin polymerization inhibitor	KRT12
GR125487	4284721	BRD-K62594868	COc1[nH]c2ccc(F)cc2c1C(=O)OCC1CCN(CCNS(C)(=O)=O)CC1	serotonin receptor antagonist	HTR4
GR46611	6160690	BRD-K98155362	COc1ccc(CNC(=O)\C=C\c2ccc3[nH]cc(CCN(C)C)c3c2)cc1	serotonin receptor agonist	HTR1D
GS-143	121513876	BRD-K99916169	OC(=O)c1ccc(cc1)N1N=C(Cc2ccccc2)\C(=C/c2ccc(o2)-c2ccccc2F)C1=O	ubiquitin ligase inhibitor	BTRC|NFKBIA
GS-39783	6604928	BRD-K75478907	CSc1nc(NC2CCCC2)c(c(NC2CCCC2)n1)[N+]([O-])=O	GABA receptor modulator	GABBR1
GS-6201	11270783	BRD-K68453341	CCCn1c(=O)n(CC)c2nc([nH]c2c1=O)-c1cnn(Cc2cccc(c2)C(F)(F)F)c1	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
GS-9620	46241268	BRD-K73585091	CCCCOc1nc(N)c2NC(=O)CN(Cc3cccc(CN4CCCC4)c3)c2n1	toll-like receptor agonist	TLR7
GS-9973	59473233	BRD-K76719364	C1CN(CCO1)c1ccc(Nc2nc(cn3ccnc23)-c2ccc3cn[nH]c3c2)cc1	syk inhibitor	SYK
GSK-J1	56963315	BRD-K32847255	OC(=O)CCNc1cc(nc(n1)-c1ccccn1)N1CCc2ccccc2CC1	histone demethylase inhibitor	KDM6B
GSK-J2	73010924	BRD-K82484347	OC(=O)CCNc1cc(nc(n1)-c1cccnc1)N1CCc2ccccc2CC1	histone demethylase inhibitor	
GSK-J4	71729975	BRD-K98203492	CCOC(=O)CCNc1cc(nc(n1)-c1ccccn1)N1CCc2ccccc2CC1	histone lysine demethylase inhibitor	KDM6A|KDM6B
GSK-J5	78243729	BRD-K55438324	CCOC(=O)CCNc1cc(nc(n1)-c1cccnc1)N1CCc2ccccc2CC1	histone demethylase control	
GSK-LSD-1	71522234	BRD-K33521504	C1[C@@H](NC2CCNCC2)[C@@H]1c1ccccc1	histone lysine demethylase inhibitor	KDM1A
GSK-0660	46233311	BRD-K98684188	COC(=O)c1sccc1S(=O)(=O)Nc1ccc(Nc2ccccc2)cc1OC	PPAR receptor antagonist	PPARD
GSK-1562590	46846503	BRD-K36697397	CN([C@@H](CN1CCCC1)c1ccc(cc1)-c1cccc(c1)C(N)=O)C(=O)CN1C(=O)COc2cc(Cl)c(Cl)cc12	urotensin receptor antagonist	UTS2R
GSK-2193874	53464483	BRD-K90737788	FC(F)(F)c1cccc(c1)-c1nc2cc(Br)ccc2c(C(=O)NC2(CC2)c2ccccc2)c1CN1CCC(CC1)N1CCCCC1	transient receptor potential channel antagonist	TRPV4
GSK-2837808A	71533725	BRD-K50679358	COc1ncc(-c2ccc3c(Nc4cc(Oc5cc(F)cc(F)c5)cc(c4)C(O)=O)c(cnc3c2)S(=O)(=O)NC2CC2)c(OC)n1	lactate dehydrogenase inhibitor	LDHA
GSK-3-inhibitor-IX		BRD-K04923131	O\N=C1/C(Nc2ccccc12)=C1/C(=O)Nc2cc(Br)ccc12	glycogen synthase kinase inhibitor; lipoxygenase inhibitor	GSK3A|GSK3B
GSK-37647	743974	BRD-K26514105	COc1ccc(cc1)S(=O)(=O)Nc1c(C)cc(C)cc1C	free fatty acid receptor agonist	FFAR4
GSK1059615	23582824	BRD-K06750613	O=C1NC(=O)\C(S1)=C\c1ccc2nccc(-c3ccncc3)c2c1	PI3K inhibitor	PIK3CG
GSK1070916	46885626	BRD-K36740062	CCn1cc(c(n1)-c1ccc(NC(=O)N(C)C)cc1)-c1ccnc2[nH]c(cc12)-c1cccc(CN(C)C)c1	Aurora kinase inhibitor	AURKA|AURKB|AURKC|CYP2D6|CYP3A4
GSK1292263	24996872	BRD-K60341624	CC(C)c1noc(n1)N1CCC(COc2ccc(nc2)-c2ccc(cc2)S(C)(=O)=O)CC1	glucose dependent insulinotropic receptor agonist	GRPR
GSK163090	11292933	BRD-K69669039	Cc1ccc2c(cccc2n1)N1CCN(CCc2cccc(c2)N2CCNC2=O)CC1	serotonin receptor antagonist	HTR1A|HTR1B|HTR1D
GSK1838705A	25182616	BRD-K06749501	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3N(CCc3cc2OC)C(=O)CN(C)C)nc2[nH]ccc12	insulin growth factor receptor inhibitor	ALK|IGF1R|INSR|RPS6KA1
GSK1904529A	25124816	BRD-K04833372	CCc1cc(Nc2nccc(n2)-c2c(nc3ccccn23)-c2ccc(OC)c(c2)C(=O)Nc2c(F)cccc2F)c(OC)cc1N1CCC(CC1)N1CCN(CC1)S(C)(=O)=O	IGF-1 inhibitor; insulin growth factor receptor inhibitor; insulin receptor ligand	IGF1R|INSR
GSK2110183	46843057	BRD-K25412176	Cn1ncc(Cl)c1-c1cc(sc1Cl)C(=O)N[C@H](CN)Cc1cccc(F)c1	AKT inhibitor	AKT1|AKT2|AKT3
GSK2126458	25167777	BRD-K07972848	COc1ncc(cc1NS(=O)(=O)c1ccc(F)cc1F)-c1ccc2nccc(-c3ccnnc3)c2c1	mTOR inhibitor; PI3K inhibitor	MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG
GSK2190915	44473151	BRD-K15691453	CCOc1ccc(cn1)-c1ccc(Cn2c(CC(C)(C)C(O)=O)c(SC(C)(C)C)c3cc(OCc4ccc(C)cn4)ccc23)cc1	lipoxygenase inhibitor	ALOX5AP
GSK2194069	67376285	BRD-K95123482	O=C(C1CC1)N1CC[C@@H](Cc2n[nH]c(=O)n2-c2ccc(cc2)-c2ccc3occc3c2)C1	fatty acid synthase inhibitor	FASN
GSK2256294A	59448236	BRD-K62738477	CNc1nc(C)nc(N[C@H]2CCC[C@H](C2)C(=O)NCc2ccc(cc2C(F)(F)F)C#N)n1	epoxide hydolase inhibitor	EPHX2
GSK2330672	53492727	BRD-K05858796	CCCC[C@]1(CC)CS(=O)(=O)c2cc(CNC(CC(O)=O)CC(O)=O)c(OC)cc2[C@H](N1)c1ccccc1	bile acid transporter inhibitor	SLC10A2
GSK2334470	46215815	BRD-K70642949	CNc1nc(cc(n1)-c1ccc2c(N)n[nH]c2c1)N1C[C@H](CC[C@H]1C)C(=O)NC1CCCCC1	phosphoinositide dependent kinase inhibitor	AURKA|AURKB|PDPK1
GSK256066	9827968	BRD-K37590257	COc1cccc(Nc2c(cnc3c(C)cc(cc23)S(=O)(=O)c2cccc(c2)C(=O)N(C)C)C(N)=O)c1	phosphodiesterase inhibitor	PDE4A
GSK2578215A	68107965	BRD-K30185465	Fc1cc(ccn1)-c1ccc(OCc2ccccc2)c(c1)C(=O)Nc1cccnc1	leucine rich repeat kinase inhibitor	LRRK2
GSK2606414	53469448	BRD-K81689258	Cn1cc(-c2ccc3N(CCc3c2)C(=O)Cc2cccc(c2)C(F)(F)F)c2c(N)ncnc12	protein kinase inhibitor	EIF2AK3|MYLK2
GSK2636771	56949517	BRD-K49215523	Cc1nc2c(cc(cc2n1Cc1cccc(c1C)C(F)(F)F)N1CCOCC1)C(O)=O	PI3K inhibitor	PIK3CB
GSK2656157	53469059	BRD-K41104902	Cc1cccc(CC(=O)N2CCc3c2ccc(-c2cn(C)c4ncnc(N)c24)c3F)n1	PERK inhibitor	
GSK269962	16095342	BRD-K89464729	CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)-c1nonc1N	rho associated kinase inhibitor	ROCK1|ROCK2
GSK2801	73010930	BRD-K48062199	CCCOc1ccn2c(cc(-c3ccccc3S(C)(=O)=O)c2c1)C(C)=O	bromodomain inhibitor	BAZ2A|BAZ2B
GSK2816126	68210102	BRD-K21867462	CC[C@H](C)n1cc(C)c2c(cc(cc12)-c1ccc(nc1)N1CCNCC1)C(=O)NCc1c(C)cc(C)[nH]c1=O	histone lysine methyltransferase inhibitor	EZH2
GSK2830371	70983932	BRD-K17472821	Cc1ncc(Cl)cc1NCc1ccc(s1)C(=O)N[C@@H](CC1CCCC1)C(=O)NC1CC1	protein phosphatase inhibitor	PPM1D
GSK2838232	71580991	BRD-K08398903	CC(C)C1=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@]2(CC1=O)[C@@H](O)CN(CCN(C)C)Cc1ccc(Cl)cc1	HIV gag inhibitor	
GSK2879552	66571643	BRD-K09223495	OC(=O)c1ccc(CN2CCC(CN[C@@H]3C[C@H]3c3ccccc3)CC2)cc1	histone lysine demethylase inhibitor	KDM1A
GSK3787	2800647	BRD-K03155172	FC(F)(F)c1ccc(nc1)S(=O)(=O)CCNC(=O)c1ccc(Cl)cc1	PPAR receptor antagonist	PPARD
GSK429286A	11373846	BRD-A10523515	CC1=C(C(CC(=O)N1)c1ccc(cc1)C(F)(F)F)C(=O)Nc1cc2cn[nH]c2cc1F	rho associated kinase inhibitor	ROCK1
GSK461364	15983966	BRD-K92428232	C[C@@H](Oc1cc(sc1C(N)=O)-n1cnc2ccc(CN3CCN(C)CC3)cc12)c1ccccc1C(F)(F)F	PLK inhibitor	PLK1
GSK503	67469117	BRD-K72293620	CC(C)n1cc(C)c2c(cc(cc12)-c1ccc(nc1)N1CCN(C)CC1)C(=O)NCc1c(C)cc(C)[nH]c1=O	histone lysine methyltransferase inhibitor	EZH2
GSK650394	25022668	BRD-K14991967	OC(=O)c1ccc(cc1C1CCCC1)-c1c[nH]c2ncc(cc12)-c1ccccc1	serum/glucocorticoid regulated kinase inhibitor	SGK1|SGK2
GSK690693	16725726	BRD-K25325018	CCn1c(nc2c(ncc(OC[C@H]3CCCNC3)c12)C#CC(C)(C)O)-c1nonc1N	AKT inhibitor	AKT1|AKT2|AKT3|PAK4|PAK6|PAK7|PRKCQ|PRKG1|PRKX
GSK9027	24882669	BRD-K29328421	Fc1ccc(cc1)-n1ncc2cc(ccc12)-c1ccc(NS(=O)(=O)Cc2ccccc2)cc1C(F)(F)F	glucocorticoid receptor agonist	NR3C1
GSK923295	46898058	BRD-K89015388	CC(C)Oc1ccc(cc1Cl)C(=O)N[C@H](CNC(=O)CN(C)C)Cc1ccc(cc1)-c1cn2cccc([C@H](C)O)c2n1	centromere associated protein inhibitor	CENPE
GTP-14564	3385203	BRD-K16664969	c1ccc(cc1)-c1n[nH]c2c1oc1ccccc21	FLT3 inhibitor; tyrosine kinase inhibitor	CSF1R|FLT3|KIT|PDGFRB
GTS21	5310985	BRD-K14235254	COc1ccc(\C=C2CCCN=C/2c2cccnc2)c(OC)c1	cholinergic receptor agonist	CHRNA7
guacetisal	68749	BRD-K00739965	COc1ccccc1OC(=O)c1ccccc1OC(C)=O	immunosuppressant	
guaiacol	460	BRD-K96282009	COc1ccccc1O	local anesthetic	CA2
guaifenesin	3516	BRD-A90515964	COc1ccccc1OCC(O)CO	expectorant	
guanaben-acetate	5702063	BRD-K62736196	NC(=N)N\N=C\c1c(Cl)cccc1Cl	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C
guanadrel	38521	BRD-A14262390	NC(=N)NCC1COC2(CCCCC2)O1	adrenergic inhibitor	SLC6A2
guanethidine	3518	BRD-K62676709	NC(=N)NCCN1CCCCCCC1	adrenergic inhibitor	SLC6A2
guanfacine	3519	BRD-K32830106	NC(=N)NC(=O)Cc1c(Cl)cccc1Cl	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C
guanidine	3520	BRD-K76037122	NC(N)=N	HSP inhibitor	ALDH2|DLG4|GAMT|RNASE1
guanidinoethyldisulfide-bicarbonate	3521	BRD-K69191882	NC(N)=NCCSSCCN=C(N)N	nitric oxide synthase inhibitor	NOS2
guanidinopropionic-acid	25200496	BRD-K50781608	NC(N)=NCCC(O)=O	creatine kinase inhibitor	CKM
guanosine	6560220	BRD-K92976206	Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@@H](CO)[C@@H](O)[C@H]1O		PNP
Gue-1654	5066134	BRD-K18745919	CSc1nc2ccc3nc(NC(=O)C(c4ccccc4)c4ccccc4)sc3c2s1	oxoeicosanoid receptor modulator	OXER1
guvacine	3532	BRD-K01980392	OC(=O)C1=CCCNC1	GABA uptake inhibitor	SLC6A1|SLC6A11|SLC6A12|SLC6A13
GW-0742	9934458	BRD-K82983861	Cc1nc(sc1CSc1ccc(OCC(O)=O)c(C)c1)-c1ccc(c(F)c1)C(F)(F)F	PPAR receptor agonist	PPARD
GW-1100	11692123	BRD-K23614267	CCOC(=O)c1ccc(cc1)-n1cc(Cc2cnc(OCC)nc2)c(=O)nc1SCc1ccc(F)cc1	G protein-coupled receptor agonist	FFAR1
GW-1929	4516886	BRD-A15415227	CN(CCOc1ccc(CC(Nc2ccccc2C(=O)c2ccccc2)C(O)=O)cc1)c1ccccn1	PPAR receptor agonist	PPARG
GW-2580	11617559	BRD-K24242599	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1	cFMS kinase inhibitor	CSF1R
GW-311616	9800961	BRD-K37864785	CC(C)[C@H]1[C@H]2[C@@H](CCN2C(=O)\C=C\CN2CCCCC2)N(C1=O)S(C)(=O)=O	leukocyte elastase inhibitor; elastase inhibitor	ELANE
GW-3965	447905	BRD-K33818169	OC(=O)Cc1cccc(OCCCN(CC(c2ccccc2)c2ccccc2)Cc2cccc(c2Cl)C(F)(F)F)c1	LXR agonist	NR1H2|NR1H3
GW-405833	9911463	BRD-K10705233	COc1ccc2n(C(=O)c3cccc(Cl)c3Cl)c(C)c(CCN3CCOCC3)c2c1	cannabinoid receptor agonist	CNR2
GW-4064	9893571	BRD-K88186167	CC(C)c1onc(c1COc1ccc(\C=C\c2cccc(c2)C(O)=O)c(Cl)c1)-c1c(Cl)cccc1Cl	FXR agonist	NR1H4
GW-438014A	6918627	BRD-K13039700	O=C(Nc1nc2ccccc2n1CCc1ccccc1)c1ccccc1	neuropeptide receptor antagonist	NPY5R
GW-441756	9943465	BRD-K41312087	Cn1cc(\C=C2/C(=O)Nc3cccnc23)c2ccccc12	growth factor receptor inhibitor	NTRK1
GW-501516	9803963	BRD-K14880289	Cc1nc(sc1CSc1ccc(OCC(O)=O)c(C)c1)-c1ccc(cc1)C(F)(F)F	PPAR receptor agonist	PPARA|PPARD
GW-5074	5034	BRD-K39520573	Oc1c(Br)cc(C=C2C(=O)Nc3ccc(I)cc23)cc1Br	RAF inhibitor; leucine rich repeat kinase inhibitor	NTRK1|RAF1
GW-542573X	24885053	BRD-K36485341	COc1ccccc1NC(=O)OCC1CCN(CC1)C(=O)OC(C)(C)C	calcium channel activator	KCNN1
GW-583340	5329480	BRD-K79930101	CS(=O)(=O)CCNCc1nc(cs1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1	EGFR inhibitor	EGFR|ERBB2
GW-627368	5312130	BRD-K50005760	CCOc1c2CN(C(=O)c2c(OCC)c2ccccc12)c1ccc(CC(=O)NS(=O)(=O)c2ccccc2)cc1	prostanoid receptor antagonist	PTGER4
GW-6471	446738	BRD-K20828910	CCC(=O)NC[C@H](Cc1ccc(OCCc2nc(oc2C)-c2ccccc2)cc1)N\C(C)=C/C(=O)c1ccc(cc1)C(F)(F)F	PPAR receptor antagonist	PPARA
GW-7647	3392731	BRD-K96263742	CC(C)(Sc1ccc(CCN(CCCCC2CCCCC2)C(=O)NC2CCCCC2)cc1)C(O)=O	PPAR receptor agonist	PPARA
GW-788388	10202642	BRD-K78086729	O=C(NC1CCOCC1)c1ccc(cc1)-c1cc(ccn1)-c1c[nH]nc1-c1ccccn1	ALK tyrosine kinase receptor inhibitor	LCK|MAPK14|TGFBR1
GW-803430	9826520	BRD-K65576800	COc1cc(ccc1OCCN1CCCC1)-n1cnc2cc(sc2c1=O)-c1ccc(Cl)cc1	melanin inhibitor	KCNH2|MCHR1
GW-842166	10253143	BRD-K26823213	FC(F)(F)c1nc(Nc2ccc(Cl)cc2Cl)ncc1C(=O)NCC1CCOCC1	cannabinoid receptor agonist	CNR2
GW-843682X	9826308	BRD-K90382497	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(N)=O)c2cc1OC	PLK inhibitor	PLK1|PLK3
GW-9508	11595431	BRD-K71534238	OC(=O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1	free fatty acid receptor agonist; G protein-coupled receptor agonist	FFAR1|FFAR4
GW-9662	644213	BRD-K93258693	[O-][N+](=O)c1ccc(Cl)c(c1)C(=O)Nc1ccccc1	PPAR receptor antagonist	NCOA2|PPARG|RXRA
GYKI-52466	3538	BRD-K24240364	CC1=NN=C(c2ccc(N)cc2)c2cc3OCOc3cc2C1	glutamate receptor antagonist	GRIA1|GRIA2|GRIA3|GRIA4
gynostemma-extract	46887681	BRD-K58775955	CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C	calcium channel modulator	
GZD824	51038269	BRD-K35329391	CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4[nH]ncc4c3)cc2C(F)(F)F)CC1	Bcr-Abl kinase inhibitor	ABL1|BCR
G007-LK	67960134	BRD-K12198961	CS(=O)(=O)c1ccc(nc1)-c1nnc(\C=C\c2nnc(o2)-c2ccc(cc2)C#N)n1-c1ccccc1Cl	tankyrase inhibitor	TNKS|TNKS2
H-89	449241	BRD-K27737647	Brc1ccc(\C=C\CNCCNS(=O)(=O)c2cccc3cnccc23)cc1	PKA inhibitor	GSG2|PKIA|PRKACA
HA-1004	3546	BRD-K05434375	NC(=N)NCCNS(=O)(=O)c1cccc2cnccc12	calcium channel blocker	
HA-130	46911532	BRD-K64452997	OB(O)c1cccc(COc2ccc(\C=C3/SC(=O)N(Cc4ccc(F)cc4)C3=O)cc2)c1	autotaxin inhibitor	ENPP2
HA-14-1	3549	BRD-A13807286	CCOC(=O)C(C#N)C1c2cc(Br)ccc2OC(N)=C1C(=O)OCC	BCL inhibitor	BCL2
HA-966-(R)-(+)	6603720	BRD-K58046914	N[C@@H]1CCN(O)C1=O	glutamate receptor agonist	GRIA1
HA-966-(S)-(-)	183351	BRD-K41304947	N[C@H]1CCN(O)C1=O	glutamate receptor antagonist	GRIA1
halazone	3552	BRD-K68091065	OC(=O)c1ccc(cc1)S(=O)(=O)N(Cl)Cl		
halcinonide	5702233	BRD-A88138582	CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)[C@@]2(O1)C(=O)CCl	glucocorticoid receptor agonist	NR3C1
halobetasol-propionate	129009989	BRD-K65877271	CCC(=O)O[C@]1([C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]12C)C(=O)CCl	glucocorticoid receptor agonist	NR3C1|PLA2G1B
halofantrine	37393	BRD-A51964809	CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(ccc12)C(F)(F)F	antimalarial agent	KCNH2|KCNN4
halofuginone	456390	BRD-K54247840	O[C@H]1CCCN[C@@H]1CC(=O)Cn1cnc2cc(Br)c(Cl)cc2c1=O	collagenase inhibitor	COL1A1|MMP2
halopemide	65490	BRD-K50055394	Oc1nc2cc(Cl)ccc2n1C1CCN(CCNC(=O)c2ccc(F)cc2)CC1	phospholipase inhibitor	PLD1|PLD2
haloperidol	3559	BRD-K67783091	OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1	dopamine receptor antagonist	DRD1|DRD2|DRD3|DRD4|DRD5|GRIN2B|HRH1|HTR1A|HTR1D|HTR2A|HTR2B|HTR7|KCNH1
haloperidol-decanoate	52919	BRD-K80859331	CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1	psychoactive drug	DRD2|DRD3|DRD4|HTR2A
haloprogin	3561	BRD-K13238168	Clc1cc(Cl)c(OCC#CI)cc1Cl	other antifungal	
halothane	3562	BRD-A20550616	FC(F)(F)C(Cl)Br	glutamate receptor antagonist	ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GNG2|GRIN2A|GRIN3A|GRIN3B|KCNJ3|KCNJ6|KCNK10|KCNK12|KCNK13|KCNK15|KCNK18|KCNK2|KCNK3|KCNK9|KCNMA1|KCNN4|MT-ND1|NPSR1|RHO
harmane	5281404	BRD-K12630395	Cc1nccc2c3ccccc3[nH]c12	monoamine oxidase inhibitor	MAOA|MAOB
harringtonine	72331	BRD-K96358241	COC(=O)C[C@@](O)(CCC(C)(C)O)C(=O)O[C@H]1[C@@H]2c3cc4OCOc4cc3CCN3CCC[C@]23C=C1OC	protein synthesis inhibitor	
HA14-1	6976314	BRD-K18163608	CCOC(=O)[C@@H](C#N)[C@@H]1c2cc(Br)ccc2OC(N)=C1C(=O)OCC	BCL inhibitor	BCL2
HC-030031	1150897	BRD-K73815512	CC(C)c1ccc(NC(=O)Cn2cnc3n(C)c(=O)n(C)c(=O)c23)cc1	TRPA1 channel blocker	TRPA1
HC-067047	2742550	BRD-K03391209	Cc1c(cc(-c2ccccc2)n1CCCN1CCOCC1)C(=O)Nc1cccc(c1)C(F)(F)F	transient receptor potential channel antagonist	TRPV4
heclin	7464118	BRD-K49788188	CCc1ccc(\C=C\C(=O)Nc2ccc(cc2)C(C)=O)o1	ubiquitin ligase inhibitor	NEDD4|SMURF2|WWP1
HEMADO	10981286	BRD-K34672903	CCCCC#Cc1nc(NC)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1		ADORA1|ADORA2A|ADORA2B|ADORA3
hematoporphyrin		BRD-A44995766	CC(O)c1c(C)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5CCC(O)=O)c(CCC(O)=O)c4C)c(C)c3C(C)O		
hematoxylin	442514	BRD-K78342372	Oc1cc2C[C@@]3(O)COc4c(ccc(O)c4O)[C@H]3c2cc1O		
hemin		BRD-M75036822	[Fe+3].Cc1c(CCC(O)=O)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C=C)c5C)c(C=C)c4C)c(C)c3CCC(O)=O	enzyme inducer	
hemoglobin-modulators-1	71602803	BRD-K43639297	CC(C)n1nccc1-c1ncccc1COc1cccc(O)c1C=O	hemoglobin modulator	
hemomex-s	11468733	BRD-K15231341	CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O)C[C@@]21C		PPARG
heptaminol	3590	BRD-A32988684	CC(N)CCCC(C)(C)O	vasoconstrictor	
HER2-Inhibitor-1	42598643	BRD-K89709433	Cc1cc(Nc2ncnc3ccc(cc23)-c2ccc(CNCCS(C)(=O)=O)o2)ccc1Oc1ccn2ncnc2c1	EGFR inhibitor	
hesperadin	10142586	BRD-K58122457	CCS(=O)(=O)Nc1ccc2NC(=O)\C(c2c1)=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1	Aurora kinase inhibitor	AURKB
hesperetin	72281	BRD-K30553453	COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O)cc(O)cc2O1	ACAT inhibitor	DGAT1|MTTP|SOAT1|SOAT2
hesperidin	10621	BRD-K38903228	COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1	flavanone glycoside	CACNA1B
hetacillin	68633	BRD-A27828834	CC1(C)S[C@@H]2C(N3C(=O)[C@H](NC3(C)C)c3ccccc3)C(=O)N2[C@H]1C(O)=O	bacterial cell wall synthesis inhibitor	
hexachlorophene	3598	BRD-K99792991	Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl	potassium channel activator	GLUD1|SDHD
hexamethonium	3604	BRD-K10598093	C[N+](C)(C)CCCCCC[N+](C)(C)C	cholinergic receptor antagonist	CHRNA2|CHRNA3|CHRNA4|CHRNA6
hexamethylenebisacetamide	3616	BRD-K04710043	CC(=O)NCCCCCCNC(C)=O	AKT inhibitor; differentiation inducer; NFKB pathway inhibitor	AKT1
hexaminolevulinate	6433083	BRD-K73753850	CCCCCCOC(=O)CCC(=O)CN		
hexasodium-phytate		BRD-K70007857	OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O		
hexestrol	3606	BRD-A01078468	CCC(C(CC)c1ccc(O)cc1)c1ccc(O)cc1	synthetic estrogen	AKR1C1|ESR1|ESR2
hexetidine	3607	BRD-A18605525	CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1	local anesthetic	
hexonic-acid	604	BRD-A63267145	OCC(O)C(O)C(O)C(O)C(O)=O		
hexoprenaline	3609	BRD-A33894669	OC(CNCCCCCCNCC(O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1	adrenergic receptor agonist	ADRB2
hexylcaine	10770	BRD-A97730597	CC(CNC1CCCCC1)OC(=O)c1ccccc1	sodium channel blocker	SCN10A|SCN5A
hexylene-glycol	7870	BRD-A14234430	CC(O)CC(C)(C)O		AKR1C3|CTPS1|DLG4|HSP90AA1|NOS3|PGF|PLA2G1B|PTPN1|SELP
hexylresorcinol	3610	BRD-K99946902	CCCCCCc1ccc(O)cc1O	local anesthetic	TYR
higenamine	114840	BRD-A55204514	Oc1ccc(CC2NCCc3cc(O)c(O)cc23)cc1	adrenergic receptor agonist	ADRB2
hippuric-acid	464	BRD-K62914667	OC(=O)CNC(=O)c1ccccc1		
histamine	774	BRD-K01674964	NCCc1c[nH]cn1	histamine receptor agonist	HRH1|HRH2|HRH3|HRH4
HJC-0350	22200891	BRD-K34411045	Cc1cc(C)n(c1)S(=O)(=O)c1c(C)cc(C)cc1C	GTPase inhibitor	RAPGEF4
HKI-357	11238512	BRD-K58811567	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C	EGFR inhibitor	EGFR
HLCL-61	2250650	BRD-K73746696	CCn1c2ccccc2c2cc(CNCc3ccccc3OC)ccc12	protein arginine N-methyltransferase inhibitor	PRMT5
HMN-214	9888590	BRD-K70511574	COc1ccc(cc1)S(=O)(=O)N(C(C)=O)c1ccccc1\C=C\c1cc[n+]([O-])cc1	PLK inhibitor	PLK1
homatropine		BRD-A74975734	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(O)c1ccccc1	acetylcholine receptor antagonist	CES1|CHRM1
homatropine-methylbromide		BRD-A43999749	C[N+]1(C)C2CC[C@H]1C[C@H](C2)OC(=O)C(O)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
homidium	101633772	BRD-K28354016	CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc12		
homochlorcyclizine	3627	BRD-A22769835	CN1CCCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1	antihistamine	HRH1
homoharringtonine	285033	BRD-K76674262	COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]1[C@H]2c3cc4OCOc4cc3CCN3CCC[C@]23C=C1OC	protein synthesis inhibitor	RPL3
homoquinolinic-acid	3080554	BRD-K30519779	OC(=O)Cc1cccnc1C(O)=O	glutamate receptor agonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
homosalate	8362	BRD-A34751532	CC1CC(CC(C)(C)C1)OC(=O)c1ccccc1O	HSP inducer	
homoveratrylamine	8421	BRD-K59570838	COc1ccc(CCN)cc1OC	dopamine analog	
honokiol	72303	BRD-K98493452	Oc1ccc(cc1CC=C)-c1cc(CC=C)ccc1O	AKT inhibitor	ALOX5|PTGS1|PTGS2
hordenine	68313	BRD-K93631643	CN(C)CCc1ccc(O)cc1		
HQK-1001	11684	BRD-K44963273	CCC(C)(C)C(O)=O		
HTH-01-015	78357766	BRD-K58726989	CN1c2cc3ccccc3cc2C(=O)N(C)c2c(C)nc(Nc3cnn(c3)C3CCNCC3)nc12	protein kinase inhibitor	NUAK1
HTMT	124846	BRD-A66435872	CC(CCCCC(=O)Nc1ccc(cc1)C(F)(F)F)NCCc1c[nH]cn1	histamine receptor agonist	HRH4
huperzine-a	854026	BRD-K62240499	C\C=C1/[C@@H]2Cc3[nH]c(=O)ccc3[C@@]1(N)CC(C)=C2	acetylcholinesterase inhibitor	ACHE
hyaluronic-acid	6852395	BRD-K59788572	CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1C(O)=O		C1QBP|CD44|HABP2|HAPLN1|HAPLN3|HAPLN4|HMMR|ICAM1|NCAN|VCAN
hycanthone	3634	BRD-K50406511	CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12	RNA synthesis inhibitor	
hydralazine	3637	BRD-K82103381	NNc1nncc2ccccc12	vasodilator	AOC3|P4HA1
hydrastine-(1r,-9s)	197835	BRD-K02715688	COc1ccc2[C@H](OC(=O)c2c1OC)[C@@H]1N(C)CCc2cc3OCOc3cc12	tyrosine hydroxylase inhibitor	
hydrastinine	3638	BRD-A57900429	CN1CCc2cc3OCOc3cc2C1O	haemostatic agent	
hydrochlorothiazide	3639	BRD-K13078532	NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl	thiazide diuretic	CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A3
hydrocortisone	5754	BRD-K93568044	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO	glucocorticoid receptor agonist	
hydrocortisone-acetate	5702068	BRD-A65767837	CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@]12C	glucocorticoid receptor agonist	NR3C1|NR3C2
hydrocortisone-butyrate	26133	BRD-K99199077	CCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)CO	glucocorticoid receptor agonist	NR3C1
hydrocortisone-hemisuccinate	5702069	BRD-A07000685	C[C@]12C[C@H](O)C3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@]2(O)C(=O)COC(=O)CCC(O)=O		
hydrocortisone-phosphate	6602442	BRD-A46186775	CC12C[C@H](O)C3C(CCC4=CC(=O)CCC34C)C1CC[C@]2(O)C(=O)COP(O)(O)=O		ANXA1|NOS2|NR3C1
hydrocortisone-valerate	45006145	BRD-A25143711	CCCCC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@]12C)C(=O)CO	glucocorticoid receptor agonist	
hydroflumethiazide	3647	BRD-K36862742	NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1C(F)(F)F	sodium/potassium/chloride transporter inhibitor	ATP1A1|CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A1|SLC12A3
hydroquinidine	442912	BRD-A06390036	CC[C@H]1CN2CCC1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12	antiarrhythmic	
hydroquinone	785	BRD-K11227669	Oc1ccc(O)cc1	melanin inhibitor	TYR
hydroxyamphetamine	3651	BRD-A80871782	CC(N)Cc1ccc(O)cc1	trace amine associated receptor agonist	TAAR1
hydroxychloroquine	3652	BRD-A99117172	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12	antimalarial agent	TLR7|TLR9
hydroxyfasudil	3064778	BRD-K77793136	Oc1nccc2c(cccc12)S(=O)(=O)N1CCCNCC1	rho associated kinase inhibitor	PKIA|PRKACA|ROCK1
hydroxyprogesterone	6710628	BRD-A39791822	CC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C	progesterone receptor agonist	PGR
hydroxyprogesterone-acetate	10156152	BRD-K92902018	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O	progesterone receptor agonist	PGR
hydroxypropyl-beta-cyclodextrin	14049689	BRD-A01412266	CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](COCC(C)O)O[C@H](O[C@@H]4[C@@H](COCC(C)O)O[C@H](O[C@@H]5[C@@H](COCC(C)O)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](COCC(C)O)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		
hydroxystilbamidine		BRD-K62186992	NC(=N)c1ccc(cc1)\C=C\c1ccc(cc1O)C(N)=N		
hydroxytacrine-maleate-(r,s)	3655	BRD-A98299281	Nc1c2C(O)CCCc2nc2ccccc12	cholinesterase inhibitor	ACHE
hydroxytoluic-acid	6738	BRD-K75608666	Cc1cccc(C(O)=O)c1O		
hydroxyurea	3657	BRD-K51747290	NC(=O)NO	ribonucleotide reductase inhibitor	RRM1|RRM2|RRM2B
hydroxyzine	3658	BRD-A62428732	OCCOCCN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1	antihistamine	HRH1
hygromycin-b	6728943	BRD-A67101513	CN[C@H]1C[C@@H](N)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@@H]3OC4(O[C@@H]3[C@@H]2O)O[C@H](C(N)CO)[C@H](O)[C@H](O)[C@H]4O)[C@@H]1O	polypeptide synthesis inhibitor	
hymecromone	5280567	BRD-K46424862	Cc1cc(=O)oc2cc(O)ccc12	monoamine oxidase inhibitor	MAOA|MAOB
hyodeoxycholic-acid	5283820	BRD-K44009692	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	atherosclerosis formation inhibitor	
hyoscyamine		BRD-K40530731	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4
hypericin	5281051	BRD-K29673530	Cc1cc(O)c2c3c1c1c(C)cc(O)c4c1c1c3c3c(c(O)cc(O)c3c2=O)c2c(O)cc(O)c(c12)c4=O	tyrosine kinase inhibitor	
hyperin	5378597	BRD-A63780829	OCC1OC(Oc2c(oc3cc(O)cc(O)c3c2=O)-c2ccc(O)c(O)c2)C(O)C(O)C1O	aldose reductase inhibitor	ACE|AKR1B1
hypoestoxide	10407195	BRD-A51571244	CC(=O)O[C@H]1CC2(C)OC2CCC2(C)OC2CC2CC(=O)C(=C)C1C2(C)C	IKK inhibitor	IKBKB|IL1B|TNF
hypoxanthine	790	BRD-K03739921	O=c1[nH]cnc2nc[nH]c12	PARP inhibitor	PNP
H2L-5765834	1365686	BRD-K26439554	OC(=O)c1ccc2C(=O)N(C(=O)c2c1)c1cccc(Oc2ccc(cc2)[N+]([O-])=O)c1	lysophosphatidic acid receptor antagonist	LPAR1|LPAR3
I-BET-762	46943432	BRD-K08109215	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc12	bromodomain inhibitor	BRD2|BRD3|BRD4
I-BET151	52912189	BRD-K36363294	COc1cc2c3n([C@H](C)c4ccccn4)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C	bromodomain inhibitor	BRD2|BRD3|BRD4
I-BRD9	91668541	BRD-K04972057	CCn1cc(-c2cccc(c2)C(F)(F)F)c2sc(cc2c1=O)C(=N)NC1CCS(=O)(=O)CC1	bromodomain inhibitor	BRD9
I-BZA	129424	BRD-K14762862	CCN(CC)CCNC(=O)c1ccc(I)cc1		
I-BZA2	1816834	BRD-K71698503	CCN(CC)CCNC(=O)c1ccccc1I		
I-CBP-112	90488984	BRD-K57090026	CCC(=O)N1CCOc2c(C1)cc(cc2OC[C@H]1CCCN(C)C1)-c1ccc(OC)c(OC)c1	bromodomain inhibitor	CREBBP|EP300
IB-MECA	123683	BRD-K31135544	CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NCc3cccc(I)c3)ncnc12	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3
ibandronate	60852	BRD-K08681769	CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O	bone resorption inhibitor	FDPS
IBC-293	2736690	BRD-K15196155	CC(C)n1nnc2cc(ccc12)C(O)=O	hydroxycarboxylic acid receptor agonist	HCAR3
IBMX	3758	BRD-K94979336	CC(C)Cn1c2[nH]cnc2c(=O)n(C)c1=O	phosphodiesterase inhibitor	ADORA1|PDE2A|PDE3B|PDE4D|PDE5A|PDE6G|PDE7A|PDE8A|PDE9A
ibotenic-acid	1233	BRD-A04628621	NC(C(O)=O)c1cc(O)no1	glutamate receptor agonist	GRIN1
ibrolipim	131601	BRD-K62490786	CCOP(=O)(Cc1ccc(cc1)C(=O)Nc1ccc(Br)cc1C#N)OCC	lipoprotein lipase activator	LPL
ibrutinib	24821094	BRD-K70301465	Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)[C@@H]1CCCN(C1)C(=O)C=C	Bruton's tyrosine kinase (BTK) inhibitor	BLK|BMX|BTK
ibudilast	3671	BRD-K16444452	CC(C)C(=O)c1c(nn2ccccc12)C(C)C	leukotriene receptor antagonist; phosphodiesterase inhibitor	IL1B|IL6|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A
ibuprofen	3672	BRD-A17655518	CC(C)Cc1ccc(cc1)C(C)C(O)=O	cyclooxygenase inhibitor	PTGS1|PTGS2
ibuprofen-(s)	39912	BRD-K14965640	CC(C)Cc1ccc(cc1)[C@H](C)C(O)=O	cyclooxygenase inhibitor	ASIC1|BCL2|CFTR|FABP2|PLAT|PPARG|PTGS1|PTGS2|SLC5A8|THBD
ibuprofen-lysine	42368	BRD-M64062803	NCCCC[C@H](N)C(O)=O.CC(C)Cc1ccc(cc1)C(C)C(O)=O	cyclooxygenase inhibitor	PTGS1|PTGS2
ibuprofen-piconol	3673	BRD-A75224450	CC(C)Cc1ccc(cc1)C(C)C(=O)OCc1ccccn1	cyclooxygenase inhibitor	PTGS1|PTGS2
ibuproxam	68704	BRD-A40940854	CC(C)Cc1ccc(cc1)C(C)C(=O)NO	cyclooxygenase inhibitor; prostaglandin inhibitor	ALOX5
ibutamoren	178024	BRD-K44771174	CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CN(c3ccccc23)S(C)(=O)=O)CC1	growth hormone secretagogue receptor agonist	GHR|GHSR
ibutilide	60753	BRD-A74391928	CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1	potassium channel blocker	CACNA1C|CACNA2D1|CACNB1|CACNG1|KCNH2|KCNH6|KCNH7|KCNJ11|KCNK1|KCNK6
ICA-069673	10149311	BRD-K59839632	Fc1ccc(cc1F)C(=O)Nc1cnc(Cl)nc1	voltage-gated potassium channel activator	KCNQ2|KCNQ3
ICA-110381	4314115	BRD-K71686520	Clc1ccc(cc1)C(=O)Nc1ccc(Cl)nc1	voltage-gated potassium channel activator	KCNQ2
ICA-121431	998021	BRD-K03149601	O=C(Nc1ccc(cc1)S(=O)(=O)Nc1nccs1)C(c1ccccc1)c1ccccc1	sodium channel blocker	SCN1A|SCN3A
icariin	5318997	BRD-K65639003	COc1ccc(cc1)-c1oc2c(CC=C(C)C)c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c2c(=O)c1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O	phosphodiesterase inhibitor	PDE5A
icaritin	5318980	BRD-K24476327	COc1ccc(cc1)-c1oc2c(CC=C(C)C)c(O)cc(O)c2c(=O)c1O	PPAR receptor antagonist	PDE5A
icatibant-acetate	6918173	BRD-K63772874	N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O	bradykinin receptor antagonist	ANPEP|BDKRB2
ICG-001	124518205	BRD-K94455792	Oc1ccc(C[C@H]2N3[C@H](CN(Cc4cccc5ccccc45)C2=O)N(CCC3=O)C(=O)NCc2ccccc2)cc1	beta-catenin inhibitor	CTNNB1
ICI-118,551	5311179	BRD-K74603273	CC(C)N[C@@H](C)[C@H](O)COc1ccc(C)c2CCCc12	adrenergic receptor antagonist	ADRB2|ADRB3
ICI-162846	134778	BRD-K11071038	NC(=O)CCCCn1ccc(n1)\N=C(/N)NCC(F)(F)F	histamine receptor antagonist	HRH2
ICI-185,282	5311390	BRD-K29133151	OC(=O)CCC\C=C/C[C@@H]1CO[C@@H](O[C@@H]1c1ccccc1O)C(F)(F)F	thromboxane receptor antagonist	
ICI-192605	6604763	BRD-K59433843	OC(=O)CC\C=C/C[C@@H]1CO[C@@H](O[C@@H]1c1ccccc1O)c1ccccc1Cl	thromboxane receptor antagonist	TBXA2R
ICI-199441	3082718	BRD-K73290745	CN([C@H](CN1CCCC1)c1ccccc1)C(=O)Cc1ccc(Cl)c(Cl)c1	opioid receptor agonist	CYP2D6|OPRD1|OPRK1|OPRM1|UTS2R
ICI-215,001	164451	BRD-K52487250	O[C@@H](CNCCOc1ccc(OCC(O)=O)cc1)COc1ccccc1	adrenergic receptor agonist	ADRB3
ICI-63197	62824	BRD-K52219182	CCCn1c2nc(N)nn2cc(C)c1=O	phosphodiesterase inhibitor	
ICI-89406	123686	BRD-A03359064	OC(CNCCNC(=O)Nc1ccccc1)COc1ccccc1C#N	adrenergic receptor antagonist	ADRB1|ADRB2
icilin	161930	BRD-K48869804	Oc1ccccc1N1CC=C(NC1=O)c1cccc(c1)[N+]([O-])=O	TRPV agonist	TRPA1|TRPM8
icomucret	5280724	BRD-K41234004	CCCCC[C@H](O)\C=C\C=C/C\C=C/C\C=C/CCCC(O)=O	mucin production enhancer	LTB4R2
icosapent	446284	BRD-K47192521	CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O	platelet aggregation inhibitor	ACSL3|ACSL4|FADS1|FFAR1|PPARD|PPARG|PTGS1|PTGS2|SLC8A1|TRPV1
icotinib	22024915	BRD-K31698212	C#Cc1cccc(Nc2ncnc3cc4OCCOCCOCCOc4cc23)c1	EGFR inhibitor	EGFR
iCRT-14	5967294	BRD-K18634484	Cc1cc(\C=C2/SC(=O)N(C2=O)c2ccccc2)c(C)n1-c1cccnc1	WNT signaling inhibitor; beta catenin inhibitor	CTNNB1|TCF4
IC261	5288600	BRD-K09638361	COc1cc(OC)c(\C=C2\C(=O)Nc3ccccc23)c(OC)c1	casein kinase inhibitor	CSNK1A1|CSNK1D|CSNK1E|CSNK1G2
ID-1101	40561613	BRD-K90305467	C[C@H](O)[C@H](C)[C@H](N)C(O)=O	insulin sensitizer	INS
ID-8	791637	BRD-K39166528	COc1ccc(cc1)-n1c(C)c([N+]([O-])=O)c2ccc(O)cc12		
idalopirdine	21071390	BRD-K79102359	FC(F)C(F)(F)COc1cccc(CNCCc2c[nH]c3cc(F)ccc23)c1	serotonin receptor antagonist	HTR6
idarubicin	42890	BRD-K69650333	C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(Cc2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c12)C(C)=O	topoisomerase inhibitor	TOP2A
idasanutlin	53358942	BRD-K62627508	COc1cc(ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@](C#N)([C@H]1c1cccc(Cl)c1F)c1ccc(Cl)cc1F)C(O)=O	MDM inhibitor	MDM2|TP53
idazoxan	54459	BRD-A18696154	C1CN=C(N1)C1COc2ccccc2O1	adrenergic receptor antagonist	ADRA2A
idazoxane		BRD-K70759443	C1CNC(N1)=C1COc2ccccc2O1	adrenergic receptor antagonist	ADRA2A|ADRA2B|ADRA2C
idebenone	3686	BRD-K37516142	COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O	calcium channel modulator	
idelalisib	11625818	BRD-K60866521	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
idoxuridine	5905	BRD-K76634210	OC[C@H]1O[C@H](C[C@@H]1O)n1cc(I)c(=O)[nH]c1=O	DNA directed DNA polymerase inhibitor	
IDO5L		BRD-K22356203	Nc1nonc1\C(NO)=N/c1ccc(F)c(Cl)c1	indoleamine 2,3-dioxygenase inhibitor	IDO1
IDRA-21	3688	BRD-A14344385	CC1Nc2ccc(Cl)cc2S(=O)(=O)N1	glutamate receptor positive allosteric modulator	GRIA1|GRIA2|GRIA3|GRIA4
idramantone	64184	BRD-A57877027	OC12CC3CC(C1)C(=O)C(C3)C2		
idronoxil	219100	BRD-K74671368	Oc1ccc(cc1)C1=Cc2ccc(O)cc2OC1	XIAP inhibitor	ENOX2|SPHK1
IEM1460	3248290	BRD-K13829090	C[N+](C)(C)CCCCCNCC12CC3CC(CC(C3)C1)C2	glutamate receptor antagonist	GRIA2
IEM1754	9887868	BRD-K80060353	NCCCCCNCC12CC3CC(CC(C3)C1)C2	glutamate receptor antagonist	GRIA1
ifenprodil	3689	BRD-A24191444	CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1	adrenergic receptor antagonist; glutamate receptor antagonist	GRIN1|GRIN2B
ifosfamide	3690	BRD-A67097164	ClCCNP1(=O)OCCCN1CCCl	DNA alkylating agent	CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1
igmesine	6438340	BRD-A48376327	CCC(C\C=C\c1ccccc1)(N(C)CC1CC1)c1ccccc1	sigma receptor agonist	SIGMAR1
iguratimod	124246	BRD-K15426076	CS(=O)(=O)Nc1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1	cyclooxygenase inhibitor; NFkB pathway inhibitor	PTGS2
IKK-16	9549298	BRD-K14618467	O=C(N1CCC(CC1)N1CCCC1)c1ccc(Nc2nccc(n2)-c2cc3ccccc3s2)cc1	IKK inhibitor	IKBKB
IKK-2-inhibitor	2807869	BRD-K26373640	NC(=O)c1sc(cc1N)-c1ccsc1	IKK inhibitor; SYK inhibitor	IKBKB
IKK-2-inhibitor-V	5081913	BRD-K74305673	Oc1ccc(Cl)cc1C(=O)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F	IKK inhibitor; NFkB pathway inhibitor	IKBKB
ilepcimide	54930	BRD-K43873574	O=C(C=Cc1ccc2OCOc2c1)N1CCCCC1	anticonvulsant	
ilomastat	132519	BRD-K51662849	CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)CC(=O)NO	matrix metalloprotease inhibitor	ACAN|ADAM28|MMP1|MMP12|MMP13|MMP14|MMP2|MMP3|MMP8|MMP9
iloperidone	71360	BRD-K48722833	COc1cc(ccc1OCCCN1CCC(CC1)c1noc2cc(F)ccc12)C(C)=O	dopamine receptor antagonist; serotonin receptor antagonist	ADRA1A|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR2A|HTR6|HTR7
iloprost	5311181	BRD-A45664787	CC#CCC(C)[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2C\C(C[C@H]12)=C/CCCC(O)=O	platelet aggregation inhibitor; prostanoid receptor agonist	PDE4A|PDE4B|PDE4C|PDE4D|PLAT|PTGDR|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|PTGIR|TBXA2R
imatinib	5291	BRD-K92723993	CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1	Bcr-Abl kinase inhibitor; KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor	ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET
imeglimin	24812808	BRD-K55822903	C[C@@H]1N=C(N)NC(=N1)N(C)C	gluconeogenesis inhibitor	
imetit	3692	BRD-K33183200	NC(=N)SCCc1c[nH]cn1	histamine receptor agonist	HRH3|HRH4
imexon	68791	BRD-A78195072	N=C1NC(=O)N2CC12	apoptosis stimulant; ribonucleotide reductase inhibitor	RRM1|RRM2
imidacloprid	86418	BRD-K76609936	[O-][N+](=O)NC1=NCCN1Cc1ccc(Cl)nc1	acetylcholine receptor antagonist	CHRFAM7A
imidafenacin	6433090	BRD-K29626940	Cc1nccn1CCC(C(N)=O)(c1ccccc1)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM3
imidapril	58153740	BRD-K34332569	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](CN(C)C1=O)C(O)=O	angiotensin converting enzyme inhibitor	ACE
imidurea	38258	BRD-A65444648	OCN1C(NC(=O)NCNC(=O)NC2N(CO)C(=O)NC2=O)C(=O)NC1=O	other antibiotic	
imiloxan	133621	BRD-A10903566	CCn1ccnc1CC1COc2ccccc2O1	adrenergic receptor antagonist	ADRA2A|ADRA2B
imipenem	104838	BRD-K23200955	C[C@@H](O)[C@@H]1[C@H]2CC(SCCNC=N)=C(N2C1=O)C(O)=O	bacterial cell wall synthesis inhibitor	
imipramine	3696	BRD-K38436528	CN(C)CCCN1c2ccccc2CCc2ccccc12	norepinephrine reputake inhibitor; serotonin reuptake inhibitor	ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCND2|KCND3|KCNH1|KCNH2|SLC6A2|SLC6A3|SLC6A4
imiquimod	57469	BRD-K26657438	CC(C)Cn1cnc2c(N)nc3ccccc3c12	interferon inducer; toll-like receptor agonist	TLR7|TLR8
immepip	3035842	BRD-K25906698	C(C1CCNCC1)c1c[nH]cn1	histamine receptor agonist	HRH3|HRH4
immethridine	9989505	BRD-K49519092	C(c1cnc[nH]1)c1ccncc1	histamine receptor agonist	HRH3
impentamine	9793868	BRD-K20049318	NCCCCCc1cnc[nH]1	histamine receptor antagonist	HRH3
IMREG-1	123715	BRD-K00926464	N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(O)=O		
INC-280	25145656	BRD-K81016934	CNC(=O)c1ccc(cc1F)-c1cnc2ncc(Cc3ccc4ncccc4c3)n2n1	c-Met inhibitor	MET
INCA-6	230748	BRD-K33308633	O=C1C=CC(=O)C2=C1C1c3ccccc3C2c2ccccc12	calcineurin inhibitor	NFATC1
INCB-003284	11527661	BRD-K28059174	COc1ccc(cn1)C1(O)CCC(CC1)N1CC[C@H](C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F	CC chemokine receptor antagonist	
INCB-024360		BRD-K79450420	NS(=O)(=O)NCCNc1nonc1\C(Nc1ccc(F)c(Br)c1)=N\O	indoleamine 2,3-dioxygenase inhibitor	IDO1
INCB-3284		BRD-K67628093	COc1ccc(cn1)[C@]1(O)CC[C@@H](CC1)N1CC[C@H](C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F	CC chemokine receptor antagonist	CCR2
indacaterol	6918554	BRD-K89208535	CCc1cc2CC(Cc2cc1CC)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12	adrenergic receptor agonist	ADRB1|ADRB2
indalpine	44668	BRD-K64973364	C(Cc1c[nH]c2ccccc12)C1CCNCC1	selective serotonin reuptake inhibitor (SSRI)	SLC6A4
indapamide	3702	BRD-A95869247	CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(c1)S(N)(=O)=O	thiazide diuretic	KCNE1|KCNQ1|SLC12A3
indatraline	126280	BRD-K01649396	CN[C@@H]1C[C@H](c2ccccc12)c1ccc(Cl)c(Cl)c1	norepinephrine transporter inhibitor	MAOA|MAOB
indeloxazine	3704	BRD-A59747053	C(Oc1cccc2C=CCc12)C1CNCCO1	norepinephrine reuptake inhibitor; serotonin reuptake inhibitor	
indibulin	2929	BRD-K74057757	Clc1ccc(Cn2cc(C(=O)C(=O)Nc3ccncc3)c3ccccc23)cc1	tubulin polymerization inhibitor	
indinavir	5362440	BRD-K33226500	CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12	HIV protease inhibitor	CYP3A4|CYP3A5|CYP3A7
indiplon	6450813	BRD-K90948141	CN(C(C)=O)c1cccc(c1)-c1ccnc2c(cnn12)C(=O)c1cccs1	benzodiazepine receptor agonist	GABRA1
indirubin	5318433	BRD-K17894950	O=C1Nc2ccccc2\C1=C1\Nc2ccccc2C1=O	CDK inhibitor; glycogen synthase kinase inhibitor	CDK1|CDK5|GSK3A
indirubin-3-monoxime		BRD-K19136521	O\N=C1c2ccccc2NC/1=C1\C(=O)Nc2ccccc12	CDK inhibitor; glycogen synthase kinase inhibitor	CDK1|CDK2|CDK5|CDK5R1|GSK3B
indisulam	216468	BRD-K17610631	NS(=O)(=O)c1ccc(cc1)S(=O)(=O)Nc1cccc2c(Cl)c[nH]c12	CDK inhibitor	CA1|CA12|CA14|CA2|CA6|CA7|CA9
indium(iii)-isopropoxide		BRD-M08274809	[In].CC(C)O.CC(C)O.CC(C)O		
indium-tri(2-propanolate)	16683751	BRD-K42332878	CC(C)O[In](OC(C)C)OC(C)C		
indobufen	107641	BRD-A16296925	CCC(C(O)=O)c1ccc(cc1)N1Cc2ccccc2C1=O	cyclooxygenase inhibitor; platelet aggregation inhibitor	PTGS1|PTGS2
indocyanine-green	19191	BRD-K80762071	CC1(C)\C(=C/C=C/C=C/C=C/C2=[N+](CCCCS(O)(=O)=O)c3ccc4ccccc4c3C2(C)C)N(CCCCS(O)(=O)=O)c2ccc3ccccc3c12	contrast agent	SLCO1B1
indole-3-carbinol	3712	BRD-K01815685	OCc1c[nH]c2ccccc12	aryl hydrocarbon receptor agonist; indoleamine 2,3-dioxygenase inhibitor	AHR
indole-3-pyrubate	803	BRD-K09109825	OC(=O)C(=O)Cc1c[nH]c2ccccc12	melatonin receptor agonist	
indomethacin	3715	BRD-K57222227	COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(O)=O)c2c1	cyclooxygenase inhibitor	GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1
indoprofen	3718	BRD-A44090213	CC(C(O)=O)c1ccc(cc1)N1Cc2ccccc2C1=O	cyclooxygenase inhibitor; prostanoid receptor antagonist	CXCR1|CXCR2|PTGS1|PTGS2
indoramin	33625	BRD-K76953762	O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2B|ADRA2C
indoximod	405012	BRD-K93255255	Cn1cc(C[C@@H](N)C(O)=O)c2ccccc12	indoleamine 2,3-dioxygenase inhibitor	IDO1
ingenol-mebutate	6918670	BRD-K93779381	C\C=C(\C)C(=O)O[C@H]1C(C)=C[C@@]23[C@H](C)C[C@@H]4[C@H]([C@H](C=C(CO)[C@@H](O)[C@]12O)C3=O)C4(C)C	PKC activator	PRKCA|PRKCB|PRKCD|PRKCE|PRKCG
INH1	959043	BRD-K70177501	Cc1ccc(c(C)c1)-c1csc(NC(=O)c2ccccc2)n1	Hec1 inhibitor	NDC80
inimur	6433427	BRD-A71407503	CSCC1CN(\N=C\c2ccc(o2)[N+]([O-])=O)C(=O)O1	other antifungal	
iniparib	9796068	BRD-K11153516	NC(=O)c1ccc(I)c(c1)[N+]([O-])=O	PARP inhibitor	PARP1
inosine	6021	BRD-K79612754	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(O)ncnc12	neurotrophic agent	PARP1|PNP
inositol		BRD-K52618540	O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O	insulin sensitizer	CDIPT|GBA
inositol-hexanicotinate		BRD-K82800842	O=C(O[C@H]1[C@H](OC(=O)c2cccnc2)[C@@H](OC(=O)c2cccnc2)[C@H](OC(=O)c2cccnc2)[C@H](OC(=O)c2cccnc2)[C@@H]1OC(=O)c1cccnc1)c1cccnc1		
INS316	59970976	BRD-A29125379	OC1[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H](C1O)n1ccc(=O)[nH]c1=O	purinergic receptor antagonist	
INT-747	447715	BRD-K30968378	CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCC(O)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CC[C@@H](O)C[C@@H]12	FXR agonist	
INT-767	23642339	BRD-K33067152	CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCOS(O)(=O)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CC[C@@H](O)C[C@@H]12	FXR agonist	GPBAR1
integrin-antagonist-1	86272865	BRD-K88165431	Cc1cc(C)n(n1)-c1cccc(c1)[C@@H](CN1CC[C@@H](CCC2=CC=C3CCCN=C3N2)C1)CC(O)=O	integrin antagonist	ITGAV|ITGB6
iobenguane	60860	BRD-K43860855	NC(=N)NCc1cccc(I)c1	antineoplastic agent	
iocetamic-acid	27648	BRD-A37492983	CC(CN(C(C)=O)c1c(I)cc(I)c(N)c1I)C(O)=O	radiopaque medium	
iodipamide	3739	BRD-K67261995	OC(=O)c1c(I)cc(I)c(NC(=O)CCCCC(=O)Nc2c(I)cc(I)c(C(O)=O)c2I)c1I	radiopaque medium	ALB
iodixanol	3724	BRD-A08660406	CC(=O)N(CC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I	radiopaque medium	
iodoantipyrine	8522	BRD-K69216798	Cc1c(I)c(=O)n(-c2ccccc2)n1C		
iododexetimide	14479846	BRD-A46813902	Ic1ccc(CN2CCC(CC2)C2(CCC(=O)NC2=O)c2ccccc2)cc1	acetylcholine receptor antagonist	
iodophenpropit	3035746	BRD-K51918615	Ic1ccc(CCNC(=N)SCCCc2c[nH]cn2)cc1	histamine receptor antagonist	HRH3|HRH4
iodoquinol	3728	BRD-K75855670	Oc1c(I)cc(I)c2cccnc12	antiseptic	
iohexol	3730	BRD-A60217728	CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I	radiopaque medium	
iopamidol	65492	BRD-K75868704	C[C@H](O)C(=O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I	radiopaque medium	
iopanic-acid	3735	BRD-A42628519	CCC(Cc1c(I)cc(I)c(N)c1I)C(O)=O	thyroid hormone inhibitor	
iopodic-acid		BRD-K51956333	CN(C)\C=N\c1c(I)cc(I)c(CCC(O)=O)c1I		
iopromide	3736	BRD-A72075775	COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I	radiopaque medium	
iothalamic-acid-d3	3737	BRD-K98250023	CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(O)=O)c1I	radiopaque medium	
ioversol	3741	BRD-A65818372	OCCN(C(=O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I	radiopaque medium	
IOWH032		BRD-K84892605	Oc1c(Br)cc(cc1Br)-c1noc(n1)C(=O)NCc1ccc(Oc2ccccc2)cc1	CFTR channel antagonist	CFTR
ioxaglic-acid	3742	BRD-K79124250	CNC(=O)c1c(I)c(N(C)C(C)=O)c(I)c(C(=O)NCC(=O)Nc2c(I)c(C(O)=O)c(I)c(C(=O)NCCO)c2I)c1I	radiopaque medium	
ioxilan	3743	BRD-A09370961	CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCCO)c(I)c(C(=O)NCC(O)CO)c1I	radiopaque medium	
IOX1	459617	BRD-K70751730	OC(=O)c1ccc(O)c2ncccc12	histone demethylase inhibitor	EGLN1|KDM3A|KDM4C|KDM6B
IOX2	54685215	BRD-K98251413	OC(=O)CNC(=O)c1c(O)c2ccccc2n(Cc2ccccc2)c1=O	hypoxia inducible factor inhibitor	EGLN1|KDM2A|KDM5C
IPA-3	521106	BRD-K38727704	Oc1ccc2ccccc2c1SSc1c(O)ccc2ccccc12	p21 activated kinase inhibitor	PAK1
IPAG	4239764	BRD-K82421491	Ic1ccc(NC(=N)NC2C3CC4CC(C3)CC2C4)cc1		
IPI-145	50905713	BRD-K93468883	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
ipidacrine	604519	BRD-K66896231	Nc1c2CCCc2nc2CCCCc12	acetylcholinesterase inhibitor	ACHE
ipragliflozin-l-proline	10453870	BRD-K51247865	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(F)c(Cc2cc3ccccc3s2)c1	sodium/glucose cotransporter inhibitor	SLC5A2
ipratropium		BRD-A47449001	CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
ipriflavone	3747	BRD-K93618743	CC(C)Oc1ccc2c(c1)occ(-c1ccccc1)c2=O	bone resorption inhibitor	
iproniazid	3748	BRD-K88568253	CC(C)NNC(=O)c1ccncc1	monoamine oxidase inhibitor	MAOA|MAOB
ipsapirone	56971	BRD-K90574421	O=C1N(CCCCN2CCN(CC2)c2ncccn2)S(=O)(=O)c2ccccc12	serotonin receptor agonist	HTR1A
irbesartan	3749	BRD-K60038276	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1	angiotensin receptor antagonist	AGTR1|JUN|SLC10A1
irinotecan	60838	BRD-K08547377	CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(OC(=O)N3CCC(CC3)N3CCCCC3)cc12	topoisomerase inhibitor	TOP1|TOP1MT
IRL-2500	5311192	BRD-K98357249	CN([C@H](Cc1ccc(cc1)-c1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O)C(=O)c1cc(C)cc(C)c1	endothelin receptor antagonist	EDNRB
irosustat	5287541	BRD-K87777313	NS(=O)(=O)Oc1ccc2c3CCCCCc3c(=O)oc2c1	steroid sulfatase inhibitor	CA2|STS
irsogladine	3752	BRD-K74195153	Nc1nc(N)nc(n1)-c1cc(Cl)ccc1Cl	phosphodiesterase inhibitor	PDE4A
isamoltane	127404	BRD-A26845397	CC(C)NCC(O)COc1ccccc1-n1cccc1	adrenergic receptor antagonist	HTR1A|HTR1B
isavuconazole	129010057	BRD-A17009129	C[C@@H](c1nc(cs1)-c1ccc(cc1)C#N)C(O)(Cn1cncn1)c1cc(F)ccc1F	cytochrome P450 inhibitor	CYP3A4
isaxonine	71169	BRD-K95957366	CC(C)Nc1ncccn1	nerve growth factor agonist	
isbufylline	65681	BRD-K06762493	CC(C)Cn1cnc2n(C)c(=O)n(C)c(=O)c12	phosphodiesterase inhibitor	
isepamicin	3037209	BRD-K74759733	CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)NC(=O)[C@@H](O)CN)OC[C@]1(C)O	protein synthesis inhibitor	
ISO-1		BRD-A94055480	COC(=O)CC1CC(=NO1)c1ccc(O)cc1	macrophage migration inhibiting factor inhibitor	MIF
isobutamben	7176	BRD-K96714749	CC(C)COC(=O)c1ccc(N)cc1	local anesthetic	
isobutyramide	68424	BRD-K54057105	CC(C)C(N)=O	gene expression stimulant	HBE1|HBG1
isocarboxazid	3759	BRD-K93332168	Cc1cc(no1)C(=O)NNCc1ccccc1	monoamine oxidase inhibitor	MAOA|MAOB
isoconazole	3760	BRD-A93353767	Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1	fungal lanosterol demethylase inhibitor	CYP17A1
isodibut	145949	BRD-K60241851	OC(=O)CCCN1C(=O)c2cccc3cccc(C1=O)c23	aldehyde reductase inhibitor	
isoetharine	3762	BRD-A24587114	CCC(NC(C)C)C(O)c1ccc(O)c(O)c1	adrenergic receptor agonist	ADRB1|ADRB2
isofloxythepin	115193	BRD-A07704283	CC(C)c1ccc2Sc3cc(F)ccc3CC(N3CCN(CCO)CC3)c2c1	dopamine receptor antagonist	
isoflupredone-acetate	224246	BRD-K29173907	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C		NR3C1
isoflurane	3763	BRD-A31564021	FC(F)OC(Cl)C(F)(F)F	inhaled anaesthetic	ATP2C1|ATP5D|CALM1|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9
isoflurophate	5936	BRD-K56575995	CC(C)OP(F)(=O)OC(C)C	cholinesterase inhibitor	ACHE|BCHE
isoguvacine	3765	BRD-K66480997	OC(=O)C1=CCNCC1	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRR1|GABRR2|GABRR3
isoleucine	57397079	BRD-A02232681	CCC(C)C(N)C(O)=O		ACADSB|BCAT1|BCAT2|IARS|IARS2
isoliquiritigenin	638278	BRD-K33583600	Oc1ccc(cc1)\C=C\C(=O)c1ccc(O)cc1O	guanylate cyclase activator	GABBR1
isometheptene-mucate	22297	BRD-A64743628	CNC(C)CCC=C(C)C		ADRA1A|SLC18A2
isoniazid	3767	BRD-K87202646	NNC(=O)c1ccncc1	FABI inhibitor	CYP1A2|CYP2C19|CYP2C8|CYP2E1|CYP3A4
isopentyl-4-methoxycinnamate	1549789	BRD-K37851352	COc1ccc(cc1)\C=C\C(=O)OCCC(C)C		
isoprenaline	3779	BRD-A04322457	CC(C)NCC(O)c1ccc(O)c(O)c1	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3|MAPK1|PIK3R1|PIK3R2|PIK3R3
isopropamide-iodide	3775	BRD-K14127446	CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C	acetylcholine receptor antagonist	CHRM3|CHRM4
isopropyl-myristate	8042	BRD-K13409143	CCCCCCCCCCCCCC(=O)OC(C)C		
isopropyl-palmitate	8907	BRD-K30758549	CCCCCCCCCCCCCCCC(=O)OC(C)C	cosmetic moisturizer	
isoquinoline,-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro,	10302	BRD-A75140635	COc1cc2CCNC(C)c2cc1OC		
isosorbide	12597	BRD-K47178855	O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12	nitric oxide stimulant	
isosorbide-dinitrate	6883	BRD-K55853390	[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O	nitric oxide stimulant	GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3|NPR1
isosorbide-mononitrate	27661	BRD-K82225283	O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+]([O-])=O	nitric oxide stimulant	GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3
isosteviol	20975216	BRD-A96529864	C[C@]12C[C@@]3(CC1=O)CC[C@H]1[C@@](C)(CCC[C@@]1(C)C(O)=O)C3CC2		
isotiquimide	3037235	BRD-A02933148	Cc1ccnc2C(CCCc12)C(N)=S		
isotretinoin	5282379	BRD-K76723084	CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C/C(O)=O	retinoid receptor agonist	RARA|RARB|RARG
isovaleramide	10930	BRD-K90069354	CC(C)CC(N)=O	alcohol dehydrogenase inhibitor	
isoxepac	41448	BRD-K92116564	OC(=O)Cc1ccc2OCc3ccccc3C(=O)c2c1	anti-inflammatory agent	
isoxicam	20507134	BRD-A75552914	CN1C(C(=O)Nc2cc(C)on2)C(=O)c2ccccc2S1(=O)=O	cyclooxygenase inhibitor	PTGS1|PTGS2
isoxsuprine	5702076	BRD-A16700644	CC(COc1ccccc1)NC(C)[C@H](O)c1ccc(O)cc1	adrenergic receptor agonist	ADRB2
ispinesib	6851740	BRD-K64881305	CC(C)[C@@H](N(CCCN)C(=O)c1ccc(C)cc1)c1nc2cc(Cl)ccc2c(=O)n1Cc1ccccc1	kinesin inhibitor	KIF11
isradipine	3784	BRD-A90799790	COC(=O)C1=C(C)NC(C)=C(C1c1cccc2nonc12)C(=O)OC(C)C	calcium channel blocker	CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2
ISRIB		BRD-K12826175	Clc1ccc(OCC(=O)N[C@H]2CC[C@@H](CC2)NC(=O)COc2ccc(Cl)cc2)cc1	eukaryotic translation initiation factor inhibitor; PERK inhibitor	EIF2A|EIF2AK3
istaroxime	9841834	BRD-K95412502	C[C@]12CC[C@H]3[C@@H](CC(=O)[C@H]4C\C(CC[C@]34C)=N\OCCN)[C@@H]1CCC2=O	ATPase inhibitor	ATP1A1
istradefylline	5311037	BRD-K87774949	CCn1c2nc(\C=C\c3ccc(OC)c(OC)c3)n(C)c2c(=O)n(CC)c1=O	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
ISX-9	19582717	BRD-K53903639	O=C(NC1CC1)c1cc(on1)-c1cccs1	neural stem cell inducer	NEUROD1
itacitinib	53380437	BRD-K67482377	Fc1c(ccnc1C(F)(F)F)C(=O)N1CCC(CC1)N1CC(CC#N)(C1)n1cc(cn1)-c1ncnc2[nH]ccc12	JAK inhibitor	JAK1
ITD-1	44135961	BRD-A56690687	CCOC(=O)C1=C(C)NC2=C(C1c1ccc(cc1)-c1ccccc1)C(=O)CC(C)(C)C2	TGF beta receptor inhibitor	TGFBR2
ITE	4668801	BRD-K60298136	COC(=O)c1csc(n1)C(=O)c1c[nH]c2ccccc12	aryl hydrocarbon receptor agonist	AHR
ITI214	42639643	BRD-K77987496	CN1C2=N[C@@H]3CCC[C@@H]3N2c2nn(Cc3ccc(cc3)-c3cccc(F)n3)c(Nc3ccccc3)c2C1=O	phosphodiesterase inhibitor	PDE1A
itopride	3792	BRD-K96740444	COc1ccc(cc1OC)C(=O)NCc1ccc(OCCN(C)C)cc1	dopamine receptor antagonist	CHRM3|DRD2
itraconazole	55283	BRD-A23067620	CCC(C)n1ncn(-c2ccc(cc2)N2CCN(CC2)c2ccc(OC[C@H]3CO[C@@](Cn4cncn4)(O3)c3ccc(Cl)cc3Cl)cc2)c1=O	cytochrome P450 inhibitor	CYP51A1
ITX3	1362865	BRD-K36515744	Cc1cc(\C=c2\sc3nc4ccccc4n3c2=O)c(C)n1-c1ccccc1	GEF inhibitor	TRIO
IT1t	25147749	BRD-K73499906	CC1(C)CN2C(CS\C(NC3CCCCC3)=N\C3CCCCC3)=CSC2=N1	CC chemokine receptor antagonist	CXCR4
IU1	675434	BRD-K45841694	Cc1cc(C(=O)CN2CCCC2)c(C)n1-c1ccc(F)cc1	ubiquitin C-terminal hydrolase inhibitor	USP14
ivabradine	21625941	BRD-K31385749	COc1cc2C[C@@H](CN(C)CCCN3CCc4cc(OC)c(OC)cc4CC3=O)c2cc1OC	HCN channel antagonist; potassium channel blocker; sodium channel blocker	HCN1|HCN3|HCN4
ivacaftor	16220172	BRD-K52818472	CC(C)(C)c1cc(c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O)C(C)(C)C	CFTR channel potentiator	CFTR
ivermectin	6321424	BRD-K85554912	CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C\C=C(C)\[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2	benzodiazepine receptor agonist	CHRNA7|GABRB3|GLRA3|P2RX7
ivosidenib	71657455	BRD-K93073858	Fc1cncc(c1)N([C@H](C(=O)NC1CC(F)(F)C1)c1ccccc1Cl)C(=O)[C@@H]1CCC(=O)N1c1cc(ccn1)C#N	isocitrate dehydrogenase inhibitor	IDH1
IWP-L6	71601111	BRD-K53234107	O=C(CSc1nc2CCSc2c(=O)n1-c1ccccc1)Nc1ccc(cn1)-c1ccccc1	porcupine inhibitor	PORCN
ixabepilone	6445540	BRD-K03601870	C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\c1csc(C)n1	microtubule stabilizing agent	TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8
ixazomib	25183872	BRD-K78659596	CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O	proteasome inhibitor	
ixazomib-citrate	49867936	BRD-A66419424	CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)CC(CC(O)=O)(O1)C(O)=O	proteasome inhibitor	
JAK3-inhibitor-V	3799	BRD-K95676198	C=CC(=O)c1ccc2ccccc2c1	JAK inhibitor	JAK3
JDTic	9956146	BRD-K95837862	CC(C)[C@@H](CN1CC[C@](C)([C@@H](C)C1)c1cccc(O)c1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1	opioid receptor antagonist	OPRK1
JHW-007		BRD-K32892871	CCCCN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(c1ccc(F)cc1)c1ccc(F)cc1	dopamine uptake inhibitor	SLC6A3
JIB04	6519698	BRD-K76180386	Clc1ccc(N\N=C(/c2ccccc2)c2ccccn2)nc1	histone lysine demethylase inhibitor	KDM4E
JK-184	1069686	BRD-K38860038	CCOc1ccc(Nc2nc(cs2)-c2c(C)nc3ccccn23)cc1	hedgehog pathway inhibitor	
JLK-6	3803	BRD-K22010301	COc1oc(=O)c2cc(N)ccc2c1Cl	gamma secretase inhibitor	PSEN1
JNJ-10191584	10446295	BRD-K15086322	CN1CCN(CC1)C(=O)c1nc2ccc(Cl)cc2[nH]1	histamine receptor antagonist	HRH4
JNJ-10397049	9869934	BRD-K61721596	CC1(C)OC[C@H](NC(=O)Nc2ccc(Br)cc2Br)[C@@H](O1)c1ccccc1	orexin receptor antagonist	HCRTR1|HCRTR2
JNJ-16259685		BRD-K25596805	CO[C@H]1CC[C@H](CC1)C(=O)c1ccc2nc3OCCCc3cc2c1	glutamate receptor antagonist	GRM1
JNJ-1661010	2809273	BRD-K47376733	O=C(Nc1ccccc1)N1CCN(CC1)c1nc(ns1)-c1ccccc1	FAAH inhibitor	FAAH
JNJ-17203212	11339118	BRD-K51770398	FC(F)(F)c1ccc(NC(=O)N2CCN(CC2)c2ncccc2C(F)(F)F)nc1	TRPV antagonist	TRPV1
JNJ-26481585	11538455	BRD-K83837640	Cn1cc(CNCC2CCN(CC2)c2ncc(cn2)C(=O)NO)c2ccccc12	HDAC inhibitor	HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|MDM2
JNJ-26990990	11687376	BRD-K24864897	NS(=O)(=O)NCc1csc2ccccc12	anticonvulsant	
JNJ-27141491	11703589	BRD-K41895652	CC[C@@H](c1ccc(F)c(F)c1)n1c(C(=O)OC)c([nH]c1=S)-c1ccno1	CC chemokine receptor antagonist	CCR2
JNJ-37822681	16058752	BRD-K31802667	Fc1ccc(CN2CCC(CC2)Nc2ccc(nn2)C(F)(F)F)cc1F	dopamine receptor antagonist	DRD2
JNJ-38877605	46911863	BRD-K02123250	Cn1cc(cn1)-c1ccc2nnc(n2n1)C(F)(F)c1ccc2ncccc2c1	tyrosine kinase inhibitor	MET
JNJ-40411813	25195461	BRD-K55029398	CCCCn1ccc(N2CCC(CC2)c2ccccc2)c(Cl)c1=O	glutamate receptor positive allosteric modulator	GRM2
JNJ-42041935	45102710	BRD-K01036220	OC(=O)c1cnn(c1)-c1nc2cc(Cl)c(OC(F)(F)F)cc2[nH]1	hypoxia inducible factor prolyl hydroxylase inhibitor	PDK2
JNJ-42165279	54576693	BRD-K70330032	FC1(F)Oc2ccc(CN3CCN(CC3)C(=O)Nc3cnccc3Cl)cc2O1	FAAH inhibitor	FAAH
JNJ-47965567	66553218	BRD-K83547600	O=C(NCC1(CCOCC1)N1CCN(CC1)c1ccccc1)c1cccnc1Sc1ccccc1	purinergic receptor antagonist	P2RX7
JNJ-63533054	2548547	BRD-K19482962	C[C@H](NC(=O)CNC(=O)c1cccc(Cl)c1)c1ccccc1	G protein-coupled receptor agonist	GPR139
JNJ-7706621	5330790	BRD-K11636097	Nc1nc(Nc2ccc(cc2)S(N)(=O)=O)nn1C(=O)c1c(F)cccc1F	CDK inhibitor	AURKA|AURKB|CDK1|CDK2
JNJ-7777120	4908365	BRD-K17774839	CN1CCN(CC1)C(=O)c1cc2cc(Cl)ccc2[nH]1	histamine receptor antagonist	HRH4
josamycin	23817954	BRD-K25837718	CO[C@H]1[C@@H](CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC(=O)CC(C)C)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C)OC(C)=O	bacterial 50S ribosomal subunit inhibitor	
JQ1-(+)	46907787	BRD-K54606188	Cc1sc-2c(c1C)C(=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n-21)c1ccc(Cl)cc1	bromodomain inhibitor	BRD4|BRDT
JTC-801	5311340	BRD-K17705806	CCc1ccc(OCc2ccccc2C(=O)Nc2ccc3nc(C)cc(N)c3c2)cc1	opioid receptor antagonist	OPRL1
JTE-013	10223146	BRD-K43330982	CC(C)c1cc(NNC(=O)Nc2cc(Cl)nc(Cl)c2)nc2n(C)nc(C)c12	lysophospholipid receptor antagonist	P2RY10|S1PR2
JTE-607	9938545	BRD-K81405859	CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c1cc(Cl)c(OCCN2CCN(C)CC2)c(Cl)c1O	cytokine production inhibitor	IL10|IL1B|IL6|TNF
JTE-907	9867770	BRD-K63150726	CCCCCOc1c(OC)ccc2cc(C(=O)NCc3ccc4OCOc4c3)c(=O)[nH]c12	cannabinoid receptor inverse agonist	CNR2
JW-55	2946601	BRD-K53328210	COc1ccc(cc1)C1(CNC(=O)c2ccc(NC(=O)c3ccco3)cc2)CCOCC1	tankyrase inhibitor	TNKS|TNKS2
JW-642	71656520	BRD-K48424871	FC(F)(F)C(OC(=O)N1CCN(Cc2cccc(Oc3ccccc3)c2)CC1)C(F)(F)F	monoacylglycerol lipase inhibitor	MGLL
JW-67	644733	BRD-K24554037	O=C1Nc2ccccc2C11OCC2(CO1)COC1(OC2)C(=O)Nc2ccccc12	Wnt pathway inhibitor	APC|AXIN1|GSK3B
JW-74	16013152	BRD-K75664313	COc1ccc(cc1)-n1c(SCc2nc(no2)-c2ccc(C)cc2)nnc1-c1ccncc1	WNT signaling inhibitor; tankyrase inhibitor	TNKS|TNKS2
JX-401	1126109	BRD-K05464208	COc1cc(SC)ccc1C(=O)N1CCC(Cc2ccccc2)CC1	p38 MAPK inhibitor	MAPK14
JZL-184	25021165	BRD-K45446451	OC(C1CCN(CC1)C(=O)Oc1ccc(cc1)[N+]([O-])=O)(c1ccc2OCOc2c1)c1ccc2OCOc2c1	monoacylglucerol lipase inhibitor	MGLL
JZL-195	46232606	BRD-K38875233	[O-][N+](=O)c1ccc(OC(=O)N2CCN(Cc3cccc(Oc4ccccc4)c3)CC2)cc1	FAAH inhibitor; monoacylglycerol lipase inhibitor	FAAH|MGLL
K-MAP	2865122	BRD-A45906415	OCC1OC(Nc2ccc(cc2)C(O)=O)C(O)C(O)C1O		
K-Ras(G12C)-inhibitor-12	73555129	BRD-K90756851	Oc1cc(Cl)c(I)cc1NCC(=O)N1CCN(CC1)C(=O)C=C	K-ras inhibitor	KRAS
K-Ras(G12C)-inhibitor-6	71815954	BRD-K26305185	SCCCC(=O)NC1CCN(CC1)C(=O)COc1ccc(Cl)cc1Cl	K-ras inhibitor	
k-strophanthidin	5702136	BRD-A55312468	C[C@]12CCC3C(CC[C@]4(O)C[C@@H](O)CC[C@]34C=O)[C@@]1(O)CCC2C1=CC(=O)OC1	ATPase inhibitor	ATP1A1
K-247	2848722	BRD-A74648924	OCC1OC(Nc2ccc(cc2)C(O)=O)C(O)C1O		
K-858	2930014	BRD-A67748489	CC(=O)NC1=NN(C(C)=O)C(C)(S1)c1ccccc1	kinesin-like spindle protein inhibitor	KIF11
kaempferol	5280863	BRD-K12807006	Oc1ccc(cc1)-c1oc2cc(O)cc(O)c2c(=O)c1O	bone resorption inhibitor; estrogen-related receptor inverse agonist	AKR1B1|ALOX15B|ALOX5|AR|CYP1B1|GLO1|HSD17B1|UGT3A1
kainic-acid	10255	BRD-K52459018	CC(=C)[C@H]1CN[C@@H]([C@H]1CC(O)=O)C(O)=O	kainate receptor agonist	GRIA1|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5
kakonein	5385074	BRD-A07815743	OCC1OC(C(O)C(O)C1O)c1c(O)ccc2c1occ(-c1ccc(O)cc1)c2=O	GABA receptor antagonist; serotonin receptor antagonist	
kanamycin	6032	BRD-K08327065	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	bacterial 30S ribosomal subunit inhibitor	
kartogenin	2826191	BRD-K27584835	OC(=O)c1ccccc1C(=O)Nc1ccc(cc1)-c1ccccc1	chondrocyte differentiation stimulator	FLNA
KB-R7943	4534086	BRD-K17743697	NC(=N)SCCc1ccc(OCc2ccc(cc2)[N+]([O-])=O)cc1	sodium/calcium exchange inhibitor	SLC8A1|TRPC3|TRPC5|TRPC6
KB-SRC-4	73349077	BRD-K88154110	Nc1ncnc2n(nc(-c3ccc(Cl)cc3)c12)-c1cccc(c1)-c1cnnn1Cc1cccc(c1)-c1ccccc1	src inhibitor	SRC
KBG	6917960	BRD-A00376169	OC1O[C@@H]2COC(O[C@H]2[C@H](O)[C@H]1O)c1ccccc1	neprilysin inhibitor	MME
KD-023	115175	BRD-K71164191	CCCCCCCCCCCCCCOc1ccc(o1)C(O)=O	ACAT inhibitor	ACACA|ACACB
KD025	11950170	BRD-K88506063	CC(C)NC(=O)COc1cccc(c1)-c1nc(Nc2ccc3[nH]ncc3c2)c2ccccc2n1	rho associated kinase inhibitor	ROCK2
kenpaullone	3820	BRD-K37312348	Brc1ccc2[nH]c-3c(CC(=O)Nc4ccccc-34)c2c1	CDK inhibitor; glycogen synthase kinase inhibitor	CCNB1|CDK1|CDK5|GSK3B
ketanserin	3822	BRD-K49671696	Fc1ccc(cc1)C(=O)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1	serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|SLC18A1|SLC18A2
ketoconazole	456201	BRD-K29113274	CC(=O)N1CCN(CC1)c1ccc(OC[C@H]2CO[C@@](Cn3ccnc3)(O2)c2ccc(Cl)cc2Cl)cc1	sterol demethylase inhibitor	AR|CYP19A1|CYP21A2|KCNA10
ketoprofen	3825	BRD-A97739905	CC(C(O)=O)c1cccc(c1)C(=O)c1ccccc1	cyclooxygenase inhibitor	CXCR1|PTGS1|PTGS2|SLC5A8
ketorolac	3826	BRD-A40639672	OC(=O)C1CCn2c1ccc2C(=O)c1ccccc1	cyclooxygenase inhibitor	PTGS1|PTGS2
ketotifen	3827	BRD-K28936863	CN1CCC(CC1)=C1c2ccsc2C(=O)Cc2ccccc12	histamine receptor agonist; leukotriene receptor antagonist; phosphodiesterase inhibitor	HRH1|PDE4A|PDE4B|PDE4C|PDE4D|PDE7A|PDE7B|PDE8A|PDE8B|PGD
kevetrin	437740	BRD-K61339991	NC(=N)SCCCC#N	p53 activator	
KF-38789		BRD-A54927599	COc1ccc(C2CC(=NCCS2)c2c(O)cc(C)oc2=O)c(OC)c1	P selectin inhibitor	SELP
KG-5	53328059	BRD-K90747162	CSc1nc(N)cc(Oc2ccc(cc2)-c2nnc(Nc3cccc(c3)C(F)(F)F)[nH]2)n1	RAF inhibitor	BRAF|FLT3|KIT|PDGFRB
KH-CB19	44237094	BRD-K01673854	CCOC(=O)c1c(\C(=C/N)C#N)c2ccc(Cl)c(Cl)c2n1C	CDC inhibitor	CLK1|CLK3|DYRK1A
khellin	3828	BRD-K80353807	COc1c2ccoc2c(OC)c2oc(C)cc(=O)c12	vasodilator	
KHK-IN-1	53348216	BRD-K84605263	CSc1ccccc1Nc1nc(nc2c(NCC3CC3)ncnc12)N1CCNCC1	hexokinase inhibitor	KHK
KHS-101	71304818	BRD-K78978711	CC(C)CNc1ccnc(NCc2csc(n2)-c2ccccc2)n1	neural stem cell inducer	TACC3
KI-16425	10367662	BRD-A25569250	CC(OC(=O)Nc1c(C)noc1-c1ccc(CSCCC(O)=O)cc1)c1ccccc1Cl	lysophosphatidic acid receptor antagonist	LPAR1|LPAR3
KI-20227	9869779	BRD-A88787317	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1	c-Fms inhibitor	CSF1R|KDR|KIT|PDGFRB
KI-8751	11317348	BRD-K47150025	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)c(F)c3)c2cc1OC	KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor	KDR
kifunensine	130611	BRD-K02898090	OC[C@@H]1[C@@H](O)[C@H](O)[C@H](O)[C@H]2NC(=O)C(=O)N12	mannosidase inhibitor	MAN1B1|MAN2A1
kinetin	3830	BRD-K65667145	C(Nc1ncnc2[nH]cnc12)c1ccco1	cell division inducer	
ki16198	9913405	BRD-A94323479	COC(=O)CCSCc1ccc(cc1)-c1onc(C)c1NC(=O)OC(C)c1ccccc1Cl	lipoprotein antagonist	LPA
KL-001	2888648	BRD-A94580299	CS(=O)(=O)N(CC(O)Cn1c2ccccc2c2ccccc12)Cc1ccco1	proteasome inhibitor	CRY1|CRY2
KML29	71656212	BRD-K46734292	OC(C1CCN(CC1)C(=O)OC(C(F)(F)F)C(F)(F)F)(c1ccc2OCOc2c1)c1ccc2OCOc2c1	monoacylglucerol lipase inhibitor	MGLL
KN-62	3838	BRD-A81177136	CN(C(Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(CC1)c1ccccc1)S(=O)(=O)c1cccc2cnccc12	calcium/calmodulin dependent protein kinase inhibitor; purinergic receptor antagonist	AKT1|CAMK2A|CHEK1|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|P2RX7|PRKCA|ROCK1|RPS6KB1|SGK1
KN-93	5312122	BRD-K93480852	COc1ccc(cc1)S(=O)(=O)N(CCO)c1ccccc1CN(C)C\C=C\c1ccc(Cl)cc1	calcium/calmodulin dependent protein kinase inhibitor	CAMK2A
Ko143	10322450	BRD-K64642496	COc1ccc2c3C[C@@H]4N([C@@H](CC(C)C)c3[nH]c2c1)C(=O)[C@H](CCC(=O)OC(C)(C)C)NC4=O	BCRP inhibitor	ABCB1|ABCC1
KP-1212	71167912	BRD-K46690591	NC1=NC(=O)N(CN1)[C@H]1C[C@@H](O)[C@@H](CO)O1		
KPT-185	53495165	BRD-K71467466	COc1cc(cc(c1)C(F)(F)F)-c1ncn(\C=C/C(=O)OC(C)C)n1	exportin antagonist	XPO1
KPT-276	71496742	BRD-K75352575	FC(F)(F)c1cc(cc(c1)C(F)(F)F)-c1ncn(n1)\C=C/C(=O)N1CC(F)(F)C1	exportin antagonist	XPO1
KRCA-0008	72547474	BRD-K40604024	COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccc(cc2OC)N2CCN(CC2)C(C)=O)n1)N1CCN(CC1)C(C)=O	ALK inihibitor	ALK
KRN-633	9549295	BRD-K90993449	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl	VEGFR inhibitor	FLT1|FLT4|KDR
KS-176	49779726	BRD-K81053848	OCCc1ccc(NC(=O)c2ccccc2NC(=O)c2ccc(cc2)[N+]([O-])=O)cc1	BCRP inhibitor	ABCG2
KT-433	3874929	BRD-K66437909	CCc1oc2ccccc2c1C(=O)c1ccc(OCC(O)=O)cc1	uricosuric agent	
ku-0063794	16736978	BRD-K67566344	COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1C[C@H](C)O[C@H](C)C1)N1CCOCC1	mTOR inhibitor	MTOR
KU-55933	5278396	BRD-K25311561	O=c1cc(oc(c1)-c1cccc2Sc3ccccc3Sc12)N1CCOCC1	ATM kinase inhibitor	ATM|PRKDC
KU-60019	15953870	BRD-K36016295	C[C@H]1CN(CC(=O)Nc2ccc3Sc4c(Cc3c2)cccc4-c2cc(=O)cc(o2)N2CCOCC2)C[C@@H](C)O1	ATM kinase inhibitor	ATM
kuromanin	441667	BRD-K51337109	OC[C@H]1O[C@@H](Oc2cc3c(O)cc(O)cc3[o+]c2-c2ccc(O)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O	ribosyl cyclase inhibitor	CD38
KU14R	4302964	BRD-A38747044	CCC1(Cc2ccccc2O1)c1ncc[nH]1	imidazoline receptor antagonist	
KW-2449	11427553	BRD-K21718444	O=C(N1CCNCC1)c1ccc(cc1)\C=C\c1n[nH]c2ccccc12	Abl kinase inhibitor; Aurora kinase inhibitor; FLT3 inhibitor	ABL1|AURKA|AURKB|FLT3
KW-2478	23116322	BRD-K41213548	CCc1c(O)cc(O)c(C(=O)c2ccc(OCCN3CCOCC3)c(OC)c2)c1CC(=O)N(CCOC)CCOC	HSP inhibitor	
KW-3902	64627	BRD-A95683721	CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)C12CC3CC1CC(C2)C3	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
KX2-391	23635314	BRD-K29968218	O=C(Cc1ccc(cn1)-c1ccc(OCCN2CCOCC2)cc1)NCc1ccccc1	src inhibitor; tubulin polymerization inhibitor	SRC
kynurenic-acid	3845	BRD-K85872723	OC(=O)c1cc(O)c2ccccc2n1	glutamate receptor antagonist	GPR35|GRIN1|GRIN2A|GRIN2B
KY02111	8582409	BRD-K13302470	COc1ccc(CCC(=O)Nc2nc3ccc(Cl)cc3s2)cc1OC	Wnt pathway inhibitor	DKK1
K02288	46173038	BRD-K58568447	COc1cc(cc(OC)c1OC)-c1cc(cnc1N)-c1cccc(O)c1	bone morphogenic protein inhibitor	BMP1
K145	71714682	BRD-K12106308	CCCCOc1ccc(CC\C=C2/SC(=O)N(CCN)C2=O)cc1	sphingosine kinase inhibitor	SPHK2
L-(+)-Rhamnose-Monohydrate	12302960	BRD-A86354194	C[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O		
L-alanine	5950	BRD-K25125382	C[C@H](N)C(O)=O		
L-Arginine	71070	BRD-K76811153	N[C@H](CCCNC(N)=N)C(O)=O	nitric oxide precursor	ARG2|ASL|ASS1|AZIN2|GPRC6A|NOS2|NOS3|SLC7A1|SLC7A3|SLC7A4
L-Ascorbyl-6-palmitate	123132491	BRD-A45419686	CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(=O)C1O		
L-asparagine	6267	BRD-K06665116	N[C@@H](CC(N)=O)C(O)=O		ASNS|ASRGL1|NARS|NARS2|SLC1A5|SLC38A3
L-asparagine-n-hydroxy	44237312	BRD-K82178523	N[C@@H](CC(=O)NO)C(O)=O		
L-Aspartic-Acid	44367445	BRD-K97163964	N[C@@H](CC(O)=O)C(O)=O	metallic radical formation stimulant	ACY1|ACY3|ADSS|ADSSL1|ASNS|ASPA|ASPH|ASRGL1|ASS1|CAD|DARS|DARS2|GOT1|GOT2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|LYZ|PAICS|RNASE1|SLC1A1|SLC25A12|SLC25A13
L-Citrulline	25244873	BRD-A12237696	NC(CCCNC(N)=O)C(O)=O	nitric oxide stimulant	ASS1|DDAH1|DDAH2|GPRC6A|NOS1|NOS2|NOS3|OTC|PADI1|PADI2|PADI3|PADI4|PADI6
L-cysteine	5862	BRD-K00795468	N[C@@H](CS)C(O)=O		CARS|CARS2|CBS|CDO-1|CDO1|CSAD|CTH|GCLC|GCLM|GOT1|GSS|MGMT|NFS1|SLC19A3
L-Cysteinesulfinic-acid	1549098	BRD-A25800195	N[C@@H](CS(O)=O)C(O)=O	glutamate receptor agonist	GRM1|GRM5|GSR|HMGCS2|PAPOLA|PRDX2
L-Cystine	24798687	BRD-A15397381	NC(CSSCC(N)C(O)=O)C(O)=O		CTNS|SLC3A1|SLC7A11|SLC7A9
L-ergothioneine	124079411	BRD-K26341917	C[N+](C)(C)[C@@H](Cc1c[nH]c(=S)[nH]1)C(O)=O	free radical scavenger	
L-glutamic-acid	33032	BRD-K62309135	N[C@@H](CCC(O)=O)C(O)=O	glutamate receptor agonist	AADAT|AASS|ABAT|ALDH18A1|ASNS|BCAT1|BCAT2|CCBL2|DNPEP|EARS2|ENPEP|EPRS|FOLH1|FPGS|FTCD|GAD1|GAD2|GATB|GCLC|GCLM|GGCX|GLS|GLS2|GLUD1|GLUD2|GLUL|GMPS|GOT1|GOT2|GPT|GPT2|GRIA1|GRIA2|GRIA3|GRIA4|GRID1|GRID2|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM1|GRM2|GRM3|GRM4|GRM6|GRM7|GRM8|LGSN|NADSYN1|NAGS|OPLAH|PFAS|PGCP|PSAT1|SLC1A1|SLC1A2|SLC1A3|SLC1A6|SLC1A7|SLC25A18|SLC25A22|SLC7A11|TAT
L-Hydroxyproline	5238478	BRD-A12454076	OC1CNC(C1)C(O)=O		
L-leucine	6106	BRD-K12853841	CC(C)C[C@H](N)C(O)=O		BCAT1|BCAT2|LARS|LARS2|LCMT1|LCMT2
L-lysine	122198194	BRD-K86016185	NCCCC[C@H](N)C(O)=O	serotonin receptor agonist	GPRC6A|KARS|SLC7A1|SLC7A2|SLC7A3|SLC7A4
L-methionine	6137	BRD-K06502269	CSCC[C@H](N)C(O)=O	voltage-gated calcium channel ligand	
L-mimosine	129010056	BRD-K98151021	N[C@@H](CN1CC(=O)C(=O)C=C1)C(O)=O	dopamine beta hydroxylase inhibitor; eukaryotic translation initiation factor inhibitor	DBH|EIF5A
L-monomethylarginine	73046	BRD-K20946707	CN[C@@H](CCCNC(N)=N)C(O)=O	nitric oxide synthase inhibitor	NOS1|NOS2
L-NAME	39836	BRD-K33141550	COC(=O)[C@@H](N)CCCNC(=N)N[N+]([O-])=O	nitric oxide synthase inhibitor	NOS3
L-NIL	2733506	BRD-K60036103	CC(=N)NCCCC[C@H](N)C(O)=O	nitric oxide synthase inhibitor	NOS1|NOS2|NOS3
L-proline	145742	BRD-K01666412	OC(=O)[C@@H]1CCCN1	glutamate receptor agonist	EPRS|L3HYPDH|P3H1|P3H2|P3H3|P4HA1|P4HA2|PARS2|PPIA|PPIB|PPIC|PPIF|PPIG|PPIH|PRODH|PROSC|PYCR1|PYCR2|PYCRL|SLC6A14|SLC6A7
L-Quisqualic-acid	40539	BRD-K92404805	N[C@@H](Cn1oc(=O)[nH]c1=O)C(O)=O	glutamate receptor agonist	FOLH1|GRIA2|GRIK1|GRIK2|GRM1|GRM2|GRM3|GRM5|GRM7|GRM8
L-Theanine	228398	BRD-A08715367	CCNC(=O)CCC(N)C(O)=O	glutamate receptor antagonist	
L-threonine	6288	BRD-K75508643	C[C@@H](O)[C@H](N)C(O)=O		TARS|TARS2|THNSL1
L-152804	3765615	BRD-A42553870	CC1(C)CC(=O)C(C2c3ccccc3OC3=C2C(=O)CC(C)(C)C3)C(=O)C1	neuropeptide receptor antagonist	NPY5R
L-161982	9961192	BRD-K39733634	CCCCc1nn(-c2ccccc2C(F)(F)F)c(=O)n1Cc1ccc(cc1)-c1ccccc1S(=O)(=O)NC(=O)c1sccc1C	prostanoid receptor antagonist	PTGER4
L-165041	6603901	BRD-K98372770	CCCc1c(OCCCOc2ccc(OCC(O)=O)cc2)ccc(C(C)=O)c1O	PPAR receptor agonist	PPARD
L-168049	5311276	BRD-K18036262	CCCOc1ccc(Br)cc1-c1cc([nH]c1-c1ccncc1)-c1ccc(Cl)cc1	glucagon receptor antagonist	GCGR
L-365260	5311201	BRD-K34277641	CN1c2ccccc2C(=N[C@@H](NC(=O)Nc2cccc(C)c2)C1=O)c1ccccc1	CCK receptor antagonist	CCKAR|CCKBR|KCNQ1
L-368899	9893887	BRD-A43930669	Cc1ccccc1N1CCN(CC1)S(=O)(=O)CC12CCC(C[C@@H]1NC(=O)[C@@H](N)CCS(C)(=O)=O)C2(C)C	oxytocin receptor antagonist	AVPR1A|AVPR2|OXTR
L-655,708	5311203	BRD-K13474508	CCOC(=O)c1ncn-2c1[C@@H]1CCCN1C(=O)c1cc(OC)ccc-21	GABA receptor inverse agonist	GABRA1|GABRA2|GABRA3|GABRA5|GABRG2
L-655240	122070	BRD-K89402695	Cc1c(CC(C)(C)C(O)=O)n(Cc2ccc(Cl)cc2)c2ccc(F)cc12	thromboxane receptor antagonist	PTGES
L-670596	129360	BRD-A85472596	CS(=O)(=O)c1ccc(Cn2c3C(CC(O)=O)CCCc3c3cc(F)cc(F)c23)cc1	prostanoid receptor antagonist	
L-689560	6604749	BRD-K74284736	OC(=O)[C@H]1C[C@H](NC(=O)Nc2ccccc2)c2c(Cl)cc(Cl)cc2N1	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
L-690330	132449	BRD-K28470988	CC(Oc1ccc(O)cc1)(P(O)(O)=O)P(O)(O)=O	inositol monophosphatase inhibitor	IMPA1
L-693403	4687238	BRD-K83322645	C(N1CCC2(CCc3ccccc23)CC1)c1ccccc1	sigma receptor agonist; sigma receptor antagonist	DRD2|SIGMAR1
L-694247	132059	BRD-K18816859	CS(=O)(=O)Nc1ccc(Cc2noc(n2)-c2ccc3[nH]cc(CCN)c3c2)cc1	serotonin receptor agonist	HTR1A|HTR1B|HTR1D
L-701252	54687453	BRD-K10176267	Oc1c(C(=O)C2CC2)c(=O)[nH]c2cc(Cl)ccc12	glutamate receptor antagonist	GRIN1
L-701324	54682505	BRD-K08109516	Oc1c(-c2cccc(Oc3ccccc3)c2)c(=O)[nH]c2cc(Cl)ccc12	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
L-732,138	44396853	BRD-K37952347	CC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)OCc1cc(cc(c1)C(F)(F)F)C(F)(F)F	tachykinin antagonist	TACR1|TACR2
L-733060	132846	BRD-K15791587	FC(F)(F)c1cc(CO[C@H]2CCCN[C@H]2c2ccccc2)cc(c1)C(F)(F)F	tachykinin antagonist	TACR1
L-741742	133008	BRD-K13211965	Cc1c(noc1-c1ccc(Cl)cc1)C1CCN(CCc2ccccc2)CC1	dopamine receptor antagonist	DRD3|DRD4|SCN1A|SCN3A
L-745870	5311200	BRD-K05528470	Clc1ccc(cc1)N1CCN(Cc2c[nH]c3ncccc23)CC1	dopamine receptor antagonist	DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2A|HTR6|HTR7
L-755507	9829836	BRD-K39359968	CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3
L-760735	9809077	BRD-K30425481	C[C@@H](O[C@H]1OCCN(Cc2nn[nH]c2CN(C)C)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F	tachykinin antagonist	TACR1
L-778123	216454	BRD-K10958118	Clc1cccc(c1)N1CCN(Cc2cncn2Cc2ccc(cc2)C#N)CC1=O	farnesyltransferase inhibitor	FNTA|FNTB|PGGT1B
L-798,106	15551229	BRD-K43905307	COc1ccc(Br)cc1S(=O)(=O)NC(=O)\C=C\c1ccccc1Cc1ccc2ccccc2c1	prostanoid receptor antagonist	PTGER3
L-838417	9908880	BRD-K46647427	Cn1ncnc1COc1nn2c(nnc2cc1C(C)(C)C)-c1cc(F)ccc1F	GABA receptor partial agonist	GABRA1|GABRA2|GABRA3|GABRA5
labetalol	3869	BRD-A07440155	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(c1)C(N)=O	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRB1|ADRB2
lacidipine	5311217	BRD-K43586850	CCOC(=O)C1=C(C)NC(C)=C(C1c1ccccc1\C=C\C(=O)OC(C)(C)C)C(=O)OCC	calcium channel blocker	CACNA1C
lacitol	157355	BRD-K40787673	OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO	osmosis stimulant	
lacosamide	219078	BRD-K68232650	COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1	collapsin response mediator protein inhibitor; collapsin response mediator protein stimulant; sodium channel blocker	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
lactulose	11333	BRD-K77258318	OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O	laxative	
lafutidine	5282136	BRD-A67516570	O=C(CS(=O)Cc1ccco1)NC\C=C/COc1cc(CN2CCCCC2)ccn1	histamine receptor antagonist	HRH2
lamivudine	3877	BRD-A02309928	Nc1ccn(C2CSC(CO)O2)c(=O)n1	nucleoside reverse transcriptase inhibitor	
lamotrigine	3878	BRD-K93460210	Nc1nnc(c(N)n1)-c1cccc(Cl)c1Cl	serotonin receptor antagonist; sodium channel blocker	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
lanatoside-c	5702228	BRD-A64242993	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](OC(C)=O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)C(CCC3C2C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1	cardiac glycoside	
landiolol	114905	BRD-K86436199	CC1(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N3CCOCC3)cc2)O1	adrenergic receptor antagonist	ADRB1
lanoconazole	3002820	BRD-A54275602	Clc1ccccc1C1CS\C(S1)=C(\C#N)n1ccnc1	sterol demethylase inhibitor	
lansoprazole	3883	BRD-A49172652	Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2[nH]1	ATPase inhibitor	ATP4A|ATP4B
lapatinib	208908	BRD-K19687926	CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1	EGFR inhibitor	EGFR|ERBB2
lappaconite	129010105	BRD-A05906449	CCN1C[C@@]2(CC[C@@H](OC)[C@@]34[C@H]5C[C@H]6[C@H](OC)[C@]5(O)[C@](O)(C[C@@H]6OC)[C@H](C[C@H]23)C14)OC(=O)c1ccccc1NC(C)=O	sodium channel blocker	
laquinimod	54677946	BRD-K60918217	CCN(C(=O)c1c(O)c2c(Cl)cccc2n(C)c1=O)c1ccccc1	immunosuppressant	CXCL2
laropiprant	9867642	BRD-K48894757	CS(=O)(=O)c1cc(F)cc2c3CC[C@H](CC(O)=O)c3n(Cc3ccc(Cl)cc3)c12	prostanoid receptor antagonist	PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGFR|PTGIR|TBXA2R
lasalocid	6708465	BRD-A72711497	CC[C@H](C1OC(CC)(C[C@@H]1C)C1CC[C@](O)(CC)[C@H](C)O1)C(=O)C(C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C(O)=O	bacterial permeability inducer	
lasofoxifene	3081919	BRD-M93148412	O[C@@H]([C@H](O)C(O)=O)C(O)=O.Oc1ccc2[C@H]([C@H](CCc2c1)c1ccccc1)c1ccc(OCCN2CCCC2)cc1	selective estrogen receptor modulator (SERM)	ESR1|ESR2
latanoprost	5311221	BRD-K10961822	CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1	prostanoid receptor agonist	PTGFR
latrepirdine	197033	BRD-K55703048	CN1CCc2c(C1)c1cc(C)ccc1n2CCc1ccc(C)nc1	glutamate receptor antagonist	HRH1|HTR6
latrunculin-b	6436219	BRD-K61292460	C[C@H]1CC[C@@H]2C[C@H](C[C@@](O)(O2)[C@@H]2CSC(=O)N2)OC(=O)\C=C(C)/CC\C=C/1	actin polymerization inhibitor	ACTA1|MKL1|SPIRE2
lauric-acid	3893	BRD-K67375056	CCCCCCCCCCCC(O)=O	bacterial permeability inducer	GPR84|HNF4A|LTF|LY96|PLA2G2A|TLR4
lauric-diethanolamide	8430	BRD-K11548689	CCCCCCCCCCCC(=O)N(CCO)CCO		
laurocapram	42981	BRD-K35698076	CCCCCCCCCCCCN1CCCCCC1=O		
lazabemide	71307	BRD-K51486818	NCCNC(=O)c1ccc(Cl)cn1	monoamine oxidase inhibitor	MAOB
LB-100	25007767	BRD-A49767491	CN1CCN(CC1)C(=O)C1[C@H]2CC[C@H](O2)C1C(O)=O	protein phosphatase inhibitor	
LB42708	10099206	BRD-K18834913	Brc1ccc(Cn2cncc2Cn2cc(C(=O)N3CCOCC3)c(c2)-c2cccc3ccccc23)cc1	farnesyltransferase inhibitor	
LCL-161	24737642	BRD-K08248804	CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc(cs1)C(=O)c1ccc(F)cc1	XIAP inhibitor	BIRC2|XIAP
LCQ908		BRD-K20008181	OC(=O)C[C@H]1CC[C@@H](CC1)c1ccc(cc1)-c1ccc(Nc2ccc(nc2)C(F)(F)F)cn1	diacylglycerol O acyltransferase inhibitor	DGAT1
LCZ696	24755620	BRD-M31057929	CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC(O)=O.CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1)[C@@H](C(C)C)C(O)=O	angiotensin receptor antagonist	
LDC1267	56847486	BRD-K44715996	CCOc1cn(nc1C(=O)Nc1ccc(Oc2ccnc3cc(OC)c(OC)cc23)c(F)c1)-c1ccc(F)cc1C	protein tyrosine kinase inhibitor	AXL|MERTK|TYRO3
LDN-209929	46871867	BRD-K61795638	COc1ccc2nc3ccc(Cl)cc3c(SCCCN)c2c1	haspin kinase inhibitor	GSG2
LDN-212854	60182388	BRD-K59831625	C1CN(CCN1)c1ccc(cc1)-c1cnc2c(cnn2c1)-c1cccc2ncccc12	bone morphogenic protein inhibitor	ABL1|ACVR1|RIPK2
LDN-27219	1150683	BRD-K51485109	NNC(=O)CSc1nc2scc(-c3ccccc3)c2c(=O)n1-c1ccccc1	tissue transglutaminase inhibitor	TGM2
LDN-57444	51537051	BRD-K94485812	CC(=O)O\N=C1\C(=O)N(Cc2cc(Cl)ccc2Cl)c2ccc(Cl)cc12	ubiquitin C-terminal hydrolase inhibitor	
LDN193189	25195294	BRD-K04853698	C1CN(CCN1)c1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccnc2ccccc12	bone morphogenic protein inhibitor	ACVR1|BMPR1A
LE-135	10410894	BRD-K06593056	CN1c2cc3c(cc2N=C(c2ccc(cc2)C(O)=O)c2ccccc12)C(C)(C)CCC3(C)C	retinoid receptor agonist	RARB
ledipasvir	67505836	BRD-K05446112	COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1c1ncc([nH]1)-c1ccc2-c3ccc(cc3C(F)(F)c2c1)-c1ccc2nc([nH]c2c1)[C@@H]1[C@H]2CC[C@H](C2)N1C(=O)[C@@H](NC(=O)OC)C(C)C	HCV inhibitor	
leflunomide	3899	BRD-K78692225	Cc1oncc1C(=O)Nc1ccc(cc1)C(F)(F)F	dihydroorotate dehydrogenase inhibitor; PDGFR tyrosine kinase receptor inhibitor	AHR|DHODH|PTK2B
lemborexant	56944144	BRD-K78666663	Cc1ncc(OC[C@]2(C[C@H]2C(=O)Nc2ccc(F)cn2)c2cccc(F)c2)c(C)n1	orexin receptor antagonist	HCRTR1|HCRTR2
lenalidomide	216326	BRD-A17883755	Nc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O	anticancer agent	CDH5|CRBN|PTGS2|TNF|TNFSF11
lenvatinib	9823820	BRD-K39974922	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O	FGFR inhibitor; KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor	FLT4|KDR
lercanidipine	65866	BRD-A18992208	COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(c1ccccc1)c1ccccc1	calcium channel blocker	CACNA2D1|CACNG1
lerisetron	65997	BRD-K62398570	C(c1ccccc1)n1c(nc2ccccc12)N1CCNCC1	serotonin receptor antagonist	HTR3A
lersivirine	16739244	BRD-K03289534	CCc1nn(CCO)c(CC)c1Oc1cc(cc(c1)C#N)C#N	non-nucleoside reverse transcriptase inhibitor	
lesinurad	53465279	BRD-K75024268	OC(=O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12	uric acid diuretic	SLC22A12
lestaurtinib	9932888	BRD-A27376179	C[C@]12OC(C[C@]1(O)CO)n1c3ccccc3c3c4C(=O)NCc4c4c5ccccc5n2c4c13	FLT3 inhibitor; growth factor receptor inhibitor; JAK inhibitor	FLT3|NTRK1
leteprinim	132123	BRD-K21612934	OC(=O)c1ccc(NC(=O)CCn2cnc3c(O)ncnc23)cc1	nerve growth factor agonist	
letermovir	45138674	BRD-K94288301	COc1cccc(c1)N1CCN(CC1)C1=Nc2c(F)cccc2[C@H](CC(O)=O)N1c1cc(ccc1OC)C(F)(F)F	CMV terminase inhibitor	
letosteine	68707	BRD-A32597168	CCOC(=O)CSCCC1NC(CS1)C(O)=O	mucolytic agent	
letrozole	3902	BRD-K88789588	N#Cc1ccc(cc1)C(c1ccc(cc1)C#N)n1cncn1	aromatase inhibitor	CYP19A1
leucomethylene-blue	164695	BRD-K27460187	CN(C)c1ccc2Nc3ccc(cc3Sc2c1)N(C)C	nitric oxide production inhibitor; tau aggregation inhibitor	MAPT
leucovorin	6006	BRD-A75919782	Nc1nc(=O)c2N(C=O)C(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2[nH]1	folate receptor ligand	TYMS
leucylleucine-methyl-ester	7016877	BRD-K81136890	COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C		
leuprolide	657181	BRD-K26323068	CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1	gonadotropin releasing factor hormone receptor agonist	GNRHR
levalbuterol	123600	BRD-K34469523	CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1	adrenergic receptor agonist	ADRB2
levallorphan	5359371	BRD-K30634073	Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC=C)c2c1	opioid antagonist	CHRNA2|OPRM1
levamisole	26879	BRD-K73107279	C1CN2C[C@@H](N=C2S1)c1ccccc1	acetylcholine receptor agonist	ALPL|ALPPL2|CHRNA3
levcromakalim	93504	BRD-K24526313	CC1(C)Oc2ccc(cc2[C@H]([C@@H]1O)N1CCCC1=O)C#N	potassium channel activator	KCNJ5
levetiracetam	5284583	BRD-K49404994	CC[C@H](N1CCCC1=O)C(N)=O	calcium channel blocker	CACNA1B|SCN1A|SV2A
levo-phencynonate	9821970	BRD-A64698388	CN1CC2CCCC(C1)C2OC(=O)C(O)(C1CCCC1)c1ccccc1	acetylcholine receptor antagonist	CHRM1
levobetaxolol	60657	BRD-K43883465	CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1	adrenergic receptor antagonist	ADRB1|ADRB2
levobunolol	39468	BRD-K31812033	CC(C)(C)NC[C@H](O)COc1cccc2C(=O)CCCc12	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3
levobunolol-(+)	5460339	BRD-K73323637	CC(C)(C)NC[C@@H](O)COc1cccc2C(=O)CCCc12	adrenergic receptor antagonist	
levobunolol-(+/-)	3914	BRD-A46876182	CC(C)(C)NCC(O)COc1cccc2C(=O)CCCc12	adrenergic receptor antagonist	
levocabastine		BRD-K33453211	C[C@@H]1CN(CC[C@]1(C(O)=O)c1ccccc1)[C@H]1CC[C@](CC1)(C#N)c1ccc(F)cc1	histamine receptor antagonist	HRH1|NTSR2
levocarnitine	10918	BRD-K59647213	C[N+](C)(C)C[C@H](O)CC(O)=O		
levocarnitine-propionate	157837	BRD-K84366268	CCC(=O)O[C@H](CC(O)=O)C[N+](C)(C)C	carnitine palmitoyltransferase inhibitor	CRAT
levocetirizine	1549000	BRD-K27184429	OC(=O)COCCN1CCN(CC1)[C@H](c1ccccc1)c1ccc(Cl)cc1	histamine receptor antagonist	HRH1
levodopa	6047	BRD-K34730807	N[C@@H](Cc1ccc(O)c(O)c1)C(O)=O	dopamine precursor	DRD1|DRD2|DRD3|DRD4|DRD5|GPR143
levodropropizine	65859	BRD-K83551379	OC[C@@H](O)CN1CCN(CC1)c1ccccc1	antitussive	
levofloxacin	149096	BRD-K09471561	C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O	bacterial DNA gyrase inhibitor	TOP2A
levomenol	442343	BRD-K62751771	CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1		
levomenthol	16666	BRD-K50329370	CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O		OPRK1|TRPA1|TRPM8|TRPV3
levomepromazine	72287	BRD-K35559145	COc1ccc2Sc3ccccc3N(C[C@H](C)CN(C)C)c2c1	dopamine receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR2A|HTR2C
levomequitazine	4066	BRD-A67616246	C(C1CN2CCC1CC2)N1c2ccccc2Sc2ccccc12	histamine receptor antagonist	HRH1
levonordefrin	164739	BRD-K02976377	C[C@H](N)[C@H](O)c1ccc(O)c(O)c1	vasodilator	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|SLC6A2
levonorgestrel	13109	BRD-K35189033	CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	estrogen receptor agonist; glucocorticoid receptor antagonist; progesterone receptor agonist; progesterone receptor antagonist	AR|ESR1|PGR|SRD5A1
levopropoxyphene	15330	BRD-A54635441	CCC(=O)OC(Cc1ccccc1)(C(C)CN(C)C)c1ccccc1	antitussive	OPRD1|OPRK1|OPRM1
levosimendan	3033825	BRD-K03095347	C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1	calcium sensitizer	KCNJ11|KCNJ8|PDE3A|TNNC1
levosulpiride	688272	BRD-K51671335	CCN1CCC[C@H]1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O	dopamine receptor antagonist	CA1|CA12|CA7|DRD2|DRD3
levothyroxine	25201348	BRD-K30685142	N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(O)=O	thyroid hormone stimulant	THRA|THRB
LFM-A13	9906875	BRD-A30655177	CC(=O)C(C#N)C(=O)Nc1cc(Br)ccc1Br	Bruton's tyrosine kinase (BTK) inhibitor	BTK
LGK-974	46926973	BRD-K16810791	Cc1cc(ccn1)-c1ncc(CC(=O)Nc2ccc(cn2)-c2cnccn2)cc1C	porcupine inhibitor	PORCN
LGX818	70311789	BRD-A56085258	COC(=O)NC(C)CNc1nccc(n1)-c1cn(nc1-c1cc(Cl)cc(NS(C)(=O)=O)c1F)C(C)C	RAF inhibitor	BRAF
LH846	851474	BRD-K47409078	Cc1cc2sc(NC(=O)Cc3ccccc3)nc2cc1Cl	casein kinase inhibitor	CSNK1D
liarozole	60652	BRD-A57133765	Clc1cccc(c1)C(c1ccc2nc[nH]c2c1)n1ccnc1	cytochrome P450 inhibitor	CYP19A1|CYP26A1
licarbazepine	114709	BRD-A22642447	NC(=O)N1c2ccccc2CC(O)c2ccccc12	voltage-gated sodium channel blocker	SCN5A
licochalcone-a	3923	BRD-K26011976	COc1cc(O)c(cc1C=CC(=O)c1ccc(O)cc1)C(C)(C)C=C	topoisomerase inhibitor	PTPN1
licofelone	133021	BRD-K08439945	CC1(C)Cc2c(c(c(CC(O)=O)n2C1)-c1ccc(Cl)cc1)-c1ccccc1	cyclooxygenase inhibitor; lipoxygenase inhibitor	ALOX5|PLA2G2E|PTGS2
lidamidine	47510	BRD-K68693535	CNC(=N)NC(=O)Nc1c(C)cccc1C	adrenergic receptor agonist	
lidocaine	3676	BRD-K52662033	CCN(CC)CC(=O)Nc1c(C)cccc1C	histamine receptor agonist	EGFR|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
lidoflazine	3926	BRD-K62996583	Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	calcium channel blocker	SCN1A|SCN3A|SLC29A1
ligustilide	5319022	BRD-K48875051	CCC\C=C1OC(=O)C2=C/1CCC=C2	tumor necrosis factor production inhibitor	TNF
limaprost-alfadex	6438378	BRD-K25015158	CCCC[C@H](C)C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O	prostanoid receptor agonist	PTGER1
LIMKi-3	56965901	BRD-K75373031	CC(C)C(=O)Nc1ncc(s1)-c1cc(nn1-c1c(Cl)cccc1Cl)C(F)F	LIM kinase inhibitor	LIMK1
limonin	179651	BRD-K05906022	CC1(C)O[C@H]2CC(=O)OC[C@@]22[C@H]1CC(=O)[C@]1(C)[C@@H]2CC[C@@]2(C)[C@@H](OC(=O)[C@H]3O[C@@]123)c1ccoc1	HIV protease inhibitor	
linaclotide	92044408	BRD-A55468767	C[C@@H](O)C1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(O)=O)NC3=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N2	guanylate cyclase activator	GUCY2C
linagliptin	10096344	BRD-K96550715	CC#CCn1c(nc2n(C)c(=O)n(Cc3nc(C)c4ccccc4n3)c(=O)c12)N1CCC[C@@H](N)C1	dipeptidyl peptidase inhibitor	DPP4
linalool	6549	BRD-A43082461	CC(C)=CCCC(C)(O)C=C	anticonvulsant	
lincomycin	5388973	BRD-K81447180	CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@@H](C)O)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@@H]1O	bacterial 30S ribosomal subunit inhibitor	
lindane		BRD-K93814253	Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl		GABRB1|GLRA1|GLRA2|GLRA3|GLRB
linezolid	441401	BRD-K66876909	CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCOCC2)c(F)c1	bacterial 50S ribosomal subunit inhibitor	MAOA|MAOB
linifanib	11485656	BRD-K99749624	Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1	PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor	CSF1|CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RET|TEK
linoleic-acid	5280450	BRD-K08973992	CCCCC\C=C/C\C=C/CCCCCCCC(O)=O	oxidative stress inducer	FABP4|FFAR1|FFAR4|HNF4A|KCNB1|PPARG|TRPM8
linopirdine	3932	BRD-K59332007	O=C1N(c2ccccc2C1(Cc1ccncc1)Cc1ccncc1)c1ccccc1	potassium channel blocker	KCNQ2|KCNQ3|KCNQ4|KCNQ5
linsidomine	65388	BRD-K86344238	Nc1c[n+](no1)N1CCOCC1	nitric oxide donor	
linsitinib		BRD-K86118762	C[C@@]1(O)C[C@@H](C1)c1nc(-c2ccc3ccc(nc3c2)-c2ccccc2)c2c(N)nccn12	IGF-1 inhibitor	IGF1R|INSR|INSRR
liothyronine	5920	BRD-K89152108	N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(O)=O	thyroid hormone stimulant	THRA|THRB
liothyronine-(isomer)	71212	BRD-K46428823	N[C@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(O)=O		
lipoamide	863	BRD-A14440173	NC(=O)CCCCC1CCSS1		
liraglutide	91978180	BRD-A48274390	CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C(CCC(O)=O)NC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)CNC(=O)C(CCC(O)=O)NC(=O)C(C)NC(=O)C(N)Cc1cnc[nH]1)C(C)O)C(C)O)C(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(Cc1ccccc1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CCCNC(N)=N)C(=O)NCC(O)=O)C(O)=O	GLP receptor agonist	GLP1R
liranaftate	3936	BRD-K35775715	COc1cccc(n1)N(C)C(=S)Oc1ccc2CCCCc2c1	fungal squalene epoxidase inhibitor	
lirimilast	6433118	BRD-K31339321	CS(=O)(=O)Oc1ccc2c(NC(N)=O)c(oc2c1)C(=O)c1ccc(Cl)cc1Cl	phosphodiesterase inhibitor	
lisadimate	8692	BRD-A76533773	Nc1ccc(cc1)C(=O)OCC(O)CO	topical sunscreen agent	
lisinopril	11865407	BRD-K67966701	NCCCC[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O	angiotensin converting enzyme inhibitor	ACE|ACE2
lisofylline	57782	BRD-A05334458	CC(O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O	interleukin receptor antagonist; STAT inhibitor	
lisuride	28864	BRD-K67943528	CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34	dopamine receptor agonist	ADRA1A|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6
lithium-acetoacetate	96	BRD-K73234506	CC(=O)CC(O)=O		
lithium-citrate		BRD-M41245765	[Li].[Li].[Li].OC(=O)CC(O)(CC(O)=O)C(O)=O		
lithocholic-acid	73707448	BRD-K04497194	C[C@H](CCC(O)=O)[C@@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	FXR antagonist; vitamin D receptor agonist	GPBAR1|NR1H4|NR1I2|VDR
litronesib	25167017	BRD-K83029223	CCNCCS(=O)(=O)NC[C@]1(SC(NC(=O)C(C)(C)C)=NN1C(=O)C(C)(C)C)c1ccccc1	kinesin-like spindle protein inhibitor	KIF11
lixivaptan	172997	BRD-K59391348	Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc23)c(Cl)c1	vasopressin receptor antagonist	AVPR2
LM-22A4	2054170	BRD-K70404782	OCCNC(=O)c1cc(cc(c1)C(=O)NCCO)C(=O)NCCO	tropomyosin receptor kinase inhibitor	NTRK2
LMI070		BRD-K08532119	CC1(C)CC(CC(C)(C)N1)Oc1ccc(nn1)-c1ccc(cc1O)-c1cn[nH]c1	survival motor neuron protein modulator	SMN1
LMK-235	71520717	BRD-K49921286	Cc1cc(C)cc(c1)C(=O)NOCCCCCC(=O)NO	HDAC inhibitor	HDAC4|HDAC5
LM11A-31	11959372	BRD-A04649065	CCC(C)C(N)C(=O)NCCN1CCOCC1	neurotrophic agent	NGFR
lobeline	101616	BRD-K66206289	CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1	acetylcholine receptor antagonist	CHRNA10|CHRNA9|SLC18A2
lobendazole	22752	BRD-K15834839	CCOC(=O)Nc1nc2ccccc2[nH]1	anthelmintic agent	
lobenzarit	3946	BRD-K55847762	OC(=O)c1ccccc1Nc1cc(Cl)ccc1C(O)=O	immunosuppressant	
lodoxamide	44564	BRD-K66937583	OC(=O)C(=O)Nc1cc(cc(NC(=O)C(O)=O)c1Cl)C#N	histamine receptor antagonist	
lofemizole	71967	BRD-K06388517	Cc1nc[nH]c1-c1ccc(Cl)cc1	cyclooxygenase inhibitor	
lofepramine	3947	BRD-K82147103	CN(CCCN1c2ccccc2CCc2ccccc12)CC(=O)c1ccc(Cl)cc1	norepinephrine reuptake inhibitor; serotonin norepinephrine reuptake inhibitor (SNRI)	HTR1A|SLC6A2|SLC6A4
lofexidine	30668	BRD-A02990301	CC(Oc1c(Cl)cccc1Cl)C1=NCCN1	adrenergic receptor agonist	ADRA2A
lomefloxacin	3948	BRD-A75850590	CCn1cc(C(O)=O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c12	bacterial DNA gyrase inhibitor	TOP2A
lomeguatrib	3025944	BRD-K27955832	Nc1nc(OCc2cc(Br)cs2)c2[nH]cnc2n1	O6-alkylguanine-DNA alkyltransferase inhibitor	MGMT
lomerizine	3949	BRD-K62858456	COc1ccc(CN2CCN(CC2)C(c2ccc(F)cc2)c2ccc(F)cc2)c(OC)c1OC	calcium channel blocker	CACNA1B|SCN5A
lometrexol	148138	BRD-K66036108	Nc1nc(O)c2C[C@@H](CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2n1	glycinamide ribonucleotide formyltransferase inhibitor	GART|MTHFD1
lomitapide	9853053	BRD-K92213669	FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)c2ccccc2-c2ccc(cc2)C(F)(F)F)c2ccccc2-c2ccccc12	microsomal trigylceride transfer protein inhibitor	MTTP
lomustine	3950	BRD-K51768138	[O-][N+]N(CCCl)C(=O)NC1CCCCC1	DNA synthesis inhibitor	STMN4
lonafarnib	148195	BRD-K41599323	NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]2c3ncc(Br)cc3CCc3cc(Cl)cc(Br)c23)CC1	farnesyltransferase inhibitor	FNTA|HRAS|KRAS|NRAS
lonidamine	39562	BRD-K78513633	OC(=O)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12	glucokinase inhibitor	GCK
loperamide	3955	BRD-K61250553	CN(C)C(=O)C(CCN1CCC(O)(CC1)c1ccc(Cl)cc1)(c1ccccc1)c1ccccc1	opioid receptor agonist	CACNA1A|CALM1|OPRD1|OPRK1|OPRM1|POMC
lopinavir	92727	BRD-K99451608	CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)COc1c(C)cccc1C)Cc1ccccc1	HIV protease inhibitor	
loracarbef	60747	BRD-A04915500	N[C@@H](C(=O)NC1C2CCC(Cl)=C(N2C1=O)C(O)=O)c1ccccc1	bacterial cell wall synthesis inhibitor	
loratadine	3957	BRD-K82795137	CCOC(=O)N1CCC(CC1)=C1c2ccc(Cl)cc2CCc2cccnc12	histamine receptor antagonist	HRH1
lorazepam	3958	BRD-A11990600	OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|TSPO
lorcaserin	11658860	BRD-K55013654	C[C@H]1CNCCc2ccc(Cl)cc12	serotonin receptor agonist	HTR2A|HTR2B|HTR2C
loreclezole	3034012	BRD-K09659835	Cl\C(=C/n1cncn1)c1ccc(Cl)cc1Cl	benzodiazepine receptor agonist	GABRB2|GABRB3
lorediplon	12004146	BRD-K42066335	CN(C(C)=O)c1cc(ccc1F)-c1ccnc2c(cnn12)C(=O)c1cccs1	GABA receptor modulator	GABRA1
lorglumide	3960	BRD-A29854054	CCCCCN(CCCCC)C(=O)C(CCC(O)=O)NC(=O)c1ccc(Cl)c(Cl)c1	CCK receptor antagonist	CCKAR|CCKBR
lorlatinib	71731823	BRD-K99879819	C[C@H]1Oc2cc(cnc2N)-c2c(CN(C)C(=O)c3ccc(F)cc13)nn(C)c2C#N	ALK tyrosine kinase receptor inhibitor	ALK
lornoxicam	17756939	BRD-A90551241	CN1C(C(=O)Nc2ccccn2)C(=O)c2sc(Cl)cc2S1(=O)=O	cyclooxygenase inhibitor	PTGS1|PTGS2
losartan	3961	BRD-K76205745	CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1	angiotensin receptor antagonist	AGTR1
losmapimod	11552706	BRD-K56195681	Cc1c(F)cc(cc1-c1ccc(cn1)C(=O)NCC(C)(C)C)C(=O)NC1CC1	p38 MAPK inhibitor	MAPK14
loteprednol	444025	BRD-K39983086	CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)OCCl	glucocorticoid receptor agonist; phospholipase inhibitor	NR3C1
lovastatin	53232	BRD-K09416995	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	HMGCR inhibitor	HDAC2|HMGCR|ITGAL|NR1I2
loxapine	3964	BRD-K39915878	CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12	dopamine receptor antagonist; serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4
loxistatin-acid	123664	BRD-K21937671	CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(O)=O	cysteine peptidase inhibitor	CTSB
LOXO-101	46188928	BRD-K36574127	O[C@H]1CCN(C1)C(=O)Nc1cnn2ccc(nc12)N1CCC[C@@H]1c1cc(F)ccc1F	tropomyosin receptor kinase inhibitor	NTRK1|NTRK2|NTRK3
loxoprofen	3965	BRD-A43082555	CC(C(O)=O)c1ccc(CC2CCCC2=O)cc1	cyclooxygenase inhibitor; prostanoid receptor antagonist	PTGS2
LPA2-antagonist-1	24882686	BRD-K32322923	C[C@@H](CN1CCN(CC1)S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ncnc2c(C)csc12	lysophosphatidic acid receptor antagonist	LPAR2
LRRK2-IN-1	46843906	BRD-K01436366	COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)C(=O)N1CCC(CC1)N1CCN(C)CC1	leucine rich repeat kinase inhibitor	LRRK2
LSN-2463359	72551298	BRD-K79337272	CC(C)NC(=O)c1ccc(cn1)C#Cc1ccncc1	glutamate receptor positive allosteric modulator	GRM5
LTA	10219864	BRD-K52914072	N=C(Nc1ccccc1)c1cccs1		
LTB4	5280492	BRD-K53124401	CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O	leukocyte activator	LTB4R|LTB4R2
Lu-AA-47070		BRD-K83970940	CC(C)(C)CC(=O)Nc1c(F)cc(cc1F)C(=O)\N=c1/sccn1COP(O)(O)=O	adenosine receptor antagonist	ADORA2A
lubiprostone	9800568	BRD-K33814251	CCCCC(F)(F)C(=O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O	chloride channel activator	CLCN2
lucitanib	25031915	BRD-K31309378	CNC(=O)c1cccc2cc(ccc12)Oc1ccnc2cc(OCC3(N)CC3)c(OC)cc12	FGFR inhibitor; VEGFR inhibitor	FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET
LUF-5834		BRD-K67079690	Nc1nc(SCc2ncc[nH]2)c(C#N)c(-c2ccc(O)cc2)c1C#N	adenosine receptor agonist	ADORA2A|ADORA2B
lufenuron	71777	BRD-A71774530	FC(C(F)(F)F)C(F)(F)Oc1cc(Cl)c(NC(=O)NC(=O)c2c(F)cccc2F)cc1Cl	chitin inhibitor	
luliconazole	3003141	BRD-K71058253	Clc1ccc([C@@H]2CS\C(S2)=C(\C#N)n2ccnc2)c(Cl)c1	sterol demethylase inhibitor	
lumacaftor	16678941	BRD-K69236721	Cc1ccc(NC(=O)C2(CC2)c2ccc3OC(F)(F)Oc3c2)nc1-c1cccc(c1)C(O)=O	CFTR channel agonist	CFTR
lumateperone	21302490	BRD-K10031916	CN1CCN2[C@H]3CCN(CCCC(=O)c4ccc(F)cc4)C[C@H]3c3cccc1c23	serotonin receptor antagonist; dopamine receptor modulator	DRD2|HTR2A
lumefantrine	6437380	BRD-A05926236	CCCCN(CCCC)CC(O)c1cc(Cl)cc2\C(=C/c3ccc(Cl)cc3)c3cc(Cl)ccc3-c12	antimalarial agent	ATP1A1
lumiracoxib	151166	BRD-K26901728	Cc1ccc(Nc2c(F)cccc2Cl)c(CC(O)=O)c1	cyclooxygenase inhibitor	PTGS1|PTGS2
lupanine	6708718	BRD-A92826379	O=C1CCCC2C3CC(CN12)[C@@H]1CCCCN1C3	sodium channel blocker	INS
lurasidone	213046	BRD-K51143828	O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12	dopamine receptor antagonist; serotonin receptor antagonist	ADRA2A|ADRA2C|DRD2|HTR1A|HTR2A|HTR7
lutein	5281243	BRD-K16742848	CC(\C=C\C=C(C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C	antioxidant	
luteolin	5280445	BRD-K05236810	Oc1cc(O)c2c(c1)oc(cc2=O)-c1ccc(O)c(O)c1	glucosidase inhibitor	TOP1
luzindole	122162	BRD-K67013324	CC(=O)NCCc1c(Cc2ccccc2)[nH]c2ccccc12	melatonin receptor antagonist	MTNR1A|MTNR1B
LXR-623	16734800	BRD-K54520417	Fc1ccc(cc1)-c1n(Cc2ccc(F)cc2Cl)nc2c(cccc12)C(F)(F)F	LXR agonist	AR|NR1H2|NR1H3|NR1I2|NR3C1
LX1031	23633604	BRD-K32101625	COc1cccc(c1)-c1ccc(cc1)[C@@H](Oc1cc(nc(N)n1)-c1ccc(C[C@H](N)C(O)=O)cc1)C(F)(F)F	tryptophan hydroxylase inhibitor	TPH1
LX7101	56962369	BRD-K21038058	CN(C)C(=O)Oc1cccc(NC(=O)C2(CN)CCN(CC2)c2ncnc3[nH]cc(C)c23)c1	LIM kinase inhibitor; rho associated kinase inhibitor	LIMK2|ROCK1|ROCK2
LY-404187	9928016	BRD-A50062753	CC(CNS(=O)(=O)C(C)C)c1ccc(cc1)-c1ccc(cc1)C#N	glutamate receptor positive allosteric modulator	GRIA1|GRIA2|GRIA3|GRIA4
lycopene	446925	BRD-K37083340	CC(C)=CCC\C(C)=C\C=C\C(C)=C\C=C\C(C)=C\C=C\C=C(C)\C=C\C=C(C)\C=C\C=C(/C)CCC=C(C)C	free radical scavenger	
lylamine	62034	BRD-K62289640	CC(C)c1ccc2c(CC[C@H]3[C@](C)(CN)CCC[C@]23C)c1	cannabinoid receptor agonist	CNR1
lymecycline	57319298	BRD-A15750551	CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)C1=O	bacterial 50S ribosomal subunit inhibitor	
lynestrenol	5857	BRD-K39707084	C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	progestogen hormone	
lypressin	644076	BRD-K93331255	NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O	vasopressin receptor agonist	AVPR1A|AVPR1B|AVPR2
LY2090314	10029385	BRD-K78055238	Fc1cc2CN(CCn3cc(C4=C(C(=O)NC4=O)c4cnc5ccccn45)c(c1)c23)C(=O)N1CCCCC1	glycogen synthase kinase inhibitor	GSK3B
LY2109761	11655119	BRD-K47557313	C(CN1CCOCC1)Oc1ccc2c(ccnc2c1)-c1c(nn2CCCc12)-c1ccccn1	TGF beta receptor inhibitor	TGFBR1|TGFBR2
LY2140023	9834591	BRD-K49519144	N[C@]1(CS(=O)(=O)[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O	glutamate receptor agonist	GRM3
LY215490	127894	BRD-K34313798	OC(=O)[C@@H]1C[C@H]2C[C@@H](CCc3nn[nH]n3)CC[C@H]2CN1	glutamate receptor antagonist	GRIA1|GRIA2|GRIA3|GRIA4|GRIK1
LY2157299	10090485	BRD-K78118466	Cc1cccc(n1)-c1nn2CCCc2c1-c1ccnc2ccc(cc12)C(N)=O	TGF beta receptor inhibitor	TGFBR1
LY2183240	11507802	BRD-K37865504	CN(C)C(=O)n1nnnc1Cc1ccc(cc1)-c1ccccc1	FAAH inhibitor; FAAH reuptake inhibitor	FAAH
LY2228820	11539025	BRD-K59227464	CC(C)(C)Cn1c(N)nc2ccc(nc12)-c1[nH]c(nc1-c1ccc(F)cc1)C(C)(C)C	p38 MAPK inhibitor	MAPK14
LY223982	6444688	BRD-K35367061	COc1ccc(\C=C\CCCCOc2ccc(cc2CCC(O)=O)C(=O)c2cccc(c2)C(O)=O)cc1	leukotriene receptor antagonist	LTB4R
LY225910	4355450	BRD-K33864865	CC(C)Oc1cccc(c1)-n1c(CCc2c[nH]c3ccc(Br)cc23)nc2ccccc2c1=O	CCK receptor antagonist	CCKBR
LY231617	3968	BRD-K85804405	CCNCc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C	lipid peroxidase inhibitor	
LY2334737	11646777	BRD-K04993719	CCCC(CCC)C(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1	antitumor agent; ribonucleotide reductase inhibitor	
LY2365109	11552757	BRD-K13888115	CN(CCOc1ccc(cc1C(C)(C)C)-c1ccc2OCOc2c1)CC(O)=O	Glycine transporter 1 inhibitor	SLC6A9
LY2452473	24963749	BRD-K90171280	CC(C)OC(=O)N[C@@H]1Cc2c(C1)c1cc(ccc1n2Cc1ccccn1)C#N	androgen receptor modulator	AR
LY255283	122023	BRD-K92492521	CCc1cc(C(C)=O)c(O)cc1OCCCCCC(C)(C)c1nnn[nH]1	leukotriene receptor antagonist	LTB4R|LTB4R2
LY2584702	25118925	BRD-K21833260	Cn1cc(nc1C1CCN(CC1)c1ncnc2[nH]ncc12)-c1ccc(F)c(c1)C(F)(F)F	ribosomal protein inhibitor	RPS6KB1
LY2603618	11955855	BRD-K14109347	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1	CHK inhibitor	CHEK1
LY2606368	46700756	BRD-K20463415	COc1cccc(OCCCN)c1-c1cc(Nc2cnc(cn2)C#N)n[nH]1	CHK inhibitor	CHEK1
LY2608204	46832368	BRD-K12068470	O=C(Nc1ncc(SCCN2CCCC2)s1)[C@@]1(C[C@H]1C1CCCCC1)c1ccc(cc1)S(=O)(=O)C1CC1	glucokinase activator	GCK
LY266097	9953185	BRD-A64004759	COc1ccc(CC2NCCc3c2[nH]c2ccc(C)cc32)c(Cl)c1OC	serotonin receptor antagonist	HTR2B
LY2784544	46213929	BRD-K25630527	Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)[nH]n1	JAK inhibitor	JAK2|JAK3
LY2801653	44603533	BRD-K18961567	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1	MET inhibitor	MET
LY2811376	44251605	BRD-K94534639	C[C@]1(CCSC(N)=N1)c1cc(c(F)cc1F)-c1cncnc1	beta-secretase inhibitor	BACE1
LY2857785		BRD-K15382985	CC(C)c1n(C)nc2ccc(cc12)-c1ccnc(N[C@H]2CC[C@@H](CC2)NC2CCOCC2)n1	CDK inhibitor	CDK9
LY2874455	46944259	BRD-K17203476	C[C@@H](Oc1ccc2[nH]nc(\C=C\c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl	FGFR antagonist	FGFR1|FGFR2|FGFR3|FGFR4|KDR
LY288513	2802894	BRD-K24675965	Brc1ccc(NC(=O)N2NC(=O)[C@H]([C@@H]2c2ccccc2)c2ccccc2)cc1	CCK receptor antagonist	CCKBR
LY2886721	73265271	BRD-K17953908	NC1=N[C@]2(COC[C@@H]2CS1)c1cc(NC(=O)c2ccc(F)cn2)ccc1F	beta-secretase inhibitor	BACE1
LY294002	3973	BRD-K27305650	O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1	mTOR inhibitor; PI3K inhibitor; DNA dependent protein kinase inhibitor; phosphodiesterase inhibitor; PLK inhibitor	AKT1|CHEK1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PLK1|PRKCA|PRKDC|ROCK1|RPS6KB1|SGK1
LY2979165	53246986	BRD-K68220839	C[C@H](N)C(=O)N[C@]1(C[C@@H](Sc2nnc[nH]2)[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O	glutamate receptor agonist	GRM2
LY3000328	67475270	BRD-K21070437	CNC(=O)O[C@H]1COc2ccc(cc2[C@@H]1NC(=O)c1ccc(F)cc1)N1CCN(CC1)C1COC1	cathepsin inhibitor	CTSS
LY3009120	71721540	BRD-K38385169	CNc1ncc2cc(c(C)nc2n1)-c1cc(NC(=O)NCCC(C)(C)C)c(F)cc1C	RAF inhibitor	BRAF|RAF1
LY3023414	57519748	BRD-K82967180	CO[C@@H](C)Cn1c2c(cnc3ccc(cc23)-c2cncc(c2)C(C)(C)O)n(C)c1=O	PI3K inhibitor; mTOR inhibitor	MTOR
LY303511	3971	BRD-K22385716	O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCNCC1	casein kinase inhibitor; mTOR inhibitor; PI3K inhibitor	BRD2|BRD3|BRD4
LY310762	4282258	BRD-K41194171	CC1(C)C(=O)N(CCN2CCC(CC2)C(=O)c2ccc(F)cc2)c2ccccc12	serotonin receptor antagonist	HTR1D
LY320135	5311257	BRD-K78637815	COc1ccc(cc1)-c1oc2cc(OC)ccc2c1C(=O)c1ccc(cc1)C#N	cannabinoid receptor antagonist	CNR1
LY344864	5311097	BRD-K95899059	CN(C)[C@@H]1CCc2[nH]c3ccc(NC(=O)c4ccc(F)cc4)cc3c2C1	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR7
LY364947	447966	BRD-K06234293	c1[nH]nc(c1-c1ccnc2ccccc12)-c1ccccn1	TGF beta receptor inhibitor; p38 MAPK inhibitor	TGFBR1
LY393558	10347428	BRD-K08534264	CC(C)N1Cc2cc(ccc2N(CCN2CCC(=CC2)c2c[nH]c3cc(F)ccc23)S1(=O)=O)S(C)(=O)=O	serotonin receptor antagonist	HTR1B|HTR1D|HTR2A|HTR2B
LY411575	10435235	BRD-K20013301	C[C@H](NC(=O)[C@@H](O)c1cc(F)cc(F)c1)C(=O)N[C@H]1c2ccccc2-c2ccccc2N(C)C1=O	gamma secretase inhibitor	
LY450108	9843690	BRD-K54538117	C[C@@H](CNS(=O)(=O)C(C)C)c1ccc(NC(=O)c2cc(F)cc(F)c2)cc1	glutamate receptor modulator	
LY456236	9926999	BRD-K87696786	COc1ccc(Nc2ncnc3ccc(OC)cc23)cc1	glutamate receptor antagonist	GRM1
m-Chlorophenylbiguanide	1354	BRD-K36965586	NC(=N)NC(=N)Nc1cccc(Cl)c1		HTR3A|HTR3B
m-THP		BRD-K91147684	Oc1cccc(c1)-c1c2ccc(n2)c(-c2cccc(O)c2)c2ccc([nH]2)c(-c2cccc(O)c2)c2ccc(n2)c(-c2cccc(O)c2)c2ccc1[nH]2		
M-14157	1825	BRD-A96977263	CCCCCC(O)CCCC(O)=O	ATP-sensitive potassium channel antagonist	KCNQ1
M-25	44250034	BRD-K51265828	CCCC(CCC)C(=O)NCc1ccc2n(ncc2c1)-c1ccccc1OC	smoothened receptor antagonist	DHH|IHH|SMO
m-3M3FBS	761523	BRD-K09635314	Cc1cc(C)c(c(C)c1)S(=O)(=O)Nc1cccc(c1)C(F)(F)F		PLCB2|PLCB3|PLCD1|PLCG1|PLCG2
M-344	3994	BRD-K45528773	CN(C)c1ccc(cc1)C(=O)NCCCCCCC(=O)NO	HDAC inhibitor	
mabuprofen	71261	BRD-A93683007	CC(C)Cc1ccc(cc1)C(C)C(=O)NCCO	cyclooxygenase inhibitor	
mabuterol	3995	BRD-A13116749	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(c1)C(F)(F)F	adrenergic receptor agonist	ADRB2
macelignan	10404245	BRD-K94948151	COc1cc(C[C@H](C)[C@H](C)Cc2ccc3OCOc3c2)ccc1O	antioxidant; antiinflammatory agent	
macitentan	16004692	BRD-K48812570	CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1	endothelin receptor antagonist	EDNRA|EDNRB
madrasin	816255	BRD-K48905682	COc1ccc2c(C)nc(Nc3nc(C)c(C)c(O)n3)nc2c1	cell splicing inhibitor	
mafenide	3998	BRD-K30649484	NCc1ccc(cc1)S(N)(=O)=O	carbonic anhydrase inhibitor	CA12|CA14|CA2|CA4|CA6|CA9
magnolol	72300	BRD-K26168087	Oc1ccc(CC=C)cc1-c1cc(CC=C)ccc1O	PPAR receptor agonist	GABRA1|PPARG
malathion	4004	BRD-A01976766	CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC	cholinesterase inhibitor	ACHE|BCHE
malic-acid	20130941	BRD-A18396475	OC(CC(O)=O)C(O)=O		CS|ME2|PKD2L1
malotilate	4006	BRD-K97884852	CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1	protein synthesis stimulant	
maltobionic-acid	7314	BRD-K01624185	OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)C(O)=O	matrix metalloprotease inhibitor	
mandelic-acid	1292	BRD-A91448670	OC(C(O)=O)c1ccccc1		
mangafodipir	131704299	BRD-K57365211	Cc1nc(COP(O)(O)=O)cc2CN(CC(O)=O)CCN(CC(O)=O)Cc3cc(COP(O)(O)=O)nc(C)c3O[Mn]Oc12	contrast agent	
manidipine	4008	BRD-A90695733	COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(c1ccccc1)c1ccccc1	calcium channel blocker	CACNA1C|CACNA1D
mannitol-D	5780	BRD-K66035042	OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO	diuretic	
maprotiline	4011	BRD-K25433859	CNCCCC12CCC(c3ccccc13)c1ccccc21	norepinephrine reputake inhibitor; tricyclic antidepressant	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR2A|HTR2C|HTR7|SLC6A2
maraviroc	483407	BRD-A04352665	CC(C)c1nnc(C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1	CC chemokine receptor antagonist	CCR5
marbofloxacin	1616426	BRD-K71926323	CN1CCN(CC1)c1c(F)cc2c3c1OCN(C)n3cc(C(O)=O)c2=O	bacterial DNA gyrase inhibitor	
maribavir	471161	BRD-K59524082	CC(C)Nc1nc2cc(Cl)c(Cl)cc2n1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O	cytomegalovirus inhibitor; protein kinase inhibitor	PYGM
marimastat	119031	BRD-K21396683	CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C	matrix metalloprotease inhibitor	MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9
maropitant	204108	BRD-K76594255	COc1ccc(cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1)C(C)(C)C	neurokinin receptor antagonist	TACR1
masitinib	10074640	BRD-K71035033	CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1	KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; src inhibitor	FGFR3|KIT|PDGFRA|PDGFRB
masoprocol	4534	BRD-A87130939	CC(Cc1ccc(O)c(O)c1)C(C)Cc1ccc(O)c(O)c1	lipoxygenase inhibitor	ALOX5
matrine	7075140	BRD-K25312248	O=C1CCC[C@@H]2[C@@H]3CCCN4CCC[C@H](CN12)[C@@H]34	opioid receptor agonist	OPRK1
mavoglurant	9926832	BRD-K07790550	COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#Cc1cccc(C)c1	glutamate receptor antagonist	GRM5
maxacalcitol	66577028	BRD-K81332461	[2H]C([2H])([2H])C(O)(CCO[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C)C([2H])([2H])[2H]	vitamin D receptor agonist	VDR
maytansinol-isobutyrate	5282049	BRD-K15898725	CO[C@@H]1\C=C\C=C(C)\Cc2cc(OC)c(Cl)c(c2)N(C)C(=O)C[C@H](OC(=O)C(C)C)[C@]2(C)O[C@H]2[C@H](C)[C@@H]2C[C@@]1(O)NC(=O)O2		
mazindol	4020	BRD-A68464583	OC1(N2CCN=C2c2ccccc12)c1ccc(Cl)cc1	dopamine reuptake inhibitor; selective serotonin reuptake inhibitor (SSRI)	SLC6A2|SLC6A3|SLC6A4
MBX-2982	25025505	BRD-K32218650	CCc1cnc(nc1)N1CCC(CC1)c1nc(COc2ccc(cc2)-n2cnnn2)cs1	glucose dependent insulinotropic receptor agonist	GPR119
MC-1	1051	BRD-K50712474	Cc1ncc(COP(O)(O)=O)c(C=O)c1O		AADAT|ABAT|AGXT|AGXT2|ALAS1|AZIN2|BCAT1|BCAT2|CBS|CCBL1|CCBL2|CSAD|CTH|DDC|FTCD|GAD1|GAD2|GADL1|GCAT|GLDC|GOT1|GOT2|GPT|GPT2|HDC|IGSF10|KYNU|MOCOS|NFS1|OAT|ODC1|PDXDC1|PDXP|PHYKPL|PNPO|PROSC|PSAT1|PYGB|PYGL|PYGM|SCLY|SDS|SDSL|SEPSECS|SGPL1|SHMT1|SHMT2|SPTLC1|SPTLC2|SPTLC3|SRR|TAT|THNSL1
MCC950	9910393	BRD-K55418700	CC(C)(O)c1coc(c1)S(=O)(=O)NC(=O)Nc1c2CCCc2cc2CCCc12	NOD like receptor inhibitor	NLRP3
McN-5652-(+/-)	6336338	BRD-K31168993	CSc1ccc(cc1)[C@H]1CN2CCC[C@H]2c2ccccc12	selective serotonin reuptake inhibitor (SSRI)	
MCOPPB	24800108	BRD-K73276278	CC1(CCCCCCC1)N1CCC(CC1)n1c(nc2ccccc12)[C@@H]1CCCNC1	nociceptin/orphanin FQ (NOP) receptor agonist	OPRL1
mCPP	1355	BRD-K75844781	Clc1cccc(c1)N1CCNCC1	serotonin receptor agonist	HTR1A|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR6
MC1568	71311876	BRD-K24031866	Cn1c(\C=C\C(=O)NO)ccc1\C=C\C(=O)c1cccc(F)c1	HDAC inhibitor	HDAC2
MD-920	6466	BRD-K92758126	C[C@@]12[C@H]3[C@H](C(O)=O)[C@@]45CC(=C)[C@@](O)(C4)CC[C@H]5[C@]3(OC1=O)C=C[C@@H]2O	NFkB pathway inhibitor	AADACL2
mdivi-1	3825829	BRD-K61128465	COc1cc(c(Cl)cc1Cl)-n1c(=S)[nH]c2ccccc2c1=O	dynamin inhibitor	DNM1
MDL-11939	71781	BRD-A62057054	OC(C1CCN(CCc2ccccc2)CC1)c1ccccc1	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C
MDL-27531	164013	BRD-K50888640	Cn1c(nnc1S(C)(=O)=O)-c1ccccc1	glycine receptor agonist	
MDL-29951	446916	BRD-K59753853	OC(=O)CCc1c([nH]c2cc(Cl)cc(Cl)c12)C(O)=O	glutamate receptor antagonist	FBP1
MDL-72832	182585	BRD-A17453586	O=C1CC2(CCCC2)CC(=O)N1CCCCNCC1COc2ccccc2O1	serotonin receptor agonist	HTR1A
MDL-73005EF	60769	BRD-A50764878	O=C1CC2(CCCC2)CC(=O)N1CCNCC1COc2ccccc2O1	serotonin receptor antagonist	HTR1A
MDMS	9083	BRD-K70840370	CS(=O)(=O)OCOS(C)(=O)=O	DNA inhibitor	
ME-0328	71571526	BRD-K24283677	C[C@H](NC(=O)CCc1nc2ccccc2c(=O)[nH]1)c1ccccc1	PPAR receptor antagonist	PARP3
mebendazole	4030	BRD-K77987382	COC(=O)Nc1nc2ccc(cc2[nH]1)C(=O)c1ccccc1	tubulin polymerization inhibitor	TUBA1A|TUBB|TUBB4B
mebeverine	4031	BRD-A09467419	CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1	acetylcholine receptor antagonist	CHRM1
mebhydrolin	22530	BRD-K29713308	CN1CCc2c(C1)c1ccccc1n2Cc1ccccc1	antihistamine	
mebhydroline-1,5-naphtalenedisulfonate	22530	BRD-K29713308	CN1CCc2c(C1)c1ccccc1n2Cc1ccccc1		
mebicar	122282	BRD-K76606751	CN1C2C(N(C)C1=O)N(C)C(=O)N2C	anxiolytic	
mebrofenin	54158	BRD-K96691275	Cc1cc(C)c(NC(=O)CN(CC(O)=O)CC(O)=O)c(C)c1Br		
mecamylamine	4032	BRD-A20119038	CNC1(C)C2CCC(C2)C1(C)C	acetylcholine receptor antagonist	CHRNA1|CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7
mecarbinate	616236	BRD-K28405228	CCOC(=O)c1c(C)n(C)c2ccc(O)cc12		
mechlorethamine	4033	BRD-K12829205	CN(CCCl)CCCl	DNA inhibitor	
meclinertant	119192	BRD-K25075681	COc1cccc(OC)c1-c1cc(nn1-c1ccnc2cc(Cl)ccc12)C(=O)NC1(C2CC3CC(C2)CC1C3)C(O)=O	neurotensin receptor antagonist	NTSR1|NTSR2
meclizine	4034	BRD-A50311610	Cc1cccc(CN2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)c1	constitutive androstane receptor (CAR) agonist	HRH1|NR1I3
meclocycline-sulfosalicylate	91414619	BRD-A07600638	CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)ccc(Cl)c4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O	bacterial 50S ribosomal subunit inhibitor	
meclofenamic-acid	4037	BRD-K50398167	Cc1ccc(Cl)c(Nc2ccccc2C(O)=O)c1Cl	cyclooxygenase inhibitor; prostanoid receptor antagonist	ALOX5|CNR1|KCNQ2|KCNQ3|PTGS1|PTGS2
meclofenoxate	4039	BRD-K10314788	CN(C)CCOC(=O)COc1ccc(Cl)cc1	nootropic agent	
mecysteine	4040	BRD-A77473570	COC(=O)C(N)CS	analgesic agent	
medetomidine	68602	BRD-A21607826	CC(c1c[nH]cn1)c1cccc(C)c1C	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
medica-16	121871	BRD-K92908289	CC(C)(CCCCCCCCCCC(C)(C)CC(O)=O)CC(O)=O	ATP citrase lyase inhibitor	FFAR1
medorinone	5362132	BRD-K40715924	Cc1nccc2[nH]c(=O)ccc12		
medronic-acid	16124	BRD-K94072573	OP(O)(=O)CP(O)(O)=O	bone resorption inhibitor	
medroxyprogesterone	10631	BRD-K99615199	C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(C)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CCC(=O)C=C12	progesterone receptor agonist	ESR1|PGR
medroxyprogesterone-acetate	5702080	BRD-A61221616	C[C@H]1CC2C3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CCC2[C@@]2(C)CCC(=O)C=C12	progesterone receptor agonist	
medrysone	44308022	BRD-A59014912	C[C@H]1CC2C3CCC(C(C)=O)C3(C)CC(O)C2C2(C)CCC(=O)C=C12	glucocorticoid receptor agonist	NR3C1
mefenamic-acid	4044	BRD-K92778217	Cc1cccc(Nc2ccccc2C(O)=O)c1C	cyclooxygenase inhibitor	KCNQ1|PTGS1|PTGS2|TRPM3
mefexamide	4045	BRD-K20655524	CCN(CC)CCNC(=O)COc1ccc(OC)cc1	psychoactive drug	
mefloquine	4046	BRD-A89585551	OC(C1CCCCN1)c1cc(nc2c(cccc12)C(F)(F)F)C(F)(F)F	adenosine receptor antagonist; hemoglobin antagonist	ADORA2A|HBA1
megestrol-acetate	11683	BRD-K19507340	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O	progesterone receptor agonist	NR3C1|PGR
meglitinide	41214	BRD-K51324732	COc1ccc(Cl)cc1C(=O)NCCc1ccc(cc1)C(O)=O	potassium channel blocker	CCR2
meglumine	8567	BRD-K28595280	CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO	excipient	
meglutol	1662	BRD-K00495673	CC(O)(CC(O)=O)CC(O)=O	HMGCR inhibitor	HMGCR
meisoindigo	5479433	BRD-K14529030	CN1C(=O)\C(c2ccccc12)=C1\C(=O)Nc2ccccc12	STAT inhibitor	STAT3
MEK1-2-inhibitor	9549284	BRD-K12244279	N\C(Sc1ccc(N)cc1)=C(\C#N)c1ccccc1C(F)(F)F	MEK inhibitor	MAP2K2
MEK162	10288191	BRD-K82244583	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(cc12)C(=O)NOCCO	MEK inhibitor	MAP2K1|MAP2K2
melatonin	896	BRD-K97530723	COc1ccc2[nH]cc(CCNC(C)=O)c2c1	melatonin receptor agonist; nitric oxide synthase inhibitor	ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB
meldonium	123869	BRD-K79392608	C[N+](C)(C)NCCC(O)=O	gamma butyrobetaine hydroxylase inhibitor	BBOX1
melengestrol-acetate	45006159	BRD-A42746051	CC(=O)O[C@]1(C(C)=O)C(=C)CC2C3C=C(C)C4=CC(=O)CC[C@]4(C)C3CC[C@]12C	progesterone receptor agonist	
melevodopa	424631	BRD-A25827085	COC(=O)C(N)Cc1ccc(O)c(O)c1	dopamine precursor; dopamine receptor agonist	DDC
meloxicam	10291556	BRD-A84174393	CN1C(C(=O)Nc2ncc(C)s2)C(=O)c2ccccc2S1(=O)=O	cyclooxygenase inhibitor	PTGS1|PTGS2
melperone	15387	BRD-K92984783	CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1	dopamine receptor antagonist; serotonin receptor antagonist	DRD2|HTR2A
melphalan	460612	BRD-K87827419	N[C@@H](Cc1ccc(cc1)N(CCCl)CCCl)C(O)=O	DNA alkylating agent; DNA inhibitor	
melphalan-n-oxide	11234795	BRD-K36394566	N[C@@H](Cc1ccc(cc1)[N+]([O-])(CCCl)CCCl)C(O)=O	hypoxia inducible factor inhibitor	HIF1A
meluadrine	162846	BRD-A07164067	CC(C)(C)NCC(O)c1ccc(O)cc1Cl		
memantine	4054	BRD-A79803969	CC12CC3CC(C)(C1)CC(N)(C3)C2	glutamate receptor antagonist	CHRFAM7A|DRD2|GRIN1|GRIN2A|GRIN2B|GRIN3A|HTR3A
menadione	4055	BRD-K78126613	CC1=CC(=O)c2ccccc2C1=O	mitochondrial DNA polymerase inhibitor; phosphatase inhibitor	AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1
menadione-bisulfite	8536	BRD-A19777893	CC1(CC(=O)c2ccccc2C1=O)S(O)(=O)=O	vitamin K	GGCX|VKORC1|VKORC1L1
menatetrenone	5282367	BRD-K75864342	CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC1=C(C)C(=O)c2ccccc2C1=O	bone resorption inhibitor	
menbutone	71818	BRD-K53852914	COc1ccc(C(=O)CCC(O)=O)c2ccccc12		
mepacrine	237	BRD-A45889380	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12	cytokine production inhibitor; NFkB pathway inhibitor; TP53 activator	PLA2G1B|PLA2G4A|PLA2G6|PLCL1
meparfylon	6494	BRD-A11662333	CCC(C)(O)C#C		
mepazine	6075	BRD-A82772293	CN1CCCC(CN2c3ccccc3Sc3ccccc23)C1	MALT1 inhibitor (JH)	MALT1
mepenzolate	4057	BRD-A62421304	C[N+]1(C)CCCC(C1)OC(=O)C(O)(c1ccccc1)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM3
mephenesin	4059	BRD-A55469827	Cc1ccccc1OCC(O)CO	muscle relaxant	
mephentermine	3677	BRD-K18194590	CNC(C)(C)Cc1ccccc1	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3
mephenytoin	4060	BRD-A83937277	CCC1(NC(=O)N(C)C1=O)c1ccccc1	hydantoin antiepileptic	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
mepiroxol	71668	BRD-K78299798	OCc1ccc[n+]([O-])c1		
mepivacaine	4062	BRD-A03216249	CN1CCCCC1C(=O)Nc1c(C)cccc1C	potassium channel blocker; sodium channel blocker	SCN10A
meprednisone	5284587	BRD-K18207669	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO		NR3C1
meprobamate	4064	BRD-K19180152	CCCC(C)(COC(N)=O)COC(N)=O		GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ
meprylcaine	4065	BRD-K65417056	CCCNC(C)(C)COC(=O)c1ccccc1	local anesthetic	
meptazinol	41049	BRD-A02710418	CCC1(CCCCN(C)C1)c1cccc(O)c1	opioid receptor agonist	BCHE
mepyramine	4992	BRD-K97564742	COc1ccc(cc1)CN(CCN(C)C)c1ccccn1	histamine receptor antagonist	HRH1
mequinol	9015	BRD-K45216060	COc1ccc(O)cc1		TYR
merbarone	4990817	BRD-K45152786	O=C(Nc1ccccc1)C1C(=O)NC(=S)NC1=O	topoisomerase inhibitor	TOP2A
merbromin		BRD-K21771665	O[Hg]c1c(O)c(Br)cc2c(-c3ccccc3C(O)=O)c3cc(Br)c(=O)cc3oc12	antiseptic	
mercaptopurine	667490	BRD-K91601245	S=c1[nH]cnc2nc[nH]c12	immunosuppressant; protein synthesis inhibitor; purine antagonist	HPRT1|IMPDH1|IMPDH2|PPAT
mercaptosuccinic-acid	6268	BRD-A43435802	OC(=O)CC(S)C(O)=O		
mericitabine	16122663	BRD-K69726595	CC(C)C(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@](C)(F)[C@@H]1OC(=O)C(C)C	HCV inhibitor	
merimepodib	153241	BRD-K09372874	COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1-c1cnco1	inosine monophosphate dehydrogenase inhibitor	IMPDH1
meropenem	40466974	BRD-K01612348	C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)=C(N2C1=O)C(O)=O	bacterial cell wall synthesis inhibitor	
mesalazine	122508122	BRD-K28849549	Nc1ccc(O)c(c1)C(O)=O	cyclooxygenase inhibitor; lipoxygenase inhibitor; prostanoid receptor antagonist	ALOX5|CHUK|IKBKB|MPO|PPARG|PTGS1|PTGS2
mesna	598	BRD-K49954789	OS(=O)(=O)CCS	antioxidant	
mesoridazine	4078	BRD-A14395271	CN1CCCCC1CCN1c2ccccc2Sc2ccc(cc12)S(C)=O	dopamine receptor antagonist	DRD2|HTR2A
mestinon	4991	BRD-K69688083	CN(C)C(=O)Oc1ccc[n+](C)c1	cholinesterase inhibitor	ACHE|BCHE
mestranol	6291	BRD-K31920458	COc1ccc2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@@H]3CCc2c1	estrogen receptor agonist	ESR1
mesulergine	68848	BRD-K91336023	CN(C)S(=O)(=O)N[C@H]1C[C@H]2[C@@H](Cc3cn(C)c4cccc2c34)N(C)C1	dopamine receptor agonist	HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|HTR7
meta-cresyl-acetate	67406	BRD-K33442414	CC(=O)Oc1cccc(C)c1		
metacetamol	12124	BRD-K16474819	CC(=O)Nc1cccc(O)c1	analgesic agent	
metacresol	342	BRD-K22518984	Cc1cccc(O)c1		INS
metafolin	444412	BRD-K28580965	CN1[C@@H](CNc2ccc(cc2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2nc(N)[nH]c(=O)c12		AMT
metamizole	3111	BRD-K76812510	CN(CS(O)(=O)=O)c1c(C)n(C)n(-c2ccccc2)c1=O	cyclooxygenase inhibitor; opioid receptor agonist	PTGS1
metaphit	114745	BRD-K95701999	S=C=Nc1cccc(c1)C1(CCCCC1)N1CCCCC1	phencyclidine receptor acylator	
metaproterenol	4086	BRD-A07780951	CC(C)NCC(O)c1cc(O)cc(O)c1	adrenergic receptor agonist	ADRB2
metaraminol	5906	BRD-K96253961	C[C@H](N)[C@H](O)c1cccc(O)c1	adrenergic receptor agonist	ADRA1A
metatinib	44155856	BRD-K27182532	Nc1nccc(Oc2ccc(NC(=O)c3c[nH]cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl	Bcr-Abl kinase inhibitor	ABL1|BCR
metaxalone	15459	BRD-A94709349	Cc1cc(C)cc(OCC2CNC(=O)O2)c1	muscle relaxant	
metazosin	93514	BRD-A78277353	COC(C)C(=O)N1CCN(CC1)c1nc(N)c2cc(OC)c(OC)cc2n1	adrenergic receptor antagonist	ADRA1A
metenkephalin	42785	BRD-A38218502	CSCCC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)C(N)Cc1ccc(O)cc1)C(O)=O	immunostimulant	OPRD1
metergoline	28693	BRD-K56699285	CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@H]2[C@H]1Cc1cn(C)c3cccc2c13	dopamine receptor agonist; serotonin receptor antagonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
metformin	4091	BRD-K79602928	CN(C)C(=N)NC(N)=N	insulin sensitizer	ACACB|PRKAB1
methacholine	1993	BRD-A18056626	CC(C[N+](C)(C)C)OC(C)=O	acetylcholine receptor agonist	CHRM2|CHRM3|CHRM4
methacycline	44246715	BRD-A49035384	CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O	protein synthesis inhibitor	
methanesulfonyl-fluoride	11207	BRD-K53896891	CS(F)(=O)=O	acetylcholinesterase inhibitor	ACHE
methantheline	4097	BRD-K09859624	CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc12	acetylcholine receptor antagonist	CHRM1|HRH2
methapyrilene	4098	BRD-K47323024	CN(C)CCN(Cc1cccs1)c1ccccn1	histamine receptor antagonist	HRH1
metharbital	4099	BRD-K88143662	CCC1(CC)C(=O)NC(=O)N(C)C1=O	GABA receptor modulator	CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2
methazolamide	4100	BRD-K13356952	CC(=O)N=c1sc(nn1C)S(N)(=O)=O	carbonic anhydrase inhibitor	CA1|CA12|CA14|CA2|CA4|CA7
methenamine	4101	BRD-K30114692	C1N2CN3CN1CN(C2)C3	bacterial DNA inhibitor	
methiazole	6604471	BRD-K02764365	COC(=O)Nc1nc2cc(SC(C)C)ccc2[nH]1	anthelmintic agent	
methicillin	6087	BRD-K34388247	COc1cccc(OC)c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O	bacterial cell wall synthesis inhibitor	
methimazole	1349907	BRD-K54416256	Cn1cc[nH]c1=S	antithyroid agent	TPO
methionine	5255805	BRD-A39515206	CSCCC(N)C(O)=O		BHMT|BHMT2|METAP2|MTR|MTRR
methiopril	2772126	BRD-A32172948	CC1CCCC(N1C(=O)CCSC(C)=O)C(O)=O	angiotensin converting enzyme inhibitor	ACE
methocarbamol	4107	BRD-A31521121	COc1ccccc1OCC(O)COC(N)=O	muscle relaxant	CA1
methoprene-(s)	1711973	BRD-K34591242	COC(C)(C)CCC[C@H](C)C\C=C\C(C)=C\C(=O)OC(C)C		
methotrexate	126941	BRD-K59456551	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(cc1)C(=O)N[C@@H](CCC(O)=O)C(O)=O	dihydrofolate reductase inhibitor	DHFR
methoxamine	6082	BRD-A39189014	COc1ccc(OC)c(c1)C(O)C(C)N	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D
methoxsalen	4114	BRD-K63430059	COc1c2occc2cc2ccc(=O)oc12	DNA synthesis inhibitor	CYP1A1|CYP1A2|CYP2A13|CYP2A6|CYP3A4
methoxyamine	4113	BRD-K79277568	CON	DNA repair enzyme inhibitor	APEX1
methoxyflurane	4116	BRD-K06152156	COC(F)(F)C(Cl)Cl	membrane permeability inhibitor	ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|MT-ND1
methoxyphenamine	4117	BRD-A21474126	CNC(C)Cc1ccccc1OC	adrenergic receptor agonist	
methscopolamine		BRD-K48619321	C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3
methsuximide	6476	BRD-A57592049	CN1C(=O)CC(C)(C1=O)c1ccccc1	T-type calcium channel binder	CACNA1G|CACNA1H|CACNA1I
methyclothiazide	4121	BRD-A95340155	CN1C(CCl)Nc2cc(Cl)c(cc2S1(=O)=O)S(N)(=O)=O	chloride reabsorption inhibitor	CA1|CA2|CA4|SLC12A1|SLC12A3
methyl-aminolevulinate	157922	BRD-K01292611	COC(=O)CCC(=O)CN	oxidizing agent	FCGR1A|FECH
methyl-nicotinate	7151	BRD-K10132944	COC(=O)c1cccnc1		
methyl-salicylate	4133	BRD-K10103010	COC(=O)c1ccccc1O		
methylatropine-nitrate	5861	BRD-A52460047	C[N+]1(C)C2CCC1CC(C2)OC(=O)C(CO)c1ccccc1	acetylcholine receptor antagonist	CHRM1
methylbenzethonium-chloride	4135	BRD-K46531780	Cc1cc(ccc1OCCOCC[N+](C)(C)Cc1ccccc1)C(C)(C)CC(C)(C)C	other antibiotic	
methyldopa	38853	BRD-K48578705	C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C|DDC
methyldopate	17277	BRD-K82259334	CCOC(=O)[C@@](C)(N)Cc1ccc(O)c(O)c1		
methylene-blue	4139	BRD-K16406336	CN(C)c1ccc2nc3ccc(cc3[s+]c2c1)N(C)C	guanylyl cyclase inhibitor; nitric oxide production inhibitor	ACHE
methylergometrine	8226	BRD-K34685430	CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34	dopamine receptor antagonist; serotonin receptor antagonist	DRD1|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C
methyllycaconitine	5288811	BRD-K43192255	CCN1C[C@]2(COC(=O)c3ccccc3N3C(=O)C[C@H](C)C3=O)CC[C@H](OC)[C@@]34[C@@H]5C[C@H]6[C@H](OC)[C@@H]5[C@](O)(C[C@@H]6OC)[C@@](O)([C@@H](OC)[C@H]23)[C@@H]14	acetylcholine receptor antagonist	CHRNA7
methylnaltrexone	124835980	BRD-K33732501	C[N@@+]1(CC2CC2)CC[C@@]23[C@H]4Oc5c2c(C[C@@H]1[C@@]3(O)CCC4=O)ccc5O	opioid receptor antagonist	OPRD1|OPRK1|OPRM1
methylparaben	7456	BRD-K78321730	COC(=O)c1ccc(O)cc1	other antifungal	
methylphenidate	4158	BRD-A19585813	COC(=O)C(C1CCCCN1)c1ccccc1	dopamine norepinephrine reuptake inhibitor	SLC6A2|SLC6A3|SLC6A4
methylprednisolone	6741	BRD-K35240538	C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12	glucocorticoid receptor agonist	NR3C1
methylprednisolone-aceponate	63019	BRD-K24452555	CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O	anti-inflammatory agent; glucocorticoid receptor agonist	NR3C1
methylprednisolone-sodium-succinate	24069687	BRD-A45044890	C[C@H]1CC2C3CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]3(C)C[C@H](O)C2[C@@]2(C)C=CC(=O)C=C12	glucocorticoid receptor agonist	
methylthiouracil	667493	BRD-K11900042	Cc1cc(=O)[nH]c(=S)[nH]1		
methysergide	9681	BRD-K35941380	CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34	serotonin receptor antagonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
meticrane	4165	BRD-K58265391	Cc1cc2CCCS(=O)(=O)c2cc1S(N)(=O)=O	diuretic	
metipranolol	31477	BRD-A99388803	CC(C)NCC(O)COc1cc(C)c(OC(C)=O)c(C)c1C	adrenergic receptor antagonist	ADRB1|ADRB2
metirosine	441350	BRD-K83766205	C[C@](N)(Cc1ccc(O)cc1)C(O)=O	tyrosine hydroxylase inhibitor	TH
metitepine	4106	BRD-A07932845	CSc1ccc2Sc3ccccc3CC(N3CCN(C)CC3)c2c1	anti-HCVE2	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
metixene	4167	BRD-A33711280	CN1CCCC(CC2c3ccccc3Sc3ccccc23)C1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
metoclopramide	4168	BRD-K75641298	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC	dopamine receptor antagonist; serotonin receptor antagonist	CHRM1|DRD2|HTR3A|HTR3B|HTR4
metocurine	21233	BRD-K16484091	COc1ccc2C[C@@H]3c4c(CC[N+]3(C)C)cc(OC)c(OC)c4Oc3ccc(C[C@H]4c5cc(Oc1c2)c(OC)cc5CC[N+]4(C)C)cc3	acetylcholine receptor antagonist	CHRM2|CHRNA2
metolazone	4170	BRD-A61793559	CC1Nc2cc(Cl)c(cc2C(=O)N1c1ccccc1C)S(N)(=O)=O	carbonic anhydrase inhibitor	SLC12A3
metoprolol	4171	BRD-A03623303	COCCc1ccc(OCC(O)CNC(C)C)cc1	adrenergic receptor antagonist	ADRB1|ADRB2
metoxibutropate	4464271	BRD-A71725768	COc1ccccc1OC(=O)C(C)c1ccc(CC(C)C)cc1	cyclooxygenase inhibitor	PTGS1|PTGS2
metrifonate	5853	BRD-A22101059	COP(=O)(OC)C(O)C(Cl)(Cl)Cl	acetylcholinesterase inhibitor	ACHE
metrizamide	443944	BRD-A45543382	CN(C(C)=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)N[C@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O)c1I	radiopaque medium	
metrizoic-acid	2528	BRD-K99241550	CN(C(C)=O)c1c(I)c(NC(C)=O)c(I)c(C(O)=O)c1I	radiopaque medium	
metronidazole	4173	BRD-K52020312	Cc1ncc(n1CCO)[N+]([O-])=O	DNA inhibitor	CYP2C9|CYP3A4
metyrapone	4174	BRD-K46862739	CC(C)(C(=O)c1cccnc1)c1cccnc1	cytochrome P450 inhibitor	CYP11B1
mevalonic-d,-l-acid-lactone	10428	BRD-A05674712	CC1(O)CCOC(=O)C1		
mevastatin	64715	BRD-K94441233	CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	HMGCR inhibitor	HMGCR
mexeneone	71645	BRD-K18613660	COc1ccc(C(=O)c2ccc(C)cc2)c(O)c1		
mexiletine	4178	BRD-A64092382	CC(N)COc1c(C)cccc1C	sodium channel blocker	AHR|SCN4A|SCN5A
mezlocillin	71729966	BRD-K45114938	CC1(C)S[C@H]2[C@@H](NC(=O)[C@@H](NC(=O)N3CCN(C3=O)S(C)(=O)=O)c3ccccc3)C(=O)N2[C@@H]1C(O)=O	bacterial cell wall synthesis inhibitor	
ME0328	51147633	BRD-A63444178	CC(NC(=O)CCc1nc(=O)c2ccccc2[nH]1)c1ccccc1	PARP inhibitor	PARP3
MF-101	114829	BRD-K34328244	Oc1ccc(cc1)[C@@H]1CC(=O)c2ccc(O)cc2O1	estrogen receptor agonist	CYP19A1|XDH
MG-132	462382	BRD-K60230970	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O	proteasome inhibitor	PSMB1
MG-624	5824382	BRD-K03128577	CC[N+](CC)(CC)CCOc1ccc(\C=C\c2ccccc2)cc1	acetylcholine receptor antagonist	CHRNA7
MGCD-265	24901704	BRD-K56277358	Cn1cnc(c1)-c1cc2nccc(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)c2s1	VEGFR inhibitor	AXL|MET
MI-14	91758319	BRD-K26726854	CN(C)S(=O)(=O)c1cccc(c1)-c1c(C)nc2c(NCCNC(C)=O)cc(Cl)nn12	PI4K inhibitor	PI4KB
mianserin	4184	BRD-A19661776	CN1CCN2C(C1)c1ccccc1Cc1ccccc21	serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD5|HRH1|HRH2|HRH4|HTR1A|HTR1F|HTR2A|HTR2B|HTR2C|HTR6|HTR7|OPRK1|SLC6A2|SLC6A3|SLC6A4
mibampator	9889366	BRD-K42981054	CC(C)S(=O)(=O)NC[C@H](C)c1ccc(cc1)-c1ccc(CCNS(C)(=O)=O)cc1	glutamate receptor modulator	GRIA1
mibefradil	60663	BRD-K09549677	COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C	T-type calcium channel blocker	ANO1|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CATSPER1|CATSPER2|CATSPER3|CATSPER4
micafungin	477468	BRD-K40407248	CCCCCOc1ccc(cc1)-c1cc(no1)-c1ccc(cc1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)c(OS(O)(=O)=O)c1)[C@H](O)CC(N)=O	fungal 1,3-beta-D-glucan synthase inhibitor	
miconazole	4189	BRD-A82396632	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1	bacterial cell wall synthesis inhibitor	KCNH2|KCNH6|KCNH7|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|NOS2|NOS3|TRPM2|TRPV5
micronomicin	3037206	BRD-K18552138	CNC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1	protein synthesis inhibitor	
midafotel	6435801	BRD-K45163704	OC(=O)[C@H]1CN(C\C=C\P(O)(O)=O)CCN1	glutamate receptor antagonist	GRIN2A|GRIN2B|GRIN2C|GRIN2D
midecamycin	5282169	BRD-K68822425	CCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)O)O[C@@H]1[C@@H](C)O[C@@H](O[C@H]2[C@@H](CC=O)C[C@@H](C)[C@@H](O)\C=C\C=C\C[C@@H](C)OC(=O)C[C@@H](OC(=O)CC)[C@@H]2OC)[C@H](O)[C@H]1N(C)C	protein synthesis inhibitor	
midodrine	4195	BRD-A79981887	COc1ccc(OC)c(c1)C(O)CNC(=O)CN	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D
midostaurin	9829523	BRD-K13646352	CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13)N(C)C(=O)c1ccccc1	FLT3 inhibitor; KIT inhibitor; PKC inhibitor	FLT3|PRKCG
mifepristone	55245	BRD-K37270826	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C	glucocorticoid receptor antagonist; progesterone receptor antagonist	AR|NR1I2|NR3C1|PGR
mifobate	60910	BRD-A72066420	COP(=O)(OC)OC(c1ccc(Cl)cc1)P(=O)(OC)OC	PPAR receptor antagonist	PPARG
miglitol	441314	BRD-K44779798	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	glucosidase inhibitor	GAA|GANAB|GANC|MGAM
miglustat	51634	BRD-K33251802	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	Glycosyl transferase inhibitor	UGCG
milacemide	53569	BRD-K64338723	CCCCCNCC(N)=O	monoamine oxidase inhibitor	MAOB
milnacipran	11622909	BRD-A15202882	CCN(CC)C(=O)C1(CC1CN)c1ccccc1	serotonin norepinephrine reuptake inhibitor (SNRI)	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A4
milrinone	4197	BRD-K67080878	Cc1[nH]c(=O)c(cc1-c1ccncc1)C#N	phosphodiesterase inhibitor	PDE2A|PDE3A|PDE3B|PDE5A
miltefosine	3600	BRD-A31811760	CCCCCCCCCCCCCCCCOP(O)(=O)OCC[N+](C)(C)C	membrane integrity inhibitor	PLA2G1B
mimosine	440473	BRD-K67642028	N[C@@H](Cn1ccc(=O)c(O)c1)C(O)=O	DNA replication inhibitor	CCL2|SHMT1|SHMT2|TYR
minaprine	4199	BRD-K02867583	Cc1cc(nnc1NCCN1CCOCC1)-c1ccccc1	serotonin reuptake inhibitor	ACHE|CHRM1|DRD1|DRD2|HTR2A|HTR2B|HTR2C|MAOA|SLC6A4
minerval	9796304	BRD-A74347210	CCCCCCCC\C=C/CCCCCCC(O)C(O)=O	FAAH inhibitor	
minocycline	54575046	BRD-A69651145	CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C	bacterial 30S ribosomal subunit inhibitor	ALOX5|CASP1|CASP3|CYCS|IL1B|MMP9|VEGFA
minodronic-acid	130956	BRD-K89337853	OC(Cc1cnc2ccccn12)(P(O)(O)=O)P(O)(O)=O	bone resorption inhibitor	FDPS|GGPS1
minoxidil		BRD-K06902185	Nc1cc(nc(N)[n+]1[O-])N1CCCCC1	KATP activator; Kir6 channel (KATP) activator; vasodilator	ABCC9|KCNJ1|KCNJ10|KCNJ11|KCNJ8|PTGS1
miocamycin	5282188	BRD-K30764557	CCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)OC(C)=O)O[C@@H]1[C@@H](C)O[C@@H](O[C@H]2[C@@H](CC=O)C[C@@H](C)[C@@H](OC(C)=O)\C=C\C=C\C[C@@H](C)OC(=O)C[C@@H](OC(=O)CC)[C@@H]2OC)[C@H](O)[C@H]1N(C)C	other antibiotic	
MIRA-1	227681	BRD-K39706510	CCC(=O)OCN1C(=O)C=CC1=O	apoptosis stimulant	
mirabegron	9865528	BRD-K47949423	Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3
mirin	1206243	BRD-K55420858	NC1=NC(=O)\C(S1)=C\c1ccc(O)cc1	MRE11A exonuclease inhibitor	MRE11A
miriplatin	72466506	BRD-M78068755	[Pt++].NC1CCCCC1N.CCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCC(O)=O	DNA synthesis inhibitor	
mirodenafil	12001014	BRD-K82967685	CCCOc1ccc(cc1-c1nc2c(CCC)cn(CC)c2c(=O)[nH]1)S(=O)(=O)N1CCN(CCO)CC1	phosphodiesterase inhibitor	PDE5A
mirtazapine	4205	BRD-A64977602	CN1CCN2C(C1)c1ccccc1Cc1cccnc21	adrenergic receptor antagonist; serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD5|HRH1|HRH3|HTR2A|HTR2B|HTR2C|HTR3A|HTR7|OPRK1|SLC6A2|SLC6A3|SLC6A4
misonidazole	26105	BRD-A16263897	COCC(O)Cn1ccnc1[N+]([O-])=O		
misoprostol	5282381	BRD-A72351335	CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC	prostanoid receptor agonist	PTGER2|PTGER3|PTGER4|PTGIR
mitiglinide	121891	BRD-K52959329	OC(=O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1	insulin secretagogue	ABCC8|KCNJ10|PPARG
mitoflaxone	55748	BRD-K35882976	OC(=O)Cc1cccc2c1oc(cc2=O)-c1ccccc1	antitumor agent	VWF
mitomycin-c	5702003	BRD-A48237631	CO[C@@]12[C@@H]3NC3CN1C1=C([C@@H]2COC(N)=O)C(=O)C(N)=C(C)C1=O	DNA alkylating agent; DNA synthesis inhibitor	
mitotane	4211	BRD-A31204924	ClC(Cl)C(c1ccc(Cl)cc1)c1ccccc1Cl	antineoplastic agent	CYP11A1|CYP11B1|ESR1|FDX1
mitoxantrone	4212	BRD-K21680192	OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12	topoisomerase inhibitor	TOP2A
mivacurium	5281042	BRD-A48465967	COc1cc2CC[N+](C)(CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]3(C)CCc4cc(OC)c(OC)cc4[C@H]3Cc3cc(OC)c(OC)c(OC)c3)[C@H](Cc3cc(OC)c(OC)c(OC)c3)c2cc1OC	acetylcholine receptor antagonist	BCHE|CHRM2|CHRM3|CHRNA2
mivobulin	129010060	BRD-K39576764	CCOC(=O)Nc1cc2NC(C)=C(Nc2c(N)n1)c1ccccc1	microtubule inhibitor	
mizolastine	65906	BRD-K21884483	CN(C1CCN(CC1)c1nc2ccccc2n1Cc1ccc(F)cc1)c1nccc(=O)[nH]1	histamine receptor antagonist	HRH1
mizoribine	104762	BRD-K88061624	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O	immunosuppressant; inosine monophosphate dehydrogenase inhibitor	IMPDH1
MJ-15	59377482	BRD-K71315565	Cc1c(nn(c1-c1ccc(Cl)cc1)-c1ccc(Cl)cc1Cl)C(=O)NCc1cccnc1	cannabinoid receptor antagonist	CNR1
MK-0354	11159621	BRD-K91405252	C1Cc2[nH]nc(-c3nnn[nH]3)c2C1	niacin receptor agonist	HCAR2|HCAR3
MK-0752		BRD-K18850819	OC(=O)CC[C@H]1CC[C@@](CC1)(c1cc(F)ccc1F)S(=O)(=O)c1ccc(Cl)cc1	gamma secretase inhibitor	
MK-0773	11950726	BRD-K38868394	CN1[C@@H]2CC[C@H]3[C@@H]4CC[C@H](C(=O)NCc5nc6cccnc6[nH]5)[C@@]4(C)CC[C@@H]3[C@@]2(C)C=C(F)C1=O	androgen receptor modulator	AR
MK-0812	11180808	BRD-K14175878	CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](C1)(C(C)C)C(=O)N1CCc2ncc(cc2C1)C(F)(F)F	CC chemokine receptor antagonist	CCR2
MK-0893	11570626	BRD-K16732600	COc1ccc2cc(ccc2c1)-c1cc(nn1[C@@H](C)c1ccc(cc1)C(=O)NCCC(O)=O)-c1cc(Cl)cc(Cl)c1	glucagon receptor antagonist	GCGR
MK-1775	24856436	BRD-K54256913	CN1CCN(CC1)c1ccc(Nc2ncc3c(n2)n(-c2cccc(n2)C(C)(C)O)n(CC=C)c3=O)cc1	WEE1 kinase inhibitor	WEE1
MK-2048	54698642	BRD-K03128512	CCN1C[C@H](C)n2c(c(O)c3c2c(nn(Cc2ccc(F)c(Cl)c2)c3=O)C(=O)NC)C1=O	HIV integrase inhibitor	
MK-2206	24964624	BRD-K68065987	NC1(CCC1)c1ccc(cc1)-c1nc2ccn3c(n[nH]c3=O)c2cc1-c1ccccc1	AKT inhibitor	AKT1|AKT2|AKT3
MK-2295	11247522	BRD-K43316319	FC(F)(F)c1ccc(Nc2ncnc3cc(ccc23)-c2ncccc2C(F)(F)F)cc1	TRPV antagonist	TRPV1
MK-2461	44137946	BRD-K56405753	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1	FGFR inhibitor; VEGFR inhibitor	FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|KDR|MERTK|MET|MST1R|NTRK1|NTRK2|PDGFRB
MK-2894	24952929	BRD-K27983781	Cc1sc(C)c(C(=O)NC2(CC2)c2ccc(cc2)C(O)=O)c1Cc1ccc(cc1)C(F)(F)F	prostaglandin inhibitor	PTGER4
MK-3207	25019940	BRD-K66911501	Fc1cc(F)cc(c1)[C@@H]1CNC2(CCCC2)C(=O)N1CC(=O)Nc1ccc2C[C@]3(Cc2c1)C(=O)Nc1ncccc31	calcitonin antagonist	CALCA
MK-3697	46190695	BRD-K95828359	COc1ccc(CNC(=O)c2cc(ncc2-c2nccs2)-c2cncc(C)c2)nc1OC	orexin receptor antagonist	HCRTR2
MK-5046	49871766	BRD-K03886848	O[C@@](Cc1nc(CC2(CC2)C(F)(F)F)c[nH]1)(c1ccc(cc1)-n1cccn1)C(F)(F)F	bombesin receptor agonist	BRS3|GRPR|NMBR
MK-5108		BRD-K53665955	OC(=O)[C@@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](CC1)Oc1cccc(Cl)c1F	Aurora kinase inhibitor	AURKA|AURKB|AURKC
MK-571	5281888	BRD-A73679382	CN(C)C(=O)CCSC(SCCC(O)=O)c1cccc(\C=C\c2ccc3ccc(Cl)cc3n2)c1	leukotriene receptor antagonist	ABCC2|CYSLTR1
MK-6096	25128145	BRD-K03894385	C[C@@H]1CC[C@@H](COc2ccc(F)cn2)CN1C(=O)c1cc(C)ccc1-c1ncccn1	orexin receptor antagonist	HCRTR1|HCRTR2
MK-8033	45142457	BRD-K55512740	Cn1cc(cn1)-c1cnc2ccc3ccc(CS(=O)(=O)NCc4ccccn4)cc3c(=O)c2c1	c-Met inhibitor	MET
MK-8245	24988881	BRD-K29656036	OC(=O)Cn1nnc(n1)-c1cc(no1)N1CCC(CC1)Oc1cc(F)ccc1Br	stearoyl-CoA desaturase inhibitor	SCD
MK-8745	11676373	BRD-K25279140	Fc1c(Cl)cccc1C(=O)N1CCN(Cc2cccc(Nc3nccs3)n2)CC1	Aurora kinase inhibitor	AURKA
MKT-077	3037934	BRD-K61695967	CCn1\c(=C/c2cccc[n+]2CC)s\c(=C2\Sc3ccccc3N2C)c1=O	HSP inhibitor	
MK2-IN-1	53475321	BRD-K90316462	Clc1ccc(cc1)-c1ccc(o1)C(=O)N(Cc1ccccn1)c1ccc(cc1)N1CCNCC1	MAP kinase inhibitor	MAPKAPK2
ML-10302	5311299	BRD-K69343602	COc1cc(N)c(Cl)cc1C(=O)OCCN1CCCCC1	serotonin receptor partial agonist	HTR3A|HTR3B|HTR4
ML-141	2950007	BRD-A28422330	COc1ccc(cc1)C1CC(=NN1c1ccc(cc1)S(N)(=O)=O)c1ccccc1	GTPase inhibitor	CDC42
ML-179	45100448	BRD-K77547509	FC(F)(F)c1cccc(c1)N1CCN(CC1)c1cc(=O)n(C2CCCCC2)c(=O)[nH]1	liver receptor homolog inverse agonist	NR5A2
ML-193	1261822	BRD-K27539181	Cc1noc(NS(=O)(=O)c2ccc(NC(=O)c3cc(nc4c(C)cc(C)cc34)-c3ccccn3)cc2)c1C	G protein-coupled receptor antagonist	GPR55
ML-213	3111211	BRD-A12633378	Cc1cc(C)c(NC(=O)C2CC3CCC2C3)c(C)c1	potassium channel activator	KCNQ4
ML-218		BRD-K92995792	CC(C)(C)CCN1C[C@H]2[C@H](CNC(=O)c3cc(Cl)cc(Cl)c3)[C@H]2C1	T-type calcium channel binder	CACNA1G|CACNA1H|CACNA1I
ML-228	46742353	BRD-K44432556	C(Nc1nc(nnc1-c1ccccc1)-c1ccccn1)c1ccc(cc1)-c1ccccc1	hypoxia inducible factor activator	HIF1A
ML-277	53347902	BRD-K60020910	COc1ccc(cc1)-c1csc(NC(=O)[C@H]2CCCCN2S(=O)(=O)c2ccc(C)cc2)n1	potassium channel activator	KCNQ1
ML-281	53377448	BRD-K48188942	CC(C)c1ccc(NC(=O)c2cccs2)c(c1)-c1nc2ccccc2[nH]c1=O	serine/threonine kinase inhibitor	STK33
ML-297	56642816	BRD-K51137250	Cc1cc(NC(=O)Nc2ccc(F)c(F)c2)n(n1)-c1ccccc1	inward rectifier potassium channel activator	KCNJ3
ML-298	53393916	BRD-K24600306	Fc1cccc(c1)N1CNC(=O)C11CCN(CCNC(=O)c2ccc(F)c(F)c2)CC1	phospholipase inhibitor	PLD2
ML-323	60167849	BRD-K93942811	CC(C)c1ccccc1-c1ncc(C)c(NCc2ccc(cc2)-n2ccnn2)n1	ubiquitin specific protease inhibitor	USP1
ML-3403	6419739	BRD-A29014990	CSc1nc(c([nH]1)-c1ccnc(NC(C)c2ccccc2)c1)-c1ccc(F)cc1	MAP kinase inhibitor	CYP3A4|MAPK11|MAPK12|MAPK14
ML-348	3238952	BRD-K81044214	FC(F)(F)c1ccc(Cl)c(NC(=O)CN2CCN(CC2)C(=O)c2ccco2)c1	lysophospholipase inhibitor	LYPLA1
ML-365	46785920	BRD-K02160913	COc1ccccc1C(=O)Nc1cccc(NC(=O)c2cccc(C)c2)c1	potassium channel blocker	KCNK3|KCNK9
ML-786	50992247	BRD-K52644305	CC(C)(N)c1cc(cc(c1)C(F)(F)F)C(=O)N[C@@H]1CCc2ccc(OC3=C4CCC(=O)N=C4NC=C3)cc2C1	RAF inhibitor	BRAF|RAF1
ML-9	4217	BRD-K68402494	Clc1cccc2c(cccc12)S(=O)(=O)N1CCCNCC1	myosin light chain kinase inhibitor	TRPC6
MLN-8054	11712649	BRD-K83963101	OC(=O)c1ccc(Nc2ncc3CN=C(c4cc(Cl)ccc4-c3n2)c2c(F)cccc2F)cc1	Aurora kinase inhibitor	AURKA
MLN0128	45375953	BRD-K59317601	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc12	mTOR inhibitor	MTOR|PIK3CA|PIK3CD|PIK3CG
MLN1117	70798655	BRD-K73877023	Nc1nc2cc(ccc2o1)-c1ccc2ncc(C(=O)N3CCOCC3)n2c1	PI3K inhibitor	PIK3CA
MLN2480	25161177	BRD-K43410529	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(s1)C(=O)Nc1cc(c(Cl)cn1)C(F)(F)F	RAF inhibitor	
MLN9708	56844015	BRD-K15203492	CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)C(CC(O)=O)(CC(O)=O)O1	proteasome inhibitor	
ML130	1088438	BRD-K89306950	Cc1ccc(cc1)S(=O)(=O)n1c(N)nc2ccccc12	NOD1 inhibitor	
ML133	781301	BRD-K33743361	COc1ccc(CNCc2cccc3ccccc23)cc1	potassium channel blocker	
ML161	1048267	BRD-K59036917	CCCC(=O)Nc1cccc(NC(=O)c2ccccc2Br)c1	protease-activated receptor inhibitor	
ML167	44968231	BRD-K64835161	Cc1ccc(CNc2ncnc3ccc(cc23)-c2ccc(CO)o2)o1	CLK inhibitor; DYRK inhibitor	CLK4|DYRK1B
ML204	230710	BRD-K80021413	Cc1cc(nc2ccccc12)N1CCCCC1	transient receptor potential channel antagonist	TRPC4|TRPC5
ML314	53245590	BRD-K92606079	COc1ccccc1N1CCN(CC1)c1nc(nc2cc(OC)c(OC)cc12)C1CC1	neurotensin agonist	NTSR1
ML324	44143209	BRD-K25611237	CN(C)CCCNC(=O)c1ccc(cc1)-c1cc(O)c2ncccc2c1	histone lysine demethylase inhibitor	KDM4A
ML347	44577753	BRD-K33892651	COc1ccc(cc1)-c1cnc2c(cnn2c1)-c1cccc2ncccc12	ALK tyrosine kinase receptor inhibitor	ACVR1|ACVRL1|BMPR1A
MM-102	54766613	BRD-K68474068	CCC(CC)(NC(=O)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NC1(CCCC1)C(=O)NC(c1ccc(F)cc1)c1ccc(F)cc1	WDR5/MLL interaction inhibitor	
MM-11253	10389639	BRD-K98353094	CC1(C)CCC(C)(C)c2cc(ccc12)C1(SCCS1)c1ccc2cc(ccc2c1)C(O)=O	retinoid receptor antagonist	RARG
MMPX	155806	BRD-K56077740	COCc1nc2n(CC(C)C)c(=O)n(C)c(=O)c2[nH]1	phosphodiesterase inhibitor	
MM77	3994476	BRD-K50293352	COc1ccccc1N1CCN(CCCCN2C(=O)CCC2=O)CC1	serotonin receptor antagonist	HTR1A
MN-64	2802462	BRD-K16183658	CC(C)c1ccc(cc1)-c1cc(=O)c2ccccc2o1	tankyrase inhibitor	TNKS
MNITMT	364622	BRD-K63151507	Cn1cnnc1Sc1c(ncn1C)[N+]([O-])=O	lymphocyte inhibitor	
MNS-(3,4-Methylenedioxy-nitrostyrene)	672296	BRD-K42205652	[O-][N+](=O)\C=C\c1ccc2OCOc2c1	src inhibitor; syk inhibitor	SRC|SYK
mocetinostat	9865515	BRD-K16485616	Nc1ccccc1NC(=O)c1ccc(CNc2nccc(n2)-c2cccnc2)cc1	HDAC inhibitor	HDAC1|HDAC11|HDAC2|HDAC3
moclobemide	4235	BRD-K07237224	Clc1ccc(cc1)C(=O)NCCN1CCOCC1	monoamine oxidase inhibitor	MAOA|MAOB
modafinil	4236	BRD-A16332958	NC(=O)CS(=O)C(c1ccccc1)c1ccccc1	adrenergic receptor agonist	ADRA1B|SLC6A3
modaline	17860	BRD-K25317177	Cc1nccnc1N1CCCCC1		
moexipril	40466988	BRD-K34441861	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(O)=O	angiotensin converting enzyme inhibitor	ACE|ACE2
mofegiline	6437850	BRD-K52598503	NC\C(CCc1ccc(F)cc1)=C\F	monoamine oxidase inhibitor	MAOA|MAOB
mofezolac	4237	BRD-K49372556	COc1ccc(cc1)-c1noc(CC(O)=O)c1-c1ccc(OC)cc1	cyclooxygenase inhibitor	PTGS1
moguisteine	65935	BRD-A87673115	CCOC(=O)CC(=O)N1CCSC1COc1ccccc1OC	ATP-sensitive potassium channel inhibitor	
molidustat	59603622	BRD-K01291782	O=c1c(c[nH]n1-c1cc(ncn1)N1CCOCC1)-n1ccnn1	hypoxia inducible factor inhibitor	EGLN2
molindone	23897	BRD-A65280694	CCc1c(C)[nH]c2CCC(CN3CCOCC3)C(=O)c12	dopamine receptor antagonist	CHRM1|DRD2|HRH1|HTR1A|HTR2A
molsidomine	4239	BRD-K63861289	CCOC(=O)Nc1c[n+](no1)N1CCOCC1	guanylate cyclase stimulant	GUCY1A3
mometasone	441335	BRD-K50265942	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl	glucocorticoid receptor agonist	NR3C1
mometasone-furoate	441336	BRD-K60640630	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl	glucocorticoid receptor agonist	NR3C1
monastrol	2987927	BRD-A78377521	CCOC(=O)C1=C(C)NC(=S)NC1c1cccc(O)c1	kinesin inhibitor	KIF11
monensin	134689114	BRD-A06627858	CC[C@]1(CC[C@@H](O1)[C@]1(C)CC[C@]2(C[C@H](O)[C@@H](C)[C@H](O2)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O1)C1O[C@H](C[C@@H]1C)C1O[C@@](O)(CO)[C@H](C)C[C@@H]1C	bacterial permeability inducer	
monobenzone	7638	BRD-K54262262	Oc1ccc(OCc2ccccc2)cc1	melanin inhibitor	TYR
monoctanoin	3033877	BRD-A48938994	CCCCCCCC(=O)OCC(O)CO		
monosodium-alpha-luminol	10638	BRD-K52559566	Nc1cccc2c1c(=O)[nH][nH]c2=O		
monostearin	24699	BRD-A31454688	CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO		
montelukast	5281040	BRD-K69470111	CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(O)=O)CC1)c1cccc(\C=C\c2ccc3ccc(Cl)cc3n2)c1	leukotriene receptor antagonist	ALOX5|CYSLTR1
moprolol	71213	BRD-A51747092	COc1ccccc1OCC(O)CNC(C)C	adrenergic receptor antagonist	
moracizine	34633	BRD-K21548250	CCOC(=O)Nc1ccc2Sc3ccccc3N(C(=O)CCN3CCOCC3)c2c1	sodium channel blocker	SCN5A
morantel	5353792	BRD-K71454870	CN1CCCN=C1\C=C\c1sccc1C	acetylcholine receptor agonist	
morin	5281670	BRD-K11590034	Oc1ccc(c(O)c1)-c1oc2cc(O)cc(O)c2c(=O)c1O	cytochrome P450 inhibitor	ADORA2A|ESR2|FASN|MCL1|SLC22A12
morinidazole	11644726	BRD-A40546373	Cc1ncc(n1CC(O)CN1CCOCC1)[N+]([O-])=O	other antibiotic	CYP51A1
morniflumate	72106	BRD-K38938675	FC(F)(F)c1cccc(Nc2ncccc2C(=O)OCCN2CCOCC2)c1	anti-inflammatory agent	
moroxydine	71655	BRD-K57291914	NC(=N)NC(=N)N1CCOCC1	antiviral	
mosapride	119584	BRD-A39052811	CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1	serotonin receptor agonist	HTR4
motesanib	11667893	BRD-K99616396	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc12	KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor	FLT1|FLT4|KDR|KIT
motolimod	16049404	BRD-K11785681	CCCN(CCC)C(=O)C1=Cc2ccc(cc2N=C(N)C1)-c1ccc(cc1)C(=O)N1CCCC1	toll-like receptor agonist	TLR8
moxalactam	5488645	BRD-K40831222	CO[C@]1(NC(=O)[C@H](C(O)=O)c2ccc(O)cc2)[C@H]2OCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O	bacterial cell wall synthesis inhibitor	
moxaverine	70882	BRD-K12742203	CCc1cc2cc(OC)c(OC)cc2c(Cc2ccccc2)n1	phosphodiesterase inhibitor	
moxidectin	16760141	BRD-K61988078	CO\N=C1\C[C@]2(C[C@@H]3C[C@@H](C\C=C(C)\C[C@@H](C)\C=C\C=C4/CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@@H]([C@H]1C)C(\C)=C\C(C)C	chloride channel antagonist	
moxifloxacin	152946	BRD-K66615216	COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c1n(cc(C(O)=O)c2=O)C1CC1	bacterial DNA gyrase inhibitor	TOP2A
moxisylyte	4260	BRD-K81144366	CC(C)c1cc(OC(C)=O)c(C)cc1OCCN(C)C	adrenergic receptor antagonist	
moxonidine	4810	BRD-K77771411	COc1nc(C)nc(Cl)c1NC1=NCCN1	imidazoline receptor agonist	ADRA2A|ADRA2B|ADRA2C
mozavaptan	119369	BRD-A31095847	CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc12	vasopressin receptor antagonist	AVPR1A|AVPR1B|AVPR2
MPEP	3025961	BRD-K60690191	Cc1cccc(n1)C#Cc1ccccc1	glutamate receptor antagonist	GRM1|GRM4|GRM5
MPI-0479605	46909588	BRD-K45551181	Cc1cc(ccc1Nc1nc(NC2CCCCC2)c2[nH]cnc2n1)N1CCOCC1	mitotic kinase inhibitor	TTK
Mps-BAY-2a	57381882	BRD-K18530250	CC(C)CNc1nc(cn2c(cnc12)-c1ccc(cc1)C(=O)NC1CC1)-c1cccc2ncccc12	monopolar spindle 1 kinase inhibitor	TTK
Mps1-IN-1	25195352	BRD-K94853001	COc1cc(ccc1Nc1cc(Nc2ccccc2S(=O)(=O)C(C)C)c2cc[nH]c2n1)N1CCC(O)CC1	monopolar spindle 1 kinase inhibitor	TTK
Mps1-IN-5	71599640	BRD-K43812936	COc1cc(ccc1Nc1nc2ccc(cn2n1)-c1ccc(NC(=O)[C@H](C)c2ccc(F)cc2)cc1)S(C)(=O)=O	protein kinase inhibitor	
MR-16728	378811	BRD-A30590053	O=C(NCCCN1CCCCCC1)C(C1CCCCC1)c1ccccc1	acetylcholine release enhancer	
MR-948	10443938	BRD-K84883208	OCCc1ccc(OCCn2ccnc2)cc1	thromboxane synthase inhibitor	TBXAS1
MRK-016	6918583	BRD-K44022883	Cc1cc(no1)-c1nncc2c(c(OCc3ncnn3C)nn12)C(C)(C)C	GABA receptor inverse agonist	GABRA1|GABRA2|GABRA3|GABRA5
MRK-409	22609888	BRD-K57416838	Cn1ncnc1COc1nn2c(nnc2cc1C1CCC1)-c1c(F)cccc1F	benzodiazepine receptor agonist	
MRK-560		BRD-K68795758	Fc1ccc(F)c(c1)[C@]1(CC[C@@H](CC1)NS(=O)(=O)C(F)(F)F)S(=O)(=O)c1ccc(Cl)cc1	gamma secretase inhibitor	APP
MRS-1220	393595	BRD-K37618799	Clc1ccc2nc(NC(=O)Cc3ccccc3)n3nc(nc3c2c1)-c1ccco1	adenosine receptor antagonist	ADORA2B|ADORA3
MRS-3777		BRD-M86143595	C1CCC(CC1)Nc1nc(Oc2ccccc2)nc2[nH]cnc12.C1CCC(CC1)Nc1nc(Oc2ccccc2)nc2[nH]cnc12	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
MRS1334	4519822	BRD-A06784547	CCOC(=O)C1=C(C)NC(c2ccccc2)=C(C1C#Cc1ccccc1)C(=O)OCc1ccc(cc1)[N+]([O-])=O	adenosine receptor antagonist	ADORA3
MRS1845	11538542	BRD-A78093359	CCOC(=O)C1=C(C)N(CC#C)C(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC	calcium channel blocker	
MRS2578	16078986	BRD-K91135178	S=C=Nc1cccc(NC(=S)NCCCCNC(=S)Nc2cccc(c2)N=C=S)c1	purinergic receptor antagonist	P2RY6
MRS3777	11771279	BRD-K10575656	C1CCC(CC1)Nc1nc(Oc2ccccc2)nc2[nH]cnc12	adenosine receptor antagonist	ADORA2A
MSX-122	11687907	BRD-K25143390	C(Nc1ncccn1)c1ccc(CNc2ncccn2)cc1	CC chemokine receptor antagonist	CXCR4
MTPG	1212	BRD-A28329383	CC(N)(C(O)=O)c1ccc(cc1)-c1nnn[nH]1	glutamate receptor antagonist	GRM2|GRM3
mubritinib	6444692	BRD-K19061412	FC(F)(F)c1ccc(\C=C\c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1	protein tyrosine kinase inhibitor	EGFR|ERBB2
mupirocin	446596	BRD-K15262564	C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O	isoleucyl-tRNA synthetase inhibitor	
muscimol	12313010	BRD-K60441002	NCc1cc(O)no1	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRR1|GABRR2|GABRR3
MUT056399	44208849	BRD-K72078047	CCc1cc(O)c(Oc2ccc(cc2F)C(N)=O)cc1F	FABI inhibitor	
MY-5445	1348	BRD-K90524085	Clc1cccc(Nc2nnc(-c3ccccc3)c3ccccc23)c1	phosphodiesterase inhibitor; platelet aggregation inhibitor	PDE5A
mycophenolate-mofetil	5281078	BRD-K92428153	COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(=O)OCCN1CCOCC1	dehydrogenase inhibitor; inositol monophosphatase inhibitor	IMPDH1|IMPDH2
mycophenolic-acid	446541	BRD-K63750851	COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(O)=O	dehydrogenase inhibitor; inositol monophosphatase inhibitor	IMPDH1|IMPDH2
myricetin	5281672	BRD-K43149758	Oc1cc(O)c2c(c1)oc(-c1cc(O)c(O)c(O)c1)c(O)c2=O	androgen receptor agonist; cytochrome P450 inhibitor	PIK3CG
myricitrin	129010103	BRD-K29834313	C[C@@H]1O[C@@H](Oc2c(oc3cc(O)cc(O)c3c2=O)-c2cc(O)c(O)c(O)c2)[C@@H](O)[C@H](O)[C@H]1O	PKC inhibitor	NOS1|PRKCA
myristyl-nicotinate	531641	BRD-K88153212	CCCCCCCCCCCCCCOC(=O)c1cccnc1	topical sunscreen agent	
M8-B	11675630	BRD-K90410034	COc1cc(CN(CCN)C(=O)c2cccs2)ccc1OCc1ccccc1	transient receptor potential channel antagonist	TRPM8
N-(2-chlorophenyl)-2-({(2E)-2-[1-(2-pyridinyl)ethylidene]hydrazino}carbothioyl)hydrazinecarbothioamide	129010081	BRD-K57027742	Clc1ccccc1NC(=S)NNC(=S)NNC(=C)c1ccccn1		
N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide	127898	BRD-K78844995	Ic1ccc(cc1)C(=O)NCCN1CCCCC1	sigma receptor ligand	
N-acetyl-D-glucosamine	1738118	BRD-K80653534	CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO		B4GALT1|B4GALT2|B4GALT3|B4GALT4|NAGK|NAGLU|NAGPA|RENBP
N-acetyl-tyrosine	89216	BRD-A24857382	CC(=O)NC(Cc1ccc(O)cc1)C(O)=O		
N-acetylcarnosine	9903482	BRD-K52523550	CC(=O)NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O		
N-acetylglycyl-D-glutamic-acid	6604718	BRD-K28121004	CC(=O)NCC(=O)N[C@H](CCC(O)=O)C(O)=O	glutamate receptor agonist	
N-acetylmannosamine	16394588	BRD-A92872453	CC(=O)NC1[C@@H](O)OC(CO)[C@@H](O)[C@H]1O		CHIT1
N-acetyltryptamine	70547	BRD-K73700643	CC(=O)NCCc1c[nH]c2ccccc12	melatonin receptor agonist	
N-alpha-Methylhistamine-dihydrochloride	912	BRD-K64422603	CNCCc1cnc[nH]1	histamine receptor agonist	HRH4
N-benzylnaltrindole	16758824	BRD-A33514596	Oc1ccc2CC3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)c1c(C[C@@]35O)c2ccccc2n1Cc1ccccc1	opioid receptor antagonist	
N-cyanopyrrolidine	73737	BRD-K90042229	N#CN1CCCC1		CTSK
N-demethylantipyrine	70335	BRD-K84517077	Cc1cc(=O)n([nH]1)-c1ccccc1		
N-hydroxynicotinamide	71211	BRD-K28030264	ONC(=O)c1cccnc1		
N-methyl-(-)ephedrine-[1r,2s]	64782	BRD-K82236108	C[C@@H]([C@H](O)c1ccccc1)N(C)C		
N-methylformamide	31254	BRD-K33445938	CNC=O		
N-methyllidocaine-iodide	168868	BRD-K60060639	CC[N+](C)(CC)CC(=O)Nc1c(C)cccc1C	antiarrhythmic medication	
N-methylpyrrolidone	13387	BRD-K52732207	CN1CCCC1=O		
N-methylquipazine	5013	BRD-K62056274	CN1CCN(CC1)c1ccc2ccccc2n1	serotonin receptor agonist	HTR1A|HTR1D|HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|SLC6A4
N-MPPP	190901	BRD-K93806173	CN([C@H](CN1CCCC1)c1ccccc1)C(=O)Cc1ccccc1	opioid receptor agonist	
N-oxydiethylenebenzothiazole-2-sulfenamide	7619	BRD-K97360717	C1CN(CCO1)Sc1nc2ccccc2s1		
N-salicoylaminophenol	4602	BRD-K39693230	Oc1ccc(NC(=O)c2ccccc2O)cc1	ribonucleotide reductase inhibitor	
NAB-2	82017756	BRD-K36804890	Cc1ccc(C)c(c1)-n1cnc2cc(ccc12)C(=O)NCc1ccccc1Cl	ubiquitin ligase transport promoter	NEDD4
nabumetone	4409	BRD-K65146499	COc1ccc2cc(CCC(C)=O)ccc2c1	cyclooxygenase inhibitor	PTGS1|PTGS2
nadide	5893	BRD-A11132253	NC(=O)c1ccc[n+](c1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O	electron acceptor	AHCY|AKR1A1|ALDH2|BLVRA|DHPS|DLD|GALE|HMGCR|HSD17B1|HSD17B4|IMPDH2|MGAM|P2RY11|SORD|TRPM2
nadifloxacin	4410	BRD-A24397426	CC1CCc2c(N3CCC(O)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O	bacterial DNA gyrase inhibitor	
nadolol	39147	BRD-A87606379	CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3
NADPH	71312102	BRD-M06409173	NC1CCCCC1.NC1CCCCC1.NC1CCCCC1.NC1CCCCC1.NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O		AASS|DPYD|GHSR|TXNRD1
nafadotride	3408722	BRD-A71262238	CCCCN1CCCC1CNC(=O)c1cc(C#N)c2ccccc2c1OC	dopamine receptor antagonist	DRD2|DRD3|HTR1A
nafamostat	4413	BRD-K06674495	NC(=N)Nc1ccc(cc1)C(=O)Oc1ccc2cc(ccc2c1)C(N)=N	serine protease inhibitor	ASIC1|ASIC2|ASIC3|C1R|PRSS1|TPSAB1|TRPM7
nafcillin	8982	BRD-K18574842	CCOc1ccc2ccccc2c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O	bacterial cell wall synthesis inhibitor	CYP1A2|CYP3A4|SLC22A6
naftidrofuryl	4417	BRD-A67862938	CCN(CC)CCOC(=O)C(CC1CCCO1)Cc1cccc2ccccc12	adrenergic receptor antagonist	
naftifine	47641	BRD-K74141488	CN(C\C=C\c1ccccc1)Cc1cccc2ccccc12	fungal squalene epoxidase inhibitor	SQLE
naftopidil	4418	BRD-A01787639	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1	adrenergic receptor antagonist	ADRA1A
nalbuphine	5311304	BRD-K66404838	O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45	opioid receptor agonist; opioid receptor antagonist	OPRD1|OPRK1|OPRM1
nalfurafine	6445230	BRD-K89272869	CN([C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CC1)c45)C(=O)\C=C\c1ccoc1	opioid receptor agonist	OPRK1|OPRM1
nalidixic-acid	4421	BRD-K47886988	CCn1cc(C(O)=O)c(=O)c2ccc(C)nc12	bacterial DNA gyrase inhibitor	
nalmefene	5284594	BRD-K68407436	Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=C)CC[C@@]35O	opioid receptor antagonist	OPRD1|OPRK1|OPRM1
naloxegol	56959087	BRD-K41458421	COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC=C)c45	opioid receptor antagonist	OPRM1
naloxone	5284596	BRD-K67511046	Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O	opioid receptor antagonist	CREB1|ESR1|OPRD1|OPRK1|OPRM1|TLR4
naloxone-benzoylhydrazone	9601084	BRD-K70898774	Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)\C(CC[C@@]35O)=N\NC(=O)c1ccccc1	opioid receptor antagonist	OPRK1|OPRM1
naltrexone	5360515	BRD-K88172511	Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O	opioid receptor antagonist	OPRD1|OPRK1|OPRM1|SIGMAR1
naltriben	13994399	BRD-A19102171	Oc1ccc2CC3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)c1oc2ccccc2c1C[C@@]35O	opioid receptor antagonist	OPRD1|OPRK1|OPRM1
naltrindole	9953592	BRD-A47342814	Oc1ccc2CC3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)c1[nH]c2ccccc2c1C[C@@]35O	opioid receptor antagonist	OPRD1|OPRK1|OPRM1
Nampt-IN-1	92044379	BRD-K18280217	CC(C)(O)CS(=O)(=O)Nc1ccc2CN(CCc2c1)C(=O)COc1cccnc1		
NAN-190	4431	BRD-K69195780	COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1	serotonin receptor agonist	ADRA1A|ADRA1B|ADRA1D|HTR1A|HTR1F
nanchangmycin	134689604	BRD-A73871920	CO[C@H]1CCC(O[C@H]2CC(O[C@]3(O[C@H](C[C@@H]3C)C3O[C@@](O)(CO)[C@H](C)C[C@@H]3C)[C@@H]2C)[C@]2(C)CC[C@]3(C[C@H](O)[C@@H](C)[C@H](O3)[C@@H](C)\C=C(/C)C(=O)[C@H](C)C[C@H](C)C(O)=O)O2)O[C@@H]1C	other antibiotic	
nandrolone	9904	BRD-K52080565	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O	imidazoline receptor agonist	AR|CYP19A1|MAOA|MAOB
nandrolone-decanoate	9677	BRD-K78352627	CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C	androgenic steroid	AR
napabucasin	10331844	BRD-K22064724	CC(=O)c1cc2c(o1)C(=O)c1ccccc1C2=O	STAT inhibitor	STAT3
naphazoline	4436	BRD-K77641333	C(C1=NCCN1)c1cccc2ccccc12	adrenergic receptor agonist	ADRA1A|ADRA2A
naphthoquine-phosphate	9851775	BRD-K13664493	CC(C)(C)NCc1cc(Nc2ccnc3cc(Cl)ccc23)c2CCCCc2c1O	antimalarial agent	
napirimus	3047779	BRD-K91234829	Cn1cc(cc1C(O)=O)C(=O)c1cccc2ccccc12	immunosuppressant	
naproxen	156391	BRD-K59197931	COc1ccc2cc(ccc2c1)[C@H](C)C(O)=O	cyclooxygenase inhibitor	PTGS1|PTGS2
narasin	6708740	BRD-A25608658	CC[C@H]([C@@H]1O[C@@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@@]3(O[C@@]4(CC[C@](C)(O4)C4CC[C@](O)(CC)[C@H](C)O4)[C@H](O)C=C3)[C@H](C)C[C@@H]2C)[C@@H](C)C[C@H]1C)C(O)=O	antiprotozoal agent	
naratriptan	4440	BRD-K61337602	CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F
naringenin	439246	BRD-K08832567	Oc1ccc(cc1)[C@@H]1CC(=O)c2c(O)cc(O)cc2O1	aromatase inhibitor; TRPV antagonist	CYP19A1|CYP1B1|ESR2|GLO1|HSD17B1
naringeninic-acid	637542	BRD-K87122641	OC(=O)\C=C\c1ccc(O)cc1		HCAR2|PTGR1
naringin	442428	BRD-K02953697	C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2Oc2cc(O)c3C(=O)C[C@H](Oc3c2)c2ccc(O)cc2)[C@H](O)[C@H](O)[C@H]1O	cytochrome P450 inhibitor	SLCO1A2
naringin-dihydrochalcone	129010054	BRD-K13511380	C[C@@H]1O[C@@H](O[C@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2Oc2cc(O)c(C(=O)CCc3ccc(O)cc3)c(O)c2)[C@H](O)[C@H](O)[C@H]1O	cytochrome P450 inhibitor	
narlaprevir	11857239	BRD-K38287497	CCCC[C@H](NC(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C)C2(C)C)C(=O)C(=O)NC1CC1	HCV inhibitor	
nastorazepide	9872609	BRD-K17295893	CC(C)(C)C(=O)CN1c2ccccc2N(C[C@@H](NC(=O)Nc2cccc(c2)C(O)=O)C1=O)C1CCCCC1	CCK receptor antagonist	CCKBR
natamycin	5284447	BRD-K90563805	C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]3O[C@@H]3\C=C\C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O	fungal ergosterol inhibitor	
nateglinide		BRD-K44353683	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](Cc1ccccc1)C(O)=O	insulin secretagogue	ABCC8|KCNJ10|KCNJ11|PPARG
NAV-26	44540282	BRD-A84202322	FC(F)(F)Oc1ccc(CNC(=O)C2N(C3CCOCC3)C(=O)c3ccccc23)cc1	voltage-gated sodium channel blocker	SCN9A
navarixin	9865554	BRD-K82850175	CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1	CC chemokine receptor antagonist	CXCR1|CXCR2
navitoclax	24978538	BRD-K82746043	CC1(C)CCC(=C(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)C1)c1ccc(Cl)cc1	BCL inhibitor	BCL2|BCL2L1|BCL2L2
NBI-27914	176157	BRD-K61177364	CCCN(CC1CC1)c1nc(C)nc(Nc2c(Cl)cc(Cl)cc2Cl)c1Cl	corticosteroid releasing factor receptor antagonist	CRHR1
NBI-74330-(+/-)	10167713	BRD-A86523169	CCOc1ccc(cc1)-n1c(nc2ncccc2c1=O)C(C)N(Cc1cccnc1)C(=O)Cc1ccc(F)c(c1)C(F)(F)F	CC chemokine receptor antagonist	CXCR3
NBQX	3272524	BRD-K11796549	NS(=O)(=O)c1cccc2c1c(cc1[nH]c(=O)c(=O)[nH]c21)[N+]([O-])=O	glutamate receptor antagonist	GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIN1|GRIN2A|GRIN2B
NCS-382	5875451	BRD-A85025557	OC1c2ccccc2CCC\C1=C/C(O)=O	GABA receptor antagonist	GABBR1|GABBR2|SLC52A2
NDT-9513727	10210160	BRD-K17539220	CCCCn1c(CN(Cc2ccc3OCOc3c2)Cc2ccc3OCOc3c2)c(nc1-c1ccccc1)-c1ccccc1	complement antagonist	C5AR1
NE-100	9841596	BRD-K11443721	CCCN(CCC)CCc1ccc(OC)c(OCCc2ccccc2)c1	sigma receptor antagonist	SIGMAR1
nebivolol	189562	BRD-K04956647	O[C@H](CNC[C@@H](O)[C@@H]1CCc2cc(F)ccc2O1)[C@H]1CCc2cc(F)ccc2O1	adrenergic receptor antagonist	ADRB1|ADRB2
nebracetam	65926	BRD-A51355958	NCC1CN(Cc2ccccc2)C(=O)C1	acetylcholine receptor agonist	CHRM1
NECA	448222	BRD-K14395568	CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3|HSP90B1
necrostatin-1	2828334	BRD-A36318220	CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O	RIPK inhibitor	RIPK1
necrostatin-2	11288934	BRD-K68851986	CN1C(=O)N[C@H](Cc2c[nH]c3c(Cl)cccc23)C1=O	necroptosis inhibitor; RIPK inhibitor	RIPK2
nedaplatin		BRD-K38820178	N[Pt++]1(N)OCC(=O)O1	DNA inhibitor	
nedocromil	50294	BRD-K64716392	CCCc1c2oc(cc(=O)c2cc2c1n(CC)c(cc2=O)C(O)=O)C(O)=O	histamine receptor antagonist	CYSLTR1|CYSLTR2|FPR1|HSP90AA1|PTGDR
nefazodone	4449	BRD-K90789829	CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1	adrenergic inhibitor; norepinephrine reuptake inhibitor; serotonin receptor antagonist; serotonin reuptake inhibitor	ADRA1A|ADRA1B|ADRA2A|CYP3A4|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A3|SLC6A4
nefiracetam	71157	BRD-K65678996	Cc1cccc(C)c1NC(=O)CN1CCCC1=O	acetylcholine receptor agonist; benzodiazepine receptor agonist	CHRM1
nefopam	4450	BRD-A78877355	CN1CCOC(c2ccccc2)c2ccccc2C1	cyclooxygenase inhibitor	
nelarabine	3011155	BRD-K84466663	COc1nc(N)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	DNA synthesis inhibitor; T cell inhibitor	POLA1
nelfinavir	64143	BRD-K74117820	Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C	HIV protease inhibitor	CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4|CYP3A7
nemonapride	76968489	BRD-M80207679	CNc1cc(OC)c(cc1Cl)C(=O)N[C@@H]1CCN(Cc2ccccc2)[C@@H]1C.CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]1CCN(Cc2ccccc2)[C@H]1C	dopamine receptor antagonist	DRD2|DRD3|DRD4
nemorubicin	65907	BRD-K51911221	CO[C@@H]1CN(CCO1)[C@H]1C[C@H](O[C@H]2C[C@@](O)(Cc3c(O)c4C(=O)c5cccc(OC)c5C(=O)c4c(O)c23)C(=O)CO)O[C@@H](C)[C@H]1O	topoisomerase inhibitor	TOP1|TOP2A
neo-gilurytmal	16396282	BRD-A53539450	CCC[N+]12[C@H]3C[C@]45C(O)C3[C@@H](CC1[C@@H]4N(C)c1ccccc51)[C@H](CC)[C@H]2O		
neohesperidin	24721685	BRD-K96299080	COc1cc(O)cc(c1)[C@@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)cc2O1		
neohesperidin-dihydrochalcone	30231	BRD-K61032563	COc1ccc(CCC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)cc2O)cc1O		
neomycin	8378	BRD-K71013094	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O	bacterial 30S ribosomal subunit inhibitor	CXCR4
neomycin-sulfate	8378	BRD-K71013094	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O	bacterial 30S ribosomal subunit inhibitor	
neostigmine	4456	BRD-K18922609	CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C	acetylcholinesterase inhibitor	ACHE
nepafenac	151075	BRD-K04112579	NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N	cyclooxygenase inhibitor	PTGS1|PTGS2
nepicastat	9796181	BRD-K09126848	NCc1c[nH]c(=S)n1[C@H]1CCc2c(F)cc(F)cc2C1	dopamine beta hydroxylase inhibitor	DBH
neratinib	9915743	BRD-K85606544	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C	EGFR inhibitor	EGFR|ERBB2|KDR
nerbacadol	65865	BRD-K43647122	Cc1oncc1C(=O)N1CCCCC1	cyclooxygenase inhibitor	
neridronic-acid	71237	BRD-K60212747	NCCCCCC(O)(P(O)(O)=O)P(O)(O)=O	bone resorption inhibitor	FDPS
nesbuvir	11561383	BRD-K79989959	CNC(=O)c1c(oc2cc(N(CCO)S(C)(=O)=O)c(cc12)C1CC1)-c1ccc(F)cc1	RNA polymerase inhibitor	
netilmicin	45006128	BRD-A59825838	CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1OC1OC[C@](C)(O)[C@H](NC)[C@H]1O	protein synthesis inhibitor	
netupitant	6451149	BRD-K97428065	CN(C(=O)C(C)(C)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)c1cnc(cc1-c1ccccc1C)N1CCN(C)CC1	tachykinin antagonist	TACR1
neurodazine	16112820	BRD-K22631935	COc1ccc(cc1)-c1nc([nH]c1-c1ccc(OC)cc1)-c1ccc(o1)-c1cccc(Cl)c1	neurogenesis of non-pluripotent C2C12 myoblast inducer	
neuropathiazol	11667240	BRD-K28567778	CCOC(=O)c1ccc(cc1)N(C)c1csc(n1)-c1ccccc1	neural stem cell inducer	BMP2|LIF
nevirapine	4463	BRD-K15502390	Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1	non-nucleoside reverse transcriptase inhibitor	CYP1A2|CYP2A6|CYP2B6|CYP2C9|CYP2D6|CYP3A4|CYP3A5
nexturastat-a	71462653	BRD-K70402238	CCCCN(Cc1ccc(cc1)C(=O)NO)C(=O)Nc1ccccc1	HDAC inhibitor	HDAC1|HDAC6
NFKB-activation-inhibitor-II	16760588	BRD-K83354763	Cc1ccc(NCCCc2ccccc2)c(N)c1	NFkB pathway inhibitor	RELA
NG-nitro-arginine	28360916	BRD-K89223384	N[C@@H](CCCNC(=N)N[N+]([O-])=O)C(O)=O	nitric oxide synthase inhibitor	NOS1|NOS2|NOS3
NGB-2904	9891901	BRD-K05181084	Clc1cccc(N2CCN(CCCCNC(=O)c3ccc-4c(Cc5ccccc-45)c3)CC2)c1Cl	dopamine receptor antagonist	DRD3
NGD-94-1	188942	BRD-K28639661	C(N1CCN(CC1)c1ncccn1)c1cnc([nH]1)-c1ccccc1	dopamine receptor antagonist	DRD4
NGD-98-2	9822241	BRD-K81779590	CCC(CC)Nc1nc(C)c(nc1OC)-c1ccc(OC(F)(F)F)cc1OC	corticosteroid releasing factor receptor antagonist	CRHR1
NHI-2	51355147	BRD-K05653025	COC(=O)c1cc2c(cc(cc2n1O)-c1ccccc1)C(F)(F)F	lactate dehydrogenase inhibitor	LDHA
NH125	10436840	BRD-K31086665	CCCCCCCCCCCCCCCC[n+]1ccn(Cc2ccccc2)c1C	eukaryotic translation elongation factor 2 inhibitor	
NI-57	91827373	BRD-K03042257	COc1cc(ccc1S(=O)(=O)Nc1ccc2n(C)c(=O)c(C)cc2c1)C#N	bromodomain inhibitor	BRD1|BRPF1|BRPF3
niacin	117629482	BRD-K60237333	OC(=O)c1cccnc1	NAD precursor; vitamin B	DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT
nialamide	4472	BRD-K12102668	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	monoamine oxidase inhibitor	COMT|MAOA|MAOB
nibentan	177906	BRD-A85876464	CCN(CC)CCCCC(NC(=O)c1ccc(cc1)[N+]([O-])=O)c1ccccc1	potassium channel blocker	
nicaraven	71234	BRD-A86871940	CC(CNC(=O)c1cccnc1)NC(=O)c1cccnc1	free radical scavenger	
nicardipine	4474	BRD-A26711594	COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN(C)Cc1ccccc1	calcium channel blocker	ADORA3|ADRA1A|ADRA1B|ADRA1D|CACNA1C|CACNA1D|CACNA2D1|CACNB2|CALM1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|PDE1A|PDE1B
nicergoline	34040	BRD-K76810206	CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13	adrenergic receptor antagonist	ADRA1A
niceritrol	4476	BRD-K11256763	O=C(OCC(COC(=O)c1cccnc1)(COC(=O)c1cccnc1)COC(=O)c1cccnc1)c1cccnc1	NAD precursor	
niclosamide	4477	BRD-K35960502	Oc1ccc(Cl)cc1C(=O)Nc1ccc(cc1Cl)[N+]([O-])=O	DNA replication inhibitor; STAT inhibitor	STAT3
nicorandil	47528	BRD-K97752965	[O-][N+](=O)OCCNC(=O)c1cccnc1	nitric oxide donor; potassium channel activator	KCNJ11
nicotinamide	936	BRD-K28912512	NC(=O)c1cccnc1	protein synthesis stimulant	BST1|LDHA|PARP1|SIRT5
nicotine	942	BRD-A93695607	CN1CCCC1c1cccnc1	acetylcholine receptor agonist	CHAT|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB2|CHRNB3|CHRNB4|CYP19A1|TBXAS1|TRPA1
nicotinyl-alcohol-tartrate	7510	BRD-K76600340	OCc1cccnc1		
NIDA-41020	11037861	BRD-K17617556	COc1ccc(cc1)-c1c(C)c(nn1-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1	cannabinoid receptor antagonist	CNR1
nifedipine	4485	BRD-K96354014	COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OC	calcium channel blocker	CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNB2|CALM1|GLRA1|GLRA3|GLRB|KCNA1|KCNA5|NR1I2|TRPM3
nifekalant	4486	BRD-K32311154	Cn1c(NCCN(CCO)CCCc2ccc(cc2)[N+]([O-])=O)cc(=O)n(C)c1=O	potassium channel blocker	
nifenalol	6317	BRD-A21280314	CC(C)NCC(O)c1ccc(cc1)[N+]([O-])=O	adrenergic receptor antagonist	ADRB1|ADRB2
nifenazone	4487	BRD-K47407372	Cc1c(NC(=O)c2cccnc2)c(=O)n(-c2ccccc2)n1C	analgesic agent	
niflumic-acid	4488	BRD-K98763141	OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F	cyclooxygenase inhibitor	ANO1|CLCN1|CLCNKA|CLCNKB|KCNQ1|PLA2G1B|PLA2G4A|PTGS1|PTGS2|UGT1A9
nifuroxazide	5337997	BRD-K68188368	Oc1ccc(cc1)C(=O)N\N=C\c1ccc(o1)[N+]([O-])=O	bacterial DNA inhibitor	
nifursol	9570327	BRD-K85757157	Oc1c(cc(cc1[N+]([O-])=O)[N+]([O-])=O)C(=O)N\N=C\c1ccc(o1)[N+]([O-])=O	bacterial DNA inhibitor	
nifurtimox	31772	BRD-A00100033	CC1CS(=O)(=O)CCN1N=Cc1ccc(o1)[N+]([O-])=O	DNA inhibitor	
niguldipine-(S)-(+)	60602	BRD-K59333713	COC(=O)C1=C(C)NC(C)=C([C@H]1c1cccc(c1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1	adrenergic receptor antagonist	ADRA1A
nikethamide	5497	BRD-K91544578	CCN(CC)C(=O)c1cccnc1	immunostimulant	
nilotinib	644241	BRD-K81528515	Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)cc(c1)C(F)(F)F	Abl kinase inhibitor; Bcr-Abl kinase inhibitor	ABL1|KIT
nilutamide	4493	BRD-K23566484	CC1(C)NC(=O)N(C1=O)c1ccc(c(c1)C(F)(F)F)[N+]([O-])=O	androgen receptor antagonist	AR
nilvadipine	4494	BRD-A84687895	COC(=O)C1=C(NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C)C#N	calcium channel blocker	CACNA1C|CACNA1D|CACNA1S|CACNA2D1|CACNA2D3|CACNB2
nimesulide	4495	BRD-K76775527	CS(=O)(=O)Nc1ccc(cc1Oc1ccccc1)[N+]([O-])=O	cyclooxygenase inhibitor	LTF|PLA2G2E|PTGS1|PTGS2
nimodipine	4497	BRD-A58048407	COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C	calcium channel blocker	AHR|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CFTR|NR3C2
nimorazole	23009	BRD-K79145628	[O-][N+](=O)c1cncn1CCN1CCOCC1	bacterial DNA inhibitor	
nimustine	39214	BRD-K13240081	Cc1ncc(CNC(=O)N(CCCl)[N+][O-])c(N)n1	DNA alkylating agent	
nintedanib	9809715	BRD-K49075727	COC(=O)c1ccc2c(NC(=O)\C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1	FGFR inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor	FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB
niraparib	24958200	BRD-K54955827	NC(=O)c1cccc2cn(nc12)-c1ccc(cc1)[C@@H]1CCCNC1	PARP inhibitor	PARP1
niridazole	6093	BRD-K53123955	[O-][N+](=O)c1cnc(s1)N1CCNC1=O	phosphofructokinase inhibitor	
nisin	16129667	BRD-A41063939	CCC(C)C(N)C(=O)N\C(=C/C)C(=O)NC1CSCC(NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(NC1=O)C(C)CC)C(=O)NC1C(C)SCC(NC(=O)CNC(=O)C2CCCN2C1=O)C(=O)NC(CCCCN)C(=O)NC1C(C)SCC(NC(=O)CNC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC1=O)C(=O)NC(CC(N)=O)C(=O)NC(CCSC)C(=O)NC(CCCCN)C(=O)NC1C(C)SCC2NC(=O)C(NC(=O)C(C)NC1=O)C(C)SCC(NC(=O)C(Cc1c[nH]cn1)NC2=O)C(=O)NC(CO)C(=O)NC(C(C)CC)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(C(C)C)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O	bacterial cell wall synthesis inhibitor	
nisoldipine	4499	BRD-A84465106	COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OCC(C)C	calcium channel blocker	CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1|CACNB2
nisoxetine	4500	BRD-A95696066	CNCCC(Oc1ccccc1OC)c1ccccc1	norepinephrine reuptake inhibitor	SLC6A2|SLC6A3|SLC6A4
nitarsone	66826	BRD-K56707426	O[As](O)(=O)c1ccc(cc1)[N+]([O-])=O		
nitazoxanide	41684	BRD-K96471533	CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+]([O-])=O	pyruvate ferredoxin oxidoreductase inhibitor	
nitecapone	5464105	BRD-K75551531	CC(=O)C(=Cc1cc(O)c(O)c(c1)[N+]([O-])=O)C(C)=O	catechol O methyltransferase inhibitor	COMT
nitenpyram	3034287	BRD-K47887731	CCN(Cc1ccc(Cl)nc1)C(\NC)=C\[N+]([O-])=O		
nithiamide	8798	BRD-K39467894	CC(=O)Nc1ncc(s1)[N+]([O-])=O	bacterial DNA inhibitor	
nitisinone	115355	BRD-K01109406	[O-][N+](=O)c1cc(ccc1C(=O)C1C(=O)CCCC1=O)C(F)(F)F	hydroxyphenylpyruvate dioxygenase inhibitor	HPD
nitrendipine	4507	BRD-A02006392	CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC	calcium channel blocker	CACNA1C|CACNA1D|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2|CACNG1|KCNN4
nitrocaramiphen	3941250	BRD-K28453807	CCN(CC)CCOC(=O)C1(CCCC1)c1ccc(cc1)[N+]([O-])=O	cholinergic receptor antagonist	CHRM1
nitrofurantoin	6604200	BRD-K76927775	[O-][N+](=O)c1ccc(\C=N\N2CC(=O)NC2=O)o1	DNA inhibitor	
nitrofurazone	5447130	BRD-K79092138	NC(=O)N\N=C\c1ccc(o1)[N+]([O-])=O	bacterial DNA inhibitor	
nitromide	4511	BRD-K76381435	NC(=O)c1cc(cc(c1)[N+]([O-])=O)[N+]([O-])=O		
nitrosodimethylurea	83273	BRD-K08927448	CNC(=O)N(C)[N+][O-]	DNA synthesis inhibitor	
nitroxoline	19910	BRD-K97534525	Oc1ccc([N+]([O-])=O)c2cccnc12	cathepsin inhibitor	METAP2
nizatidine	3033637	BRD-K73589491	CN\C(NCCSCc1csc(CN(C)C)n1)=C/[N+]([O-])=O	histamine receptor antagonist	HRH2
nizofenone	4514	BRD-K84011460	CCN(CC)Cc1nccn1-c1ccc(cc1C(=O)c1ccccc1Cl)[N+]([O-])=O	ion channel antagonist	
NK-252	71618700	BRD-K47441935	O=C(NCc1ccccn1)Nc1nnc(o1)-c1ccco1	NRF2 activator	NFE2L2
NKP-1339		BRD-K74796838	Cl[Ru+3](Cl)(Cl)(Cl)([n+]1cc2ccccc2[nH]1)[n+]1cc2ccccc2[nH]1	HSP inhibitor	
NKY-80	2772368	BRD-A75015151	Nc1ncc2C(=O)CC(Cc2n1)c1ccco1	adenylyl cyclase inhibitor	ADCY5
NLG919	66558287	BRD-A62133859	OC(CC1c2ccccc2-c2cncn12)C1CCCCC1	indoleamine 2,3-dioxygenase inhibitor	IDO1
NMDA	22880	BRD-K62414032	CN[C@H](CC(O)=O)C(O)=O	glutamate receptor agonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
NMS-E973		BRD-K58770988	CN1CCC(CC1)NC(=O)c1cc(on1)-c1c(O)cc(O)cc1Oc1ccc(cc1)[N+]([O-])=O	HSP inhibitor	
NMS-P715	44556162	BRD-K54170555	CCc1cccc(CC)c1NC(=O)c1nn(C)c-2c1CCc1cnc(Nc3ccc(cc3OC(F)(F)F)C(=O)NC3CCN(C)CC3)nc-21	protein kinase inhibitor	
NMS-1286937	49792852	BRD-K83699324	CN1CCN(CC1)c1ccc(OC(F)(F)F)c(Nc2ncc3CCc4c(nn(CCO)c4-c3n2)C(N)=O)c1	PLK inhibitor	FLT3|PLK1|PLK2|PLK3
NMS-873	71521142	BRD-K26253904	Cc1cc(OCc2nnc(SC3CCCC3)n2-c2cccnc2)ccc1-c1ccc(cc1)S(C)(=O)=O	ATPase inhibitor	VCP
NM107	13871033	BRD-A66966115	CC1(O)C(O)C(CO)OC1n1ccc(N)nc1=O	RNA polymerase inhibitor	
NNC-05-2090	9888030	BRD-K85015012	COc1ccccc1C1(O)CCN(CCCn2c3ccccc3c3ccccc23)CC1	GABA uptake inhibitor; GAT inhibitor	SLC6A12
NNC-55-0396	9957280	BRD-K78122587	CC(C)[C@H]1c2ccc(F)cc2CC[C@@]1(CCN(C)CCCc1nc2ccccc2[nH]1)OC(=O)C1CC1	T-type calcium channel blocker	CATSPER1|CATSPER2|CATSPER3|CATSPER4
NNC-63-0532	9803475	BRD-K72904818	COC(=O)CN1CN(c2ccccc2)C2(CCN(Cc3cccc4ccccc34)CC2)C1=O	opioid receptor agonist	OPRL1
NNC-711	4515	BRD-K42221274	OC(=O)C1=CCCN(CCON=C(c2ccccc2)c2ccccc2)C1	GABA uptake inhibitor	SIGMAR1|SLC6A1
NO-ASA	119032	BRD-K08807999	CC(=O)Oc1ccccc1C(=O)Oc1cccc(CO[N+]([O-])=O)c1	cyclooxygenase inhibitor	PTGS2
nobiletin	72344	BRD-K06753942	COc1ccc(cc1OC)-c1cc(=O)c2c(OC)c(OC)c(OC)c(OC)c2o1	MEK inhibitor	MAP2K1
nocodazole	4122	BRD-K12539581	COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c1cccs1	tubulin polymerization inhibitor	HPGDS
nolatrexed	108189	BRD-K36636143	Cc1ccc2nc(N)nc(O)c2c1Sc1ccncc1	thymidylate synthase inhibitor	TYMS
nomegestrol-acetate	91668	BRD-K27351809	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C(C)=O	progesterone receptor agonist	PGR
nomifensine	4528	BRD-A29644307	CN1CC(c2ccccc2)c2cccc(N)c2C1	dopamine uptake inhibitor; noradrenaline uptake inhibitor	DRD2|MAOA|MAOB|MPO|SLC6A2|SLC6A3
nonivamide	2998	BRD-K05907307	CCCCCCCCC(=O)NCc1ccc(O)c(OC)c1	TRPV agonist	TRPV1
nonoxynol-9	72385	BRD-K88625236	CCCCCCCCCc1ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)cc1	membrane integrity inhibitor	
nor-Binaltorphimine-dihydrochloride	5480230	BRD-K36381762	Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)c1[nH]c2[C@@H]4Oc6c7c(C[C@H]8N(CC9CC9)CC[C@@]47[C@@]8(O)Cc2c1C[C@@]35O)ccc6O	opioid receptor antagonist	OPRD1|OPRK1|OPRM1
norcyclobenzaprine	9918	BRD-K63165456	CNCCC=C1c2ccccc2C=Cc2ccccc12	adrenergic receptor agonist; serotonin receptor antagonist	
norelgestromin	9568628	BRD-K42504537	CC[C@]12CC[C@H]3[C@@H](CCC4=C\C(CC[C@H]34)=N\O)[C@@H]1CC[C@@]2(O)C#C		PGR
norepinephrine	439260	BRD-K87349682	NC[C@H](O)c1ccc(O)c(O)c1	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|SLC18A1|SLC18A2
norethindrone	6230	BRD-K92073408	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	progesterone receptor agonist	PGR
norethindrone-acetate	5702094	BRD-A09349126	CC(=O)O[C@]1(CCC2C3CCC4=CC(=O)CC[C@@H]4C3CC[C@]12C)C#C	progesterone receptor agonist	
norethisterone-enanthate	229295	BRD-K07625016	CCCCCCC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C	contraceptive agent	
noretynodrel	5702095	BRD-A00758722	C[C@]12CCC3C(CCC4=C3CCC(=O)C4)C1CC[C@@]2(O)C#C	progestogen hormone	PGR
norfloxacin	4539	BRD-K11196887	CCn1cc(C(O)=O)c(=O)c2cc(F)c(cc12)N1CCNCC1	bacterial DNA gyrase inhibitor	TOP2A
norfluoxetine	4541	BRD-A79769222	NCCC(Oc1ccc(cc1)C(F)(F)F)c1ccccc1	selective serotonin reuptake inhibitor (SSRI)	HTR2B
norgestimate	6540478	BRD-K38041788	CC[C@]12CC[C@H]3[C@@H](CCC4=C\C(CC[C@H]34)=N\O)[C@@H]1CC[C@@]2(OC(C)=O)C#C	progesterone receptor agonist	ESR1|PGR
norgestrel	124079495	BRD-A14886633	CC[C@]12CCC3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	progesterone receptor agonist	PGR
nornicotine	412	BRD-A24543851	C1CNC(C1)c1cccnc1	acetylcholine receptor agonist	
nortriptyline	4543	BRD-K91263825	CNCCC=C1c2ccccc2CCc2ccccc12	tricyclic antidepressant	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|HTR6|KCNJ10|PGRMC1|SIGMAR1|SLC6A2|SLC6A4
norvancomycin	13366009	BRD-A08791201	CC(C)CC(N)C(=O)NC1C(O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)C(O)C5NC(=O)C(NC(=O)C4NC(=O)C(CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1C(NC5=O)C(O)=O)c3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1)c(Cl)c2		
noscapine	275196	BRD-K89237706	COc1ccc2[C@H](OC(=O)c2c1OC)[C@@H]1N(C)CCc2cc3OCOc3c(OC)c12	bradykinin receptor antagonist; tubulin polymerization inhibitor	SIGMAR1
NOV-002	16401161	BRD-K11411329	N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@@H](N)C(O)=O)C(=O)NCC(O)=O)C(=O)NCC(O)=O)C(O)=O		GSR|GSTM2
novobiocin	54675769	BRD-K85307935	CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C	bacterial DNA gyrase inhibitor	
NPC-01	94141	BRD-K58277159	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O	steroid	
NPC-15199	1549477	BRD-K65275554	CC(C)C[C@@H](NC(=O)OCC1c2ccccc2-c2ccccc12)C(O)=O	ICAM1 antagonist	PPARG
NPPB	4549	BRD-K89272762	OC(=O)c1cc(ccc1NCCCc1ccccc1)[N+]([O-])=O	chloride channel blocker	ANO1|CLCN2|CLCN7|TRPA1
NPS-2143	6918446	BRD-K75506300	CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1cccc(Cl)c1C#N	calcium receptor antagonist	CASR
NPY-5RA972	9884833	BRD-K95600043	CC(C)n1c2ccccc2c2c(C)c(NC(=O)N3CCOCC3)ccc12	neuropeptide receptor antagonist	NPY5R
NQDI-1	5522952	BRD-K61918008	CCOC(=O)c1c(O)nc2cccc3C(=O)c4ccccc4-c1c23	caspase inhibitor	CASP3
NS-018	46866319	BRD-K21865955	C[C@H](Nc1cc(cc(Nc2cnccn2)n1)-c1cnn(C)c1)c1ccc(F)cc1	JAK inhibitor	JAK1|JAK2|JAK3|TYK2
NS-11021	24825677	BRD-K94342292	FC(F)(F)c1cc(NC(=S)Nc2ccc(Br)cc2-c2nnn[nH]2)cc(c1)C(F)(F)F	calcium-activated potassium channel activator	KCNMA1
NS-1643	10177784	BRD-K73738482	Oc1ccc(cc1NC(=O)Nc1cc(ccc1O)C(F)(F)F)C(F)(F)F	voltage-gated potassium channel activator	KCNH2|KCNH6|KCNMA1
NS-19504	727750	BRD-K03808106	Nc1ncc(Cc2ccc(Br)cc2)s1	calcium-activated potassium channel activator	KCNMA1
NS-309	11637204	BRD-K37602296	ON=C1C(=O)Nc2c1ccc(Cl)c2Cl	calcium-activated potassium channel activator	KCNN1|KCNN2|KCNN3|KCNN4
NS-3623	9954236	BRD-K24434292	FC(F)(F)c1cccc(NC(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)c1	voltage-gated potassium channel activator	KCNH2
NS-3861	9838728	BRD-A23155040	CN1C2CCC1C=C(C2)c1sccc1Br	acetylcholine receptor agonist	CHRNA3|CHRNB4
NS-5806	11642685	BRD-K93314017	FC(F)(F)c1cc(NC(=O)Nc2c(Br)cc(Br)cc2-c2nnn[nH]2)cc(c1)C(F)(F)F	voltage-gated potassium channel activator	KCND3
NS-8	10176749	BRD-K22667752	Cc1c([nH]c(N)c1C#N)-c1ccccc1F	potassium channel agonist	KCNMA1
NS-8593	11587013	BRD-K34624869	C1C[C@@H](Nc2nc3ccccc3[nH]2)c2ccccc2C1	calcium-activated potassium channel modulator	KCNN1|KCNN2|KCNN3
NS-9283	11998180	BRD-K40176866	N#Cc1cccc(c1)-c1nc(no1)-c1cccnc1	acetylcholine receptor allosteric modulator	CHRNA4
NSC-23766	409805	BRD-A80213327	CCN(CC)CCCC(C)Nc1nc(C)cc(Nc2ccc3nc(C)cc(N)c3c2)n1	Ras GTPase inhibitor	
NSC-319726	5351307	BRD-K99170882	C\C(c1ccccn1)=N/NC(=S)N1CCC1	p53 activator	
NSC-3852	19103	BRD-K13169950	Oc1ccc([N+][O-])c2cccnc12	HDAC inhibitor	HDAC1
NSC-405020	346721	BRD-A67975844	CCCC(C)NC(=O)c1ccc(Cl)c(Cl)c1	matrix metalloprotease inhibitor	MMP1
NSC-4644	72326	BRD-K64874225	CC(=C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12	ACAT inhibitor; sterol regulatory element binding protein (SREBP) inhibitor	PYGM
NSC-625987	3004085	BRD-K62949423	COc1ccc(OC)c2c1[nH]c1ccccc1c2=S	CDK inhibitor	CDK2|CDK4
NSC-632839	5351363	BRD-K81197548	Cc1ccc(cc1)\C=C1/CNC\C(C1=O)=C/c1ccc(C)cc1	ubiquitin specific protease inhibitor	SENP2|USP1|USP2|USP7
NSC-663284	379077	BRD-K03109492	ClC1=C(NCCN2CCOCC2)C(=O)c2ncccc2C1=O	CDC inhibitor	CDC25A|CDC25B|CDC25C
NSC-697923	394449	BRD-K20605374	Cc1ccc(cc1)S(=O)(=O)c1ccc(o1)[N+]([O-])=O	ubiquitin-conjugating enzyme inhibitor	UBE2N
NSC-95397	262093	BRD-K68143200	OCCSC1=C(SCCO)C(=O)c2ccccc2C1=O	CDC inhibitor	CDC25A|CDC25B
NSC-9965	31762	BRD-K49811169	CO[C@H]1CC=C2CCN3CCC4=C(CC(=O)OC4)[C@]23C1	acetylcholine receptor antagonist	CHRNA4|CHRNB2
NSC5844	221354	BRD-K73799155	C(CNc1ccnc2cc(Cl)ccc12)Nc1ccnc2cc(Cl)ccc12	CC chemokine receptor agonist	CCR1
NSC636819	6288112	BRD-K61120504	[O-][N+](=O)c1cc(c(\C=C\c2ccc(Cl)c(Cl)c2)cc1\C=C\c1ccc(Cl)c(Cl)c1)[N+]([O-])=O	histone demethylase inhibitor	KDM4A|KDM4B
NSI-189	50922681	BRD-K74371986	CC(C)CCNc1ncccc1C(=O)N1CCN(Cc2ccccc2)CC1	neurotrophic agent	
NTNCB		BRD-A40413915	[O-][N+](=O)c1ccccc1S(=O)(=O)NC[C@H]1CC[C@H](CNCC2CCc3ccccc3C2)CC1	neuropeptide receptor antagonist	NPY5R
NTRC-824	101873359	BRD-K07788774	CC(C)C[C@H](NC(=O)Cn1cc(C(=O)C(F)(F)F)c2cc(NS(=O)(=O)c3ccc(C)cc3)ccc12)C(O)=O	neurotensin receptor antagonist	NTSR2
nTZDpa	9954280	BRD-K54708045	OC(=O)c1n(Cc2ccc(Cl)cc2)c2ccc(Cl)cc2c1Sc1ccccc1	PPAR receptor agonist	PPARG
NT157		BRD-K54098378	Oc1cc(CNC(=S)\C=C\c2cc(O)c(O)c(Br)c2)cc(O)c1O	IGF-1 inhibitor	IGF1R
NU-1025	63306	BRD-K48692744	Cc1nc2c(O)cccc2c(=O)[nH]1	PARP inhibitor	PARP1
NU-2058	4564	BRD-K20976221	Nc1nc(OCC2CCCCC2)c2[nH]cnc2n1	cyclin D inhibitor	CCNA2|CDK2
NU-7026	9860529	BRD-K09537769	O=c1cc(oc2c3ccccc3ccc12)N1CCOCC1	DNA dependent protein kinase inhibitor; mTOR inhibitor; PI3K inhibitor	PRKDC
NU-7441	11327430	BRD-K00337317	O=c1cc(oc2c(cccc12)-c1cccc2c3ccccc3sc12)N1CCOCC1	DNA dependent protein kinase inhibitor	PRKDC
nuclomedone	128798	BRD-A96466199	Clc1ccc(CC2C(=O)N=C3SCCN3C2=O)cc1	immunosuppressant	
nutlin-3	216345	BRD-A12230535	COc1ccc(C2=NC(C(N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1	MDM inhibitor	MDM2|TP53
NU6027	398148	BRD-K03294269	Nc1nc(N)c([N+][O-])c(OCC2CCCCC2)n1	CDK inhibitor	CCNA2|CDK2
NVP-ADW742		BRD-K15179513	Nc1ncnc2n(cc(-c3cccc(OCc4ccccc4)c3)c12)[C@H]1C[C@H](CN2CCCC2)C1	insulin growth factor receptor inhibitor	IGF1R
NVP-AEW541		BRD-K24696047	Nc1ncnc2n(cc(-c3cccc(OCc4ccccc4)c3)c12)[C@@H]1C[C@H](CN2CCC2)C1	IGF-1 inhibitor	IGF1R|INSR
NVP-AUY922		BRD-K41859756	CCNC(=O)c1noc(c1-c1ccc(CN2CCOCC2)cc1)-c1cc(C(C)C)c(O)cc1O	HSP inhibitor	HSP90AA1|HSP90AB1
NVP-BEZ235	11977753	BRD-K12184916	Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1	mTOR inhibitor; PI3K inhibitor	ATR|MTOR|PIK3CA|PIK3CD|PIK3CG
NVP-BGJ398	53235510	BRD-K42728290	CCN1CCN(CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)cc1	FGFR inhibitor	FGFR1|FGFR2|FGFR3|FGFR4|KDR
NVP-BHG712	16747388	BRD-K79259477	Cc1ccc(cc1Nc1nc(nc2n(C)ncc12)-c1cccnc1)C(=O)Nc1cccc(c1)C(F)(F)F	ephrin inhibitor	EPHB4
NVP-BSK805	46398810	BRD-K02017404	Fc1cc(cc(F)c1CN1CCOCC1)-c1cccc2ncc(nc12)-c1cnn(c1)C1CCNCC1	JAK inhibitor	JAK2
NVP-BVU972	44206063	BRD-K77943374	Cn1cc(cn1)-c1ccc2ncc(Cc3ccc4ncccc4c3)n2n1	MET inhibitor	MET
NVP-DPP728	9796290	BRD-K77396579	O=C(CNCCNc1ccc(cn1)C#N)N1CCC[C@H]1C#N	dipeptidyl peptidase inhibitor	DPP4
NVP-HSP990	46216556	BRD-K67915505	COc1cccc(n1)-c1cc(F)ccc1[C@H]1Cc2nc(N)nc(C)c2C(=O)N1	HSP inhibitor	HSP90AA1|HSP90AB1
NVP-TAE226	9934347	BRD-K21025364	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(cc2OC)N2CCOCC2)ncc1Cl	protein tyrosine kinase inhibitor	PTK2
NVP-TAE684	16038120	BRD-K50140147	COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1)N1CCC(CC1)N1CCN(C)CC1	ALK tyrosine kinase receptor inhibitor	ALK|INSR
NVP-TNKS656	71227201	BRD-K87454346	COc1ccc(cc1)C(=O)C1CCN(CC(=O)N(CC2CC2)Cc2nc3CCOCc3c(=O)[nH]2)CC1	tankyrase inhibitor	TNKS2
NVP-231	4096211	BRD-K01573278	O=C(Nc1nc2ccc(NC(=O)C34CC5CC(CC(C5)C3)C4)cc2s1)c1ccccc1	ceramidase inhibitor	CERK
NVS-PAK1-1	122187564	BRD-K28132190	CC(C)NC(=O)N1CC[C@@H](C1)NC1=Nc2cc(F)ccc2N(CC(F)F)c2ccc(Cl)cc12	p21 activated kinase inhibitor	PAK1
NXY-059	6913176	BRD-K46133855	CC(C)(C)[N+](\[O-])=C\c1ccc(cc1S(O)(=O)=O)S(O)(=O)=O	free radical scavenger	
nystatin	11286230	BRD-K21656326	C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O	fungal ergosterol inhibitor	
N20C	6603827	BRD-K41143549	NC(=O)CNCCC(c1ccccc1)c1ccccc1	glutamate receptor antagonist	
N6-cyclopentyladenosine	657378	BRD-K60150510	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NC3CCCC3)ncnc12	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3|SLC29A1
N6-methyladenosine	102175	BRD-K81807412	CNc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		
N6022	44623946	BRD-K82522873	Cc1cc(ccc1-n1c(CCC(O)=O)ccc1-c1ccc(cc1)-n1ccnc1)C(N)=O	alcohol dehydrogenase inhibitor	ADH5
o-acetyl-L-serine	6971051	BRD-K63247785	CC(=O)OC[C@H](N)C(O)=O		PTGS1
o-mercapto-benzoic-acid	5443	BRD-K36998189	OC(=O)c1ccccc1S		
O-1918	40469923	BRD-K18316707	COc1cc(C)cc(OC)c1[C@@H]1C=C(C)CC[C@H]1C(C)=C	cannabinoid receptor antagonist	
o-3M3FBS	770820	BRD-K46384212	Cc1cc(C)c(c(C)c1)S(=O)(=O)Nc1ccccc1C(F)(F)F	phospholipase activator	
OAC1	789882	BRD-K10878147	O=C(Nc1cc2cc[nH]c2cn1)c1ccccc1	Oct activator	
OAC2	2814138	BRD-K18305454	O=C(Nc1ccc2[nH]ccc2c1)c1ccccc1	Oct activator	POU5F1
obatoclax		BRD-K15600710	COC1=CC(=N\C\1=C/c1[nH]c(C)cc1C)c1cc2ccccc2[nH]1	BCL inhibitor	BCL2
obeticholic-acid	21882238	BRD-A75838038	CCC1C(O)C2C3CCC(C(C)CCC(O)=O)C3(C)CCC2C2(C)CCC(O)CC12	FXR agonist	NR1H4
obidoxime	5485192	BRD-K33588785	O\N=C\c1cc[n+](COC[n+]2ccc(cc2)\C=N\O)cc1	cholinesterase reactivator	ACHE
ochromycinone	11808929	BRD-K92524032	C[C@@H]1CC(=O)c2c(C1)ccc1C(=O)c3c(O)cccc3C(=O)c21	STAT inhibitor	STAT3
ocinaplon	216456	BRD-K92581468	O=C(c1cnn2c(ccnc12)-c1ccncc1)c1ccccn1	GABA receptor modulator	GABRA1|GABRA2|GABRA3|GABRA5
OCO-1112	3081027	BRD-K22097830	CC(C)c1ccc(cc1)C(=O)NCCOc1ccc(cc1)C(O)=O	cholesterol inhibitor	
octadecan-1-ol	8221	BRD-K20501889	CCCCCCCCCCCCCCCCCCO		
octamethyltrisiloxane	24705	BRD-K73201113	C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C		
octenidine	51167	BRD-K04568635	CCCCCCCCN=c1ccn(CCCCCCCCCCn2ccc(cc2)=NCCCCCCCC)cc1	membrane integrity inhibitor	
octinoxate	6993341	BRD-K19972289	CCCC[C@@H](CC)COC(=O)\C=C\c1ccc(OC)cc1		
octisalate	1550885	BRD-K95161686	CCCC[C@@H](CC)COC(=O)c1ccccc1O		
octocrylene	40424580	BRD-K39023557	CCCC[C@@H](CC)COC(=O)C(C#N)=C(c1ccccc1)c1ccccc1		
octodrine	10982	BRD-A37873789	CC(C)CCCC(C)N	antitumor agent	
octopamine	4581	BRD-A14240607	NCC(O)c1ccc(O)cc1	trace amine associated receptor agonist	F10|TAAR1
octreotide	383414	BRD-A64173453	CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1	somatostatin receptor agonist	SSTR1|SSTR2|SSTR3|SSTR5
OC000459	11462174	BRD-K36463073	Cc1c(Cc2ccc3ccccc3n2)c2cc(F)ccc2n1CC(O)=O	CRTH receptor antagonist	PTGDR2
odanacatib	10152654	BRD-K22822991	CC(C)(F)C[C@H](N[C@@H](c1ccc(cc1)-c1ccc(cc1)S(C)(=O)=O)C(F)(F)F)C(=O)NC1(CC1)C#N	cathepsin inhibitor	CTSK
ODM-201	67171867	BRD-A44971162	C[C@@H](Cn1ccc(n1)-c1ccc(C#N)c(Cl)c1)NC(=O)c1cc([nH]n1)C(C)O	androgen receptor antagonist	AR
ODQ	1456	BRD-K26015241	O=c1onc2cnc3ccccc3n12	guanylyl cyclase inhibitor	GUCY1A2|GUCY1A3|GUCY1B3
OF-1	35397514	BRD-K92658264	COc1cc2n(C)c(=O)n(C)c2cc1NS(=O)(=O)c1ccc(Br)cc1C	bromodomain inhibitor	BRD1
ofloxacin	3288597	BRD-A24228527	CC1COc2c(N3CCN(C)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O	bacterial DNA gyrase inhibitor	TOP2A
OG-L002	56639570	BRD-K26349472	N[C@H]1C[C@@H]1c1ccc(cc1)-c1cccc(O)c1	histone lysine demethylase inhibitor	KDM1A
oglemilast	11387409	BRD-K92303087	CS(=O)(=O)Nc1ccc2oc3c(OC(F)F)ccc(C(=O)Nc4c(Cl)cncc4Cl)c3c2c1	phosphodiesterase inhibitor	
OICR-9429	91623360	BRD-K94083718	CN1CCN(CC1)c1ccc(cc1NC(=O)c1c[nH]c(=O)cc1C(F)(F)F)-c1cccc(CN2CCOCC2)c1	WDR5/MLL interaction inhibitor	WDR5
olanzapine		BRD-K18895904	CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12	dopamine receptor antagonist; serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7
olaparib	23725625	BRD-K02113016	Fc1ccc(Cc2n[nH]c(=O)c3ccccc23)cc1C(=O)N1CCN(CC1)C(=O)C1CC1	PARP inhibitor	PARP1|PARP2
OLDA	5282106	BRD-K95523387	CCCCCCCC\C=C/CCCCCCCC(=O)NCCc1ccc(O)c(O)c1	TRPV agonist	GPR119
oleamide	5283387	BRD-K06644925	CCCCCCCC\C=C/CCCCCCCC(N)=O	cannabinoid receptor agonist	HTR7|PLA2G2A
oleandrin	11541511	BRD-K98006098	CO[C@H]1C[C@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H]([C@H](C[C@]43O)OC(C)=O)C3=CC(=O)OC3)C2)O[C@@H](C)[C@@H]1O	Na/K-ATPase inhibitor	
oleanolic-acid	10494	BRD-K90647725	CC1(C)CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2C1)C(O)=O	G protein-coupled receptor agonist	GPBAR1
oleoylethanolamide	5283454	BRD-K66956375	CCCCCCCC\C=C/CCCCCCCC(=O)NCCO	cannabinoid receptor agonist; glucose dependent insulinotropic receptor agonist; potassium channel blocker; PPAR receptor agonist	CNR1|GPR119|GPR55|PPARA
olesoxime	9930827	BRD-K18210059	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=C\C(CC[C@]4(C)[C@H]3CC[C@]12C)=N\O	apoptosis stimulant	
oleuropein	5923508	BRD-A00842753	COC(=O)C1=COC(OC2OC(CO)C(O)C(O)C2O)\C(=C/C)C1CC(=O)OCCc1ccc(O)c(O)c1	estrogen receptor agonist	GPER1
oligomycin-a	6364620	BRD-A81541225	CCC1CCC2OC3(CC[C@@H](C)C(C[C@H](C)O)O3)[C@H](C)C(OC(=O)\C=C\[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@@](C)(O)[C@H](O)[C@@H](C)C\C=C\C=C\1)[C@H]2C	ATP synthase inhibitor; ATPase inhibitor	ATP5A1
olmesartan	158781	BRD-K83144676	CCCc1nc(c(C(O)=O)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)C(C)(C)O	angiotensin receptor antagonist	AGTR1
olmesartan-medoxomil	130881	BRD-K78485176	CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1	angiotensin receptor antagonist	AGTR1
olmutinib	54758501	BRD-K60421517	CN1CCN(CC1)c1ccc(Nc2nc(Oc3cccc(NC(=O)C=C)c3)c3sccc3n2)cc1	EGFR inhibitor; Bruton's tyrosine kinase (BTK) inhibitor	BTK|EGFR
olomoucine	4592	BRD-K82731415	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12	CDK inhibitor	CDK1|CDK2|CDK5|MAPK1
olopatadine	25271818	BRD-K67637637	CN(C)CC\C=C1\c2ccccc2COc2ccc(CC(O)=O)cc12	histamine receptor antagonist	HRH1|S100A1|S100A12|S100A13|S100A2|S100B
olprinone	4593	BRD-K20745393	Cc1[nH]c(=O)c(cc1-c1ccc2nccn2c1)C#N	phosphodiesterase inhibitor	PDE3A
olsalazine		BRD-K57853941	OC(=O)c1cc(ccc1O)\N=N\c1ccc(O)c(c1)C(O)=O	cyclooxygenase inhibitor	IFNG|TPMT
oltipraz	47318	BRD-K86972824	Cc1c(ssc1=S)-c1cnccn1	nuclear factor erythroid derived; like (NRF2) activator	ANG
olvanil	5311093	BRD-K31560319	CCCCCCCC\C=C/CCCCCCCC(=O)NCc1ccc(O)c(OC)c1	TRPV agonist	CNR1|GPR119|TRPV1
omadacycline	11318920	BRD-A72591750	CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(CNCC(C)(C)C)c(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C	bacterial 30S ribosomal subunit inhibitor	
omarigliptin	46209133	BRD-K14171291	CS(=O)(=O)n1cc2CN(Cc2n1)[C@H]1CO[C@@H]([C@@H](N)C1)c1cc(F)ccc1F	dipeptidyl peptidase inhibitor	DPP4
ombitasvir	54767916	BRD-K11072003	COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)Nc1ccc(cc1)[C@@H]1CC[C@H](N1c1ccc(cc1)C(C)(C)C)c1ccc(NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)C(C)C)cc1	HCV inhibitor	
OMDM-2	6604915	BRD-K48830578	CCCCCCCC\C=C/CCCCCCCC(=O)N[C@@H](CO)Cc1ccc(O)cc1	FAAH inhibitor	GPR119
omecamtiv-mecarbil	11689883	BRD-K36680103	COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1	cardiac myosin activator	MYBPC3
omega-(4-Iodophenyl)pentadecanoic acid	123810	BRD-K53156781	OC(=O)CCCCCCCCCCCCCCc1ccc(I)cc1		
omega-3-acid-esters	9831415	BRD-K31139048	CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC	cholesterol inhibitor	
omeprazole	4594	BRD-A55962179	COc1ccc2nc([nH]c2c1)S(=O)Cc1ncc(C)c(OC)c1C	ATPase inhibitor	ATP4A|CLCN2
omeprazole-magnesium	130564	BRD-A56892734	COc1ccc2n([Mg]n3c(nc4cc(OC)ccc34)S(=O)Cc3ncc(C)c(OC)c3C)c(nc2c1)S(=O)Cc1ncc(C)c(OC)c1C	proton pump inhibitor	ATP4A|ATP4B
omeprazole-sulfide	155794	BRD-K69035426	COc1ccc2nc(SCc3ncc(C)c(OC)c3C)[nH]c2c1	ATPase inhibitor	
ON-01500	11486204	BRD-K55790047	COc1cc(OC)c(\C=C\S(=O)(=O)Cc2ccc(OC)c(N)c2)c(OC)c1	apoptosis stimulant	
oncrasin-1	872445	BRD-K43449605	Clc1ccc(Cn2cc(C=O)c3ccccc23)cc1	apoptosis stimulant	
ONC201	73777259	BRD-K58529924	Cc1ccccc1CN1C2=NCCN2C2=C(CN(Cc3ccccc3)CC2)C1=O	AKT inhibitor; MAP kinase inhibitor	TNFSF10
ondansetron	4595	BRD-A19736161	Cc1nccn1CC1CCc2c(C1=O)c1ccccc1n2C	serotonin receptor antagonist	HTR1A|HTR1B|HTR3A|HTR3B|HTR4|OPRM1
ONO-AE3-208	10111831	BRD-A80567330	CC(C(=O)Nc1cc(ccc1CCCC(O)=O)C#N)c1ccc(F)c2ccccc12	prostanoid receptor antagonist	PTGER4
ONO-4059	121540650	BRD-A13689093	Nc1ncnc2n(C3CCCN(C3)C(=O)C=C)c(=O)n(-c3ccc(Oc4ccccc4)cc3)c12	Bruton's tyrosine kinase (BTK) inhibitor	BTK
ONO-4817	9888141	BRD-K58894520	CCOCOC[C@H](C[C@H](C)C(=O)NO)NC(=O)c1ccc(Oc2ccccc2)cc1	matrix metalloprotease inhibitor	MMP8
ONO-8130	9827317	BRD-K76725781	CC(C)CN(c1cc2CCCc2cc1OCc1ccc(cc1)C(O)=O)S(=O)(=O)c1nc(C)cs1	prostanoid receptor antagonist	PTGER1
ONX-0914	46218908	BRD-K60446698	COc1ccc(C[C@H](NC(=O)[C@H](C)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@]2(C)CO2)cc1	proteasome inhibitor	
ON123300	56649281	BRD-K88554883	CN1CCN(CC1)c1ccc(Nc2ncc3cc(C#N)c(=O)n(C4CCCC4)c3n2)cc1	CDK inhibitor	CDK4|NUAK1|PDGFRB
OPC-21268	114904	BRD-K19426040	CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2ccccc12	vasopressin receptor antagonist	AVPR1A|AVPR2|OXTR
opicapone		BRD-K66192203	Cc1c(Cl)c(C)[n+]([O-])c(Cl)c1-c1noc(n1)-c1cc(O)c(O)c(c1)[N+]([O-])=O	catechol O methyltransferase inhibitor	COMT
opipramol	9417	BRD-K43786866	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc23)CC1	sigma receptor agonist	
oprozomib	17753743	BRD-A36331462	COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C1(C)CO1	proteasome inhibitor	
OR-486	3870203	BRD-K18602506	Oc1cc(cc(c1O)[N+]([O-])=O)[N+]([O-])=O	catechol O methyltransferase inhibitor	COMT
orantinib	5329099	BRD-K55966568	Cc1[nH]c(\C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O	FGFR inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor	AURKA|AURKB|EGFR|FGFR1|FGFR2|KDR|PDGFRA|PDGFRB
orbifloxacin	60605	BRD-K63001556	C[C@H]1CN(C[C@@H](C)N1)c1c(F)c(F)c2c(c1F)n(cc(C(O)=O)c2=O)C1CC1	bacterial DNA gyrase inhibitor	
ORE1001	448281	BRD-K67068943	CC(C)C[C@H](N[C@@H](Cc1cncn1Cc1cc(Cl)cc(Cl)c1)C(O)=O)C(O)=O	angiotensin converting enzyme inhibitor	ACE2
Org-12962	9796408	BRD-K07409305	FC(F)(F)c1ccc(nc1Cl)N1CCNCC1	serotonin receptor agonist	HTR2A|HTR2B|HTR2C
Org-25543	5311287	BRD-K32853922	COc1cc(cc(OC)c1OCc1ccccc1)C(=O)NCC1(CCCC1)N(C)C	glycine transporter inhibitor	GLRB|SLC6A5
org-26576	13584912	BRD-K40002998	O=C1N2CCC[C@H]2COc2ncccc12	glutamate receptor modulator	
org-27569	44828492	BRD-K57597776	CCc1c([nH]c2ccc(Cl)cc12)C(=O)NCCc1ccc(cc1)N1CCCCC1	cannabinoid receptor modulator	CNR1
org-9768	22152353	BRD-K41434598	CC1(CN)Cc2ccccc2C1	adrenergic receptor antagonist	ADRA2A
oridonin	134689197	BRD-K23925186	O[C@@H]1[C@H]2CC[C@@H]3[C@@]45CO[C@](O)(C[C@@H]4C(C)(C)CC[C@@H]5O)[C@@]13C(=O)C2=C	BCL inhibitor	BCL2
oritavancin	74089869	BRD-A33352494	CNC(CC(C)C)C(=O)NC1C(O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)C(OC5CC(C)(N)C(O)C(C)O5)C5NC(=O)C(NC(=O)C4NC(=O)C(CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1C(NC5=O)C(O)=O)c3OC1OC(CO)C(O)C(O)C1OC1CC(C)(NCc3ccc(cc3)-c3ccc(Cl)cc3)C(O)C(C)O1)c(Cl)c2	bacterial cell wall synthesis inhibitor	
orlistat	6710691	BRD-K94062100	CCCCCCCCCCC[C@@H](C[C@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@@H](CC(C)C)NC=O	lipase inhibitor	CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP
ornidazole	28061	BRD-A42759514	Cc1ncc(n1CC(O)CCl)[N+]([O-])=O	antiprotozoal agent	
ornithine	389	BRD-A13561534	NCCCC(N)C(O)=O	NFkB pathway modulator	ARG1|ARG2|GATM|GPRC6A|OAT|OAZ1|OAZ2|OAZ3|OTC|SLC25A15|SLC25A2|SLC7A1|SLC7A2|SLC7A3|SLC7A4
orotic-acid	967	BRD-K32572029	OC(=O)c1cc(=O)[nH]c(=O)[nH]1		DHODH
orphanin-fq	16131448	BRD-K05717154	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O	opioid receptor agonist	OPRL1|OPRM1
orphenadrine	4601	BRD-A53576514	CN(C)CCOC(c1ccccc1)c1ccccc1C	acetylcholine receptor antagonist	GRIN1|GRIN2D|GRIN3A|GRIN3B|HRH1|SCN10A|SLC6A2
orteronel	10335364	BRD-K00674894	CNC(=O)c1ccc2cc(ccc2c1)[C@]1(O)CCn2cncc12	androgen biosynthesis inhibitor; androgen receptor antagonist; cytochrome P450 inhibitor	CYP17A1
ORY-1001	71543365	BRD-K59711701	NC1CCC(CC1)N[C@@H]1C[C@H]1c1ccccc1	histone lysine demethylase inhibitor	KDM1A
oseltamivir-carboxylate	44310478	BRD-K93767137	CCC(CC)O[C@@H]1C=C(C[C@H](N)[C@H]1NC(C)=O)C(O)=O	neuraminidase inhibitor	
oseltamivir-phosphate	65028	BRD-K76011241	CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1	neuraminidase inhibitor	CES1|NEU1|NEU2
osemozotan	198747	BRD-K60371362	C(CNC[C@H]1COc2ccccc2O1)COc1ccc2OCOc2c1	serotonin receptor agonist	HTR1A
OSI-027		BRD-K87124298	COc1cccc2cc([nH]c12)-c1nc([C@H]2CC[C@@H](CC2)C(O)=O)n2ncnc(N)c12	mTOR inhibitor	MTOR
OSI-420	10317566	BRD-K73309154	COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCO	EGFR inhibitor	EGFR
OSI-930	9868037	BRD-K25340465	FC(F)(F)Oc1ccc(NC(=O)c2sccc2NCc2ccnc3ccccc23)cc1	KIT inhibitor; VEGFR inhibitor	KDR|KIT
osimertinib	71496458	BRD-K42805893	COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc1nccc(n1)-c1cn(C)c2ccccc12	EGFR inhibitor	EGFR
ospemifene	3036505	BRD-K44184170	OCCOc1ccc(cc1)C(\c1ccccc1)=C(\CCCl)c1ccccc1	selective estrogen receptor modulator (SERM)	ESR1|ESR2
ostarine	11326715	BRD-K29735307	C[C@](O)(COc1ccc(cc1)C#N)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F	androgen receptor modulator	AR
osthol	10228	BRD-K78294846	COc1ccc2ccc(=O)oc2c1CC=C(C)C	calcium channel blocker	
OT-R-antagonist-1	9690136	BRD-K42009284	CO\N=C1\C[C@H](N(C1)C(=O)c1ccc(cc1)-c1ccccc1C)C(=O)NC[C@@H](O)c1ccccc1	oxytocin receptor antagonist	AVPR1A|OXTR
otamixaban	5496659	BRD-K80082640	COC(=O)[C@H](Cc1cccc(c1)C(N)=N)[C@@H](C)NC(=O)c1ccc(cc1)-c1cc[n+]([O-])cc1	coagulation factor inhibitor	F10
otenzepad	107867	BRD-A00520476	CCN(CC)CC1CCCCN1CC(=O)N1c2ccccc2C(=O)Nc2cccnc12	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
otilonium	72093	BRD-K85337334	CCCCCCCCOc1ccccc1C(=O)Nc1ccc(cc1)C(=O)OCC[N+](C)(CC)CC	acetylcholine receptor antagonist	CACNA1C
OTS167		BRD-K53417444	CN(C)C[C@H]1CC[C@@H](CC1)Nc1c(cnc2ccc(nc12)-c1cc(Cl)c(O)c(Cl)c1)C(C)=O	maternal embryonic leucine zipper kinase inhibitor	MELK
OTS514	67448836	BRD-K38018935	C[C@@H](CN)c1ccc(cc1)-c1c(O)cc(C)c2[nH]c(=O)c3sccc3c12	TOPK inhibitor	
OTX015	9936746	BRD-K43471985	Cc1sc-2c(c1C)C(=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n-21)c1ccc(Cl)cc1	bromodomain inhibitor	BRD2|BRD3|BRD4
ouabain	11527152	BRD-K33277808	C[C@@H]1O[C@@H](O[C@@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C2=CC(=O)OC2)[C@H](O)[C@H](O)[C@H]1O	ATPase inhibitor	ATP1A1
OXA-06	24857242	BRD-K98736329	Fc1ccccc1CNCc1ccc(cc1)-c1ccnc2[nH]ccc12	rho associated kinase inhibitor	ROCK1|ROCK2
oxacillin	6196	BRD-K96786677	Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1ccccc1	bacterial cell wall synthesis inhibitor	
oxacyclohexadecan-2-one	235414	BRD-K36982194	O=C1CCCCCCCCCCCCCCO1	protein kinase inhibitor	
oxaliplatin	11947679	BRD-K78960041	O=C1O[Pt]2(N[C@@H]3CCCC[C@H]3N2)OC1=O	DNA inhibitor	
oxaloacetate	970	BRD-K61279411	OC(=O)CC(=O)C(O)=O	glutamate release inhibitor	CS|SPR
oxandrolone	5878	BRD-K92467929	C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)OC[C@]4(C)[C@H]3CC[C@]12C	androgen receptor agonist	AR
oxantel	5281087	BRD-K66019333	CN1CCCN=C1\C=C\c1cccc(O)c1	anthelmintic agent	
oxaprozin	4614	BRD-K25394294	OC(=O)CCc1nc(c(o1)-c1ccccc1)-c1ccccc1	cyclooxygenase inhibitor	PTGS1|PTGS2
oxatomide	1385580	BRD-K02079473	O=c1[nH]c2ccccc2n1CCCN1CCN(CC1)C(c1ccccc1)c1ccccc1	histamine receptor antagonist	HRH1
oxazepam	4616	BRD-A50049929	OC1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O	GABA benzodiazepine site receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3
oxcarbazepine	34312	BRD-K04196797	NC(=O)N1c2ccccc2CC(=O)c2ccccc12	sodium channel blocker	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
oxelaidin	4619	BRD-K17977438	CCN(CC)CCOCCOC(=O)C(CC)(CC)c1ccccc1	antitussive	
oxethazaine	4621	BRD-K56940463	CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1	local anesthetic	
OXF-BD-02	56929801	BRD-A73891132	Cc1noc(C)c1-c1cc(O)cc(c1)C(O)c1ccccc1	bromodomain inhibitor	BRD4
oxfendazole	40854	BRD-A33447119	COC(=O)Nc1nc2ccc(cc2[nH]1)S(=O)c1ccccc1	anthelmintic agent	
oxfenicine	25200582	BRD-K30373577	N[C@@H](C(O)=O)c1ccc(O)cc1	carnitine palmitoyltransferase inhibitor	CPT1A|CPT1B
oxibendazole	4622	BRD-K52075715	CCCOc1ccc2nc(NC(=O)OC)[nH]c2c1	tubulin polymerization inhibitor	TUBB|TUBB4B
oxiconazole	5353853	BRD-K56104152	Clc1ccc(CO\N=C(/Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1	bacterial cell wall synthesis inhibitor	
oxidopamine	4624	BRD-K41809988	NCCc1cc(O)c(O)cc1O	neurotoxin	
oxiniacic-acid	16976	BRD-K20417253	OC(=O)c1ccc[n+]([O-])c1		
oxiperomide	68634	BRD-K78096648	Oc1nc2ccccc2n1C1CCN(CCOc2ccccc2)CC1	dopamine receptor antagonist	
oxiracetam	3051965	BRD-K50677762	NC(=O)CN1C[C@H](O)CC1=O	acetylcholine receptor agonist	
oxolamine	13738	BRD-K42596464	CCN(CC)CCc1nc(no1)-c1ccccc1	antitussive	
oxolinic-acid	4628	BRD-K73394555	CCn1cc(C(O)=O)c(=O)c2cc3OCOc3cc12	bacterial DNA gyrase inhibitor	
oxonic-acid	4604	BRD-K31468676	OC(=O)c1nc(=O)[nH]c(=O)[nH]1	uricase inhibitor	
oxotremorine-m	4629	BRD-K01942991	C[N+](C)(C)CC#CCN1CCCC1=O	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4
oxotremorine-sesquifumarate	4630	BRD-K21936341	O=C1CCCN1CC#CCN1CCCC1	cholinergic receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4
oxprenolol	4631	BRD-A43671941	CC(C)NCC(O)COc1ccccc1OCC=C	adrenergic receptor antagonist	ADRB1|ADRB2
oxtriphylline	2153	BRD-K97799481	Cn1c2nc[nH]c2c(=O)n(C)c1=O	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE4A|PDE4B|PDE5A
oxybenzone	4632	BRD-K59037100	COc1ccc(C(=O)c2ccccc2)c(O)c1	lipase inhibitor	LIPE
oxybuprocaine	4633	BRD-K04185004	CCCCOc1cc(ccc1N)C(=O)OCCN(CC)CC	local anesthetic	SCN10A
oxybutynin	4634	BRD-A65013509	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3
oxyclozanide	16779	BRD-K07283971	Oc1c(Cl)cc(Cl)cc1NC(=O)c1c(O)c(Cl)cc(Cl)c1Cl		
oxyfedrine	5489013	BRD-K73027814	COc1cccc(c1)C(=O)CCN[C@@H](C)[C@H](O)c1ccccc1	adrenergic receptor agonist	
oxymatrine	7082413	BRD-A57833392	[O-][N+]12CCC[C@@H]3CN4[C@H](CCCC4=O)[C@H](CCC1)[C@@H]23		
oxymetazoline	4636	BRD-K16195444	Cc1cc(c(O)c(C)c1CC1=NCCN1)C(C)(C)C	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C
oxymetholone	73707603	BRD-A93291428	CC1(O)CCC2C3CCC4CC(=O)C(CC4(C)C3CCC12C)C=O	androgen receptor agonist	AR
oxyphenbutazone	4641	BRD-A33749298	CCCCC1C(=O)N(N(C1=O)c1ccc(O)cc1)c1ccccc1	cyclooxygenase inhibitor	PLA2G2E|PTGS1|PTGS2
oxyphencyclimine	4642	BRD-A58193911	CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)c1ccccc1	cholinergic receptor antagonist	CHRM1|CHRM2|CHRM3
oxyphenonium	5749	BRD-A14208071	CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)c1ccccc1	cholinergic receptor antagonist	CHRM1
oxypurinol	4644	BRD-K31841515	O=c1[nH]c2n[nH]cc2c(=O)[nH]1	xanthine oxidase inhibitor	XDH
oxyquinoline	1923	BRD-K66808046	Oc1cccc2cccnc12	chelating agent	METAP2
oxytetracycline	57004235	BRD-A22740840	CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O	bacterial 30S ribosomal subunit inhibitor	
oxytocin	439302	BRD-K25243230	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O	oxytocin receptor agonist	AVPR1A|AVPR1B|AVPR2|OXTR
ozagrel	5282440	BRD-K53061490	OC(=O)\C=C\c1ccc(Cn2ccnc2)cc1	thromboxane synthase inhibitor	TBXAS1
ozanimod	52938427	BRD-K46625559	CC(C)Oc1ccc(cc1C#N)-c1nc(no1)-c1cccc2[C@H](CCc12)NCCO	sphingosine 1 phosphate receptor agonist	S1PR1
ozolinone	6436036	BRD-A72297358	CN1C(=O)C(S\C1=C/C(O)=O)N1CCCCC1	diuretic	
O4I1	2774690	BRD-K53849769	COc1ccc(COc2ccc(CC#N)cc2)cc1	Oct inducer	POU5F1
O6-Benzylguanine	4578	BRD-K92041145	Nc1nc(OCc2ccccc2)c2[nH]cnc2n1	O6-alkylguanine-DNA alkyltransferase inhibitor	MGMT
p-dimethylinamyl-benzoate	26890	BRD-K42336459	CCCCCOC(=O)c1ccc(cc1)N(C)C		
PA-452	9803242	BRD-K11428250	CCCCCCOc1cc2c(cc1N(C)c1ncc(cn1)C(O)=O)C(C)(C)CCC2(C)C	retinoid receptor antagonist	RXRA
PA-824	456199	BRD-K96671969	[O-][N+](=O)c1cn2C[C@@H](COc2n1)OCc1ccc(OC(F)(F)F)cc1	nitric oxide donor	FASN
PAC-1	9675990	BRD-K92991072	Oc1c(CC=C)cccc1\C=N\NC(=O)CN1CCN(Cc2ccccc2)CC1	caspase activator	CASP3
paclitaxel	36314	BRD-K62008436	CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1	tubulin polymerization inhibitor	BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBB|TUBB1
PACOCF3	4670	BRD-K05677083	CCCCCCCCCCCCCCCC(=O)C(F)(F)F	phospholipase inhibitor	PLA2G4A
pacritinib	46216796	BRD-K19034817	C(CN1CCCC1)Oc1ccc2Nc3nccc(n3)-c3cccc(COC\C=C\COCc1c2)c3	FLT3 inhibitor; JAK inhibitor	FLT3|JAK1|JAK2|JAK3
paeoniflorin	442534	BRD-K83631119	C[C@@]12C[C@@]3(O)O[C@@H](O1)[C@]1(COC(=O)c4ccccc4)[C@H]3C[C@]21O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O	anticonvulsant	
paeonol	11092	BRD-K94239562	COc1ccc(C(C)=O)c(O)c1	anti-inflammatory agent	
pafuramidine	44332876	BRD-K68805147	CONC(=N)c1ccc(cc1)-c1ccc(o1)-c1ccc(cc1)C(=N)NOC	DNA synthesis inhibitor	
palbociclib	5330286	BRD-K51313569	CC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n(C2CCCC2)c1=O	CDK inhibitor	CDK4|CDK6
palifosfamide	100427	BRD-K12047401	OP(=O)(NCCCl)NCCCl	DNA alkylating agent	
paliperidone	115237	BRD-A99888680	Cc1nc2C(O)CCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12	dopamine receptor antagonist; serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CYP2D6|CYP3A4|CYP3A5|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1D|HTR2A|HTR2C
palmatine-chloride	19009	BRD-K58466253	COc1cc2CC[n+]3cc4c(OC)c(OC)ccc4cc3-c2cc1OC	dopamine synthesis inhibitor	CYP3A4
palmitoleic-acid	445638	BRD-K91356052	CCCCCC\C=C/CCCCCCCC(O)=O		
palmitoylcarnitine	462	BRD-A77577770	CCCCCCCCCCCCCCCC(=O)OC(CC(O)=O)C[N+](C)(C)C	protein kinase inhibitor	
palmitoylethanolamide	4671	BRD-K68095457	CCCCCCCCCCCCCCCC(=O)NCCO	cannabinoid receptor agonist	CNR2|GPR119|GPR55
palomid-529	11998575	BRD-A50998626	COc1ccc(COc2cc3oc(=O)c4cc(ccc4c3cc2OC)C(C)O)cc1	AKT inhibitor; mTOR inhibitor	MTOR
palonosetron	6337614	BRD-K08924299	O=C1N(C[C@H]2CCCc3cccc1c23)[C@@H]1CN2CCC1CC2	serotonin receptor antagonist	HTR3A
palosuran	10173280	BRD-K07682953	Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1	urotensin receptor antagonist	UTS2R
palovarotene	10295295	BRD-K83794243	CC1(C)CCC(C)(C)c2cc(\C=C\c3ccc(cc3)C(O)=O)c(Cn3cccn3)cc12	retinoid receptor agonist	RARG
pamabrom	11806	BRD-M67659203	CC(C)(N)CO.Cn1c2nc(Br)[nH]c2c(=O)n(C)c1=O	diuretic	
pamidronate	44400012	BRD-K58513245	NCCC(O)(P(O)(O)=O)P(O)(O)=O	bone resorption inhibitor	FDPS
pancuronium	441289	BRD-K50817623	CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1	acetylcholine receptor antagonist	CHRM2|CHRM3|CHRNA1|CHRNA2
panobinostat	6918837	BRD-K02130563	Cc1[nH]c2ccccc2c1CCNCc1ccc(\C=C\C(=O)NO)cc1	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8|HDAC9
pantethine	452306	BRD-K68764924	CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO	coenzyme A precursor	
pantoprazole	4679	BRD-A22380646	COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1OC	ATPase inhibitor	ATP4A
pantothenic-acid	6613	BRD-K29392254	CC(C)(CO)[C@@H](O)C(=O)NCCC(O)=O	coenzyme A precursor	
PAOPA	44281634	BRD-K18573821	NC(=O)CN1CC[C@@H](NC(=O)[C@@H]2CCCN2)C1=O	dopamine receptor modulator	DRD2
papaverine	4680	BRD-K15567136	COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC	phosphodiesterase inhibitor	PDE10A|PDE4B|PDE5A
para-toluenesulfonamide	56635390	BRD-K62412084	Cc1ccc(cc1)S(N)(=O)=O		CA12|CA2|CA6|CA9
paracetamol	1983	BRD-K41524689	CC(=O)Nc1ccc(O)cc1	cyclooxygenase inhibitor	FAAH|PTGS1|PTGS2|TRPV1
parachlorophenol	4684	BRD-K40992116	Oc1ccc(Cl)cc1	antiinfective drug	
paramethadione	8280	BRD-A22128695	CCC1(C)OC(=O)N(C)C1=O	anticonvulsant	CACNA1G|CACNA1H|CACNA1I
paraxanthine	4687	BRD-K24084088	Cn1cnc2[nH]c(=O)n(C)c(=O)c12	adenosine receptor antagonist	
parbendazole	26596	BRD-K02407574	CCCCc1ccc2[nH]c(NC(=O)OC)nc2c1	tubulin polymerization inhibitor	TUBB
pardoprunox	6918525	BRD-K11851476	CN1CCN(CC1)c1cccc2[nH]c(=O)oc12	serotonin receptor agonist; dopamine receptor agonist	DRD2|DRD3|DRD4|HTR1A|HTR7
parecoxib	119828	BRD-K13800121	CCC(=O)NS(=O)(=O)c1ccc(cc1)-c1c(C)onc1-c1ccccc1	cyclooxygenase inhibitor	LTF
parethoxycaine	7183	BRD-K54799382	CCOc1ccc(cc1)C(=O)OCCN(CC)CC	local anesthetic	
pargyline	4688	BRD-K83597974	CN(CC#C)Cc1ccccc1	monoamine oxidase inhibitor	MAOA|MAOB
paricalcitol	5281104	BRD-K60585088	C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1C[C@@H](O)C[C@H](O)C1	vitamin D receptor agonist	VDR
paritaprevir	45110509	BRD-K89920762	Cc1cnc(cn1)C(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)Oc1nc2ccccc2c2ccccc12)C(=O)NS(=O)(=O)C1CC1	HCV inhibitor	
paromomycin	165580	BRD-K36524108	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O	bacterial 30S ribosomal subunit inhibitor	
paroxetine	43815	BRD-K37991163	Fc1ccc(cc1)[C@@H]1CCNC[C@H]1COc1ccc2OCOc2c1	selective serotonin reuptake inhibitor (SSRI)	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR2A|SLC6A2|SLC6A4
paroxypropione	6271	BRD-K07441213	CCC(=O)c1ccc(O)cc1	gonadotropin inhibitor	
parthenolide	6473881	BRD-K98548675	C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1	NFkB pathway inhibitor	
parthenolide-(-)	5420805	BRD-K34851558	C\C1=C\CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1	NFkB pathway inhibitor	HDAC1
parthenolide-(alternate-stereo)	7251185	BRD-K28120222	C\C1=C/CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1	NFkB pathway inhibitor	IKBKB|RELA
pasiniazid	3767	BRD-K87202646	NNC(=O)c1ccncc1	cyclooxygenase inhibitor	
pasireotide	9941444	BRD-K59715032	NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O)OC(=O)NCCN)c1ccccc1	somatostatin receptor agonist	SSTR1|SSTR2|SSTR3|SSTR5
pazopanib	10113978	BRD-K74514084	CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1	KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor	CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3
pazufloxacin	40466872	BRD-K66412701	C[C@H]1COc2c(c(F)cc3c2n1cc(C(O)=O)c3=O)C1(N)CC1	topoisomerase inhibitor	
PCA-4248	4698	BRD-A29289453	COC(=O)C1=C(C)NC(C)=C(C1C)C(=O)OCCSc1ccccc1	platelet activating factor receptor antagonist	PTAFR
PCI-24781	11749858	BRD-K12867552	CN(C)Cc1c(oc2ccccc12)C(=O)NCCOc1ccc(cc1)C(=O)NO	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC6
PCI-29732	22347110	BRD-K71223042	Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)C1CCCC1	Bruton's tyrosine kinase (BTK) inhibitor	BTK
PCI-34051	24753719	BRD-K88742110	COc1ccc(Cn2ccc3ccc(cc23)C(=O)NO)cc1	HDAC inhibitor	HDAC1|HDAC10|HDAC6|HDAC8
PCO-400	129348	BRD-K52721684	CC1(C)Oc2ccc(cc2[C@@H](OC2=CC(=O)CC2)[C@@H]1O)C#N	potassium channel activator	KCNJ8
PD-0325901	9826528	BRD-K49865102	OC[C@@H](O)CONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F	MEK inhibitor	MAP2K1
PD-102807	4995951	BRD-A89337244	CCOC(=O)c1c(C)[nH]c2ccc3OC4N(CCc5cc(OC)ccc45)Cc3c12	acetylcholine receptor antagonist	CHRM4
PD-118057	9864959	BRD-K34657753	OC(=O)c1ccccc1Nc1ccc(CCc2ccc(Cl)c(Cl)c2)cc1	potassium channel activator	KCNH2
PD-123319	5311345	BRD-K34713073	CN(C)c1ccc(Cn2cnc3CN([C@@H](Cc23)C(O)=O)C(=O)C(c2ccccc2)c2ccccc2)cc1C	angiotensin antagonist	AGTR2
PD-128907	44329754	BRD-K20260086	CCCN1CCO[C@H]2[C@@H]1COc1ccc(O)cc21	dopamine receptor agonist	DRD2|DRD3
PD-153035	4705	BRD-K26603252	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC	EGFR inhibitor	EGFR|KDR
PD-156707	9871594	BRD-K13826399	COc1ccc(cc1)C(=O)C(\Cc1cc(OC)c(OC)c(OC)c1)=C(/C(O)=O)c1ccc2OCOc2c1	endothelin receptor antagonist	EDNRA|EDNRB
PD-158780	4707	BRD-K48735772	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1	EGFR inhibitor	EGFR
PD-160170	9820766	BRD-K12079898	CC(C)c1ccccc1S(=O)(=O)c1cc(N)c2ncccc2c1[N+]([O-])=O	neuropeptide receptor antagonist	NPY1R
PD-161570	5328135	BRD-K97152684	CCN(CC)CCCCNc1ncc2cc(c(NC(=O)NC(C)(C)C)nc2n1)-c1c(Cl)cccc1Cl	FGFR inhibitor	FGFR1
PD-166285	5311382	BRD-K93217218	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1	src inhibitor	EGFR|FGFR1|PDGFRB|PKMYT1|SRC|WEE1
PD-166793	9887870	BRD-K60984070	CC(C)[C@H](NS(=O)(=O)c1ccc(cc1)-c1ccc(Br)cc1)C(O)=O	collagenase inhibitor; metalloproteinase inhibitor	MMP13|MMP2|MMP3
PD-168077	3645619	BRD-K47761761	Cc1cccc(c1)C(=O)NCN1CCN(CC1)c1ccccc1C#N	dopamine receptor agonist	DRD2
PD-168393	4708	BRD-K17702546	Brc1cccc(Nc2ncnc3ccc(NC(=O)C=C)cc23)c1	EGFR inhibitor	EGFR|ERBB2|SRC
PD-168568	9819770	BRD-A82013137	Cc1ccc(cc1C)N1CCN(CCC2NC(=O)c3ccccc23)CC1	dopamine receptor antagonist	DRD2|DRD4
PD-173074	1401	BRD-K97764662	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1	FGFR inhibitor; VEGFR inhibitor	FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB
PD-173212	9916734	BRD-K04426574	CC(C)C[C@H](N(C)Cc1ccc(cc1)C(C)(C)C)C(=O)N[C@@H](Cc1ccc(OCc2ccccc2)cc1)C(=O)NC(C)(C)C	calcium channel blocker	CACNA1B
PD-184352	6918454	BRD-K05104363	Fc1ccc(C(=O)NOCC2CC2)c(Nc2ccc(I)cc2Cl)c1F	MEK inhibitor	MAP2K1|MAP3K1|MAP3K2
PD-198306	9956637	BRD-K88677950	Cc1cc(I)ccc1Nc1c(F)c(F)c(F)cc1C(=O)NOCC1CC1	MAP kinase inhibitor; MEK inhibitor	MAP2K1|MAP2K2
PD-318088	10231331	BRD-A57798112	OCC(O)CONC(=O)c1cc(Br)c(F)c(F)c1Nc1ccc(I)cc1F	MEK inhibitor	MAP2K1
PD-407824	4369491	BRD-K82823804	Oc1ccc2[nH]c3cc(c4C(=O)NC(=O)c4c3c2c1)-c1ccccc1	PKC inhibitor	WEE1
PD-81723	122028	BRD-K77951111	Cc1sc(N)c(C(=O)c2cccc(c2)C(F)(F)F)c1C	adenosine receptor agonist	ADORA1
PD-98059	4713	BRD-K62810658	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N	MEK inhibitor	AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1
PDE10-IN-1	72709059	BRD-K38145871	Cc1c(nc2c3cccnc3ccn12)[C@@H]1C[C@H]1c1nc2c(C)ncc(C)n2n1	phosphodiesterase inhibitor	PDE10A
PDP-EA	69724031	BRD-K26358347	CCCCCCCCCCCCCCCc1cccc(OCC(=O)NCCO)c1	FAAH activator	FAAH
PD1-PDL-inhibitor-1	91663303	BRD-K04032780	COc1cc(OCc2cccc(-c3ccccc3)c2C)cc(OC)c1CN1CCCC[C@H]1C(O)=O	programmed death ligand inhibitor	CD274
peficitinib		BRD-K21225231	NC(=O)c1cnc2[nH]ccc2c1N[C@H]1[C@H]2C[C@H]3C[C@@H]1C[C@](O)(C3)C2	JAK inhibitor	JAK1|JAK2|JAK3
pefloxacin	51081	BRD-K55034111	CCn1cc(C(O)=O)c(=O)c2cc(F)c(cc12)N1CCN(C)CC1	bacterial DNA gyrase inhibitor	TOP2A
pelanserin	65435	BRD-K96436774	O=c1[nH]c2ccccc2c(=O)n1CCCN1CCN(CC1)c1ccccc1	serotonin receptor antagonist	HTR2A
pelitinib	6445562	BRD-K08799216	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C	EGFR inhibitor	EGFR
pemetrexed	446556	BRD-K32842773	Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1	dihydrofolate reductase inhibitor; thymidylate synthase inhibitor	ATIC|DHFR|GART|TYMS
pemirolast	57697	BRD-K31731454	Cc1cccn2c1ncc(-c1nnn[nH]1)c2=O	mediator release inhibitor	HRH1
pempidine	6603	BRD-K71075093	CN1C(C)(C)CCCC1(C)C	ganglionic blocker	
penbutolol	37464	BRD-K55705469	CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1	adrenergic receptor antagonist	ADRB1|ADRB2|HTR1A|HTR1B
penciclovir	4725	BRD-K47780086	Nc1nc(O)c2ncn(CCC(CO)CO)c2n1	DNA directed DNA polymerase inhibitor	
penfluridol	33630	BRD-K15409150	OC1(CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1)c1ccc(Cl)c(c1)C(F)(F)F	T-type calcium channel blocker	CACNA1G
penicillamine-(D)	5852	BRD-K17518951	CC(C)(S)[C@@H](N)C(O)=O	chelating agent	
penicillamine-(racemic)	3799362	BRD-A16376407	CC(C)(S)C(N)C(O)=O		
penicillin-v-potassium	6869	BRD-K43966364	CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(O)=O	bacterial cell wall synthesis inhibitor	
pentacosanoic-acid	10468	BRD-K48996094	CCCCCCCCCCCCCCCCCCCCCCCCC(O)=O		
pentagastrin	9853654	BRD-K78789465	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O	CCK receptor agonist	CCKBR
pentamidine	4735	BRD-K13183738	NC(=N)c1ccc(OCCCCCOc2ccc(cc2)C(N)=N)cc1	anti-pneumocystis agent	TRDMT1
pentetic-acid	3053	BRD-K40621224	OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CCN(CC(O)=O)CC(O)=O	chelating agent	PGD
pentobarbital	4737	BRD-A44448661	CCCC(C)C1(CC)C(=O)NC(=O)NC1=O	barbiturate antiepileptic; GABA receptor modulator	CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B
pentolinium	5850	BRD-K44942604	C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1	cholinergic receptor antagonist	CHRNA10|CHRNA3|CHRNA4|CHRNB4
pentostatin	439693	BRD-K91543828	OC[C@H]1O[C@H](C[C@@H]1O)n1cnc2[C@H](O)CNC=Nc12	adenosine deaminase inhibitor; ribonucleotide reductase inhibitor	ADA
pentoxifylline	4740	BRD-K57569181	CC(=O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O	phosphodiesterase inhibitor	ADORA1|ADORA2A|ADORA2B|ADRA2B|NT5E|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|TNF
pentylenetetrazol	5917	BRD-K57718010	C1CCc2nnnn2CC1	GABA receptor antagonist	
pepstatin	5478883	BRD-K13571841	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC(C)C)C(C)C)C(C)C)[C@@H](O)CC(O)=O	aspartic protease inhibitor	CTSB|CTSD|CTSL|REN
peramivir	154234	BRD-K00519864	CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O	neuraminidase inhibitor	
perampanel	9924495	BRD-K41438959	O=c1c(cc(cn1-c1ccccc1)-c1ccccn1)-c1ccccc1C#N	glutamate receptor antagonist	GRIA1|GRIA2|GRIA3|GRIA4
perchlozone	1655860	BRD-K86435560	NC(=S)NN=Cc1ccncc1		
peretinoin	6437836	BRD-K99431849	CC(C)=CCC\C(C)=C\CC\C(C)=C\C=C\C(C)=C\C(O)=O	retinoid receptor agonist	RXRA
perfluamine	67645	BRD-K16758059	FC(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)F		
perflubron	9873	BRD-K92988025	FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br	contrast agent	
perfluorodecalin	9386	BRD-K55401595	FC1(F)C(F)(F)C(F)(F)C2(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C2(F)C1(F)F		
pergolide	47811	BRD-K60770992	CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13	dopamine receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C
perhexiline	4746	BRD-A19633847	C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1	carnitine palmitoyltransferase inhibitor	CPT1A|CPT2
perifosine	148178	BRD-A89082344	CCCCCCCCCCCCCCCCCCOP(O)(=O)OC1CC[N+](C)(C)CC1	AKT inhibitor	AKT1
perillyl-alcohol	10819	BRD-A13323580	CC(=C)C1CCC(CO)=CC1	apoptosis stimulant; farnesyltransferase inhibitor	FNTA
perindopril	107807	BRD-K92731339	CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(=O)OCC	angiotensin converting enzyme inhibitor	ACE
perindoprilat	72022	BRD-K00768353	CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(O)=O	angiotensin converting enzyme inhibitor	ACE
permethrin	40326	BRD-A25366096	CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1		SCN1A
perospirone	115368	BRD-K85503079	O=C1[C@H]2CCCC[C@H]2C(=O)N1CCCCN1CCN(CC1)c1nsc2ccccc12	dopamine receptor antagonist; serotonin receptor antagonist	DRD2|DRD3|DRD4
perphenazine	4748	BRD-K10995081	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1	dopamine receptor antagonist	CALM1|DRD1|DRD2|HRH1|HTR2A|HTR2C|HTR6|HTR7
peruvoside	73438925	BRD-A72716251	CO[C@H]1[C@@H](O)C(C)O[C@@H](O[C@H]2CC[C@@]3(C=O)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H](CC[C@]43O)C3=CC(=O)OC3)C2)C1O	cardiac glycoside	
perzinfotel	6918236	BRD-K04643877	OP(O)(=O)CCN1CCCNc2c1c(=O)c2=O	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B
PETCM	224859	BRD-A93477898	OC(Cc1ccncc1)C(Cl)(Cl)Cl	caspase activator	CASP3
pevonedistat	16720766	BRD-K67844266	NS(=O)(=O)OC[C@@H]1C[C@H](C[C@@H]1O)n1ccc2c(N[C@H]3CCc4ccccc34)ncnc12	nedd activating enzyme inhibitor	NAE1|UBA3
pexidartinib	25151352	BRD-K54519451	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1	tyrosine kinase inhibitor	CSF1R|FLT3|KIT
pexmetinib	24765037	BRD-K53405000	Cc1ccc(cc1)-n1nc(cc1NC(=O)NCc1cc(F)ccc1Oc1ccc2n(CCO)ncc2c1)C(C)(C)C	TIE tyrosine kinase inhibitor; MAP kinase inhibitor	MAPK14|TEK
PF-02545920	11581936	BRD-K31519811	Cn1cc(c(n1)-c1ccc(OCc2ccc3ccccc3n2)cc1)-c1ccncc1	phosphodiesterase inhibitor	PDE10A
PF-03049423	24963293	BRD-K07070922	CCCOCCn1c2cc(ncc2nc(N2CCN(CCO)CC2)c1=O)-c1ccc(OC)nc1	phosphodiesterase inhibitor	PDE5A
PF-03084014	46224413	BRD-K61691541	CCC[C@H](N[C@H]1CCc2cc(F)cc(F)c2C1)C(=O)Nc1cn(cn1)C(C)(C)CNCC(C)(C)C	gamma secretase inhibitor	
PF-03758309	25227462	BRD-K37764012	CN(C)C[C@@H](NC(=O)N1Cc2c(Nc3nc(C)nc4ccsc34)n[nH]c2C1(C)C)c1ccccc1	p21 activated kinase inhibitor	PAK4
PF-03814735	51346455	BRD-K68747584	CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1c1cc(Nc3ncc(c(NC4CCC4)n3)C(F)(F)F)ccc21	Aurora kinase inhibitor	AURKA|AURKB
PF-03882845	129009901	BRD-K51041191	OC(=O)c1ccc2C3=C(CCc2c1)[C@H](C1CCCC1)N(N3)c1ccc(C#N)c(Cl)c1		
PF-04136309		BRD-K94420399	O[C@]1(CC[C@@H](CC1)N[C@H]1CCN(C1)C(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccc(cn1)-c1ncccn1	CC chemokine receptor antagonist	
PF-04217903	17754438	BRD-K73319509	OCCn1cc(cn1)-c1cnc2nnn(Cc3ccc4ncccc4c3)c2n1	c-Met inhibitor	MET
PF-04418948	25114442	BRD-K54871792	COc1ccc2cc(OCC3(CN(C3)C(=O)c3ccc(F)cc3)C(O)=O)ccc2c1	prostaglandin inhibitor	PTGER2
PF-04447943		BRD-K50031829	C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1nc2n(ncc2c(=O)[nH]1)C1CCOCC1	phosphodiesterase inhibitor	PDE9A
PF-04457845	24771824	BRD-K86816506	FC(F)(F)c1ccc(Oc2cccc(C=C3CCN(CC3)C(=O)Nc3cccnn3)c2)nc1	FAAH inhibitor	FAAH
PF-04620110		BRD-K30550578	Nc1ncnc2OCCN(c3ccc(cc3)[C@H]3CC[C@H](CC(O)=O)CC3)C(=O)c12	diacylglycerol O acyltransferase inhibitor	DGAT1
PF-04691502		BRD-K07310275	COc1ccc(cn1)-c1cc2c(C)nc(N)nc2n([C@H]2CC[C@@H](CC2)OCCO)c1=O	mTOR inhibitor; PI3K inhibitor	MTOR|PIK3CA
PF-04885614	65459349	BRD-K92435527	CC(C)(N)c1nc(c[nH]1)-c1ccc(OC(F)(F)F)cc1	voltage-gated sodium channel blocker	SCN10A
PF-04937319	46916694	BRD-K27755542	CN(C)C(=O)c1ncc(Oc2cc(cc3oc(C)cc23)C(=O)Nc2cnc(C)cn2)cn1	glucokinase activator	GCK
PF-05190457	58438464	BRD-K02554563	Cc1cn2cc(CC(=O)N3CCC4(CN(C4)[C@@H]4CCc5cc(ccc45)-c4cc(C)ncn4)CC3)nc2s1	growth hormone secretagogue receptor inverse agonist	GHSR
PF-05212384	44516953	BRD-K07955840	CN(C)C1CCN(CC1)C(=O)c1ccc(NC(=O)Nc2ccc(cc2)-c2nc(nc(n2)N2CCOCC2)N2CCOCC2)cc1	mTOR inhibitor; PI3K inhibitor	MTOR|PIK3CA
PF-06447475	72706840	BRD-K83114366	N#Cc1cccc(c1)-c1c[nH]c2ncnc(N3CCOCC3)c12	serine/threonine kinase inhibitor	LRRK2
PF-06463922	78162481	BRD-A23124853	CC1Oc2cc(cnc2N)-c2c(CN(C)C(=O)c3ccc(F)cc13)nn(C)c2C#N	ALK tyrosine kinase receptor inhibitor	ALK|FES|ROS1
PF-3274167	11683187	BRD-K31417912	COCc1nnc(N2CC(C2)Oc2ccc(F)cc2Cl)n1-c1ccc(OC)nc1	oxytocin receptor antagonist	AVPR1A|OXTR
PF-3845	25154867	BRD-K68997413	FC(F)(F)c1ccc(Oc2cccc(CC3CCN(CC3)C(=O)Nc3cccnc3)c2)nc1	FAAH inhibitor	FAAH
PF-429242	23661637	BRD-K11821338	CCN(CC)Cc1ccc(cc1)C(=O)N(CCc1ccccc1OC)[C@@H]1CCNC1	SREBP inhibitor	MBTPS1
PF-431396	11598628	BRD-K93788137	CN(c1ccccc1CNc1nc(Nc2ccc3NC(=O)Cc3c2)ncc1C(F)(F)F)S(C)(=O)=O	focal adhesion kinase inhibitor	PTK2|PTK2B
PF-4708671	51371303	BRD-K14711741	CCc1cncnc1N1CCN(CC1)Cc1nc2cc(ccc2[nH]1)C(F)(F)F	ribosomal protein inhibitor	RPS6KB1
PF-477736		BRD-K03063480	Cn1cc(cn1)-c1[nH]c2cc(NC(=O)[C@H](N)C3CCCCC3)cc3c2c1cn[nH]c3=O	CHK inhibitor	CHEK1|CHEK2
PF-4800567	53472153	BRD-K43428468	Nc1ncnc2n(nc(COc3cccc(Cl)c3)c12)C1CCOCC1	casein kinase inhibitor	CSNK1D|CSNK1E
PF-4981517	71315139	BRD-K78318619	Cc1ccc(cc1)-c1c(cnn1C)-c1nn(C)c2ncnc(N3CC[C@@H](C3)N3CCCCC3)c12	cytochrome P450 inhibitor	CYP3A4
PF-5274857	56956240	BRD-K40302533	Cc1cnc(c(C)c1)-c1cc(ncc1Cl)N1CCN(CC1)C(=O)CCS(C)(=O)=O	smoothened receptor antagonist	SMO
PF-562271	11713159	BRD-K99545815	CN(c1ncccc1CNc1nc(Nc2ccc3NC(=O)Cc3c2)ncc1C(F)(F)F)S(C)(=O)=O	focal adhesion kinase inhibitor	PTK2|PTK2B
PF-573228	11612883	BRD-K79239947	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4NC(=O)CCc4c3)ncc2C(F)(F)F)c1	focal adhesion kinase inhibitor	CDK1|CDK2|CDK7|GSK3B|IKBKB
PF-670462	11681588	BRD-K96295391	Nc1nccc(n1)-c1c(ncn1C1CCCCC1)-c1ccc(F)cc1	casein kinase inhibitor	CSNK1D|CSNK1E
PF-750	25154868	BRD-K83213911	O=C(Nc1ccccc1)N1CCC(Cc2cnc3ccccc3c2)CC1	FAAH inhibitor	FAAH
PF-8380	25265312	BRD-K50865540	Clc1cc(Cl)cc(COC(=O)N2CCN(CCC(=O)c3ccc4[nH]c(=O)oc4c3)CC2)c1	autotaxin inhibitor	ENPP2
PF-915275	23725123	BRD-K18289362	Nc1cccc(NS(=O)(=O)c2ccc(cc2)-c2ccc(cc2)C#N)n1	11-beta hydroxysteroid dehydrogenase inhibitor	HSD11B1
PFI-1	71271629	BRD-K13094524	COc1ccccc1S(=O)(=O)Nc1ccc2NC(=O)N(C)Cc2c1	bromodomain inhibitor	BRD4
PFI-3	78243717	BRD-K61524559	Oc1ccccc1C(=O)\C=C\N1C[C@H]2C[C@@H]1CN2c1ccccn1	bromodomain inhibitor	PBRM1|SMARCA4
PFI-4	40642506	BRD-K13106865	COc1ccccc1C(=O)Nc1cc2n(C)c(=O)n(C)c2cc1N1CCCC1	bromodomain inhibitor	BRPF1
PFK-015	25142799	BRD-K95573441	O=C(\C=C\c1ccc2ccccc2n1)c1ccncc1	phosphofructokinase inhibitor	PFKFB3
PFK-158	71730058	BRD-K28010364	FC(F)(F)c1ccc2ccc(\C=C\C(=O)c3ccncc3)nc2c1	phosphofructokinase inhibitor	PFKFB3
PG-9	133002	BRD-A70268693	CC(C(=O)OC1CC2CCC(C1)N2C)c1ccc(Br)cc1	acetylcholine receptor agonist	
PGL5001	10195250	BRD-A53813595	N#CC(c1nc2ccccc2s1)c1ccnc(OCc2ccc(CN3CCOCC3)cc2)n1	JNK inhibitor	MAPK10|MAPK8|MAPK9
PH-797804	22049997	BRD-K95880107	CNC(=O)c1ccc(C)c(c1)-n1c(C)cc(OCc2ccc(F)cc2F)c(Br)c1=O	p38 MAPK inhibitor	MAPK11|MAPK14
PHA-568487	9932000	BRD-K48053228	O=C(N[C@H]1CN2CCC1CC2)c1ccc2OCCOc2c1	nicotinic receptor agonist	CHRNA7
PHA-665752	10461815	BRD-K95435023	Cc1[nH]c(\C=C2/C(=O)Nc3ccc(cc23)S(=O)(=O)Cc2c(Cl)cccc2Cl)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1	c-Met inhibitor	MET
PHA-680632	11249084	BRD-K09443272	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1	Aurora kinase inhibitor	AURKA|AURKB|AURKC
PHA-767491	11715767	BRD-K50000283	O=C1NCCc2[nH]c(cc12)-c1ccncc1	CDC inhibitor	CDK1|RPS6KB1
PHA-793887	46191454	BRD-K64800655	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C	CDK inhibitor	CDK1|CDK2|CDK4|CDK5|CDK7|CDK9
PHA-848125	16718576	BRD-K60997853	CNC(=O)c1nn(C)c-2c1C(C)(C)Cc1cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc-21	CDK inhibitor; growth factor receptor inhibitor	CDK2|CDK4|CDK7|NTRK1
PHCCC	5866327	BRD-A59709458	O\N=C1/C2CC2(Oc2ccccc12)C(=O)Nc1ccccc1	glutamate receptor agonist	GRM1|GRM4
phenacaine	7588	BRD-K81092066	CCOc1ccc(NC(C)=Nc2ccc(OCC)cc2)cc1	local anesthetic	
phenacemide	4753	BRD-K40905133	NC(=O)NC(=O)Cc1ccccc1	sodium channel blocker	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
phenacetin	4754	BRD-K38323065	CCOc1ccc(NC(C)=O)cc1	cyclooxygenase inhibitor	PTGS1
phenazone	2206	BRD-K46937689	Cc1cc(=O)n(-c2ccccc2)n1C	cyclooxygenase inhibitor	PTGS1|PTGS2
phenazopyridine		BRD-K76304753	Nc1ccc(\N=N\c2ccccc2)c(N)n1	local anesthetic	SCN1A
phenelzine	3675	BRD-K87024524	NNCCc1ccccc1	monoamine oxidase inhibitor	ABAT|AOC3|GAD2|GPT|GPT2|MAOA|MAOB|SLC6A2|SLC6A3|SLC6A4
phenethicillin	272833	BRD-A66025870	CC(Oc1ccccc1)C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O	bacterial cell wall synthesis inhibitor	
phenethyl-isothiocyanate	16741	BRD-K56700933	S=C=NCCc1ccccc1	anticancer agent	CYP2E1
phenformin	8249	BRD-K11399644	NC(=N)NC(=N)NCCc1ccccc1	AMPK activator	KCNJ8|PRKAA1
phenindamine	11291	BRD-A33178345	CN1CCC2=C(C1)C(c1ccccc21)c1ccccc1	histamine receptor antagonist	HRH1
phenindione	4760	BRD-K70592963	O=C1C(C(=O)c2ccccc12)c1ccccc1	vitamin K antagonist	VKORC1
pheniramine	4761	BRD-A23072235	CN(C)CCC(c1ccccc1)c1ccccn1	histamine receptor antagonist	HRH1
phenol	20488062	BRD-K76549667	Oc1ccccc1		CA1|CA12|CA14|CA2|CA4|CA9
phenolphthalein	4764	BRD-K19227686	Oc1ccc(cc1)C1(OC(=O)c2ccccc12)c1ccc(O)cc1	indicator dye	UGT1A9
phenolsulfonphthalein	4766	BRD-K79892937	Oc1ccc(cc1)C1(OS(=O)(=O)c2ccccc12)c1ccc(O)cc1		
phenothiazine	7108	BRD-K59597909	N1c2ccccc2Sc2ccccc12	dopamine receptor antagonist	
phenothrin	4767	BRD-A22106989	CC(C)=CC1C(C(=O)OCc2cccc(Oc3ccccc3)c2)C1(C)C		
phenoxybenzamine	4768	BRD-A67799922	CC(COc1ccccc1)N(CCCl)Cc1ccccc1	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB2|CALM1
phenprobamate	4770	BRD-K22009844	NC(=O)OCCCc1ccccc1	muscle relaxant	
phenprocoumon	54680692	BRD-A49838158	CCC(c1ccccc1)c1c(O)c2ccccc2oc1=O	vitamin K antagonist	VKORC1
phenserine	192706	BRD-K46580984	CN1CC[C@]2(C)[C@H]1N(C)c1ccc(OC(=O)Nc3ccccc3)cc21	acetylcholinesterase inhibitor; beta amyloid synthesis inhibitor	ACHE|BCHE
phensuximide	6839	BRD-A18043272	CN1C(=O)CC(C1=O)c1ccccc1	succinimide antiepileptic	CACNA1G|CACNA1H|CACNA1I
phentermine	4771	BRD-K96319534	CC(C)(N)Cc1ccccc1	dopamine uptake inhibitor; serotonin reuptake inhibitor	MAOA|MAOB|SLC6A2|SLC6A3|SLC6A4
phentolamine	4920903	BRD-K90333595	Cc1ccc(cc1)N(CC1=NCCN1)c1cccc(O)c1	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
phenyl-aminosalicylate	8609	BRD-K73157543	Nc1ccc(C(=O)Oc2ccccc2)c(O)c1		
phenyl-salicylate	8361	BRD-K44091963	Oc1ccccc1C(=O)Oc1ccccc1	antiseptic	
phenylacetylglutamine	92258	BRD-K70592483	NC(=O)CC[C@H](NC(=O)Cc1ccccc1)C(O)=O	DNA methylase inhibitor; protein synthesis inhibitor	
phenylbenzimidazole-sulfonic-acid	1712019	BRD-K02729857	OS(=O)(=O)c1ccc2[nH]c(nc2c1)-c1ccccc1		
phenylbutazone	4781	BRD-K10843433	CCCCC1C(=O)N(N(C1=O)c1ccccc1)c1ccccc1	cyclooxygenase inhibitor; prostanoid receptor antagonist	PTGIS|PTGS1|PTGS2
phenylbutyrate	4775	BRD-K67102207	OC(=O)CCCc1ccccc1	HDAC inhibitor	HDAC1
phenylephrine	6041	BRD-K73381542	CNC[C@H](O)c1cccc(O)c1	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D
phenylethyl-alcohol	6054	BRD-K42371134	OCCc1ccccc1		
phenylmercuric-acetate	102256511	BRD-K74193284	CC(=O)O[Hg]c1ccccc1	other antifungal	
phenylmethylsulfonyl-fluoride	4784	BRD-K33422401	FS(=O)(=O)Cc1ccccc1	serine protease inhibitor	
phenylpiracetam	132441	BRD-A65683612	NC(=O)CN1CC(CC1=O)c1ccccc1	noradrenaline uptake inhibitor	
phenytoin	1775	BRD-K55930204	O=C1NC(=O)C(N1)(c1ccccc1)c1ccccc1	hydantoin antiepileptic	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
PhiKan-083	4722579	BRD-K44400149	CCn1c2ccccc2c2cc(CNC)ccc12	p53 stabilizing agent	TP53
phloretin	4788	BRD-K15563106	Oc1ccc(CCC(=O)c2c(O)cc(O)cc2O)cc1	sodium/glucose cotransporter inhibitor	AQP9|CLCN3|SLC23A1
phlorizin	25791508	BRD-K24601397	OC[C@H]1O[C@@H](Oc2cc(O)cc(O)c2C(=O)CCc2ccc(O)cc2)[C@@H](O)[C@@H](O)[C@@H]1O	sodium/glucose cotransporter inhibitor	SLC5A1|SLC5A11|SLC5A2|SLC5A3
phloroglucin	359	BRD-K00405906	Oc1cc(O)cc(O)c1		
phortress	399465	BRD-K74558903	Cc1cc(ccc1NC(=O)[C@@H](N)CCCCN)-c1nc2cc(F)ccc2s1	aryl hydrocarbon receptor ligand	AHR
phosphatidylcholine		BRD-U51753822			PCTP
PHP-501	46204221	BRD-K07460388	On1ncc(C2CCNCC2)c1-c1cccc(c1)-c1ccccc1	GABA receptor antagonist	GABRA1|GABRB2|GABRG2
PHT-427	44240850	BRD-K59745944	CCCCCCCCCCCCc1ccc(cc1)S(=O)(=O)Nc1nncs1	AKT inhibitor; pyruvate dehydrogenase inhibitor	AKT2|PDPK1
phthalylsulfacetamide	8574	BRD-K77115421	CC(=O)NS(=O)(=O)c1ccc(NC(=O)c2ccccc2C(O)=O)cc1		
phthalylsulfathiazole	4806	BRD-K64659768	OC(=O)c1ccccc1C(=O)Nc1ccc(cc1)S(=O)(=O)Nc1nccs1	dihydropteroate synthetase inhibitor	
PHTPP	11201035	BRD-K76568384	Oc1ccc(cc1)-c1c(nn2c(cc(nc12)C(F)(F)F)C(F)(F)F)-c1ccccc1	estrogen receptor antagonist	ESR2
physostigmine	5983	BRD-K25650355	CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1	cholinesterase inhibitor	ACHE|BCHE
physostigmine-salicylate	5983	BRD-K25650355	CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1	acetylcholinesterase inhibitor	
phytonadione	5284607	BRD-K76661572	CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CC1=C(C)C(=O)c2ccccc2C1=O		BGLAP|GGCX
phytosphingosine	122121	BRD-K05048137	CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO		
PI-103	9884685	BRD-K67868012	Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1	mTOR inhibitor; PI3K inhibitor	MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC
PI-828	25181195	BRD-K97365803	Nc1ccc(cc1)-c1cccc2c1oc(cc2=O)N1CCOCC1	PI3K inhibitor	
pibenzimol	249097	BRD-K79132813	c1ccc2[nH]c(nc2c1)-c1nc2ccccc2[nH]1	DNA inhibitor	
piboserod	177336	BRD-K02750403	CCCCN1CCC(CNC(=O)c2c3OCCCn3c3ccccc23)CC1	serotonin receptor antagonist	HTR2B|HTR4
picartamide	3034005	BRD-A71765060	CNC(=S)C1(CCCS1)c1ccccn1	H+/K+-ATPase inhibitor	ATP4A
piceatannol	667639	BRD-K91509126	Oc1cc(O)cc(c1)\C=C\c1ccc(O)c(O)c1	SYK inhibitor	ATP5A1|ATP5B|ATP5C1|IRF3
piclamilast	154575	BRD-K47642186	COc1ccc(cc1OC1CCCC1)C(=O)Nc1c(Cl)cncc1Cl	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4C|PDE4D
picolamine	31018	BRD-K68653965	NCc1cccnc1		
picolinic-acid	151932	BRD-K01029106	O=C(O[Cr](OC(=O)c1ccccn1)OC(=O)c1ccccn1)c1ccccn1	chelating agent	
piconol	11474	BRD-K28492574	OCc1ccccn1		
picotamide	4814	BRD-K67277431	COc1ccc(cc1C(=O)NCc1cccnc1)C(=O)NCc1cccnc1	thromboxane receptor antagonist; thromboxane synthase inhibitor	TBXA2R
picrotin	4815	BRD-A91822151	CC(C)(O)C1C2OC(=O)C1C1(O)CC3OC33C(=O)OC2C13C	GABA receptor antagonist	GABRA1|GABRR1|GLRA1|GLRA2|GLRA3|GLRB
picrotoxinin	7098683	BRD-K36461289	CC(=C)[C@@H]1[C@H]2OC(=O)[C@H]1[C@]1(O)C[C@H]3O[C@]33C(=O)O[C@H]2[C@]13C	GABA receptor antagonist	GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B
pidolic-acid	7405	BRD-K57313110	OC(=O)[C@@H]1CCC(=O)N1		ADAM28|AMY1A|AMY2A|AMY2B|ANG|CCL8|HCRT|IGLC1|KRTAP5-2|TFF2|VEGFA
pidotimod	65944	BRD-K44442813	OC(=O)[C@@H]1CSCN1C(=O)[C@@H]1CCC(=O)N1	interferon receptor agonist; interleukin receptor agonist	
pifithrin-alpha	4817	BRD-K66874953	Cc1ccc(cc1)C(=O)Cn1c2CCCCc2sc1=N	TP53 inhibitor	TP53
pifithrin-cyclic	443278	BRD-K31792052	Cc1ccc(cc1)-c1cn2c3CCCCc3sc2n1	TP53 inhibitor	TP53
pifithrin-mu	327653	BRD-K96799727	NS(=O)(=O)C#Cc1ccccc1	HSP inhibitor	HSPA1A|TP53
PIK-293	53245636	BRD-K30977212	Cc1ccccc1-n1c(Cn2ncc3c(N)ncnc23)nc2cccc(C)c2c1=O	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
PIK-294	24905149	BRD-K50631926	Cc1ccccc1-n1c(Cn2nc(-c3cccc(O)c3)c3c(N)ncnc23)nc2cccc(C)c2c1=O	PI3K inhibitor	PIK3CB|PIK3CD|PIK3CG
PIK-75	10275789	BRD-K49371609	CN(\N=C\c1cnc2ccc(Br)cn12)S(=O)(=O)c1cc(ccc1C)[N+]([O-])=O	DNA protein kinase inhibitor; PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC
PIK-93	6852167	BRD-K29395450	CC(=O)Nc1nc(C)c(s1)-c1ccc(Cl)c(c1)S(=O)(=O)NCCO	PI3K inhibitor	PI4KB|PIK3C3|PIK3CG
pikamilone	60608	BRD-K56691760	OC(=O)CCCNC(=O)c1cccnc1		
piketoprofen	68801	BRD-A85548292	CC(C(=O)Nc1cc(C)ccn1)c1cccc(c1)C(=O)c1ccccc1	cyclooxygenase inhibitor	
pilaralisib	56599306	BRD-K49456274	COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1	PI3K inhibitor	
pilocarpine	5910	BRD-K85090592	CC[C@H]1[C@@H](Cc2cncn2C)COC1=O	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
pilsicainide	4820	BRD-K83245588	Cc1cccc(C)c1NC(=O)CC12CCCN1CCC2	sodium channel blocker	SCN5A
PIM-1-Inhibitor-2	2765355	BRD-K48832421	Nc1nccc(n1)-c1ccc2noc(-c3ccc(Cl)cc3)c2c1	Pim kinase inhibitor	PIM1
pimavanserin	10071196	BRD-K83405785	CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1	serotonin receptor inverse agonist	DRD2|HTR2A
pimecrolimus	6509979	BRD-K92107055	CC[C@@H]1\C=C(C)\C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)C(\C)=C\[C@@H]1CC[C@H](Cl)[C@@H](C1)OC	calcineurin inhibitor	FKBP1A|MTOR
pimethixene	4822	BRD-K88090157	CN1CCC(CC1)=C1c2ccccc2Sc2ccccc12	antihistamine	
pimobendan	4823	BRD-A84575140	COc1ccc(cc1)-c1nc2cc(ccc2[nH]1)C1=NNC(=O)CC1C	calcium sensitizer; phosphodiesterase inhibitor	PDE3A
pimonidazole	50981	BRD-A67521319	OC(CN1CCCCC1)Cn1ccnc1[N+]([O-])=O		
pimozide	16362	BRD-K01292756	Fc1ccc(cc1)C(CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc(F)cc1	dopamine receptor antagonist	CACNA1I|CALM1|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|KCNA10|KCNH2
pinacidil	4826	BRD-A43882281	CC(N\C(Nc1ccncc1)=N\C#N)C(C)(C)C	ATP channel activator; potassium channel activator	ABCC8|ABCC9
pinanediol	6553875	BRD-K69885552	CC1(C)[C@@H]2C[C@H]1[C@@](C)(O)[C@@H](O)C2		
pinaverium	13981868	BRD-A70998768	COc1cc(Br)c(C[N+]2(CCOCCC3CC[C@H]4C[C@@H]3C4(C)C)CCOCC2)cc1OC	T-type calcium channel blocker	CACNA1C
pincainide	71267	BRD-K90727284	Cc1cccc(C)c1NC(=O)CN1CCCCCC1	antiarrhythmic	
pindolol	4828	BRD-A97701745	CC(C)NCC(O)COc1cccc2[nH]ccc12	adrenergic receptor antagonist	ADRB1|ADRB2|HTR1A|HTR1B|HTR2A|HTR2B
pindolol-(-)	688095	BRD-K95598440	CC(C)NC[C@H](O)COc1cccc2[nH]ccc12	adrenergic receptor antagonist; serotonin receptor antagonist	HTR1A
pinitol	16395057	BRD-A69275535	COC1C(O)[C@@H](O)C(O)C(O)[C@H]1O	gamma secretase inhibitor	
pinocembrin	68071	BRD-K94689771	Oc1cc(O)c2C(=O)C[C@H](Oc2c1)c1ccccc1	cytochrome P450 inhibitor	CYP1B1
pioglitazone	4829	BRD-A48430263	CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1	insulin sensitizer; PPAR receptor agonist	PPARG|TRPM3
pipamperone	4830	BRD-K26801045	NC(=O)C1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)N1CCCCC1	dopamine receptor antagonist	DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR2A
pipecuronium	45358549	BRD-A21544762	CC(=O)OC1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1	neuromuscular blocker	CHRM2|CHRM3|CHRNA2
pipemidic-acid	4831	BRD-K08999871	CCn1cc(C(O)=O)c(=O)c2cnc(nc12)N1CCNCC1	topoisomerase inhibitor	
pipenzolate	4832	BRD-A53561827	CC[N+]1(C)CCCC(C1)OC(=O)C(O)(c1ccccc1)c1ccccc1	cholinergic receptor antagonist	CHRM1
piperacetazine	19675	BRD-K16277217	CC(=O)c1ccc2Sc3ccccc3N(CCCN3CCC(CCO)CC3)c2c1	dopamine receptor antagonist	
piperacillin	43672	BRD-K86873305	CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)c2ccccc2)C(=O)C1=O	bacterial cell wall synthesis inhibitor	
piperaquine-phosphate	122262	BRD-K27382019	Clc1ccc2c(ccnc2c1)N1CCN(CCCN2CCN(CC2)c2ccnc3cc(Cl)ccc23)CC1	antimalarial agent	
piperazine	4837	BRD-K13249881	C1CNCCN1	benzodiazepine receptor agonist	GABRB3
piperazinedione	7817	BRD-K95941975	O=C1CNC(=O)CN1	DNA synthesis inhibitor	
piperidolate	4839	BRD-A97479839	CCN1CCCC(C1)OC(=O)C(c1ccccc1)c1ccccc1	acetylcholine receptor antagonist	CHRM1
piperine	638024	BRD-K59522102	O=C(\C=C\C=C\c1ccc2OCOc2c1)N1CCCCC1	monoamine oxidase inhibitor	MAOA|MAOB|TRPV1
piperonyl-butoxide	5794	BRD-K76452401	CCCCOCCOCCOCc1cc2OCOc2cc1CCC	cytochrome P450 inhibitor	
pipobroman	4842	BRD-K15656090	BrCCC(=O)N1CCN(CC1)C(=O)CCBr	DNA alkylating agent	
pipotiazine-palmitate	37767	BRD-K48429278	CCCCCCCCCCCCCCCC(=O)OCCC1CCN(CCCN2c3ccccc3Sc3ccc(cc23)S(=O)(=O)N(C)C)CC1	dopamine receptor antagonist; serotonin receptor antagonist	DRD1|DRD2|HTR1A|HTR2A
piracetam	4843	BRD-K19456237	NC(=O)CN1CCCC1=O	acetylcholine receptor agonist	GRIA1|GRIA2|GRIA3|GRIA4
pirarubicin	11296583	BRD-K83794624	COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O[C@@H]6CCCCO6)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO	topoisomerase inhibitor	TOP2A
pirenoxine	4846	BRD-K65992024	OC(=O)c1cc(O)c2c3nc4ccccc4oc3cc(=O)c2n1	AGE inhibitor	
pirenperone	4847	BRD-K25224017	Cc1nc2ccccn2c(=O)c1CCN1CCC(CC1)C(=O)c1ccc(F)cc1	serotonin receptor antagonist	HTR2A|HTR7
pirenzepine	4848	BRD-K89375097	CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc23)CC1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
piretanide	4849	BRD-K87990216	NS(=O)(=O)c1cc(cc(N2CCCC2)c1Oc1ccccc1)C(O)=O	glucocorticoid receptor agonist	SLC12A1|SLC12A2
pirfenidone	40632	BRD-K96862998	Cc1ccc(=O)n(c1)-c1ccccc1	TGF beta receptor inhibitor	FURIN|TNF
piribedil	4850	BRD-K47936004	C(N1CCN(CC1)c1ncccn1)c1ccc2OCOc2c1	dopamine receptor agonist	ADRA1A|ADRA2A|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR2B
piricapiron	2772320	BRD-A04203391	CC1(C)C2CCC1(C)C(=O)N(CCCCN1CCN(CC1)c1ccccn1)C2=O	dopamine receptor antagonist; serotonin receptor antagonist	HTR2A
pirinixic-acid	5694	BRD-K01902415	Cc1cccc(Nc2cc(Cl)nc(SCC(O)=O)n2)c1C	PPAR receptor agonist	PPARA
pirlindole	68802	BRD-A54490543	Cc1ccc2n3CCNC4CCCc(c34)c2c1	monoamine oxidase inhibitor	MAOA
piroctone-olamine	50259	BRD-A96510685	CC(Cc1cc(C)cc(=O)n1O)CC(C)(C)C		
pirodavir	71345	BRD-K22261391	CCOC(=O)c1ccc(OCCC2CCN(CC2)c2ccc(C)nn2)cc1		
piromidic-acid	4855	BRD-K37682401	CCn1cc(C(O)=O)c(=O)c2cnc(nc12)N1CCCC1	bacterial DNA gyrase inhibitor	
piroxicam	9880620	BRD-A57382968	CN1C(C(=O)Nc2ccccn2)C(=O)c2ccccc2S1(=O)=O	cyclooxygenase inhibitor	PTGS1|PTGS2
piroximone	55263	BRD-K71977764	CCc1[nH]c(O)nc1C(=O)c1ccncc1	phosphodiesterase inhibitor	PDE3A
pirquinozol		BRD-K63651590	OCc1cc2c3ccccc3[nH]c(=O)n2n1	histamine release inhibitor	
PIT	124334	BRD-K43978949	[O-][N+]1=C(C(=O)c2ccccc12)c1ccccn1	purinergic receptor antagonist	P2RY1
pitavastatin	5282452	BRD-K75958547	O[C@H](C[C@H](O)\C=C\c1c(nc2ccccc2c1-c1ccc(F)cc1)C1CC1)CC(O)=O	HMGCR inhibitor	HMGCR
pivagabine	68888	BRD-K62264492	CC(C)(C)C(=O)NCCCC(O)=O	corticosteroid releasing factor receptor antagonist	CRHR1|CRHR2
pivampicillin	33478	BRD-K32791151	CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O	bacterial cell wall synthesis inhibitor	
pivanex	60748	BRD-K20504455	CCCC(=O)OCOC(=O)C(C)(C)C	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC8
pivmecillinam		BRD-K67100011	CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](\N=C\N1CCCCCC1)C2=O	bacterial cell wall synthesis inhibitor	
pixantrone	134019	BRD-K48304345	NCCNc1ccc(NCCN)c2C(=O)c3cnccc3C(=O)c12	topoisomerase inhibitor	TOP2A
pizotifen	27400	BRD-K75958195	CN1CCC(CC1)=C1c2ccsc2CCc2ccccc12	serotonin receptor antagonist	HTR1A|HTR2A|HTR2C
PI3K-IN-2	58507717	BRD-K62374002	Nc1cc(c(cn1)-c1nc(nc(n1)N1CCOCC1)N1CCOCC1)C(F)(F)F	PI3K inhibitor	
PI4KIII-beta-inhibitor-1	71549093	BRD-K75528696	COc1ccc(cc1S(=O)(=O)Nc1ccc(O)cc1)-c1sc(NC(=O)C(C)(C)C)nc1C	PI4K inhibitor	PI4K2B
PJ-34	4858	BRD-K11853856	CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1	PARP inhibitor	EEF2|PARP1|PARP15|PARP3
PK-THPP	53464059	BRD-K44043890	CCCC(=O)C1CCN(CC1)c1ncnc2CCN(Cc12)C(=O)c1ccc(cc1)-c1ccccc1	potassium channel blocker	KCNK9
PK-11195	1345	BRD-A41451487	CCC(C)N(C)C(=O)c1cc2ccccc2c(n1)-c1ccccc1Cl	benzodiazepine receptor antagonist	TSPO
PK-44	46208486	BRD-K04035716	N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc1n[nH]c2c(F)c(F)ccc12	dipeptidyl peptidase inhibitor	DPP4
PKI-166	6918403	BRD-K10115470	C[C@@H](Nc1ncnc2[nH]c(cc12)-c1ccc(O)cc1)c1ccccc1	EGFR inhibitor	EGFR
PKI-179	46947264	BRD-A28467416	O=C(Nc1ccncc1)Nc1ccc(cc1)-c1nc(nc(n1)N1CCOCC1)N1C2CCC1COC2	mTOR inhibitor; PI3K inhibitor	MTOR
pleconaril	1684	BRD-K27625831	Cc1cc(CCCOc2c(C)cc(cc2C)-c2noc(n2)C(F)(F)F)on1		
plerixafor	65015	BRD-K33240821	C(N1CCCNCCNCCCNCC1)c1ccc(CN2CCCNCCNCCCNCC2)cc1	CC chemokine receptor antagonist	ACKR3|CCR4|CXCR4
plicamycin	457831	BRD-K36368047	CO[C@@H]([C@@H]1Cc2cc3cc(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@@H](O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@H]2C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@H](O)[C@@H](C)O2)[C@H](O)[C@@H](C)O1)C(=O)[C@@H](O)[C@@H](C)O	alcohol dehydrogenase inhibitor	
plinabulin	9949641	BRD-K99498722	CC(C)(C)c1[nH]cnc1\C=c1/[nH]c(=O)\c(=C\c2ccccc2)[nH]c1=O	tubulin polymerization inhibitor	
plovamer-acetate	1153	BRD-A20781140	NC(Cc1ccc(O)cc1)C(O)=O		TAT|TH|YARS|YARS2
plurisin-#1	225362	BRD-K99149715	O=C(NNc1ccccc1)c1ccncc1	stearoyl-CoA desaturase inhibitor	SCD
PLX-4720	24180719	BRD-K16478699	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F	RAF inhibitor	BRAF|KDR
PLX-647	11545419	BRD-K79294107	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncccc34)cn2)cc1	receptor tyrosine protein kinase inhibitor	CSF1R|KIT
PLX8394	90116675	BRD-K53723268	F[C@@H]1CCN(C1)S(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)-c2cnc(nc2)C2CC2)c1F	serine/threonine kinase inhibitor	BRAF
PMPA	10130754	BRD-A74387232	OC(=O)CCC(CP(O)(O)=O)C(O)=O	glutamate receptor antagonist	FOLH1
PNU-120596	311434	BRD-K71731651	COc1cc(OC)c(NC(=O)Nc2cc(C)on2)cc1Cl	acetylcholine receptor agonist	CHRNA7
PNU-142633	9845148	BRD-K81616657	CNC(=O)c1ccc2[C@H](CCN3CCN(CC3)c3ccc(cc3)C(N)=O)OCCc2c1	serotonin receptor agonist	HTR1D
PNU-177864	9887351	BRD-K04635846	CCCNCCc1ccc(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)cc1	dopamine receptor antagonist	DRD3
PNU-22394	27559	BRD-K16551401	Cn1c2CCNCCc2c2ccccc12	serotonin receptor agonist	HTR2A|HTR2B|HTR2C|MAOA|MAOB
PNU-282987	9795278	BRD-K28863208	Clc1ccc(cc1)C(=O)N[C@H]1CN2CCC1CC2	cholinergic receptor agonist	CHRNA7
PNU-37883	64393	BRD-K12769093	C1CCC(CC1)N\C(N1CCOCC1)=N\C12CC3CC(CC(C3)C1)C2	ATP-sensitive potassium channel antagonist	
PNU-74654	9836739	BRD-K30707190	Cc1ccc(\C=N\NC(=O)c2ccccc2Oc2ccccc2)o1	beta-catenin inhibitor	CTNNB1|TCF4
PNU-89843	154689	BRD-K84507776	Cc1cc2c(nc(nc2n1C)N1CCCC1)N1CCCC1	benzodiazepine receptor agonist	GABBR1
podophyllotoxin	10607	BRD-K47869605	COc1cc(cc(OC)c1OC)[C@H]1[C@@H]2[C@H](COC2=O)[C@@H](O)c2cc3OCOc3cc12	microtubule inhibitor; tubulin polymerization inhibitor	IGF1R|TOP2A|TUBA4A|TUBB
polidocanol	656641	BRD-K35798650	CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO	local anesthetic	
polydatin	5281718	BRD-K43236057	OC[C@H]1O[C@@H](Oc2cc(O)cc(\C=C\c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O	ICAM1 expression inhibitor	ICAM1
polyinosine	797	BRD-A67531813	OC1C(COP(O)(O)=O)OC(C1O)n1cnc2c(O)ncnc12	immunostimulant	ADSSL1|HPRT1|IMPDH2|PYGM
polymyxin-b-sulfate	4868	BRD-A08641215	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(Cc2ccccc2)NC(=O)C(CCN)NC1=O)C(C)O	bacterial permeability inducer	
polythiazide	4870	BRD-A15739803	CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(cc2S1(=O)=O)S(N)(=O)=O	sodium/chloride cotransporter inhibitor	SLC12A3
pomalidomide	134780	BRD-A12994259	Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12	angiogenesis inhibitor; tumor necrosis factor production inhibitor	CRBN|PTGS2|TNF
ponatinib	24826799	BRD-K44227013	CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1	Bcr-Abl kinase inhibitor; FLT3 inhibitor; PDGFR tyrosine kinase receptor inhibitor	ABL1|BCR|FGFR1|FGFR2|FGFR3|FGFR4|FLT3|KDR|KIT|LCK|LYN|PDGFRA|RET|SRC|TEK
ponesimod		BRD-K44030614	CCC\N=C1/S\C(=C/c2ccc(OC[C@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C	sphingosine 1 phosphate receptor agonist	S1PR1
posaconazole	468595	BRD-K06222852	CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(cc2)N2CCN(CC2)c2ccc(OC[C@@H]3CO[C@](Cn4cncn4)(C3)c3ccc(F)cc3F)cc2)c1=O	sterol demethylase inhibitor	CYP3A4
potassium-canrenoate	656615	BRD-K46556543	C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)CCC(O)=O	mineralocorticoid receptor antagonist	NR3C2
potassium-iodide		BRD-M55321172	[K].I		
potassium-p-aminobenzoate	7057990	BRD-K58497451	Nc1ccc(cc1)C(O)=O		
pozanicline	178052	BRD-K79803033	Cc1ncccc1OC[C@@H]1CCCN1	acetylcholine receptor antagonist	CHRNA4|CHRNB2
poziotinib	25127713	BRD-K50010139	COc1cc2ncnc(Nc3ccc(Cl)c(Cl)c3F)c2cc1OC1CCN(CC1)C(=O)C=C	EGFR inhibitor	EGFR|ERBB2|ERBB4
PP-1	1400	BRD-K47598052	Cc1ccc(cc1)-c1nn(c2ncnc(N)c12)C(C)(C)C	src inhibitor	HCK|RET
PP-121	24905142	BRD-K81801188	C1CCC(C1)n1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc12	protein tyrosine kinase inhibitor	ABL1|EGFR|HCK|KDR|MTOR|PDGFRA|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC|SRC
PP-2	4878	BRD-K95785537	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc12	src inhibitor	ABL1|LCK|LYN|RIPK2|SRC
PPT		BRD-K00312224	CCCc1c(nn(c1-c1ccc(O)cc1)-c1ccc(O)cc1)-c1ccc(O)cc1	estrogen receptor agonist	ESR1
PPY-A	16750094	BRD-K72514671	COc1ccccc1-c1c[nH]c2ncc(cc12)-c1cncc(c1)C(=O)N(C)C	Abl kinase inhibitor	ABL1|BCR
PP242		BRD-K87112191	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc12	mTOR inhibitor	MTOR|PASK
PQ-401	9549305	BRD-K67537649	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12	IGF-1 inhibitor	IGF1R
PR-619	2817763	BRD-K54395039	Nc1nc(N)c(SC#N)cc1SC#N	DUB inhibitor	
practolol	4883	BRD-A41304429	CC(C)NCC(O)COc1ccc(NC(C)=O)cc1	adrenergic receptor antagonist	ADRB1
pralatrexate	148121	BRD-A74914197	Nc1nc(N)c2nc(CC(CC#C)c3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)cnc2n1	dihydrofolate reductase inhibitor	DHFR|TYMS
pralidoxime	6789253	BRD-K84281997	C[n+]1ccccc1\C=N\O	acetylcholinesterase inhibitor	ACHE|BCHE
pralidoxime-chloride	54072659	BRD-K24221957	C[n+]1ccccc1C[N+][O-]	acetylcholinesterase inhibitor	ACHE|BCHE
pramipexole	119570	BRD-K06388322	CCCN[C@H]1CCc2nc(N)sc2C1	dopamine receptor agonist	ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C
pramiracetam	51712	BRD-K21123171	CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C	acetylcholine receptor agonist	
pramoxine	4886	BRD-K46523383	CCCCOc1ccc(OCCCN2CCOCC2)cc1	topical anesthetic	
pranidipine	6436048	BRD-A68083442	COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC\C=C\c1ccccc1	calcium channel blocker	CACNA1C
pranlukast	4887	BRD-K97045029	O=C(Nc1cccc2c1oc(cc2=O)-c1nnn[nH]1)c1ccc(OCCCCc2ccccc2)cc1	leukotriene receptor antagonist	CYSLTR1|CYSLTR2|IL5|MUC2|NFKB1|RNASE3|TNF
pranoprofen	4888	BRD-A64610707	CC(C(O)=O)c1ccc2Oc3ncccc3Cc2c1	cyclooxygenase inhibitor	
prasterone-acetate	6710660	BRD-A20758144	CC(=O)O[C@H]1CC[C@]2(C)C3CC[C@@]4(C)C(CCC4=O)C3CC=C2C1		
prasugrel	6918456	BRD-A83029242	CC(=O)Oc1cc2CN(CCc2s1)C(C(=O)C1CC1)c1ccccc1F	purinergic receptor antagonist	P2RY12
pravadoline	56463	BRD-K46209126	COc1ccc(cc1)C(=O)c1c(C)n(CCN2CCOCC2)c2ccccc12	cyclooxygenase inhibitor	CNR1|CNR2
pravastatin	54687	BRD-K60511616	CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12	HMGCR inhibitor	HMGCR|SLCO1B1
praziquantel	4891	BRD-A21858158	O=C(C1CCCCC1)N1CC2N(CCc3ccccc23)C(=O)C1	anthelmintic agent	
prazosin	4893	BRD-K49111258	COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)c1ccco1	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|KCNH2|KCNH6|KCNH7
PRE-084	126402	BRD-K57304726	O=C(OCCN1CCOCC1)C1(CCCCC1)c1ccccc1	sigma receptor agonist	SIGMAR1
preclamol	202478	BRD-K02908048	CCCN1CCC[C@@H](C1)c1cccc(O)c1	dopamine receptor agonist	DRD2
prednicarbate	60148445	BRD-A93963402	CCOC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)C=C[C@]4(C)C3[C@@H](O)C[C@]12C)C(=O)COC(=O)CC	phospholipase activator	NR3C1|PLA2G1B
prednisolone	5702106	BRD-A27887842	C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)CO	glucocorticoid receptor agonist	NR3C1|NR3C2|SERPINA6
prednisolone-acetate	5834	BRD-K45664306	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C	glucocorticoid receptor agonist	NR3C1
prednisolone-hemisuccinate	9847023	BRD-A78391468	C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)COC(=O)CCC(O)=O	glucocorticoid receptor agonist	NR3C1
prednisolone-sodium-phosphate	10484458	BRD-A94523291	C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)COP(O)(O)=O	glucocorticoid receptor agonist	NR3C1
prednisolone-tebutate	45006124	BRD-A53151380	CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)C=C[C@]4(C)C3[C@@H](O)C[C@]12C	anti-inflammatory agent	
prednisone	5865	BRD-K85883481	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO	glucocorticoid receptor agonist	HSD11B1|NR3C1
pregabalin	25271887	BRD-K66786476	CC(C)C[C@H](CN)CC(O)=O	voltage-gated calcium channel ligand	CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8
pregnanolone	22833567	BRD-A03204438	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	GABA receptor positive allosteric modulator	
pregnenolone	8955	BRD-K43880410	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	glutamate receptor modulator	CYP17A1|SULT2B1
pregnenolone-succinate	45006141	BRD-A35912562	CC(=O)[C@H]1CCC2C3CC=C4C[C@H](CC[C@]4(C)C3CC[C@]12C)OC(=O)CCC(O)=O	GABA receptor negative allosteric modulator	
preladenant	10117987	BRD-K46290096	COCCOc1ccc(cc1)N1CCN(CCn2ncc3c2nc(N)n2nc(nc32)-c2ccco2)CC1	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
prenylamine	9801	BRD-A10662413	CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1	calcium channel blocker	CALM1|MYLK2
presatovir	58029842	BRD-K45906612	Cc1cn2nc(cc2nc1N1CC[C@H](N)C1)[C@@H]1CCCCN1C(=O)c1cc(Cl)ccc1NS(C)(=O)=O	RSV fusion inhibitor	
pridinol	4904	BRD-K17565903	OC(CCN1CCCCC1)(c1ccccc1)c1ccccc1	muscle relaxant	
prilocaine	4906	BRD-A53952395	CCCNC(C)C(=O)Nc1ccccc1C	local anesthetic	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
primaquine	4908	BRD-A55913614	COc1cc(NC(C)CCCN)c2ncccc2c1	antimalarial agent; DNA inhibitor	KRT7|NQO2
PRIMA1	322968	BRD-K15318909	OCC1(CO)N2CCC(CC2)C1=O	TP53 reactivator	TP53
primidone	4909	BRD-K32247306	CCC1(C(=O)NCNC1=O)c1ccccc1	GABA receptor antagonist	CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
prinaberel		BRD-K87316765	Oc1cc(C=C)c2oc(nc2c1)-c1ccc(O)c(F)c1	estrogen receptor agonist	ESR2|NCOA1
priralfinamide	5745207	BRD-K01662324	C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O	sodium channel blocker	CACNA1B
pritelivir	491941	BRD-K25204779	CN(C(=O)Cc1ccc(cc1)-c1ccccn1)c1nc(C)c(s1)S(N)(=O)=O	helicase primase inhibitor	
proacipimox	3068148	BRD-K53605365	COCc1c[n+]([O-])c(C)cn1	cholesterol inhibitor	
proadifen	4910	BRD-K46317332	CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1	nitric oxide synthase inhibitor	NOS1
probenecid	4911	BRD-K95237249	CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(O)=O	uricosuric blocker	PANX1|SLC22A11|SLC22A6|SLC22A8|SLCO1C1
probucol	4912	BRD-K72029282	CC(C)(Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C	atherogenesis inhibitor	ABCA1|ABCB11|CES1
procainamide	4913	BRD-K75089421	CCN(CC)CCNC(=O)c1ccc(N)cc1	sodium channel blocker	DNMT1|SCN5A
procaine	4914	BRD-K24616672	CCN(CC)CCOC(=O)c1ccc(N)cc1	HMGCR inhibitor	CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3
procarbazine	4915	BRD-K13032584	CNNCc1ccc(cc1)C(=O)NC(C)C	monoamine oxidase inhibitor	
procaterol	688561	BRD-K78666826	CC[C@H](NC(C)C)[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12	adrenergic receptor agonist	ADRB2
prochlorperazine	4917	BRD-K19352500	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1	dopamine receptor antagonist	DRD1|DRD2|DRD3|DRD4
procodazole	4739544	BRD-K54824716	OC(=O)CCc1nc2ccccc2[nH]1	immunostimulant	
procyanidin-b-2	11250133	BRD-K72093555	O[C@H]1Cc2c(O)cc(O)c([C@@H]3[C@@H](O)[C@H](Oc4cc(O)cc(O)c34)c3ccc(O)c(O)c3)c2O[C@@H]1c1ccc(O)c(O)c1		
procyclidine	4919	BRD-A31800922	OC(CCN1CCCC1)(C1CCCCC1)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4
procysteine	72390	BRD-K92413528	OC(=O)[C@@H]1CSC(=O)N1	glutathione synthase stimulant	
profenamine	3290	BRD-A16311756	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc12	butyrylcholinesterase inhibitor; cholinergic receptor antagonist	CHRM1|CHRM2|GRIN3A
proflavine-hemisulfate	7099	BRD-K68408467	Nc1ccc2cc3ccc(N)cc3nc2c1	topical anesthetic	F2
progesterone	5994	BRD-K64994968	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	progesterone receptor agonist	CATSPER1|CATSPER2|CATSPER3|CATSPER4|CYP17A1|ESR1|NR3C2|OPRK1|PGR|TRPC5
proglumetacin	4921	BRD-A19458515	CCCN(CCC)C(=O)C(CCC(=O)OCCCN1CCN(CCOC(=O)Cc2c(C)n(C(=O)c3ccc(Cl)cc3)c3ccc(OC)cc23)CC1)NC(=O)c1ccccc1	cyclooxygenase inhibitor	PTGS1|PTGS2
proglumide	4922	BRD-A44863528	CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)c1ccccc1	CCK receptor antagonist	CCKAR|CCKBR
proguanil	4923	BRD-K28183345	CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1	dihydrofolate reductase inhibitor	DHFR
prolylleucylglycinamide	3896043	BRD-A09911125	CC(C)CC(NC(=O)C1CCCN1)C(=O)NCC(N)=O	melanocyte-stimulating hormone release inhibitor	
promazine	4926	BRD-K06980535	CN(C)CCCN1c2ccccc2Sc2ccccc12	dopamine receptor antagonist	ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|HRH1|HTR2A|HTR2C
promestriene	9883915	BRD-K75097983	CCCOc1ccc2[C@H]3CC[C@]4(C)[C@H](CC[C@H]4[C@@H]3CCc2c1)OC	estrogen receptor agonist	ESR1
promethazine	4927	BRD-A46335897	CC(CN1c2ccccc2Sc2ccccc12)N(C)C	histamine receptor antagonist	ADRA1A|CALM1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR2A
pronethalol	4930	BRD-A87715314	CC(C)NCC(O)c1ccc2ccccc2c1	adrenergic receptor antagonist	
propacetamol	68865	BRD-K54496168	CCN(CC)CC(=O)Oc1ccc(NC(C)=O)cc1	cyclooxygenase inhibitor	PTGS2
propafenone	4932	BRD-A26334849	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1	antiarrhythmic	ADRB1|ADRB2|KCNA5|KCNH2|SCN5A
propagermanium	83030	BRD-K53382462	OC(=O)CC[Ge](=O)O[Ge](=O)CCC(O)=O	interferon receptor agonist; CCR agonist	CCR2
propantheline	4934	BRD-K90885812	CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc12)C(C)C	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4
propatylnitrate	66261	BRD-K56276053	CCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O		
propentofylline	4938	BRD-K59273480	CCCn1cnc2n(C)c(=O)n(CCCCC(C)=O)c(=O)c12	adenosine reuptake inhibitor; phosphodiesterase inhibitor	PDE1A
propidium-iodide	101643283	BRD-K14821965	CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc12		ACHE
propiolactone	2365	BRD-K76867903	O=C1CCO1		
propiverine	4942	BRD-K91244729	CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1	acetylcholine receptor antagonist	CHRM1
propofol	4943	BRD-K82255054	CC(C)c1cccc(C(C)C)c1O	benzodiazepine receptor agonist	FAAH|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|SCN2A|SCN4A
propoxur	4944	BRD-K08231299	CNC(=O)Oc1ccccc1OC(C)C		
propoxycaine	6843	BRD-K18250272	CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC	local anesthetic	
propranolol	4946	BRD-A10070317	CC(C)NCC(O)COc1cccc2ccccc12	adrenergic receptor antagonist	
propranolol-(R)	21138	BRD-K92830582	CC(C)NC[C@@H](O)COc1cccc2ccccc12	adrenergic receptor antagonist	ADRB2|ADRB3
propranolol-(S)	91536	BRD-K13994703	CC(C)NC[C@H](O)COc1cccc2ccccc12	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3|HTR1A|HTR1B|HTR5A|SLC10A1
propyl-benzoate	16846	BRD-K15329706	CCCOC(=O)c1ccccc1		
propylene-glycol	1030	BRD-A19232309	CC(O)CO		F13A1
propylhexedrine	7558	BRD-A35667010	CNC(C)CC1CCCCC1	adrenergic receptor agonist	SLC18A2|TAAR1
propylparaben	7175	BRD-K60783397	CCCOC(=O)c1ccc(O)cc1		
propylthiouracil	657298	BRD-K48168960	CCCc1cc(=O)[nH]c(=S)[nH]1	thyroid peroxidase inhibitor	DIO1|TPO
proquazone	31508	BRD-K54339150	CC(C)n1c2cc(C)ccc2c(nc1=O)-c1ccccc1	cyclooxygenase inhibitor	PTGS1|PTGS2
proscillaridin-a	124079498	BRD-A11815689	C[C@@H]1O[C@@H](O[C@H]2CC[C@]3(C)C4CC[C@]5(C)[C@H](CC[C@]5(O)C4CCC3=C2)c2ccc(=O)oc2)C(O)C(O)[C@H]1O		
protionamide	666418	BRD-K75360161	CCCc1cc(ccn1)C(S)=N		
protirelin	32281	BRD-A16997652	NC(=O)C1CCCN1C(=O)C(Cc1c[nH]cn1)NC(=O)C1CCC(=O)N1	thyrotropin releasing hormone receptor agonist	TRHR
protoporphyrin-ix		BRD-K26813314	Cc1c(CCC(O)=O)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5C=C)c(C)c4C=C)c(C)c3CCC(O)=O	heme oxygenase inhibitor	HMOX1
protriptyline	4976	BRD-K42098891	CNCCCC1c2ccccc2C=Cc2ccccc12	tricyclic antidepressant	SLC6A2|SLC6A4
proxodolol	660984	BRD-A29944538	Cc1noc(COc2ccccc2OCC(O)CNC(C)(C)C)n1	adrenergic receptor antagonist	
proxyfan	6421522	BRD-K77171813	C(COCc1ccccc1)Cc1cnc[nH]1	histamine receptor modulator	HRH3
proxymetacaine	4935	BRD-K79116891	CCCOc1ccc(cc1N)C(=O)OCCN(CC)CC	sodium channel blocker	SCN10A|SCN5A
proxyphylline	4977	BRD-A28887267	CC(O)Cn1cnc2n(C)c(=O)n(C)c(=O)c12		
PRT062070	44595079	BRD-K25835157	CCS(=O)(=O)N1CCN(CC1)c1ccc(Nc2ncc(C(N)=O)c(NC3CC3)n2)cc1	JAK inhibitor; syk inhibitor	SYK
PRT062607	44462758	BRD-K53734668	N[C@H]1CCCC[C@H]1Nc1ncc(C(N)=O)c(Nc2cccc(c2)-n2nccn2)n1	syk inhibitor	FGR|MAP3K9|SYK
PRT4165	207893	BRD-K32456483	O=C1C(=Cc2cccnc2)C(=O)c2ccccc12	polycomb repressive complex inhibitor	PRC1
prucalopride	3052762	BRD-K33681278	COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(N)c2CCOc12	serotonin receptor agonist	HTR4
prulifloxacin	4916641	BRD-A92341659	CC1Sc2c(C(O)=O)c(=O)c3cc(F)c(cc3n12)N1CCN(Cc2oc(=O)oc2C)CC1	bacterial DNA gyrase inhibitor	
pruvanserin	6433122	BRD-K43837174	Fc1ccc(CCN2CCN(CC2)C(=O)c2cccc3c(c[nH]c23)C#N)cc1	serotonin receptor antagonist	HTR2A|HTR2C
PRX-08066	11502243	BRD-K16757695	Fc1ccc(CN2CCC(CC2)Nc2ncnc3sc(Cl)cc23)cc1C#N	serotonin receptor antagonist	HTR2B
PSB-06126	25124826	BRD-K71266197	Nc1c2C(=O)c3ccccc3C(=O)c2c(Nc2cccc3ccccc23)cc1S(O)(=O)=O	NTPDase inhibitor	ENTPD3
PSB-11	9882625	BRD-K10177585	CC[C@@H]1CN2C(=N1)c1[nH]c(nc1N(C)C2=O)-c1ccccc1	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA3
PSB-1115	5311479	BRD-K49027941	CCCn1c(=O)[nH]c2nc([nH]c2c1=O)-c1ccc(cc1)S(O)(=O)=O	adenosine receptor antagonist	ADORA1|ADORA2B|ADORA3
PSB-36	11689583	BRD-A70407468	CCCCn1c(=O)n(CCCO)c2nc([nH]c2c1=O)C12CC3CC1CC(C2)C3	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
PSB-603	44185871	BRD-K05419687	CCCn1c(=O)[nH]c2nc([nH]c2c1=O)-c1ccc(cc1)S(=O)(=O)N1CCN(CC1)c1ccc(Cl)cc1	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
PSI-6130	6481236	BRD-K07798980	C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O	RNA polymerase inhibitor	
PSI-7976	45375809	BRD-K05674516	CC(C)OC(=O)[C@H](C)N[P@@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1	HCV inhibitor	
PSN-375963	2875918	BRD-K25524093	CCCCC1CCC(CC1)c1nc(no1)-c1ccncc1	glucose dependent insulinotropic receptor agonist	GPR119
PSNCBAM-1	11560249	BRD-K33502629	Clc1ccc(NC(=O)Nc2cccc(c2)-c2cccc(n2)N2CCCC2)cc1	cannabinoid receptor modulator	CNR1
psoralen	6199	BRD-K47264279	O=c1ccc2cc3ccoc3cc2o1		MAOA|MAOB
PS178990	9882972	BRD-K99092662	Cc1c(ccc(C#N)c1Cl)N1C(=O)[C@@H]2[C@H](O)CCN2C1=O	androgen receptor modulator	AR
PT-2385	91754484	BRD-K20850787	CS(=O)(=O)c1ccc(Oc2cc(F)cc(c2)C#N)c2CC(F)(F)[C@@H](O)c12	hypoxia inducible factor inhibitor	EPAS1
PTC-209	1117196	BRD-K83834509	COc1cc(Br)c(Nc2nc(cs2)-c2c(C)nc3ncccn23)c(Br)c1	BMI-1 inhibitor	
pterostilbene	160517	BRD-K53097745	COc1cc(OC)cc(C=Cc2ccc(O)cc2)c1	cyclooxygenase inhibitor; PPAR receptor agonist	PTGS2
PU-H71	9549213	BRD-K36529613	CC(C)NCCCn1c(Sc2cc3OCOc3cc2I)nc2c(N)ncnc12	HSP inhibitor	HSP90AA1
puerarin	5281807	BRD-K89048337	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1c(O)ccc2c1occ(-c1ccc(O)cc1)c2=O	serotonin receptor antagonist	
pumosetrag	154104	BRD-K44164034	Oc1c(cnc2ccsc12)C(=O)N[C@H]1CN2CCC1CC2	serotonin receptor agonist	HTR3A|HTR4
purmorphamine	5284329	BRD-K73397362	C1CCC(CC1)n1cnc2c(Nc3ccc(cc3)N3CCOCC3)nc(Oc3cccc4ccccc34)nc12	smoothened receptor agonist	SMO
puromycin	5702164	BRD-A28970875	COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)OC([C@@H]2O)n2cnc3c(ncnc23)N(C)C)cc1	protein synthesis inhibitor	NHP2L1|RPL10L|RPL11|RPL13A|RPL15|RPL19|RPL23|RPL23A|RPL26L1|RPL3|RPL37|RPL8|RSL24D1
purvalanol-a	456214	BRD-K50836978	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1	CDK inhibitor	CDK1|CDK2|CDK4|CDK5|CSNK1G3|RPS6KA1|SRC
purvalanol-b	448991	BRD-K41564320	CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(O)=O)c(Cl)c2)c2ncn(C(C)C)c2n1	tyrosine kinase inhibitor	CDK2|CDK4|CDK5|MAPK1|MAPK3|SRPK2
putrescine	1045	BRD-K75282878	NCCCCN	tissue transglutaminase inhibitor	AMD1|KCNJ4|ODC1
PX-12	219104	BRD-A56592690	CCC(C)SSc1ncc[nH]1	thioredoxin inhibitor	TXN|TXNRD1
PX-478	11255684	BRD-A26835809	NC(Cc1ccc(cc1)[N+]([O-])(CCCl)CCCl)C(O)=O	hypoxia inducible factor inhibitor	
PYM50028	92095	BRD-K62277907	C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@]11CC[C@H](C)CO1	neurotrophic agent	
PYR-41	5335621	BRD-K66101666	CCOC(=O)c1ccc(cc1)N1NC(=O)\C(=C\c2ccc(o2)[N+]([O-])=O)C1=O	ubiquitin activating enzyme inhibitor	
pyrantel	54742459	BRD-K82118441	OC(=O)c1cc2ccccc2c(Cc2c(O)c(cc3ccccc23)C(O)=O)c1O	nicotinic receptor agonist	
pyrantel-pamoate	708857	BRD-K20672254	CN1CCCN=C1\C=C\c1cccs1	neuromuscular blocker	
pyrantel-tartrate	708857	BRD-K20672254	CN1CCCN=C1\C=C\c1cccs1	acetylcholine receptor agonist	CHRNA1
pyrazinamide	1046	BRD-K28667793	NC(=O)c1cnccn1	fatty acid synthase inhibitor	FASN
pyrazinoylguanidine	124704	BRD-K61693562	NC(=N)NC(=O)c1cnccn1	diuretic	
pyrazolanthrone	8515	BRD-K01567962	O=C1c2ccccc2-c2n[nH]c3cccc1c23	JNK inhibitor	MAPK10|MAPK8|MAPK8IP1|MAPK9|TTK
pyrazoloacridine		BRD-K42607789	COc1ccc2[nH]c3c(ccc4n(CCCN(C)C)nc(c34)c2c1)[N+]([O-])=O	topoisomerase inhibitor	TOP1|TOP2A
pyrethrins	45006080	BRD-K79856453	CC(C)=C[C@@H]1[C@@H](C(=O)O[C@H]2CC(=O)C(C\C=C/C=C)=C2)C1(C)C		
pyridoxal	1050	BRD-K76204040	Cc1ncc(CO)c(C=O)c1O		PDXK
pyridoxal-isonicotinoyl-hydrazone		BRD-K42019693	Cc1ncc(CO)c(\C=N\NC(=O)c2ccncc2)c1O	apoptosis stimulant	
pyridoxamine	1052	BRD-K96669468	Cc1ncc(CO)c(CN)c1O	AGE inhibitor	
pyridoxine	1054	BRD-K14349461	Cc1ncc(CO)c(CO)c1O	vitamin B	DDC|PDXK
pyrimethamine	4993	BRD-K88429204	CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1	dihydrofolate reductase inhibitor	DHFR|SLC47A1
pyrintegrin	46223724	BRD-K94659840	Oc1ccc2N(CCCc2c1)c1ccnc(Nc2ccc(cc2)S(=O)(=O)NCC2CC2)n1	integrin signaling activator	
pyrithione-zinc		BRD-K16136380	O1[n+]2ccccc2S[Zn]11O[n+]2ccccc2S1	ATP synthase inhibitor	KCNQ1|KCNQ2|KCNQ4|KCNQ5
pyrithyldione	4994	BRD-K36116267	CCC1(CC)C(=O)NC=CC1=O	psychoactive drug	
pyritinol	14190	BRD-K82181219	Cc1ncc(CSSCc2cnc(C)c(O)c2CO)c(CO)c1O		
pyronaridine		BRD-K73132780	COc1ccc2nc3cc(Cl)ccc3c(Nc3cc(CN4CCCC4)c(O)c(CN4CCCC4)c3)c2n1	antimalarial agent	
pyroxamide	4996	BRD-K11663430	ONC(=O)CCCCCCC(=O)Nc1cccnc1	HDAC inhibitor	HDAC1
pyrrolidine-dithiocarbamate	65351	BRD-K80970344	SC(=S)N1CCCC1	NFkB pathway inhibitor	HSD11B1|RELA
pyrvinium	117737649	BRD-M55114534	CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1.CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1	androgen receptor antagonist	
pyrvinium-pamoate	117737649	BRD-M55114534	CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1.CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1	androgen receptor antagonist	AR
P22077	46931953	BRD-K97714174	CC(=O)c1cc(c(Sc2ccc(F)cc2F)s1)[N+]([O-])=O	ubiquitin specific protease inhibitor	USP7
P276-00	23643976	BRD-K51791723	CN1CC[C@H]([C@@H]1CO)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl	CDK inhibitor	CDK1|CDK4|CDK9
P5091	2819993	BRD-K13606314	CC(=O)c1cc(c(Sc2cccc(Cl)c2Cl)s1)[N+]([O-])=O	ubiquitin specific protease inhibitor	USP7
P7C3	2836187	BRD-A09487507	OC(CNc1ccccc1)Cn1c2ccc(Br)cc2c2cc(Br)ccc12	NAMPT inhibitor	NAMPT
Q-203	68234908	BRD-K59853741	CCc1nc2ccc(Cl)cn2c1C(=O)NCc1ccc(cc1)N1CCC(CC1)c1ccc(OC(F)(F)F)cc1	ATP synthase inhibitor	
quazinone	57046956	BRD-K63631219	Cc1c(O)nc2Nc3cccc(Cl)c3Cn12	phosphodiesterase inhibitor	PDE3A|PDE3B
quercetin	5280343	BRD-K97399794	Oc1cc(O)c2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O	polar auxin transport inhibitor	ATP5A1|ATP5B|ATP5C1|HCK|HIBCH|PIK3CG|PIM1|STK17B|UGT3A1
quetiapine	5002	BRD-K68867920	OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12	dopamine receptor antagonist; serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A2
quiflapon	60923	BRD-K39503511	CC(C)(C)Sc1c(CC(C)(C)C(O)=O)n(Cc2ccc(Cl)cc2)c2ccc(OCc3ccc4ccccc4n3)cc12	leukotriene synthesis inhibitor	ALOX5|ALOX5AP
quinagolide	3086401	BRD-K02995728	CCCN1C[C@H](C[C@@H]2Cc3c(O)cccc3C[C@@H]12)NS(=O)(=O)N(CC)CC	dopamine receptor agonist	DRD2
quinapril	40466957	BRD-K72222507	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(O)=O	angiotensin converting enzyme inhibitor	ACE
quinaprilat	107994	BRD-K42317111	C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1Cc2ccccc2C[C@H]1C(O)=O	angiotensin converting enzyme inhibitor	ACE
quinelorane	57242	BRD-K13261168	CCCN1CCC[C@@H]2Cc3nc(N)ncc3C[C@@H]12	dopamine receptor agonist	DRD2|DRD3
quinestrol	51371331	BRD-A16439188	C[C@]12CCC3C(CCc4cc(OC5CCCC5)ccc34)C1CC[C@@]2(O)C#C	estrogen receptor agonist	ESR1
quinethazone	6307	BRD-A59303141	CCC1NC(=O)c2cc(c(Cl)cc2N1)S(N)(=O)=O	thiazide diuretic	CA1|CA2|SLC12A1|SLC12A2|SLC12A3
quinidine	441074	BRD-K59632282	COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)c2c1	sodium channel blocker	KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4
quinine	3034034	BRD-K07940445	COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1	hemozoin biocrystallization inhibitor	GP9|KCNB2|KCNN4|SLC29A4
quinine-ethyl-carbonate	5702001	BRD-K97028990	CCOC(=O)O[C@H]([C@H]1C[C@@H]2CC[N@]1C[C@@H]2C=C)c1ccnc2ccc(OC)cc12		
quinolinic-acid	1066	BRD-K51885093	OC(=O)c1cccnc1C(O)=O	glutamate receptor agonist	
quinpirol-(-)	54562	BRD-K26548821	CCCN1CCC[C@@H]2Cc3n[nH]cc3C[C@@H]12	dopamine receptor agonist	DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2A|HTR2B|HTR2C
quipazine	5011	BRD-K77925998	C1CN(CCN1)c1ccc2ccccc2n1	serotonin receptor agonist	
quizartinib	24889392	BRD-K93918653	CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1	FLT3 inhibitor	CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET
QX-222	5014	BRD-K40782193	Cc1cccc(C)c1NC(=O)C[N+](C)(C)C	sodium channel blocker	
QX-314	3925	BRD-K56596464	CC[N+](CC)(CC)CC(=O)Nc1c(C)cccc1C	sodium channel blocker	MAPK14|TGFBR1
r(-)-apomorphine	2215	BRD-A35931254	CN1CCc2cccc-3c2C1Cc1ccc(O)c(O)c-31	dopamine receptor agonist	DRD2|HTR5A
R-1479	132283238	BRD-K28442028	Nc1ccn([C@@H]2O[C@@](CO)(N=[N+]=[N-])[C@@H](O)[C@H]2O)c(=O)n1	HCV inhibitor	
R-1485	11689373	BRD-K96418224	Fc1ccccc1S(=O)(=O)N1CCOc2c(cccc12)N1CCNCC1	serotonin receptor antagonist	HTR6
R-268712	11703284	BRD-K83904070	Cc1cccc(n1)-c1n[nH]cc1-c1ccc(F)c(c1)-c1cnn(CCO)c1	serine/threonine kinase inhibitor	TGFBR1
R-428	46215462	BRD-K14870255	Nc1nc(Nc2ccc3CC[C@@H](CCc3c2)N2CCCC2)nn1-c1cc2CCCc3ccccc3-c2nn1	AXL kinase inhibitor	AXL
R-59022	3012	BRD-K54665485	Cc1nc2sccn2c(=O)c1CCN1CCC(CC1)=C(c1ccccc1)c1ccc(F)cc1	diacylglycerol kinase inhibitor; protein kinase inhibitor	DGKA
R-96544	10668211	BRD-K15588452	COc1cccc(CCc2ccccc2OCC[C@@H]2C[C@@H](O)CN2C)c1	serotonin receptor antagonist	HTR2A
rabeprazole	5029	BRD-A39390670	COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C	ATPase inhibitor; gastrin inhibitor	ATP4A
rac-BHFF	4332683	BRD-A11069678	CC(C)(C)c1cc2c(OC(=O)C2(O)C(F)(F)F)c(c1)C(C)(C)C	GABA receptor positive allosteric modulator	GABBR1
racecadotril	107751	BRD-A08187463	CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1	enkephalinase inhibitor	MME
raclopride	3033769	BRD-K04111260	CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC	dopamine receptor antagonist	DRD2|DRD3|HTR1A
ractopamine	56052	BRD-A86414188	CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)cc1	adrenergic receptor agonist	
radafaxine	9795056	BRD-K13394247	C[C@@H]1NC(C)(C)CO[C@@]1(O)c1cccc(Cl)c1	dopamine norepinephrine reuptake inhibitor	SLC6A3
radezolid	11224409	BRD-K84683831	CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(c(F)c1)-c1ccc(CNCc2cnn[nH]2)cc1	bacterial 30S ribosomal subunit inhibitor; bacterial 50S ribosomal subunit inhibitor	
RAF265	11656518	BRD-K93123848	Cn1c(Nc2ccc(cc2)C(F)(F)F)nc2cc(Oc3ccnc(c3)-c3ncc([nH]3)C(F)(F)F)ccc12	RAF inhibitor; VEGFR inhibitor	BRAF
raloxifene	5035	BRD-K63828191	Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1	estrogen receptor antagonist; selective estrogen receptor modulator (SERM)	ESR1|ESR2
raltegravir	54671008	BRD-K05658747	Cc1nnc(o1)C(=O)NC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C	HIV integrase inhibitor	
raltitrexed	104758	BRD-K89839824	CN(Cc1ccc2[nH]c(C)nc(=O)c2c1)c1ccc(s1)C(=O)N[C@@H](CCC(O)=O)C(O)=O	thymidylate synthase inhibitor	FPGS|TYMS
ramatroban	123879	BRD-K08586861	OC(=O)CCn1c2CC[C@H](Cc2c2ccccc12)NS(=O)(=O)c1ccc(F)cc1	prostanoid receptor antagonist	PTGDR2|TBXA2R
ramelteon	208902	BRD-K28761891	CCC(=O)NCC[C@@H]1CCc2ccc3OCCc3c12	melatonin receptor agonist	MTNR1A|MTNR1B
ramifenazone	5037	BRD-K85333151	CC(C)Nc1c(C)n(C)n(-c2ccccc2)c1=O	cyclooxygenase inhibitor	
ramipril	5362129	BRD-K89348303	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H]2CCC[C@H]2C[C@H]1C(O)=O	angiotensin converting enzyme inhibitor	ACE
ramosetron	108000	BRD-K85046107	Cn1cc(C(=O)[C@@H]2CCc3nc[nH]c3C2)c2ccccc12	serotonin receptor antagonist	HTR3A
ranirestat	153948	BRD-K50489389	Fc1cc(Br)ccc1CN1C(=O)c2cccn2[C@@]2(CC(=O)NC2=O)C1=O	aldose reductase inhibitor	AKR1B1
ranitidine	3001055	BRD-K70505054	CN\C(NCCSCc1ccc(CN(C)C)o1)=C/[N+]([O-])=O	histamine receptor antagonist	HRH2
ranolazine	56959	BRD-A97674275	COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1	sodium channel blocker	SCN10A|SCN4A|SCN5A|SCN9A
rapastinel	14539800	BRD-K02206208	C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(N)=O	glutamate receptor agonist	
rasagiline	3052776	BRD-K58114536	C#CCN[C@@H]1CCc2ccccc12	monoamine oxidase inhibitor	BCL2|MAOB
rauwolscine	643606	BRD-K77474816	COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12	adrenergic receptor antagonist	ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR1E|HTR2B
ravoxertinib	71727581	BRD-K86309810	Cn1nccc1Nc1nccc(n1)-c1ccn([C@H](CO)c2ccc(Cl)c(F)c2)c(=O)c1	ERK1 and ERK2 phosphorylation inhibitor	MAPK1|MAPK3
ravuconazole	467825	BRD-K03503561	C[C@@H](c1nc(cs1)-c1ccc(cc1)C#N)[C@](O)(Cn1cncn1)c1ccc(F)cc1F	sterol demethylase inhibitor	
RBC8	6626226	BRD-A67036568	COc1ccc(OC)c(c1)C1c2c(OC(N)=C1C#N)[nH]nc2-c1ccc2ccccc2c1	Ral GTPase inhibitor	RALA|RALB
rebamipide	5042	BRD-A15909516	OC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1	free radical scavenger	FPR1
rebastinib	25066467	BRD-K76694128	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1	Bcr-Abl kinase inhibitor; TIE tyrosine kinase inhibitor; VEGFR inhibitor	ABL1|BCR|FGR|FLT3|HCK|LYN|SRC
reboxetine	76960974	BRD-M39350793	CCOc1ccccc1O[C@@H]([C@H]1CNCCO1)c1ccccc1.CCOc1ccccc1O[C@H]([C@@H]1CNCCO1)c1ccccc1	adrenergic receptor antagonist	SLC6A2
Rec-15/2615	9891980	BRD-K84924479	COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C	adrenergic receptor antagonist	ADRA1A
refametinib	44182295	BRD-K85751432	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1	MEK inhibitor	MAP2K1|MAP2K2
regadenoson	68741978	BRD-A78341343	CNC(=O)c1cnn(c1)-c1nc(N)c2ncn([C@@H]3O[C@H](CO)C(O)C3O)c2n1	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3
regorafenib	11167602	BRD-K16730910	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1	FGFR inhibitor; KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; RAF inhibitor; RET tyrosine kinase inhibitor; VEGFR inhibitor	ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK
relcovaptan	60943	BRD-K96720755	COc1ccc(cc1OC)S(=O)(=O)N1[C@@H](C(=O)N2CCC[C@H]2C(N)=O)[C@](O)(c2cc(Cl)ccc12)c1ccccc1Cl	vasopressin receptor antagonist	AVPR1A|AVPR1B|AVPR2|OXTR
relebactam	121301826	BRD-K63018010	OS(=O)(=O)ON1[C@H]2CN([C@@H](CC2)C(=O)NC2CCNCC2)C1=O	beta lactamase inhibitor	
remacemide	60511	BRD-A36074203	CC(Cc1ccccc1)(NC(=O)CN)c1ccccc1	glutamate receptor antagonist	GRIN1
remimazolam	9867812	BRD-K89413285	COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc12	benzodiazepine receptor agonist	GABBR1
remodelin	44442376	BRD-K75349868	N#Cc1ccc(cc1)-c1csc(NN=C2CCCC2)n1	transferase inhibitor	NAT10
remoxipride	54477	BRD-K54094468	CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC	dopamine receptor antagonist	DRD2|DRD3|DRD4|HTR2A|SIGMAR1
repaglinide	65981	BRD-K82846253	CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(O)=O	insulin secretagogue	ABCC8|KCNJ11|PPARG
reparixin	9838712	BRD-K58486055	CC(C)Cc1ccc(cc1)[C@@H](C)C(=O)NS(C)(=O)=O	CC chemokine receptor antagonist	CXCR1|CXCR2
repsox	449054	BRD-K80480517	Cc1cccc(n1)-c1n[nH]cc1-c1ccc2ncccc2n1	TGF beta receptor inhibitor	TGFBR1
resatorvid	11703255	BRD-K61567297	CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)Nc1ccc(F)cc1Cl	toll-like receptor antagonist	TLR4
reserpine	5770	BRD-K95921201	CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1	vesicular monoamine transporter inhibitor	SLC18A1|SLC18A2
resibufogenin	6917974	BRD-K25970317	C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@]11O[C@@H]1C[C@@H]2c1ccc(=O)oc1	Na/K-ATPase inhibitor	
resiquimod	159603	BRD-K76210423	CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O	toll-like receptor agonist	TLR7|TLR8
resminostat	11609955	BRD-K28822270	CN(C)Cc1ccc(cc1)S(=O)(=O)n1ccc(c1)\C=C\C(=O)NO	HDAC inhibitor	HDAC1|HDAC3|HDAC6|HDAC8
resorcinol	5054	BRD-K74190368	Oc1cccc(O)c1	phosphodiesterase inhibitor	CA12|CA14|CA2|PTGS1
resorcinol-monoacetate	5055	BRD-K85603128	CC(=O)Oc1cccc(O)c1	antiseptic	
resveratrol	445154	BRD-K80738081	Oc1ccc(cc1)\C=C\c1cc(O)cc(O)c1	cytochrome P450 inhibitor; SIRT activator	CSNK2A1|NQO2|PTGS1|PTGS2
retapamulin		BRD-K33082088	C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CS[C@H]1C[C@@H]2CC[C@H](C1)N2C	protein synthesis inhibitor	
retaspimycin	11534420	BRD-K67935717	CO[C@H]1C[C@H](C)Cc2c(O)c(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)cc(O)c2NCC=C	HSP inhibitor	HSP90AA1
retigabine	121892	BRD-K89917372	CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N	potassium channel activator	KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5
retinaldehyde	638015	BRD-K79884267	CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/C=O		
retinol	445354	BRD-K22429181	CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/CO	retinoid receptor ligand	ALDH1A1|ALDH1A2|ALDH1A3|DHRS3|DHRS4|LRAT|NR2C2|RBP1|RBP3|RDH11|RDH12|RDH13|RDH14|RDH5|RDH8|RETSAT|RHO|RLBP1|RXRA|RXRB|RXRG
retinyl-acetate	638034	BRD-K65331431	CC(=O)OC\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C		
retinyl-palmitate	5280531	BRD-K80595380	CCCCCCCCCCCCCCCC(=O)OC\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C		
REV-5901	5059	BRD-A68281735	CCCCCC(O)c1cccc(OCc2ccc3ccccc3n2)c1	leukotriene receptor antagonist; lipoxygenase inhibitor	ALOX5
revaprazan	204104	BRD-A51497544	CC1N(CCc2ccccc12)c1nc(Nc2ccc(F)cc2)nc(C)c1C	potassium-competitive acid antagonist	ATP4A
reversan	2298706	BRD-K79700588	O=C(NCCCN1CCOCC1)c1cnn2c(cc(nc12)-c1ccccc1)-c1ccccc1	MRP inhibitor	ABCC1
reversine	210332	BRD-K77286328	C1CCC(CC1)Nc1nc(Nc2ccc(cc2)N2CCOCC2)nc2[nH]cnc12	Aurora kinase inhibitor	AURKB|INCENP|MAP2K1
RGB-286638	11285002	BRD-K20986415	COCCN1CCN(Cc2ccc(cc2)-c2n[nH]c3-c4cccc(NC(=O)NN5CCOCC5)c4C(=O)c23)CC1	CDK inhibitor	CDK1|CDK2|CDK3|CDK4|CDK5|CDK6|CDK7|CDK9|FLT3|GSK3B|JAK2|MAP3K7|MAPK9
RGFP966	56650312	BRD-K61688984	Nc1cc(F)ccc1NC(=O)\C=C\c1cnn(C\C=C\c2ccccc2)c1	HDAC inhibitor	HDAC3
RG108	702558	BRD-K89391146	OC(=O)[C@H](Cc1c[nH]c2ccccc12)N1C(=O)c2ccccc2C1=O	DNA methyltransferase inhibitor	DNMT1|DNMT3B
RG1530	11610113	BRD-K32942258	COc1cc2N=C3NNC(C)=C3N=C(c3ccccc3Cl)c2cc1F	FGFR inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor	FGFR1|FGFR2
RG2833	56654642	BRD-K02389548	Cc1ccc(cc1)C(=O)NCCCCCC(=O)Nc1ccccc1N	HDAC inhibitor	HDAC1|HDAC3
RG4733	49867930	BRD-K22024824	CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@H]1c2ccccc2-c2ccccc2NC1=O	gamma secretase inhibitor	PSEN1
RG7112	76525291	BRD-A78210457	CCOc1cc(ccc1C1=NC(C)(c2ccc(Cl)cc2)C(C)(N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1)c1ccc(Cl)cc1)C(C)(C)C	MDM inhibitor	MDM2
RHC-80267	5063	BRD-K56047318	O=C(NCCCCCCNC(=O)ON=C1CCCCC1)ON=C1CCCCC1	triacylglycerol lipase inhibitor	DAGLA|DAGLB
rhein	10168	BRD-K27335680	OC(=O)c1cc(O)c2C(=O)c3c(O)cccc3C(=O)c2c1		HSP90AA1
rheochrysidin	10639	BRD-K67772619	COc1cc(O)c2C(=O)c3c(O)cc(C)cc3C(=O)c2c1	protein tyrosine kinase inhibitor	PTPN1
rhodamine-123		BRD-K47169076	COC(=O)c1ccccc1-c1c2ccc(N)cc2[o+]c2cc(N)ccc12		
RI-1	1074953	BRD-K79555887	ClC1=C(N2CCOCC2)C(=O)N(C1=O)c1ccc(Cl)c(Cl)c1		RAD51
ribavirin	37542	BRD-K60369935	NC(=O)c1ncn(n1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	antiviral	ADK|ENPP1|IMPDH1|IMPDH2|NT5C2
ribitol		BRD-K49313711	OC[C@H](O)[C@H](O)[C@H](O)CO		
ribociclib	44631912	BRD-K36788280	CN(C)C(=O)c1cc2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n1C1CCCC1	CDK inhibitor	CDK4|CDK6
riboflavin	6759	BRD-K70246307	Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@@H](O)[C@@H](O)[C@@H](O)CO)c2cc1C	vitamin B2	BLVRB|RFK
riboflavin-5-phosphate-sodium	643976	BRD-K09229706	Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)c2cc1C		BLVRB|DHODH|DPYD|HAO1|HAO2|MT-ND1|NOS1|PNPO|POR|PPCDC|RFK|RPS6KA4|SGK1
ribostamycin	33042	BRD-K55188888	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O	bacterial 30S ribosomal subunit inhibitor	
ribostamycin-sulfate	5702280	BRD-A03826781	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)C2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O	bacterial 30S ribosomal subunit inhibitor	P4HB
ricinoleic-acid	643684	BRD-K33682646	CCCCCC[C@@H](O)C\C=C/CCCCCCCC(O)=O	prostanoid receptor agonist	PTGER3
rifabutin		BRD-K30563334	CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(c(O)c3C)c(O)c(NC(=O)\C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c1=NC3(CCN(CC(C)C)CC3)N=c21	protein synthesis inhibitor	HSP90AA1|HSP90B1
rifampin		BRD-K01507359	CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)c(\C=N\N4CCN(C)CC4)c(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C	RNA polymerase inhibitor	NR1I2|SLCO1A2|SLCO1B1|SLCO1B3
rifamycin	6324616	BRD-K38512030	CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)cc(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C	DNA directed RNA polymerase inhibitor	SLCO1A2|SLCO1B1|SLCO1B3|SLCO2B1
rifamycin-sv	129010042	BRD-K13277760	CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c(O)cc(NC(=O)\C(C)=C/C=C\[C@@H](C)[C@@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@H]([C@H]1C)C(=O)OC)c(O)c2c(O)c3C	RNA synthesis inhibitor	
rifapentine		BRD-K28346421	CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)c(\C=N\N4CCN(CC4)C4CCCC4)c(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C	RNA polymerase inhibitor	CYP2C8|CYP2C9|CYP3A4
rifaximin	57507834	BRD-K92838188	CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c4nc5cc(C)ccn5c4c(NC(=O)\C(C)=C/C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C	RNA synthesis inhibitor	NR1I2
rigosertib	6918736	BRD-K55187425	COc1cc(OC)c(\C=C\S(=O)(=O)Cc2ccc(OC)c(NCC(O)=O)c2)c(OC)c1	cell cycle inhibitor; PLK inhibitor	PLK1
rilmenidine	68712	BRD-K01638814	C1CC1C(NC1=NCCO1)C1CC1	adrenergic receptor agonist; imidazoline receptor agonist	ADRA2A
rilpivirine	6451164	BRD-K06240250	Cc1cc(\C=C\C#N)cc(C)c1Nc1ccnc(Nc2ccc(cc2)C#N)n1	non-nucleoside reverse transcriptase inhibitor	NR1I2|SCN10A
riluzole	5070	BRD-K21283037	Nc1nc2ccc(OC(F)(F)F)cc2s1	glutamate inhibitor	KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11
rimantadine	5071	BRD-A75479906	CC(N)C12CC3CC(CC(C3)C1)C2	antiviral; RNA synthesis inhibitor	
rimcazole	53389	BRD-K70490179	C[C@H]1CN(CCCn2c3ccccc3c3ccccc23)C[C@@H](C)N1	sigma receptor antagonist	SIGMAR1
rimexolone	5311412	BRD-K31627533	CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C	glucocorticoid receptor agonist	NR3C1|SERPINA6
rimonabant	104850	BRD-K13296708	Cc1c(nn(c1-c1ccc(Cl)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1	cannabinoid receptor antagonist	CNR1|GPR55
riociguat	11304743	BRD-K84783599	COC(=O)N(C)c1c(N)nc(nc1N)-c1nn(Cc2ccccc2F)c2ncccc12	guanylate cyclase stimulant	GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3
riodipine	68909	BRD-K36379990	COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1OC(F)F)C(=O)OC	calcium channel blocker	
riodoxol	152256	BRD-K48963429	Oc1c(I)cc(I)c(O)c1I	other antibiotic	
ripasudil	9863672	BRD-K53814070	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12	rho associated kinase inhibitor	ROCK1|ROCK2
ripazepam	33474	BRD-K57427145	CCn1nc(C)c2NC(=O)CN=C(c12)c1ccccc1	benzodiazepine receptor agonist	GABRA1
risedronate	44400168	BRD-K05185389	OC(Cc1cccnc1)(P(O)(O)=O)P(O)(O)=O	osteoclast inhibitor	FDPS
risperidone	5073	BRD-K53857191	Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12	dopamine receptor antagonist; serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|HTR7
RITA	374536	BRD-K00317371	OCc1ccc(s1)-c1ccc(o1)-c1ccc(CO)s1	MDM inhibitor	MDM2
ritanserin	5074	BRD-K40887525	Cc1nc2sccn2c(=O)c1CCN1CCC(CC1)=C(c1ccc(F)cc1)c1ccc(F)cc1	serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
ritodrine	688570	BRD-K14003026	C[C@@H](NCCc1ccc(O)cc1)[C@@H](O)c1ccc(O)cc1	adrenergic receptor agonist	ADRB2
ritonavir	392622	BRD-K51485625	CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1	HIV protease inhibitor	CYP1A2|CYP2B6|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP2E1|CYP3A4|CYP3A5|CYP3A7
rivanicline	5310967	BRD-K79966802	CNCC\C=C\c1cccnc1	acetylcholine receptor agonist	CHRNA4|CHRNB2|CXCL8
rivaroxaban	9875401	BRD-K37130656	Clc1ccc(s1)C(=O)NC[C@H]1CN(C(=O)O1)c1ccc(cc1)N1CCOCC1=O	coagulation factor inhibitor	F10
rivastigmine	77991	BRD-K10706131	CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C	acetylcholinesterase inhibitor	ACHE|BCHE
rizatriptan	5078	BRD-K75699339	CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F
RKI-1447	60138149	BRD-K19333160	Oc1cccc(CNC(=O)Nc2nc(cs2)-c2ccncc2)c1	rho associated kinase inhibitor	CDC42BPA|DMPK|LIMK1|MYLK|PAK1|PKN1|ROCK1|ROCK2
RLX	78144	BRD-K28773847	O=c1n2CCCCCc2nc2ccccc12		
RN-1	45376076	BRD-K41415459	CN1CCN(CC1)C(=O)CN[C@@H]1C[C@H]1c1ccc(OCc2ccccc2)cc1	histone demethylase inhibitor	KDM1A
RN-1734	3601086	BRD-K95581532	CC(C)NCCN(C(C)C)S(=O)(=O)c1ccc(Cl)cc1Cl	TRPV antagonist	TRPV4
RN-1747	5068295	BRD-K45519571	[O-][N+](=O)c1cc(Cl)ccc1S(=O)(=O)N1CCN(Cc2ccccc2)CC1	TRPV agonist	TRPV4
Ro-04-5595	46740	BRD-A63546914	COc1cc2CCN(C)C(CCc3ccc(Cl)cc3)c2cc1O		GRIN2B
Ro-08-2750	17756791	BRD-K00486786	Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C)c2cc1C=O		NGF
Ro-10-5824	16759175	BRD-K79684402	Cc1ncc(CN2CCC(=CC2)c2ccccc2)c(N)n1	dopamine receptor agonist	DRD4
Ro-106-9920	3906779	BRD-A53134341	O=S(c1ccccc1)c1ccc2nnnn2n1	NFkB pathway inhibitor	
Ro-1138452	9839644	BRD-K77220725	CC(C)Oc1ccc(Cc2ccc(NC3=NCCN3)cc2)cc1	prostanoid receptor antagonist	PTGIR
Ro-15-4513	5081	BRD-K82823076	CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(ccc-21)N=[N+]=[N-]		GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB2|GABRG2
Ro-19-4605	127382	BRD-K80778372	CN1Cc2c(ncn2-c2ccsc2C1=O)C(=O)OC(C)(C)C		GABRA1|GABRA2|GABRA3|GABRA5
Ro-20-1724	5087	BRD-A07207424	CCCCOc1cc(CC2CNC(=O)N2)ccc1OC	phosphodiesterase inhibitor	PDE3A|PDE4A|PDE4B|PDE4C|PDE4D
Ro-25-6981	6604887	BRD-K51541829	C[C@@H](CN1CCC(Cc2ccccc2)CC1)[C@@H](O)c1ccc(O)cc1		GRIN2B
Ro-28-1675	9886086	BRD-K21672174	CS(=O)(=O)c1ccc(cc1)[C@@H](CC1CCCC1)C(=O)Nc1nccs1	glucokinase activator	GCK
RO-3	11289644	BRD-K00354853	COc1cc(Cc2cnc(N)nc2N)c(cc1OC)C(C)C	purinergic receptor antagonist	P2RX3
Ro-3306	11631681	BRD-K78373679	O=C1N=C(NCc2cccs2)S\C1=C/c1ccc2ncccc2c1	CDK inhibitor	CDK1
Ro-48-8071	1949	BRD-K55192287	CN(CCCCCCOc1ccc(C(=O)c2ccc(Br)cc2)c(F)c1)CC=C	oxidosqualene cyclase inhibitor	LSS
Ro-4987655	11548630	BRD-K64538373	OCCONC(=O)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F	MEK inhibitor	MAP2K1
Ro-5126766	16719221	BRD-K82804538	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F	RAF inhibitor; MEK inhibitor	BRAF|MAP2K1|MAP2K2|RAF1
Ro-60-0175	3045227	BRD-K28007504	C[C@H](N)Cn1ccc2cc(F)c(Cl)cc12		HTR2A|HTR2B|HTR2C
Ro-61-8048	5282337	BRD-K12639498	COc1ccc(cc1OC)S(=O)(=O)Nc1nc(cs1)-c1cccc(c1)[N+]([O-])=O	kynurenine 3-monooxygenase inhibitor	KMO
Ro-67-7476	32681978	BRD-K91333421	Cc1ccc(cc1)S(=O)(=O)N1CCC[C@H]1c1ccc(F)cc1	glutamate receptor positive allosteric modulator	GRM1
Ro-90-7501	824226	BRD-K58299615	Nc1ccc(cc1)-c1nc2ccc(cc2[nH]1)-c1nc2ccc(N)cc2[nH]1		APP
Ro-9187	11514721	BRD-K57284066	Nc1ccn([C@@H]2O[C@@](CO)(N=[N+]=[N-])[C@@H](O)[C@@H]2O)c(=O)n1	HCV inhibitor	
robalzotan	3055171	BRD-K26169680	NC(=O)c1ccc(F)c2OC[C@@H](Cc12)N(C1CCC1)C1CCC1	serotonin receptor antagonist	HTR1A
rociletinib	57335384	BRD-K33610132	COc1cc(ccc1Nc1ncc(c(Nc2cccc(NC(=O)C=C)c2)n1)C(F)(F)F)N1CCN(CC1)C(C)=O	EGFR inhibitor	EGFR
rocuronium	441290	BRD-K43305603	CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1	acetylcholine receptor antagonist	CHRM2|CHRNA2|HTR3A
rofecoxib	5090	BRD-K21733600	CS(=O)(=O)c1ccc(cc1)C1=C(C(=O)OC1)c1ccccc1	cyclooxygenase inhibitor	ELN|PTGS2
roflumilast	449193	BRD-K03194791	FC(F)Oc1ccc(cc1OCC1CC1)C(=O)Nc1c(Cl)cncc1Cl	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4C|PDE4D
rolipram	5092	BRD-A34255068	COc1ccc(cc1OC1CCCC1)C1CNC(=O)C1	phosphodiesterase inhibitor	
rolipram-R(-)	448055	BRD-K75516118	COc1ccc(cc1OC1CCCC1)[C@@H]1CNC(=O)C1	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4C|PDE4D|PDE5A
rolipram-S(+)	158758	BRD-K65856711	COc1ccc(cc1OC1CCCC1)[C@H]1CNC(=O)C1	phosphodiesterase inhibitor	
rolitetracycline	16760201	BRD-A62336573	CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(=O)NCN2CCCC2)C1=O	bacterial 30S ribosomal subunit inhibitor	
rolziracetam	71893	BRD-K38564664	O=C1CCC2CCC(=O)N12		
romidepsin	5352062	BRD-K61397605	C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
ronidazole	5094	BRD-K94266545	Cn1c(COC(N)=O)ncc1[N+]([O-])=O	antiprotozoal agent	
ropinirole	5095	BRD-K15933101	CCCN(CCC)CCc1cccc2NC(=O)Cc12	dopamine receptor agonist	ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C
ropivacaine	175805	BRD-K50938786	CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C	sodium channel blocker	SCN10A
roquinimex	54676478	BRD-K03384561	CN(C(=O)c1c(O)c2ccccc2n(C)c1=O)c1ccccc1	angiogenesis inhibitor; tumor necrosis factor production inhibitor	
rosamicin	5383587	BRD-A38799180	CCC1OC(=O)CC(O)C(C)C(OC2OC(C)CC(C2O)N(C)C)C(CC=O)CC(C)C(=O)\C=C\C2(C)OC2C1C	protein synthesis inhibitor	
roscovitine	160355	BRD-K07691486	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	CDK inhibitor	CDK2|CDK9
rose-bengal	25474	BRD-K33623053	OC(=O)c1c(Cl)c(Cl)c(Cl)c(Cl)c1-c1c2cc(I)c(O)c(I)c2oc2c(I)c(=O)c(I)cc12	contrast agent	
rose-bengal-lactone	69439	BRD-K36163066	Oc1c(I)cc2c(Oc3c(I)c(O)c(I)cc3C22OC(=O)c3c2c(Cl)c(Cl)c(Cl)c3Cl)c1I	coloring agent	
rosiglitazone	77999	BRD-A97437073	CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1	insulin sensitizer; PPAR receptor agonist	ACSL4|FFAR1|PPARG|TRPC5|TRPM3
rosmarinic-acid	5281792	BRD-K20313525	OC(=O)[C@@H](Cc1ccc(O)c(O)c1)OC(=O)\C=C\c1ccc(O)c(O)c1	GABA transaminase inhibitor	MCL1|TYR
rosoxacin	287180	BRD-K49841478	CCn1cc(C(O)=O)c(=O)c2ccc(cc12)-c1ccncc1	topoisomerase inhibitor	
rostafuroxine	153976	BRD-K11672787	C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@]2(O)c1ccoc1	ATPase inhibitor	ATP1A1
rosuvastatin	446157	BRD-K82941592	CC(C)c1nc(nc(-c2ccc(F)cc2)c1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O	HMGCR inhibitor	HMGCR
rotigotine	59227	BRD-K91111634	CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1	dopamine receptor agonist	ADRA2B|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A
rotundine	72301	BRD-K35719256	COc1cc2CCN3Cc4c(C[C@H]3c2cc1OC)ccc(OC)c4OC	serotonin receptor agonist	DRD1|DRD2|DRD3|HTR1A
roxarsone	5104	BRD-K22685337	Oc1ccc(cc1[N+]([O-])=O)[As](O)(O)=O	antiprotozoal agent	
roxatidine-acetate	5105	BRD-K81855038	CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1	histamine receptor antagonist	HRH2
roxithromycin	6915744	BRD-K38684403	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)\C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O	bacterial 50S ribosomal subunit inhibitor	ABCB1|MLNR
RP-001	50911934	BRD-A29148886	CC(C)Oc1ccc(cc1C#N)-c1nc(no1)-c1cccc2C(CCc12)NCCC(O)=O	sphingosine 1 phosphate receptor agonist	S1PR1
RP67580		BRD-K40767677	COc1ccccc1C=C(N)N1C[C@H]2[C@@H](C1)C(CCC2=O)(c1ccccc1)c1ccccc1		
RQ-00203078	49783953	BRD-K87973152	OC(=O)c1ccc(cc1)S(=O)(=O)N(Cc1ccc(OC(F)(F)F)cc1)c1ncc(cc1Cl)C(F)(F)F	transient receptor potential channel antagonist	TRPM8
RRx-001	15950826	BRD-K06894065	[O-][N+](=O)C1(CN(C1)C(=O)CBr)[N+]([O-])=O	glucose 6-phosphate dehydrogenase inhibitor	G6PD
RS-0481	124405	BRD-A00055058	CC(NC(=O)C1CSCN1C(=O)c1ccccc1)c1ccccc1	immunostimulant	
RS-100329	3567002	BRD-K08640512	Cc1c[nH]c(=O)n(CCCN2CCN(CC2)c2ccccc2OCC(F)(F)F)c1=O	adrenergic receptor antagonist	ADRA1A|ADRA1D
RS-102221	3693566	BRD-K87048468	COc1cc(OC)c(cc1NS(=O)(=O)c1ccc(cc1)C(F)(F)F)C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C
RS-102895	10000456	BRD-K83063356	FC(F)(F)c1ccc(CCN2CCC3(CC2)OC(=O)Nc2ccccc32)cc1	CCR antagonist	CCR2
RS-127445	196968	BRD-K90825648	CC(C)c1cc(nc(N)n1)-c1ccc(F)c2ccccc12	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C
RS-16566	6604794	BRD-K80725821	CC(C)n1cnc2c(cc(Cl)cc12)C(=O)N[C@H]1CN2CCC1CC2	serotonin receptor antagonist	
RS-17053	3894573	BRD-K76840893	CC(C)(Cc1c[nH]c2ccc(Cl)cc12)NCCOc1ccccc1OCC1CC1	adrenergic receptor antagonist	ADRA1A|ADRA1D
RS-23597-190	182593	BRD-K01868942	COc1cc(N)c(Cl)cc1C(=O)OCCCN1CCCCC1	serotonin receptor antagonist	HTR4
RS-39604	5145950	BRD-K20742498	COc1cc(COc2cc(N)c(Cl)cc2C(=O)CCC2CCN(CCNS(C)(=O)=O)CC2)cc(OC)c1	serotonin receptor antagonist	HTR4
RS-45041-190	127951	BRD-K26160755	Clc1cccc2CN(Cc12)C1=NCCN1	imidazoline receptor agonist	
RS-504393	9953769	BRD-K87510569	Cc1oc(nc1CCN1CCC2(CC1)OC(=O)Nc1ccc(C)cc21)-c1ccccc1	CC chemokine receptor antagonist	CCL2|CCR2
RS-56812	6604789	BRD-K20714604	Cn1cc(C(=O)C(=O)N[C@H]2CN3CCC2CC3)c2ccccc12	serotonin receptor partial agonist	HTR3A
RS-67333	183782	BRD-K46142322	CCCCN1CCC(CCC(=O)c2cc(Cl)c(N)cc2OC)CC1	serotonin receptor partial agonist	HTR4
RS-67506	133076	BRD-K50018155	COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(CCNS(C)(=O)=O)CC1	serotonin receptor partial agonist	HTR4
RS-79948	9908992	BRD-K86600316	CCS(=O)(=O)N1CCC[C@@H]2CN3CCc4cc(OC)ccc4[C@@H]3C[C@H]12	adrenergic receptor antagonist	ADRA2A
RSV604	5279172	BRD-K30159788	Fc1ccccc1NC(=O)N[C@H]1N=C(c2ccccc2)c2ccccc2NC1=O	RSV replication inhibitor	
RTA-408	71811910	BRD-K56211775	CC(F)(F)C(=O)N[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2	nitric oxide production inhibitor	NFE2L2
RU-SKI-43	46006640	BRD-A33603104	CCC(C)CNCC(=O)N1CCc2sccc2C1COc1cccc(C)c1	hedgehog pathway inhibitor	HHAT
RU-24969	108029	BRD-K00234327	COc1ccc2[nH]cc(C3=CCNCC3)c2c1	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR6
RU-28318	3034004	BRD-K37687387	CCC[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]3(O)CCC(O)=O)[C@H]12	cytochrome P450 inhibitor	NR3C2
RU-42173	3086576	BRD-K85285268	CC(C)N[C@@H]1CCn2c3c(cccc3[nH]c2=O)[C@H]1O	adrenergic receptor agonist	ADRB2
RU-58841	132981	BRD-K62762455	CC1(C)N(CCCCO)C(=O)N(C1=O)c1ccc(C#N)c(c1)C(F)(F)F	androgen receptor antagonist	AR
rubitecan	472335	BRD-K79821389	CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cccc([N+]([O-])=O)c4cc3Cn1c2=O	topoisomerase inhibitor	TOP1
rucaparib	9931954	BRD-K88560311	CNCc1ccc(cc1)-c1[nH]c2cc(F)cc3C(=O)NCCc1c23	PARP inhibitor	PARP1|PARP2
rucinol	205912	BRD-K61036791	CCCCc1ccc(O)cc1O	tyrosinase inhibitor	TYR
rufinamide	129228	BRD-K20079257	NC(=O)c1cn(Cc2c(F)cccc2F)nn1	voltage-gated sodium channel blocker	GRM5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
rufloxacin	4979271	BRD-K62374253	CN1CCN(CC1)c1c(F)cc2c3c1SCCn3cc(C(O)=O)c2=O	bacterial DNA gyrase inhibitor	
rupatadine	133017	BRD-K98004573	Cc1cncc(CN2CCC(CC2)=C2c3ccc(Cl)cc3CCc3cccnc23)c1	histamine receptor antagonist; platelet activating factor receptor antagonist	HRH1|PTAFR
rutaecarpine	65752	BRD-K94723713	O=c1n2CCc3c([nH]c4ccccc34)-c2nc2ccccc12	cyclooxygenase inhibitor	PTGS2
rutin	5280805	BRD-K20482099	C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(oc4cc(O)cc(O)c4c3=O)-c3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O	antioxidant; capillary stabilizing agent; nitric oxide scavenger	AKR1C3
ruxolitinib	25126798	BRD-K53972329	N#CC[C@H](C1CCCC1)n1cc(cn1)-c1ncnc2[nH]ccc12	JAK inhibitor	JAK1|JAK2|JAK3|TYK2
ruxolitinib-(S)	50878566	BRD-K19601669	N#CC[C@@H](C1CCCC1)n1cc(cn1)-c1ncnc2[nH]ccc12	JAK inhibitor	JAK1|JAK2
RWJ-21757	60737	BRD-K00091711	Nc1nc2n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c(=O)n(CC=C)c2c(=O)[nH]1	toll-like receptor agonist	TLR7
RWJ-50271	9953357	BRD-K94623186	Cc1c(cnn1-c1nc(cs1)-c1cccc(c1)C(F)(F)F)C(=O)NCCCO	integrin inhibitor	ICAM1
RWJ-67657	3008319	BRD-K07074923	OCCC#Cc1nc(c(-c2ccncc2)n1CCCc1ccccc1)-c1ccc(F)cc1	MAP kinase inhibitor	MAPK14|PTGS2
RX-3117	11242315	BRD-K66213167	Nc1ccn([C@H]2[C@H](O)[C@H](O)C(CO)=C2F)c(=O)n1	DNA synthesis inhibitor; CDK inhibitor	CDK2|DNMT1
RX-821002	108094	BRD-A65597028	COC1(COc2ccccc2O1)C1=NCCN1	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
ryuvidine	481747	BRD-K06426971	Cc1nc2c(s1)C(=O)C=C(Nc1ccc(C)cc1)C2=O	histone lysine methyltransferase inhibitor	CDK2|CDK4
R112	9904854	BRD-K23902832	Oc1cccc(Nc2ncc(F)c(Nc3cccc(O)c3)n2)c1	syk inhibitor	SYK
R306465	10309899	BRD-K86687746	ONC(=O)c1cnc(nc1)N1CCN(CC1)S(=O)(=O)c1ccc2ccccc2c1	HDAC inhibitor	
R406	11213558	BRD-K20285085	COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)Nc4n3)n2)cc(OC)c1OC	SYK inhibitor	RET|SYK
R547	6918852	BRD-K52233191	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(CC2)S(C)(=O)=O)nc1N	CDK inhibitor	CDK1|CDK2|CDK4|CDK7
S-Isopropylisothiourea	445319	BRD-K10673031	CC(C)SC(N)=N	nitric oxide synthase inhibitor	NOS3
S-methylcysteine	24417	BRD-K63123526	CSC[C@H](N)C(O)=O		CTSD|MGMT
S-Nitrosoglutathione	104858	BRD-K94780074	N[C@@H](CCC(=O)N[C@@H](CS[N+][O-])C(=O)NCC(O)=O)C(O)=O	nitric oxide stimulant	PTPN1
S-Sulfo-L-cysteine-sodium-salt	115015	BRD-K59527975	N[C@@H](CSS(O)(=O)=O)C(O)=O	glutamate receptor agonist	
S-Trityl-L-cysteine	7271795	BRD-K09774593	N[C@H](CSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(O)=O	mitotic kinesin inhibitor	
S-07662	2732040	BRD-K37635256	Cc1oc2ccccc2c1CNC(=O)NCc1cccs1	CAR antagonist	NR1I3
S-111	11213350	BRD-K60005752	CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@@]21C	PARP inhibitor	PARP1
S-14506	131906	BRD-K46766488	COc1ccc2cccc(N3CCN(CCNC(=O)c4ccc(F)cc4)CC3)c2c1	serotonin receptor agonist	HTR1A
SA-47	9840648	BRD-K99819791	CNC(=O)COC(=O)NCCC1CCN(CC1)c1cccc(C)n1	FAAH inhibitor	FAAH
saccharin	5143	BRD-K46493214	O=C1NS(=O)(=O)c2ccccc12	DNA polymerase inhibitor	CA1|CA12|CA2|CA9
saclofen	122150	BRD-A24122750	NCC(CS(O)(=O)=O)c1ccc(Cl)cc1	GABA receptor antagonist	GABBR1|GABBR2|KCTD12|KCTD16|KCTD8
sacubitril	9811834	BRD-K91456750	CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC(O)=O	neprilysin inhibitor	MME
safflower-yellow	129010072	BRD-A96503329	OC[C@H]1OC([C@H](O)[C@@H](O)[C@@H]1O)[C@]1(O)C(=O)C(\C=C2/C(=O)C(C(=O)\C=C\c3ccc(O)cc3)C(=O)[C@@](O)(C3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C2=O)C(=O)C(C(=O)\C=C\c2ccc(O)cc2)C1=O	anti-inflammatory agent	
safinamide	131682	BRD-K92613113	C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O	dopamine uptake inhibitor; glutamate inhibitor; monoamine oxidase inhibitor	MAOB
safingol	91486	BRD-K93944989	CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO	PKC inhibitor	TRPM3
safranal	61041	BRD-K90582192	CC1=C(C=O)C(C)(C)CC=C1	benzodiazepine receptor agonist	GABBR1
SAG		BRD-K99433989	CN[C@H]1CC[C@@H](CC1)N(Cc1cccc(c1)-c1ccncc1)C(=O)c1sc2ccccc2c1Cl	smoothened receptor agonist	SMO|TRPC6
salazodine		BRD-K15045219	COc1ccc(NS(=O)(=O)c2ccc(cc2)N=Nc2ccc(O)c(c2)C(O)=O)nn1		
salicin	439503	BRD-K64614248	OC[C@H]1O[C@@H](Oc2ccccc2CO)[C@H](O)[C@@H](O)[C@@H]1O	anti-inflammatory agent	
salicyl-alcohol	5146	BRD-K08493205	OCc1ccccc1O		
salicylamide	5147	BRD-K81130846	NC(=O)c1ccccc1O	analgesic agent	
salicylanilide	6872	BRD-K83036479	Oc1ccccc1C(=O)Nc1ccccc1	other antibiotic	
salicylic-acid	118212070	BRD-K93632104	OC(=O)c1ccccc1O	cyclooxygenase inhibitor	AKR1C1|PTGS1|PTGS2
salidroside	159278	BRD-K66030860	OC[C@H]1O[C@@H](OCCc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O	beta amyloid protein neurotoxicity inhibitor	APP
salinomycin	16213105	BRD-A28301258	CC[C@H](C1CC[C@H](C)C(O1)[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)C1O[C@@]2(O[C@@]3(CC[C@](C)(O3)C3CC[C@](O)(CC)[C@H](C)O3)[C@H](O)C=C2)[C@H](C)C[C@@H]1C)C(O)=O		
salirasib	5469318	BRD-K98453471	CC(C)=CCC\C(C)=C\CC\C(C)=C\CSc1ccccc1C(O)=O	mTOR inhibitor	TRPA1
salmeterol	5152	BRD-A01320529	OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1	adrenergic receptor agonist	ADRB2
salsolinol-1-carboxylic-acid	100185	BRD-A49952467	CC1(NCCc2cc(O)c(O)cc12)C(O)=O		
salubrinal	5717801	BRD-A45107007	ClC(Cl)(Cl)C(NC(=O)\C=C\c1ccccc1)NC(=S)Nc1cccc2cccnc12	eukaryotic translation initiation factor inhibitor	EIF2S1
salvianolic-acid-B	11629084	BRD-K18898553	OC(=O)[C@@H](Cc1ccc(O)c(O)c1)OC(=O)\C=C\c1ccc(O)c2O[C@H]([C@H](C(=O)O[C@H](Cc3ccc(O)c(O)c3)C(O)=O)c12)c1ccc(O)c(O)c1	metalloproteinase inhibitor; EGFR inhibitor	MMP9
salvinorin-a	128563	BRD-K19284129	COC(=O)[C@@H]1C[C@H](OC(C)=O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@@H](C[C@]21C)c1ccoc1	opioid receptor agonist	OPRD1|OPRK1|OPRM1
sal003	5717737	BRD-A45869167	Clc1ccc(cc1)NC(=S)NC(C(Cl)(Cl)Cl)NC(=O)\C=C\c1ccccc1	eukaryotic translation initiation factor inhibitor	EIF2A
sanazole	119163	BRD-K37747025	COCCNC(=O)Cn1cnc(n1)[N+]([O-])=O		
sangivamycin	16760643	BRD-A64064900	NC(=O)c1cn(C2OC(CO)[C@H](O)[C@@H]2O)c2ncnc(N)c12	DNA inhibitor	
sanguinarium-chloride	5154	BRD-K66898851	C[n+]1cc2c3OCOc3ccc2c2ccc3cc4OCOc4cc3c12	apoptosis stimulant	CASP3
SANT-1	6878030	BRD-K99741577	Cc1nn(c(C)c1\C=N\N1CCN(Cc2ccccc2)CC1)-c1ccccc1	smoothened receptor antagonist	SHH|SMO
SANT-2	1367095	BRD-K35781423	CCOc1cc(cc(OCC)c1OCC)C(=O)Nc1ccc(Cl)c(c1)-c1nc2ccccc2[nH]1	smoothened receptor antagonist	SHH|SMO
sapropterin	44257	BRD-K36859431	C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)nc(O)c2N1	phenylalanine 4-hydroxylase stimulant	NOS3|PAH|TH|TPH1
saquinavir	441243	BRD-K09963420	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1	HIV protease inhibitor	CYP3A4
SAR-245409	49867926	BRD-K75308783	COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(NC(=O)c3ccc(C)c(OC)c3)cc2)cc(OC)c1	PI3K inhibitor	MTOR|PIK3CG
saracatinib	10302451	BRD-K19540840	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c5OCOc5ccc4Cl)ncnc3c2)CC1	src inhibitor	ABL1|LCK|SRC|YES1
sarafloxacin	25273230	BRD-K08525451	OC(=O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O	bacterial DNA gyrase inhibitor	
sarcosine	1088	BRD-K51263939	CNCC(O)=O	Glycine transporter 1 inhibitor	SLC6A9
sari-59-801	133298	BRD-A92448440	CCc1noc(C)c1-c1[nH]c2ccccc2c1C(O)CN(C)C		
saroglitazar	60151560	BRD-K79878800	CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(O)=O	PPAR receptor agonist	PPARA|PPARG
sarpogrelate	5160	BRD-A34358106	COc1cccc(CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(O)=O)c1	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C
SAR131675	71295845	BRD-K38904395	CCn1c(N)c(C(=O)NC)c(=O)c2ccc(nc12)C#C[C@@](C)(O)COC	VEGFR inhibitor	FLT4
SAR405	72709209	BRD-K72868067	C[C@@H]1COCCN1c1cc(=O)n2CC[C@H](N(Cc3cncc(Cl)c3)c2n1)C(F)(F)F	PI3K inhibitor	PIK3C3
SAR405838		BRD-K86736469	CC(C)(C)C[C@H]1N[C@H]([C@H](c2cccc(Cl)c2F)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)N[C@H]1CC[C@H](O)CC1	MDM inhibitor	MDM2
SAR407899	15604510	BRD-K56912469	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12	rho associated kinase inhibitor	ROCK1
sasapyrine	5161	BRD-K48892307	OC(=O)c1ccccc1OC(=O)c1ccccc1O	NFkB pathway inhibitor	PTGS1|PTGS2
satraplatin		BRD-M31395033	NC1CCCCC1.CC(=O)O[Pt+4](C)(C)(Cl)(Cl)OC(C)=O	DNA alkylating agent	
savolitinib	68289010	BRD-K98028353	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(nc12)-c1cnn(C)c1	c-Met inhibitor	MET
saxagliptin	11243969	BRD-A81513827	N[C@H](C(=O)N1[C@H]2C[C@H]2C[C@H]1C#N)C12CC3CC(CC(O)(C3)C1)C2	dipeptidyl peptidase inhibitor	DPP4
SB-200646	126769	BRD-K77677632	Cn1ccc2cc(NC(=O)Nc3cccnc3)ccc12	serotonin receptor antagonist	HTR2B|HTR2C
SB-202190		BRD-K54330070	Oc1ccc(cc1)-c1nc(c([nH]1)-c1ccncc1)-c1ccc(F)cc1	p38 MAPK inhibitor	AKT1|ALOX5|CHEK1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SGK1
SB-203186	3272300	BRD-K27141178	O=C(OCCN1CCCCC1)c1c[nH]c2ccccc12	serotonin receptor antagonist	HTR4
SB-203580	176155	BRD-A37704979	CS(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccncc1)-c1ccc(F)cc1	p38 MAPK inhibitor	AKT1|ALOX5|CHEK1|CYP2D6|CYP3A4|GAK|GSK3B|LCK|MAPK1|MAPK10|MAPK11|MAPK12|MAPK14|MAPK8|MAPK9|PRKCA|RAF1|RIPK2|ROCK1|RPS6KB1|SGK1|SRC|TNF
SB-205384	197690	BRD-A22707317	CC#CCOC(=O)c1c(C)nc2sc3CC(O)CCc3c2c1N	GABA receptor modulator	GABRA3|GABRA5|GABRA6
SB-206553	5163	BRD-K36395411	Cn1ccc2cc3N(CCc3cc12)C(=O)Nc1cccnc1	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C
SB-216641	3292447	BRD-K30867024	COc1ccc(NC(=O)c2ccc(cc2)-c2ccc(cc2C)-c2noc(C)n2)cc1OCCN(C)C	serotonin receptor antagonist	HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C
SB-216763	176158	BRD-K59184148	Cn1cc(C2=C(C(=O)NC2=O)c2ccc(Cl)cc2Cl)c2ccccc12	glycogen synthase kinase inhibitor	CCNA2|CDK2|GSK3A|GSK3B
SB-218078	3387354	BRD-A06352508	O=C1NC(=O)c2c1c1c3ccccc3n3C4CCC(O4)n4c5ccccc5c2c4c13	CHK inhibitor	CHEK1
SB-218795	6604858	BRD-K61097567	COC(=O)[C@H](NC(=O)c1cc(nc2ccccc12)-c1ccccc1)c1ccccc1	tachykinin antagonist	TACR3
SB-221284	443389	BRD-K14807180	CSc1cc2CCN(C(=O)Nc3cccnc3)c2cc1C(F)(F)F	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C
SB-222200	6604009	BRD-K04414442	CC[C@H](NC(=O)c1c(C)c(nc2ccccc12)-c1ccccc1)c1ccccc1	tachykinin antagonist	TACR3
SB-225002	3854666	BRD-K61323504	Oc1cc(ccc1NC(=O)Nc1ccccc1Br)[N+]([O-])=O	CC chemokine receptor antagonist	CXCR2
SB-228357	443390	BRD-K15424032	COc1cc2CCN(C(=O)Nc3cc(F)cc(c3)-c3cccnc3)c2cc1C(F)(F)F	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C
SB-2343	46912230	BRD-K98795921	CC(C)n1c(C)nc2c(nc(nc12)N1CCOCC1)-c1cnc(N)nc1	mTOR inhibitor; PI3K inhibitor	MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG
SB-239063		BRD-K82091397	COc1nccc(n1)-c1c(ncn1[C@H]1CC[C@H](O)CC1)-c1ccc(F)cc1	p38 MAPK inhibitor	MAPK11|MAPK14|PTGS2
SB-242235	9863367	BRD-K19412355	COc1nccc(n1)-c1c(ncn1C1CCNCC1)-c1ccc(F)cc1	p38 MAPK inhibitor	HSPB1|MAPK14
SB-243213	443391	BRD-K99968849	Cc1cc2CCN(C(=O)Nc3ccc(Oc4cccnc4C)nc3)c2cc1C(F)(F)F	serotonin receptor inverse agonist	HTR2A|HTR2B|HTR2C|HTR6
SB-258585	3248571	BRD-K80639402	COc1ccc(NS(=O)(=O)c2ccc(I)cc2)cc1N1CCN(C)CC1	serotonin receptor antagonist	HTR6
SB-268262	6918567	BRD-A91031770	CN(C(=O)c1ccc(c(c1)[N+]([O-])=O)S(=O)c1nccs1)c1ccccc1C	calcitonin antagonist	CALCA
SB-269970	6604889	BRD-K24201553	CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1	serotonin receptor antagonist	HTR7
SB-271046	5312149	BRD-K82467063	COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1	serotonin receptor antagonist	HTR6
SB-297006	9840971	BRD-K16107558	CCOC(=O)[C@H](Cc1ccc(cc1)[N+]([O-])=O)NC(=O)c1ccccc1	CC chemokine receptor antagonist	CCR3
SB-328437	10474776	BRD-K78720403	COC(=O)[C@H](Cc1ccc(cc1)[N+]([O-])=O)NC(=O)c1cccc2ccccc12	CCR antagonist	
SB-334867	6604926	BRD-K41567364	Cc1nc2ccc(NC(=O)Nc3ccnc4cccnc34)cc2o1	orexin receptor antagonist	HCRTR1|HCRTR2
SB-366791	667594	BRD-K61536336	COc1cccc(NC(=O)\C=C\c2ccc(Cl)cc2)c1	TRPV antagonist	TRPV1
SB-399885	6918649	BRD-K03988082	COc1ccc(cc1N1CCNCC1)S(=O)(=O)Nc1cc(Cl)cc(Cl)c1OC	serotonin receptor antagonist	HTR6
SB-408124	4331799	BRD-K53913732	CN(C)c1ccc(NC(=O)Nc2cc(C)nc3c(F)cc(F)cc23)cc1	orexin receptor antagonist	HCRTR1|HCRTR2
SB-415286	4210951	BRD-K76805682	Oc1ccc(NC2=C(C(=O)NC2=O)c2ccccc2[N+]([O-])=O)cc1Cl	glycogen synthase kinase inhibitor	GSK3A|GSK3B|RPS6KB1
SB-431542	4521392	BRD-K67298865	NC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccccn1)-c1ccc2OCOc2c1	TGF beta receptor inhibitor	ACVR1C|TGFBR1
SB-452533	9842609	BRD-K03665769	CCN(CCNC(=O)Nc1ccccc1Br)c1cccc(C)c1	TRPV antagonist	TRPV1
SB-505124	9858940	BRD-K40109029	Cc1cccc(n1)-c1[nH]c(nc1-c1ccc2OCOc2c1)C(C)(C)C	ALK tyrosine kinase receptor inhibitor	TGFBR1
SB-525334	9967941	BRD-K37720887	Cc1cccc(n1)-c1[nH]c(nc1-c1ccc2nccnc2c1)C(C)(C)C	TGF beta receptor inhibitor	TGFBR1
SB-590885		BRD-K78809024	CN(C)CCOc1ccc(cc1)-c1nc(c([nH]1)-c1ccc2c(CC\C2=N/O)c1)-c1ccncc1	RAF inhibitor	BRAF
SB-612111	10047612	BRD-K08333979	Cc1cccc2[C@@H](O)C[C@@H](CN3CCC(CC3)c3c(Cl)cccc3Cl)CCc12	nociceptin/orphanin FQ (NOP) receptor antagonist	OPRL1
SB-657510	11272107	BRD-K95292280	COc1cc(Br)c(cc1OC)S(=O)(=O)Nc1ccc(Cl)c(O[C@@H]2CCN(C)C2)c1	urotensin receptor antagonist	UTS2R
SB-683698	9912743	BRD-K24968862	COc1cccc(OC)c1-c1ccc(C[C@H](NC(=O)c2c(Cl)cccc2Cl)C(O)=O)cc1	integrin antagonist	ITGA4|ITGAV|ITGB1|ITGB7
SB-705498	9910486	BRD-K65991129	FC(F)(F)c1ccc(nc1)N1CC[C@H](C1)NC(=O)Nc1ccccc1Br	TRPV antagonist	TRPV1
SB-706375	21023902	BRD-K68633027	COc1cc(Br)c(cc1OC)S(=O)(=O)Nc1ccc(c(O[C@@H]2CCN(C)C2)c1)C(F)(F)F	urotensin receptor antagonist	UTS2R
SB-742457	11256720	BRD-K78941306	O=S(=O)(c1ccccc1)c1cnc2c(cccc2c1)N1CCNCC1	serotonin receptor antagonist	HTR6
SB-743921	9936388	BRD-K68532323	CC(C)[C@@H](N(CCCN)C(=O)c1ccc(C)cc1)c1oc2cc(Cl)ccc2c(=O)c1Cc1ccccc1	kinesin-like spindle protein inhibitor	KIF11
SB-747651A	11393719	BRD-K49597925	CCn1c(nc2cncc(CNC3CCNCC3)c12)-c1nonc1N	kinase inhibitor	AKT1|AKT3|ROCK1|RPS6KA5|RPS6KB1
SB-756050	1520267	BRD-K45168550	COc1ccc(cc1OC)S(=O)(=O)N1CCCN(CC1)S(=O)(=O)c1ccc(OC)c(OC)c1	G protein-coupled receptor agonist	GPBAR1
SB-772077B	16095343	BRD-K49110935	CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)-c1nonc1N	rho associated kinase inhibitor	ROCK1|ROCK2
SB-939	49855250	BRD-K86797399	CCCCc1nc2cc(ccc2n1CCN(CC)CC)\C=C\C(=O)NO	HDAC inhibitor	HDAC1|HDAC10|HDAC3|HDAC4|HDAC5|HDAC9
SBE-13	4719406	BRD-K71667152	COc1ccc(CCNCc2ccc(OCc3ccc(Cl)nc3)c(OC)c2)cc1OC	PLK inhibitor	PLK1
SBHA	5173	BRD-K54729176	ONC(=O)CCCCCCC(=O)NO	HDAC inhibitor	HDAC1|HDAC3
SC-10	5175	BRD-K05361803	CCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12	protein kinase activator	PRKCA
SC-12267	9820008	BRD-K40797222	COc1cccc(c1)-c1ccc(NC(=O)C2=C(CCC2)C(O)=O)c(F)c1	dihydroorotate dehydrogenase inhibitor	IL17A
SC-144	400169	BRD-K55305701	Fc1ccc2c(c1)nc(NNC(=O)c1cnccn1)c1cccn21	P glycoprotein inhibitor	
SC-19220	4336830	BRD-K52512893	CC(=O)NNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc12	prostanoid receptor antagonist	PTGER1
SC-236	9865808	BRD-K76365178	NS(=O)(=O)c1ccc(cc1)-n1nc(cc1-c1ccc(Cl)cc1)C(F)(F)F	cyclooxygenase inhibitor	PTGS2
SC-51089	132749	BRD-K62715847	Clc1ccc2Oc3ccccc3CN(C(=O)NNC(=O)CCc3ccncc3)c2c1	prostanoid receptor antagonist	PTGER1
SC-560	4306515	BRD-K14767410	COc1ccc(cc1)-n1nc(cc1-c1ccc(Cl)cc1)C(F)(F)F	cyclooxygenase inhibitor	PTGS1
SC-9	124172	BRD-K25875056	Clc1cccc2c(cccc12)S(=O)(=O)NCCCCCCc1ccccc1	protein tyrosine kinase activator	PRKCA
SCH-202676	682802	BRD-K29562203	CN=c1nc(-c2ccccc2)n(s1)-c1ccccc1	G protein-coupled receptor modulator	CHRM1|CHRM2|DRD1|DRD2
SCH-221510	9887077	BRD-A06700447	Cc1ccccc1C(N1C2CCC1CC(O)(C2)c1ccccc1)c1ccccc1C	nociceptin/orphanin FQ (NOP) receptor agonist	OPRL1
SCH-23390	3036864	BRD-K45435259	CN1CCc2cc(Cl)c(O)cc2[C@H](C1)c1ccccc1	dopamine receptor antagonist	DRD1|DRD5|HTR2C|KCNJ4|KCNJ6
SCH-28080	108137	BRD-K55748775	Cc1nc2c(OCc3ccccc3)cccn2c1CC#N	ATPase inhibitor	ATP4A
SCH-51344	9995890	BRD-K02460719	COc1ccc2[nH]c3nnc(C)c3c(NCCOCCO)c2c1	MTH1 inhibitor	NUDT1
SCH-58261	176408	BRD-K81225797	Nc1nc2n(CCc3ccccc3)ncc2c2nc(nn12)-c1ccco1	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
SCH-900776	46239015	BRD-K75009076	Cn1cc(cn1)-c1cnn2c(N)c(Br)c(nc12)[C@@H]1CCCNC1	CHK inhibitor	CDK2|CHEK1
schisandrin-b	14515706	BRD-K86294588	COc1cc2C[C@H](C)[C@@H](C)Cc3cc4OCOc4c(OC)c3-c2c(OC)c1OC	antioxidant	ATR
schisandrol-b	3001662	BRD-K18878288	COc1cc2C[C@](C)(O)[C@@H](C)Cc3cc4OCOc4c(OC)c3-c2c(OC)c1OC	lipid peroxidase inhibitor	
sclareol	16394480	BRD-A23127772	CC(O)(CC[C@H]1[C@](C)(O)CCC2C(C)(C)CCC[C@]12C)C=C		
sclareolide	929262	BRD-K72925150	C[C@@]12CC[C@H]3C(C)(C)CCC[C@]3(C)[C@H]1CC(=O)O2	other antifungal	
SCMC-Lys	193653	BRD-K33809398	N[C@@H](CSCC(O)=O)C(O)=O	mucolytic agent	GSTP1
scopine		BRD-K75923785	CN1[C@H]2C[C@H](O)C[C@@H]1[C@H]1O[C@@H]21		
scopolamine		BRD-K89923877	CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1	acetylcholine receptor antagonist	
scopolamine-n-oxide		BRD-A49906757	C[N+]1([O-])[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|SI
SCP-1	667575	BRD-K20548681	Oc1ccc(NC(=O)CN2C(=O)c3ccccc3S2(=O)=O)cc1	analgesic agent	
scriptaid	5186	BRD-K22503835	ONC(=O)CCCCCN1C(=O)c2cccc3cccc(C1=O)c23	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
SCS		BRD-K78496197	Oc1ccccc1\C=N\NC(=O)c1ccccc1O		
SD-169	14973220	BRD-K91904471	NC(=O)c1ccc2[nH]ccc2c1	p38 MAPK inhibitor	MAPK14
SD-208	10316032	BRD-K24566386	Fc1ccc(Cl)cc1-c1nc(Nc2ccncc2)c2nccnc2n1	TGF beta receptor inhibitor	TGFBR1
SD-2590	9892815	BRD-K51102532	COCCN1CCC(CC1)(C(=O)NO)S(=O)(=O)c1ccc(Oc2ccc(OC(F)(F)F)cc2)cc1	matrix metalloprotease inhibitor	MMP1|MMP13|MMP2
SDM25N	16741282	BRD-A75769826	CC(=C)CN1CC[C@@]23[C@H]4Oc5c2c(CC1[C@]3(O)Cc1c4[nH]c2ccccc12)ccc5O	opioid receptor antagonist	OPRD1
SDZ-NKT-343	9851211	BRD-K65820248	CN(Cc1ccccc1)C(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@@H]1CCCN1C(=O)Nc1ccccc1[N+]([O-])=O	tachykinin antagonist	TACR1
SDZ-SER-082	9859407	BRD-K31339597	CN1CC[C@@H]2CN3CCc4cccc([C@@H]2C1)c34	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C
SDZ-WAG-994	164305	BRD-K39558284	CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(NC3CCCCC3)ncnc12	adenosine receptor agonist	ADORA1
SDZ-205-557	5191	BRD-K15868788	CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC	serotonin receptor antagonist	HTR3A|HTR3B
SDZ-21009	193949	BRD-A15530910	CC(C)OC(=O)c1cc2c(OCC(O)CNC(C)(C)C)cccc2[nH]1	adrenergic receptor antagonist; serotonin receptor antagonist	HTR1A|HTR1B
SDZ-220-040	6604839	BRD-K82266792	N[C@@H](Cc1cc(cc(CP(O)(O)=O)c1O)-c1ccc(Cl)cc1Cl)C(O)=O	glutamate receptor antagonist	GRIN1
SDZ-220-581	128019	BRD-K27168049	N[C@@H](Cc1cc(CP(O)(O)=O)cc(c1)-c1ccccc1Cl)C(O)=O	glutamate receptor antagonist	GRIN1
se-methylselenocysteine	147004	BRD-K74227499	C[Se]C[C@H](N)C(O)=O		
secalciferol	5283748	BRD-K02965577	C[C@H](CC[C@@H](O)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C	vitamin D receptor agonist	VDR
seclazone	34443	BRD-A53472930	Clc1ccc2OC3CCON3C(=O)c2c1	anti-inflammatory agent	
secnidazole	71815	BRD-A70083328	CC(O)Cn1c(C)ncc1[N+]([O-])=O	acetylcholinesterase inhibitor; microtubule inhibitor	
secoisolariciresinol-(-)	65373	BRD-K91733562	COc1cc(C[C@@H](CO)[C@H](CO)Cc2ccc(O)c(OC)c2)ccc1O		
secoisolariciresinol-diglucoside	9917980	BRD-K77320845	COc1cc(C[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)Cc2ccc(O)c(OC)c2)ccc1O	antioxidant	
securinine	442872	BRD-K49071277	O=C1O[C@@]23C[C@@H](C=CC2=C1)N1CCCC[C@H]31	GABA receptor antagonist; TP53 activator	GABRA1
selamectin	16667695	BRD-A58564983	CO[C@H]1CC(O[C@H]2[C@@H](C)\C=C\C=C3/CO[C@@H]4C(=N/O)\C(C)=C[C@@H](C(=O)O[C@H]5C[C@@H](C\C=C2/C)O[C@@]2(CC[C@H](C)[C@H](O2)C2CCCCC2)C5)[C@]34O)O[C@@H](C)C1O	nematocide	
selegiline	5195	BRD-A28545468	CC(Cc1ccccc1)N(C)CC#C	monoamine oxidase inhibitor	MAOA|MAOB
selenomethionine	15103	BRD-A18774709	C[Se]CCC(N)C(O)=O		
selexipag	9913767	BRD-K21191422	CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(n1)-c1ccccc1	platelet aggregation inhibitor; IP1 prostacyclin receptor agonist	PTGIR
selfotel	6604838	BRD-K48738253	OC(=O)[C@H]1C[C@@H](CP(O)(O)=O)CCN1	glutamate receptor antagonist	GRIN2A|GRIN2B|GRIN2C|GRIN2D
selinexor	71481097	BRD-K21361524	FC(F)(F)c1cc(cc(c1)C(F)(F)F)-c1ncn(\C=C/C(=O)NNc2cnccn2)n1	exportin antagonist	XPO1
selumetinib	10127622	BRD-K57080016	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(cc12)C(=O)NOCCO	MEK inhibitor	MAP2K1
semagacestat	92144482	BRD-K81957469	CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1c2ccccc2CCN(C)C1=O	gamma secretase inhibitor	PSEN1
semapimod	129010076	BRD-K21237892	NC(=N)NNC(=C)c1cc(NC(=O)CCCCCCCCC(=O)Nc2cc(cc(c2)C(=C)NNC(N)=N)C(=C)NNC(N)=N)cc(c1)C(=C)NNC(N)=N	cytokine production inhibitor; p38 MAPK inhibitor	MAPK14
semaxanib	5329098	BRD-K63504947	Cc1cc(C)c(\C=C2/C(=O)Nc3ccccc23)[nH]1	VEGFR inhibitor	FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET
semustine	5198	BRD-K13281575	CC1CCC(CC1)NC(=O)N(CCCl)[N+][O-]	DNA alkylating agent	
SEN-1269	46835756	BRD-K70614402	CN(C)c1cccc(Oc2cnc(Nc3cccc(O)c3)nc2)c1	beta amyloid inhibitor	APP
senicapoc	216327	BRD-K21295289	NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1	intermediate conductance potassium channel blocker	KCNN4
sennoside-a	129010028	BRD-A30370660	OC[C@H]1O[C@H](Oc2cccc3C([C@H]4c5cccc(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c5C(=O)c5c(O)cc(cc45)C(O)=O)c4cc(cc(O)c4C(=O)c23)C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O	glycoside agonist	
sennoside-protonated	90826123	BRD-A53504839	OCC1OC(Oc2cccc3c(-c4c5cccc(OC6OC(CO)C(O)C(O)C6O)c5c(O)c5c(O)cc(cc45)C(O)=O)c4cc(cc(O)c4c(O)c23)C(O)=O)C(O)C(O)C1O		
seocalcitol	5288149	BRD-K28456624	CCC(O)(CC)\C=C\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	vitamin D receptor agonist	VDR
SEP-227900	7141881	BRD-K49504902	OC(=O)c1cc2occc2[nH]1	D-Amino Acid Oxidase Inhibitor	DAO
seratrodast	2449	BRD-A60765580	CC1=C(C)C(=O)C(C(CCCCCC(O)=O)c2ccccc2)=C(C)C1=O	prostanoid receptor antagonist	TBXA2R
serdemetan	11609586	BRD-K65924316	C(Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccncc2)cc1	MDM inhibitor	MDM2
serotonin	5202	BRD-K38580127	NCCc1c[nH]c2ccc(O)cc12	growth factor receptor activator	DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR4|HTR5A|HTR6|HTR7|SLC36A1
sertaconazole	65863	BRD-A95939040	Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1	sterol demethylase inhibitor	
sertindole	60149	BRD-K69116396	Fc1ccc(cc1)-n1cc(C2CCN(CCN3CCNC3=O)CC2)c2cc(Cl)ccc12	dopamine receptor antagonist; serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|KCNH2
sertraline	68617	BRD-K82036761	CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc12	selective serotonin reuptake inhibitor (SSRI)	SLC6A3|SLC6A4
sesamin	72307	BRD-K11631773	C1Oc2ccc(cc2O1)[C@H]1OC[C@H]2[C@@H]1CO[C@@H]2c1ccc2OCOc2c1	NFkB pathway inhibitor	
setipiprant	49843471	BRD-K24497734	OC(=O)Cn1c2CCN(Cc2c2cc(F)ccc12)C(=O)c1cccc2ccccc12	prostaglandin inhibitor	PTGDR2
setiptiline	5205	BRD-K36732695	CN1CCC2=C(C1)c1ccccc1Cc1ccccc21	adrenergic receptor antagonist	HRH1|HTR2A|HTR2C
sevelamer		BRD-U45393375		phosphate antagonist	
sevoflurane	5206	BRD-K05638300	FCOC(C(F)(F)F)C(F)(F)F	membrane integrity inhibitor	ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9|MT-ND1
SEW-2871	4077460	BRD-K15601958	FC(F)(F)c1sc(cc1-c1ccccc1)-c1nc(no1)-c1cccc(c1)C(F)(F)F	lysophospholipid receptor agonist	S1PR1
SF-11	2936384	BRD-K42629487	CCOc1ccc(cc1)NC(=S)N1CCC(CC1)C(O)(c1ccccc1)c1ccccc1	neuropeptide receptor antagonist	MCOLN3|NPY2R
SGC-CBP30	72201027	BRD-K24821794	COc1ccc(CCc2nc3cc(ccc3n2C[C@H](C)N2CCOCC2)-c2c(C)noc2C)cc1Cl	bromodomain inhibitor	CREBBP|EP300
SGC-0946	56962337	BRD-K69577666	CC(C)N(CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc(Br)c2c(N)ncnc12	histone lysine methyltransferase inhibitor	
SGC-707	90642938	BRD-K86718786	O=C(NCC(=O)N1CCCC1)Nc1ccc2cnccc2c1	protein arginine N-methyltransferase inhibitor	PRMT3
SGI-1027	24858111	BRD-K61228301	Cc1cc(Nc2ccc(NC(=O)c3ccc(Nc4ccnc5ccccc45)cc3)cc2)nc(N)n1	DNA methyltransferase inhibitor	DNMT1|DNMT3A|DNMT3B
SGI-1776	24795070	BRD-K80700417	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1	Pim kinase inhibitor	FLT3|PIM1|PIM2|PIM3
SGX523	24779724	BRD-K19477839	Cn1cc(cn1)-c1ccc2nnc(Sc3ccc4ncccc4c3)n2n1	hepatocyte growth factor receptor inhibitor	MET
SHA-68	11374217	BRD-A63344375	Fc1ccc(CNC(=O)N2CCN3C(C2)C(OC3=O)(c2ccccc2)c2ccccc2)cc1	neuropeptide receptor antagonist	NPSR1
shikimic-acid	49867941	BRD-A92096630	O[C@@H]1CC(=CC(O)C1O)C(O)=O		
SHP099	118238298	BRD-K00818915	CC1(N)CCN(CC1)c1cnc(c(N)n1)-c1cccc(Cl)c1Cl	protein tyrosine kinase inhibitor	PTPN11
SIB-1553A	5310968	BRD-A79052425	CN1CCCC1CCSc1ccc(O)cc1	acetylcholine receptor agonist	CHRNB4
SIB-1757		BRD-K98157055	Cc1ccc(O)c(N=Nc2ccccc2)n1	glutamate receptor antagonist	GRM5
SIB-1893	5311432	BRD-K14561059	Cc1cccc(\C=C\c2ccccc2)n1	glutamate receptor antagonist	GRM4|GRM5
sibutramine	5210	BRD-A23359898	CC(C)CC(N(C)C)C1(CCC1)c1ccc(Cl)cc1	serotonin norepinephrine reuptake inhibitor (SNRI)	SLC6A2|SLC6A3|SLC6A4
SID-7969543	4076092	BRD-A43885598	CCOC(=O)C(C)Oc1cccc2c1ccn(CC(=O)Nc1ccc3OCCOc3c1)c2=O	steroidogenic factor antagonist	NR5A1
siguazodan	72124	BRD-A62071884	CN\C(NC#N)=N/c1ccc(cc1)C1=NNC(=O)CC1C	phosphodiesterase inhibitor	PDE3A
sildenafil	5212	BRD-K79759585	CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(C)CC1	phosphodiesterase inhibitor	PDE5A|PDE6G|PDE6H|SLCO1B1|SLCO1B3
silibinin	31553	BRD-K80353138	COc1cc(ccc1O)[C@H]1Oc2cc(ccc2O[C@@H]1CO)[C@H]1Oc2cc(O)cc(O)c2C(=O)[C@@H]1O	cytochrome P450 inhibitor	ALOX5
silodosin	5312125	BRD-K10906636	C[C@H](Cc1cc2CCN(CCCO)c2c(c1)C(N)=O)NCCOc1ccccc1OCC(F)(F)F	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D
silver-sulfadiazine	441244	BRD-K68379918	Nc1ccc(cc1)S(=O)(=O)N([Ag])c1ncccn1	PABA antagonist	
silymarin	3085830	BRD-A06629414	COc1cc(ccc1O)C1Oc2ccc(cc2OC1CO)C1Oc2cc(O)cc(O)c2C(=O)C1O		
simeprevir	66576988	BRD-A68493689	COc1ccc2c(O[C@@H]3C[C@@H]4C(C3)C(=O)N(C)CCCC\C=C/[C@@H]3C[C@]3(NC4=O)C(=O)NS(=O)(=O)C3CC3)cc(nc2c1C)-c1nc(cs1)C(C)C	HCV inhibitor	CYP1A2|CYP3A4
simvastatin	54454	BRD-K22134346	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	HMGCR inhibitor	HMGCR|ITGB2
sinefungin	65482	BRD-K91100918	N[C@@H](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12	DNA methyltransferase inhibitor; RNA synthesis inhibitor	CARM1
sinomenine	5459308	BRD-K83459933	COC1=C[C@@H]2[C@@H]3Cc4ccc(OC)c(O)c4[C@]2(CCN3C)CC1=O	angiogenesis inhibitor	
sipatrigine	60803	BRD-K53195974	CN1CCN(CC1)c1ncc(c(N)n1)-c1cc(Cl)cc(Cl)c1Cl	voltage-gated sodium channel blocker	CACNA1D|SCN10A|SCN1A|SCN3A|SCN4A|SCN5A|SCN9A
siponimod	44599207	BRD-K62384160	CCc1cc(ccc1CN1CC(C1)C(O)=O)C(\C)=N\OCc1ccc(C2CCCCC2)c(c1)C(F)(F)F	sphingosine phosphate receptor modulator	S1PR1
siramesine	9829526	BRD-K51333959	Fc1ccc(cc1)-n1cc(CCCCN2CCC3(CC2)OCc2ccccc32)c2ccccc12	sigma receptor antagonist	ADRA1A|ADRA1B|ADRA1D
sirolimus	5284616	BRD-K84937637	CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O	mTOR inhibitor	FGF2|FKBP1A|MTOR
SirReal-2	1096292	BRD-K16472653	Cc1cc(C)nc(SCC(=O)Nc2ncc(Cc3cccc4ccccc34)s2)n1	SIRT inhibitor	SIRT2
sirtinol		BRD-A23747351	CC(NC(=O)c1ccccc1\N=C\c1c(O)ccc2ccccc12)c1ccccc1	SIRT inhibitor	SIRT1|SIRT2
sisomicin	36119	BRD-K71772032	CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O	protein synthesis inhibitor	
sisomicin-sulfate	5702116	BRD-A68997559	CN[C@@H]1C(O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O	bacterial 30S ribosomal subunit inhibitor	
SIS3	10138988	BRD-K38905597	COc1cc2CCN(Cc2cc1OC)C(=O)\C=C\c1c(-c2ccccc2)n(C)c2ncccc12	serine/threonine kinase inhibitor	SMAD3|TGFBR1
sitafloxacin	40466933	BRD-K10836013	N[C@@H]1CN(CC11CC1)c1c(F)cc2c(c1Cl)n(cc(C(O)=O)c2=O)[C@@H]1C[C@@H]1F	bacterial DNA gyrase inhibitor	
sitagliptin	4369359	BRD-K19416115	N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc1cc(F)c(F)cc1F	dipeptidyl peptidase inhibitor	DPP4
sitaxentan	216235	BRD-K63806092	Cc1noc(NS(=O)(=O)c2ccsc2C(=O)Cc2cc3OCOc3cc2C)c1Cl	endothelin receptor antagonist	EDNRA
sitosterol	222284	BRD-K79402892	CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C		
sivelestat	107706	BRD-K02152879	CC(C)(C)C(=O)Oc1ccc(cc1)S(=O)(=O)Nc1ccccc1C(=O)NCC(O)=O	elastase inhibitor	CELA1|ELANE
SJ-172550	1317464	BRD-K35945299	CCOc1cc(\C=C2C(=O)N(N=C\2C)c2ccccc2)cc(Cl)c1OCC(=O)OC	MDM inhibitor	MDM4
SK&F-10047-(+)	44273461	BRD-A47364545	C[C@H]1C2Cc3ccc(O)cc3[C@@]1(C)CCN2CC=C	sigma receptor agonist	SIGMAR1
SKA-31	94880	BRD-K67304264	Nc1nc2c(ccc3ccccc23)s1	potassium channel activator	KCNN4
skepinone-l	45279963	BRD-K83607951	OC[C@@H](O)COc1ccc2CCc3cc(Nc4ccc(F)cc4F)ccc3C(=O)c2c1	p38 MAPK inhibitor	MAPK14
SKF-38393	1242	BRD-A88548664	Oc1cc2CCNCC(c3ccccc3)c2cc1O	dopamine receptor agonist	CALY|DRD1|DRD5
SKF-77434	1241	BRD-A64227845	Oc1cc2CCN(CC=C)CC(c3ccccc3)c2cc1O	dopamine receptor agonist	DRD1
SKF-81297	1218	BRD-A09828896	Oc1cc2C(CNCCc2c(Cl)c1O)c1ccccc1	dopamine receptor agonist	DRD1|DRD5
SKF-83566	1243	BRD-A52588987	CN1CCc2cc(Br)c(O)cc2C(C1)c1ccccc1	dopamine receptor antagonist	DRD1|DRD5
SKF-86002	5228	BRD-K96809896	Fc1ccc(cc1)-c1nc2SCCn2c1-c1ccncc1	p38 MAPK inhibitor	ALOX5|MAPK14
SKF-89976A	92409	BRD-A49046702	OC(=O)C1CCCN(CCC=C(c2ccccc2)c2ccccc2)C1	GABA uptake inhibitor	SLC6A1
SKF-91488	5227	BRD-K49776472	CN(C)CCCCSC(N)=N	histamine N-methyltransferase inhibitor	HNMT
SKF-96365	104956	BRD-A72703248	COc1ccc(CCCOC(Cn2ccnc2)c2ccc(OC)cc2)cc1	calcium channel blocker	CYP3A4|PKD2|TRPC1|TRPC3|TRPC4|TRPC5|TRPV2
SKI-II	753704	BRD-K20755323	Oc1ccc(Nc2nc(cs2)-c2ccc(Cl)cc2)cc1	sphingosine kinase inhibitor	SPHK1
SKLB1002	71461003	BRD-K29895144	COc1cc2ncnc(Sc3nnc(C)s3)c2cc1OC	VEGFR inhibitor	KDR
SLV-319-(+/-)	11179267	BRD-A54228901	C\N=C(\NS(=O)(=O)c1ccc(Cl)cc1)N1CC(C(=N1)c1ccc(Cl)cc1)c1ccccc1	cannabinoid receptor antagonist	CNR1|DRD2|HTR1A
SLV-320		BRD-K34445261	O[C@H]1CC[C@@H](CC1)Nc1nc(nc2[nH]ccc12)-c1ccccc1	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
SM-108	124343	BRD-K70053378	NC(=O)c1[nH]cnc1O		
SM-164	17756618	BRD-K06191411	CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)N[C@H](c1cn(CCCCc2ccc(CCCCn3cc(nn3)[C@@H](NC(=O)[C@@H]3CC[C@@H]4CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N34)c3ccccc3)cc2)nn1)c1ccccc1	XIAP inhibitor	BIRC2|BIRC3|XIAP
SM-21	4679312	BRD-A92933783	CCC(Oc1ccc(Cl)cc1)C(=O)OC1CC2CCC(C1)N2C	sigma receptor antagonist	PGRMC1
SMER-28	1560402	BRD-K08478539	Brc1ccc2ncnc(NCC=C)c2c1	autophagy inducer	SNCA
SMI-4a	1361332	BRD-K70159787	FC(F)(F)c1cccc(c1)\C=C1\SC(=O)NC1=O	Pim kinase inhibitor	PIM1
SN-2	11834987	BRD-A64319165	Cc1cc(C)c(C2=NOC3C4CCC(C4)C23)c(C)c1	transient receptor potential channel agonist	MCOLN3
SN-38	104842	BRD-K89561498	CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(O)cc12	topoisomerase inhibitor	TOP1
SN-6	10222761	BRD-A14316475	CCOC(=O)C1CSC(N1)Cc1ccc(OCc2ccc([N+]([O-])=O)cc2)cc1	sodium/calcium exchange inhibitor	
SNAP	5231	BRD-A67006024	CC(=O)NC(C(O)=O)C(C)(C)S[N+][O-]	nitric oxide donor	PTPN1
SNAP-5089	9809007	BRD-A21428877	COC(=O)C1=C(C)NC(C)=C(C1c1ccc(cc1)[N+]([O-])=O)C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CACNA1C|CACNA1D
SNAP-94847	16756754	BRD-K49702221	CC(C)C(=O)Nc1ccc(C)c(c1)C1CCN(Cc2ccc(Oc3ccc(F)c(F)c3)cc2)CC1		ADRA1A|DRD2
SNC-80	123924	BRD-K29546239	CCN(CC)C(=O)c1ccc(cc1)[C@@H](N1C[C@@H](C)N(CC=C)C[C@@H]1C)c1cccc(OC)c1		OPRD1
SNG-1153	71621167	BRD-K75016267	CC(C)=CCc1c(O)cc(O)c2c1oc(-c1ccc(cc1)C(F)(F)F)c(O)c2=O	selective estrogen receptor modulator (SERM)	ESR1
SNS-314	24995524	BRD-K71512533	Clc1cccc(NC(=O)Nc2ncc(CCNc3ncnc4ccsc34)s2)c1	Aurora kinase inhibitor	AURKA|AURKB|AURKC
SNX-2112		BRD-K71281111	CC1(C)Cc2c(c(nn2-c2ccc(C(N)=O)c(N[C@H]3CC[C@H](O)CC3)c2)C(F)(F)F)C(=O)C1	HSP inhibitor	
SNX-5422		BRD-K73197500	CC1(C)Cc2c(c(nn2-c2ccc(C(N)=O)c(N[C@H]3CC[C@@H](CC3)OC(=O)CN)c2)C(F)(F)F)C(=O)C1	HSP inhibitor	HSP90AA1
sobetirome	9862248	BRD-K85406984	CC(C)c1cc(Cc2c(C)cc(OCC(O)=O)cc2C)ccc1O	thyroid hormone receptor agonist	THRA|THRB
sobrepin	854498	BRD-K58262380	CC1=CC[C@H](C[C@@H]1O)C(C)(C)O	mucolytic agent	
sodium-ascorbate	13304188	BRD-A67265925	OC[C@H](O)[C@H]1OC(=O)C(O)C1O		
sodium-butyrate	264	BRD-K05878375	CCCC(O)=O	HDAC inhibitor	BCHE|FFAR2|FFAR3|HDAC1|HDAC2|HDAC3|HDAC8
sodium-danshensu	439435	BRD-A93699261	OC(Cc1ccc(O)c(O)c1)C(O)=O		
sodium-dodecyl-sulfate		BRD-M58433298	[Na].CCCCCCCCCCCCOS(O)(=O)=O		ALB|LYZ
sodium-glucoheptonate	25588	BRD-K35952844	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O		
sodium-gluconate	10690	BRD-K93201765	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O		
sodium-gualenate	2275	BRD-K80043866	CC(C)c1ccc(C)c2c(cc(C)c2c1)S(O)(=O)=O	antacid	
sodium-monofluorophosphate	24267	BRD-K99308954	OP(O)(F)=O		PYGM
sodium-nitrite		BRD-K61230716	[O-][N+][O-]	nitric oxide donor	
sodium-nitroprusside		BRD-K48526231	[O-][N+][Fe--](C#N)(C#N)(C#N)(C#N)C#N	nitric oxide donor	
sodium-orthovanadate	417214	BRD-K60600693	O[V](O)(O)=O		
sodium-oxybate	10413	BRD-K82166906	OCCCC(O)=O	benzodiazepine receptor agonist	GABRB1|HCAR1|SLC52A2
sodium-picosulfate	5243	BRD-K77251551	OS(=O)(=O)Oc1ccc(cc1)C(c1ccc(OS(O)(=O)=O)cc1)c1ccccn1		
sodium-salicylate	118212070	BRD-K93632104	OC(=O)c1ccccc1O	prostanoid receptor antagonist	ASIC3|PTGS1|PTGS2
sodium-stibogluconate		BRD-A60786380	OCC(O)C1O[Sb]2(O)(O[Sb]34(O)OC(C(O)CO)C(O3)C(O4)C(O)=O)OC1C(O2)C(O)=O	tyrosine phosphatase inhibitor	PTPN6|TOP1
sodium-tanshinone-ii-a-sulfonate	125782	BRD-K84798689	Cc1c2c(oc1S(O)(=O)=O)-c1ccc3c(CCCC3(C)C)c1C(=O)C2=O	potassium channel activator	
sodium-tetradecyl-sulfate	8771	BRD-A55664972	CCCCC(CC)CCC(CC(C)C)OS(O)(=O)=O		PROC|PROS1
sofalcone	5282219	BRD-K01039503	CC(C)=CCOc1ccc(\C=C\C(=O)c2ccc(OCC=C(C)C)cc2OCC(O)=O)cc1	mucus protecting agent	CBR1
sofosbuvir	45375809	BRD-K05674516	CC(C)OC(=O)[C@H](C)N[P@@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1	RNA polymerase inhibitor	
solamargine	437080	BRD-A65562236	CC1C2C(CC3C4CC=C5CC(CCC5(C)C4CCC23C)OC2OC(CO)C(OC3OC(C)C(O)C(O)C3O)C(O)C2OC2OC(C)C(O)C(O)C2O)OC11CCC(C)CN1	apoptosis inhibitor	
solcitinib	44603362	BRD-K69215269	CC1(C)CN(C1)C(=O)c1ccc(cc1)-c1cccc2nc(NC(=O)C3CC3)nn12	JAK inhibitor	JAK1
solifenacin-succinate	154059	BRD-K24723746	O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
solithromycin	25242512	BRD-K32256160	CC[C@H]1OC(=O)[C@@](C)(F)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cc(nn3)-c3cccc(N)c3)C(=O)O[C@]12C)OC	protein synthesis inhibitor	
somantadine	50234	BRD-K85764479	CC(C)(N)CC12CC3CC(CC(C3)C1)C2	antiviral	
somatostatin	101826531	BRD-K14681867	C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC1=O)[C@@H](C)O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N	somatostatin receptor agonist	OPRD1|OPRM1|SSTR1|SSTR2|SSTR3|SSTR4|SSTR5
sonidegib	24775005	BRD-K19796430	C[C@H]1CN(C[C@@H](C)O1)c1ccc(NC(=O)c2cccc(-c3ccc(OC(F)(F)F)cc3)c2C)cn1	smoothened receptor antagonist	SMO
sophocarpine	115269	BRD-K66845263	O=C1C=CC[C@@H]2[C@H]3CCCN4CCC[C@@H](CN12)[C@@H]34		
sorafenib	216239	BRD-K23984367	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1	FLT3 inhibitor; KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; RAF inhibitor; RET tyrosine kinase inhibitor; VEGFR inhibitor	BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET
sorbic-acid	5251	BRD-K55892330	CC=CC=CC(O)=O		
sorbinil	5252	BRD-A89164055	Fc1ccc2OCCC3(NC(=O)NC3=O)c2c1	aldose reductase inhibitor	AKR1B1
sorbitan-monostearate	13267937	BRD-A70197423	CCCCCCCCCCCCCCCCCC(=O)OCC(O)[C@H]1OC[C@H](O)[C@H]1O		
sorbitol	5780	BRD-K66035042	OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO	mucolytic agent	
sotagliflozin	24831714	BRD-K05850076	CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](SC)[C@@H](O)[C@H](O)[C@H]2O)cc1	sodium/glucose cotransporter inhibitor	SLC5A1|SLC5A2
sotalol	5253	BRD-A33168282	CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1	adrenergic receptor antagonist	ADRB1|ADRB2|KCNH2
sotrastaurin	10296883	BRD-K16761703	CN1CCN(CC1)c1nc(C2=C(C(=O)NC2=O)c2c[nH]c3ccccc23)c2ccccc2n1	PKC inhibitor	PRKCA|PRKCB|PRKCD|PRKCE|PRKCH|PRKCQ
SP-100030	9910975	BRD-K71900389	FC(F)(F)c1cc(NC(=O)c2cnc(Cl)nc2C(F)(F)F)cc(c1)C(F)(F)F	NFkB pathway inhibitor	JUN|NFKB1
SP-141	59620153	BRD-K28571773	COc1ccc2[nH]c3c(nccc3c2c1)-c1cccc2ccccc12	ubiquitin ligase inhibitor	MDM2
SP-420		BRD-K23005288	COCCOCCOc1ccc(C2=N[C@](C)(CS2)C(O)=O)c(O)c1		
spaglumic-acid	188803	BRD-K68405354	CC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O	glutamate receptor antagonist	GRM3
sparfloxacin	60464	BRD-K07612980	C[C@H]1CN(C[C@@H](C)N1)c1c(F)c(N)c2c(c1F)n(cc(C(O)=O)c2=O)C1CC1	bacterial DNA gyrase inhibitor	TOP2A
sparfosate	4312	BRD-A81539525	OC(=O)CC(NC(=O)CP(O)(O)=O)C(O)=O	aspartate carbamoyltransferase inhibitor	CA2|CA4|CAD
sparteine-sulfate	442965	BRD-K32847234	C1CCN2C[C@H]3C[C@@H](CN4CCCC[C@H]34)[C@@H]2C1		
spautin-1	51037431	BRD-K84964099	Fc1ccc(CNc2ncnc3ccc(F)cc23)cc1	deubiquitinase inhibitor	USP10|USP13
spectinomycin	15541	BRD-K11905747	CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@]3(O)[C@@H](O[C@H](C)CC3=O)O[C@@H]2[C@H]1O	bacterial 30S ribosomal subunit inhibitor	
spermidine	1102	BRD-K40438880	NCCCCNCCCN	glutamate receptor modulator	KCNJ4|TXNRD1
spermine	1103	BRD-K18375018	NCCCNCCCCNCCCN		CA14|CA4|CA6|CA9|CASR|GRIN1|GRIN2A|KCNJ4|ODC1|SMOX|SMS|TRPM4|TRPM5
sphingosylphosphorylcholine	25245908	BRD-A35379661	CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)COP(O)(=O)OCC[N+](C)(C)C	gene expression stimulant	GPR12
spiperone	5265	BRD-K55468218	Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1	dopamine receptor antagonist	ADRA1A|ADRA1B|ADRA1D|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7
spiradoline	55652	BRD-K28192623	CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1)C(=O)Cc1ccc(Cl)c(Cl)c1	opioid receptor agonist	OPRK1
spiramycin	9832498	BRD-A67305656	CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1OC1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C	bacterial 50S ribosomal subunit inhibitor	
spirobromin	72115	BRD-K96684644	BrCCC(=O)N1CC[N+]2(CC1)CC[N+]1(CCN(CC1)C(=O)CCBr)CC2		
spironolactone	5833	BRD-K90027355	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]33CCC(=O)O3)[C@H]12	mineralocorticoid receptor antagonist	AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG
spiroxatrine	5268	BRD-A72483914	O=C1NCN(c2ccccc2)C11CCN(CC2COc3ccccc3O2)CC1	serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1A|HTR2B
spizofurone	71755	BRD-K94934625	CC(=O)c1ccc2OC3(CC3)C(=O)c2c1		
splitomycin	5269	BRD-K27710560	O=C1CCc2c(O1)ccc1ccccc21	SIRT inhibitor	SIRT1
SPP-86	66549796	BRD-K63253858	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc12	receptor tyrosine protein kinase inhibitor	RET
SPP301	9912992	BRD-K19203487	COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(nc1OC)-c1ccncc1	endothelin receptor antagonist	EDNRA
SQ-109		BRD-A08772153	CC(C)=CCC\C(C)=C\CNCCNC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2	bacterial cell wall synthesis inhibitor	FDFT1
SQ-22536	5270	BRD-A56987319	Nc1ncnc2n(cnc12)C1CCCO1	adenylyl cyclase inhibitor	ADCY1
SR-1078	17980288	BRD-K26501486	OC(C(F)(F)F)(C(F)(F)F)c1ccc(cc1)NC(=O)c1ccc(cc1)C(F)(F)F	retinoid receptor agonist	RORA|RORC
SR-11302	9976842	BRD-K16229414	CC(\C=C\C=C(\C=C\C1=C(C)CCCC1(C)C)c1ccc(C)cc1)=C/C(O)=O		
SR-140333	108167	BRD-K60931454	CC(C)Oc1cccc(CC(=O)N2CCC[C@@](CC[N+]34CCC(CC3)(CC4)c3ccccc3)(C2)c2ccc(Cl)c(Cl)c2)c1	neurokinin receptor antagonist	TACR1
SR-1664	53239854	BRD-K62814487	C[C@H](NC(=O)c1ccc2n(Cc3ccc(cc3)-c3ccccc3C(O)=O)c(C)c(C)c2c1)c1ccc(cc1)[N+]([O-])=O	PPAR receptor ligand	PPARG
SR-2211	51035449	BRD-K11641193	OC(c1ccc(c(F)c1)-c1ccc(CN2CCN(Cc3ccncc3)CC2)cc1)(C(F)(F)F)C(F)(F)F	retinoid receptor inverse agonist	RORC
SR-2640	128355	BRD-K62562723	OC(=O)c1ccccc1Nc1cccc(OCc2ccc3ccccc3n2)c1	leukotriene receptor antagonist	CYSLTR1
SR-27897	122077	BRD-K35629949	OC(=O)Cn1c(cc2ccccc12)C(=O)Nc1nc(cs1)-c1ccccc1Cl	CCK receptor antagonist	CCKAR
SR-3306	57519510	BRD-K60952143	Cc1ccc(cn1)-c1ncn(n1)-c1ccc(Nc2nccc(n2)-c2cccc(c2)N2CCOCC2)cc1	JNK inhibitor	MAPK10|MAPK8|MAPK9
SR-33805	9850876	BRD-K43002771	COc1ccc(CCN(C)CCCOc2ccc(cc2)S(=O)(=O)c2c(C(C)C)c3ccccc3n2C)cc1OC	calcium channel blocker	
SR-3576	70702008	BRD-K50378376	COc1cc(NC(=O)c2cccc(c2)-n2cc(NC(=O)Nc3cccc(C)c3)cn2)cc(OC)c1OC	JNK inhibitor	MAPK10
SR-3677	25093235	BRD-A86468475	CN(C)CCOc1cc(ccc1NC(=O)C1COc2ccccc2O1)-c1cn[nH]c1	rho associated kinase inhibitor	ROCK2
SR-57227A	131747	BRD-K09397065	NC1CCN(CC1)c1cccc(Cl)n1	serotonin receptor agonist	HTR3A
SR-59230A	5311452	BRD-K35430135	CCc1ccccc1OC[C@@H](O)CN[C@H]1CCCc2ccccc12	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3
SR-95639A	195165	BRD-K19309090	C(CN1CCOCC1)Nc1cc2CCCc3ccccc3-c2nn1	acetylcholine receptor agonist	CHRM1
SRC-kinase-inhibitor-I	1474853	BRD-K50495309	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC	src inhibitor	CSK|LCK|RIPK2
SRPIN340	2797577	BRD-K62621335	FC(F)(F)c1ccc(N2CCCCC2)c(NC(=O)c2ccncc2)c1	serine arginine protein kinase inhibitor	SRPK1|SRPK2
SRT1720	24180125	BRD-K95926480	O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1	SIRT activator	SIRT1
SRT2104	25108829	BRD-K48452630	Cc1nc(sc1C(=O)Nc1ccccc1-c1cn2c(CN3CCOCC3)csc2n1)-c1cccnc1	SIRT activator	SIRT1
SSR-180711	9797360	BRD-K02782351	Brc1ccc(OC(=O)N2CCN3CCC2CC3)cc1	acetylcholine receptor agonist	CHRNA7
SSR128129E	11347895	BRD-K65890018	COc1c(C)c(C(=O)c2ccc(N)c(c2)C(O)=O)n2ccccc12		
ST-1859	14187	BRD-K73524797	Oc1ccc2ccccc2c1Cc1c(O)ccc2ccccc12	antiamyloidogenic agent	
ST-2825	24808138	BRD-K68470841	NC(=O)[C@H]1CCS[C@@H]2C[C@]3(CCCN3C(=O)Cc3ccc(NC(=O)COc4ccc(Cl)cc4Cl)cc3)C(=O)N12	myeloid differentiation primary response inhibitor	MYD88
ST-91	20864	BRD-K18905250	CCc1cccc(CC)c1N=C1NCCN1	adrenergic receptor agonist	
STA-5326	10173277	BRD-K41783120	Cc1cccc(\C=N\Nc2cc(nc(OCCc3ccccn3)n2)N2CCOCC2)c1	interleukin synthesis inhibitor	IL12A
stanozolol	25249	BRD-K46791647	C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4Cc5[nH]ncc5C[C@]4(C)[C@H]3CC[C@]12C	androgen receptor agonist	AR
stattic	2779853	BRD-K17061841	[O-][N+](=O)c1ccc2C=CS(=O)(=O)c2c1		
STAT3-inhibitor-VI	252682	BRD-K40853697	Cc1ccc(cc1)S(=O)(=O)OCC(=O)Nc1ccc(C(O)=O)c(O)c1	STAT inhibitor	STAT3
stavudine	18283	BRD-K93880783	Cc1cn([C@@H]2O[C@H](CO)C=C2)c(=O)[nH]c1=O	DNA directed DNA polymerase inhibitor; nucleoside reverse transcriptase inhibitor	
stemregenin-1	46199207	BRD-K36739687	CC(C)n1cnc2c(NCCc3ccc(O)cc3)nc(nc12)-c1csc2ccccc12	aryl hydrocarbon receptor antagonist	AHR
stepronin	54120	BRD-A04506385	CC(SC(=O)c1cccs1)C(=O)NCC(O)=O	mucolytic agent	
stetaderm	92730	BRD-K93900986	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O)C[C@]12C		
STF-083010		BRD-K13049524	Oc1ccc2ccccc2c1\C=N\S(=O)(=O)c1cccs1	serine/threonine kinase inhibitor	ERN1
STF-118804	20916937	BRD-K39171998	Cc1oc(nc1CS(=O)(=O)c1ccc(C)cc1)-c1ccc(cc1)C(=O)NCc1cccnc1	NAMPT inhibitor	NAMPT
STF-31	984333	BRD-K22477529	CC(C)(C)c1ccc(cc1)S(=O)(=O)NCc1ccc(cc1)C(=O)Nc1cccnc1	NAMPT inhibitor	NAMPT|SLC2A1
STF-62247	704473	BRD-K85479953	Cc1cccc(Nc2nc(cs2)-c2ccncc2)c1	autophagy inducer	
stigmasterol	5280794	BRD-K41422683	CC[C@H](\C=C\[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C		
stiripentol	5311454	BRD-A72441487	CC(C)(C)C(O)\C=C\c1ccc2OCOc2c1	GABA uptake inhibitor	GABRA3
stobadine	65684	BRD-A85069489	CN1CCC2Nc3ccc(C)cc3C2C1	adrenergic receptor antagonist	ADRA1A
streptomycin	19649	BRD-K07166362	CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O	bacterial 30S ribosomal subunit inhibitor	
streptozotocin	29327	BRD-K34411947	CN([N+][O-])C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O	DNA alkylating agent	SLC2A2
strontium-ranelate	46782942	BRD-K83146339	O=C1CN(CC(=O)O[Sr]O1)c1sc2c(CC(=O)O[Sr]OC2=O)c1C#N	bone formation stimulant; bone resorption inhibitor	CASR
strychnine	5702135	BRD-A09094913	O=C1CC2OCC=C3CN4CC[C@@]56C4C[C@@H]3[C@@H]2C5N1c1ccccc61	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA10|CHRNA9|GLRA1|GLRA2|GLRA3|GLRB
SU-11274	9549297	BRD-K02965346	CN(c1cccc(Cl)c1)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3[nH]c(C)c(C(=O)N4CCN(C)CC4)c3C)c2c1	hepatocyte growth factor receptor inhibitor; tyrosine kinase inhibitor	MET
SU-16f	5329150	BRD-K91106808	Cc1[nH]c(\C=C2/C(=O)Nc3cc(ccc23)-c2ccccc2)c(C)c1CCC(O)=O	PDGFR tyrosine kinase receptor inhibitor	PDGFRB
SU-4312	6450842	BRD-K20287671	CN(C)c1ccc(cc1)\C=C1/C(=O)Nc2ccccc12	PDGFR tyrosine kinase receptor inhibitor; tyrosine kinase inhibitor; VEGFR inhibitor	KDR|PDGFRB
substance-p	36511	BRD-K23106423	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(N)=O	neurokinin receptor antagonist	TACR1|TACR2|TACR3
succinic-acid	1110	BRD-K45238818	OC(=O)CCC(O)=O		ALDH5A1|ASPH|BBOX1|HSD17B6|OXCT1|OXCT2|P3H1|P3H2|P3H3|P4HA1|P4HA2|PLOD1|PLOD3|SDHA|SDHB|SDHC|SDHD|SLC13A1|SLC13A2|SLC13A3|SLC25A10|SUCLA2|SUCLG1|SUCLG2|SUCNR1|TMLHE
succinylcholine-chloride	5314	BRD-K45497762	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C		CHRFAM7A|CHRM1|CHRM2|CHRM3|CHRNA1|CHRNA10
succinylsulfathiazole	5315	BRD-K01950558	OC(=O)CCC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1nccs1	dihydrofolate reductase inhibitor	DHFR
sucralfate		BRD-M71167108	O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O	antacid	EGF|FGA|FGB|FGF2|FGG
sucralose	71485	BRD-K58968598	OC[C@H]1O[C@H](O[C@]2(CCl)O[C@H](CCl)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1Cl		
sucrose	5988	BRD-K74724920	OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O		ACTA1|ATOX1|C22orf28|LYZ
sucrose-octaacetate	31340	BRD-K01294196	CC(=O)OC[C@H]1O[C@@](COC(C)=O)(O[C@H]2O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O		
sudan-iv		BRD-K65989725	Cc1ccccc1N=Nc1ccc(N=Nc2c(O)ccc3ccccc23)c(C)c1		
sufentanil	41693	BRD-K21547160	CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1	opioid receptor modulator	OPRD1|OPRK1|OPRM1
sulbactam	130313	BRD-K44133266	CC1(C)[C@@H](N2[C@@H](CC2=O)S1(=O)=O)C(O)=O	beta lactamase inhibitor	
sulbactam-pivoxil	50491	BRD-A63431791	CC(C)(C)C(=O)OCOC(=O)C1N2C(CC2=O)S(=O)(=O)C1(C)C	beta lactamase inhibitor	
sulbentine	67686	BRD-K72384124	S=C1SCN(Cc2ccccc2)CN1Cc1ccccc1	other antifungal	
sulbutiamine	3002120	BRD-K12539416	CC(C)C(=O)OCC\C(SS\C(CCOC(=O)C(C)C)=C(/C)N(Cc1cnc(C)nc1N)C=O)=C(\C)N(Cc1cnc(C)nc1N)C=O	acetylcholine receptor antagonist	
sulconazole	5318	BRD-A70649075	Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1	sterol demethylase inhibitor	
sulfabenzamide	5319	BRD-K59983611	Nc1ccc(cc1)S(=O)(=O)NC(=O)c1ccccc1	bacterial antifolate	
sulfacarbamide	11033	BRD-K13486660	NC(=O)NS(=O)(=O)c1ccc(N)cc1		
sulfacetamide	5320	BRD-K21520694	CC(=O)NS(=O)(=O)c1ccc(N)cc1	PABA antagonist	
sulfachlorpyridazine	6634	BRD-K32021043	Nc1ccc(cc1)S(=O)(=O)Nc1ccc(Cl)nn1	bacterial antifolate	
sulfadiazine	5215	BRD-K32273377	Nc1ccc(cc1)S(=O)(=O)Nc1ncccn1	bacterial antifolate	
sulfadoxine	17134	BRD-K55250441	COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC	dihydropteroate synthase inhibitor	
sulfafurazole	5344	BRD-K50859149	Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C	bacterial antifolate	
sulfaguanidine	5324	BRD-K45086103	NC(=N)NS(=O)(=O)c1ccc(N)cc1	bacterial antifolate	
sulfamerazine	5325	BRD-K93524252	Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1	bacterial antifolate	
sulfameter	5326	BRD-K87492696	COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1	dihydrofolate reductase inhibitor	DHFR
sulfamethazine	5327	BRD-K11640013	Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1	PABA antagonist	
sulfamethizole	5328	BRD-K31682896	Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1	bacterial antifolate	
sulfamethoxazole	5329	BRD-K28494619	Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1	PABA antagonist	
sulfamethoxypyridazine	5330	BRD-K00938507	COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1	bacterial antifolate	
sulfametopyrazine	9047	BRD-K17205817	COc1nccnc1NS(=O)(=O)c1ccc(N)cc1	PABA antagonist	
sulfamonomethoxine	5332	BRD-K14116214	COc1cc(NS(=O)(=O)c2ccc(N)cc2)ncn1	bacterial antifolate	
sulfamoxole	12894	BRD-K19742012	Cc1nc(NS(=O)(=O)c2ccc(N)cc2)oc1C	PABA antagonist	
sulfanilamide	129828936	BRD-K02594908	Nc1ccc(cc1)S(N)(=O)=O	carbonic anhydrase inhibitor	CYP2C19|CYP2C9|CYP2D6|CYP2E1|CYP3A4
sulfanilate-zinc	60148414	BRD-K04254814	Nc1ccc(cc1)S(=O)(=O)O[Zn]OS(=O)(=O)c1ccc(N)cc1		
sulfanitran	5334	BRD-K76845197	CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)[N+]([O-])=O		
sulfaphenazole	5335	BRD-K10671814	Nc1ccc(cc1)S(=O)(=O)Nc1ccnn1-c1ccccc1	dihydropteroate synthetase inhibitor	DHPS
sulfapyridine	5336	BRD-K41406082	Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1	PABA antagonist	
sulfaquinoxaline	5338	BRD-K71133585	Nc1ccc(cc1)S(=O)(=O)Nc1cnc2ccccc2n1	vitamin K antagonist	
sulfasalazine		BRD-K10670311	OC(=O)c1cc(ccc1O)\N=N\c1ccc(cc1)S(=O)(=O)Nc1ccccn1	cyclooxygenase inhibitor	ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1
sulfathiazole	5340	BRD-K14705039	Nc1ccc(cc1)S(=O)(=O)Nc1nccs1	dihydropteroate synthase inhibitor	
sulfinpyrazone	5342	BRD-A36217750	O=C1C(CCS(=O)c2ccccc2)C(=O)N(N1c1ccccc1)c1ccccc1	uricosuric blocker	ABCC1|ABCC2|FPR1|SLC22A12
sulfisoxazole-acetyl	6662	BRD-K84810336	CC(=O)N(c1onc(C)c1C)S(=O)(=O)c1ccc(N)cc1	folic acid antagonist	
sulforaphane	5350	BRD-A58955223	CS(=O)CCCCN=C=S	anticancer agent; aryl hydrocarbon receptor antagonist	NFE2L2
sulindac	1548887	BRD-A13946108	CC1=C(CC(O)=O)c2cc(F)ccc2C\1=C/c1ccc(cc1)S(C)=O	cyclooxygenase inhibitor	AKR1B1|MAPK3|PPARD|PTGDR2|PTGS1|PTGS2
sulisobenzone	19988	BRD-K38602774	COc1cc(O)c(cc1S(O)(=O)=O)C(=O)c1ccccc1		
sulmazole	5353	BRD-A22081593	COc1cc(ccc1-c1nc2ncccc2[nH]1)S(C)=O	adenosine receptor antagonist	
sulmetozine	65790	BRD-K29570907	COc1cc(cc(OC)c1OC)C(=S)N1CCOCC1	gastrin inhibitor	GAST
suloctidil	5354	BRD-A34205397	CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1	adrenergic receptor antagonist	
sulphadimethoxine	5323	BRD-K71125014	COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1	dihydropteroate synthetase inhibitor	
sulpiride	5355	BRD-A55272860	CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O	dopamine receptor antagonist	
sumanirole	9818479	BRD-K30485548	CN[C@@H]1Cc2cccc3nc(O)n(C1)c23	dopamine receptor agonist	DRD2
sumatriptan	5358	BRD-K50938287	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR5A|HTR6|HTR7
SUN-B-8155		BRD-K36274133	C\C(=N/c1ccccc1N)c1c(C)cc(=O)n(O)c1O	calcitonin agonist	CALCR
SUN-11602	22245705	BRD-K71250460	CN(C1CCN(Cc2ccc(cc2)C(N)=O)CC1)C(=O)CNc1c(C)c(C)c(N)c(C)c1C	fibroblast growth factor mimetic	FGFR1
sunitinib	5329102	BRD-K42828737	CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C	FLT3 inhibitor; KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; RET tyrosine kinase inhibitor; VEGFR inhibitor	CSF1R|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB|RET
suplatast	101611567	BRD-A98427211	CCOCC(O)COc1ccc(NC(=O)CC[S+](C)C)cc1	histamine release inhibitor; immunoglobulin inhibitor	
suprofen	5359	BRD-A34006693	CC(C(O)=O)c1ccc(cc1)C(=O)c1cccs1	cyclooxygenase inhibitor	PTGS1|PTGS2
suramin	4261196	BRD-K70327167	Cc1ccc(cc1NC(=O)c1cccc(NC(=O)Nc2cccc(c2)C(=O)Nc2cc(ccc2C)C(=O)Nc2ccc(c3cc(cc(c23)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)c1)C(=O)Nc1ccc(c2cc(cc(c12)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O	DNA synthesis inhibitor	F2|FSHR|P2RY1|P2RY11|P2RY13|P2RY2|PLA2G2A|RYR1|RYR2|SIRT5
suritozole	25431	BRD-K98557884	Cn1nc(-c2cccc(F)c2)n(C)c1=S	GABA receptor inverse agonist	GABBR1
sutezolid	465951	BRD-K86670086	CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCSCC2)c(F)c1	protein synthesis inhibitor	
suvorexant	24965990	BRD-K94293891	C[C@@H]1CCN(CCN1C(=O)c1cc(C)ccc1-n1nccn1)c1nc2cc(Cl)ccc2o1	orexin receptor antagonist	HCRTR1|HCRTR2
suxibuzone	5362	BRD-K78815826	CCCCC1(COC(=O)CCC(O)=O)C(=O)N(N(C1=O)c1ccccc1)c1ccccc1	cyclooxygenase inhibitor	
SU014813	87217390	BRD-K75911534	Cc1[nH]c(\C=C2\C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1	PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor	KDR
SU3327	11837140	BRD-K32730239	Nc1nnc(Sc2ncc(s2)[N+]([O-])=O)s1	JNK inhibitor	MAPK8
SU9516	5289419	BRD-K94883909	COc1ccc2NC(=O)\C(=C/c3c[nH]cn3)c2c1	CDK inhibitor	CDK1|CDK2|CDK4|CDK5
swainsonine	51683	BRD-K15170068	O[C@@H]1CN2CCC[C@@H](O)[C@@H]2[C@@H]1O	alpha mannosidase inhibitor	MAN2A1
SX-011	9935015	BRD-K45385835	CN(C)C(=O)C(=O)c1cn(C)c2cc(Cl)c(cc12)C(=O)N1CCC(Cc2ccc(F)cc2)CC1	MAP kinase inhibitor	MAPK14
SYM-2081	95883	BRD-K72106461	C[C@H](C[C@H](N)C(O)=O)C(O)=O	kainate receptor antagonist	GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SLC1A2
SYM-2206	5039877	BRD-A77218119	CCCNC(=O)N1N=C(c2ccc(N)cc2)c2cc3OCOc3cc2C1C	glutamate receptor antagonist	GRIA1|GRIA2|GRIA3|GRIA4
symclosene	6909	BRD-K33642804	Cln1c(=O)n(Cl)c(=O)n(Cl)c1=O		
synephrine	7172	BRD-A04327189	CNCC(O)c1ccc(O)cc1	adrenergic receptor agonist	ADRA1A
S1P1-agonist-III	54764919	BRD-K12745498	COc1ccncc1C(=O)NC(=O)Nc1ccc(-c2ccccc2)c(c1)C(F)(F)F	sphingosine kinase inhibitor	S1PR1
S18986	637863	BRD-K02501528	O=S1(=O)N[C@H]2CCCN2c2ccccc12	glutamate receptor modulator	GRIA1|GRIA2|GRIA3|GRIA4
S26948	9958279	BRD-K48826825	COC(=O)C(Cc1ccc(OCCn2c3ccc(cc3sc2=O)C(=O)c2ccccc2)cc1)C(=O)OC	PPAR receptor agonist	PPARG
S4	53342705	BRD-K96798615	Cc1cc(C)cc(NC(=O)Nc2ccc(OS(N)(=O)=O)cc2)c1	carbonic anhydrase inhibitor	CA12|CA9
T-0070907	2777391	BRD-K31843556	[O-][N+](=O)c1ccc(Cl)c(c1)C(=O)Nc1ccncc1	PPAR receptor antagonist	PPARG
T-0156	5368	BRD-K63516691	COC(=O)c1c(-c2cc(OC)c(OC)c(OC)c2)c2ccnc(OCc3ncccn3)c2c(=O)n1Cc1ccnc(C)c1	phosphodiesterase inhibitor	PDE5A
T-0901317	447912	BRD-K23383398	OC(c1ccc(cc1)N(CC(F)(F)F)S(=O)(=O)c1ccccc1)(C(F)(F)F)C(F)(F)F	LXR agonist	NCOA1|NCOA2|NR1H2|NR1H3|NR1I2|RXRB
T-5224	23626877	BRD-K84925803	OC(=O)CCc1cc(ccc1OCc1ccc2c(O)noc2c1)C(=O)c1ccc(OC2CCCC2)cc1O	AP inhibitor	JUN
T-5601640	9438169	BRD-K83492904	Cc1cc(on1)C(=O)Nc1cccc(c1)C(=O)Nc1cccc(c1)C(F)(F)F	LIM kinase inhibitor	LIMK2
T-62	855908	BRD-K09001147	Nc1sc2CCCCc2c1C(=O)c1ccc(Cl)cc1	adenosine receptor modulator	ADORA2A
TA-01	91691129	BRD-K79856806	Fc1ccc(cc1)-c1nc([nH]c1-c1ccncc1)-c1c(F)cccc1F	casein kinase inhibitor; MAP kinase inhibitor	CSNK1D|CSNK1E|MAPK14
tabimorelin	9810101	BRD-K53600683	CNC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc1ccc2ccccc2c1)N(C)C(=O)\C=C\CC(C)(C)N	growth hormone secretagogue receptor agonist	GHSR
tacalcitol	5283734	BRD-K73237276	CC(C)[C@H](O)CC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	vitamin D receptor agonist	VDR
tacedinaline	2746	BRD-K52313696	CC(=O)Nc1ccc(cc1)C(=O)Nc1ccccc1N	HDAC inhibitor	HDAC1
tacrine	1935	BRD-K81473089	Nc1c2CCCCc2nc2ccccc12	acetylcholinesterase inhibitor	ACHE|BCHE
tacrolimus	445643	BRD-K69608737	CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC	calcineurin inhibitor	FKBP1A
tadalafil	110635	BRD-K93645900	CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3OCOc3c2)C1=O	phosphodiesterase inhibitor	PDE11A|PDE5A
tafamidis-meglumine	11001318	BRD-K23728141	OC(=O)c1ccc2nc(oc2c1)-c1cc(Cl)cc(Cl)c1	transthyretin amyloid inhibitor	TTR
tafenoquine	115358	BRD-A78965079	COc1cc(C)c2c(Oc3cccc(c3)C(F)(F)F)c(OC)cc(NC(C)CCCN)c2n1	antimalarial agent	
tagatose	1101	BRD-A73556557	OCC(O)C(O)C(O)C(=O)CO	phosphorylase inhibitor	PYGL
TAK-063	46848915	BRD-K57155378	COc1cn(nc(-c2ccnn2-c2ccccc2)c1=O)-c1ccc(cc1F)-n1cccn1	phosphodiesterase inhibitor	PDE10A
TAK-220	5275766	BRD-K38793468	CC(=O)N1CCC(CC1)C(=O)N(CCCN1CCC(Cc2ccc(cc2)C(N)=O)CC1)c1ccc(C)c(Cl)c1	CC chemokine receptor antagonist	CCR5
TAK-285	11620908	BRD-K80343549	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(c4)C(F)(F)F)c(Cl)c3)c12	EGFR inhibitor	ERBB2
TAK-593	24767976	BRD-K67262033	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1	VEGFR inhibitor	PDGFRA
TAK-632	46209401	BRD-K31866293	Fc1ccc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2C#N)cc1NC(=O)Cc1cccc(c1)C(F)(F)F	RAF inhibitor	BRAF
TAK-715	9952773	BRD-K52751261	CCc1nc(c(s1)-c1ccnc(NC(=O)c2ccccc2)c1)-c1cccc(C)c1	p38 MAPK inhibitor	MAPK14
TAK-733	24963252	BRD-K26667523	Cn1c2ncn(C[C@@H](O)CO)c(=O)c2c(Nc2ccc(I)cc2F)c(F)c1=O	MEK inhibitor	MAP2K1
TAK-875	24857286	BRD-K58501140	Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3[C@H](CC(O)=O)COc3c2)c1	insulin secretagogue	FFAR1
TAK-901	16124208	BRD-K01683783	CCS(=O)(=O)c1cccc(c1)-c1cc(C(=O)NC2CCN(C)CC2)c(C)c2[nH]c3ncc(C)cc3c12	Aurora kinase inhibitor	AURKB
TAK-960	53357478	BRD-K48059512	COc1cc(C(=O)NC2CCN(C)CC2)c(F)cc1Nc1ncc2N(C)C(=O)C(F)(F)CN(C3CCCC3)c2n1	PLK inhibitor	PLK1
talabostat	6918572	BRD-K37419961	CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O	dipeptidyl peptidase inhibitor; fibroblast activation protein inhibitor	DPP4
taladegib	49848070	BRD-K50498985	CN(C1CCN(CC1)c1nnc(-c2ccnn2C)c2ccccc12)C(=O)c1ccc(F)cc1C(F)(F)F	smoothened receptor antagonist	DHH|IHH|SMO
talampanel	164509	BRD-K80359953	C[C@@H]1Cc2cc3OCOc3cc2C(=NN1C(C)=O)c1ccc(N)cc1	glutamate receptor antagonist	GRIA1|GRIA2|GRIA3|GRIA4
talarozole	9799888	BRD-A95755460	CCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n1cncn1	cytochrome P450 inhibitor	CYP26A1
talazoparib		BRD-K95142244	Cn1ncnc1[C@@H]1[C@H](Nc2cc(F)cc3c2c1n[nH]c3=O)c1ccc(F)cc1	PARP inhibitor	PARP2
talc	44134961	BRD-M92352362	O=[Mg].O=[Mg].O=[Mg].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O		
talinolol	68770	BRD-A94276798	CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1	adrenergic receptor antagonist	ADRB1
talipexole	5374	BRD-K75615183	Nc1nc2CCN(CC=C)CCc2s1	adrenergic receptor agonist; dopamine receptor agonist	ADRA2A|DRD2|HTR3A
talmapimod	9871074	BRD-K17555800	C[C@H]1CN([C@H](C)CN1Cc1ccc(F)cc1)C(=O)c1cc2c(cn(C)c2cc1Cl)C(=O)C(=O)N(C)C	p38 MAPK inhibitor	MAPK11|MAPK14
talnetant	5311424	BRD-K47095176	CC[C@H](NC(=O)c1c(O)c(nc2ccccc12)-c1ccccc1)c1ccccc1	tachykinin antagonist	TACR2|TACR3
talniflumate	48229	BRD-A98378129	FC(F)(F)c1cccc(Nc2ncccc2C(=O)OC2OC(=O)c3ccccc23)c1	cyclooxygenase inhibitor	CLCA1
talopram	23573	BRD-A02532772	CNCCCC1(OC(C)(C)c2ccccc12)c1ccccc1	adrenergic inhibitor	SLC6A2
taltirelin	114750	BRD-K93869735	CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(N)=O	thyrotropin releasing hormone receptor agonist	TRHR
taltobulin	6918637	BRD-K87512222	CN[C@H](C(=O)N[C@H](C(=O)N(C)[C@@H](C(C)C)\C=C(/C)C(O)=O)C(C)(C)C)C(C)(C)c1ccccc1	tubulin polymerization inhibitor	
TAME	1550286	BRD-K72231366	COC(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)c1ccc(C)cc1		
tamibarotene	108143	BRD-K36627727	CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(cc3)C(O)=O)ccc12	retinoid receptor agonist	RARA|RARB
tamoxifen	2733526	BRD-K93754473	CC\C(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1	estrogen receptor antagonist; selective estrogen receptor modulator (SERM)	EBP|ESR1|ESR2|GPER1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCI|PRKCQ|PRKCZ
tamsulosin	129211	BRD-K74339692	CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(c1)S(N)(=O)=O	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D
tanaproget	4369524	BRD-K99604664	Cn1c(ccc1-c1ccc2NC(=S)OC(C)(C)c2c1)C#N	progesterone receptor agonist	PGR
tandospirone	91273	BRD-K65904673	O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(CC1)c1ncccn1	serotonin receptor agonist	HTR1A
tandutinib	3038522	BRD-K89162000	COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1	FLT3 inhibitor; KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor	CSF1R|FLT3|KIT|PDGFD|PDGFRB
tanespimycin	6505803	BRD-K81473043	CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O	HSP inhibitor	HSP90AA1
tangeritin	68077	BRD-K25186396	COc1ccc(cc1)-c1cc(=O)c2c(OC)c(OC)c(OC)c(OC)c2o1	cell cycle inhibitor	
tannic-acid	16134267	BRD-K67392463	Oc1cc(cc(O)c1O)C(=O)Oc1cc(cc(O)c1O)C(=O)OC[C@H]1O[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1	PARG inhibitor	ANO1
tanshinone-i	114917	BRD-K34073885	Cc1coc-2c1C(=O)C(=O)c1c-2ccc2c(C)cccc12	AP inhibitor	IFNG
tanshinone-iia	164676	BRD-K00141480	Cc1coc-2c1C(=O)C(=O)c1c-2ccc2c1CCCC2(C)C	anti-inflammatory agent; interleukin inhibitor	IL1B|NR1I2|TNF
tapentadol	23654757	BRD-K25699529	CC[C@@H]([C@@H](C)CN(C)C)c1cccc(O)c1	opioid receptor agonist	HTR3A|OPRD1|OPRK1|OPRM1|SLC6A2|SLC6A4
taprenepag	18376177	BRD-K88854110	OC(=O)COc1cccc(CN(Cc2ccc(cc2)-n2cccn2)S(=O)(=O)c2cccnc2)c1	prostaglandin receptor agonist	PTGER2
tarafenacin	25147683	BRD-K59390331	Fc1cccc(c1)N(Cc1cc(F)c(F)c(F)c1)C(=O)O[C@H]1CN2CCC1CC2	acetylcholine receptor antagonist	CHRM3
taranabant	11226090	BRD-K35169477	C[C@H](NC(=O)C(C)(C)Oc1ccc(cn1)C(F)(F)F)[C@@H](Cc1ccc(Cl)cc1)c1cccc(c1)C#N	cannabinoid receptor inverse agonist	CNR1
targinine	132862	BRD-K59506194	CNC(=N)NCCC[C@H](N)C(O)=O	nitric oxide synthase inhibitor	NOS3
tariquidar	148201	BRD-K09353376	COc1cc2CCN(CCc3ccc(NC(=O)c4cc(OC)c(OC)cc4NC(=O)c4cnc5ccccc5c4)cc3)Cc2cc1OC	P glycoprotein inhibitor	ABCB1
tartaric-acid	444305	BRD-K36474365	O[C@H]([C@@H](O)C(O)=O)C(O)=O	antioxidant	ATP6V1C1|B3GAT1|DDX6|HIF1AN|TREM1
TAS-103		BRD-K09426783	CN(C)CCNc1nc2cc(O)ccc2c2-c3ccccc3C(=O)c12	topoisomerase inhibitor	TOP1
taselisib	51001932	BRD-K44844162	CC(C)n1nc(C)nc1-c1cn2CCOc3cc(ccc3-c2n1)-c1cnn(c1)C(C)(C)C(N)=O	PI3K inhibitor	PIK3CA
tasimelteon	10220503	BRD-K62971431	CCC(=O)NC[C@@H]1C[C@H]1c1cccc2OCCc12	melatonin receptor agonist	MTNR1A|MTNR1B
tasisulam	10160238	BRD-K42495768	Clc1ccc(C(=O)NS(=O)(=O)c2ccc(Br)s2)c(Cl)c1	apoptosis stimulant	
tasquinimod	54682876	BRD-K14653796	COc1cccc2n(C)c(=O)c(C(=O)N(C)c3ccc(cc3)C(F)(F)F)c(O)c12	angiogenesis inhibitor; S100A9 inhibitor	HDAC4
tasuldine	65666	BRD-K10415035	C(Sc1ncccn1)c1cccnc1	mucolytic agent	
taurine	1123	BRD-K51474575	NCCS(O)(=O)=O	antioxidant	
taurocholate	6675	BRD-K81062487	C[C@H](CCC(=O)NCCS(O)(=O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	G protein-coupled receptor agonist	CEL|FABP6|SLCO1C1
taurolidine	29566	BRD-K98765504	O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1	apoptosis stimulant	
tavaborole	11499245	BRD-K76713213	OB1OCc2cc(F)ccc12	leucyl-tRNA synthetase inhibitor	
taxifolin	439533	BRD-K94649603	O[C@@H]1[C@H](Oc2cc(O)cc(O)c2C1=O)c1ccc(O)c(O)c1	opioid receptor antagonist	ADIPOR2
tazarotene	5381	BRD-K76841105	CCOC(=O)c1ccc(nc1)C#Cc1ccc2SCCC(C)(C)c2c1	retinoid receptor agonist	RARA|RARB|RARG|RXRB
tazemetostat	66558664	BRD-K11215326	CCN(C1CCOCC1)c1cc(cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)-c1ccc(CN2CCOCC2)cc1	histone lysine methyltransferase inhibitor	EZH2
tazobactam	51371314	BRD-A18611368	C[C@]1(Cn2ccnn2)C(N2C(CC2=O)S1(=O)=O)C(O)=O	beta lactamase inhibitor	
TBA-354	49836057	BRD-K56405978	[O-][N+](=O)c1cn2C[C@@H](COc2n1)OCc1ccc(nc1)-c1ccc(OC(F)(F)F)cc1		
TBOA-(DL)	90479771	BRD-M77041484	N[C@@H]([C@H](OCc1ccccc1)C(O)=O)C(O)=O.N[C@H]([C@@H](OCc1ccccc1)C(O)=O)C(O)=O	excitatory amino acid transporter inhibitor	SLC1A1|SLC1A2|SLC1A3|SLC1A6|SLC1A7
TC-A-2317	46911726	BRD-A12147465	CC(CCCC(C)(C)O)Nc1nc(Nc2cc(C)[nH]n2)cc(C)c1C#N	Aurora kinase inhibitor	AURKA
TC-ASK-10	24944925	BRD-K29660062	CC(C)(C)c1ccc(cc1)C(=O)Nc1cn2cc(ccc2n1)-n1ccnc1	MAP kinase inhibitor	MAP3K5|MAP3K6
TC-E-5002	71735843	BRD-K15256258	ON(CCC(O)=O)C(=O)CCCCCCCCC1CC1	histone demethylase inhibitor	KDM2A|KDM4A|KDM4C|KDM5A|KDM6A|KDM7A|PHF8
TC-E-5006	68414868	BRD-A66521565	CC(C(O)=O)c1ccc(C(N2CCC(C)CC2)c2ccc(F)cc2)c(c1)-c1ccc(cc1)C(F)(F)F	gamma secretase modulator	APP
TC-F-2	25198728	BRD-K26041695	CCn1c2ccccc2n([C@H]2CCCN(C2)c2nccc(n2)-c2cc3ccccc3o2)c1=O	FAAH inhibitor	FAAH
TC-FPR-43	24776341	BRD-K16497916	CC(C)c1c(NC(=O)Nc2ccc(Cl)cc2)c(=O)n(-c2ccccc2)n1C	formyl peptide receptor agonist	FPR2
TC-G-1000	10220232	BRD-K27010807	Cc1sc(C)c2c1CCC=C2c1c[nH]cn1	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C
TC-G-1004	25074316	BRD-K76989898	COC1CCN(CC1)c1cccc(n1)-c1cc(NC(C)=O)nc(n1)-n1nc(C)cc1C	adenosine receptor antagonist	ADORA2A
TC-G-1005	71450251	BRD-K16939217	Cc1ccc(C)c(Oc2ccncc2C(=O)N2CCN(C3CC3)c3ccccc23)c1	G protein-coupled receptor agonist	GPBAR1
TC-G-1008	91826086	BRD-K87199310	CNc1nc(NCc2ccc(NS(C)(=O)=O)cc2Cl)cc(n1)-c1ccccn1	G protein-coupled receptor agonist	GPR39
TC-H-106	16070100	BRD-K45044657	Cc1ccc(NC(=O)CCCCCC(=O)Nc2ccccc2N)cc1	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC8
TC-I-15	90488948	BRD-K17621556	CC1(C)SCN([C@@H]1C(=O)N[C@@H](CNC(=O)NCc1ccccc1)C(O)=O)S(=O)(=O)c1ccccc1	integrin inhibitor	ITGA2|ITGB1
TC-I-2000	57326210	BRD-A83792282	Fc1ccc(NC(=O)N2CCc3ccccc3C2c2ccc(cc2)C(F)(F)F)cc1	transient receptor potential channel antagonist	TRPM8
TC-I-2014		BRD-K05262258	FC(F)(F)c1ccccc1-c1cc(c2[nH]c(nc2c1)C1=NOC2(C1)CCCCC2)C(F)(F)F	transient receptor potential channel antagonist	TRPM8
TC-LPA5-4	66552906	BRD-K32031961	COc1cccc(c1)-n1nc(cc1-c1ccc(C2CCCCC2)c(Cl)c1)C(O)=O	lysophosphatidic acid receptor antagonist	LPAR5
TC-Mps1-12	70682875	BRD-K76792630	CC(C)(C)Nc1nc(Nc2ccc(cc2)C(N)=O)cc(N)c1C#N	monopolar spindle 1 kinase inhibitor	TTK
TC-N-1752	53361524	BRD-K78161388	CC(=O)Nc1cccc(Nc2ncnc(n2)N2CCC(CC2)OCc2ccc(OC(F)(F)F)cc2)c1C	sodium channel blocker	SCN9A
TC-NTR1-17	44157038	BRD-K79608170	COc1cccc(OC)c1-c1cc(nn1-c1ccnc2cc(Cl)ccc12)C(=O)N[C@@H](CC(C)C)C(O)=O	neurotensin agonist	NTSR1
TC-O-9311	3376937	BRD-K54297077	COc1cc(OC)cc(c1)C(=O)NNC(=O)Nc1cccc2ccccc12	G protein-coupled receptor agonist	GPR139
TC-OT-39		BRD-K55013981	CN1CCCN(CC1)C(=S)[C@@H]1CCCN1C(=O)NCc1ccc(cc1C)C(=O)N1Cc2cnn(C)c2Nc2ccccc12	oxytocin receptor agonist; vasopressin receptor agonist	AVPR1A|OXT
TC-S-7003	11785878	BRD-K34362291	CN1CCN(CC1)c1ccc(Nc2ncc3c(n2)n2c4ccccc4nc2n(-c2c(C)cccc2C)c3=O)cc1	src inhibitor	LCK
TC-S-7004	57523919	BRD-K89517477	COc1ncc2cc(C(=O)Nc3cc(ccc3Cl)C(=O)NCc3cccc(Cl)c3)c(=O)[nH]c2n1	DYRK inhibitor	DYRK1A|DYRK1B
TC-S-7005	24971422	BRD-K89584803	C[C@H](Nc1cc2c(noc2cn1)-c1ccc2OCOc2c1)c1ccccc1	PLK inhibitor	PLK2
TC-S-7006	9549300	BRD-K51776215	Fc1ccc(Nc2c(cnc3cnc(NCc4cccnc4)cc23)C#N)cc1Cl	MAP kinase inhibitor	MAP3K8
TC-S-7009	70697712	BRD-K21894922	[O-][N+](=O)c1c(Nc2cc(F)cc(Cl)c2)ccc2nonc12	hypoxia inducible factor inhibitor	EPAS1
TC-SP-14	51346934	BRD-K87461578	OC(=O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5F)ccc4s3)c(F)c2)C1	sphingosine 1 phosphate receptor agonist	S1PR1
TCID	2729042	BRD-K27536248	Clc1c2C(=O)CC(=O)c2c(Cl)c(Cl)c1Cl		
TCN-238	46911068	BRD-K77915400	Nc1nccc(\C=C\c2ccccc2)n1	glutamate receptor positive allosteric modulator	GRM4
TCN201	4787937	BRD-K09787262	Fc1ccc(cc1Cl)S(=O)(=O)NCc1ccc(cc1)C(=O)NNC(=O)c1ccccc1	glutamate receptor antagonist	GRIN2A
TCS-HDAC6-20b	23636017	BRD-K68358632	CC(C)C(=O)SCCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)NC12CC3CC(CC(C3)C1)C2	HDAC inhibitor	HDAC6
TCS-OX2-29	10408514	BRD-K29424831	COc1cc2CCN(Cc2cc1OC)C(=O)[C@@H](NCc1ccncc1)C(C)(C)C	orexin receptor antagonist	HCRTR2
TCS-PIM-1-1	1235170	BRD-K08902330	Oc1ccc(Br)cc1-c1cc(-c2ccccc2)c(C#N)c(=O)[nH]1	Pim kinase inhibitor	PIM1
TCS-21311	50925411	BRD-K49461364	CC(C)(O)C(=O)N1CCN(CC1)c1ccc(c(c1)C1=C(C(=O)NC1=O)c1c[nH]c2ccccc12)C(F)(F)F	JAK inhibitor	JAK3
TCS-2210	44607172	BRD-K19958299	ONC(=O)c1ccc2[nH]c(=O)c(CCCc3ccccc3)nc2c1	neural stem cell inducer	
TCS-2314	11226207	BRD-K55216666	Cc1ccccc1NC(=O)Nc1ccc(CC(=O)N2CCOC[C@H]2C(=O)N2CCC(CC(O)=O)CC2)cc1	integrin inhibitor	ITGA4|ITGB1
TCS-3035	2295463	BRD-K81935556	OC(=O)COc1ccc(cc1)\C=C1/SC(=O)NC1=O	G protein-coupled receptor agonist	GPR35
TCS-359	1048845	BRD-K81376179	COc1ccc(cc1OC)C(=O)Nc1sc2CCCCc2c1C(N)=O	FLT3 inhibitor	FLT3
TCS-5861528	2873523	BRD-A16560607	CCC(C)c1ccc(NC(=O)Cn2cnc3n(C)c(=O)n(C)c(=O)c23)cc1	transient receptor potential channel antagonist	TRPA1
TCS2002	24855958	BRD-A50028488	Cc1nnc(o1)-c1ccc2occ(-c3ccc(cc3)S(C)=O)c2c1	glycogen synthase kinase inhibitor	GSK3B
TC1	10040286	BRD-A13964793	OC12C3C4C5C3C(C3C5CC4C13)N2CCc1cccc(F)c1	beta-secretase inhibitor	BACE1
TC2559	9823180	BRD-K24227647	CCOc1cncc(\C=C\CCNC)c1	acetylcholine receptor agonist	CHRNA4
tebipenem	129010004	BRD-K06900071	C[C@@H](O)[C@@H]1[C@@H]2[C@H](C)C(SC3CN(C3)C3=NCCS3)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C	bacterial cell wall synthesis inhibitor	CNR1
tecalcet	158797	BRD-K41662846	COc1cccc(c1)[C@@H](C)NCCCc1ccccc1Cl	calcium-sensing receptor agonist	CASR
tecastemizole	123618	BRD-K48195801	Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc23)cc1	histamine receptor antagonist	KCNH2
tecovirimat	16124688	BRD-K24312986	FC(F)(F)c1ccc(cc1)C(=O)NN1C(=O)[C@H]2[C@H]([C@H]3C=C[C@@H]2[C@@H]2C[C@H]32)C1=O	orthopoxvirus egress inhibitor	
tedizolid	11234049	BRD-K59436580	Cn1nnc(n1)-c1ccc(cn1)-c1ccc(cc1F)N1C[C@H](CO)OC1=O	bacterial 50S ribosomal subunit inhibitor	
tedizolid-phosphate	11476460	BRD-K89121095	Cn1nnc(n1)-c1ccc(cn1)-c1ccc(cc1F)N1C[C@H](COP(O)(O)=O)OC1=O	protein synthesis inhibitor	
tegaserod		BRD-K88743730	CCCCCNC(=N)N\N=C\c1c[nH]c2ccc(OC)cc12	serotonin receptor partial agonist	HTR2A|HTR2B|HTR2C|HTR4
tegobuvir	23649154	BRD-K26701552	Fc1ccccc1-c1nc2ccn(Cc3ccc(nn3)-c3ccc(cc3C(F)(F)F)C(F)(F)F)cc2n1	HCV inhibitor; protease inhibitor	
teicoplanin	16129701	BRD-K07712545	CCCCCCCCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1Oc1c2Oc3ccc(C[C@H]4NC(=O)[C@@H](N)c5ccc(O)c(Oc6cc(O)cc(c6)[C@H](NC4=O)C(=O)N[C@@H]4c(c2)cc1Oc1ccc(cc1Cl)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)[C@@H]1NC(=O)[C@H](NC4=O)c2ccc(O)c(c2)-c2c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc2[C@@H](NC1=O)C(O)=O)c5)cc3Cl	bacterial cell wall synthesis inhibitor	
teicoplanin-A2-1	45006162	BRD-A09761158	CCCCC\C=C\CCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1Oc1c2Oc3ccc(CC4NC(=O)[C@H](N)c5ccc(O)c(Oc6cc(O)cc(c6)[C@H](NC4=O)C(=O)N[C@@H]4c(c2)cc1Oc1ccc(cc1Cl)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)[C@@H]1NC(=O)[C@H](NC4=O)c2ccc(O)c(c2)-c2c(OC4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc2[C@H](NC1=O)C(O)=O)c5)cc3Cl	bacterial cell wall synthesis inhibitor	
teicoplanin-a2-3	129009877	BRD-K96571715	CC(C)CCCCCCCC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1Oc1c2Oc3ccc(C[C@H]4NC(=O)[C@H](N)c5ccc(O)c(Oc6cc(O)cc(c6)[C@H](NC4=O)C(=O)N[C@H]4c(c2)cc1Oc1ccc(cc1Cl)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1NC(C)=O)[C@@H]1NC(=O)[C@@H](NC4=O)c2ccc(O)c(c2)-c2c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc2[C@@H](NC1=O)C(O)=O)c5)cc3Cl	bacterial cell wall synthesis inhibitor	
Teijin-compound-1	44453327	BRD-K51528698	FC(F)(F)c1cccc(c1)C(=O)NCC(=O)N[C@@H]1CCN(Cc2ccc(Cl)cc2)C1	CC chemokine receptor antagonist	CCR2
telaprevir	3010818	BRD-K72912098	CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1	HCV inhibitor	CTSA|PGR
telatinib	9808844	BRD-K84564571	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1	KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor	KDR
telbivudine	159269	BRD-K15976406	Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O	DNA polymerase inhibitor	TK2
telcagepant	11319053	BRD-K91159026	Fc1cccc([C@@H]2CC[C@@H](NC(=O)N3CCC(CC3)n3c4cccnc4[nH]c3=O)C(=O)N(CC(F)(F)F)C2)c1F	calcitonin antagonist	CALCRL|RAMP1
telenzepine	5387	BRD-K06147391	CN1CCN(CC(=O)N2c3c(C)scc3C(=O)Nc3ccccc23)CC1	acetylcholine receptor antagonist	CHRM1
telithromycin	126480043	BRD-A94008949	CCC1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](OC2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@@H](C)[C@@H]2N(CCCCn3cnc(c3)-c3cccnc3)C(=O)O[C@]12C)OC	bacterial 30S ribosomal subunit inhibitor; bacterial 50S ribosomal subunit inhibitor	CYP1A2|CYP2D6|CYP3A4|CYP3A5|CYP3A7
telmesteine	11615393	BRD-A05523972	CCOC(=O)N1CSCC1C(O)=O	mucolytic agent	
telmisartan	65999	BRD-K73999723	CCCc1nc2c(C)cc(cc2n1Cc1ccc(cc1)-c1ccccc1C(O)=O)-c1nc2ccccc2n1C	angiotensin receptor antagonist	AGTR1|PPARG
telotristat	25025298	BRD-K63178091	Cc1ccn(n1)-c1cc(Cl)ccc1[C@@H](Oc1cc(nc(N)n1)-c1ccc(C[C@H](N)C(O)=O)cc1)C(F)(F)F	tryptophan hydroxylase inhibitor	TPH1
telotristat-ethyl	25181577	BRD-K94559059	CCOC(=O)[C@@H](N)Cc1ccc(cc1)-c1cc(O[C@H](c2ccc(Cl)cc2-n2ccc(C)n2)C(F)(F)F)nc(N)n1	tryptophan hydroxylase inhibitor	TPH1
temazepam	5391	BRD-A93093700	CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3|TSPO
temefos	5392	BRD-K51805276	COP(=S)(OC)Oc1ccc(Sc2ccc(OP(=S)(OC)OC)cc2)cc1	cholinesterase inhibitor	
temocapril	40466973	BRD-K10784860	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CS[C@@H](CN(CC(O)=O)C1=O)c1cccs1	angiotensin converting enzyme inhibitor	ACE
temoporfin	60751	BRD-K63712959	Oc1cccc(c1)-c1c2CCc(n2)c(-c2cccc(O)c2)c2ccc([nH]2)c(-c2cccc(O)c2)c2ccc(n2)c(-c2cccc(O)c2)c2ccc1[nH]2	radical formation stimulant	
temozolomide	5394	BRD-K32107296	Cn1nnc2c(ncn2c1=O)C(N)=O	DNA alkylating agent	MGMT
tempol	5395	BRD-K95053546	CC1(C)CC(O)CC(C)(C)N1O	free radical scavenger	
temsirolimus	129009966	BRD-K42898655	CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@@H]1OC(=O)C(C)(CO)CO	mTOR inhibitor	MTOR
tenatoprazole	636411	BRD-A42270467	COc1ccc2[nH]c(nc2n1)S(=O)Cc1ncc(C)c(OC)c1C	ATPase inhibitor	IDO1
teneligliptin	11949652	BRD-K48068743	Cc1cc(N2CCN(CC2)[C@@H]2CN[C@@H](C2)C(=O)N2CCSC2)n(n1)-c1ccccc1	dipeptidyl peptidase inhibitor	DPP4
tenidap	57946	BRD-A87479750	NC(=O)N1C(=O)C(C(=O)c2cccs2)c2cc(Cl)ccc12	cyclooxygenase inhibitor	KCNJ4|PTGS1
tenilsetam	65649	BRD-A41835910	O=C1NCCNC1c1cccs1	AGE inhibitor	
teniposide	452548	BRD-K10362825	COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@H](O[C@H]3[C@H](O)[C@H]2O)c2cccs2)c2cc3OCOc3cc12	topoisomerase inhibitor	TOP2A|TOP2B
tenofovir	464205	BRD-K15891719	C[C@H](Cn1cnc2c(N)ncnc12)OCP(O)(O)=O	HIV integrase inhibitor; nucleoside reverse transcriptase inhibitor	
tenofovir-alafenamide	72370618	BRD-A25988899	CC(C)OC(=O)C(C)NP(=O)(COC(C)Cn1cnc2c(N)ncnc12)Oc1ccccc1	nucleoside reverse transcriptase inhibitor	
tenofovir-disoproxil	5481350	BRD-K61868322	CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)OCOC(=O)OC(C)C	nucleoside reverse transcriptase inhibitor	CYP1A2
tenovin-1	1013376	BRD-K05977823	CC(=O)Nc1ccc(NC(=S)NC(=O)c2ccc(cc2)C(C)(C)C)cc1	SIRT inhibitor; TP53 activator	SIRT1
tenovin-6	24772043	BRD-K13949769	CN(C)CCCCC(=O)Nc1ccc(NC(=S)NC(=O)c2ccc(cc2)C(C)(C)C)cc1	SIRT inhibitor	SIRT1|SIRT2|SIRT3
tenoxicam	9927768	BRD-A22844106	CN1C(C(=O)Nc2ccccn2)C(=O)c2sccc2S1(=O)=O	cyclooxygenase inhibitor	PTGS1|PTGS2
tenylidone	1550999	BRD-K91298281	O=C1\C(CCC\C1=C/c1cccs1)=C\c1cccs1		
tepoxalin	59757	BRD-K89714990	COc1ccc(cc1)-n1nc(CCC(=O)N(C)O)cc1-c1ccc(Cl)cc1	cyclooxygenase inhibitor; lipoxygenase inhibitor	ALOX5
TEPP-46	44246499	BRD-A18279961	Cn1c2cc(sc2c2cnn(Cc3cccc(N)c3)c(=O)c12)S(C)=O	pyruvate kinase isozyme activator	PKM
teprenone	5282199	BRD-K11510141	CC(=O)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C	mucus protecting agent	
terameprocol	476861	BRD-K76788410	COc1ccc(C[C@H](C)[C@H](C)Cc2ccc(OC)c(OC)c2)cc1OC	lipoxygenase inhibitor	BIRC5|CDK1
terazosin	5401	BRD-A22256192	COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|KCNH2|KCNH6|KCNH7
terbinafine	1549008	BRD-K68132782	CN(C\C=C\C#CC(C)(C)C)Cc1cccc2ccccc12	fungal squalene epoxidase inhibitor	SQLE
terbutaline	5403	BRD-A50157456	CC(C)(C)NCC(O)c1cc(O)cc(O)c1	adrenergic receptor agonist	ADRB2
terciprazine	68763	BRD-A11725667	OC(COC1(CCCCC1)C#C)CN1CCN(CC1)c1cccc(c1)C(F)(F)F		
terconazole	441383	BRD-K86204871	CC(C)N1CCN(CC1)c1ccc(OC[C@H]2CO[C@@](Cn3cncn3)(O2)c2ccc(Cl)cc2Cl)cc1	sterol demethylase inhibitor	
terfenadine	5405	BRD-A06352418	CC(C)(C)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1	histamine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|KCNH1|KCNH2
terguride	37816	BRD-A89207210	CCN(CC)C(=O)N[C@H]1CC2C(Cc3c[nH]c4cccc2c34)N(C)C1	dopamine receptor agonist; serotonin receptor antagonist	ADRA1A|ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C
teriflunomide	23500906	BRD-A42699921	CC(=O)C(C#N)C(=O)Nc1ccc(cc1)C(F)(F)F	dihydroorotate dehydrogenase inhibitor	DHODH
terlipressin	72081	BRD-K73451719	NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O	vasopressin receptor agonist	AVPR1A|AVPR1B|AVPR2
terodiline	23480	BRD-A33479817	CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C	cholinergic receptor antagonist	
teroxirone	17142	BRD-A39935389	O=c1n(CC2CO2)c(=O)n(CC2CO2)c(=O)n1CC1CO1	DNA inhibitor	
terpene	6651	BRD-K93396439	CC(C)(O)C1CCC(C)(O)CC1		
terreic-acid-(-)	44483234	BRD-A64228451	CC1C(=O)[C@H]2O[C@H]2C(=O)C1=O	Bruton's tyrosine kinase (BTK) inhibitor	BTK
terutroban	9938840	BRD-K43975632	Cc1ccc2C[C@@H](CCc2c1CCC(O)=O)NS(=O)(=O)c1ccc(Cl)cc1	prostanoid receptor antagonist	TBXA2R
tesaglitazar	208901	BRD-K15507868	CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(O)=O	insulin sensitizer; PPAR receptor agonist	PPARA|PPARG
testolactone	13769	BRD-K69636617	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CCC(=O)O2	aromatase inhibitor	CYP19A1
testosterone	5701998	BRD-A55393291	C[C@]12CCC3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@@H]2O	androgen receptor agonist	AR
testosterone-enanthate	9416	BRD-K89657519	CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	androgen receptor agonist	AR
testosterone-propionate	5701990	BRD-A48720949	CCC(=O)O[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C	androgen receptor agonist	AR
testosterone-undecanoate	65157	BRD-K70650177	CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	androgen receptor agonist	AR
tetrabenazine	11634155	BRD-K95739795	COc1cc2CCN3C[C@H](CC(C)C)C(=O)C[C@H]3c2cc1OC	vesicular monoamine transporter inhibitor	DRD2|SLC18A1|SLC18A2
tetracaine	5411	BRD-K45071273	CCCCNc1ccc(cc1)C(=O)OCCN(C)C	membrane integrity inhibitor	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
tetracycline	54091660	BRD-A34788695	CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O	bacterial 30S ribosomal subunit inhibitor	PRNP
tetradecylthioacetic-acid	114924	BRD-K47539947	CCCCCCCCCCCCCCSCC(O)=O	lipid peroxidase inhibitor	
tetraethylenepentamine	8197	BRD-K41298358	NCCNCCNCCNCCN	superoxide dismutase inhibitor	SOD1|SOD2
tetrahydrofolic-acid	91443	BRD-A36978621	Nc1nc(O)c2NC(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2n1		ALDH1L1|AMT|ATIC|FOLR2|FTCD|MTFMT|MTHFD1|MTHFD2|MTHFR|MTR|SHMT1|SHMT2
tetrahydropapaverine	5418	BRD-A91831168	COc1ccc(CC2NCCc3cc(OC)c(OC)cc23)cc1OC		
tetrahydrouridine	29243	BRD-A86248581	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC(O)NC1=O	cytidine deaminase inhibitor	CDA
tetrahydrozoline	5419	BRD-A28856712	C1CN=C(N1)C1CCCc2ccccc12	adrenergic receptor agonist	
tetramethylthiuram-monosulfide	7347	BRD-K36889451	CN(C)C(=S)SC(=S)N(C)C		
tetramisole	3913	BRD-A46393198	C1CN2CC(N=C2S1)c1ccccc1	immunostimulant	
tetrandrine	73078	BRD-K08078237	COc1ccc2C[C@@H]3N(C)CCc4cc(OC)c(OC)c(Oc5cc6[C@H](Cc7ccc(Oc1c2)cc7)N(C)CCc6cc5OC)c34	calcium channel blocker	SLC6A3
tetrazol-5-yl-glycine-(RS)	126383	BRD-A14757586	NC(C(O)=O)c1nnn[nH]1	glutamate receptor agonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
tetrindole	160020	BRD-A52660433	C1CCC(CC1)c1ccc2n3CCNC4CCCc(c34)c2c1	monoamine oxidase inhibitor	MAOA
tetroquinone	36689751	BRD-K90177246	OC1C(=O)C(=O)C(O)C(=O)C1=O		
tezacaftor	46199646	BRD-K97101532	CC(C)(CO)c1cc2cc(NC(=O)C3(CC3)c3ccc4OC(F)(F)Oc4c3)c(F)cc2n1C[C@@H](O)CO	CFTR channel agonist	
TFC-007	16040067	BRD-K57708067	O=C(Nc1ccc(cc1)N1CCC(CC1)C(=O)N1CCOCC1)c1cnc(Oc2ccccc2)nc1	prostaglandin inhibitor	HPGDS
TG-003	1893668	BRD-K97072811	CCN1\C(Sc2ccc(OC)cc12)=C\C(C)=O	CLK inhibitor	CLK1|CLK4|DYRK1A|DYRK1B
TG-02	16739650	BRD-K14560436	CN1C\C=C\CCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2	CDK inhibitor; FLT3 inhibitor; JAK inhibitor	CDK1|CDK2|CDK7|CDK9|FLT3|JAK2
TG-100572	11712625	BRD-K18424115	Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)-c1cc(O)ccc1Cl	src inhibitor; VEGFR inhibitor	KDR|SRC
TG-100713	17751063	BRD-K46392623	Nc1nc(N)c2nc(cnc2n1)-c1cccc(O)c1	PI3K inhibitor	
TG-100801	11973736	BRD-K12735121	Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)-c1cc(OC(=O)c2ccccc2)ccc1Cl	src inhibitor; VEGFR inhibitor	FGFR1|FLT1|KDR|SRC
TG-101209	16722832	BRD-K39841531	CN1CCN(CC1)c1ccc(Nc2ncc(C)c(Nc3cccc(c3)S(=O)(=O)NC(C)(C)C)n2)cc1	JAK inhibitor	JAK2|JAK3
TG-101348	16722836	BRD-K12502280	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C	FLT3 inhibitor; JAK inhibitor	BRD4|JAK1|JAK2|JAK3|TYK2
TGR-1202	72950888	BRD-K52579889	CC(C)Oc1ccc(cc1F)-c1nn([C@@H](C)c2oc3ccc(F)cc3c(=O)c2-c2cccc(F)c2)c2ncnc(N)c12	PI3K inhibitor	
TGX-221	9907093	BRD-A41692738	CC(Nc1ccccc1)c1cc(C)cn2c1nc(cc2=O)N1CCOCC1	PI3K inhibitor	PIK3CB|PIK3CD
TG100-115	10427712	BRD-K64785675	Nc1nc(N)c2nc(-c3cccc(O)c3)c(nc2n1)-c1cccc(O)c1	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
TH-302	11984561	BRD-K20958582	Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+]([O-])=O	DNA alkylating agent	
thaliblastine	21470	BRD-K87548127	COc1cc(C[C@@H]2N(C)CCc3cc(OC)c(OC)cc23)c(Oc2cc3C[C@@H]4N(C)CCc5cc(OC)c(OC)c(-c3cc2OC)c45)cc1OC	DNA inhibitor	
thalidomide	5426	BRD-A93255169	O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12	tumor necrosis factor production inhibitor	CRBN|FGFR2|NFKB1|ORM1|ORM2|PTGS2|TNF
theobromine	5429	BRD-K34888156	Cn1cnc2n(C)c(=O)[nH]c(=O)c12	phosphodiesterase inhibitor	ADORA1|ADORA2A|PDE4B
theophylline	2153	BRD-K97799481	Cn1c2nc[nH]c2c(=O)n(C)c1=O	adenosine receptor antagonist	
thiamet-g	24808478	BRD-K38380126	CCNC1=N[C@H]2[C@H](O[C@H](CO)[C@@H](O)[C@@H]2O)S1	GLCNAC phosphotransferase inhibitor	MGEA5
thiamine	1130	BRD-K95785345	Cc1c(CCO)sc[n+]1Cc1cnc(C)nc1N	vitamin B	SLC19A2|SLC19A3|TPK1
thiamine-pyrophosphate	1132	BRD-A09994331	Cc1c(CCOP(O)(=O)OP(O)(O)=O)sc[n+]1Cc1cnc(C)nc1N		
thiamphenicol	27200	BRD-K79711234	CS(=O)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl	bacterial 50S ribosomal subunit inhibitor	
thiamylal	3032285	BRD-A23970436	CCCC(C)C1(CC=C)C(=O)NC(S)=NC1=O	glutamate receptor antagonist	GABRA1|KCNJ11|KCNJ8
thiazovivin	46209426	BRD-K03164761	O=C(NCc1ccccc1)c1csc(Nc2ccncn2)n1	rho associated kinase inhibitor	
thiethylperazine	5440	BRD-K69600043	CCSc1ccc2Sc3ccccc3N(CCCN3CCN(C)CC3)c2c1	dopamine receptor antagonist	DRD1|DRD2|DRD4
thiocolchicoside	9915886	BRD-K26619122	COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc2CC[C@H](NC(C)=O)c3cc(=O)c(SC)ccc3-c2c1OC	GABA receptor antagonist	GABRA1|GABRB2|GABRG2|GLRA1|GLRB
thioctic-acid	864	BRD-A16347691	OC(=O)CCCCC1CCSS1	reducing agent	ACHE|LIAS|LIPT1|PTGS2|SLC5A6
thiodiglycol	5447	BRD-K54521836	OCCSCCO		
thioguanine	2723601	BRD-K49350383	Nc1nc2nc[nH]c2c(=S)[nH]1	purine antagonist	IMPDH1|IMPDH2
thiomersal	101639657	BRD-K61443650	CC[Hg]Sc1ccccc1C(O)=O	other antibiotic	OXCT1
thiopental	3000715	BRD-A72603112	CCCC(C)C1(CC)C(=O)NC(S)=NC1=O	GABA receptor antagonist	CHRNA4|CHRNA7|FAAH|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GRIA2|GRIK2
thioperamide	3035905	BRD-K63874012	S=C(NC1CCCCC1)N1CCC(CC1)c1c[nH]cn1	histamine receptor antagonist	HRH3|HRH4
thiophanate	3032791	BRD-K90168339	COC(=O)NC(=S)Nc1ccccc1NC(=S)NC(=O)OC		
thioproperazine	9429	BRD-K08619574	CN(C)S(=O)(=O)c1ccc2Sc3ccccc3N(CCCN3CCN(C)CC3)c2c1	dopamine receptor antagonist	ADRA1A|ADRA1B|DRD1|DRD2|HTR1A|HTR2A
thioridazine	5452	BRD-A84481105	CSc1ccc2Sc3ccccc3N(CCC3CCCCN3C)c2c1	dopamine receptor antagonist	ADRA1A|ADRA1B|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCNH2
thiorphan	3132	BRD-A56012032	OC(=O)CNC(=O)C(CS)Cc1ccccc1	membrane metalloendopeptidase inhibitor	MME
thiostrepton	101290202	BRD-A20697603	CCC(C)C1NC2C=Cc3c(cc(nc3C2O)C(=O)OC(C)C2NC(=O)c3csc(n3)C(NC(=O)C3CSC(=N3)\C(NC(=O)C(NC(=O)c3csc(n3)C3(CCC(=NC3c3csc2n3)c2nc(cs2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC1=O)C(C)O)=C/C)C(C)(O)C(C)O)C(C)O	FOXM1 inhibitor; protein synthesis inhibitor	FOXM1
thiotepa	5453	BRD-K09631521	S=P(N1CC1)(N1CC1)N1CC1	cytochrome P450 inhibitor	CYP2B6|CYP3A4
thiothixene	941650	BRD-K97309399	CN(C)S(=O)(=O)c1ccc2Sc3ccccc3\C(=C/CCN3CCN(C)CC3)c2c1	dopamine receptor antagonist	DRD1|DRD2|HRH1|HTR2A
thiram	5455	BRD-K29254801	CN(C)C(=S)SSC(=S)N(C)C		JAK2
thonzonium	5456	BRD-K13387373	CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(OC)cc1)c1ncccn1	ATPase inhibitor	
thonzylamine	5457	BRD-K88405679	COc1ccc(CN(CCN(C)C)c2ncccn2)cc1	antihistamine	
threo-2-methylisocitrate-(DL)	129010094	BRD-M01344114	CC(O)([C@@H](CC(O)=O)C(O)=O)C(O)=O.CC(O)([C@H](CC(O)=O)C(O)=O)C(O)=O	isocitrate lyase substrate	
thymol	6989	BRD-K17458574	CC(C)c1ccc(C)cc1O	GABA receptor positive allosteric modulator	TRPA1
thymol-iodide	11088	BRD-K36617478	CC(C)c1cc(c(C)cc1OI)-c1cc(C(C)C)c(OI)cc1C		
THZ1	73602827	BRD-K66401437	CN(C)C\C=C\C(=O)Nc1ccc(cc1)C(=O)Nc1cccc(Nc2ncc(Cl)c(n2)-c2c[nH]c3ccccc23)c1	CDK inhibitor	CDK7
THZ1-R	119081415	BRD-K02135007	CN(C)CCCC(=O)Nc1ccc(cc1)C(=O)Nc1cccc(Nc2ncc(Cl)c(n2)-c2c[nH]c3ccccc23)c1	CDK inhibitor	CDK7
THZ2	78357763	BRD-K95902121	CN(C)C\C=C\C(=O)Nc1cccc(c1)C(=O)Nc1cccc(Nc2ncc(Cl)c(n2)-c2c[nH]c3ccccc23)c1	CDK inhibitor	CDK7
TH588	73389731	BRD-K01054709	Nc1nc(NC2CC2)cc(n1)-c1cccc(Cl)c1Cl	MTH1 inhibitor	NUDT1
tiabendazole	5430	BRD-K77695569	c1nc(cs1)-c1nc2ccccc2[nH]1	angiogenesis inhibitor	
tiagabine	40467242	BRD-K60160658	Cc1ccsc1C(=CCCN1CCC[C@H](C1)C(O)=O)c1sccc1C	GABA uptake inhibitor	SLC6A1
tianeptine	68870	BRD-A53077924	CN1c2ccccc2C(NCCCCCCC(O)=O)c2ccc(Cl)cc2S1(=O)=O	selective serotonin reuptake enhancer (SSRE)	OPRD1|OPRK1|OPRM1
tiapride	5467	BRD-K57432881	CCN(CC)CCNC(=O)c1cc(ccc1OC)S(C)(=O)=O	dopamine receptor antagonist	DRD2|DRD3
tiaprofenic-acid	5468	BRD-A72988804	CC(C(O)=O)c1ccc(s1)C(=O)c1ccccc1	cyclooxygenase inhibitor	PTGS1|PTGS2
tiaramide	5469	BRD-K27293958	OCCN1CCN(CC1)C(=O)Cn1c2cc(Cl)ccc2sc1=O	anti-inflammatory agent	
tibolone	60148444	BRD-A82522119	C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@H](CC[C@@]3(O)C#C)C12	androgen receptor agonist; estrogen receptor agonist; progesterone receptor agonist	ESR1
ticagrelor	124226581	BRD-K44974079	CCCSc1nc(N[C@@H]2C[C@@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@H](O)[C@H]3O)c2n1	purinergic receptor antagonist	P2RY12
ticarcillin	36921	BRD-K29229654	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(O)=O)c3ccsc3)C(=O)N2[C@H]1C(O)=O	lactamase inhibitor	
ticlopidine	5472	BRD-K00603606	Clc1ccccc1CN1CCc2sccc2C1	purinergic receptor antagonist	P2RY12
TIC10	85090241	BRD-K01115818	Cc1ccccc1CN1CC2=C(CCN(Cc3ccccc3)C2=O)N2CCN=C12	AKT inhibitor; TRAIL modulator	AKT1|MAPK1
tideglusib	11313622	BRD-K81330143	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1	glycogen synthase kinase inhibitor	GSK3B
tienilic-acid	38409	BRD-K34098590	OC(=O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl	sodium/potassium/chloride transporter inhibitor; cytochrome P450 inhibitor	CYP2C9|SLC12A1
tie2-kinase-inhibitor	23625762	BRD-A92800748	COc1ccc2cc(ccc2c1)-c1nc([nH]c1-c1ccncc1)-c1ccc(cc1)S(C)=O	TIE tyrosine kinase inhibitor	KDR|MAPK14
tifenazoxide	219048	BRD-K20568871	CC1(CC1)NC1=NS(=O)(=O)c2sc(Cl)cc2N1	ATP-sensitive potassium channel agonist	ABCC8|KCNJ11
tigecycline	73707446	BRD-A34462049	CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(NC(=O)CNC(C)(C)C)c(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C	bacterial 30S ribosomal subunit inhibitor	
tiletamine	26533	BRD-A30582499	CCNC1(CCCCC1=O)c1cccs1	glutamate receptor antagonist	
tilmicosin	16667713	BRD-K26634012	CC[C@@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@@H]([C@H]2O)N(C)C)[C@@H](CCN2C[C@@H](C)C[C@@H](C)C2)C[C@@H](C)C(=O)\C=C\C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC	bacterial 50S ribosomal subunit inhibitor	
tilorone	5475	BRD-K34568562	CCN(CC)CCOc1ccc2-c3ccc(OCCN(CC)CC)cc3C(=O)c2c1	interferon inducer	
tiludronate	60937	BRD-K10845183	OP(O)(=O)C(Sc1ccc(Cl)cc1)P(O)(O)=O	bone resorption inhibitor; osteoclast inhibitor	ATP6V1A|MMP2|PTPN1
timofibrate	68834	BRD-A64406146	CC(C)(Oc1ccc(Cl)cc1)C(=O)N1CSCC1C(O)=O	cholesterol inhibitor; lipase clearing factor inhibitor	LPL
timolol	168613	BRD-K30421593	CC(C)(C)NC[C@@H](O)COc1nsnc1N1CCOCC1	adrenergic receptor antagonist	ADRB1|ADRB2
timonacic	5081328	BRD-A38592941	OC(=O)C1CSCN1	antioxidant	ANXA5
tinidazole	5479	BRD-K89125793	CCS(=O)(=O)CCn1c(C)ncc1[N+]([O-])=O	antiprotozoal agent	
tioconazole	5482	BRD-A33084557	Clc1sccc1COC(Cn1ccnc1)c1ccc(Cl)cc1Cl	sterol demethylase inhibitor	CYP51A1
tioguanine	2724387	BRD-K75649340	Nc1nc(S)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1	purine antagonist	
tiopronin	5483	BRD-A85295731	CC(S)C(=O)NCC(O)=O	chelating agent; reducing agent	
tiotidine	50287	BRD-K15071410	CN\C(NCCSCc1csc(N=C(N)N)n1)=N/C#N	histamine receptor antagonist	HRH2
tiotropium		BRD-K62782754	C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3
tioxolone	72139	BRD-K41876534	Oc1ccc2sc(=O)oc2c1	carbonic anhydrase inhibitor	CA2
tipifarnib	159324	BRD-K62965247	Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2n(C)c(=O)cc(-c3cccc(Cl)c3)c2c1	farnesyltransferase inhibitor	FNTA|FNTB
tipiracil	6323266	BRD-K11973162	Clc1c(CN2CCCC2=N)[nH]c(=O)[nH]c1=O	thymidine phosphorylase inhibitor	TYMP
tiplaxtinin	6450819	BRD-K30882994	OC(=O)C(=O)c1cn(Cc2ccccc2)c2ccc(cc12)-c1ccc(OC(F)(F)F)cc1	plasminogen activator inhibitor	SERPINE1
tipranavir	9830191	BRD-A10039652	CCC[C@@]1(CCc2ccccc2)CC(=O)C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)c2)C(=O)O1	HIV protease inhibitor	
tiprenolol	38353	BRD-A73566563	CSc1ccccc1OCC(O)CNC(C)C	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3
tiquizium	72160	BRD-K77552740	C[N@+]12CCCC[C@@H]1CCC(C2)=C(c1cccs1)c1cccs1	acetylcholine receptor antagonist	
tiracizine	71264	BRD-K75250001	CCOC(=O)Nc1ccc2CCc3ccccc3N(C(=O)CN(C)C)c2c1	sodium channel blocker	SCN5A
tirapazamine		BRD-K92968657	Nc1n[n+]([O-])c2ccccc2[n+]1[O-]	DNA inhibitor	
tirasemtiv	23729157	BRD-K51087630	CCC(CC)n1c2nc(cnc2[nH]c1=O)C#C	troponin activator	
tiratricol	5803	BRD-K61236135	OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1	thyroid hormone stimulant	THRA|THRB
tirofiban	40466968	BRD-K37872686	CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(O)=O	platelet aggregation inhibitor; structural glycoprotein antagonist	ITGA2B|ITGB3
titanocene-dichloride	101920955	BRD-K60284353	Cl[Ti](Cl)(C1C=CC=C1)C1C=CC=C1	apoptosis stimulant	
tivantinib	11494412	BRD-K33379087	O=C1NC(=O)[C@H]([C@@H]1c1c[nH]c2ccccc12)c1cn2CCCc3cccc1c23	tyrosine kinase inhibitor	MET
tivozanib	9911830	BRD-K53414658	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC	VEGFR inhibitor	FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB
tizanidine	5487	BRD-K06335600	Clc1ccc2nsnc2c1NC1=NCCN1	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C|NISCH
TMC-353121	11249932	BRD-K66097663	Cc1ccc(CCCO)c(NCc2ccc3nc(NCCCN4CCOCC4)n(Cc4nc(C)ccc4O)c3c2)c1	RSV fusion inhibitor	
TMC647055	44556044	BRD-K49659468	COc1ccc2-c3c(C4CCCCC4)c4ccc5cc4n3CC(=Cc2c1)C(=O)N(C)CCOCCN(C)S(=O)(=O)NC5=O	RNA polymerase inhibitor	
TMN-355	44249042	BRD-K24527118	Fc1cccc(Cl)c1C(=O)NC(=O)NC1c2ccccc2-c2ccccc12	cyclophilin inhibitor	PPIA
TMPH	11207937	BRD-K49119234	CCCCCCC(=O)OC1CC(C)(C)NC(C)(C)C1		
TMS	5354004	BRD-K96233303	COc1ccc(\C=C\c2cc(OC)cc(OC)c2)c(OC)c1		
TNP-470	369976	BRD-K53597484	CO[C@@H]1[C@@H](CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)NC(=O)CCl	methionine aminopeptidase inhibitor	
tobramycin	36294	BRD-K05619559	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O	bacterial 30S ribosomal subunit inhibitor	
tocainide	38945	BRD-A92670106	CC(N)C(=O)Nc1c(C)cccc1C	sodium channel blocker	SCN5A
toceranib	5329106	BRD-K62040061	Cc1[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NCCN1CCCC1	protein tyrosine kinase inhibitor	FLT1|FLT3|KDR|PDGFRA|PDGFRB
tocofersolan	71406	BRD-A39830855	CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(OC(=O)CCC(=O)OCCO)c(C)c(C)c2O1	antioxidant	
todralazine	5501	BRD-K68553471	CCOC(=O)NNc1nncc2ccccc12	antihypertensive agent	
tofacitinib	9926791	BRD-K31283835	C[C@@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N	JAK inhibitor	JAK1|JAK2|JAK3|TYK2
tofisopam	129009868	BRD-K94830213	CCC1=C(C)NN=C(c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc12	phosphodiesterase inhibitor; cytochrome P450 inhibitor	CYP3A4|PDE10A|PDE2A|PDE3A|PDE4A
tofogliflozin	46908929	BRD-K96344439	CCc1ccc(Cc2ccc3CO[C@]4(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c3c2)cc1	sodium/glucose cotransporter inhibitor	GCK
tolamolol	37910	BRD-A60498477	Cc1ccccc1OCC(O)CNCCOc1ccc(cc1)C(N)=O	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3
tolazamide	5503	BRD-K32164935	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CCCCCC1	ATP channel blocker	ABCC8|KCNJ1|KCNJ10|KCNJ11
tolazoline	5504	BRD-K46211610	C(C1=NCCN1)c1ccccc1	adrenergic receptor antagonist	ADRA1A|ADRA2A|ADRA2B|ADRA2C|HRH1|HRH2
tolbutamide	5505	BRD-K85119730	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1	ATP channel blocker	ABCC8|KCNJ1|KCNJ11|KCNJ8
tolcapone	4659569	BRD-K10852020	Cc1ccc(cc1)C(=O)c1cc(O)c(O)c(c1)[N+]([O-])=O	catechol O methyltransferase inhibitor	COMT
tolfenamic-acid	610479	BRD-K50133271	Cc1c(Cl)cccc1Nc1ccccc1C(O)=O	cyclooxygenase inhibitor; prostanoid receptor antagonist	
tolimidone	39065	BRD-K41772907	Cc1cccc(Oc2cnc(=O)[nH]c2)c1	src activator	LYN|SRC
tolmetin	5509	BRD-K82562631	Cc1ccc(cc1)C(=O)c1ccc(CC(O)=O)n1C	cyclooxygenase inhibitor	PTGS1|PTGS2
tolnaftate	5510	BRD-K44273375	CN(C(=S)Oc1ccc2ccccc2c1)c1cccc(C)c1	fungal squalene epoxidase inhibitor	
tolonidine	72138	BRD-K82687598	Cc1ccc(NC2=NCCN2)c(Cl)c1	adrenergic receptor antagonist	ADRA2A
tolonium		BRD-K94882685	CN(C)c1ccc2nc3cc(C)c(N)cc3[s+]c2c1		
toloxatone	34521	BRD-A67182178	Cc1cccc(c1)N1CC(CO)OC1=O	monoamine oxidase inhibitor	MAOA|MAOB
tolperisone	5511	BRD-A27732521	CC(CN1CCCCC1)C(=O)c1ccc(C)cc1	voltage-gated sodium channel blocker	CYP2C19|CYP2D6
tolrestat	53359	BRD-K85693895	COc1ccc2c(cccc2c1C(F)(F)F)C(=S)N(C)CC(O)=O	aldose reductase inhibitor	AKR1A1|AKR1B1|AKR1B10
tolterodine	443879	BRD-K54316499	CC(C)N(CC[C@H](c1ccccc1)c1cc(C)ccc1O)C(C)C	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
toltrazuril	68591	BRD-K64514229	Cc1cc(ccc1Oc1ccc(SC(F)(F)F)cc1)-n1c(=O)[nH]c(=O)n(C)c1=O	antiprotozoal agent	
tolvaptan	216237	BRD-A82035391	Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc23)c(C)c1	vasopressin receptor antagonist	AVPR1A|AVPR2
tomelukast	3969	BRD-K74765201	CCCc1c(OCCCCc2nnn[nH]2)ccc(C(C)=O)c1O	leukotriene receptor antagonist	CYSLTR1
tonabersat	6918324	BRD-K36970462	CC(=O)c1ccc2OC(C)(C)[C@@H](O)[C@@H](NC(=O)c3ccc(F)c(Cl)c3)c2c1	gap junction modulator; nitric oxide production inhibitor	
topiramate	5284627	BRD-K29653726	CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1	carbonic anhydrase inhibitor; glutamate receptor antagonist; kainate receptor antagonist	CA1|CA12|CA2|CA4|CA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
topiroxostat	5288320	BRD-K77561571	N#Cc1cc(ccn1)-c1n[nH]c(n1)-c1ccncc1	xanthine oxidase inhibitor	XDH
topotecan	60700	BRD-K55696337	CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)c(CN(C)C)c4cc3Cn1c2=O	topoisomerase inhibitor	TOP1|TOP1MT
torasemide	41781	BRD-K30480208	CC(C)NC(=O)NS(=O)(=O)c1cnccc1Nc1cccc(C)c1	electrolyte reabsorption inhibitor; thromboxane receptor antagonist	SLC12A1
torcetrapib	159325	BRD-K55675242	CCOC(=O)N1[C@H](CC)C[C@H](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(=O)OC)c2cc(ccc12)C(F)(F)F	cholesteryl ester transfer protein inhibitor	CETP
torcitabine	13711	BRD-K91822704	Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1	DNA polymerase inhibitor	DCK|TK2
toremifene	3005573	BRD-K51350053	CN(C)CCOc1ccc(cc1)C(\c1ccccc1)=C(\CCCl)c1ccccc1	estrogen receptor antagonist; selective estrogen receptor modulator (SERM)	ESR1
torin-1	49836027	BRD-K40175214	CCC(=O)N1CCN(CC1)c1ccc(cc1C(F)(F)F)-n1c2c(ccc1=O)cnc1ccc(cc21)-c1cnc2ccccc2c1	mTOR inhibitor	MTOR
torin-2	51358113	BRD-K68174511	Nc1ccc(cn1)-c1ccc2ncc3ccc(=O)n(-c4cccc(c4)C(F)(F)F)c3c2c1	mTOR inhibitor	MTOR
tosedostat	15547703	BRD-K92241597	CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1	peptidase inhibitor	ANPEP|LAP3|NPEPPS
tosufloxacin	5517	BRD-A41450521	NC1CCN(C1)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)-c1ccc(F)cc1F	bacterial DNA gyrase inhibitor	
toyocamycin	11824	BRD-K26420709	Nc1ncnc2n(cc(C#N)c12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	serine/threonine kinase inhibitor	ERN1
tozadenant	11618368	BRD-K93045741	COc1ccc(N2CCOCC2)c2sc(NC(=O)N3CCC(C)(O)CC3)nc12	adenosine receptor antagonist	ADORA2A
tozasertib	5494449	BRD-K59369769	CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1	Aurora kinase inhibitor; Bcr-Abl kinase inhibitor; FLT3 inhibitor; JAK inhibitor	AURKA|AURKB|AURKC|LCK
TP-003	10001434	BRD-K87941707	CC(C)(O)c1ccn2c(cnc2c1F)-c1ccc(F)c(c1)-c1ccc(F)cc1C#N	GABA receptor inverse agonist	GABRA1|GABRA2|GABRA3|GABRA5
TP-0903	56839178	BRD-K84034737	CN(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(CN3CCN(C)CC3)cc2)ncc1Cl	AXL kinase inhibitor	AXL
TPCA-1	9903786	BRD-K51575138	NC(=O)Nc1sc(cc1C(N)=O)-c1ccc(F)cc1	IKK inhibitor	IKBKB
TPPS4		BRD-K39805756	OS(=O)(=O)c1ccc(cc1)-c1c2ccc(n2)c(-c2ccc(cc2)S(O)(=O)=O)c2ccc([nH]2)c(-c2ccc(cc2)S(O)(=O)=O)c2ccc(n2)c(-c2ccc(cc2)S(O)(=O)=O)c2ccc1[nH]2		
tracazolate	5522	BRD-K34154330	CCCCNc1c(C(=O)OCC)c(C)nc2n(CC)ncc12	GABA receptor modulator	GABRA1
TRAM-34	656734	BRD-K30071764	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1cccn1	potassium channel antagonist	KCNN4
TRAM-39	9861261	BRD-K81341251	Clc1ccccc1C(C#N)(c1ccccc1)c1ccccc1	calcium-activated potassium channel activator	KCNN4
tramadol	667511	BRD-K51033547	COc1cccc(c1)[C@]1(O)CCCC[C@H]1CN(C)C	norepinephrine reputake inhibitor; opioid receptor agonist; serotonin reuptake inhibitor	CHRFAM7A|CHRM3|GRIN3A|HTR2C|OPRD1|OPRK1|OPRM1|SLC6A2|SLC6A4
trametinib	11707110	BRD-K12343256	CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O	MEK inhibitor	MAP2K1|MAP2K2
tramiprosate	1646	BRD-K82234479	NCCCS(O)(=O)=O	beta amyloid protein neurotoxicity inhibitor	APP
trandolapril	6710733	BRD-A32505112	CCOC(=O)[C@H](CCc1ccccc1)N[C@H](C)C(=O)N1C2CCCCC2C[C@H]1C(O)=O	angiotensin converting enzyme inhibitor	ACE
tranexamic-acid		BRD-K15014948	NC[C@H]1CC[C@@H](CC1)C(O)=O	antifibrinolytic; plasminogen activator inhibitor	PLG
tranilast	5282230	BRD-K17849083	COc1ccc(\C=C\C(=O)Nc2ccccc2C(O)=O)cc1OC	angiogenesis inhibitor	HPGDS|HRH1
trans-10,cis-12-Conjugated-linoleic-acid	5282800	BRD-K26222048	CCCCC\C=C/C=C/CCCCCCCCC(O)=O		
trans-2-Undecenoic-acid	5282728	BRD-K42959922	CCCCCCCC\C=C\C(O)=O		
trans-4-[8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl]cyclohexanecarboxylic-acid	9924539	BRD-K75080769	OC(=O)C1CCC(CC1)c1cc2cccnc2c(n1)-c1cccc(F)c1		
trans-4-Hydroxycrotonic-acid	6155526	BRD-K91614056	OC\C=C\C(O)=O	gamma hydroxybutyric acid ligand	
trans-4-Methoxycinnamic-acid	699414	BRD-K26273521	COc1ccc(cc1)\C=C\C(O)=O		
tranylcypromine	26070	BRD-K88809146	N[C@H]1C[C@@H]1c1ccccc1	monoamine oxidase inhibitor	KDM1A|MAOA|MAOB
trap-101	11494970	BRD-K69837166	CCn1c2ccccc2n(C2=C(CO)CN(CC3CCCCCCC3)CC2)c1=O	nociceptin/orphanin FQ receptor antagonist; opioid receptor antagonist	OPRL1
trapidil	5531	BRD-K95763993	CCN(CC)c1cc(C)nc2ncnn12	PDGFR tyrosine kinase receptor inhibitor	PDGFRA
travoprost	5282226	BRD-K23976833	CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COc1cccc(c1)C(F)(F)F	prostanoid receptor agonist	PTGFR
traxoprodil	219101	BRD-K38158531	C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(CC1)c1ccccc1	glutamate receptor antagonist	GRIN2B
trazodone	5533	BRD-K70778732	Clc1cccc(c1)N1CCN(CCCn2nc3ccccn3c2=O)CC1	adrenergic receptor antagonist; serotonin receptor antagonist; serotonin reuptake inhibitor	ADRA1A|ADRA2A|HRH1|HTR1A|HTR2A|HTR2B|HTR2C|SLC6A4
trebenzomine	32142	BRD-A20686268	CC1Oc2ccccc2CC1N(C)C		
trelagliptin	11360300	BRD-A88369366	Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2cc(F)ccc2C#N)c1=O	dipeptidyl peptidase inhibitor	DPP4
tremorine	5534	BRD-K08619838	C(C#CCN1CCCC1)N1CCCC1	acetylcholine receptor agonist	
treosulfan	9882105	BRD-K20902145	CS(=O)(=O)OC[C@H](O)[C@@H](O)COS(C)(=O)=O	DNA synthesis inhibitor	
trepibutone	5536	BRD-K37543758	CCOc1cc(OCC)c(cc1OCC)C(=O)CCC(O)=O	cholinergic receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4
trequinsin		BRD-K84663978	COc1cc2CCn3c(c\c(=N/c4c(C)cc(C)cc4C)n(C)c3=O)-c2cc1OC	phosphodiesterase inhibitor	PDE5A
tretazicar	89105	BRD-K08748705	NC(=O)c1cc(N2CC2)c(cc1[N+]([O-])=O)[N+]([O-])=O	DNA replication inhibitor	NQO2
tretinoin	444795	BRD-K71879491	CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(O)=O	retinoid receptor agonist; retinoid receptor ligand	ALDH1A1|ALDH1A2|GPRC5A|NR0B1|NR2C2|PPARD|RARA|RARB|RARG|RARRES1|RORB|RORC|RXRB|RXRG
triacetin	5541	BRD-K92844263	CC(=O)OCC(COC(C)=O)OC(C)=O		
triamcinolone	31307	BRD-K77554836	C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO	glucocorticoid receptor agonist	NR3C1|SERPINA6
triamcinolone-acetonide	5702126	BRD-A92439610	CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	glucocorticoid receptor agonist; immunosuppressant	NR3C1
triamterene	5546	BRD-K92049597	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1	sodium channel blocker	SCNN1A|SCNN1B|SCNN1D|SCNN1G
triapine	9571836	BRD-K01669786	NC(=S)N\N=C\c1ncccc1N	ribonucleotide reductase inhibitor	RRM1|RRM2
triazolam	5556	BRD-K76890464	Cc1nnc2CN=C(c3ccccc3Cl)c3cc(Cl)ccc3-n12	GABA benzodiazepine site receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3|TSPO
tribenoside	196122	BRD-A60294240	CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O	anti-inflammatory agent; capillary stabilizing agent	
tribomsalan	14868	BRD-K09118247	Oc1c(Br)cc(Br)cc1C(=O)Nc1ccc(Br)cc1		
tribromoethanol	6400	BRD-K69632891	OCC(Br)(Br)Br	analgesic agent	
tributyrin	6050	BRD-K38969488	CCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC	HDAC inhibitor	
tricaprylin	10850	BRD-K24790130	CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC		
trichlormethiazide	5560	BRD-A28940325	NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C(Cl)Cl)cc1Cl	chloride channel blocker	ATP1A1|CA1|CA2|CA4|SLC12A1|SLC12A3
trichlormethine	5561	BRD-K29888499	ClCCN(CCCl)CCCl	DNA alkylating agent	
trichloroacetic-acid	23223116	BRD-K42090719	OC(=O)C(Cl)(Cl)Cl		
trichloroethylene	6575	BRD-K46435528	ClC=C(Cl)Cl		
trichostatin-a	444732	BRD-K68202742	C[C@H](\C=C(C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C	HDAC inhibitor	HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
triciribine	65399	BRD-K80431395	Cn1nc(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23	AKT inhibitor	AKT1|AKT2|AKT3
triclabendazole	50248	BRD-K81916719	CSc1nc2cc(Cl)c(Oc3cccc(Cl)c3Cl)cc2[nH]1	microtubule inhibitor	DNMT1
triclocarban	7547	BRD-K25029121	Clc1ccc(NC(=O)Nc2ccc(Cl)c(Cl)c2)cc1	other antibiotic	
triclosan	5564	BRD-K41731458	Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl	antibacterial agent	DNMT1
tridihexethyl	20299	BRD-A22152765	CC[N+](CC)(CC)CCC(O)(C1CCCCC1)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3
trientine	5565	BRD-K37111771	NCCNCCNCCN	chelating agent	CA14
trifluoperazine	5566	BRD-K89732114	CN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1	dopamine receptor antagonist	ADRA1A|CALM1|CALY|DRD2|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1
triflupromazine	5568	BRD-K63675182	CN(C)CCCN1c2ccccc2Sc2ccc(cc12)C(F)(F)F	dopamine receptor antagonist	CHRM1|CHRM2|DRD1|DRD2|HTR2B
trifluridine	6256	BRD-K03243820	OC[C@H]1O[C@H](C[C@@H]1O)n1cc(c(=O)[nH]c1=O)C(F)(F)F	DNA directed DNA polymerase inhibitor; thymidylate synthase inhibitor	TYMS
triflusal	9458	BRD-K71696703	CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F	cyclooxygenase inhibitor; platelet aggregation inhibitor; thromboxane synthase inhibitor	NFKB1|NOS2|PDE10A|PTGS1
trigonelline	5571	BRD-K69231085	C[n+]1cccc(c1)C(O)=O		
trihexyphenidyl	5572	BRD-A48180038	OC(CCN1CCCCC1)(C1CCCCC1)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
trilostane	6917849	BRD-A04497688	C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(=O)C(C[C@]35C)C#N)[C@@H]1CC[C@@H]2O	3beta-hydroxy-delta5-steroid dehydrogenase inhibitor	ESR1|ESR2|HSD3B1|HSD3B2
TRIM	1359	BRD-K36851334	FC(F)(F)c1ccccc1-n1ccnc1		
trimebutine	5573	BRD-A92630576	CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(N(C)C)c1ccccc1	opioid receptor agonist	OPRD1|OPRK1|OPRM1
trimeprazine	73707352	BRD-M58473998	CC(CN(C)C)CN1c2ccccc2Sc2ccccc12.CC(CN(C)C)CN1c2ccccc2Sc2ccccc12	histamine receptor ligand; histamine receptor antagonist	HRH1
trimetazidine	21109	BRD-K88366685	COc1ccc(CN2CCNCC2)c(OC)c1OC	3-ketoacyl CoA thiolase inhibitor	ACAA2
trimethadione	5576	BRD-K16606819	CN1C(=O)OC(C)(C)C1=O	oxazolidine antiepileptic	CACNA1G|CACNA1H|CACNA1I
trimethobenzamide	5577	BRD-K34415467	COc1cc(cc(OC)c1OC)C(=O)NCc1ccc(OCCN(C)C)cc1	histamine receptor antagonist	DRD2
trimethoprim	5578	BRD-K07208025	COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC	dihydrofolate reductase inhibitor	DHFR|TYMS
trimethoquinol	5581	BRD-A56241705	COc1cc(CC2NCCc3cc(O)c(O)cc23)cc(OC)c1OC	adrenergic receptor antagonist	ADRB2|ADRB3
trimethylolpropane-triacrylate	27423	BRD-K24483849	CCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C		
trimetozine	12478	BRD-K53220666	COc1cc(cc(OC)c1OC)C(=O)N1CCOCC1	sedative	
trimipramine	5584	BRD-A19195498	CC(CN(C)C)CN1c2ccccc2CCc2ccccc12	norepinephrine reputake inhibitor; tricyclic antidepressant	ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR1D|HTR2A|HTR2C|HTR3A|SLC6A2|SLC6A3|SLC6A4
trioxsalen	5585	BRD-K54790157	Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1	DNA synthesis inhibitor	
tripelennamine	5587	BRD-K57033106	CN(C)CCN(Cc1ccccc1)c1ccccn1	histamine receptor antagonist	HRH1
triprolidine	5282443	BRD-K11742128	Cc1ccc(cc1)C(=C/CN1CCCC1)\c1ccccn1	histamine receptor antagonist	HRH1
triptan	10044	BRD-K19427720	CC(C)C(C)(C)C	serotonin receptor agonist	HTR1B|HTR1D
triptolide	107985	BRD-K39484304	CC(C)[C@]12O[C@H]1[C@@H]1O[C@]11[C@]3(O[C@H]3C[C@H]3C4=C(CC[C@]13C)C(=O)OC4)[C@@H]2O	RNA polymerase inhibitor	RELA
triptorelin	25074470	BRD-K62685538	CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O	gonadotropin releasing factor hormone receptor agonist	GNRHR
troclosene	16726	BRD-K76375510	Cln1c(=O)[nH]c(=O)n(Cl)c1=O		
trofinetide	3080768	BRD-K83502127	NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O	cytokine production inhibitor	IFNG|IL6|TNF
troglitazone	5591	BRD-A13084692	Cc1c(C)c2OC(C)(COc3ccc(CC4SC(=O)NC4=O)cc3)CCc2c(C)c1O	insulin sensitizer; PPAR receptor agonist	ACSL4|ESRRA|ESRRG|PPARG|SERPINE1|SLC29A1|TRPM3
troleandomycin	6708521	BRD-A24297246	CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](OC3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O	protein synthesis inhibitor	
trolox	40634	BRD-A17846016	Cc1c(C)c2OC(C)(CCc2c(C)c1O)C(O)=O	antioxidant	
tromaril	31635	BRD-K91422571	OC(=O)c1ccccc1NCCc1ccccc1	prostanoid receptor antagonist	
trometamol	6503	BRD-K47978074	NC(CO)(CO)CO		AMD1|CANT1|DCN|NEIL1|VEGFA
tropanyl-3,5-dimethylbenzoate	2837530	BRD-A84389633	CN1C2CCC1CC(C2)OC(=O)c1cc(C)cc(C)c1	serotonin receptor antagonist	HTR3A|HTR3B
tropesin	47530	BRD-A34603619	COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)OCC(C(O)=O)c3ccccc3)c2c1	cyclooxygenase inhibitor	PTGS1|PTGS2
tropicamide	5593	BRD-A79672927	CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4
tropisetron		BRD-K50866992	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)c1c[nH]c2ccccc12	serotonin receptor antagonist	GLRA1|GLRA2|GLRB|HTR3A|HTR4
trospium		BRD-K69469734	OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]21CCCC1)(c1ccccc1)c1ccccc1	acetylcholine receptor antagonist	CHRM1
trovafloxacin		BRD-K00494077	N[C@H]1[C@@H]2CN(C[C@H]12)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)-c1ccc(F)cc1F	bacterial DNA gyrase inhibitor	TOP2A
troventol	180481	BRD-A35868371	CCC(CO)(C(=O)OC1CC2CCC(C1)[N+]2(C)C)c1ccccc1		
trovirdine	3000870	BRD-K00989047	Brc1ccc(NC(=S)NCCc2ccccn2)nc1	non-nucleoside reverse transcriptase inhibitor	
troxerutin	5486699	BRD-K73529671	C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(oc4cc(OCCO)cc(O)c4c3=O)-c3ccc(OCCO)c(OCCO)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O	antioxidant	
troxipide	5597	BRD-A68589262	COc1cc(cc(OC)c1OC)C(=O)NC1CCCNC1	glucosamine synthetase stimulant	
TRV130	66553195	BRD-K35626314	COc1ccsc1CNCC[C@]1(CCOC2(CCCC2)C1)c1ccccn1	opioid receptor agonist	OPRM1
tryptanthrin	73549	BRD-K76973696	O=C1c2ccccc2-n2c1nc1ccccc1c2=O	cyclooxygenase inhibitor	IDO1
tryptophan	6305	BRD-K83776863	N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O	serotonin receptor partial agonist	CASR|IDO1|SLC36A1|WARS|WARS2
TTNPB	5289501	BRD-K49685476	C\C(=C/c1ccc(cc1)C(O)=O)c1ccc2c(c1)C(C)(C)CCC2(C)C	retinoid receptor agonist	RARA|RARB|RARG
TTP-22	1536915	BRD-K64852730	Cc1ccc(cc1)-c1csc2ncnc(SCCC(O)=O)c12	casein kinase inhibitor	CSNK2A1
TU-2100	4342838	BRD-K44590731	CCOC(=O)c1ccccc1OC(=O)CCCCCCCC(=O)Oc1ccccc1C(=O)OCC		
tuaminoheptane	5603	BRD-A19958636	CCCCCC(C)N		
tubastatin-a	49850262	BRD-K00627859	CN1CCc2c(C1)c1ccccc1n2Cc1ccc(cc1)C(=O)NO	HDAC inhibitor	HDAC6
tubocurarine	6000	BRD-K99621550	COc1cc2CCN(C)[C@H]3Cc4ccc(Oc5c(O)c(OC)cc6CC[N+](C)(C)[C@H](Cc7ccc(O)c(Oc1cc23)c7)c56)cc4	acetylcholine receptor antagonist	ACHE|CHRNA2|HTR3A|HTR3B|KCNN1|KCNN2|KCNN3|ZACN
tucatinib	51039094	BRD-K26026438	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1	EGFR inhibitor	ERBB2
TUG-770	66553168	BRD-K56086081	OC(=O)CCc1ccc(cc1F)C#Cc1ccccc1CC#N	free fatty acid receptor agonist	FFAR1
TUG-891	57522038	BRD-K24282351	Cc1ccc(cc1)-c1ccc(F)cc1COc1ccc(CCC(O)=O)cc1	free fatty acid receptor agonist	FFAR4
tulobuterol	5606	BRD-A37441042	CC(C)(C)NCC(O)c1ccccc1Cl	adrenergic receptor agonist	ADRB2
TW-37	11455910	BRD-K28360340	CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(cc2)S(=O)(=O)c2ccccc2C(C)(C)C)c(O)c(O)c1O	BCL inhibitor	BCL2|BCL2L1|MCL1
TWS-119	9549289	BRD-K94176593	Nc1cccc(c1)-c1cc2c(Oc3cccc(O)c3)ncnc2[nH]1	glycogen synthase kinase inhibitor	GSK3B|JUN|MYC
TXA127	123805	BRD-K36040345	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O	angiotensin receptor agonist	
TY-52156	16046248	BRD-K66584608	CC(C)(C)C(=O)C(\NNc1ccc(Cl)cc1)=N\c1ccc(Cl)cc1	sphingosine 1-phosphate receptor antagonist	S1PR3
tylosin	5280440	BRD-K37753391	CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC	protein synthesis inhibitor	
tyloxapol	71388	BRD-M08959712	C=O.C1CO1.CC(C)(C)CC(C)(C)c1ccc(O)cc1	NFkB pathway inhibitor	LPL|NFKB2
tymazoline	129009968	BRD-K64414150	CC(C)c1ccc(C)cc1OC=C1NCCN1		
tyrphostin-AG-1296	2049	BRD-K76064317	COc1cc2ncc(nc2cc1OC)-c1ccccc1	FLT3 inhibitor	FLT3
tyrphostin-AG-1478	2051	BRD-K68336408	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC	EGFR inhibitor	EGFR|MAPK14
tyrphostin-AG-18	2052	BRD-K49657628	Oc1ccc(C=C(C#N)C#N)cc1O	EGFR inhibitor; tyrosine kinase inhibitor	EGFR
tyrphostin-AG-494	5328771	BRD-K34533029	Oc1ccc(cc1O)\C=C(/C#N)C(=O)Nc1ccccc1	EGFR inhibitor	EGFR
tyrphostin-AG-825	6091659	BRD-K87919739	COc1cc(\C=C(/C#N)C(N)=O)cc(CSc2nc3ccccc3s2)c1O	protein tyrosine kinase inhibitor	ERBB2
tyrphostin-AG-835	5328769	BRD-K17415526	C[C@H](NC(=O)C(=C\c1ccc(O)c(O)c1)\C#N)c1ccccc1	protein tyrosine kinase inhibitor	EGFR
tyrphostin-AG-879		BRD-K59469039	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)\C=C(/C#N)C(N)=S	tyrosine kinase inhibitor	ERBB2|KDR|NTRK1
tyrphostin-AG-99	5328768	BRD-K60184833	NC(=O)C(=C\c1ccc(O)c(O)c1)\C#N	tyrosine kinase inhibitor	EGFR
tyrphostin-A9	5614	BRD-K40255344	CC(C)(C)c1cc(C=C(C#N)C#N)cc(c1O)C(C)(C)C	protein tyrosine kinase inhibitor; tyrosine kinase inhibitor	
U-0124	5842955	BRD-K63169195	CS\C(N)=C(C#N)\C(C#N)=C(/N)SC	MEK inhibitor	
U-0126	5354033	BRD-K91701654	N\C(Sc1ccccc1N)=C(C#N)/C(C#N)=C(/N)Sc1ccccc1N	MEK inhibitor	AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAP2K2|MAP2K7|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1
U-0521	21632	BRD-K08953028	CC(C)C(=O)c1ccc(O)c(O)c1	catechol O methyltransferase inhibitor	COMT
U-104	310360	BRD-K77867004	NS(=O)(=O)c1ccc(NC(=O)Nc2ccc(F)cc2)cc1	carbonic anhydrase inhibitor	CA1|CA12|CA2|CA9
U-18666A	9954083	BRD-K22025381	CCN(CC)CCO[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CCC4=O)[C@@H]3CC=C2C1	oxidosqualene cyclase inhibitor	
U-50488-(-)	6604724	BRD-K53532120	CN([C@H]1CCCC[C@@H]1N1CCCC1)C(=O)Cc1ccc(Cl)c(Cl)c1	opioid receptor agonist	OPRK1
U-54494A	183470	BRD-K20995441	CN([C@@H]1CCCC[C@@H]1N1CCCC1)C(=O)c1ccc(Cl)c(Cl)c1	opioid receptor agonist	OPRK1
U-75799E	9919153	BRD-K77070363	C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O	growth hormone releasing factor agonist	GHSR
U-99194	5626	BRD-K70281171	CCCN(CCC)C1Cc2cc(OC)c(OC)cc2C1	dopamine receptor antagonist	DRD3
UAMC-00039	11232124	BRD-K38966689	N[C@@H](CCNCc1ccc(Cl)cc1)C(=O)N1CCCCC1	dipeptidyl peptidase inhibitor	DPP4|DPP7
UB-165	4694339	BRD-A14574269	Clc1ccc(cn1)C1=CCCC2CCC1N2	acetylcholine receptor agonist	CHRNA3|CHRNA4|CHRNB2
ubenimex	6992132	BRD-K59574735	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(O)=O	leukotriene synthesis inhibitor	LTA4H|RNPEP
UBP-296	11674376	BRD-A45499626	NC(Cn1ccc(=O)n(Cc2ccccc2C(O)=O)c1=O)C(O)=O	glutamate receptor antagonist	GRIK1
UBP-302	6420161	BRD-K79753741	N[C@@H](Cn1ccc(=O)n(Cc2ccccc2C(O)=O)c1=O)C(O)=O	glutamate receptor antagonist	GRIK1
UBP-310	6420160	BRD-K09597601	Cc1cn(C[C@H](N)C(O)=O)c(=O)n(Cc2ccsc2C(O)=O)c1=O	glutamate receptor antagonist	GRIK1|GRIK5
UC-112	30918719	BRD-K73610817	Oc1c(CN2CCCC2)cc(COCc2ccccc2)c2cccnc12	XIAP inhibitor	XIAP
UCL-2077	24868317	BRD-K50325075	C(NC(c1ccccc1)(c1ccccc1)c1ccccc1)c1cccnc1	slow afterhyperpolarization channel blocker	
UF-010	4596836	BRD-K20480395	CCCCNNC(=O)c1ccc(Br)cc1	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC8
ufenamate	5632	BRD-K84173274	CCCCOC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F	cyclooxygenase inhibitor	PTGS1|PTGS2
UH-232-(+)	6604756	BRD-K66715657	CCCN(CCC)[C@@H]1CCc2c(OC)cccc2[C@@H]1C	dopamine receptor antagonist	DRD2|DRD3|DRD4|HTR1A
UK-356618	10370504	BRD-K57011718	C[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCc1ccc(c(C)c1)-c1ccccc1)CC(=O)NO)C(C)(C)C)c1ccccc1	metalloproteinase inhibitor	MMP13|MMP14|MMP2|MMP3|MMP9
UK-383367	9818682	BRD-K06294530	NC(=O)c1noc(n1)[C@H](CCCC1CCCCC1)CC(=O)NO	Procollagen C-Endopeptidase Inhibitors	BMP1
UK-5099	6438504	BRD-K19558579	OC(=O)C(=C\c1cn(-c2ccccc2)c2ccccc12)\C#N	monocarboxylate transporter inhibitor	SLC16A1
ulifloxacin	124225	BRD-A61633223	CC1Sc2c(C(O)=O)c(=O)c3cc(F)c(cc3n12)N1CCNCC1		
ulipristal	130904	BRD-K64381438	CN(C)c1ccc(cc1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(OC(C)=O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12	progesterone receptor antagonist	PGR
umeclidinium	11519070	BRD-K46692793	OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3
UNBS-5162	16048966	BRD-K30933884	CN(C)CCN1C(=O)c2cccc3cc(NC(N)=O)cc(C1=O)c23	CC chemokine receptor antagonist	
UNC-2327	71583615	BRD-K60635008	O=C(NCC(=O)N1CCCCC1)Nc1ccc2nnsc2c1	protein arginine N-methyltransferase inhibitor	PRMT3
UNC-3230	46355372	BRD-K46344388	NC(=O)c1nc(Nc2ccccc2)sc1NC(=O)C1CCCCC1	phosphatidyl-inositol activator	PIP5K1C
UNC-926	61041645	BRD-K22229656	Brc1cccc(c1)C(=O)N1CCC(CC1)N1CCCC1	MBT inhibitor	L3MBTL1
UNC0224	44251522	BRD-K77428767	COc1cc2c(NC3CCN(C)CC3)nc(nc2cc1OCCCN(C)C)N1CCCN(C)CC1	histone lysine methyltransferase inhibitor	EHMT1|EHMT2
UNC0321	46901937	BRD-K74236984	COc1cc2c(NC3CCN(C)CC3)nc(nc2cc1OCCOCCN(C)C)N1CCCN(C)CC1	histone lysine methyltransferase inhibitor	EHMT2
UNC0631	53315868	BRD-K13060017	COc1cc2c(NC3CCN(CC4CCCCC4)CC3)nc(nc2cc1OCCCN1CCCCC1)N1CCCN(CC1)C(C)C	histone lysine methyltransferase inhibitor	EHMT2
UNC0638	46224516	BRD-K86856088	COc1cc2c(NC3CCN(CC3)C(C)C)nc(nc2cc1OCCCN1CCCC1)C1CCCCC1	histone lysine methyltransferase inhibitor	EHMT1|EHMT2
UNC0642	53315878	BRD-K60130390	COc1cc2c(NC3CCN(CC3)C(C)C)nc(nc2cc1OCCCN1CCCC1)N1CCC(F)(F)CC1	histone lysine methyltransferase inhibitor	EHMT1|EHMT2
UNC0646	53315882	BRD-K87465484	COc1cc2c(NC3CCN(CC3)C3CCCCC3)nc(nc2cc1OCCCN1CCCCC1)N1CCCN(CC1)C(C)C	histone lysine methyltransferase inhibitor	EHMT2
UNC0737	52953431	BRD-K02988401	COc1cc2c(nc(nc2cc1OCCCN1CCCC1)C1CCCCC1)N(C)C1CCN(CC1)C(C)C	histone lysine methyltransferase inhibitor	EHMT1|EHMT2
UNC1215	57339144	BRD-K83189926	O=C(N1CCC(CC1)N1CCCC1)c1ccc(C(=O)N2CCC(CC2)N2CCCC2)c(Nc2ccccc2)c1	L3MBTL antagonist	L3MBTL3
UNC1999	72551585	BRD-K26989966	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(cc2n(ncc12)C(C)C)-c1ccc(nc1)N1CCN(CC1)C(C)C	histone lysine methyltransferase inhibitor	EZH2
UNC2025		BRD-K91283740	CCCCNc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1ccc(CN2CCN(C)CC2)cc1	MER tyrosine kinase inhibitor; FLT3 inhibitor	FLT3|MERTK
UNC2250		BRD-K01773560	CCCCNc1ncc(-c2ccc(CN3CCOCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1	MER tyrosine kinase inhibitor	MERTK
UNC669	46931242	BRD-K21906513	Brc1cncc(c1)C(=O)N1CCC(CC1)N1CCCC1	L3MBTL antagonist	L3MBTL1
undecylenic-acid	5634	BRD-K19189338	OC(=O)CCCCCCCCC=C	other antifungal	
UPF-1069	25015515	BRD-K77950083	O=C(COc1cccc2c1cc[nH]c2=O)c1ccccc1	PARP inhibitor	PARP2
uprosertib	51042438	BRD-K38332599	Cn1ncc(Cl)c1-c1cc(oc1Cl)C(=O)N[C@H](CN)Cc1ccc(F)c(F)c1	AKT inhibitor	AKT1|AKT2|AKT3
uracil	1174	BRD-K80129304	Oc1ccnc(O)n1		DPYD|UCKL1
uracil-mustard	6194	BRD-K10180294	Oc1ncc(N(CCCl)CCCl)c(O)n1	DNA synthesis inhibitor	
urapidil	5639	BRD-K73196317	COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1	adrenergic receptor antagonist	HTR1A
URB597	1383884	BRD-K92169341	NC(=O)c1cccc(c1)-c1cccc(OC(=O)NC2CCCCC2)c1	FAAH inhibitor	FAAH|FAAH2|TRPA1
urea	1176	BRD-K88052444	NC(N)=O	hydroxy radical formation stimulant	ARG1|CA2|CTNNB1
urethane	5641	BRD-K24297741	CCOC(N)=O	local anesthetic	
uric-acid	1175	BRD-K01295354	O=c1[nH]c2[nH]c(=O)[nH]c(=O)c2[nH]1		PYGL
uridine	6029	BRD-K13050303	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc(=O)[nH]c1=O	dopamine receptor agonist	LSM6|TYMP
uridine-triacetate	20058	BRD-K18323388	CC(=O)OC[C@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)n1ccc(=O)[nH]c1=O		
uridine-5'-triphosphate	6133	BRD-A89637065	O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O	purinergic receptor activator	P2RY11|P2RY2|P2RY4|P2RY6|UCK2
URMC-099	54764565	BRD-K66908976	CN1CCN(Cc2ccc(cc2)-c2cnc3[nH]cc(-c4ccc5[nH]ccc5c4)c3c2)CC1	mixed lineage kinase inhibitor	CDKL2|DAPK3|FLT3|LRRK2|MAP3K10|MAP3K11|MAP3K2|MAP3K9|SRPK2
ursodeoxycholyltaurine	9848818	BRD-K45245728	C[C@H](CCC(=O)NCCS(O)(=O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	cholesterol inhibitor	
ursodiol	31401	BRD-K15697815	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	nuclear factor erythroid derived; like (NRF2) activator	NR1H4
ursolic-acid	64945	BRD-K68185022	C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O	ATPase inhibitor; NFkB pathway inhibitor; STAT inhibitor	HSD11B1|PLA2G1B|PTPN1|PYGM
usniacin-(+)	461310	BRD-A12417644	CC(=O)C1C(=O)C=C2Oc3c(c(O)c(C)c(O)c3C(C)=O)[C@@]2(C)C1=O	MAP kinase activator	PTPN1
V-51	1376860	BRD-K75052463	COc1cc(CN2CCN(CC2)c2ccc(F)cc2)cc(OC)c1OC	adrenergic receptor antagonist	
val	6971095	BRD-K59424860	CC(C)[C@@H](N)C(O)=O		BCAT1|PCCB|VARS
valaciclovir	60773	BRD-K46435977	CC(C)[C@H](N)C(=O)OCCOCn1cnc2c1nc(N)[nH]c2=O	DNA polymerase inhibitor	
valdecoxib	119607	BRD-K12994359	Cc1onc(c1-c1ccc(cc1)S(N)(=O)=O)-c1ccccc1	cyclooxygenase inhibitor	CA12|PTGS2
valethamate	5648	BRD-A56613951	CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1	acetylcholine receptor antagonist	CHRM1|CHRM4|CHRM5
valganciclovir	64147	BRD-A50922295	CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c1nc(N)[nH]c2=O	DNA synthesis inhibitor	
valnemulin	15093181	BRD-K33813875	CC(C)[C@@H](N)C(=O)NCC(C)(C)SCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@]23CCC(=O)[C@H]2[C@]1(C)[C@H](C)CC3	bacterial 50S ribosomal subunit inhibitor	
valnoctamide	20140	BRD-A96644976	CCC(C)C(CC)C(N)=O	arachidonic acid acylation inhibitor; benzodiazepine receptor agonist	
valproic-acid	3121	BRD-K41260949	CCCC(CCC)C(O)=O	HDAC inhibitor	ABAT|ACADSB|ALDH5A1|HDAC1|HDAC2|HDAC9|OGDH|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A
valpromide	71113	BRD-K54698528	CCCC(CCC)C(N)=O	epoxide hydolase inhibitor	
valrocemide	6918293	BRD-K32804101	CCCC(CCC)C(=O)NCC(N)=O		
valrubicin	454216	BRD-K72951360	CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1	DNA inhibitor; topoisomerase inhibitor	TOP2A
valsartan	60846	BRD-K45158365	CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)[C@@H](C(C)C)C(O)=O	angiotensin receptor antagonist	AGTR1
valspodar	5281884	BRD-K19412342	C\C=C\C[C@@H](C)C(=O)[C@@H]1N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@@H](NC1=O)C(C)C)C(C)C	P glycoprotein inhibitor	ABCB1
vancomycin	14969	BRD-K91065602	CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)[C@@H](O)[C@@H]5NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@H](NC5=O)C(O)=O)c3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1)c(Cl)c2	bacterial cell wall synthesis inhibitor	
vandetanib	3081361	BRD-K77625799	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1	EGFR inhibitor; RET tyrosine kinase inhibitor; VEGFR inhibitor	EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA
vanillin	1183	BRD-K24258499	COc1cc(C=O)ccc1O		ABAT|ALDH5A1
vanillylacetone	31211	BRD-K33510429	COc1cc(CCC(C)=O)ccc1O		
vanitiolide		BRD-K26502378	COc1cc(ccc1O)C(=S)N1CCOCC1		
vanoxerine	3455	BRD-K32501161	Fc1ccc(cc1)C(OCCN1CCN(CCCc2ccccc2)CC1)c1ccc(F)cc1	dopamine uptake inhibitor	SLC6A3
vardenafil	110634	BRD-K13926615	CCCc1nc(C)c2n1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC)CC1	phosphodiesterase inhibitor	PDE5A|PDE6G|PDE6H
varenicline	170361	BRD-A86216746	C1C2CNCC1c1cc3nccnc3cc21	acetylcholine receptor agonist	CHRNA3|CHRNA4|CHRNA6|CHRNA7
varespladib	155815	BRD-K09711437	CCc1c(C(=O)C(N)=O)c2c(OCC(O)=O)cccc2n1Cc1ccccc1	secretory phospholipase inhibitor	PLA2G2A
vasopressin	644077	BRD-K73028949	N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O	vasopressin receptor agonist	AVPR1A|AVPR1B|AVPR2|OXTR
vatalanib	151194	BRD-K70163715	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1	KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor	EGFR|FLT1|FLT4|KDR|PDGFRB
VBY-825	70945511	BRD-K36338614	CC[C@H](NC(=O)[C@H](CS(=O)(=O)CC1CC1)N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)C(=O)NC1CC1	cathepsin inhibitor	CTSB|CTSL|CTSS
VCH-916		BRD-K75956464	CO[C@H]1CC[C@@H](CC1)N(C(=O)[C@H]1CC[C@H](C)CC1)c1cc(sc1C(O)=O)C1=CCCCC1	HCV inhibitor	
VE-821	51000408	BRD-K26756394	CS(=O)(=O)c1ccc(cc1)-c1cnc(N)c(n1)C(=O)Nc1ccccc1	ATR kinase inhibitor	ATR
VE-822	59472121	BRD-K04701033	CNCc1ccc(cc1)-c1cc(on1)-c1nc(cnc1N)-c1ccc(cc1)S(=O)(=O)C(C)C	ATR kinase inhibitor	ATM|ATR|MTOR|PIK3CG
vecuronium	39765	BRD-K20168442	CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1	acetylcholine receptor antagonist	CHRNA2
veliflapon	123723	BRD-K12852738	OC(=O)[C@H](C1CCCC1)c1ccc(OCc2ccc3ccccc3n2)cc1	leukotriene synthesis inhibitor	ALOX5AP
veliparib	11842604	BRD-K12737986	C[C@]1(CCCN1)c1nc2c(cccc2[nH]1)C(N)=O	PARP inhibitor	PARP1|PARP2
velneperit		BRD-K06357403	CC(C)(C)S(=O)(=O)N[C@H]1CC[C@@H](CC1)C(=O)Nc1ccc(cn1)C(F)(F)F	neuropeptide receptor antagonist	NPY5R
vemurafenib	42611257	BRD-K56343971	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)-c2ccc(Cl)cc2)c1F	RAF inhibitor	BRAF|RAF1
venetoclax	49846579	BRD-K62391742	CC1(C)CCC(CN2CCN(CC2)c2ccc(C(=O)NS(=O)(=O)c3ccc(NCC4CCOCC4)c(c3)[N+]([O-])=O)c(Oc3cnc4[nH]ccc4c3)c2)=C(C1)c1ccc(Cl)cc1	BCL inhibitor	BCL2
venlafaxine	5656	BRD-A51714012	COc1ccc(cc1)C(CN(C)C)C1(O)CCCCC1	adrenergic inhibitor; norepinephrine reuptake inhibitor; serotonin norepinephrine reuptake inhibitor (SNRI)	SLC6A2|SLC6A3|SLC6A4
VER-155008	25195348	BRD-K32330832	Nc1ncnc2n([C@@H]3O[C@H](COCc4ccc(cc4)C#N)[C@@H](O)[C@H]3O)c(NCc3ccc(Cl)c(Cl)c3)nc12	HSP inhibitor	HSPA1A
VER-49009		BRD-K38548312	CCNC(=O)c1[nH]nc(c1-c1ccc(OC)cc1)-c1cc(Cl)c(O)cc1O	HSP inhibitor	HSP90AA1
verapamil	2520	BRD-A09533288	COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC	calcium channel blocker	CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CYP3A4|KCNA10|KCNA7|KCNH2|KCNJ11|NALCN|SCN5A|SLC29A4|SLC6A4
verbascoside	5281800	BRD-K36201510	C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)\C=C\c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O	PKC inhibitor; NFkB pathway inhibitor	
vercirnon	10343454	BRD-K47929404	CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc1ccc(Cl)cc1C(=O)c1cc[n+]([O-])cc1	CC chemokine receptor antagonist	CCR9
verinurad	54767229	BRD-K36741660	CC(C)(Sc1ccncc1-c1ccc(C#N)c2ccccc12)C(O)=O	urate transporter inhibitor	SLC22A12
vernakalant	9930049	BRD-K19741547	COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC	potassium channel blocker	KCNA5
verteporfin	5362420	BRD-K81849500	COC(=O)CCc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)c(CCC(O)=O)c5C)c(C=C)c4C)C1=CC=C([C@@H](C(=O)OC)[C@@]31C)C(=O)OC	photosensitizing agent	
verubulin	11414799	BRD-K42673188	COc1ccc(cc1)N(C)c1nc(C)nc2ccccc12	tubulin polymerization inhibitor	TUBB
vesamicol	659840	BRD-K14765469	O[C@@H]1CCCC[C@H]1N1CCC(CC1)c1ccccc1	acetylcholinesterase inhibitor	SLC18A3
vesnarinone	5663	BRD-K13414800	COc1ccc(cc1OC)C(=O)N1CCN(CC1)c1ccc2NC(=O)CCc2c1	phosphodiesterase inhibitor	KCNH2|PDE3A
VGX-1027	10798271	BRD-A32269193	OC(=O)CC1CC(=NO1)c1ccccc1	tumor necrosis factor receptor antagonist	TLR4
vicriviroc	3009355	BRD-K84748119	COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F	CC chemokine receptor antagonist	CCR5
vidarabine	21704	BRD-K72093121	Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	antiviral	ADA
vigabatrin	25202592	BRD-A07893380	NC(CCC(O)=O)C=C	GABA aminotransferase inhibitor	ABAT|GABBR1|SLC32A1
vilanterol	44482554	BRD-M36487418	OC(=O)C(c1ccccc1)(c1ccccc1)c1ccccc1.OCc1cc(ccc1O)[C@@H](O)CNCCCCCCOCCOCc1c(Cl)cccc1Cl	adrenergic receptor agonist	ADRB2
vilazodone	6918314	BRD-K58010567	NC(=O)c1cc2cc(ccc2o1)N1CCN(CCCCc2c[nH]c3ccc(cc23)C#N)CC1	serotonin reuptake inhibitor	DRD2|DRD3|HRH1|HTR1A|HTR4|SLC6A4
vildagliptin	6918537	BRD-A94993966	OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N	dipeptidyl peptidase inhibitor	DPP4
viloxazine	5666	BRD-A59198242	CCOc1ccccc1OCC1CNCCO1	norepinephrine reuptake inhibitor	SLC6A2
vinblastine	13342	BRD-K06519765	CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC	microtubule inhibitor; tubulin polymerization inhibitor	JUN|TUBA1A|TUBB|TUBD1|TUBE1|TUBG1
vinburnine	71203	BRD-K40227168	CC[C@@]12CCCN3CCc4c([C@H]13)n(C(=O)C2)c1ccccc41	adrenergic receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4
vincamine	637570	BRD-K89704198	CC[C@@]12CCCN3CCc4c([C@H]13)n(c1ccccc41)[C@@](O)(C2)C(=O)OC	adrenergic receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4
vincristine	5388993	BRD-K12251893	CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC	tubulin polymerization inhibitor	TUBA4A|TUBB
vindesine	40839	BRD-K59753975	CC[C@]1(O)C[C@H]2CN(C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](O)[C@]1(O)C(N)=O	tubulin polymerization inhibitor	TUBB|TUBB1
vinflunine	11967282	BRD-K64120610	CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)c1cc(OC)c(cc41)[C@]1(C[C@@H]3C[C@H](C[N@@](C3)CCc3c1[nH]c1ccccc31)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(C)=O)C(=O)OC	microtubule inhibitor	
vinorelbine	5311497	BRD-K04269837	CCC1=C[C@@H]2C[N@](C1)Cc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC	tubulin polymerization inhibitor	TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8
vinpocetine	443955	BRD-K53318339	CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c([C@H]23)n1c1ccccc41	phosphodiesterase inhibitor; sodium channel blocker	PDE1A|PDE1C
viomycin	3003721	BRD-A42379279	NCCC[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@@H](NC(=O)\C(NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O)=C\NC(N)=O)C1C[C@H](O)N=C(N)N1	protein synthesis inhibitor	
vipadenant	21874557	BRD-K56565215	Cc1cc(Cn2nnc3c(nc(N)nc23)-c2ccco2)ccc1N	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
vismodegib	24776445	BRD-K44827188	Clc1cc(ccc1C(=O)Nc1ccc(Cl)c(c1)-c1ccccn1)S(C)(=O)=O	hedgehog pathway inhibitor; smoothened receptor antagonist	SMO
vitamin-b12		BRD-A75369945	C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2[N+]3=C1C(C)=C1[C@@H](CCC(N)=O)C(C)(C)C4=[N+]1[Co]31(C#N)N3C([C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@]23C)=C(C)C2=[N+]1C(=C4)[C@@H](CCC(N)=O)[C@]2(C)CC(N)=O)OP(O)(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)n1cnc2cc(C)c(C)cc12		
vitamin-E	14985	BRD-K97091514	CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(O)c(C)c(C)c2O1	PKC inhibitor; LDL oxidation inhibitor	ALOX5|DGKA|NR1I2|PPP2CA|PPP2CB|PRKCA|PRKCB|SEC14L2|SEC14L3|SEC14L4
VLX-600		BRD-K26122255	Cc1cccc2c1[nH]c1nc(NNC(=C)c3ccccn3)nnc21	antitumor agent	TP53
VLX600	6413301	BRD-K89053832	C\C(=N\Nc1nnc2c(n1)[nH]c1c(C)cccc21)c1ccccn1	ubiquitin C-terminal hydrolase inhibitor	USP14
voglibose	444020	BRD-K66850609	OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O	glucosidase inhibitor	MGAM
volasertib		BRD-K69776681	CC[C@H]1N(C(C)C)c2nc(Nc3ccc(cc3OC)C(=O)N[C@H]3CC[C@@H](CC3)N3CCN(CC4CC4)CC3)ncc2N(C)C1=O	PLK inhibitor	PLK1
volinanserin	5311271	BRD-K23647661	COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C|KCNH2
vonoprazan	15981397	BRD-K32768103	CNCc1cc(-c2ccccc2F)n(c1)S(=O)(=O)c1cccnc1	potassium-competitive acid antagonist	ATP4A
vorapaxar	10077130	BRD-K93442924	CCOC(=O)N[C@@H]1CC[C@@H]2[C@H](C[C@@H]3[C@@H]([C@@H](C)OC3=O)[C@H]2\C=C\c2ccc(cn2)-c2cccc(F)c2)C1	thrombin receptor antagonist	F2R
voreloxin	9952884	BRD-K23677682	CN[C@H]1CN(C[C@@H]1OC)c1ccc2c(n1)n(cc(C(O)=O)c2=O)-c1nccs1	topoisomerase inhibitor	TOP2A
voriconazole	71616	BRD-K06557128	C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F	cytochrome P450 inhibitor	CYP2C19|CYP2C9|CYP3A4|CYP3A5|PTGS1
vorinostat	5311	BRD-K81418486	ONC(=O)CCCCCCC(=O)Nc1ccccc1	HDAC inhibitor	HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC5|HDAC6|HDAC8|HDAC9
vortioxetine	9966051	BRD-K53963539	Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1	serotonin receptor agonist; serotonin receptor antagonist	HTR1A|HTR1B|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A4
voxtalisib	16123056	BRD-K56291712	CCn1c2nc(N)nc(C)c2cc(-c2cc[nH]n2)c1=O	mTOR inhibitor; PI3K inhibitor	MTOR|PIK3CA
VP-20629	3744	BRD-K21071223	OC(=O)CCc1c[nH]c2ccccc12	beta amyloid antagonist	PLA2G2E|SLC36A1
VS-4718	25073775	BRD-K09877029	CNC(=O)c1ccccc1Nc1cc(Nc2ccc(cc2OC)N2CCOCC2)ncc1C(F)(F)F	focal adhesion kinase inhibitor	
VT-464	78357816	BRD-K72005722	CC(C)[C@@](O)(c1c[nH]nn1)c1ccc2cc(OC(F)F)c(OC(F)F)cc2c1	cytochrome P450 inhibitor	CYP17A1
VTP-27999	16126898	BRD-K81694556	CN[C@H](CNC(=O)N1CCC[C@H](C1)[C@@H](OCCNC(=O)OC)c1cccc(Cl)c1)C[C@H]1CCCOC1	renin inhibitor	REN
VU-0240551	7211972	BRD-K27074404	Cc1csc(NC(=O)CSc2ccc(nn2)-c2ccccc2)n1	potassium/chloride cotransporter inhibitor	SLC12A5
VU-0364739	46937439	BRD-K93317811	Fc1cccc(c1)N1CNC(=O)C11CCN(CCNC(=O)c2ccc3ccccc3c2)CC1	phospholipase inhibitor	PLD2
VU-0422288	73058507	BRD-K68674163	Clc1ccc(Oc2ccc(NC(=O)c3ccccn3)cc2Cl)nc1	glutamate receptor allosteric modulator	GRM3
VU-152100	864492	BRD-K87727457	COc1ccc(CNC(=O)c2sc3nc(C)cc(C)c3c2N)cc1	acetylcholine receptor allosteric modulator	CHRM4
VUF10166	24278976	BRD-K11046126	CN1CCN(CC1)c1nc2ccccc2nc1Cl	serotonin receptor antagonist	HTR3A|HTR3B
VUF10460	25129523	BRD-K90082312	CN1CCN(CC1)c1cc(nc(N)n1)-c1ccccc1	histamine receptor agonist	HRH4
VUF11207	59052285	BRD-A93717708	COc1cc(cc(OC)c1OC)C(=O)N(CCC1CCCN1C)C\C(C)=C\c1ccccc1F	CC chemokine receptor agonist	ACKR3
VU0155069	25105713	BRD-K48535733	C[C@@H](CN1CCC(CC1)n1c2ccc(Cl)cc2[nH]c1=O)NC(=O)c1ccc2ccccc2c1	phospholipase inhibitor	PLD1
VU0238429	42633508	BRD-K24187789	COc1ccc(CN2C(=O)C(=O)c3cc(OC(F)(F)F)ccc23)cc1	acetylcholine receptor allosteric modulator	CHRM5
VU0357121	2296132	BRD-K86109159	CCCCOc1ccc(cc1)C(=O)Nc1ccc(F)cc1F	glutamate receptor positive allosteric modulator	GRM5
VU0360172	53318624	BRD-K83649660	Fc1cccc(c1)C#Cc1ccc(cn1)C(=O)NC1CCC1	glutamate receptor positive allosteric modulator	GRM5
VU0361737	44191096	BRD-K45462423	COc1cc(NC(=O)c2ccccn2)ccc1Cl	glutamate receptor positive allosteric modulator	GRM4
VU0364439	46934289	BRD-K72687424	Clc1ccccc1NS(=O)(=O)c1ccc(NC(=O)c2ccccn2)cc1Cl	glutamate receptor positive allosteric modulator	GRM4
VU0364770	836002	BRD-K66527818	Clc1cccc(NC(=O)c2ccccn2)c1	glutamate receptor positive allosteric modulator	GRM4
VU10010	714286	BRD-K12483104	Cc1cc(C)c2c(N)c(sc2n1)C(=O)NCc1ccc(Cl)cc1	acetylcholine receptor allosteric modulator	CHRM4
VU1545	11625520	BRD-K48371964	[O-][N+](=O)c1ccc(cc1)C(=O)Nc1cc(nn1-c1ccccc1F)-c1ccccc1	glutamate receptor positive allosteric modulator	GRM5
VU29	11610682	BRD-K54783522	[O-][N+](=O)c1ccc(cc1)C(=O)Nc1cc(nn1-c1ccccc1)-c1ccccc1	glutamate receptor potentiator	GRM5
VU591	44123657	BRD-K72063794	[O-][N+](=O)c1ccc2nc(COCc3nc4ccc(cc4[nH]3)[N+]([O-])=O)[nH]c2c1	potassium channel blocker	KCNJ1
VX-11e	11634725	BRD-K93725829	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(c1)C(=O)N[C@H](CO)c1cccc(Cl)c1	MAP kinase inhibitor	MAPK1
VX-222		BRD-K70610771	C[C@H]1CC[C@@H](CC1)C(=O)N([C@@H]1CC[C@H](O)CC1)c1cc(sc1C(O)=O)C#CC(C)(C)C	HCV inhibitor	
VX-702	10341154	BRD-K07736136	NC(=O)N(c1ccc(C(N)=O)c(n1)-c1ccc(F)cc1F)c1c(F)cccc1F	p38 MAPK inhibitor	MAPK11|MAPK12|MAPK14
VX-745	3038525	BRD-K91900765	Fc1ccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)c(F)c1	p38 MAPK inhibitor	MAPK11|MAPK12|MAPK14
VX-765	59772309	BRD-K26712974	CCO[C@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1ccc(N)c(Cl)c1)C(C)(C)C	caspase inhibitor	CASP1
W-54011	5311122	BRD-A00559310	COc1ccc2CCCC(C(=O)N(Cc3ccc(cc3)N(C)C)c3ccc(cc3)C(C)C)c2c1	anaphylatoxin chemotactic receptor antagonist	C5AR1
walrycin-b	3164070	BRD-K01129913	Cn1nc(nc2c1nc(=O)n(C)c2=O)-c1ccc(cc1)C(F)(F)F	transcriptional regulatory protein WalR	
warfarin	54678486	BRD-A24514565	CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O	vitamin K antagonist	VKORC1
WAY-100635	5684	BRD-K69812556	COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1	serotonin receptor antagonist	HTR1A
WAY-161503	3906894	BRD-A62021152	Clc1cc2NC(=O)C3CNCCN3c2cc1Cl	serotonin receptor agonist	HTR2C
WAY-170523	9830392	BRD-K36198571	Cc1cc(C)c(N(Cc2ccccc2)S(=O)(=O)c2ccc(OCCNC(=O)c3cc4ccccc4o3)cc2)c(c1)C(=O)NO	metalloproteinase inhibitor	MMP13
WAY-200070		BRD-K08223200	Oc1ccc(cc1)-c1nc2cc(O)cc(Br)c2o1	estrogen receptor agonist	ERBB2|ERBB3|ERBB4|ESR2
WAY-207024	11496610	BRD-K08657056	CC(C)(C)c1ccc(cc1)-c1nc2cccc(N3CCN(Cc4ccc5nccnc5c4)CC3)c2[nH]1	gonadotropin releasing factor hormone receptor antagonist	GNRHR|HRH2|TACR2
WAY-208466	10337743	BRD-K63483542	CN(C)CCn1cc(c2cccnc12)S(=O)(=O)c1cccc(F)c1	serotonin receptor agonist	DRD2|HTR2A|HTR2C|HTR6|HTR7
WAY-213613	11531745	BRD-K96758128	N[C@@H](CC(=O)Nc1ccc(Oc2cc(F)c(F)cc2Br)cc1)C(O)=O	glutamate inhibitor	SLC1A2
WAY-316606	16727102	BRD-K61871885	FC(F)(F)c1ccc(cc1S(=O)(=O)NC1CCNCC1)S(=O)(=O)c1ccccc1	secreted frizzled related protein inhibitor	SFRP1
WAY-362450	10026128	BRD-K54640016	CC(C)OC(=O)C1=CN(CC(C)(C)c2c1[nH]c1ccccc21)C(=O)c1ccc(F)c(F)c1	FXR agonist	NR1H4
WAY-600	25229526	BRD-K85920262	C(N1CCC(CC1)n1ncc2c(nc(nc12)-c1ccc2[nH]ccc2c1)N1CCOCC1)c1cccnc1	mTOR inhibitor	MTOR
WAY-629	6604933	BRD-K55430733	C1CCc2c(C1)n1CCNCc3cccc2c13	serotonin receptor agonist	HTR2C
WB-4101	5685	BRD-A01493904	COc1cccc(OC)c1OCCNCC1COc2ccccc2O1	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1A
WDR5-0103	6457069	BRD-K47726410	COC(=O)c1ccc(N2CCN(C)CC2)c(NC(=O)c2cccc(OC)c2)c1	histone lysine methyltransferase inhibitor	WDR5
WEHI-345-analog	56602558	BRD-K55487946	Cc1ccc(cc1)-c1nn(c2ncnc(N)c12)C(C)(C)CNC(=O)c1ncccc1C	src inhibitor	
WH-4-023	11844351	BRD-K50199947	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(cc3)N3CCN(C)CC3)n2)c(OC)c1	src inhibitor	LCK|SRC
WHI-P154	3795	BRD-K07487750	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC	JAK inhibitor	EGFR|JAK1|JAK2|JAK3
WIKI4	2984337	BRD-K19316653	COc1ccc(cc1)-n1c(SCCCN2C(=O)c3cccc4cccc(C2=O)c34)nnc1-c1ccncc1	Wnt pathway inhibitor; tankyrase inhibitor	TNKS2
WIN-18446	15134	BRD-K30930903	ClC(Cl)C(=O)NCCCCCCCCNC(=O)C(Cl)Cl	aldehyde dehydrogenase inhibitor	ALDH1A2
WIN-64338	101653257	BRD-K22662557	CCCC[P+](CCCC)(CCCC)Cc1ccc(NC(=O)[C@H](Cc2ccc3ccccc3c2)N\C(NC2CCCCC2)=N\C2CCCCC2)cc1	bradykinin receptor antagonist	BDKRB2
wiskostatin	2775510	BRD-A18579359	CN(C)CC(O)Cn1c2ccc(Br)cc2c2cc(Br)ccc12	neural Wiskott-Aldrich syndrome protein inhibitor; actin related protein inhibitor	WAS|WASL
wnt-c59	57519544	BRD-K78455053	Cc1cc(ccn1)-c1ccc(CC(=O)Nc2ccc(cc2)-c2cccnc2)cc1	porcupine inhibitor	PORCN
wortmannin	312145	BRD-K87343924	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C([C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O)C3=O	PI3K inhibitor	PI4KA|PI4KB|PIK3CA|PIK3CD|PIK3CG|PIK3R1|PLK1|PRKDC
WP1066	11210478	BRD-K05445342	C[C@H](NC(=O)C(=C\c1cccc(Br)n1)\C#N)c1ccccc1	STAT inhibitor	STAT3
WP1130	11222830	BRD-K43644456	CCC[C@H](NC(=O)C(=C\c1cccc(Br)n1)\C#N)c1ccccc1	deubiquitinase inhibitor	JAK2|UCHL5|USP14|USP9X
WR99210	121750	BRD-K45973863	CC1(C)N=C(N)N=C(N)N1OCCCOc1cc(Cl)c(Cl)cc1Cl	dihydrofolate reductase inhibitor	TYMS
WWL-113	17759482	BRD-K49389158	CCOC(=O)c1ccc(cc1)-c1ccc(OC(=O)N(C)Cc2cccc(c2)-c2ccncc2)cc1	carboxylesterase inhibitor	CES3
WWL-123	90209976	BRD-K83176916	CN(Cc1cccc(c1)-c1ccccc1)C(=O)Oc1ccc(cc1)-c1ccc(cc1)C(N)=O	monoacylglycerol lipase inhibitor	ABHD6
Wy-16922	198325	BRD-K43419711	CCOC(=O)C(=O)Nc1cccc(OC)c1C(N)=O	histamine release inhibitor	
WYE-125132	25260757	BRD-A45498368	CNC(=O)Nc1ccc(cc1)-c1nc(N2CC3CCC(C2)O3)c2cnn(C3CCC4(CC3)OCCO4)c2n1	mTOR inhibitor	MTOR
WYE-354	44219749	BRD-K77008974	COC(=O)Nc1ccc(cc1)-c1nc(N2CCOCC2)c2cnn(C3CCN(CC3)C(=O)OC)c2n1	mTOR inhibitor	MTOR
WYE-687	25229450	BRD-K49900195	COC(=O)Nc1ccc(cc1)-c1nc(N2CCOCC2)c2cnn(C3CCN(Cc4cccnc4)CC3)c2n1	mTOR inhibitor	MTOR
WZ-3146	44607360	BRD-K73293050	CN1CCN(CC1)c1ccc(Nc2ncc(Cl)c(Oc3cccc(NC(=O)C=C)c3)n2)cc1	EGFR inhibitor	EGFR
WZ-4002	44607530	BRD-K72420232	COc1cc(ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)C=C)c2)n1)N1CCN(C)CC1	EGFR inhibitor	EGFR|ERBB2
WZ4003	72200024	BRD-K45909031	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(cc3OC)N3CCN(C)CC3)ncc2Cl)c1	AMPK inhibitor	NUAK1|NUAK2
WZ8040	44607531	BRD-K81728688	CN1CCN(CC1)c1ccc(Nc2ncc(Cl)c(Sc3cccc(NC(=O)C=C)c3)n2)cc1	EGFR inhibitor	EGFR
WZ811	11565518	BRD-K25359048	C(Nc1ccccn1)c1ccc(CNc2ccccn2)cc1	CC chemokine receptor antagonist	CXCR4
xaliproden	128919	BRD-K88358234	FC(F)(F)c1cccc(c1)C1=CCN(CCc2ccc3ccccc3c2)CC1	serotonin receptor agonist	HTR1A
xamoterol	155774	BRD-A59337442	OC(CNCCNC(=O)N1CCOCC1)COc1ccc(O)cc1	adrenergic receptor agonist	ADRB1
xanomeline	60809	BRD-K72815923	CCCCCCOc1nsnc1C1=CCCN(C)C1	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6|HTR7
xanthone	7020	BRD-K27135764	O=c1c2ccccc2oc2ccccc12	antimalarial agent	
XAV-939	2726824	BRD-K12762134	Oc1nc(nc2CCSCc12)-c1ccc(cc1)C(F)(F)F	tankyrase inhibitor	TNKS|TNKS2
XBD173	6433109	BRD-K45875383	CCN(Cc1ccccc1)C(=O)Cn1c2nc(ncc2n(C)c1=O)-c1ccccc1	benzodiazepine receptor ligand	TSPO
XD-14	52670832	BRD-K69211575	CCN(CC)S(=O)(=O)c1ccc(O)c(NC(=O)c2[nH]c(C)c(C(C)=O)c2CC)c1	bromodomain inhibitor	BRD2|BRD3|BRD4|BRDT
XE-991	656732	BRD-K42748308	O=C1c2ccccc2C(Cc2ccncc2)(Cc2ccncc2)c2ccccc12	potassium channel blocker	KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5
xenalipin	55251	BRD-K99506538	OC(=O)c1ccccc1-c1ccc(cc1)C(F)(F)F		
xibenolol	146256	BRD-A21446384	Cc1cccc(OCC(O)CNC(C)(C)C)c1C	adrenergic receptor antagonist	
xilobam	6434391	BRD-K79633074	CN1CCC\C1=N\C(=O)Nc1c(C)cccc1C		
xipamide	26618	BRD-K27393415	Cc1cccc(C)c1NC(=O)c1cc(c(Cl)cc1O)S(N)(=O)=O	carbonic anhydrase inhibitor	SLC12A3
XL-147	1893730	BRD-K95901403	Cc1ccc(cc1)S(=O)(=O)Nc1nc2ccccc2nc1Nc1ccc2nsnc2c1	PI3K inhibitor	PIK3CA|PIK3CD|PIK3CG
XL-647		BRD-K03765900	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@H]1C[C@H]2CN(C)C[C@H]2C1	EGFR inhibitor; VEGFR inhibitor	EGFR|EPHB4|ERBB2|FLT4|KDR
XL019	57990869	BRD-K04266228	O=C(Nc1ccc(cc1)-c1ccnc(Nc2ccc(cc2)N2CCOCC2)n1)[C@@H]1CCCN1	JAK inhibitor	JAK1|JAK2|JAK3
XL228	59757974	BRD-K14274271	CC(C)c1cc(CNc2nc(Nc3cc([nH]n3)C3CC3)cc(n2)N2CCN(C)CC2)on1	Abl kinase inhibitor; insulin growth factor receptor inhibitor; src inhibitor	IGF1R|SRC
XL388	59604787	BRD-K03549949	Cc1c(F)c(ccc1C(=O)N1CCOc2ccc(cc2C1)-c1ccc(N)nc1)S(C)(=O)=O	mTOR inhibitor	MTOR
XL888	57748689	BRD-A03506276	CC[C@@H](C)Nc1cc(C(=O)NC2CC3CCC(C2)N3c2ccc(cn2)C(=O)C2CC2)c(C)cc1C(N)=O	HSP inhibitor	
XMD17-109	71604307	BRD-K48449981	CCOc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C3CCCC3)c2n1)C(=O)N1CCC(CC1)N1CCN(C)CC1	MAP kinase inhibitor	MAPK7
XMD8-92	46843772	BRD-K50387473	CCOc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCC(O)CC1	MAP kinase inhibitor	DCLK2|MAPK7|PLK4|TNK1
xylazine	5707	BRD-K21565985	Cc1cccc(C)c1NC1=NCCCS1	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C
xylometazoline	5709	BRD-K08356259	Cc1cc(cc(C)c1CC1=NCCN1)C(C)(C)C	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
xylose	644160	BRD-K10759144	OC[C@@H](O)[C@H](O)[C@@H](O)C=O		
Y-11	427018	BRD-K09317629	OCC[N+]12CN3CN(CN(C3)C1)C2	focal adhesion kinase inhibitor	PTK2
Y-134	11784736	BRD-K94832621	CC(C)N1CCN(CC1)c1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1	estrogen receptor antagonist	ESR1|ESR2
Y-26763	121878	BRD-K45117373	CC(=O)N(O)[C@H]1[C@H](O)C(C)(C)Oc2ccc(cc12)C#N	potassium channel activator	KCNJ8
Y-27152	6918184	BRD-K42679050	CC(=O)N(OCc1ccccc1)[C@H]1[C@H](O)C(C)(C)Oc2ccc(cc12)C#N	potassium channel activator	KCNJ8
Y-27632		BRD-K44084986	C[C@@H](N)[C@H]1CC[C@@H](CC1)C(=O)Nc1ccncc1	rho associated kinase inhibitor	PKIA|PKN2|PRKACA|PRKCE|ROCK1|ROCK2
Y-29794	195609	BRD-K48449073	CC(C)c1ccc(C(=O)c2cccs2)c(SCCCCCCCCN(C)C)n1	prolyl endopeptidase inhibitor	PREP
Y-320	22227931	BRD-K96259238	Cc1c(cnn1-c1ccc(Cl)cc1)C(=O)Nc1ccc(N2CCC(CC2)N2CCOCC2)c(c1)C#N	interleukin inhibitor	IL17A
Y-39983	9810884	BRD-K56751279	C[C@@H](N)c1ccc(cc1)C(=O)Nc1ccnc2[nH]ccc12	rho associated kinase inhibitor	ROCK1|ROCK2
YC-1	5712	BRD-K60476892	OCc1ccc(o1)-c1nn(Cc2ccccc2)c2ccccc12	guanylyl cyclase activator	GUCY1A2|GUCY1A3|GUCY1B3|HIF1A
YIL-781	23631116	BRD-K91403886	CC(C)N1CCC[C@H](Cn2c(C)nc3ccc(Oc4ccc(F)cc4)cc3c2=O)C1	ghrelin receptor antagonist	GHSR
YK-4-279	44632017	BRD-A62182663	COc1ccc(cc1)C(=O)CC1(O)C(=O)Nc2c1c(Cl)ccc2Cl	apoptosis inhibitor	EWSR1|FLI1
YM-155	10126189	BRD-K76703230	COCCn1c2c(C(=O)c3ccccc3C2=O)[n+](Cc2cnccn2)c1C	survivin inhibitor	BIRC5
YM-201636	9956222	BRD-K48488978	Nc1ccc(cn1)C(=O)Nc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1	PI3K inhibitor	
YM-244769	11442117	BRD-K52087522	Nc1cccc(CNC(=O)c2ccc(Oc3ccc(OCc4cccc(F)c4)cc3)nc2)c1	sodium/calcium exchange inhibitor	
YM-298198	9819432	BRD-K59650319	CN(C1CCCCC1)C(=O)c1sc2nc3ccc(N)cc3n2c1C	glutamate receptor antagonist	GRM1
YM-511	177865	BRD-K38398115	Brc1ccc(CN(c2ccc(cc2)C#N)n2cnnc2)cc1	aromatase inhibitor	CYP19A1
YM-58483	2455	BRD-K42563464	Cc1nnsc1C(=O)Nc1ccc(cc1)-n1nc(cc1C(F)(F)F)C(F)(F)F	calcium channel blocker	TRPC3|TRPC5|TRPM4
YM-750	9911716	BRD-K91716465	Cc1cc(C)c(NC(=O)N(Cc2ccc-3c(Cc4ccccc-34)c2)C2CCCCCC2)c(C)c1	ACAT inhibitor	SOAT1
YM-90709	1103147	BRD-K06712146	COc1cc2CC(C)(C)n3c(cc4nc5ccccc5nc34)-c2cc1OC	IL5 inhibitor	CSF2RB|IL5RA
YM-976	6604918	BRD-K12932420	CCc1ccc2c(nc(=O)n(CC)c2n1)-c1cccc(Cl)c1	phosphodiesterase inhibitor	PDE4A
YM022	122130	BRD-K09436144	Cc1cccc(NC(=O)N[C@@H]2N=C(c3ccccc3)c3ccccc3N(CC(=O)c3ccccc3C)C2=O)c1	CCK receptor antagonist	CCKBR
YO-01027	11454028	BRD-K04622161	C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@H]1c2ccccc2-c2ccccc2N(C)C1=O	gamma secretase inhibitor	
yoda-1	2746822	BRD-K88570498	Clc1cccc(Cl)c1CSc1nnc(s1)-c1cnccn1	piezo channel activator	PIEZO1
yohimbine	8969	BRD-K35586044	COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12	adrenergic receptor antagonist	ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|KCNJ1|KCNJ10|KCNJ11|KCNJ12|KCNJ14|KCNJ15|KCNJ8
YS-035	5714	BRD-K06208435	COc1ccc(CCN(C)CCc2ccc(OC)c(OC)c2)cc1OC	calcium channel blocker	
YZ9	5289613	BRD-K53438416	CCOC(=O)c1cc2ccc(O)cc2oc1=O	phosphofructokinase inhibitor	MIF|PFKFB3
Y16	989521	BRD-K81865756	Cc1cccc(COc2cccc(\C=C3/C(=O)NN(C3=O)c3ccccc3)c2)c1	rho associated kinase inhibitor	RHOA
zacopride	108182	BRD-A65615053	COc1cc(N)c(Cl)cc1C(=O)NC1CN2CCC1CC2	serotonin receptor antagonist	HTR3A|HTR3B|HTR4|HTR5A
zafirlukast	5717	BRD-K71289571	COc1cc(ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12)C(=O)NS(=O)(=O)c1ccccc1C	leukotriene receptor antagonist	CYSLTR1|CYSLTR2
zalcitabine	24066	BRD-K85925969	Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1	nucleoside reverse transcriptase inhibitor	
zaldaride	65909	BRD-A26032986	CC1(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)OCc2ccccc2-n2cccc12	calmodulin antagonist	CALM1
zaleplon	5719	BRD-K92657060	CCN(C(C)=O)c1cccc(c1)-c1ccnc2c(cnn12)C#N	benzodiazepine receptor agonist	GABRA1|GABRB1|GABRG2|TSPO
zaltidine	56051	BRD-K12261274	Cc1ncc([nH]1)-c1csc(NC(N)=N)n1	histamine receptor antagonist	HRH2
zaltoprofen	5720	BRD-A00578795	CC(C(O)=O)c1ccc2Sc3ccccc3C(=O)Cc2c1	cyclooxygenase inhibitor	
ZAMI-633	75743	BRD-K11984358	CCC(=O)NO	urease inhibitor	
zamifenacin	3086618	BRD-K80451230	C(Cc1ccc2OCOc2c1)N1CCC[C@H](C1)OC(c1ccccc1)c1ccccc1	acetylcholine receptor antagonist	CHRM3
zanamivir	60855	BRD-K23067689	CC(=O)N[C@@H]1[C@@H](NC(N)=N)C=C(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O	neuraminidase inhibitor	NEU2
ZAPA	6604703	BRD-K44825564	NC(=N)S\C=C/C(O)=O		
zaprinast	5722	BRD-K16542329	CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1	phosphodiesterase inhibitor	GPR35|PDE1A|PDE4D|PDE5A|PDE9A
zardaverine	5723	BRD-K37561857	COc1cc(ccc1OC(F)F)-c1ccc(=O)[nH]n1	phosphodiesterase inhibitor	PDE4D
zatebradine	65637	BRD-K92446736	COc1ccc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1OC	HCN channel blocker	HCN1|HCN2|HCN3|HCN4
ZCL-278	1791111	BRD-K22829793	Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)COc3ccc(Br)cc3Cl)cc2)n1	CDC inhibitor	CDC42
ZD-2079	158794	BRD-K64157027	O[C@@H](CNCCOc1ccc(CC(O)=O)cc1)c1ccccc1	adrenergic receptor agonist	ADRB3
ZD-7114	121877	BRD-K28971625	COCCNC(=O)COc1ccc(OCCNC[C@H](O)COc2ccccc2)cc1	adrenergic receptor agonist	ADRB3
ZD-7155	4673492	BRD-K11373525	CCc1cc2N(Cc3ccc(cc3)-c3ccccc3-c3nnn[nH]3)C(=O)CCc2c(CC)n1	angiotensin receptor antagonist	AGTR1
ZD-7288	3938007	BRD-K18678457	CCN(c1ccccc1)c1cc(NC)[n+](C)c(C)n1	HCN channel blocker	HCN1|HCN2|HCN3|HCN4
zeatin	449093	BRD-K90033078	C\C(CO)=C/CNc1[nH]cnc2ncnc12		
zebularine	100016	BRD-K87714311	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cccnc1=O	DNA methyltransferase inhibitor	CDA|DNMT1
zibotentan	9910224	BRD-K31553034	COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(cc1)-c1nnco1	endothelin receptor antagonist	EDNRA
zidovudine	35370	BRD-K72903603	Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O	nucleoside reverse transcriptase inhibitor	TERT
zileuton	60490	BRD-A56359832	CC(N(O)C(N)=O)c1cc2ccccc2s1	leukotriene synthesis inhibitor; lipoxygenase inhibitor	ALOX5
zilpaterol	25218684	BRD-K42816473	CC(C)N[C@H]1CCn2c(O)nc3cccc([C@@H]1O)c23	adrenergic receptor agonist	ADRB2
zimelidine	5365247	BRD-K46914825	CN(C)C\C=C(\c1ccc(Br)cc1)c1cccnc1	selective serotonin reuptake inhibitor (SSRI)	MAOA|MAOB|SLC6A4
zinc-undecylenate	11179	BRD-K13330768	C=CCCCCCCCCC(=O)O[Zn]OC(=O)CCCCCCCCC=C	other antifungal	
zindotrine	41856	BRD-K26598477	Cc1cc(nn2cnnc12)N1CCCCC1	phosphodiesterase inhibitor	
ziprasidone	60854	BRD-K29582115	Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12	dopamine receptor antagonist; serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4
ZK-164015	9806489	BRD-K05151076	CCCCCS(=O)(=O)CCCCCCCCCCn1c(c(C)c2cc(O)ccc12)-c1ccc(O)cc1	estrogen receptor antagonist	ESR1|ESR2
ZK-200775	208953	BRD-K67525671	OP(O)(=O)Cn1c2cc(N3CCOCC3)c(cc2[nH]c(=O)c1=O)C(F)(F)F	kainate receptor antagonist	
ZK-93423	121926	BRD-K33882852	CCOC(=O)c1ncc2[nH]c3ccc(OCc4ccccc4)cc3c2c1COC	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2
ZK-93426	115210	BRD-K68392338	CCOC(=O)c1ncc2[nH]c3cccc(OC(C)C)c3c2c1C	benzodiazepine receptor antagonist	GABRA1|GABRA2|GABRA3|GABRA5
ZK811752	512282	BRD-K91825936	C[C@@H]1CN(Cc2ccc(F)cc2)CCN1C(=O)COc1ccc(Cl)cc1NC(N)=O	CC chemokine receptor antagonist	CCR1
ZLN-024	1825716	BRD-K64103579	Cc1ccc(OCCSc2ncccn2)c(Br)c1	AMPK activator	PRKAA1|PRKAB1|PRKAG1
ZLN005	899323	BRD-K73073971	CC(C)(C)c1ccc(cc1)-c1nc2ccccc2[nH]1		
ZM-226600	5240098	BRD-A62209527	CC(O)(C(=O)Nc1ccc(cc1)S(=O)(=O)c1ccccc1)C(F)(F)F	Kir6 channel (KATP) activator	
ZM-241385	176407	BRD-K19605405	Nc1nc(NCCc2ccc(O)cc2)nc2nc(nn12)-c1ccco1	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
ZM-306416	5329006	BRD-K41337261	COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC	Abl kinase inhibitor; src inhibitor; VEGFR inhibitor	EGFR|FLT1|FLT4|KDR
ZM-323881	16759369	BRD-K67831364	Cc1cc(F)c(Nc2ncnc3cc(OCc4ccccc4)ccc23)cc1O	VEGFR inhibitor	KDR
ZM-336372	5730	BRD-K73789395	CN(C)c1cccc(c1)C(=O)Nc1ccc(C)c(NC(=O)c2ccc(O)cc2)c1	RAF inhibitor	BRAF|LCK|MAPK14|RAF1
ZM-39923	3797	BRD-K40624912	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1	JAK inhibitor	JAK1|JAK3
ZM-447439	9914412	BRD-K72703948	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1	Aurora kinase inhibitor	AURKA|AURKB
zofenopril-calcium	92400	BRD-K46654563	C[C@H](CSC(=O)c1ccccc1)C(=O)N1C[C@H](C[C@H]1C(O)=O)Sc1ccccc1	angiotensin converting enzyme inhibitor	ACE
zolantidine	91769	BRD-K08996725	C(CNc1nc2ccccc2s1)COc1cccc(CN2CCCCC2)c1	histamine receptor antagonist	
zoledronic-acid	68740	BRD-K84253429	OC(Cn1ccnc1)(P(O)(O)=O)P(O)(O)=O	bone resorption inhibitor	FDPS|GGPS1
zolimidine	14652	BRD-K45125084	CS(=O)(=O)c1ccc(cc1)-c1cn2ccccc2n1	mucus protecting agent	
zolmitriptan	60857	BRD-K54314721	CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F
zolpidem	5732	BRD-K44876623	CN(C)C(=O)Cc1c(nc2ccc(C)cn12)-c1ccc(C)cc1	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3
zomepirac	5733	BRD-K81326768	Cc1cc(CC(O)=O)n(C)c1C(=O)c1ccc(Cl)cc1	prostaglandin synthesis inhibitor	PTGDR2
zometapine		BRD-K14571191	Cc1nn(C)c2NCCN=C(c12)c1cccc(Cl)c1		
zoniporide	6433110	BRD-K43992824	NC(N)=NC(=O)c1cnn(c1C1CC1)-c1cccc2ncccc12	sodium/hydrogen exchanger inhibitor	SLC9A1
zonisamide	11967800	BRD-K48300629	NS(=O)(=O)Cc1noc2ccccc12	sodium channel blocker; T-type calcium channel blocker	CA1|CA10|CA11|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA8|CA9|CACNA1G|CACNA1H|CACNA1I|MAOA|MAOB|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A
zopolrestat		BRD-K84459715	OC(=O)C=C1NN(Cc2nc3cc(ccc3s2)C(F)(F)F)C(=O)c2ccccc12		
zosuquidar		BRD-K70557564	O[C@@H](COc1cccc2ncccc12)CN1CCN(CC1)[C@@H]1c2ccccc2[C@@H]2[C@H](c3ccccc13)C2(F)F	P glycoprotein inhibitor	ABCB1|ABCB4
zotarolimus	9876378	BRD-K46843573	CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@@H]1n1cnnn1	mTOR inhibitor	FKBP1A
zotepine	5736	BRD-K64557645	CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc12	dopamine receptor antagonist; serotonin receptor antagonist	ADRA2B|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR6|HTR7|SLC6A2|SLC6A4
zoxazolamine	6103	BRD-K66353228	Nc1nc2cc(Cl)ccc2o1	myorelaxant	
ZSTK-474	11647372	BRD-K63068307	FC(F)c1nc2ccccc2n1-c1nc(nc(n1)N1CCOCC1)N1CCOCC1	PI3K inhibitor	PIK3CB|PIK3CD|PIK3CG
zuclopenthixol	5311507	BRD-K28761384	OCCN1CCN(CC\C=C2\c3ccccc3Sc3ccc(Cl)cc23)CC1	dopamine receptor antagonist	ADRA1A|ADRA2A|DRD1|DRD2|DRD5|HRH1|HTR2A
Z160	4988454	BRD-K16037980	O=C(CC(c1ccccc1)c1ccccc1)N1CCN(CC1)C(c1ccccc1)c1ccccc1	N-type calcium channel blocker	CACNA2D1
1,12-Besm	4283	BRD-K04603573	CCNCCCNCCCCNCCCNCC	polyamine biosynthesis inhibitor	
1,2,3,4,5,6-hexabromocyclohexane	74603	BRD-K06817181	BrC1C(Br)C(Br)C(Br)C(Br)C1Br	JAK inhibitor	JAK2
1,3-dipropyl-8-phenylxanthine	128784	BRD-K41853443	CCCn1c2[nH]c(nc2c(=O)n(CCC)c1=O)-c1ccccc1	adenosine receptor antagonist	
1,4-butanediol	8064	BRD-K22346679	OCCCCO	benzodiazepine receptor agonist; gamma hydroxybutyric acid agonist	MAN1B1|PLA2G2A|PLA2G2E
1,5-dicaffeoylquinic-acid	6474640	BRD-K53083666	O[C@@H]1C[C@@](C[C@@H](OC(=O)\C=C\c2ccc(O)c(O)c2)[C@@H]1O)(OC(=O)\C=C\c1ccc(O)c(O)c1)C(O)=O		
1-((Z)-3-Chloroallyl)-1,3,5,7-tetraazaadamantan-1-ium	5846454	BRD-K88956297	Cl\C=C/C[N+]12CN3CN(CN(C3)C1)C2		
1-(1,2-Diphenylethyl)piperidine-(+/-)	206666	BRD-A86415025	C(C(N1CCCCC1)c1ccccc1)c1ccccc1	glutamate receptor antagonist	
1-(2-chloro-5-methylphenoxy)-3-(isopropylamino)-2-propanol	20497006	BRD-A95802703	CC(C)NCC(O)COc1cc(C)ccc1Cl		
1-acetyl-4-methylpiperazine	550758	BRD-K96055017	CN1CCN(CC1)C(C)=O	acetylcholine receptor agonist	
1-azakenpaullone	6538897	BRD-K03273112	Brc1ccc2[nH]c-3c(CC(=O)Nc4cccnc-34)c2c1	glycogen synthase kinase inhibitor	CCNB1|CDK1|CDK5|GSK3B
1-deoxymannojirimycin	72258	BRD-K89665618	OC[C@H]1NC[C@@H](O)[C@@H](O)[C@@H]1O	alpha mannosidase inhibitor	MAN2A1
1-EBIO	82320	BRD-K70586315	CCn1c2ccccc2[nH]c1=O	potassium channel activator	KCNN1|KCNN2|KCNN3|KCNN4
1-ethyl-2-pyrrolidone	17595	BRD-K08288352	CCN1CCCC1=O	transdermal absorption-enhancing compound	
1-hexadecanal	984	BRD-K35114608	CCCCCCCCCCCCCCCC=O	sphingosine 1 phosphate receptor substrate	DBI|RHO
1-hexadecanol	2682	BRD-K37203094	CCCCCCCCCCCCCCCCO		
1-naphthyl-PP1	4877	BRD-K29542628	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc12	src inhibitor	SRC
1-octacosanol	68406	BRD-K03083257	CCCCCCCCCCCCCCCCCCCCCCCCCCCCO		
1-octanol	957	BRD-K09338665	CCCCCCCCO		GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1
1-phenylbiguanide	4780	BRD-K31491153	NC(=N)NC(=N)Nc1ccccc1	serotonin receptor agonist	HTR3A|HTR3B
1E-1-(2-hydroxy-5-methylphenyl)-1-dodecanone oxime	54108714	BRD-A37752546	CCCCCCCCCCCC([N+][O-])c1cc(C)ccc1O		
1s,2r-phenylpropanolamine	26934	BRD-K27853494	C[C@@H](N)[C@@H](O)c1ccccc1	adrenergic receptor agonist	ADRA1A|ADRA2A|ADRB1|ADRB2|DRD1
10-deacetylbaccatin	154272	BRD-K96631475	CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](O)C(C)=C([C@@H](O)C1=O)C2(C)C	antitumor agent	
10-DEBC	10521421	BRD-K70792160	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc12	AKT inhibitor	PIM1
10-hydroxycamptothecin	97226	BRD-K63784565	CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)cc4cc3Cn1c2=O	topoisomerase inhibitor	TOP1
10058-F4	1271002	BRD-K49460120	CCc1ccc(cc1)\C=C1\SC(=S)NC1=O	c-Myc inhibitor	
12-O-tetradecanoylphorbol-13-acetate	27924	BRD-K68552125	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@]2(O)[C@@H]3C=C(C)C(=O)[C@@]3(O)CC(CO)=C[C@H]2[C@@H]2C(C)(C)[C@]12OC(C)=O	PKC activator	KCNT2|TRPV4
1400W	1433	BRD-K30237152	CC(=N)NCc1cccc(CN)c1	nitric oxide synthase inhibitor	NOS1|NOS2|NOS3
16,16-dimethylprostaglandin-e2	5283066	BRD-K92301463	CCCCC(C)(C)[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O	prostanoid receptor agonist	HPGD
17-alpha-methyltestosterone	6010	BRD-K84036904	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	aromatase inhibitor	AR
17-hydroxyprogesterone-caproate	5702072	BRD-A29731977	CCCCCC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C)C(C)=O	progesterone receptor agonist	AR|ESR1|ESR2|NR1H4|NR1I2|NR3C1|PGR
17-PA	25068278	BRD-K07395323	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@]34C)[C@@H]1CC=C2c1ccccc1	glucocorticoid receptor agonist	
2'-c-methylguanosine	500901	BRD-K78092779	C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(O)nc(N)nc12	HCV inhibitor	
2'-MeCCPA	10475082	BRD-K63932022	C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(NC3CCCC3)nc(Cl)nc12	adenosine receptor agonist	ADORA1
2,3-cis/exo-camphanediol	11768995	BRD-K44602126	CC1(C)[C@@H]2CC[C@@]1(C)[C@H](O)[C@@H]2O		
2,3-cis/exo-pinanediol	12518181	BRD-A75263867	CC1(C)C2CC1[C@](C)(O)[C@H](O)C2		
2,3-DCPE	2250975	BRD-K61734568	OCCNCCCOc1cccc(Cl)c1Cl	Bcl-XL downregulator	BCL2L1
2,4-dinitrochlorobenzene	6	BRD-K97833335	[O-][N+](=O)c1ccc(Cl)c(c1)[N+]([O-])=O	thioredoxin inhibitor	TXN
2,4-dinitrophenol	1493	BRD-K21910317	Oc1ccc(cc1[N+]([O-])=O)[N+]([O-])=O	ATP synthase inhibitor	APP
2,5-furandimethanol	74663	BRD-K29791386	OCc1ccc(CO)o1	hemoglobin modulator	HBB
2,6-dimethylpiperidine	68843	BRD-A21276153	CC1CCCC(C)N1		
2-(chloromethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one		BRD-K46989997	ClC=C1Nc2sc3CCCCc3c2C(=O)N1		
2-(3-mercaptopropyl)pentanedioic acid	10198171	BRD-A66788520	OC(=O)CCC(CCCS)C(O)=O	glutamate carboxypeptidase inhibitor	FOLH1
2-[1-(4-piperonyl)piperazinyl]benzothiazole	127902	BRD-K91868854	C(N1CCN(CC1)c1nc2ccccc2s1)c1ccc2OCOc2c1	serotonin receptor agonist	HTR4
2-aminobenzenesulfonamide	72894	BRD-K32681104	Nc1ccccc1S(N)(=O)=O	carbonic anhydrase inhibitor	CA12|CA14|CA2|CA6|CA9
2-APB	1598	BRD-K13346085	NCCOB(c1ccccc1)c1ccccc1	1,4,5-trisphosphate inhibitor	TRPC1|TRPC3|TRPC4|TRPC5|TRPC6|TRPC7|TRPM2|TRPM3|TRPM6|TRPV1|TRPV6
2-BFI	3080926	BRD-K22745370	C1CN=C(N1)c1cc2ccccc2o1	imidazoline receptor ligand	ADRA2A|ADRA2B|ADRA2C|MAOA|MAOB
2-chloro-N6-cyclopentyladenosine	123807	BRD-K70088346	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NC3CCCC3)nc(Cl)nc12	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3
2-chloroadenosine	8974	BRD-K79511609	Nc1nc(Cl)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B
2-Chloropyrazine	73277	BRD-K84075000	Clc1cnccn1		
2-CMDO	32224	BRD-K92588747	CN1CCN(CC1)C1=Cc2ccccc2Oc2ccc(Cl)cc12	dopamine receptor antagonist	DRD2|DRD4
2-cyanopyrimidine	2757979	BRD-K95015809	N#Cc1ncccn1	cathepsin inhibitor	
2-Deoxy-2-{[methyl(nitroso)carbamoyl]amino}hexose	5299	BRD-A55902763	CN([N+][O-])C(=O)NC(C=O)C(O)C(O)C(O)CO		
2-deoxyglucose	9062	BRD-K97808269	OC[C@H]1O[C@H](O)C[C@@H](O)[C@@H]1O	glycolysis inhibitor	SLC2A1|SLC2A2|SLC2A3|SLC2A4
2-ethoxybenzoic-acid	67252	BRD-K04843302	CCOc1ccccc1C(O)=O	analgesic agent	
2-ethyl-1,3-hexanediol	7211	BRD-A55455283	CCCC(O)C(CC)CO		
2-fluoro-2-deoxy-D-galactose	315411	BRD-A53037300	OCC1OC(O)C(F)C(O)C1O		LCT
2-hydroxy-4-((E)-3-(4-hydroxyphenyl)acryloyl)-2-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)cyclohexane-1,3,5-trione		BRD-A52169337	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1C(=O)C(C(=O)\C=C\c2ccc(O)cc2)C(=O)C(O)([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C1=O		
2-hydroxyethyl-salicylate	6880	BRD-K41866823	OCCOC(=O)c1ccccc1O		
2-hydroxyflutamide	91649	BRD-K82027074	CC(C)(O)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+]([O-])=O	androgen receptor antagonist	AR
2-hydroxysaclofen	1564	BRD-A27924917	NCC(O)(CS(O)(=O)=O)c1ccc(Cl)cc1	GABA receptor antagonist	GABBR1|GABBR2
2-iminobiotin	128878	BRD-K07954936	OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=N)N[C@H]12	nitric oxide synthase inhibitor	NOS1|NOS2
2-iodohippuric-acid	8614	BRD-K56634222	OC(=O)CNC(=O)c1ccccc1I		
2-iodomelatonin	115348	BRD-K25649279	COc1ccc2[nH]c(I)c(CCNC(C)=O)c2c1	melatonin receptor agonist	MTNR1A|MTNR1B|NQO2
2-methoxyestradiol	66414	BRD-K44408410	COc1cc2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCc2cc1O	hypoxia inducible factor inhibitor	COMT|CYP19A1|CYP1A1|CYP1B1|HIF1A|TUBB
2-methyl-5-hydroxytryptamine	1574	BRD-K64137799	Cc1[nH]c2ccc(O)cc2c1CCN	serotonin receptor agonist	HTR1B|HTR1D|HTR1E|HTR1F|HTR3A|HTR3B|HTR6
2-methyl-5-nitrophenol	93576	BRD-K22327730	Cc1ccc(cc1O)[N+]([O-])=O		
2-methylimidazole	12749	BRD-K68534611	Cc1ncc[nH]1	cholesterol inhibitor	
2-octyldodecan-1-ol	21414	BRD-A51407134	CCCCCCCCCCC(CO)CCCCCCCC		
2-Oleoylglycerol	5319879	BRD-K77087341	CCCCCCCC\C=C/CCCCCCCC(=O)OC(CO)CO	glucose dependent insulinotropic receptor ligand	GPR119
2-oxoglutaric-acid	51	BRD-K89712525	OC(=O)CCC(=O)C(O)=O		OXGR1
2-oxopropanoate	1060	BRD-K86587225	CC(=O)C(O)=O	pyruvate dehydrogenase kinase inhibitor	ABAT|AGXT2|PC|PDHB|PKLR|PKM|SLC16A1|SLC16A2|SLC16A3|SLC16A4|SLC16A5|SLC16A6|SLC16A7|SLC16A8
2-phenylmelatonin	4018512	BRD-K41869275	COc1ccc2[nH]c(c(CCNC(C)=O)c2c1)-c1ccccc1	melatonin receptor agonist	MTNR1A|MTNR1B
2-PMDQ	6081682	BRD-A04661934	O=C1Nc2ccccc2C2=NC(CN3CCN(CC3)c3ccccc3)CN12	adrenergic receptor antagonist	ADRA1A
2-pyridylethylamine	75919	BRD-K17874705	NCCc1ccccn1	histamine receptor agonist	HRH1
2-TEDC	6069552	BRD-K89072800	Oc1ccc(\C=C(/C#N)C(=O)OCCc2cccs2)cc1O	lipoxygenase inhibitor	ALOX12
2-thiouracil	1269845	BRD-K58819470	Oc1ccnc(S)n1		
20-hydroxyecdysone	25749233	BRD-K28343777	CC(C)(O)CC[C@@H](O)[C@](C)(O)[C@@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@@H]3CC[C@]12C	ecdysone receptor modulator	
3'-fluorobenzylspiperone	3248000	BRD-K45662124	Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CN(Cc1cccc(F)c1)C2=O)c1ccccc1	dopamine receptor ligand	DRD2
3,3'-dichlorobenzaldazine	6861557	BRD-K82903013	Clc1cccc(c1)\C=N\N=C\c1cccc(Cl)c1	glutamate receptor allosteric ligand	GRM5
3,3'-diindolylmethane	3071	BRD-K37846922	C(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12	CHK inhibitor; cytochrome P450 activator; indoleamine 2,3-dioxygenase inhibitor	AR|HIF1A|IFNG|PI3
3,4-DCPG-(+/-)	3313698	BRD-A49947412	NC(C(O)=O)c1ccc(C(O)=O)c(c1)C(O)=O	glutamate receptor agonist	GRM8
3,4-DCPG-(R)	6604849	BRD-K06204668	N[C@@H](C(O)=O)c1ccc(C(O)=O)c(c1)C(O)=O	glutamate receptor antagonist	
3,4-DCPG-(S)	16062593	BRD-K86305586	N[C@H](C(O)=O)c1ccc(C(O)=O)c(c1)C(O)=O	glutamate receptor agonist	GRM8
3,5-DHPG-(S)	443586	BRD-K57796080	N[C@H](C(O)=O)c1cc(O)cc(O)c1	glutamate receptor agonist	GRM1
3-(4-methylbenzylidene)camphor	6440721	BRD-A55464252	Cc1ccc(cc1)\C=C1\C2CCC(C)(C1=O)C2(C)C	endocrine disruptor	
3-alpha-bis-(4-fluorophenyl)-methoxytropane	3929516	BRD-A85216385	CN1C2CCC1CC(C2)OC(c1ccc(F)cc1)c1ccc(F)cc1	dopamine uptake inhibitor	CHRM1|SLC6A2|SLC6A3|SLC6A4
3-alpha-Hydroxy-5-beta-androstan-17-one	6420080	BRD-A43598550	C[C@]12CCC3[C@@H](CC[C@@H]4C[C@H](O)CC[C@]34C)[C@@H]1CCC2=O		
3-amino-benzamide	1645	BRD-K08703257	NC(=O)c1cccc(N)c1	PARP inhibitor	PARP1
3-anilinopropan-1-ol	410467	BRD-K49721826	OCCCNc1ccccc1		
3-AQC	3073499	BRD-K38370968	C=CCN1CCN(CC1)c1nc2ccccc2nc1C#N	serotonin receptor agonist	HTR3A
3-bromo-7-nitroindazole	1649	BRD-K24689407	[O-][N+](=O)c1cccc2c(Br)n[nH]c12	nitric oxide synthase inhibitor	NOS1|NOS2|NOS3
3-bromocamphor	6438	BRD-A62841832	CC1(C)C2CCC1(C)C(=O)C2Br		
3-bromopyruvate	70684	BRD-K92980438	OC(=O)C(=O)CBr	hexokinase inhibitor	HK2
3-carboxy-4-hydroxyphenylglycine-(R)	6604713	BRD-K76592088	N[C@@H](C(O)=O)c1ccc(O)c(c1)C(O)=O	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B|GRIN2C
3-carboxy-4-hydroxyphenylglycine-(S)	5311460	BRD-K61585876	N[C@H](C(O)=O)c1ccc(O)c(c1)C(O)=O	glutamate receptor antagonist	GRM1|GRM5
3-CPMT	1687	BRD-A51713165	CN1C2CCC1CC(C2)OC(c1ccccc1)c1ccc(Cl)cc1	dopamine reuptake inhibitor	
3-deazaadenosine	44386188	BRD-A79431551	Nc1nccc2n(cnc12)[C@@H]1O[C@H](CO)C(O)C1O	adenosylhomocysteinase inhibitor	AHCY
3-deazaneplanocin-A	73087	BRD-K77791657	Nc1nccc2n(cnc12)[C@@H]1C=C(CO)[C@@H](O)[C@H]1O	histone lysine methyltransferase inhibitor	EZH2
3-deazauridine	277822	BRD-A26105646	OCC1OC(C(O)C1O)N1C=CC(=O)CC1=O	cytidine deaminase inhibitor	
3-hydroxy-3-phenylpentanamide	64814	BRD-A66143912	CCC(O)(CC(N)=O)c1ccccc1	GABA receptor modulator	
3-indolebutyric-acid	8617	BRD-K43187796	OC(=O)CCCc1c[nH]c2ccccc12		B2M|HLA-A|TRAC|TRBC1
3-MATIDA	10398360	BRD-A87125127	Cc1cc(sc1C(N)C(O)=O)C(O)=O		GRM1
3-methyl-GABA	3539719	BRD-A62890442	CC(CN)CC(O)=O	GABA aminotransferase activator	ABAT
3-methyladenine		BRD-K81647657	Cn1cnc(=N)c2nc[nH]c12	PI3K inhibitor	PI3
3-MPPI	4013695	BRD-K62581435	COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c4ccccc4[nH]c3c2=O)CC1	adrenergic receptor ligand	ADRA1A
3PO	5720233	BRD-K58413118	O=C(\C=C\c1cccnc1)c1ccncc1	phosphofructokinase inhibitor	PFKFB3
4,4'-DDT	3036	BRD-K51799616	Clc1ccc(cc1)C(c1ccc(Cl)cc1)C(Cl)(Cl)Cl		
4,4-pentamethylenepiperidine	417412	BRD-K49545903	C1CCC2(CC1)CCNCC2	M2 channel blocker	
4,5,6,7-tetrabromobenzotriazole	1694	BRD-K97118047	Brc1c(Br)c(Br)c2[nH]nnc2c1Br	casein kinase inhibitor	AKT1|CHEK1|CSNK2A1|GSK3B|LCK|MAP2K1|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SGK1
4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine	5234410	BRD-K47337578	Fc1ccc(cc1)C(=O)C1CCN(CCCCc2ccccc2)CC1	serotonin receptor antagonist	HTR2A
4-acetyl-1,1-dimethylpiperazinium	4392675	BRD-K97019106	CC(=O)N1CC[N+](C)(C)CC1	acetylcholine receptor agonist	
4-aminohippuric-acid	2148	BRD-K65544384	Nc1ccc(cc1)C(=O)NCC(O)=O		SLC22A6
4-carboxy-3-hydroxyphenylglycine-(RS)	1297	BRD-A80383043	NC(C(O)=O)c1ccc(C(O)=O)c(O)c1	glutamate receptor agonist; glutamate receptor antagonist	GRM1
4-carboxy-3-hydroxyphenylglycine-(S)	5311455	BRD-K74133873	N[C@H](C(O)=O)c1ccc(C(O)=O)c(O)c1	glutamate receptor agonist; glutamate receptor antagonist	GRM1|GRM2
4-chlorophenylguanidine	2757788	BRD-K39160765	NC(=N)Nc1ccc(Cl)cc1	urokinase inhibitor	PLAUR
4-CMTB	4307629	BRD-A54139254	CC(C)C(C(=O)Nc1nccs1)c1ccc(Cl)cc1	free fatty acid receptor agonist	FFAR2
4-DAMP	1734	BRD-K29313239	C[N+]1(C)CCC(CC1)OC(=O)C(c1ccccc1)c1ccccc1	cholinergic receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
4-galactosyllactose	10874809	BRD-A32796301	OC[C@H]1O[C@@H](O[C@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](CO)OC(O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O		AMY2B
4-HQN	63112	BRD-K91758890	Oc1ncnc2ccccc12	PARP inhibitor	PARP1
4-hydroxy-phenazone	98889	BRD-K49759007	Cc1c(O)c(=O)n(-c2ccccc2)n1C		
4-IBP	132995	BRD-K62537556	Ic1ccc(cc1)C(=O)NC1CCN(Cc2ccccc2)CC1	sigma receptor agonist	SIGMAR1
4-iodo-L-phenylalanine	2733279	BRD-K66664625	N[C@H](Cc1ccc(I)cc1)C(O)=O		DPP4
4-iodo-6-phenylpyrimidine	817368	BRD-K25690923	Ic1cc(ncn1)-c1ccccc1	macrophage migration inhibiting factor inhibitor	MIF
4-methylgenistein	5280373	BRD-K73303757	COc1ccc(cc1)-c1coc2cc(O)cc(O)c2c1=O	protein tyrosine kinase inhibitor	CYP19A1|ESRRA|ESRRB|ESRRG|FASN
4-methylhistamine	37463	BRD-K70821460	Cc1nc[nH]c1CCN	histamine receptor agonist	HRH4
4-mu-8C	12934390	BRD-K81316007	Cc1cc(=O)oc2c(C=O)c(O)ccc12	IRE1 inhibitor	ERN1
4-P-PDOT	3976006	BRD-A67482312	CCC(=O)NC1CC(c2ccccc2)c2ccccc2C1	melatonin receptor antagonist	MTNR1A|MTNR1B
4-phenolsulfonic-acid	4765	BRD-K41024817	Oc1ccc(cc1)S(O)(=O)=O		
4-phenyl-1,2,3,4-tetrahydroisoquinoline	12999296	BRD-M10474530	Cl.C1NCc2ccccc2C1c1ccccc1	dopamine release inhibitor	
4-PPBP	3035672	BRD-K78061844	C(CCc1ccccc1)CN1CCC(CC1)c1ccccc1	sigma receptor ligand	SIGMAR1
4-propylbenzoic-acid	137601	BRD-K42108215	CCCc1ccc(cc1)C(O)=O		
4-pyrimidinecarbonitrile	10313094	BRD-K04552268	N#Cc1ccncn1		
4-tert-butylphenol	7393	BRD-K06338106	CC(C)(C)c1ccc(O)cc1		
4BP-TQS	2857838	BRD-A18598741	NS(=O)(=O)c1ccc2NC(C3CC=CC3c2c1)c1ccc(Br)cc1	nicotinic receptor agonist	CHRNA7
4EGI-1	5717952	BRD-K52366702	OC(=O)C(\Cc1ccccc1[N+]([O-])=O)=N\Nc1nc(cs1)-c1ccc(Cl)c(Cl)c1	protein synthesis inhibitor	EIF4E
4E1RCat	16195554	BRD-K67173685	OC(=O)c1ccc(cc1)N1C(=O)C(\C=C1c1ccccc1)=C\c1ccc(o1)-c1ccc(cc1)[N+]([O-])=O	protein synthesis inhibitor	EIF4E|EIF4G1
4SC-202	15985904	BRD-K11773281	Cn1cc(cn1)-c1ccc(cc1)S(=O)(=O)n1ccc(\C=C\C(=O)Nc2ccccc2N)c1	HDAC inhibitor	HDAC1
5'-Chloro-5'-deoxy-ENBA-(+/-)	42636897	BRD-A13598753	O[C@@H]1[C@@H](CCl)O[C@H]([C@@H]1O)n1cnc2c(NC3CC4CCC3C4)ncnc12	adenosine receptor agonist	ADORA1
5,7-dichlorokynurenic-acid	1779	BRD-K60287130	OC(=O)c1cc(O)c2c(Cl)cc(Cl)cc2n1	glutamate receptor antagonist	GLRA2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
5,7-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-2H-chromene-3,4-dione	9969271	BRD-A61299447	COc1ccc(cc1)C1Oc2c(CC=C(C)C)c(O)cc(O)c2C(=O)C1=O		
5-(4chlorophenyl)-4-ethyl-2,4-dihydro-3H-1,2,4-triazol-3-one	35793	BRD-K58146797	CCn1c(O)nnc1-c1ccc(Cl)cc1		
5-Amino-3-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	72231	BRD-K87535339	Nc1nc2n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c(=O)sc2c(=O)[nH]1		
5-aminolevulinic-acid	137	BRD-K57631554	NCC(=O)CCC(O)=O	oxidizing agent	ALAD
5-BDBD	9841560	BRD-K33690734	Brc1cccc(c1)C1=NCC(=O)Nc2c1oc1ccccc21	purinergic receptor antagonist	P2RX4
5-carboxamidotryptamine	1809	BRD-K92382976	NCCc1c[nH]c2ccc(cc12)C(N)=O	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
5-fluoro-3-pyridyl-methanol	152449	BRD-K73381198	OCc1cncc(F)c1		
5-fluorouracil	3385	BRD-K24844714	Fc1c[nH]c(=O)[nH]c1=O	thymidylate synthase inhibitor	DPYD|TYMS
5-FP	101498	BRD-K34437622	Oc1ncc(F)cn1	thymidylate synthase inhibitor	TYMS
5-HMF	237332	BRD-K86799112	OCc1ccc(C=O)o1		
5-hydroxyectoine	129010107	BRD-K03871161	O[C@H]1CNC(=C)N[C@@H]1C(O)=O		
5-hydroxymethyl-tolterodine	9819382	BRD-K24603946	CC(C)N(CC[C@H](c1ccccc1)c1cc(CO)ccc1O)C(C)C	acetylcholine receptor antagonist	CHRM3
5-hydroxytryptophan	144	BRD-A73930134	NC(Cc1c[nH]c2ccc(O)cc12)C(O)=O	neurotransmitter	SLC36A1|SLC36A2
5-iodo-A-85380	6604876	BRD-K90065682	Ic1cncc(OC[C@@H]2CCN2)c1	acetylcholine receptor agonist	
5-methylfurmethiodide	4141	BRD-K45437867	Cc1ccc(C[N+](C)(C)C)o1	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4
5-methylhydantoin-(D)	1615267	BRD-K06050544	C[C@H]1NC(=O)NC1=O		
5-methylhydantoin-(L)	6419931	BRD-K56033645	C[C@@H]1NC(=O)NC1=O		
6,_7-dehydro-17-acetoxy-progesterone	200136	BRD-K48329353	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O	steroidal progestin	
6-aminochrysene	17534	BRD-K00656370	Nc1cc2c3ccccc3ccc2c2ccccc12	transferase inhibitor	
6-aminopenicillanic-acid	11082	BRD-K30284967	CC1(C)S[C@@H]2[C@H](N)C(=O)N2[C@H]1C(O)=O		
6-benzylaminopurine	62389	BRD-K62929068	N(Cc1ccccc1)c1ncnc2nc[nH]c12	purinergic receptor activator	
6-chloromelatonin	1858	BRD-K34663752	COc1cc2c(CCNC(C)=O)c[nH]c2cc1Cl	melatonin receptor agonist	MTNR1A|MTNR1B
6-iodo-nordihydrocapsaicin	5149140	BRD-K49236613	CCCCCCCCC(=O)NCc1cc(OC)c(O)cc1I	TRPV antagonist	TRPV1
7,8,9,10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one		BRD-K77756533	O=C1N2CCCCC=C2Nc2ccccc12		
7-aminocephalosporanic-acid	441328	BRD-K65377893	CC(=O)OCC1=C(N2[C@H](SC1)[C@H](N)C2=O)C(O)=O	beta lactamase inhibitor	
7-chlorokynurenic-acid	1884	BRD-K84214706	OC(=O)c1cc(O)c2ccc(Cl)cc2n1	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B|GRIN2C
7-hydroxy-DPAT	1219	BRD-A18795974	CCCN(CCC)C1CCc2ccc(O)cc2C1	dopamine receptor agonist	DRD2|DRD3
7-hydroxy-PIPAT	6305587	BRD-A01295252	CCCN(C\C=C\I)C1CCc2ccc(O)cc2C1	dopamine receptor ligand	DRD3
7-hydroxystaurosporine	3078519	BRD-K45293975	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13	CDK inhibitor; CHK inhibitor; PKC inhibitor	CHEK1|MARK3|PDPK1
7-keto-DHEA	9798229	BRD-K07785030	CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CCC4=O)[C@@H]3C(=O)C=C2C1	steroid	
7-methoxytacrine	119053	BRD-K53156626	COc1ccc2nc3CCCCc3c(N)c2c1	acetylcholinesterase inhibitor	ACHE
7-methylxanthine	68374	BRD-K41592905	Cn1cnc2nc(O)nc(O)c12	adenosine receptor antagonist	
7-nitroindazole	1893	BRD-K04430056	[O-][N+](=O)c1cccc2cn[nH]c12	nitric oxide synthase inhibitor	NOS1|NOS2|NOS3
8-bromo-cAMP	32014	BRD-A09554849	Nc1ncnc2n([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)c(Br)nc12	PKA activator	
8-bromo-cGMP	104767	BRD-A00077618	Nc1nc(O)c2nc(Br)n([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)c2n1	PKA activator	PRKG1
8-hydroxy-DPAT	1220	BRD-A48015106	CCCN(CCC)C1CCc2cccc(O)c2C1	serotonin receptor agonist	CDK1|CHEK1|CHEK2|GSK3B|HTR5A|HTR7|LCK|MAPK14|MARK1|PDPK1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG
8-hydroxy-PIPAT	6142670	BRD-A60594020	CCCN(C\C=C\I)C1CCc2cccc(O)c2C1	dopamine receptor ligand	DRD2|DRD3
8-M-PDOT	5170952	BRD-A07232941	CCC(=O)NC1CCc2cccc(OC)c2C1	melatonin receptor agonist	MTNR1A|MTNR1B
80841-78-7	9855518	BRD-K03044000	Cc1oc(=O)oc1CCl		
9-aminoacridine	7019	BRD-K00535541	Nc1c2ccccc2nc2ccccc12		
9-aminocamptothecin	72402	BRD-K09291936	CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cccc(N)c4cc3Cn1c2=O	topoisomerase inhibitor	TOP1
9-anthracenecarboxylic-acid	2201	BRD-K62607075	OC(=O)c1c2ccccc2cc2ccccc12		ANO1|CLCN1